{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "a4bd7c59",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import spacy\n",
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "b18be1ce",
   "metadata": {},
   "outputs": [],
   "source": [
    "os.chdir('..')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "66ef31bb",
   "metadata": {},
   "outputs": [],
   "source": [
    "BioTech_df = pd.read_csv('E:\\\\Zemoso Personal\\\\NLP_Final\\\\BioTech\\\\Biotech_Corpora.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "dfe485d0",
   "metadata": {},
   "outputs": [],
   "source": [
    "BioTech_df['Articles']=BioTech_df['Articles'].apply(str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "bf4d3e5c",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# Remove punctuation\n",
    "BioTech_df['article_text_processed'] = \\\n",
    "BioTech_df['Articles'].map(lambda x: re.sub('[,\\.!?]', '', x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "7415df7f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Convert the titles to lowercase\n",
    "BioTech_df['article_text_processed'] = \\\n",
    "BioTech_df['article_text_processed'].map(lambda x: x.lower())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "2c003c23",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    with $122m startup idrx intends to stop cancer...\n",
       "1    axcella makes progress against long covid as n...\n",
       "2    abbvie and sosei lead slate of early august r&...\n",
       "3    kaziaâ€™s star asset suffers surprise letdown in...\n",
       "4    aaic: amyloid-beta oligomers an intranasal ant...\n",
       "Name: article_text_processed, dtype: object"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "BioTech_df['article_text_processed'].head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "48f7f4c1",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     C:\\Users\\punee\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "import gensim\n",
    "from gensim.utils import simple_preprocess\n",
    "import nltk\n",
    "nltk.download('stopwords')\n",
    "from nltk.corpus import stopwords"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "dc061a60",
   "metadata": {},
   "outputs": [],
   "source": [
    "stop_words = stopwords.words('english')\n",
    "stop_words.extend(['from', 'subject', 're', 'edu', 'use','said','world','using','ask_hn','show_hn','new','first','high','could','development','company','patient','study','development','diseases','include','disease','cell','development','medicine','year','research','patient','include','disease','study','forward look', 'company','statement','treatment','cell','medicine','development','other','datum','vertex','research','therapy','clinical','mutation','potential','people','year','phase','age'])\n",
    "\n",
    "def sent_to_words(sentences):\n",
    "    for sentence in sentences:\n",
    "        # deacc=True removes punctuations\n",
    "        yield(gensim.utils.simple_preprocess(str(sentence), deacc=True))\n",
    "        \n",
    "def remove_stopwords(texts):\n",
    "    return [[word for word in simple_preprocess(str(doc)) \n",
    "             if word not in stop_words] for doc in texts]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "86f9d10c",
   "metadata": {},
   "outputs": [],
   "source": [
    "data = BioTech_df.article_text_processed.values.tolist()\n",
    "data_words = list(sent_to_words(data))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "83aaddd5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# remove stop words\n",
    "data_words = remove_stopwords(data_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "38f0ebb7",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['startup', 'idrx', 'intends', 'stop', 'cancer', 'mutations', 'tracks']\n"
     ]
    }
   ],
   "source": [
    "print(data_words[:1][0][:30])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "6ca46729",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\punee\\AppData\\Roaming\\Python\\Python39\\site-packages\\spacy\\util.py:275: UserWarning: [W031] Model 'en_core_web_sm' (2.2.0) requires spaCy v2.2 and is incompatible with the current spaCy version (2.3.5). This may lead to unexpected results or runtime errors. To resolve this, download a newer compatible model or retrain your custom model with the current spaCy version. For more details and available updates, run: python -m spacy validate\n",
      "  warnings.warn(warn_msg)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "startup idrx intend stop cancer mutation track\n"
     ]
    }
   ],
   "source": [
    "def lemmatization(texts, allowed_postags=[\"NOUN\", \"ADJ\", \"VERB\", \"ADV\"]):\n",
    "    nlp = spacy.load(\"en_core_web_sm\", disable=[\"parser\", \"ner\"])\n",
    "    texts_out = []\n",
    "    for text in texts:\n",
    "        doc = nlp(text)\n",
    "        new_text = []\n",
    "        for token in doc:\n",
    "            if token.pos_ in allowed_postags:\n",
    "                new_text.append(token.lemma_)\n",
    "        final = \" \".join(new_text)\n",
    "        texts_out.append(final)\n",
    "    return (texts_out)\n",
    "\n",
    "\n",
    "lemmatized_texts = lemmatization(data)\n",
    "print (lemmatized_texts[0][0:90])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "5a8ab291",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['startup', 'idrx', 'intend', 'stop', 'cancer', 'mutation', 'track']\n"
     ]
    }
   ],
   "source": [
    "def gen_words(texts):\n",
    "    final = []\n",
    "    for text in texts:\n",
    "        new = gensim.utils.simple_preprocess(text, deacc=True)\n",
    "        final.append(new)\n",
    "    return (final)\n",
    "\n",
    "data_words = gen_words(lemmatized_texts)\n",
    "\n",
    "print (data_words[0][0:20])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "411ab84e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['startup', 'idrx', 'intend', 'stop', 'cancer', 'mutation', 'track'], ['make', 'progress', 'long_covid', 'new', 'symptom', 'emerge'], ['lead', 'slate', 'early', 'deal'], ['suffer', 'surprise', 'letdown', 'global', 'glioblastoma', 'study'], ['amyloid_beta', 'oligomer', 'intranasal', 'antibody', 'vaccine', 'target', 'tau'], ['psychedelic', 'therapy', 'advance', 'regulator', 'weigh', 'result', 'safety'], ['new', 'direction', 'allarity', 'deem', 'risk', 'monotherapie', 'too', 'high'], ['press', 'play', 'celyad', 'pause', 'beam', 'cancer', 'candidate'], ['organization', 'strategy', 'busy', 'life_science', 'professional'], ['provide', 'program', 'update'], ['repligen', 'report_second_quarter', 'financial', 'result', 'raise', 'full_year_financial_guidance'], ['harmony_bioscience', 'report_second_quarter', 'financial', 'result', 'business', 'update'], ['announce', 'first', 'patient', 'dose', 'avtx', 'pivotal', 'trial', 'ladder', 'treatment', 'leukocyte', 'adhesion', 'pivotal', 'trial', 'result', 'expect'], ['completion', 'capital', 'raise'], ['avidity', 'bioscience', 'enroll', 'patient', 'open_label_extension', 'study'], ['scientific', 'commence', 'sale', 'compuflo', 'epidural', 'system', 'incorporation', 'student', 'register', 'nurse'], ['imagine', 'pharma', 'award', 'contract', 'digestive', 'kidney_disease', 'integrate', 'islet', 'distribution', 'program', 'provide', 'human', 'islet'], ['announce', 'precision', 'phase_study', 'open', 'enrol', 'patient', 'transplant', 'center'], ['cd', 'target', 'antibody', 'clinical_trial', 'report'], ['national', 'awareness', 'month', 'webinar', 'service', 'host', 'benefit', 'immune', 'monitoring'], ['biospace', 'expand', 'executive', 'leadership_team', 'appoint', 'manage', 'editor'], ['announce', 'seed', 'funding'], ['announce', 'new', 'datum', 'presentation', 'ongoing', 'ph', 'clinical_trial', 'program', 'ibezapolstat', 'th', 'biennial'], ['lead', 'manufacturing'], ['bioscience', 'complete_enrollment', 'phase_study', 'treatment', 'diabetic', 'kidney', 'diseasetop', 'line', 'datum', 'subject', 'expect', 'first_quarter'], ['bioimage', 'datum', 'cloud', 'ome', 'ngff', 'support', 'omero', 'omero'], ['therapeutic', 'appoint', 'experience', 'clinical', 'development', 'leader', 'director'], ['appoint', 'executive', 'director'], ['report_second_quarter', 'financial', 'result', 'provide', 'business', 'update'], ['scientific', 'bolster', 'distribution', 'sale', 'capability', 'acquisition', 'nci'], ['report_second_quarter', 'financial', 'operating', 'result'], ['distribute', 'harmony', 'robotic', 'rehabilitation', 'system'], ['forma', 'therapeutic', 'agreement', 'novel', 'mutant', 'idh', 'inhibitor', 'potential', 'treatment', 'relapsed', 'refractory', 'acute', 'myeloid', 'leukemia'], ['announce', 'completion_enrollment', 'summit', 'pivotal', 'phase', 'efficacy', 'trial', 'acute', 'treatment', 'migraine'], ['present', 'datum', 'show', 'blood', 'base', 'biomarker', 'test', 'diagnose', 'predict', 'disease'], ['renovion', 'receive', 'notice', 'study', 'proceed', 'status', 'lung', 'transplant', 'program'], ['west', 'german', 'study', 'group', 'announce', 'new', 'study', 'validate', 'detection', 'minimal', 'residual', 'disease', 'early_stage', 'breast_cancer', 'patient'], ['announce', 'initial', 'outcome', 'mark', 'enable', 'study'], ['receive', 'approval', 'oral', 'testosterone', 'replacement', 'therapy'], ['partner', 'health', 'remote', 'patient', 'monitoring', 'rpm'], ['launch', 'provide', 'broad', 'gene_edit', 'access', 'drug_discovery', 'development'], ['become', 'featured', 'blood', 'purification', 'therapy', 'care', 'critical_care', 'platform'], ['salarius', 'pharmaceutical', 'volitionrx', 'enter', 'collaboration', 'agreement'], ['announce', 'start', 'enrollment', 'colonoscopy', 'study'], ['positive', 'result', 'announce', 'phase', 'imscin', 'study', 'evaluate', 'subcutaneous', 'formulation', 'enhanze', 'advanced', 'non', 'small', 'cell', 'lung', 'cancer'], ['board_director'], ['announce', 'presentation', 'topline', 'result', 'study', 'evaluate', 'vivjoa', 'oteseconazole', 'capsule', 'patient', 'recurrent', 'vulvovaginal', 'candidiasis', 'rvvc', 'annual_meeting'], ['diagnostic', 'laboratory', 'execute', 'new', 'participate', 'provider', 'agreement'], ['announce', 'management', 'structure'], ['report_second_quarter', 'result', 'provide', 'business', 'update'], ['announce', 'new', 'employment', 'inducement', 'grant'], ['anti', 'cd', 'antibody', 'patent', 'grant'], ['bolster', 'team', 'accelerate', 'roll', 'out', 'computationally', 'intelligent', 'technology'], ['announce', 'inducement', 'grant', 'listing', 'rule'], ['twist', 'bioscience', 'highlight', 'paper', 'sizing', 'future', 'datum', 'storage', 'market'], ['receive', 'federal', 'grant', 'drug', 'abuse', 'advance', 'development', 'tnx', 'treatment', 'cocaine_intoxication'], ['announce', 'advance', 'rna', 'therapy', 'oncology'], ['solution', 'announce', 'first', 'patient', 'dose', 'phase_study', 'bat', 'antibody', 'drug', 'conjugate', 'target', 'treatment', 'advanced', 'solid_tumor'], ['appoint', 'blunt', 'board_director'], ['initiate', 'analytical', 'validation', 'pcr', 'base', 'diagnostic', 'test', 'specific', 'monkeypox', 'virus'], ['therapeutic', 'establish', 'collaborative', 'relationship'], ['receive', 'designation', 'treatment', 'small', 'cell', 'lung', 'cancer'], ['vaxxinity', 'anti', 'pcsk', 'candidate', 'demonstrate_durable', 'ldl', 'cholesterol', 'lower', 'non', 'human', 'primate'], ['science', 'award', 'additional', 'patent', 'cloud', 'enable', 'connectivity', 'medical', 'device'], ['announce', 'authorization', 'phase', 'clinical_trial', 'patient', 'recurrent', 'high', 'grade', 'glioma'], ['novel', 'fast', 'typing', 'method', 'develop', 'control', 'monkeypox', 'molecular', 'biology', 'system', 'collaboration', 'umc', 'danish', 'rigshospitalet'], ['join', 'everythingal', 'open', 'innovation', 'consortium', 'set', 'enroll', 'patient', 'phase_study'], ['twist', 'bioscience', 'biotia', 'receive', 'expand', 'emergency', 'use', 'authorization', 'report', 'genetic_variant'], ['report', 'first', 'human', 'use', 'ono', 'retrieval', 'system', 'percutaneous', 'removal', 'intracardiac', 'now', 'removal', 'tumor', 'typically', 'require', 'open', 'heart', 'surgery'], ['seek', 'volunteer', 'phase', 'clinical', 'research', 'study', 'chronic', 'rhinosinusitis'], ['volitionrx', 'limit', 'collaborate', 'develop', 'net', 'target', 'adoptive', 'cell', 'therapy', 'treatment', 'cancer'], ['acquire', 'service', 'broaden', 'offering', 'analysis'], ['announce', 'second_quarter', 'result'], ['appoint', 'director', 'clinical', 'education', 'professional', 'development'], ['disease', 'centre', 'advance', 'novel', 'treatment', 'muscular_dystrophy'], ['announce', 'close', 'series', 'financing'], ['unlimited', 'science', 'announce', 'groundbreake', 'new', 'study', 'observe', 'effect', 'trauma'], ['enter', 'preferred', 'provider', 'agreement', 'river', 'provider', 'network', 'novel', 'dcis', 'test', 'dcisionrt'], ['blueprint', 'report_second_quarter', 'result'], ['announce', 'first', 'patient', 'dose', 'phase', 'clinical_trial', 'diabetic'], ['announce', 'designation', 'grant', 'csf', 'inhibitor', 'treatment', 'idiopathic_pulmonary_fibrosis'], ['announce', 'strategic', 'partnership', 'agreement', 'bone', 'graft', 'solution'], ['announce', 'vaccine', 'trial', 'include', 'needle', 'free', 'delivery'], ['announce', 'first', 'patient', 'save', 'jewel', 'patch', 'cardioverter', 'defibrillator', 'wcd'], ['report_second_quarter', 'financial', 'result', 'provide', 'update', 'key', 'clinical', 'program'], ['laboratory', 'announce', 'second_quarter', 'result'], ['participate', 'pacgrow', 'virtual', 'healthcare', 'conference'], ['enter', 'discovery', 'collaboration', 'license_agreement', 'novel', 'bispecific_antibody'], ['corvel', 'announce', 'revenue', 'earning'], ['announce', 'highly', 'promising', 'result', 'phase', 'placebo_control', 'clinical_trial', 'long_covid'], ['report_second_quarter', 'result'], ['hold', 'second_quarter_financial', 'result', 'conference_call'], ['allarity', 'therapeutic', 'refocus', 'oncology', 'pipeline', 'strategy', 'combination', 'therapy'], ['acquire', 'lead', 'online', 'platform', 'veterinary', 'pharmaceutical'], ['present', 'new', 'clinical', 'datum', 'neurorestore', 'conference', 'aaic'], ['grant', 'new', 'patent', 'cover', 'lytic', 'crispr', 'phage'], ['chromadex', 'report_second_quarter', 'financial', 'result'], ['acurable', 'enter', 'distribution', 'agreement', 'acupebble', 'home', 'sleep', 'test'], ['acquisition'], ['science', 'report', 'fourth_quarter', 'fiscal_year', 'financial', 'result'], ['announce', 'second_quarter_financial', 'result', 'highlight', 'pipeline', 'business', 'progress'], ['subcutaneous', 'formulation', 'demonstrate', 'positive', 'phase', 'result'], ['pharmadrug', 'announce', 'non', 'brokered', 'offering', 'convertible', 'secured', 'debenture', 'issuance', 'common_share'], ['pharming', 'announce', 'new', 'code', 'rare', 'primary'], ['injection', 'system', 'show', 'produce', 'consistently', 'high', 'cell', 'count', 'viability', 'cell', 'therapy', 'injection'], ['present', 'study', 'design', 'upcoming', 'phase', 'disease'], ['idrx', 'launch', 'series', 'financing', 'treat', 'cancer', 'purpose', 'build', 'precision', 'combination', 'therapy'], ['oral', 'contraceptive', 'nominate', 'good', 'pharmaceutical', 'agent'], ['effectively', 'kill', 'cancer', 'cell', 'directly', 'elicit', 'dna', 'damage'], ['participate', 'biotechnology_conference'], ['peptilogic', 'participate', 'musculoskeletal', 'infection', 'society', 'msis', 'nd', 'annual', 'open', 'scientific', 'meeting'], ['participate', 'biotechnology_conference'], ['mink', 'therapeutic', 'participate', 'biotechnology_conference'], ['present'], ['infinity', 'pharmaceutical', 'announce', 'date', 'second_quarter_financial', 'result', 'conference_call_webcast'], ['present', 'virtual', 'conference'], ['recursion', 'participate', 'upcoming', 'investor', 'conference'], ['mindme', 'participate', 'genuity', 'annual', 'growth', 'conference'], ['present', 'annual', 'growth', 'conference'], ['present', 'worldleish', 'conference'], ['announce', 'second_quarter', 'result', 'release', 'date', 'conference_call', 'detail'], ['syro', 'report_second_quarter', 'financial', 'result'], ['participate'], ['syndax', 'announce', 'second_quarter_financial', 'result', 'host_conference_call_webcast'], ['announce', 'second_quarter_financial', 'result'], ['bioscience', 'participate', 'biotechnology_conference'], ['host', 'second_quarter_financial', 'result', 'conference_call'], ['participate'], ['pharmaceutical', 'report_second_quarter', 'financial', 'result'], ['present', 'th', 'annual'], ['pharmaceutical', 'participate'], ['intra', 'cellular', 'therapy', 'host', 'second_quarter_financial', 'result', 'conference_call_webcast'], ['participate', 'panel_discussion'], ['biotechnology', 'report_second_quarter', 'financial'], ['announce', 'second_quarter_financial', 'operating', 'result'], ['announce', 'second_quarter_financial', 'result', 'host_conference_call'], ['bioscience', 'host', 'second_quarter_financial', 'result', 'company', 'update', 'conference_call_webcast'], ['report_second_quarter', 'financial', 'result', 'provide', 'corporate', 'business', 'update'], ['participate', 'btig', 'biotechnology_conference'], ['provide', 'corporate', 'update', 'report_second_quarter', 'financial', 'result'], ['announce', 'second_quarter_financial', 'result', 'provide', 'business', 'highlight'], ['present', 'annual', 'growth', 'conference'], ['therapeutic', 'present'], ['participate_fireside_chat', 'biotechnology_conference'], ['biolife', 'solution', 'report_second_quarter', 'financial', 'result', 'provide', 'business', 'update'], ['report_second_quarter', 'financial', 'result'], ['announce', 'second_quarter', 'operate', 'financial', 'result'], ['atricure', 'report_second_quarter', 'financial', 'result'], ['announce', 'second_quarter_financial', 'result'], ['announce', 'second_quarter', 'result'], ['cytosorbent', 'report_second_quarter', 'financial', 'operational', 'result'], ['announce', 'second_quarter_financial', 'result'], ['announce', 'financial', 'result', 'third_quarter', 'fiscal_year'], ['announce', 'second_quarter_financial', 'result'], ['generation', 'bio', 'present'], ['revance', 'release', 'second_quarter_financial', 'result'], ['pharma', 'report', 'first_quarter', 'financial', 'result'], ['announce', 'publication', 'article', 'bioconjugate', 'chemistry', 'describe', 'extension', 'proprietary', 'technology_platform', 'base', 'bicyclic', 'peptide'], ['present', 'preclinical', 'datum'], ['orasure', 'technology', 'hold', 'second_quarter', 'earning', 'conference_call', 'pm'], ['announce', 'result', 'annual_meeting'], ['report_second_quarter', 'financial', 'result', 'business', 'update'], ['evogene', 'financial', 'result', 'earning', 'announcement', 'schedule', 'second_quarter'], ['participate'], ['spineology', 'announce', 'key', 'leadership', 'appointment', 'welcome', 'new', 'vice_president', 'marketing'], ['nucleai', 'appoint', 'new', 'head', 'pathology', 'support', 'expansion', 'clinical', 'market'], ['oncternal', 'provide', 'business', 'update', 'report_second_quarter', 'financial', 'result'], ['report_second_quarter', 'financial', 'result'], ['report_second_quarter', 'operational', 'financial', 'result'], ['chief_executive_officer', 'ceo'], ['schedule', 'first_quarter', 'conference_call'], ['win', 'funding'], ['lundbeck', 'present', 'phase', 'datum', 'brexpiprazole', 'patient', 'dementia'], ['announce', 'second_quarter_financial', 'result'], ['veterinary', 'market', 'current', 'trend', 'application', 'growth', 'opportunity', 'industry', 'analysis'], ['teleradiology_market', 'rise', 'number', 'radiology', 'image', 'procedure', 'drive', 'market'], ['telemedicine_market', 'rise', 'demand', 'radiological', 'service', 'favor', 'expansion', 'market'], ['plasmon', 'market', 'outlook', 'driver', 'trend', 'geographic', 'analysis'], ['safety_needle', 'market', 'insight', 'size', 'share', 'trend', 'growth', 'global', 'industry', 'analysis'], ['nurse_call_system', 'market', 'drive', 'rise', 'home', 'healthcare', 'nursing', 'home', 'facility'], ['viral_vector_manufacture', 'market', 'increase', 'number', 'gene', 'therapy', 'candidate', 'due', 'rapid', 'development', 'disease', 'drive', 'market'], ['management_solution', 'market', 'trend', 'opportunity', 'driver', 'restraint', 'regional', 'analysis'], ['farm', 'drug', 'market', 'analysis', 'key', 'factor', 'support', 'growth', 'livestock', 'industry', 'all', 'globe'], ['epharmacy', 'market', 'increase', 'popularity', 'prescription', 'technology', 'drive', 'market'], ['congestive_heart', 'failure', 'treatment', 'device', 'market', 'depth', 'analysis'], ['clinical', 'laboratory_service', 'market', 'increase', 'infectious_disease', 'fuel', 'market', 'demand'], ['print_medical', 'application', 'market', 'increase', 'demand', 'customize', 'print', 'accelerate', 'market', 'growth'], ['market', 'competitive_landscape', 'analysis', 'forecast'], ['non_invasive_prenatal_testing', 'market', 'increase', 'demand', 'early', 'non_invasive', 'fetal', 'testing', 'procedure', 'drive', 'market'], ['ptosis', 'market', 'revenue', 'trend', 'company', 'profile', 'revenue', 'share', 'analysis'], ['contusion', 'market', 'size', 'analysis', 'trend', 'recent', 'development', 'forecast'], ['idrx', 'attempt', 'stop', 'cancer', 'mutation', 'start', 'launch', 'oversubscribed', 'series', 'financing'], ['base', 'found', 'clinical_stage', 'firm', 'aim', 'create', 'highly', 'selective', 'aligned', 'drug', 'combination', 'purpose', 'build', 'cancer', 'therapy', 'support', 'prolonged', 'durable', 'response'], ['serial', 'entrepreneur', 'lab', 'incubate', 'idrx', 'premise', 'intelligently', 'design', 'medicine', 'intelligently', 'design', 'combination', 'moniker', 'idrx', 'stand'], ['co_founder', 'tell', 'how', 'intelligently', 'design', 'combination', 'approach', 'prevent', 'escape', 'mutation'], ['many', 'case', 'even', 'hit', 'driver', 'mutation', 'secondary', 'mutation', 'so', 'call', 'escape', 'mutation', 'emerge', 'well', 'could', 'design', 'combination', 'hit', 'just', 'primary', 'driver', 'also', 'hit', 'mutation', 'emerge', 'therapy', 'take', 'goal', 'outset'], ['intention', 'company', 'begin', 'life', 'world', 'impressive', 'pipeline', 'include', 'enhancement', 'small_molecule', 'tyrosine', 'kinase', 'inhibitor', 'acquire', 'license_agreement', 'merck', 'kgaa', 'blueprint', 'medicine', 'deal', 'merck', 'yield', 'idrx', 'already', 'initiate', 'phase', 'first', 'human', 'trial', 'agreement', 'blueprint', 'lead', 'now', 'advance', 'clinic'], ['grant', 'drug', 'designation', 'type', 'sarcoma', 'tract', 'call', 'stromal', 'tumor', 'gist'], ['idrx', 'leverage', 'deep', 'scientific', 'insight', 'tumor', 'biology', 'now', 'available', 'drug', 'engineering', 'capability', 'pioneer', 'novel', 'selective', 'intelligently', 'design', 'combination', 'therapy', 'aim', 'hit', 'driver', 'mutation', 'hard', 'cover', 'escape', 'pathway', 'provide', 'sufficient', 'therapeutic', 'index', 'safety_profile', 'use', 'early', 'line', 'treatment', 'where', 'good', 'potential', 'provide', 'patient', 'durable', 'clinical', 'benefit', 'borisy', 'idrx', 'co_founder', 'say', 'statement'], ['series', 'lead', 'science', 'partner', 'other', 'unnamed', 'investor', 'also', 'contribute', 'substantial', 'financing', 'round'], ['founding', 'leadership_team', 'make', 'industry', 'leader', 'life_science', 'space', 'together', 'involve', 'develop_commercialize', 'approve', 'medication', 'co_founder', 'forrester', 'also', 'serve', 'cxo', 'round', 'co', 'founding', 'team'], ['leadership_team', 'include', 'chief', 'development', 'operation', 'officer', 'chief', 'product', 'development', 'officer', 'desai', 'regulatory', 'affair', 'clinical', 'operation', 'scientific', 'adviser'], ['proud', 'assemble', 'expert', 'team', 'founder', 'leader', 'precision_medicine', 'gist', 'launch', 'clinical_stage', 'company', 'first', 'human', 'study', 'initiate', 'note', 'same', 'announcement', 'goal', 'build', 'combination', 'serve', 'transformative', 'cancer', 'treatment'], ['elaborate', 'approach', 'offer', 'opportunity', 'develop', 'more', 'effective', 'cancer', 'medicine', 'patient', 'intentionally', 'build', 'treatment', 'combination', 'start', 'stromal', 'tumor', 'gist', 'where', 'tumor', 'biology', 'well', 'known', 'same', 'time', 'remain', 'high_unmet', 'medical', 'need'], ['long', 'technical', 'name', 'post', 'acute', 'sequelae', 'infection', 'pasc', 'describe', 'symptom', 'persist', 'least', 'week', 'infection', 'accord', 'recent', 'study', 'people', 'report', 'least', 'persistent', 'symptom', 'month', 'infection', 'qualify', 'long_covid'], ['new', 'research', 'reveal', 'more', 'chronic', 'condition', 'potential', 'avenue', 'treat'], ['experimental', 'improve', 'mental', 'physical', 'fatigue'], ['base', 'report', 'topline', 'result', 'phase', 'trial', 'patient', 'fatigue', 'relate', 'long_covid', 'study', 'patient', 'enrol', 'receive', 'gram', 'day', 'axa', 'match', 'placebo', 'divide', 'dose', 'day', 'week', 'safety', 'follow_up'], ['endpoint', 'include', 'recovery', 'time', 'follow', 'moderate', 'exercise', 'assess', 'magnetic', 'resonance', 'spectroscopy', 'use', 'evaluate', 'mitochondrial', 'function', 'clinically', 'relevant', 'endpoint', 'include', 'self', 'report', 'mental', 'physical', 'fatigue', 'evaluate', 'chalder', 'fatigue', 'questionnaire', 'walk', 'test', 'serum', 'lactate', 'level'], ['patient', 'receive', 'drug', 'improvement', 'measure', 'mental', 'physical', 'fatigue', 'highly', 'statistically_significant', 'clinically', 'relevant', 'compare_placebo', 'cohort', 'researcher', 'note', 'phosphocreatine', 'recovery', 'time', 'patient', 'significantly', 'high', 'high_degree', 'variability', 'previously', 'see', 'literature'], ['finding', 'support', 'hypothesis', 'significant', 'mitochondrial', 'dysfunction', 'patient', 'limit', 'utility', 'parameter', 'clinical_trial', 'company', 'note'], ['long', 'so', 'new', 'so', 'relatively', 'understudied', 'standard', 'endpoint', 'however', 'base', 'result', 'company', 'plan', 'talk', 'regulator', 'how', 'drug', 'authorize', 'long_covid'], ['believe', 'already', 'demonstrate', 'just', 'month', 'dose', 'profound', 'effect', 'say'], ['drug', 'originally', 'design', 'fight', 'muscle', 'weakness', 'fatigue', 'link', 'form', 'fatty', 'liver', 'disease', 'appear', 'positive', 'impact', 'mitochondrial', 'function', 'bioenergetic', 'inflammation'], ['category', 'long_covid'], ['new', 'research', 'suggest', 'different', 'form', 'long_covid', 'category', 'have', 'own', 'symptom', 'category', 'include', 'neurological', 'symptom', 'fatigue'], ['appear', 'occur', 'people', 'contract', 'alpha', 'delta', 'variant', 'accord', 'study', 'college', 'more', 'common', 'first', 'wave'], ['second', 'category', 'define', 'respiratory', 'issue', 'such', 'shortness', 'breath', 'chest', 'pain', 'also', 'associate', 'first', 'wave', 'pandemic', 'suggest', 'lung_damage'], ['third', 'group', 'come', 'wide_range', 'symptom', 'include', 'muscle', 'ache', 'pain', 'change', 'skin', 'hair', 'heart', 'palpitation', 'associate', 'variant'], ['researcher', 'evaluate', 'people', 'live', 'long_covid', 'part', 'health', 'study', 'report', 'symptom', 'least', 'week', 'infection'], ['steve', 'clinical', 'lead', 'author', 'say', 'datum', 'show', 'clearly', 'post', 'covid', 'syndrome', 'just', 'condition', 'appear', 'several', 'subtype', 'understand', 'root', 'cause', 'subtype', 'help', 'find', 'treatment', 'strategy', 'moreover', 'datum', 'emphasize', 'need', 'long_covid', 'service', 'incorporate', 'personalized', 'approach', 'sensitive', 'issue', 'individual'], ['new', 'symptom', 'long_covid'], ['study', 'publish', 'nature', 'medicine', 'evaluate', 'adult', 'long_covid', 'researcher', 'find', 'broad_range', 'symptom', 'include', 'hair', 'loss', 'difficulty', 'ejaculate', 'reduce', 'problem', 'urinate', 'hot', 'flash', 'classify', 'emerge', 'symptom', 'associate', 'long'], ['reaction', 'study', 'sound', 'right', 'microbiologist', 'study', 'chronic', 'condition', 'tell', 'insider', 'chronic', 'consequence', 'virus', 'immense', 'when', 'start', 'actually', 'account', 'symptom'], ['catch', 'twice', 'increase', 'long_term', 'health', 'risk'], ['immunity', 'previous', 'infection', 'vaccine', 'wane', 'more', 'people', 'catch', 'second', 'time', 'exacerbate', 'highly', 'infectious', 'omicron', 'subvariant', 'infection', 'tend', 'mild', 'datum', 'suggest', 'catch', 'virus', 'second', 'time', 'increase', 'long_term', 'health', 'risk', 'particularly', 'long_covid'], ['yet', 'peer', 'review', 'study', 'veteran', 'second', 'infection', 'contribute', 'additional', 'risk', 'cause', 'mortality', 'hospitalization', 'adverse', 'health', 'outcome', 'appear', 'increase', 'risk', 'diabetes', 'fatigue', 'mental_health', 'disorder', 'study', 'people', 'catch', 'second', 'time', 'time', 'great', 'risk', 'develop', 'heart', 'lung', 'disease', 'have', 'blood', 'clot', 'problem'], ['additive', 'risk', 'really', 'trivial', 'insignificant', 'clinical', 'epidemiologist', 'chief', 'research', 'development', 'say'], ['persistent', 'loss', 'smell', 'associate', 'cognitive_impairment'], ['research', 'study', 'analyze', 'adult', 'age', 'researcher', 'follow', 'subject', 'year', 'conduct', 'series', 'physical', 'cognitive', 'test', 'group', 'infection', 'control', 'clinical', 'evaluation', 'find', 'functional', 'memory', 'impairment', 'third', 'people', 'infection', 'find', 'persistent', 'loss', 'smell', 'significant', 'predictor', 'cognitive_impairment', 'severity', 'initial', 'infection'], ['more', 'insight', 'cause', 'least', 'predict', 'experience', 'significant', 'long_term', 'cognitive', 'impact', 'infection', 'well', 'track', 'begin', 'develop', 'method', 'prevent', 'professor', 'aire', 'say'], [], ['company', 'often', 'partner', 'one', 'utilize', 'strength', 'particularly', 'large', 'pharma', 'company', 'leverage', 'technology_platform', 'small', 'biotech', 'firm', 'here', 'look', 'collaboration', 'announcement', 'kick', 'month'], ['sosei', 'add', 'neurological', 'target', 'new', 'deal'], ['ink', 'new', 'drug_discovery', 'collaboration', 'option', 'license', 'deal', 'focus', 'find', 'develop_commercialize', 'small_molecule', 'compound', 'modulate', 'novel', 'protein', 'couple', 'receptor', 'gpcr', 'target', 'associate', 'neurological', 'disease'], ['partner', 'plan', 'combine', 'heptare', 'structure', 'base', 'drug', 'design', 'platform', 'neuroscience', 'expertise', 'expand', 'already', 'exist', 'collaboration', 'enter', 'focus', 'inflammatory', 'autoimmune', 'disease'], ['term', 'pact', 'run', 'fund', 'activity', 'completion', 'ind_enable', 'study', 'option', 'license', 'program', 'then', 'take', 'clinical', 'regulatory', 'commercial', 'development'], ['pay', 'sosei', 'upfront', 'eligible', 'near_term', 'research', 'milestone_payment', 'development', 'commercial_milestone', 'as_well', 'tiere', 'royalty', 'global', 'sale'], ['delighted', 'enter', 'new', 'multi', 'target', 'discovery', 'collaboration', 'neuroscience', 'area', 'therapeutic', 'area', 'share', 'deep', 'complementary', 'experience', 'expertise', 'head', 'development', 'say', 'statement'], ['cancer', 'therapy'], ['hot', 'celebrated', 'yesterday', 'annual', 'day', 'end', 'enter_strategic', 'alliance', 'advance', 'former', 'pipeline', 'cancer', 'therapy', 'diagnostic', 'candidate'], ['lead', 'therapeutic', 'candidate', 'design', 'multiple', 'metastatic', 'cancer', 'schedule', 'first', 'human', 'phase', 'trial', 'demonstrate', 'deliver', 'therapy', 'metastatic', 'lesion', 'patient', 'advanced', 'solid_tumor'], ['base', 'therapeutic', 'offer', 'exciting', 'possibility', 'treat', 'cancer', 'professor', 'translational', 'molecular', 'pathology', 'say', 'statement', 'now', 'examine', 'how', 'regulatory', 'affect', 'signal', 'spatially', 'temporally', 'single', 'cell', 'level', 'tumor', 'cell', 'immune', 'cell', 'stem', 'cell', 'critical', 'tumor', 'progression', 'relapse', 'immune', 'evasion', 'goal', 'collaborate', 'transcode', 'gain', 'deep_understanding', 'rna', 'target', 'therapy', 'bring', 'innovative', 'new', 'treatment_option', 'patient'], ['volitionrx', 'unite', 'develop', 'net', 'target', 'therapy', 'cancer'], ['xenetic', 'volitionrx', 'announce', 'collaboration', 'develop', 'neutrophil', 'extracellular', 'trap', 'net', 'cancer', 'treatment', 'partnership', 'design', 'evaluate', 'potential', 'combination', 'volition', 'dnase', 'armored', 'car_platform'], ['term', 'deal', 'volition', 'pay', 'research', 'program', 'partner', 'share', 'proceed', 'licensing', 'commercial', 'product', 'come'], ['xenetic', 'focus', 'immune', 'oncology', 'company', 'dnase', 'oncology', 'platform', 'target', 'net', 'personalized', 'car_platform', 'technology', 'develop', 'make', 'cell', 'base', 'drug', 'target', 'unique', 'cell', 'receptor', 'malignant', 'tumor', 'cell', 'treat', 'cell', 'lymphomas'], ['volitionrx', 'focus', 'epigenetic', 'field', 'gene', 'regulation', 'where', 'environmental', 'factor', 'switch', 'gene', 'off', 'depend', 'epigenetic', 'modification'], ['in', 'license', 'dnase', 'base', 'oncology', 'platform', 'year', 'team', 'intently', 'focused', 'drive', 'technology', 'forward', 'goal', 'improve', 'outcome', 'exist', 'therapeutic', 'agent', 'multiple', 'solid_tumor', 'indication', 'state', 'pleased', 'enter', 'first', 'industry', 'research', 'development', 'collaboration', 'just', 'few', 'short', 'month', 'acquire', 'technology_platform'], ['partner', 'breast_cancer', 'combo', 'trial'], ['announce', 'ink', 'deal', 'test', 'evaluate', 'breast_cancer', 'combination', 'treatment'], ['part', 'deal', 'context', 'oral', 'progesterone', 'receptor', 'antagonist', 'use', 'combination', 'elacestrant', 'receptor', 'positive', 'metastatic_breast_cancer', 'patient', 'phase', 'trial', 'exchange', 'supply', 'elacestrant', 'cost', 'menarini', 'provide', 'funding'], ['trial', 'anticipate', 'begin', 'end', 'year', 'accord', 'context'], ['announce', 'lead', 'candidate', 'fail', 'meet', 'pre', 'define', 'criterion', 'move', 'second', 'phase', 'large', 'pivotal', 'glioblastoma', 'clinical_trial'], ['currently', 'assess', 'study', 'global', 'adaptive', 'umbrella', 'trial', 'design', 'investigate', 'several', 'potential', 'therapy', 'parallel', 'study', 'sponsor', 'global', 'coalition', 'adaptive', 'research', 'inform', 'drug', 'fall', 'short', 'particular', 'measure', 'carry', 'second', 'stage', 'enrollment'], ['remain', 'blind', 'trial', 'detail', 'currently', 'unable', 'identify', 'pre', 'define', 'criterion', 'however', 'design', 'advance', 'treatment', 'find', 'effective', 'candidate', 'drop', 'prove', 'unsafe', 'further', 'testing', 'deem', 'futile', 'primary_endpoint', 'overall', 'survival'], ['challenge', 'lay', 'ahead'], ['exact', 'implication', 'paxalisib', 'still', 'unclear', 'highly', 'likely', 'candidate', 'drop', 'umbrella', 'trial'], ['news', 'define', 'remain', 'trajectory', 'study', 'modestly', 'positive', 'implication', 'cost', 'timeline', 'chief_executive_officer', 'say', 'statement', 'allow', 'draw', 'meaningful', 'inference', 'outcome', 'study', 'indeed', 'critical', 'regulatory', 'purpose', 'remain', 'blinded', 'evolve', 'datum', 'final', 'result', 'expect', 'next', 'year'], ['flag', 'potential', 'regulatory', 'hurdle', 'face', 'enrollment', 'close', 'trial', 'long', 'open', 'paxalisib', 'arm', 'lead', 'issue', 'east', 'country', 'require', 'local', 'datum', 'drug', 'approve', 'chinese', 'pharma', 'firm', 'simcere', 'license', 'right', 'great', 'area', 'work', 'way', 'forward', 'paxalisib', 'region'], ['formerly', 'earn', 'exclusive', 'global', 'license', 'paxalisib', 'genentech', 'candidate', 'inhibitor', 'well', 'validate', 'class', 'anti', 'cancer', 'drug', 'approve', 'chronic', 'lymphocytic', 'leukemia', 'also', 'work', 'target', 'paxalisib', 'set', 'apart', 'other', 'inhibitor', 'able', 'cross', 'near', 'impregnable', 'blood', 'brain', 'barrier', 'critical', 'hurdle', 'other', 'drug', 'hope', 'target', 'brain'], ['prove', 'mechanism_action', 'combine', 'unique', 'ability', 'enter', 'brain', 'make', 'asset', 'thus', 'far', 'early', 'company', 'present', 'final', 'phase', 'datum', 'american', 'society', 'clinical', 'oncology', 'annual_meeting', 'show', 'paxalisib', 'lead', 'well', 'overall', 'progression', 'free', 'survival', 'glioblastoma', 'patient', 'also', 'have', 'acceptable', 'safety_profile', 'shortly', 'poster_presentation', 'th', 'international', 'symposium', 'pediatric', 'oncology', 'underscore', 'value', 'paxalisib', 'rare', 'brain', 'cancer', 'kid'], ['also', 'earn', 'food', 'rare_pediatric', 'disease', 'designation', 'last', 'month', 'treatment', 'rare', 'aggressive', 'atypical', 'rhabdoid', 'teratoid', 'tumor', 'child'], ['make', 'failure', 'gbm', 'agile', 'trial', 'surprising', 'determined', 'stand', 'currently', 'assess', 'value', 'other', 'indication'], ['excite', 'emerge', 'datum', 'diffuse', 'intrinsic', 'brain', 'metastasis', 'become', 'increasingly', 'important', 'area', 'focus', 'company', 'look_forward', 'share', 'more', 'detail', 'activity', 'due', 'course', 'garner', 'say'], ['run', 'online', 'here', 'highlight', 'present', 'so', 'far'], ['selectivity', 'amyloid_beta', 'oligomer'], ['many', 'drug', 'develop', 'target', 'amyloid_beta', 'abnormal', 'protein', 'associate', 'disease', 'different', 'form', 'oligomer', 'protein', 'neuroscience', 'present', 'poster', 'describe', 'selectivity', 'experimental', 'compound', 'pmn', 'target', 'toxic', 'oligomer'], ['company', 'note', 'evidence', 'suggest', 'most', 'pathogenic', 'form', 'amyloid_beta', 'make', 'soluble', 'toxic', 'oligomer', 'compare', 'insoluble', 'fibril', 'plaque', 'monomer', 'study', 'demonstrate', 'little', 'interaction', 'monomer', 'least', 'impact', 'excess', 'monomer', 'competition', 'bind', 'synthetic', 'oligomer', 'naturally_occur', 'toxic', 'oligomer', 'ad', 'brain', 'extract'], ['intranasal', 'antibody', 'disease'], ['life_science', 'present', 'animal', 'study', 'intranasal', 'anti', 'cd', 'monoclonal_antibody', 'disease', 'preclinical', 'study', 'demonstrate', 'activity', 'microglia', 'brain', 'specific', 'immune', 'cell', 'restore', 'cognition', 'improve', 'receive', 'treatment'], ['antibody', 'also', 'induce', 'migration', 'regulatory', 'cell', 'treg', 'brain', 'then', 'interact', 'excessive', 'microglial', 'cell', 'activation', 'associate', 'number', 'disease', 'include', 'multiple'], ['nasal', 'provide', 'unique', 'approach', 'treat', 'progressive', 'neurologic', 'disease', 'modulate', 'microglial', 'cell', 'director', 'neurologic', 'disease', 'woman', 'chairman', 'scientific', 'say', 'nasal', 'route', 'immunotherapy', 'minimal', 'toxicity', 'induce', 'regulator', 'cell', 'locally', 'then', 'migrate', 'brain', 'dampen', 'brain', 'inflammation', 'exciting', 'option', 'open', 'entirely', 'new', 'approach', 'immunotherapy', 'neurologic', 'disease', 'look_forward', 'evaluate', 'foralumab', 'clinically', 'area', 'disease'], [], ['vaxxinity', 'present', 'new', 'preclinical', 'datum', 'vaccine', 'candidate', 'target', 'abnormal', 'form', 'protein', 'disease', 'amyloid_beta', 'tau', 'protein', 'accumulate', 'abnormally', 'brain', 'people', 'disease', 'generally', 'amyloid_beta', 'observe', 'early', 'disease', 'later', 'on', 'formation', 'neurofibrillary', 'develop', 'first', 'symptom', 'disease'], ['finding', 'show', 'specific', 'form', 'tau', 'target', 'vaccine', 'subsequent', 'functional', 'impact', 'director', 'translational', 'science', 'vaxxinity', 'say', 'preclinical', 'research', 'complement', 'amyloid_beta', 'target', 'investigational', 'vaccine', 'grant_fast', 'track_designation', 'clinical', 'development', 'disease'], ['go', 'say', 'vaccine', 'uniquely', 'suited', 'deliver', 'multiple', 'antigen', 'single', 'formulation', 'thus', 'rather', 'rely', 'select', 'just', 'epitope', 'target', 'multiple', 'tau', 'epitope', 'provide', 'more', 'efficient', 'way', 'neutralize', 'toxic', 'tau', 'specie', 'program', 'look_forward', 'continued', 'evaluation', 'candidate', 'potential', 'innovative', 'solution', 'patient', 'option', 'far', 'too', 'long'], ['assist', 'therapy', 'space', 'try', 'leave', 'stigma', 'drug', 'culture', 'become', 'mainstream', 'therapy', 'multiple', 'psychiatric', 'condition', 'overcome', 'popular', 'perception', 'cotton', 'candy', 'sky', 'groovy', 'hallucination', 'good', 'trip', 'total', 'freak', 'out', 'bad', 'trip', 'sometimes', 'deadly', 'result', 'prove', 'safe', 'accept', 'regulatory_authority', 'include'], ['psychedelic', 'assist', 'therapy', 'offer', 'exciting', 'potential', 'treatment_option', 'come', 'potential', 'risk', 'psychiatric', 'mental_health', 'nurse', 'work', 'tell', 'biospace'], ['most', 'research', 'psychedelic', 'show', 'risk', 'addiction', 'say', 'however', 'risk', 'negative', 'outcome', 'people', 'properly', 'screen', 'example', 'active', 'ingredient', 'magic', 'mushroom', 'risk', 'psychosis', 'mania', 'especially', 'people', 'family', 'history', 'bipolar', 'disorder', 'psychotic', 'disorder', 'risk', 'present', 'even', 'short', 'term', 'use'], ['risk', 'manage', 'careful', 'patient', 'selection', 'begin', 'physical', 'examination', 'assess', 'patient', 'mental_health', 'history', 'rule', 'family', 'history', 'psychosis', 'mania', 'bipolar', 'disorder', 'compound', 'ketamine', 'example', 'enable', 'non', 'ordinary', 'state', 'consciousness', 'experience', 'trip', 'definitely', 'need', 'full', 'medical', 'evaluation', 'say'], ['research', 'suggest', 'pass', 'phase', 'trial', 'recategorize', 'schedule', 'drug', 'medical', 'potential', 'schedule', 'drug', 'line', 'prescription', 'sleep', 'medication', 'tight', 'control'], ['now', 'bi', 'partisan', 'right', 'try', 'clarification', 'recently', 'introduce', 'make', 'psychedelic', 'other', 'schedule', 'drug', 'accessible', 'patient', 'exhaust', 'other', 'treatment_option', 'eligible', 'clinical_trial', 'propose', 'act', 'allow', 'patient', 'treat', 'unapproved', 'potential', 'therapy', 'complete', 'phase', 'trial'], ['fast', 'path', 'effective', 'result'], ['executive', 'company', 'develop', 'psychedelic', 'assist', 'drug', 'sometimes', 'point', 'therapy', 'help', 'patient', 'achieve', 'result', 'month', 'rather', 'year', 'routine', 'therapy', 'typically', 'take', 'result', 'last', 'month', 'long'], ['medicine', 'study', 'psychedelic', 'treatment', 'include', 'psilocybin', 'decade', 'research', 'publish', 'university', 'early', 'year', 'report', 'effect', 'psilocybin', 'assist', 'therapy', 'administer', 'supportive', 'psychotherapy', 'treat', 'major', 'depressive', 'disorder', 'last', 'at_least', 'year', 'patient'], ['such', 'result', 'universally', 'achievable', 'make', 'blanket', 'statement', 'claim', 'difficult', 'respond', 'caution', 'promotion', 'medium', 'indicate', 'end', 'cure', 'therapy', 'lot', 'people', 'great', 'speed', 'bit', 'misleading', 'case', 'really', 'exciting', 'also', 'possibility', 'people', 'bad'], ['sometimes', 'see', 'zig', 'zag', 'phenomenon', 'when', 'be', 'explore', 'non', 'ordinary', 'state', 'consciousness', 'client', 'immense', 'healing', 'also', 'relive', 'traumatic', 'experience', 'very', 'upsetting', 'content', 'explain', 'death', 'experience', 'just', 'example', 'happen', 'incredibly', 'profound'], ['unsettling', 'unprecedented'], ['also', 'profoundly', 'unsettling', 'other', 'hallucination', 'therapy', 'patient', 'experience', 'content', 'challenge', 'core', 'belief', 'self', 'family', 'spirituality', 'enter', 'extreme', 'spiritual', 'crisis', 'take', 'time', 'heal', 'say', 'perhaps', 'part', 'accelerated', 'healing', 'process', 'perhaps', 'need', 'go', 'deep', 'order', 'heal'], ['of', 'course', 'individual', 'patient', 'actually', 'experience', 'varie', 'people', 'tend', 'receive', 'experience', 'seem', 'exactly', 'need', 'say', 'experience', 'very', 'spiritual', 'revisit', 'past', 'trauma', 'involve', 'benefit', 'ability', 'view', 'examine', 'experience', 'even', 'intense', 'scary', 'one', 'different', 'perspective', 'find', 'healing', 'resolution'], ['important', 'patient', 'undergo', 'therapy', 'experience', 'safe', 'environment', 'train', 'therapist', 'help', 'guide', 'hope', 'patient', 'alert', 'experience', 'intense', 'unsettling', 'prepared', 'proper', 'guide', 'duration', 'treatment', 'long', 'enough', 'say'], ['guide', 'patient', 'experience', 'non', 'ordinary', 'state', 'consciousness', 'therapist', 'need', 'well', 'train', 'field', 'ideally', 'say', 'very', 'experienced', 'have', 'mentorship', 'area', 'only', 'work', 'state', 'consciousness', 'deal', 'realm', 'therapy', 'most', 'clinician', 'see', 'office', 'regular', 'basis'], ['change', 'regulatory', 'environment'], ['get', 'training', 'moment', 'difficult', 'psychedelic', 'schedule', 'substance', 'therefore', 'tightly', 'control', 'beginning', 'change'], ['become', 'first', 'state', 'allow', 'use', 'psilocybin', 'medically', 'new', 'therapy', 'available', 'only', 'session', 'increment', 'occur', 'state', 'license', 'clinic', 'still', 'roll', 'therapist', 'train', 'license', 'runup', 'election', 'campaign', 'ballot', 'measure', 'allow', 'use', 'psilocybin', 'cite', 'safety', 'reason'], ['city', 'port', 'decriminalize', 'possession'], ['global', 'psychadelic', 'situation'], ['right', 'now', 'lsd', 'generally', 'illegal', 'world', 'internationally', 'legal', 'special', 'access', 'program', 'treat', 'specific', 'illness', 'rest', 'decriminalize', 'possession', 'quantity', 'personal', 'use', 'decriminalize', 'have', 'large', 'quantity', 'mass', 'distribution', 'come', 'serious', 'criminal', 'penalty'], ['local', 'regulation', 'other', 'psychedelic', 'also', 'appear', 'loosen', 'ketamine', 'legalize', 'many', 'area', 'mdma', 'methamphetamine', 'designate', 'breakthrough', 'therapy', 'grant', 'expand', 'access', 'late', 'now', 'use', 'multiple', 'clinical_trial'], ['psychedelic', 'move', 'mainstream', 'say', 'concerned', 'health', 'treatment', 'disparity', 'community', 'allow', 'psychedelic', 'therapy', 'other', 'as_well', 'ethical', 'concern', 'take', 'substance', 'part', 'traditional', 'culture', 'sacred', 'rite', 'introduce', 'biomedical', 'model'], ['overall', 'however', 'exciting', 'time', 'psychiatry', 'novel', 'approach', 'treatment', 'say', 'believe', 'offer', 'beautiful', 'path', 'healing'], ['allarity', 'therapeutic', 'veer', 'away', 'monotherapy', 'development', 'activity', 'focus', 'time', 'resource', 'more', 'promising', 'combination', 'oncologic', 'therapy'], ['move', 'come', 'board_director', 'conduct', 'depth', 'evaluation', 'current', 'asset', 'decide', 'refocus', 'company', 'oncology', 'pipeline', 'strategy', 'factor', 'lead', 'decision', 'include', 'viability', 'exist', 'opportunity', 'fund', 'availability', 'timeline', 'cost', 'development', 'potential', 'clinical', 'commercial', 'regulatory', 'risk'], ['shift', 'away', 'activity', 'monotherapy', 'product', 'company', 'say', 'plan', 'bolster', 'ability', 'attract', 'funding', 'opportunity', 'institutional', 'life_science', 'investor', 'allarity', 'also', 'indicate', 'openness', 'commercially', 'partner', 'large', 'pharmaceutical', 'company', 'future', 'maximize', 'platform', 'technology', 'asset', 'pipeline'], ['new', 'therapeutic', 'development', 'recognize', 'very', 'challenging', 'endeavor', 'constantly', 'shift', 'regulatory', 'requirement', 'standard_care', 'improvement', 'new', 'drug', 'come', 'market', 'financial', 'market', 'challenge', 'therefore', 'become', 'increasingly', 'difficult', 'advance', 'development', 'monotherapie', 'increasingly', 'competitive', 'therapeutic', 'space', 'interim', 'chief_executive_officer', 'allarity', 'comment'], ['confident', 'strategic', 'shift', 'focus', 'resource', 'correct', 'path', 'forward', 'allarity', 'give', 'current', 'regulatory', 'market', 'reality', 'well', 'leverage', 'companion_diagnostic', 'match', 'right', 'patient', 'cancer', 'therapeutic', 'most', 'likely', 'benefit', 'add'], ['also', 'second_quarter', 'allarity', 'receive', 'feedback', 'administration', 'regard', 'plan', 'phase', 'clinical', 'development', 'monotherapy', 'third', 'line', 'treatment', 'metastatic', 'renal', 'cell', 'carcinoma', 'advise', 'company', 'conduct', 'new', 'dose', 'trial', 'drug', 'move', 'phase', 'trial', 'lead', 'submission', 'new', 'drug_application', 'mean', 'further', 'delay', 'increase', 'cost', 'high', 'market', 'risk', 'give', 'competitiveness'], ['give', 'situation', 'allarity', 'decide', 'no', 'longer', 'pursue', 'commercial', 'possibility', 'use', 'monotherapy', 'adult', 'drug', 'however', 'still', 'develop', 'externally', 'partnership', 'oncoheroe', 'bioscience', 'time', 'single', 'therapy', 'pediatric', 'case'], ['new', 'direction', 'allarity', 'initiate', 'enrollment', 'phase', 'trial', 'parp', 'inhibitor', 'combine', 'second', 'line', 'later', 'treatment', 'metastatic', 'ovarian_cancer', 'trial', 'site', 'set'], ['meanwhile', 'company', 'ongoing', 'phase_study', 'monotherapy', 'ovarian_cancer', 'ixempra', 'monotherapy', 'metastatic_breast_cancer', 'continue', 'interim', 'datum', 'readout', 'fourth_quarter', 'first_quarter', 'pipeline', 'activity', 'continue', 'use', 'drug', 'specific', 'companion_diagnostic', 'screen', 'treat', 'patient'], ['determine', 'allarity', 'future', 'pipeline', 'focus', 'development', 'promise', 'combination', 'therapy', 'approach', 'utilize', 'current', 'asset', 'together', 'companion_diagnostic', 'chairman', 'note', 'remain', 'very', 'enthusiastic', 'company', 'vision', 'mission', 'strategy', 'strategic', 'refocus', 'combination', 'therapy', 'together', 'core', 'drp', 'technology', 'give', 'allarity', 'good', 'chance', 'success', 'as_well', 'good', 'optimize', 'shareholder', 'return', 'investment'], ['image'], ['announce', 'place', 'clinical', 'hold', 'investigational', 'new', 'drug_application', 'candidate', 'relapsed', 'refractory', 'cell', 'acute', 'lymphoblastic', 'leukemia', 'cell', 'lymphoblastic', 'lymphoma'], ['short', 'statement', 'post', 'website', 'base', 'firm', 'say', 'inform', 'decision', 'email', 'last', 'reason', 'share', 'regulator', 'set', 'provide', 'official', 'clinical', 'hold', 'notice', 'beam', 'day'], ['company', 'expect', 'provide', 'more', 'detail', 'clinical', 'hold', 'future', 'plan', 'pende', 'discussion'], ['base', 'editing', 'efficiency', 'safety'], ['found', 'beam', 'build', 'science', 'base', 'editing', 'most', 'gene_editing', 'therapy', 'break', 'strand', 'introduce', 'desire', 'change', 'base', 'editor', 'employ', 'enzyme', 'chemically', 'transform', 'single', 'nucleotide', 'base', 'cytosine', 'thymine', 'example', 'cut', 'need', 'more', 'specific', 'approach', 'only', 'more', 'efficient', 'also', 'make', 'sense', 'most', 'disease', 'cause', 'mutation', 'after', 'all', 'due', 'change', 'nucleotide'], ['take', 'same', 'approach', 'candidate', 'donor', 'derive', 'car', 'cell', 'investigational', 'therapy', 'undergo', 'multiplex', 'base', 'edit', 'become', 'universally', 'compatible', 'resistant', 'host', 'rejection', 'also', 'effective', 'target', 'cancer', 'cell'], ['decision', 'place', 'hold', 'asset', 'remain', 'unexplained', 'likely', 'due', 'uncertainty', 'surround', 'novel', 'technology', 'base', 'editing', 'potential', 'safety', 'risk', 'allogeneic', 'shelf', 'nature', 'beam', 'candidate'], ['regulatory', 'body', 'choose', 'side', 'caution', 'regard', 'kind', 'treatment', 'past', 'when', 'put', 'car', 'cell', 'therapy', 'clinical', 'hold', 'patient', 'develop', 'chromosomal', 'abnormality', 'month', 'later', 'company', 'find', 'adverse_event', 'unrelated', 'candidate', 'hold', 'lift'], ['play', 'colorectal', 'cancer', 'hopeful'], ['lymphoma', 'leukemia', 'base', 'editor', 'look', 'potential', 'month', 'long', 'pause', 'hit', 'resume', 'oncology', 'car', 'candidate', 'colorectal', 'cancer', 'cyad'], ['belgian', 'announce', 'regulatory', 'body', 'lift', 'clinical', 'hold', 'phase', 'trial', 'company', 'make', 'key', 'change', 'study', 'eligibility', 'criterion', 'late', 'year', 'follow', 'patient', 'death', 'celyad', 'voluntarily', 'stall', 'cyad', 'study', 'cite', 'insufficient', 'information', 'assess', 'risk', 'study', 'subject', 'formalize', 'clinical', 'hold', 'few', 'day', 'later'], ['candidate', 'hold', 'cyad', 'allogeneic', 'car', 'cell', 'investigational', 'therapy', 'however', 'colorectal', 'cancer', 'hopeful', 'gene_edit', 'cyad', 'design', 'express', 'nkg', 'receptor', 'typically', 'find', 'natural', 'killer', 'cell', 'novel', 'inhibitory', 'test', 'combination', 'anti', 'pd'], ['clinical', 'hold', 'ground', 'safety', 'concern', 'all', 'too', 'common', 'car', 'therapy', 'space', 'japanese', 'multinational', 'pharma', 'face', 'clinical', 'hold', 'patient', 'die', 'follow', 'treatment', 'gene', 'therapy', 'candidate', 'last', 'year', 'tmunity', 'therapeutic', 'found', 'car', 'therapy', 'also', 'see', 'lead', 'program', 'halt', 'patient', 'death', 'report', 'news', 'portal', 'onclive'], ['life_science', 'professional', 'busy', 'people', 'planet', 'meeting', 'deadline', 'travel', 'work', 'handle', 'ever', 'grow', 'list', 'difficult', 'find', 'time', 'else', 'accord', 'nature', 'study', 'poll', 'research', 'scientist', 'globe', 'respondent', 'report', 'work', 'more', 'hour', 'week', 'report', 'work', 'more', 'hour'], ['just', 'busy', 'mean', 'let', 'organizational', 'skill', 'suffer', 'fact', 'lack', 'free', 'time', 'even', 'more', 'reason', 'stay', 'organized', 'save', 'time', 'energy', 'long', 'run', 'help', 'compile', 'doable', 'effective', 'time', 'save', 'strategy', 'stay', 'organize', 'fast', 'pace', 'life_science', 'medical', 'industry'], ['stay', 'prepared', 'emergency'], ['no', 'matter', 'how', 'well', 'plan', 'always', 'time', 'when', 'come', 'require', 'attention', 'last', 'minute', 'meeting', 'unexpected', 'problem', 'prepare', 'emergency', 'save', 'lot', 'time', 'stress'], ['keep', 'list', 'emergency', 'contact', 'hand', 'as_well', 'list', 'task', 'need', 'do', 'case', 'emergency', 'way', 'will', 'prepare', 'come', 'focus', 'solve', 'problem', 'hand'], ['even', 'take', 'step', 'far', 'create', 'system', 'handle', 'emergency', 'example', 'designate', 'person', 'handle', 'paperwork', 'last', 'minute', 'travel', 'plan', 'way', 'focus', 'work', 'leave', 'detail', 'else'], ['set', 'time', 'planning'], ['good', 'way', 'stay', 'organize', 'set', 'time', 'day', 'plan', 'first', 'thing', 'morning', 'lunch', 'break', 'even', 'end', 'day'], ['use', 'time', 'review', 'schedule', 'day', 'week', 'month', 'ahead', 'upcoming', 'deadline', 'meeting', 'make', 'sure', 'calendar', 'also', 'use', 'time', 'review', 'list', 'see', 'need', 'do'], ['take', 'few', 'minute', 'day', 'plan', 'save', 'lot', 'time', 'long', 'run', 'only', 'less', 'likely', 'forget', 'thing', 'will', 'also', 'able', 'focus', 'most', 'important', 'day'], ['automate', 'task'], ['good', 'way', 'save', 'time', 'automate', 'as', 'many', 'task', 'possible', 'certain', 'thing', 'daily', 'weekly', 'basis', 'see', 'way', 'set', 'happen', 'automatically', 'include', 'set', 'automatic', 'bill', 'payment', 'invest', 'software', 'streamline', 'workflow', 'create', 'template', 'commonly', 'use', 'document'], ['medical', 'professional', 'streamline', 'repetitive', 'task', 'key', 'success', 'important', 'make', 'most', 'minute', 'spend', 'patient', 'many', 'great', 'software', 'option', 'available', 'automate', 'task', 'such', 'contact', 'management', 'appointment', 'scheduling', 'free', 'valuable', 'time', 'focus', 'job'], ['manage', 'email'], ['big', 'time', 'waster', 'profession', 'deal', 'cluttered', 'inbox', 'constantly', 'sift', 'old', 'email', 'tough', 'find', 'important', 'message', 'require', 'attention', 'combat', 'set', 'system', 'manage', 'email', 'as_soon', 'come', 'in'], ['involve', 'use', 'folder', 'label', 'prioritize', 'message', 'set', 'specific', 'time', 'day', 'check', 'respond', 'email', 'use', 'tool', 'schedule', 'message'], ['invest', 'quality', 'calendar'], ['calendar', 'essential', 'keep', 'track', 'important', 'date', 'deadline', 'meeting', 'variety', 'calendar', 'app', 'program', 'available', 'so', 'find', 'one', 'work', 'well', 'need', 'calendar', 'most_common', 'send', 'notification', 'when', 'meeting', 'event', 'come'], ['travel', 'often', 'work', 'sure', 'invest', 'travel', 'planner', 'help', 'keep', 'track', 'upcoming', 'trip', 'as_well', 'deadline', 'meeting', 'need', 'schedule', 'travel'], ['set', 'filing', 'system'], ['deal', 'physical', 'digital', 'file', 'important', 'system', 'place', 'organize', 'store', 'save', 'time', 'when', 'need', 'find', 'specific', 'document', 'help', 'keep', 'track', 'hand'], ['work', 'lot', 'file', 'consider', 'use', 'tool', 'drive', 'store', 'cloud', 'way', 'access', 'anywhere', 'share', 'colleague', 'spend', 'too', 'much', 'time', 'energy', 'money'], ['track', 'time'], ['list', 'great', 'way', 'keep', 'track', 'task', 'make', 'sure', 'stay', 'top', 'many_different', 'list', 'app', 'available', 'so', 'find', 'one', 'work', 'well'], ['addition', 'use', 'list', 'consider', 'track', 'time', 'app', 'rescuetime', 'toggl', 'helpful', 'identify', 'area', 'where', 'waste', 'time', 'help', 'see', 'how', 'much', 'time', 'actually', 'spend', 'productive', 'task'], ['organize', 'workspace'], ['lab', 'worker', 'medical', 'industry', 'have', 'well', 'organize', 'workspace', 'difference', 'successful', 'study', 'complete', 'disaster'], ['give', 'estimate', 'how', 'long', 'task', 'take', 'then', 'create', 'schedule', 'help', 'stay', 'track', 'avoid', 'run', 'time', 'management', 'problem', 'road'], ['also', 'important', 'designate', 'space', 'type', 'tool', 'piece', 'equipment', 'help', 'find', 'need', 'quickly', 'avoid', 'waste', 'time', 'look', 'where', 'suppose', 'sure', 'supply', 'need', 'hand', 'take', 'time', 'organize', 'label', 'workspace', 'easy', 'find'], ['even', 'work', 'lab', 'sure', 'keep', 'work', 'area', 'clean', 'organize', 'only', 'erase', 'need', 'large', 'time', 'consume', 'clean', 'later', 'clean', 'workspace', 'help', 'increase', 'focus', 'concentration'], ['avoid', 'multi', 'tasking'], ['seem', 'multi', 'tasking', 'good', 'way', 'more', 'do', 'less', 'time', 'actually', 'when', 'try', 'too', 'many', 'thing', 'once', 'brain', 'able', 'focus', 'task', 'end', 'take', 'long', 'complete'], ['accord', 'experimental', 'psychology', 'individual', 'frequently', 'multitask', 'less', 'effective', 'task', 'switching', 'more', 'likely', 'great', 'difficulty', 'filter', 'irrelevant', 'information'], ['want', 'more', 'productive', 'focus', 'task', 'time', 'avoid', 'try', 'too', 'many', 'thing', 'once'], ['bottom', 'line'], ['put', 'organization', 'think', 'time', 'take', 'few', 'minute', 'organize', 'save', 'hour', 'long', 'run', 'follow', 'tip', 'make', 'sure', 'make', 'most', 'time', 'strategy', 'help', 'more', 'productive', 'efficient', 'successful', 'fast', 'pace', 'life_science', 'industry'], ['clinical_stage', 'biotechnology', 'company', 'focus', 'develop', 'novel', 'therapy', 'neuronal', 'excitability', 'disorder', 'address_unmet', 'need', 'chronic', 'pain', 'psychiatry', 'epilepsy', 'other', 'disorder', 'peripheral', 'central_nervous_system', 'today', 'report', 'result', 'phase', 'clinical_trial', 'investigate', 'treatment', 'lumbosacral', 'radicular', 'pain'], ['novel', 'new', 'chemical', 'entity', 'prodrug', 'bioactive', 'lipid', 'pea', 'evaluate', 'phase', 'clinical_trial', 'subject', 'diabetic', 'peripheral', 'neuropathic_pain', 'subject', 'lsrp', 'commonly', 'refer'], ['phase', 'clinical_trial', 'lsrp', 'achieve', 'statistically_significant', 'separation', 'placebo', 'trial', 'primary_endpoint', 'assess', 'change_baseline', 'week', 'weekly', 'average_daily', 'pain', 'score', 'measure', 'pain_intensity', 'numerical', 'rating_scale', 'pi', 'result', 'consistent', 'lack', 'separation', 'placebo', 'observe', 'phase', 'clinical_trial', 'report', 'therefore', 'company', 'elect', 'discontinue', 'further_development'], ['company', 'recently', 'provide', 'update', 'capital', 'sufficient_fund', 'key', 'pipeline', 'catalyst', 'operation', 'mid', 'discontinuation', 'company', 'anticipate', 'cash_runway', 'extend', 'time', 'expect', 'provide', 'more', 'detail', 'extended', 'cash_runway', 'connection', 'second_quarter_financial', 'result', 'release'], ['disappointed', 'phase', 'datum', 'obtain', 'dpnp', 'lsrp', 'indication', 'say_chief_executive_officer', 'dpnp', 'trial', 'believe', 'lsrp', 'trial', 'well', 'execute', 'trial', 'balanced', 'study', 'arm', 'observed', 'placebo', 'effect', 'consistent', 'expectation', 'thus', 'confident', 'result', 'unambiguous', 'demonstrate', 'show', 'clinical', 'benefit', 'sincerely', 'thank', 'patient', 'participate', 'trial', 'investigator', 'clinical', 'staff', 'team', 'manage', 'study'], ['multi_center', 'randomize_double_blind_placebo', 'control', 'parallel', 'group', 'clinical_trial', 'evaluate', 'efficacy_safety', 'subject', 'lsrp', 'week', 'dose', 'patient', 'randomize', 'mg', 'daily', 'placebo', 'well_tolerate', 'study', 'safety_profile', 'consistent', 'previous', 'study', 'however', 'primary_endpoint', 'study', 'achieve', 'separation', 'placebo', 'observe', 'week', 'dosing'], ['therapeutic'], ['clinical_stage', 'biotechnology', 'company', 'focus', 'develop', 'novel', 'therapy', 'neuronal', 'excitability', 'disorder', 'address_unmet', 'need', 'chronic', 'pain', 'psychiatry', 'epilepsy', 'other', 'disorder', 'peripheral', 'central_nervous_system', 'disorder', 'often', 'occur', 'when', 'neuron', 'overly', 'excited', 'inhibit', 'lead', 'imbalance', 'focus', 'restore', 'homeostasis', 'develop', 'pipeline', 'clinically', 'differentiate', 'product_candidate', 'focus', 'validate', 'mechanism_action', 'broad', 'therapeutic', 'potential', 'deliver', 'improved', 'therapeutic', 'patient', 'disorder', 'eliem', 'channel', 'experience', 'energy', 'passion', 'improve', 'patient', 'quality_life', 'fuel', 'effort', 'develop', 'life', 'change', 'novel', 'therapy', 'core', 'team', 'motivate', 'promise', 'help', 'patient', 'live', 'happy', 'more', 'fulfilling', 'life', 'learn_more', 'follow'], ['forward_look_statement'], ['press_release_contain', 'forward_look_statement', 'include_limitation', 'statement', 'relate', 'discontinuation', 'further_development', 'program', 'belief', 'reference', 'trial', 'well', 'execute', 'continue', 'development', 'clinical', 'therapeutic', 'potential', 'other', 'product_candidate', 'belief', 'sufficient', 'capital', 'fund', 'key', 'pipeline', 'catalyst', 'operation', 'mid', 'expectation', 'provide', 'more', 'detail', 'extended', 'cash_runway', 'connection', 'second_quarter_financial', 'result', 'release', 'commitment', 'develop', 'therapy', 'target', 'debilitate', 'disorder', 'word', 'such', 'anticipate', 'believe', 'differentiate', 'expect', 'extend', 'focus', 'potential', 'sufficient', 'other', 'similar_expression', 'identify', 'forward_look_statement', 'absence', 'word', 'necessarily', 'mean', 'statement', 'forward_look', 'addition', 'statement', 'refer', 'expectation', 'projection', 'other', 'future', 'event_circumstance', 'forward_look_statement', 'forward_look_statement', 'press_release_base', 'current', 'plan', 'assumption', 'belief', 'expectation', 'estimate', 'projection', 'involve_substantial_risk_uncertainty', 'actual', 'result', 'timing', 'event', 'differ_materially', 'anticipate', 'forward_look_statement', 'due', 'risk_uncertainty', 'as_well', 'other', 'factor', 'include_limitation', 'clinical', 'therapeutic', 'commercial', 'value', 'preclinical', 'program', 'risk', 'relate', 'potential', 'failure', 'etx', 'demonstrate', 'safety_efficacy', 'clinical', 'testing', 'ability', 'initiate', 'conduct', 'clinical_trial', 'study', 'etx', 'sufficient', 'achieve', 'positive', 'completion', 'availability', 'datum', 'expect', 'time', 'ability_obtain', 'protect', 'intellectual_property', 'right', 'operate', 'infringe', 'intellectual_property', 'right', 'other', 'uncertain', 'timing', 'level', 'expense', 'associate', 'preclinical', 'clinical', 'development', 'activity', 'sufficiency', 'capital', 'other', 'resource', 'risk_uncertainty', 'relate', 'regulatory', 'application', 'review', 'approval', 'process', 'compliance', 'applicable', 'legal', 'regulatory', 'requirement', 'market', 'competition', 'change', 'economic', 'business', 'condition', 'impact', 'business', 'due', 'external', 'event', 'include', 'health', 'pandemic', 'other', 'contagious', 'outbreak', 'such', 'current', 'pandemic', 'other', 'factor', 'discuss', 'caption', 'risk_factor', 'quarterly_report_form', 'quarterly', 'period', 'end', 'filing', 'available', 'website', 'additional', 'information', 'also', 'set', 'other', 'report', 'filing_make', 'time', 'time', 'forward_look_statement', 'make', 'press_release', 'speak_only', 'date_press_release', 'eliem', 'expressly', 'disclaim', 'duty', 'obligation_undertaking', 'release', 'publicly_update', 'revision', 'forward_look_statement', 'contain', 'reflect', 'change', 'expectation_regard', 'change', 'event', 'condition', 'circumstance', 'such', 'statement', 'base'], [], ['scientific'], ['repligen', 'corporation', 'life_science', 'company', 'focus', 'bioprocesse', 'technology', 'leadership', 'today', 'report', 'financial', 'result', 'second_quarter_end', 'provide', 'press_release', 'financial', 'highlight', 'three', 'month', 'period', 'end', 'update', 'financial_guidance', 'year', 'access', 'information', 'today', 'conference_call'], ['president_chief_executive_officer', 'say', 'be', 'very_pleased', 'performance', 'second_quarter', 'where', 'generate', 'revenue', 'represent', 'year', 'year', 'organic', 'growth', 'continue', 'encourage', 'strength', 'base', 'business', 'up', 'quarter', 'lead', 'filtration', 'chromatography', 'franchise', 'see', 'market', 'momentum', 'core', 'monoclonal_antibody', 'gene', 'therapy', 'market', 'new', 'manufacturing', 'capacity', 'come', 'line', 'strong', 'first_half', 'order', 'confident', 'finish', 'now', 'expect', 'overall', 'revenue', 'range', 'year'], ['financial', 'highlight', 'second_quarter'], ['financial', 'detail', 'second_quarter', 'first_half'], ['revenue'], ['revenue'], ['gross_profit', 'gross_margin'], ['operating_income'], ['net_income'], ['earning_share', 'eps'], ['ebitda'], ['cash'], ['reconciliation_gaap', 'adjust', 'non_gaap', 'figure', 'above', 'as_well', 'ebitda_adjust_ebitda', 'detail', 'reconciliation', 'table', 'include', 'later', 'press_release'], ['financial_guidance'], ['financial_guidance', 'fiscal_year', 'base', 'expectation', 'exist', 'business', 'include', 'financial', 'impact', 'acquisition', 'bioflex', 'solution', 'close', 'close', 'polymem', 'close', 'guidance', 'below', 'exclude', 'impact', 'potential', 'additional', 'acquisition', 'future', 'fluctuation', 'foreign_currency_exchange_rate'], ['fiscal_year', 'guidance'], ['non_gaap', 'guidance', 'fiscal_year', 'exclude', 'follow', 'item'], ['non_gaap', 'guidance', 'fiscal_year', 'include'], ['reconciliation_gaap', 'adjust', 'non_gaap', 'guidance', 'detailed', 'table', 'include', 'later', 'press_release'], ['conference', 'host_conference_call_webcast', 'today', 'am', 'est', 'discuss', 'second_quarter_financial', 'result', 'corporate', 'development', 'conference_call', 'accessible', 'dial', 'toll', 'free', 'domestic', 'caller', 'international_caller', 'passcode', 'require', 'live', 'call', 'addition', 'webcast', 'accessible', 'investor_relation', 'section', 'company', 'website', 'conference_call', 'archive', 'period', 'time', 'follow', 'live', 'event', 'replay', 'dial', 'number', 'international_caller', 'replay', 'listener', 'provide', 'passcode'], ['non_gaap_measure', 'financial_performance', 'supplement', 'financial', 'statement', 'present', 'basis', 'generally_accept', 'accounting_principle', 'follow', 'non_gaap_measure', 'financial_performance', 'include', 'release', 'revenue_growth', 'rate', 'constant_currency', 'adjust', 'gross_profit', 'adjust', 'gross_margin', 'adjusted', 'income', 'operation', 'adjust', 'operating_income', 'adjust_net_income', 'earning', 'interest', 'taxis', 'depreciation_amortization', 'ebitda_adjust_ebitda', 'adjust_net_income', 'adjust_net_income', 'share', 'dilute', 'adjust', 'fully', 'dilute_earning', 'share', 'adjust', 'cost_sale', 'adjust', 'expense', 'adjust', 'expense', 'company', 'provide', 'organic', 'revenue_growth', 'rate', 'constant_currency', 'exclude', 'impact', 'foreign_currency', 'translation', 'impact', 'acquisition', 'revenue', 'current', 'year', 'period', 'prior', 'year', 'comparable', 'order', 'facilitate', 'comparison', 'current', 'revenue', 'performance', 'past', 'revenue', 'performance', 'company', 'provide', 'revenue_growth', 'rate', 'constant_currency', 'order', 'facilitate', 'comparison', 'current', 'revenue', 'performance', 'past', 'revenue', 'performance', 'calculate', 'revenue_growth', 'rate', 'constant_currency', 'company', 'convert', 'actual', 'net_sale', 'local', 'currency', 'dollar', 'use', 'constant', 'foreign_currency_exchange_rate', 'current', 'prior_period'], ['company', 'non_gaap', 'financial', 'result', 'non_gaap', 'guidance_exclude', 'impact', 'acquisition_relate', 'inventory', 'step', 'cost', 'acquisition', 'integration', 'cost', 'intangible', 'amortization', 'cost', 'contingent_consideration', 'expense', 'relate', 'company', 'acquisition', 'amortization', 'debt', 'issuance', 'cost', 'relate', 'company', 'convertible', 'debt', 'non_cash', 'interest', 'expense', 'loss', 'conversion', 'debt', 'related', 'impact', 'tax', 'non_gaap', 'charge', 'cost', 'exclude', 'management_believe', 'such', 'expense', 'direct', 'correlation', 'future', 'business_operation', 'result', 'charge', 'record', 'accurately', 'reflect', 'performance', 'ongoing', 'operation', 'period', 'such', 'charge', 'record'], ['reconciliation_gaap', 'adjusted', 'non_gaap_financial_measure', 'include', 'attachment', 'press_release', 'when', 'analyze', 'company', 'operating', 'performance', 'guidance', 'investor', 'consider', 'non_gaap_measure', 'substitutable', 'comparable', 'financial_measure', 'prepare', 'accordance_gaap'], ['global', 'life_science', 'company', 'develop_commercialize', 'highly', 'innovative', 'bioprocessing', 'technology', 'system', 'increase', 'efficiency', 'process', 'manufacture', 'biological', 'drug', 'inspire', 'advance', 'bioprocesse', 'customer', 'serve', 'primarily', 'drug', 'developer', 'contract', 'development', 'manufacturing', 'organization', 'cdmos', 'worldwide', 'corporate', 'headquarter', 'locate', 'additional', 'administrative', 'manufacture', 'operation', 'worldwide', 'majority', 'manufacturing', 'site', 'locate', 'site', 'more', 'information', 'company', 'include', 'repligen', 'news', 'release', 'see', 'website', 'follow_twitter'], ['statement', 'safeharbor', 'investor_caution', 'statement', 'press_release', 'strictly', 'historical', 'statement', 'include_limitation', 'express_imply', 'statement', 'guidance_regard', 'current', 'future', 'financial_performance', 'position', 'include', 'cash', 'investment', 'position', 'demand', 'market', 'operate', 'expect', 'performance', 'business', 'expect', 'performance', 'acquire', 'business', 'ability', 'continue', 'generate', 'magnitude', 'covid', 'relate', 'revenue', 'expected', 'performance', 'success', 'strategic', 'partnership', 'strategy', 'plan_objective', 'future', 'operation', 'acquisition', 'product', 'development', 'sale', 'sell', 'general_administrative', 'expenditure', 'intellectual_property', 'development', 'manufacturing', 'plan', 'availability', 'material', 'product', 'adequacy', 'capital', 'resource', 'financing', 'plan', 'project', 'impact', 'response', 'coronavirus_pandemic', 'business', 'global', 'economy', 'constitute_forward_look', 'statement', 'identify_word', 'believe', 'expect', 'seek', 'anticipate', 'project', 'estimate', 'similar_expression', 'forward_look_statement', 'historical_fact', 'assurance', 'future', 'performance', 'forward_look_statement', 'relate', 'future', 'subject', 'number_risk_uncertainty', 'cause_actual_result_differ', 'materially', 'anticipate', 'include_limitation', 'risk_associate', 'follow', 'effect', 'coronavirus_pandemic', 'include', 'mitigation', 'effort', 'economic', 'effect', 'business_operation', 'operation', 'customer', 'supplier', 'ultimate', 'impact', 'coronavirus_pandemic', 'business', 'financial', 'result', 'ability', 'successfully', 'grow', 'bioprocessing', 'business', 'include', 'result', 'acquisition', 'partnership', 'opportunity', 'ability', 'develop_commercialize', 'product', 'market', 'acceptance', 'product', 'ability', 'successfully', 'integrate', 'acquire', 'business', 'business', 'achieve', 'expect', 'benefit', 'such', 'acquisition', 'reduce', 'demand', 'product', 'adversely', 'impact', 'future', 'revenue', 'cash_flow', 'result', 'operation', 'financial', 'condition', 'ability', 'compete', 'large', 'better', 'finance', 'bioprocessing', 'pharmaceutical', 'biotechnology', 'company', 'compliance', 'food', 'regulation', 'volatile', 'stock', 'price', 'other', 'risk', 'detail', 'repligen', 'annual_report_form', 'year', 'end', 'most', 'recently', 'file', 'quarterly_report_form', 'file', 'other', 'report', 'repligen', 'periodically', 'file', 'security', 'exchange', 'rely', 'forward_look_statement', 'theseforward', 'expectation', 'assumption', 'regard', 'future', 'business', 'future', 'plan', 'strategy', 'projection', 'anticipate', 'event', 'trend', 'economy', 'other', 'future', 'condition', 'base', 'only', 'information', 'currently', 'available', 'write', 'oralanyofthese', 'forward_look_statement', 'reflect', 'change', 'view', 'event_circumstance', 'result', 'new', 'information', 'future', 'development', 'otherwise', 'occur', 'datehereof', 'require'], ['global', 'head', 'investor_relation'], ['net', 'revenue', 'second_quarter', 'increase', 'same_period'], ['average', 'number', 'patient', 'wakix', 'increase'], ['sign', 'new', 'agreement', 'focused', 'develop', 'innovative', 'therapeutic', 'base', 'pitolisant', 'expand', 'harmony', 'opportunity', 'narcolepsy'], ['phase', 'idiopathic', 'intune', 'study', 'track', 'site', 'activation', 'patient', 'enrollment'], ['conference_call_webcast', 'hold', 'today', 'am'], ['harmony', 'harmony', 'company', 'pharmaceutical', 'company', 'focus', 'deliver', 'innovative', 'therapy', 'improve', 'health', 'people', 'live', 'rare', 'neurological', 'disease', 'today', 'report', 'financial', 'result', 'business', 'update', 'quarter_end'], ['continue', 'momentum', 'help', 'deliver', 'quarter', 'strong', 'growth', 'wakix', 'net', 'revenue', 'average', 'number', 'patient', 'wakix', 'second_quarter', 'represent', 'good', 'quarter', 'performance', 'top', 'line', 'prescription', 'demand', 'year', 'state', 'president_chief_executive_officer', 'harmony'], ['addition', 'excited', 'announce', 'new', 'agreement', 'design', 'leverage', 'drug_discovery', 'capability', 'combination', 'prove', 'commercial', 'expertise', 'market', 'develop', 'innovative', 'therapeutic', 'base', 'pitolisant', 'successful', 'effort', 'expand', 'franchise', 'narcolepsy', 'yield', 'more', 'new', 'product', 'potential', 'launch'], ['very', 'excited', 'transaction', 'design', 'benefit', 'patient', 'strengthen', 'partnership', 'bioprojet', 'harmony_bioscience', 'say', 'founder'], ['second_quarter_financial', 'result'], ['net_product_revenue', 'quarter_end', 'compare', 'same_period', 'growth', 'same_period', 'primarily', 'attribute', 'strong', 'commercial', 'sale', 'wakix', 'drive', 'continued', 'organic', 'demand', 'average', 'number', 'patient', 'wakix', 'increase', 'approximately', 'quarter_end'], ['gaap', 'net_income', 'quarter_end', 'diluted', 'share', 'compare', 'gaap', 'net_income', 'dilute', 'share', 'same_period', 'non_gaap', 'adjust_net_income', 'dilute', 'share', 'quarter_end', 'compare', 'non_gaap', 'adjust_net_income', 'dilute', 'share', 'same_period'], ['reconciliation', 'applicable', 'gaap_financial', 'measure', 'non_gaap_financial_measure', 'include', 'end', 'press_release'], ['operating', 'expense', 'include', 'follow'], ['harmony', 'cash_cash_equivalent', 'investment'], ['recent', 'update'], ['conference_call', 'today', 'am', 'host', 'second_quarter_financial', 'result', 'conference_call_webcast', 'today', 'begin', 'am_eastern', 'time', 'live', 'replay', 'webcast', 'call', 'available', 'investor_relation', 'page', 'website', 'participate', 'live', 'call', 'phone_dial', 'domestic', 'international', 'reference', 'passcode', 'hrmyq'], ['non_gaap_financial_measure', 'addition', 'gaap', 'result', 'present', 'certain', 'non_gaap', 'metric', 'include', 'non_gaap', 'adjust_net_income', 'non_gaap', 'adjust_net_income', 'share', 'believe', 'provide', 'important', 'supplemental', 'information', 'management', 'investor', 'regard', 'performance', 'measurement', 'substitute', 'gaap', 'measurement', 'manner', 'calculate', 'non_gaap', 'adjust_net_income', 'non_gaap', 'adjust_net_income', 'share', 'identical', 'manner', 'other', 'company', 'calculate', 'adjust_net_income', 'adjust_net_income', 'share', 'company', 'use', 'non_gaap', 'measurement', 'aid', 'monitor', 'financial_performance', 'quarter', 'quarter', 'year', 'year', 'benchmarke', 'comparable', 'company'], ['non_gaap_financial_measure', 'consider_isolation', 'substitute', 'comparable', 'gaap', 'measure', 'read', 'conjunction', 'consolidated_financial', 'statement', 'prepare', 'accordance_gaap', 'standardized', 'meaning', 'prescribe', 'gaap', 'prepare', 'comprehensive', 'set', 'accounting', 'rule', 'principle', 'addition', 'time', 'time', 'future', 'other', 'item', 'exclude', 'purpose', 'non_gaap_financial_measure', 'future', 'cease', 'exclude', 'item', 'historically', 'exclude', 'purpose', 'non_gaap_financial_measure'], ['pitolisant', 'tablet', 'first_class', 'medication', 'approve', 'administration', 'treatment', 'excessive', 'daytime', 'sleepiness', 'cataplexy', 'adult', 'patient', 'narcolepsy', 'commercially', 'available', 'grant', 'drug', 'designation', 'treatment', 'narcolepsy', 'breakthrough', 'therapy', 'designation', 'treatment', 'wakix', 'selective', 'histamine', 'receptor', 'antagonist', 'inverse', 'agonist', 'mechanism_action', 'wakix', 'unclear', 'however', 'efficacy', 'mediate', 'activity', 'receptor', 'thereby', 'increase', 'synthesis', 'release', 'histamine', 'wake', 'promote', 'design', 'develop', 'harmony', 'exclusive', 'license', 'develop', 'manufacture', 'commercialize', 'pitolisant'], ['indication', 'usage', 'indicate', 'treatment', 'excessive', 'daytime', 'sleepiness', 'cataplexy', 'adult', 'patient', 'narcolepsy'], ['important', 'safety', 'information'], ['contraindicate', 'patient', 'know', 'pitolisant', 'component', 'formulation', 'report', 'wakix', 'also', 'contraindicate', 'patient', 'severe', 'hepatic', 'impairment'], ['warning', 'precaution', 'prolong', 'interval', 'avoid', 'use', 'wakix', 'patient', 'know', 'prolongation', 'combination', 'other', 'drug', 'know', 'prolong', 'interval', 'avoid', 'use', 'patient', 'history', 'cardiac', 'arrhythmia', 'as_well', 'other', 'circumstance', 'increase', 'risk', 'occurrence', 'pointe', 'sudden', 'death', 'include', 'symptomatic', 'presence', 'congenital', 'prolongation', 'interval'], ['risk', 'prolongation', 'great', 'patient', 'hepatic', 'renal', 'impairment', 'high', 'concentration', 'pitolisant', 'monitor', 'patient', 'increase', 'dosage', 'modification', 'recommend', 'patient', 'moderate', 'hepatic', 'impairment', 'moderate_severe', 'renal', 'impairment', 'see_full', 'prescribing_information', 'wakix', 'recommend', 'patient', 'end', 'stage', 'renal', 'disease'], ['adverse_reaction', 'placebo_control', 'clinical_trial', 'conduct', 'patient', 'narcolepsy', 'cataplexy', 'most_common', 'adverse_reaction', 'twice', 'placebo', 'wakix', 'nausea', 'anxiety', 'other', 'adverse_reaction', 'occur', 'more', 'frequently', 'patient', 'treat', 'placebo', 'include', 'infection', 'musculoskeletal', 'pain', 'heart', 'rate', 'increase', 'hallucination', 'abdominal_pain', 'sleep', 'disturbance', 'decrease', 'mouth'], ['drug', 'interaction', 'administration', 'strong', 'cyp', 'inhibitor', 'increase', 'pitolisant', 'exposure', 'reduce', 'dose', 'wakix', 'half'], ['concomitant', 'use', 'wakix', 'strong', 'cyp', 'inducer', 'decrease', 'exposure', 'pitolisant', 'dosage', 'adjustment', 'require', 'see_full', 'prescribing_information'], ['receptor', 'antagonist', 'cross', 'blood', 'brain', 'barrier', 'reduce', 'effectiveness', 'wakix', 'patient', 'avoid', 'centrally', 'act', 'receptor', 'antagonist'], ['borderline', 'weak', 'inducer', 'cyp', 'therefore', 'reduce', 'effectiveness', 'sensitive', 'cyp', 'substrate', 'occur', 'when', 'use', 'concomitantly', 'wakix', 'effectiveness', 'hormonal_contraceptive', 'reduce', 'when', 'use', 'wakix', 'effectiveness', 'reduce', 'day', 'discontinuation', 'therapy'], ['use', 'specific', 'population', 'wakix', 'reduce', 'effectiveness', 'hormonal_contraceptive', 'patient', 'use', 'hormonal', 'contraception', 'advise', 'use', 'alternative', 'non', 'hormonal_contraceptive', 'method', 'treatment', 'wakix', 'at_least', 'day', 'discontinue', 'treatment'], ['pregnancy', 'exposure', 'registry', 'monitor', 'pregnancy', 'outcome', 'woman', 'expose', 'wakix', 'pregnancy', 'patient', 'encourage', 'enroll', 'pregnancy', 'registry', 'become_pregnant', 'enroll', 'obtain', 'information', 'registry', 'patient', 'call', 'safety', 'effectiveness', 'wakix', 'establish', 'patient', 'less', 'year', 'age'], ['extensively', 'metabolize', 'liver', 'wakix', 'contraindicate', 'patient', 'severe', 'hepatic', 'impairment', 'dosage', 'adjustment', 'require', 'patient', 'moderate', 'hepatic', 'impairment'], ['recommend', 'patient', 'end', 'stage', 'renal', 'disease', 'dosage', 'adjustment', 'wakix', 'recommend', 'patient', 'moderate_severe', 'renal', 'impairment'], ['dosage', 'reduction', 'recommend', 'patient', 'know', 'poor', 'cyp', 'metabolizer', 'patient', 'high', 'concentration', 'wakix', 'normal', 'cyp', 'metabolizer'], ['see_full', 'prescribing_information', 'wakix', 'more', 'information'], ['report', 'suspect', 'adverse_reaction', 'contact', 'harmony_bioscience'], ['rare', 'chronic', 'debilitate', 'neurological', 'disease', 'sleep', 'wake', 'state', 'instability', 'impact', 'approximately', 'primarily', 'characterize', 'excessive', 'daytime', 'sleepiness', 'cardinal', 'symptom', 'other', 'manifestation', 'rem', 'sleep', 'dysregulation', 'hallucination', 'sleep', 'paralysis', 'intrude', 'wakefulness', 'eds', 'inability', 'stay', 'awake', 'alert', 'day', 'symptom', 'present', 'people', 'live', 'narcolepsy', 'most', 'patient', 'narcolepsy', 'cause', 'loss', 'orexin', 'neuropeptide', 'brain', 'support', 'sleep', 'wake', 'state', 'stability', 'disease', 'affect', 'man', 'woman', 'equally', 'typical', 'symptom', 'onset', 'adolescence', 'young', 'adulthood', 'however', 'take', 'decade', 'properly', 'diagnose'], ['idiopathic', 'rare', 'chronic', 'neurological', 'disease', 'characterize', 'excessive', 'daytime', 'sleepiness', 'eds', 'sufficient', 'even', 'long', 'sleep', 'time', 'eds', 'can', 'alleviate', 'nap', 'long', 'sleep', 'more', 'efficient', 'sleep', 'people', 'live', 'experience', 'significant', 'ed', 'symptom', 'sleep', 'prolonged', 'difficulty', 'wake', 'sleep', 'brain', 'fog', 'impair', 'cognition', 'attention', 'alertness', 'cause', 'unknown', 'likely', 'due', 'alteration', 'area', 'brain', 'stabilize', 'state', 'sleep', 'central', 'disorder', 'hypersomnolence', 'narcolepsy', 'debilitate', 'sleep', 'disorder', 'result', 'significant', 'disruption', 'daily', 'functioning'], ['investigational', 'compound', 'melanin', 'concentrate', 'hormone', 'receptor', 'antagonist', 'target', 'mch', 'neuron', 'brain', 'potential', 'first_class', 'molecule', 'novel', 'mechanism_action', 'offer', 'new', 'approach', 'treatment', 'variety', 'rare', 'neurological', 'disease'], ['harmony_bioscience', 'harmony_bioscience', 'specialize', 'develop', 'deliver', 'treatment', 'rare', 'neurological', 'disease', 'other', 'often', 'overlook', 'believe', 'where', 'empathy', 'innovation', 'meet', 'well', 'life', 'begin', 'people', 'live', 'neurological', 'disease', 'establish', 'bioscience', 'headquarter', 'plymouth', 'meeting', 'team', 'expert', 'wide', 'variety', 'disciple', 'experience', 'drive', 'shared', 'conviction', 'innovative', 'science', 'translate', 'therapeutic', 'possibility', 'patient', 'heart', 'more_information_visit'], ['forward_look_statement', 'press_release_contain', 'forward_look_statement_meaning', 'private_security', 'statement_contain_press', 'release', 'relate', 'matter', 'historical_fact', 'consider', 'forward_look_statement', 'include', 'statement', 'regard', 'product', 'wakix', 'new', 'agreement', 'bioprojet', 'statement', 'promise_guarantee', 'involve', 'know_unknown', 'risk_uncertainty', 'other', 'important_factor', 'cause_actual', 'result', 'performance_achievement', 'materially_different', 'future', 'result', 'performance_achievement', 'express_imply', 'forward_look_statement', 'include', 'limit', 'follow', 'effort', 'strategy', 'wakix', 'rate', 'degree', 'market', 'acceptance', 'clinical', 'utility', 'wakix', 'pitolisant', 'additional', 'indication', 'approve', 'other', 'product_candidate', 'develop', 'acquire', 'approve', 'research', 'development', 'plan', 'include', 'development', 'activity', 'bioprojet', 'plan', 'explore', 'therapeutic', 'potential', 'pitolisant', 'additional', 'indication', 'ongoing', 'plan', 'clinical_trial', 'availability', 'favorable', 'insurance', 'coverage', 'reimbursement', 'wakix', 'impact', 'pandemic', 'include', 'current', 'future', 'variant', 'timing', 'ability_obtain', 'regulatory_approval', 'pitolisant', 'other', 'indication', 'as_well', 'product_candidate', 'include', 'develop', 'bioprojet', 'failure', 'satisfy', 'closing', 'condition', 'new', 'agreement', 'include', 'obtain', 'clearance', 'act', 'failure', 'achieve', 'potential', 'benefit', 'new', 'agreement', 'estimate', 'regard', 'expense', 'future', 'revenue', 'capital', 'requirement', 'need', 'additional', 'financing', 'ability', 'identify', 'additional', 'product', 'product_candidate', 'significant', 'commercial', 'potential', 'consistent', 'commercial', 'objective', 'marketing', 'manufacturing_capability', 'strategy', 'significant', 'competition', 'industry', 'intellectual_property', 'position', 'loss', 'retirement', 'key', 'member', 'management', 'failure', 'successfully', 'execute', 'growth', 'strategy', 'include', 'delay', 'planned', 'future', 'growth', 'failure', 'maintain', 'effective', 'internal', 'control', 'impact', 'government', 'law', 'regulation', 'volatility', 'fluctuation', 'price', 'common_stock', 'significant', 'cost', 'require', 'management', 'time', 'result', 'operate', 'public', 'company', 'fact', 'price', 'harmony', 'common_stock', 'volatile', 'fluctuate', 'substantially', 'significant', 'cost', 'require', 'management', 'time', 'result', 'operate', 'public', 'company', 'other', 'important_factor', 'discuss', 'caption', 'risk_factor_annual_report', 'form', 'file', 'other', 'filing', 'cause_actual_result_differ', 'materially_indicate', 'forward_look_statement', 'make', 'press_release', 'such_forward_look', 'statement_represent', 'management', 'estimate', 'date_press_release', 'elect', 'update', 'such_forward_look', 'statement', 'point', 'future', 'disclaim_obligation', 'so', 'even', 'subsequent', 'event', 'cause', 'view', 'change'], ['subsidiary'], ['consolidated', 'statement', 'operation', 'comprehensive', 'income', 'thousand_share', 'share', 'datum'], ['balance_sheet', 'thousand_share', 'share', 'datum'], ['reconciliation_gaap_non_gaap', 'financial', 'result', 'thousand_share', 'share', 'datum'], ['include', 'amortization', 'defer', 'finance', 'charge', 'include', 'amortization', 'intangible_asset', 'relate', 'calculate', 'use', 'report', 'effective_tax_rate', 'period', 'present'], ['harmony_bioscience', 'investor_contact', 'lsanay'], ['harmony_bioscience', 'medium_contact', 'nleone'], ['announce', 'first', 'patient', 'dose', 'pivotal', 'ladder', 'trial', 'phase_randomize_double', 'blind', 'period', 'crossover', 'withdrawal', 'study', 'assess', 'efficacy_safety', 'subject', 'leukocyte', 'adhesion', 'deficiency', 'avtx', 'therapy', 'develop', 'study', 'treatment', 'leukocyte', 'adhesion', 'also', 'know', 'avtx', 'grant', 'rare_pediatric', 'disease', 'designation', 'drug', 'designation', 'odd', 'fast_track_designation', 'ftd'], ['excited', 'announce', 'first', 'patient', 'dose', 'ladder', 'pivotal', 'trial', 'substantially', 'advance', 'program', 'approve', 'treatment_option', 'patient', 'also', 'potential', 'prv', 'say', 'president_chief_executive_officer', 'therapeutic'], ['avtx', 'active', 'ingredient', 'fucose', 'plant', 'derive', 'naturally_occur', 'monosaccharide', 'high', 'solubility', 'water', 'isolate', 'white', 'crystalline', 'powder', 'oral', 'formulation', 'fucose', 'enhance', 'fucosylation', 'protein', 'absence', 'function', 'gdp', 'transporter', 'partially', 'restore', 'protein', 'function', 'grant', 'ftd', 'odd', 'rpdd', 'make', 'potentially', 'eligible', 'priority_review', 'voucher', 'prv'], ['pivotal', 'trial', 'ladder', 'trial', 'pivotal', 'randomize_double_blind', 'period', 'crossover', 'withdrawal', 'study', 'assess', 'efficacy_safety', 'patient', 'primary_endpoint', 'comparison', 'leukocyte', 'function', 'determine', 'sialyl', 'slx', 'expression', 'leukocyte', 'treatment', 'period', 'trial', 'conclude', 'end', 'study', 'early', 'termination', 'visit', 'time', 'subject', 'permit', 'enroll', 'long_term', 'open_label', 'safety_efficacy', 'study'], ['ultra', 'rare', 'inherit', 'congenital', 'disorder', 'glycosylation', 'previously', 'know', 'also', 'refer', 'disease', 'autosomal', 'recessive', 'characterize', 'reduced', 'absent', 'fucosylation', 'certain', 'glycoprotein', 'patient', 'lad', 'present', 'multi_system', 'phenotype', 'include', 'leukocytosis', 'recurrent', 'infection', 'reduce', 'selectin', 'expression', 'bind', 'bombay', 'blood', 'group', 'poor', 'feed', 'short', 'stature', 'coarse', 'facial', 'feature', 'global', 'developmental', 'delay', 'psychomotor', 'retardation', 'case', 'symptom', 'lead_death', 'most', 'lad', 'patient', 'disorder', 'negatively', 'impact', 'quality_life', 'lead', 'clinical_stage', 'precision_medicine', 'company', 'discover_develop', 'commercialize', 'target', 'therapeutic', 'patient', 'significant', 'unmet', 'clinical', 'need', 'immunology', 'rare', 'genetic', 'disease', 'company', 'build', 'diverse', 'portfolio', 'innovative', 'therapy', 'deliver', 'meaningful', 'medical', 'impact', 'patient', 'urgent', 'need', 'company', 'clinical', 'candidate', 'commonly', 'prove', 'mechanistic', 'rationale', 'biomarker', 'establish', 'proof_concept', 'expedite', 'increase', 'probability', 'success'], ['more_information_visit'], ['forward_look_statement', 'press_release_include', 'forward_look_statement', 'make', 'pursuant', 'private_security_forward_look', 'statement', 'statement_historical_fact', 'such_forward_look', 'statement', 'subject', 'significant', 'risk_uncertainty', 'subject', 'change', 'base', 'various', 'factor', 'many', 'control', 'cause_actual_result_differ', 'forward_look_statement', 'such', 'statement', 'include_limitation', 'statement', 'respect', 'plan_objective', 'projection', 'expectation', 'intention', 'other', 'statement', 'identify_word', 'such', 'project', 'continue', 'seek', 'aim', 'predict', 'believe', 'expect', 'anticipate', 'estimate', 'intend', 'plan', 'potential', 'similar_expression', 'include', 'use', 'negative', 'discussion', 'future', 'matter', 'such', 'development', 'product_candidate', 'product', 'timing', 'success', 'trial', 'result', 'regulatory', 'review', 'potential', 'attribute', 'benefit', 'product_candidate', 'future', 'financial', 'operational', 'outlook', 'other', 'statement', 'historical', 'statement', 'base', 'current', 'belief', 'expectation', 'management', 'subject', 'significant', 'risk_uncertainty', 'include', 'drug', 'development', 'cost', 'timing', 'other', 'risk', 'include', 'reliance', 'investigator', 'enrollment', 'patient', 'clinical_trial', 'slow', 'pandemic', 'cash', 'position', 'potential', 'need', 'raise', 'additional', 'capital', 'reliance', 'key', 'personnel', 'include', 'result', 'recent', 'management', 'change', 'regulatory', 'risk', 'general_economic', 'market', 'risk_uncertainty', 'include', 'cause', 'pandemic', 'tension', 'other', 'risk', 'detail', 'filing', 'actual_result_differ', 'set_forth', 'forward_look_statement', 'require_applicable', 'law', 'avalo', 'expressly', 'disclaim_obligation', 'undertaking', 'release', 'publicly_update', 'revision', 'forward_look_statement', 'contain', 'reflect', 'change', 'expectation', 'respect', 'thereto', 'change', 'event', 'condition', 'circumstance', 'statement', 'base'], ['medium', 'investor', 'inquiry'], [], [], [], [], ['clinical_stage', 'regenerative_medicine', 'company', 'mesenchymal', 'stromal', 'cell', 'produce', 'result', 'year', 'research', 'development', 'treatment', 'horse', 'dog', 'institution', 'recognize', 'top', 'veterinary', 'university', 'world', 'together', 'translational'], ['also', 'conduct', 'clinical_trial', 'septic', 'arthritis', 'horse', 'use', 'msc', 'treat', 'chronic', 'drug', 'resistant', 'infection', 'more_information_visit'], [], ['private', 'equity', 'fund', 'invest', 'food'], ['innovation', 'small', 'business', 'growth', 'acc', 'aim', 'discover_develop', 'nurture', 'canadian', 'agricultural', 'business', 'capital', 'investment', 'business', 'management', 'mentorship', 'entrepreneurial', 'expertise', 'more', 'information', 'acc', 'visit'], ['medium_contact'], [], [], [], [], ['lead', 'developer', 'computerized', 'drug_delivery', 'instrument', 'provide', 'painless', 'precise', 'injection', 'today_announce', 'commence', 'sale', 'compuflo', 'epidural', 'system', 'incorporation', 'student', 'register', 'nurse', 'program'], ['doctor', 'nursing', 'practice', 'register', 'nurse', 'anesthetist', 'administrator', 'state', 'proper', 'training', 'essential', 'perform', 'epidural', 'procedure', 'give', 'inherent', 'associate', 'risk', 'epidural', 'system', 'transform', 'procedure', 'art', 'science', 'provide', 'real', 'time', 'visual', 'audio', 'feedback', 'exact', 'placement', 'tip', 'needle', 'real', 'time', 'turn', 'help', 'dramatically', 'reduce', 'risk', 'dural', 'puncture', 'other', 'potential', 'complication', 'arise', 'mission', 'educate', 'student', 'late', 'advancement', 'medicine', 'carry', 'skill', 'forward', 'workplace', 'career'], ['comment', 'honor', 'incorporate', 'epidural', 'system', 'srna', 'program', 'believe', 'selection', 'reinforce', 'prove', 'clinical', 'safety', 'benefit', 'technology', 'back', 'numerous', 'clinical', 'study', 'demonstrate', 'reduction', 'epidural', 'puncture', 'complication', 'rate', 'notably', 'accord', 'statistic', 'nurse', 'anesthetist', 'already', 'outnumber', 'great', 'number', 'nurse', 'anesthetist', 'enter', 'field', 'play', 'increasingly', 'important', 'role', 'believe', 'train', 'next_generation', 'nurse', 'anesthetist', 'use', 'instrument', 'critical', 'achieve', 'goal', 'establish', 'epidural', 'system', 'new', 'standard_care', 'labor', 'delivery', 'as_well', 'pain', 'management', 'like', 'commend', 'commitment', 'educate', 'student', 'late', 'technology', 'ensure', 'good', 'patient', 'provider', 'experience'], ['technology', 'focus', 'medical', 'research', 'development', 'company', 'patent', 'design', 'develop', 'innovative', 'injection', 'technology', 'instrument', 'medical', 'dental', 'cosmetic', 'application', 'computer', 'control', 'system', 'design', 'make', 'injection', 'precise', 'efficient', 'increase', 'overall', 'patient', 'comfort', 'safety', 'proprietary', 'dps', 'dynamic', 'pressure', 'sense', 'technology', 'instrument', 'platform', 'advance', 'development', 'next_generation', 'device', 'regulate', 'flow', 'rate', 'monitor', 'pressure', 'tip', 'needle', 'platform', 'extension', 'subcutaneous', 'drug_delivery', 'include', 'local', 'anesthetic', 'learn_more', 'view', 'brand', 'video', 'visit'], ['statement', 'press_release_contain', 'forward_look_statement', 'regard', 'timing', 'financial', 'impact', 'ability', 'implement', 'business', 'plan', 'expect', 'revenue', 'timing', 'regulatory_approval', 'future', 'success', 'statement', 'involve', 'number_risk_uncertainty', 'base', 'assumption', 'involve', 'judgment', 'respect', 'future', 'economic', 'competitive', 'market', 'condition', 'future', 'business', 'decision', 'regulatory', 'development', 'difficult', 'impossible', 'predict', 'accurately', 'many', 'control', 'important_factor', 'cause_actual_result_differ', 'materially_indicate', 'forward_look_statement', 'general_economic', 'condition', 'failure', 'achieve', 'expect', 'revenue_growth', 'change', 'operating', 'expense', 'adverse', 'patent', 'ruling', 'legal', 'development', 'competitive', 'pressure', 'change', 'customer', 'market', 'requirement', 'standard', 'risk_factor', 'detail', 'time', 'time', 'periodic', 'filing', 'include_limitation', 'annual_report', 'year', 'end', 'forward_look_statement', 'press_release_base', 'management', 'reasonable', 'belief', 'date_hereof', 'milestone', 'undertake_obligation_revise', 'update', 'publicly', 'forward_look_statement', 'reason'], ['contact', 'email', 'tel'], ['global', 'inhibitor', 'drug', 'clinical_trial', 'report', 'highlight'], ['sample', 'report', 'cd', 'inhibitor', 'drug', 'clinical_trial'], ['technological_advancement', 'field', 'cancer', 'biology', 'lead', 'identification', 'next_generation', 'therapeutic', 'target', 'cd', 'integrin', 'associate', 'protein', 'trans', 'membrane', 'glycoprotein', 'widely', 'express', 'normal', 'cell', 'function', 'mainly', 'marker', 'macrophage', 'differentiate', 'self', 'non', 'self', 'apart', 'overexpression', 'also', 'associate', 'several', 'cancer', 'such', 'ovarian_cancer', 'leukemia', 'other', 'further', 'signal', 'pathway', 'also', 'critical', 'progression', 'cancer', 'owe', 'characteristic', 'therapeutic', 'target', 'gain', 'significant', 'interest', 'pharmaceutical', 'company', 'worldwide'], ['currently', 'cd', 'target', 'therapy', 'development', 'confine', 'preclinical', 'clinical_stage', 'keep', 'mind', 'huge', 'clinical', 'success', 'monoclonal_antibody', 'researcher', 'develop', 'cd', 'target', 'monoclonal_antibody', 'several', 'potential', 'monoclonal_antibody', 'develop', 'include', 'other', 'ongoing', 'clinical_trial', 'evaluate', 'role', 'monoclonal_antibody', 'monotherapy', 'combination', 'therapy', 'wide_range', 'solid_tumor', 'as_well', 'hematological', 'malignancy', 'instance', 'develop', 'akeso', 'evaluate', 'phase', 'trial', 'monotherapy', 'combination', 'azacitidine', 'pacilataxel', 'management', 'solid_tumor'], ['further', 'progress', 'antibody', 'engineering', 'lead', 'development', 'dual', 'target', 'antibody', 'bispecific_antibody', 'ability', 'target', 'different', 'antigen', 'simultaneously', 'currently', 'only', 'few', 'bispecific_antibody', 'construct', 'develop', 'include', 'imm', 'rapidly', 'demonstrate', 'encourage', 'datum', 'instance', 'innovent', 'biologic', 'recently', 'announce', 'encouraging', 'result', 'phase', 'trial', 'anti', 'cd', 'bispecific_antibody', 'company', 'report', 'investigational', 'bispecific_antibody', 'construct', 'show', 'favorable', 'safety_tolerability', 'profile', 'patient', 'advanced', 'solid_tumor', 'further', 'trial', 'initiate', 'further', 'explore', 'safety_efficacy', 'multiple', 'oncological', 'condition'], ['global', 'inhibitor', 'market', 'highly', 'competitive', 'wide_range', 'pharmaceutical', 'company', 'actively', 'invest', 'research', 'development', 'activity', 'relate', 'segment', 'key', 'player', 'market', 'also', 'adopt', 'strategic', 'alliance', 'such', 'collaboration', 'partnership', 'acquisition', 'joint', 'venture', 'maintain', 'position', 'global', 'market', 'instance', 'actinium', 'pharmaceutical', 'enter', 'research', 'collaboration', 'epicentrx', 'study', 'actinium', 'actimab', 'target', 'radiotherapy', 'combination', 'epicentrx', 'novel_small_molecule', 'immunotherapy', 'target', 'company', 'initiate', 'clinical_trial', 'evaluate', 'role', 'novel', 'combination', 'patient', 'acute', 'myeloid', 'leukemia'], ['major', 'region', 'favor', 'research', 'development', 'activity', 'relate', 'cd', 'target', 'therapy', 'much', 'progress', 'inhibitor', 'also', 'witness', 'date', 'more', 'drug', 'approve', 'clinical', 'research', 'nmpa', 'account', 'almost', 'half', 'clinical', 'pipeline', 'product', 'globally', 'domestic', 'chinese', 'pharmaceutical', 'company', 'include', 'other', 'develop', 'robust_pipeline', 'cd', 'target', 'agent', 'expect', 'gain', 'approval', 'future'], ['report', 'finding', 'global', 'inhibitor', 'market', 'surpass', 'huge', 'growth', 'rate', 'forecast_period', 'attribute', 'several', 'factor', 'such', 'increase', 'research', 'development', 'activity', 'pharmaceutical', 'company', 'surge', 'prevalence', 'cancer', 'associate', 'demand', 'targeted', 'therapy', 'favorable', 'government', 'initiative', 'expect', 'inhibitor', 'hold', 'significant', 'share', 'global', 'cancer', 'immunotherapy', 'market', 'future'], ['contact'], [], [], ['research', 'head'], [], [], ['national', 'awareness', 'month', 'webinar', 'service', 'host', 'benefit', 'aditxtscore', 'immune', 'monitoring'], ['help', 'physician', 'determine', 'patient', 'immune', 'status', 'appropriate', 'timing', 'vaccination', 'boost'], ['mark', 'first', 'day', 'national', 'awareness', 'month', 'begin', 'premier', 'medical', 'laboratory_service', 'advanced', 'medical', 'diagnostic', 'lab', 'kick', 'first', 'several', 'webinar', 'month', 'healthcare_provider', 'cover', 'benefit', 'aditxtscore', 'immune', 'monitoring', 'webinar', 'physician', 'learn_more', 'test', 'how', 'quantify', 'patient', 'individual', 'immune', 'profile', 'speaker', 'discuss', 'how', 'test', 'provide', 'more', 'clarity', 'regard', 'patient', 'immune_response', 'virus', 'vaccine', 'immune_response', 'likely', 'provide', 'protection', 'future', 'infection'], ['individual', 'vaccinate', 'experience', 'symptomatic', 'asymptomatic', 'infection', 'provide', 'timely', 'information', 'immune', 'status', 'base', 'individual', 'unique', 'circumstance', 'vaccinate', 'previously', 'infect', 'aditxtscore', 'provide', 'powerful', 'new', 'tool', 'physician', 'use', 'current', 'phase', 'pandemic', 'laboratory_service', 'host', 'webinar', 'believe', 'test', 'effectively', 'help', 'manage', 'future', 'surge', 'case', 'take', 'subjectivity', 'equation', 'when', 'determine', 'next_step', 'vaccination', 'boosting', 'precautionary', 'measure', 'aditxtscore', 'help', 'determine', 'vulnerable'], ['hope', 'webinar', 'help', 'equip', 'physician', 'most', 'advanced', 'test', 'allow', 'comprehensive', 'view', 'patient', 'health', 'status', 'say', 'service', 'aditxtscore', 'individual', 'make', 'more', 'informed', 'decision', 'vaccination', 'booster', 'other', 'risk', 'mitigation', 'strategy', 'right', 'course', 'action', 'base', 'high', 'precision', 'datum', 'specific'], ['use', 'routinely', 'track', 'change', 'immune_response', 'time', 'contribute', 'greatly', 'continue', 'understanding', 'response', 'test', 'help', 'minimize', 'vaccine', 'hesitancy', 'protect', 'antibody'], ['learn_more', 'physician', 'healthcare_provider', 'register', 'webinar', 'follow', 'date', 'link', 'th', 'st'], ['result', 'provide', 'answer', 'follow', 'question', 'individual', 'antibody', 'present', 'so', 'robust', 'individual', 'antibody', 'present', 'result', 'vaccination', 'viral', 'infection', 'individual', 'immune_response', 'likely', 'provide', 'protection', 'future', 'infection'], ['authorize', 'evaluate', 'person', 'level', 'protection', 'infection', 'offer', 'premier', 'medical', 'laboratory_service', 'authorized', 'channel', 'partner', 'additional', 'term', 'condition', 'restriction', 'apply', 'click', 'following', 'link', 'further', 'information', 'immune'], ['service', 'headquarter', 'official', 'health', 'wellness', 'partner', 'advanced', 'molecular', 'diagnostic', 'lab', 'fully', 'certify', 'top', 'laboratory', 'accrediting', 'organization', 'include', 'pride', 'deliver', 'most', 'rapid', 'turnaround', 'time', 'testing', 'result', 'industry', 'patient', 'friendly', 'bill', 'expansive', 'menu', 'highly', 'advanced', 'test', 'screening', 'include', 'genomic', 'risk', 'assessment', 'assay', 'various', 'cancer', 'heart', 'disease', 'diabete', 'as_well', 'woman', 'health', 'panel', 'toxicology', 'allergy', 'testing', 'pharmacogenomic', 'routine', 'blood', 'chemistry', 'noninvasive', 'prenatal_testing', 'heartfelt', 'mission', 'improve', 'patient', 'care', 'house', 'research', 'development', 'team', 'phd', 'scientist', 'forward', 'think', 'laboratory', 'staff', 'continually', 'innovate', 'way', 'provide', 'most', 'highly', 'advanced', 'medical', 'diagnostic', 'available', 'more_information_visit', 'call'], ['biotech', 'innovation', 'company', 'develop_commercialize', 'technology', 'focus', 'monitor', 'reprogramme', 'immune_system', 'aditxt', 'immune', 'monitoring', 'technology', 'design', 'provide', 'personalize', 'immune', 'profile', 'aditxt', 'immune', 'reprogramme', 'technology', 'currently', 'preclinical', 'develop', 'retrain', 'immune_system', 'induce', 'tolerance', 'address', 'rejection', 'transplanted', 'organ', 'autoimmune', 'disease', 'allergy'], ['more_information_visit'], ['medium_contact'], ['corporate_communication'], [], ['biospace', 'large', 'digital', 'medium', 'recruitment', 'platform', 'life_science', 'industry', 'welcome', 'manage', 'editor'], ['responsible', 'realign', 'develop', 'biospace', 'content', 'initiative', 'better', 'serve', 'community', 'life_science', 'support', 'growth', 'editorial', 'team', 'say', 'excited', 'sarita', 'bring', 'entrepreneurial', 'mindset', 'scientific', 'background', 'biospace', 'lead', 'evolution', 'content', 'offering', 'assist', 'grow', 'community', 'life_science', 'professional'], ['academic', 'professional', 'career'], ['award', 'win', 'life_science', 'professional', 'bring', 'more', 'year', 'combined', 'experience', 'academic', 'research', 'publishing'], ['have', 'work', 'academia', 'industry', 'publishing', 'be', 'very', 'excited', 'bring', 'knowledge', 'leadership', 'experience', 'biospace', 'continue', 'build', 'incredible', 'community', 'say'], ['prior', 'join', 'biospace', 'work', 'independent', 'consultant', 'serve', 'role', 'provide', 'content', 'strategy', 'editorial', 'support', 'company', 'life_science', 'industry', 'include', 'blue'], ['grow', 'where', 'earn', 'bachelor', 'chemistry', 'go', 'obtain', 'master', 'biotechnology', 'come', 'phd'], ['research', 'interest', 'training', 'primarily', 'field', 'cancer', 'cell', 'biology', 'begin', 'phd', 'dissertation', 'where', 'research', 'role', 'intracellular', 'redox', 'environment', 'tumorigenesis', 'go', 'pursue', 'postdoctoral', 'work', 'university', 'research', 'focus', 'gene', 'regulation', 'also', 'win', 'american', 'award', 'find', 'way', 'back', 'cancer', 'cell', 'biology', 'second', 'postdoctoral', 'position'], ['leave', 'academic', 'research', 'spend', 'year', 'adjunct', 'faculty', 'bioscience', 'department', 'downtown', 'experience', 'make', 'realize', 'importance', 'build', 'strong', 'science', 'math', 'foundation', 'child', 'early', 'age', 'how', 'much', 'impact', 'lifelong', 'success', 'say'], ['dedication', 'equity', 'transition', 'publishing'], ['drive', 'realization', 'sarita', 'venture', 'world', 'publishing', 'launch', 'smore', 'science', 'international', 'science_magazine', 'inspire', 'child', 'especially', 'young', 'girl', 'pursue', 'stem', 'future', 'lead', 'editorial', 'marketing', 'strategy', 'smore', 'succeed', 'grow', 'brand', 'where', 'now', 'reach', 'thousand', 'child', 'worldwide', 'receive', 'notable', 'mention', 'lead', 'medium', 'outlet', 'academic', 'institution'], ['woman', 'science', 'trench', 'sarita', 'also', 'passionate', 'advocate', 'equal', 'woman', 'minority', 'representation', 'science', 'share', 'thought', 'tedx'], ['think', 'critical', 'spotlight', 'celebrate', 'scientific', 'contribution', 'population', 'part', 'diversity', 'inclusion', 'effort', 'academia', 'industry', 'sarita', 'note'], ['shape', 'future', 'biospace'], ['incredible', 'opportunity', 'build', 'coalition', 'scientific', 'community', 'life_science', 'industry', 'biospace', 'so', 'much', 'potential', 'space', 'enable', 'connect', 'thrive', 'be', 'excited', 'part', 'say'], ['company', 'clinical_stage', 'company', 'develop', 'innovative', 'therapy', 'design', 'treat', 'reverse', 'disease', 'announce_today', 'completion_enrollment', 'dose', 'phase_open_label', 'proof_concept_study', 'regenerative', 'cell', 'therapy', 'investigational', 'product', 'intra', 'renal', 'artery', 'administration', 'treatment', 'diabetic', 'kidney_disease', 'company', 'expect', 'announce', 'top', 'line', 'datum', 'subject', 'first_quarter'], ['pleased', 'announce', 'treat', 'last', 'subject', 'phase', 'clinical_trial', 'evaluate', 'focus', 'individual', 'exhibit', 'rapidly', 'progress', 'stage', 'dkd', 'state', 'executive_vice_president_chief', 'medical_officer', 'look_forward', 'share', 'top', 'line', 'datum', 'subject', 'complete', 'month', 'follow', 'visit'], ['intra', 'renal', 'artery', 'infusion', 'cell', 'breakthrough', 'treatment', 'diabetic', 'disease', 'excited', 'work', 'program', 'state', 'research', 'director', 'principal', 'investigator', 'study', 'look_forward', 'review', 'result', 'study', 'potential', 'development', 'treatment', 'patient', 'need'], ['phase', 'clinical_trial', 'treatment', 'dkd'], ['failure', 'associate', 'attrition', 'preclinical', 'study', 'kidney_disease', 'injury', 'model', 'demonstrate', 'protection', 'replenishment', 'result', 'improve', 'kidney', 'function', 'base', 'observation', 'company', 'recently', 'initiate', 'phase_open_label', 'proof_concept', 'trial', 'evaluate', 'regenerative', 'cell', 'therapy', 'investigational', 'product', 'intra', 'renal', 'artery', 'administration', 'patient', 'dkd', 'patient', 'select', 'study', 'pre', 'dialysis', 'stage', 'kidney_disease', 'exhibit', 'rapidly', 'progress', 'stage', 'disease', 'objective', 'protocol', 'evaluate', 'tolerance', 'intra', 'renal', 'cell', 'therapy', 'injection', 'dkd', 'patient', 'as_well', 'ability', 'regenerate', 'kidney', 'function', 'more', 'information', 'study', 'visit', 'identifier'], ['disease'], ['also', 'call', 'diabetic', 'serious', 'kidney', 'relate', 'complication', 'diabetes', 'diabetes_mellitus', 'lead', 'cause', 'kidney_disease', 'approximately', 'individual', 'diabetes', 'dkd', 'time', 'high', 'blood', 'sugar', 'poorly', 'control', 'diabetes', 'damage', 'small', 'blood', 'vessel', 'kidney', 'lead', 'kidney', 'damage', 'microvascular', 'complication', 'eventually', 'develop', 'approximately', 'patient', 'type_diabetes', 'approximately', 'patient', 'type_diabete', 'all', 'cause', 'mortality', 'patient', 'dkd', 'report', 'high', 'patient', 'diabetes', 'kidney_disease'], ['bioscience'], ['clinical_stage', 'company', 'dedicate', 'development', 'innovative', 'therapy', 'design', 'treat', 'reverse', 'disease', 'currently', 'develop', 'first_class', 'autologous', 'cell', 'therapy', 'product', 'base', 'finely', 'tune', 'mechanism', 'self', 'repair', 'exist', 'human', 'body', 'technology', 'leverage', 'enable', 'mechanism', 'form', 'specific', 'cell', 'use', 'formulation', 'mode', 'delivery', 'unique', 'medical', 'indication'], ['company', 'current', 'product_candidate', 'include', 'subject', 'recently', 'complete', 'positive', 'phase_study', 'ongoing', 'phase_study', 'wwwfreedom', 'treatment', 'coronary', 'microvascular', 'dysfunction', 'recipient', 'sakigake', 'designation', 'eligible', 'early', 'conditional', 'approval', 'treatment', 'critical', 'limb', 'ischemia', 'disease', 'base', 'result', 'ongoing', 'clinical_trial', 'design_assess', 'safety_efficacy', 'cell', 'therapy', 'treatment', 'dkd', 'more', 'information', 'company', 'visit', 'wwwcaladriuscom'], ['company', 'recently', 'announce', 'sign', 'definitive', 'merger', 'agreement', 'cend', 'form', 'lisata', 'therapeutic', 'closing', 'lisata', 'publicly', 'trade', 'company', 'advanced', 'clinical', 'development', 'pipeline', 'strong', 'balance_sheet', 'expect', 'fund', 'product_candidate', 'next', 'development', 'milestone', 'merger', 'expect', 'close', 'third_quarter'], ['communication', 'contain_forward_look', 'statement', 'involve_substantial_risk_uncertainty', 'purpose', 'safe_harbor', 'provide', 'private_security', 'statement', 'other', 'statement_historical_fact', 'include', 'communication', 'regard', 'strategy', 'future', 'operation', 'future', 'financial', 'position', 'future', 'revenue', 'project', 'expense', 'prospect', 'plan_objective', 'management', 'forward_look_statement', 'addition', 'when', 'use', 'communication', 'word', 'anticipate', 'believe', 'expect', 'intend', 'predict', 'see', 'similar_expression', 'variant', 'relate', 'management', 'company', 'before', 'aforementioned', 'merger', 'identify', 'forward_look_statement', 'example', 'forward_look_statement', 'include', 'limit', 'statement', 'relate', 'timing', 'completion', 'propose', 'merger', 'continue', 'list', 'capital', 'market', 'closing', 'propose', 'merger', 'combine', 'company', 'listing', 'capital', 'market', 'closing', 'propose', 'merger', 'expectation_regard', 'capitalization', 'resource', 'ownership', 'structure', 'combine', 'company', 'approach', 'cend', 'take', 'discover_develop', 'novel', 'therapeutic', 'adequacy', 'combine', 'company', 'capital', 'support', 'future', 'operation', 'ability', 'successfully', 'initiate', 'complete', 'clinical_trial', 'difficulty', 'predict', 'time', 'cost', 'development', 'cend', 'product_candidate', 'nature', 'strategy', 'focus', 'combine', 'company', 'executive', 'board', 'structure', 'combine', 'company', 'expectation_regard', 'vote', 'cend', 'stockholder', 'actual_result_differ', 'materially', 'contain_forward_look', 'statement', 'result', 'various', 'factor', 'include_limitation', 'risk', 'condition', 'closing_transaction', 'satisfied', 'include', 'failure', 'timely', 'at_all', 'obtain', 'stockholder', 'approval', 'transaction', 'uncertainty', 'timing', 'consummation', 'transaction', 'ability', 'caladrius', 'cend', 'consummate', 'transaction', 'risk', 'relate', 'ability', 'correctly', 'estimate', 'operating', 'expense', 'expense', 'associate', 'transaction', 'ability', 'caladrius', 'cend', 'protect', 'respective', 'intellectual_property', 'right', 'unexpected', 'cost', 'charge', 'expense', 'result', 'transaction', 'potential', 'adverse_reaction', 'change', 'business', 'relationship', 'result', 'announcement', 'completion', 'transaction', 'legislative', 'regulatory', 'political_economic', 'development', 'forego', 'review', 'important_factor', 'cause_actual_event', 'differ', 'expectation', 'construe', 'exhaustive', 'read', 'conjunction', 'statement', 'include', 'elsewhere', 'include', 'risk_factor', 'include', 'annual_report_form', 'file', 'give', 'assurance', 'condition', 'transaction', 'satisfied', 'require_applicable', 'law', 'undertake_obligation_revise', 'update', 'forward_look_statement', 'make', 'other', 'forward_look_statement', 'result', 'new', 'information', 'future', 'event', 'otherwise'], ['investor', 'investor_relation', 'corporate_communication', 'phone', 'email'], ['bring', 'more', 'decade', 'experience', 'medical_affair', 'clinical', 'development', 'support', 'successful', 'product', 'launch'], ['join', 'accomplish', 'drug', 'development', 'regulatory', 'strategy', 'leader', 'more', 'year', 'experience', 'develop', 'novel', 'therapeutic'], ['appointment', 'highlight', 'continue', 'commitment', 'evolve', 'board', 'composition'], ['clinical_stage', 'company', 'dedicate', 'advance', 'target_protein_degradation', 'science', 'develop', 'new', 'generation', 'small_molecule', 'medicine', 'transform', 'how', 'disease', 'treat', 'today_announce', 'appointment', 'board_director'], ['delighted', 'announce', 'donna', 'new', 'director', 'extensive', 'search', 'include', 'talented', 'diverse', 'pool', 'clinical', 'development', 'leader', 'experience', 'help', 'company', 'bring', 'innovative', 'therapy', 'patient', 'say', 'chairman', 'behalf', 'board_director', 'look_forward', 'work_closely', 'donna', 'continue', 'evolve', 'pursuit', 'deliver', 'potential', 'target_protein_degradation', 'science', 'create', 'new', 'generation', 'medicine', 'change', 'how', 'disease', 'treat'], ['eager', 'use', 'broad', 'experience', 'medical_affair', 'clinical', 'development', 'help', 'advance', 'multiple', 'oncology', 'program', 'benefit', 'patient', 'say', 'stage', 'program', 'clinic', 'additional', 'program', 'prepare', 'advance', 'clinical_trial', 'excited', 'help', 'capitalize', 'opportunity', 'ahead'], ['comment', 'join', 'board_director', 'say', 'exciting', 'time', 'join', 'partner', 'company', 'navigate', 'drug', 'development', 'regulatory', 'milestone', 'advance', 'innovative', 'portfolio', 'small_molecule', 'medicine', 'look_forward', 'work', 'colleague', 'help', 'company', 'apply', 'industry', 'lead', 'target_protein_degradation', 'science', 'transform', 'how', 'patient', 'treat'], ['currently', 'serve', 'manage', 'partner', 'advisor', 'where', 'provide', 'strategic', 'clinical', 'medical_affair', 'advice', 'client', 'biotechnology', 'pharmaceutical', 'industry', 'previously', 'hold', 'role', 'increase', 'responsibility', 'career', 'most', 'recently', 'vice_president', 'head', 'medical', 'tenure', 'help', 'launch', 'new', 'product', 'include', 'eliquis', 'co', 'lead', 'partnership', 'develop', 'also', 'co', 'lead', 'development', 'life', 'cycle', 'management', 'launch', 'investment', 'principle', 'early', 'career', 'serve', 'medical_affair', 'role', 'pharmaceutical', 'currently', 'serve', 'board_director', 'artiva', 'biotherapeutic', 'oncology', 'company', 'develop', 'advance', 'shelf', 'allogeneic', 'natural', 'killer', 'cell', 'therapy', 'patient', 'hematologic', 'cancer', 'solid_tumor', 'receive', 'degree', 'bs', 'biochemistry'], ['currently', 'serve', 'principal', 'consulting', 'where', 'support', 'client', 'drug', 'development', 'regulatory', 'strategy', 'trial', 'design', 'datum', 'interpretation', 'serve', 'chief_medical_officer', 'pharmaceutical', 'acquire', 'previously', 'serve', 'chief_medical_officer', 'several', 'healthcare', 'venture', 'portfolio', 'company', 'include', 'apofore', 'decimmune', 'serve', 'chief_medical_officer', 'senior_vice_president', 'clinical', 'development', 'foldrx', 'pharmaceutical', 'acquire', 'early', 'career', 'hold', 'role', 'increase', 'responsibility', 'where', 'involve', 'multiple', 'high', 'profile', 'product', 'approval', 'include', 'previously', 'serve', 'board', 'member', 'include', 'membership', 'pharmaceutical', 'acquire', 'hold', 'college'], ['clinical_stage', 'company', 'dedicate', 'deliver', 'promise', 'target_protein_degradation', 'science', 'create', 'new', 'generation', 'medicine', 'transform', 'patient', 'live', 'leverage', 'torpedo', 'platform', 'efficiently', 'design', 'optimize', 'small_molecule', 'medicine', 'harness', 'body', 'natural', 'protein', 'recycling', 'system', 'rapidly', 'degrade', 'disease', 'cause', 'protein', 'offer', 'potential', 'overcome', 'drug', 'resistance', 'drug', 'undruggable', 'target', 'improve', 'patient', 'outcome', 'advance', 'multiple', 'target', 'oncology', 'program', 'clinic', 'expand', 'research', 'platform', 'deliver', 'next', 'wave', 'medicine', 'difficult', 'treat', 'disease', 'more_information_visit'], ['forward_look_statement', 'press_release_contain', 'forward_look_statement_meaning', 'private_security_forward_look', 'statement', 'include', 'limit', 'express_imply', 'statement', 'regard', 'ability', 'develop', 'potential', 'therapy', 'patient', 'design', 'potential', 'efficacy', 'therapeutic', 'approach', 'predictive', 'capability', 'torpedo', 'platform', 'development', 'novel', 'selective', 'orally', 'bioavailable', 'degrader', 'potential', 'timing', 'design', 'advancement', 'pre', 'clinical', 'study', 'clinical_trial', 'include', 'potential', 'timing', 'regulatory', 'authorization', 'relate', 'clinical_trial', 'other', 'clinical', 'development', 'activity', 'ability', 'potential', 'successfully', 'manufacture', 'supply', 'product_candidate', 'clinical_trial', 'ability', 'replicate', 'result', 'achieve', 'pre', 'clinical', 'study', 'clinical_trial', 'future', 'study', 'trial', 'regulatory', 'development', 'foreign', 'country', 'forward_look_statement', 'press_release_base', 'management', 'current', 'expectation', 'belief', 'future', 'event', 'subject', 'number_risk_uncertainty', 'cause_actual_result_differ', 'materially_adversely', 'set_forth', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include', 'limit', 'uncertainty', 'relate', 'initiation', 'timing', 'advancement', 'conduct', 'pre', 'clinical', 'clinical', 'study', 'other', 'development', 'requirement', 'product_candidate', 'risk', 'more', 'product_candidate', 'cost', 'more', 'develop', 'successfully', 'develop_commercialize', 'risk', 'result', 'pre', 'clinical', 'study', 'clinical_trial', 'predictive', 'result', 'connection', 'future', 'study', 'trial', 'discussion', 'other', 'risk_uncertainty', 'other', 'important_factor', 'cause_actual_result_differ', 'contain_forward_look', 'statement', 'see', 'section', 'entitle', 'risk_factor_most_recent', 'annual_report_form', 'quarterly_report_form', 'file', 'information', 'press_release', 'date', 'release', 'therapeutic', 'undertake', 'duty', 'update_information', 'require_law'], ['investor_contact', 'investor', 'kendraadams', 'therapeuticscom'], ['medium_contact', 'director', 'corporate_communication', 'advocacy'], ['photo', 'accompany', 'announcement', 'available'], ['newsroom'], ['newsroom'], ['company', 'focus', 'develop_commercialize', 'novel', 'treatment', 'disease', 'today', 'report', 'financial', 'result', 'second_quarter', 'provide', 'recent', 'business', 'update'], ['second_quarter', 'pivotal', 'phathom', 'team', 'continue', 'achieve', 'major', 'milestone', 'include', 'approval', 'first', 'product', 'receipt', 'early', 'expect', 'pdufa', 'date', 'nda', 'key', 'progress', 'enrollment', 'phase', 'nerd', 'trial', 'say', 'president_chief_executive_officer', 'phathom', 'pharmaceutical', 'industry', 'global', 'regulatory_agency', 'continue', 'develop', 'standard', 'help', 'detect', 'control', 'level', 'nitrosamine', 'impurity', 'commonly', 'find', 'water', 'meat', 'vegetable', 'detect', 'trace', 'level', 'nitrosamine', 'vonoprazan', 'drug', 'product', 'post', 'approval', 'testing', 'prepare', 'commercial', 'launch', 'discuss', 'new', 'test', 'method', 'control', 'confirm', 'assessment', 'drug', 'product', 'acceptable', 'intake', 'level', 'goal', 'make', 'product', 'available', 'pylori', 'patient', 'as_soon', 'possible', 'however', 'now', 'plan', 'combine', 'full', 'commercial', 'launch', 'pylori', 'ee', 'first_quarter', 'believe', 'combine', 'launch', 'bring', 'significant', 'operational', 'financial', 'benefit'], ['second_quarter', 'recent', 'business', 'update'], ['second_quarter_financial', 'result'], ['table', 'follow'], ['pharmaceutical', 'company', 'focus', 'development', 'novel', 'treatment', 'disease', 'disorder', 'phathom', 'in', 'license', 'exclusive', 'right', 'first_class', 'potassium', 'competitive', 'acid', 'blocker', 'base', 'regimen', 'approve', 'part', 'co', 'package', 'product', 'combination', 'antibiotic', 'treatment', 'pylori', 'infection', 'adult', 'market', 'triple', 'pak', 'dual', 'pak', 'phathom', 'submit', 'new', 'drug_application', 'erosive', 'esophagitis', 'study', 'use', 'vonoprazan', 'treatment', 'non', 'erosive', 'reflux', 'disease', 'nerd', 'more', 'information', 'phathom', 'visit', 'company', 'website', 'follow', 'company', 'twitter'], ['forward_look_statement', 'phathom', 'caution', 'statement_contain_press', 'release', 'regard', 'matter', 'historical_fact', 'forward_look_statement', 'statement', 'base', 'company', 'current', 'belief', 'expectation', 'such_forward_look', 'statement', 'include', 'limit', 'statement', 'regard', 'expect', 'pdufa_target_action', 'date', 'potential', 'approval', 'plan', 'launch', 'vonoprazan', 'pylori', 'indication', 'timing_thereof', 'expect', 'timing', 'topline', 'datum', 'nerd', 'phase', 'trial', 'plan', 'address', 'trace', 'level', 'nitrosamine', 'impurity', 'observe', 'vonoprazan', 'drug', 'product', 'voquezna', 'dual', 'triple', 'pak', 'obtain_approval', 'enable', 'commercial', 'launch', 'product', 'inclusion', 'forward_look_statement', 'regard', 'representation', 'phathom', 'plan', 'achieve', 'actual_result_differ', 'set_forth', 'press_release', 'risk_uncertainty', 'inherent', 'phathom', 'business', 'include_limitation', 'disagree', 'exist', 'safety_efficacy', 'datum', 'sufficient', 'approve', 'include', 'result', 'trace', 'level', 'nitrosamine', 'impurity', 'observe', 'commercial', 'batch', 'vonoprazan', 'drug', 'product', 'voquezna', 'dual', 'triple', 'pak', 'potential', 'delay', 'pdufa_target_action', 'date', 'relate', 'internal', 'resource', 'constraint', 'other_reason', 'inherent', 'risk', 'clinical', 'development', 'phathom', 'dependence', 'third_party', 'connection', 'product', 'manufacturing', 'research', 'preclinical', 'clinical', 'testing', 'ability', 'successfully', 'address', 'formation', 'nitrosamine', 'impurity', 'commercial', 'batch', 'vonoprazan', 'drug', 'product', 'gain', 'approval', 'such', 'resolution', 'include', 'applicable', 'acceptable', 'daily', 'intake', 'limit', 'regulatory', 'development', 'foreign', 'country', 'unexpected', 'adverse', 'side_effect', 'inadequate', 'efficacy', 'limit', 'development', 'regulatory_approval', 'result', 'recall', 'product', 'liability', 'claim', 'phathom', 'ability', 'access', 'additional', 'capital', 'term', 'loan', 'facility', 'royalty', 'interest', 'finance', 'agreement', 'subject', 'certain', 'condition', 'phathom', 'ability_obtain', 'maintain', 'intellectual_property', 'protection', 'ability', 'comply', 'license_agreement', 'ability', 'maintain', 'undisrupted', 'business_operation', 'due', 'ongoing', 'spread', 'coronaviru', 'include', 'delaying', 'otherwise', 'disrupt', 'clinical_trial', 'manufacturing', 'supply_chain', 'other', 'risk', 'describe', 'company', 'prior', 'press_release', 'company', 'filing', 'include', 'heading_risk', 'factor', 'company', 'annual_report_form', 'subsequent_filing', 'caution_place_undue_reliance', 'forward_look_statement', 'speak_only', 'date_hereof', 'phathom', 'undertake_obligation_update', 'such', 'statement', 'reflect', 'event', 'occur', 'circumstance', 'exist', 'date_hereof', 'forward_look_statement', 'qualified', 'entirety', 'cautionary', 'statement', 'make', 'safe_harbor', 'provision', 'private_security'], ['investor'], [], ['pharmaceutical', 'right', 'reserve'], ['dual', 'pak', 'phathom', 'pharmaceutical', 'respective', 'logo', 'register_trademark', 'trademark'], ['select', 'condensed', 'balance_sheet', 'unaudited', 'thousand'], ['statement', 'operation', 'comprehensive', 'loss', 'unaudited', 'thousand_share', 'share_amount'], ['commercial', 'stage', 'medical', 'technology', 'company', 'strategic', 'vision', 'transform_life', 'patient', 'whenever', 'wherever', 'need', 'help', 'good', 'neurohealth', 'therapy', 'world', 'today_announce', 'financial', 'operating', 'result', 'second_quarter'], ['second_quarter', 'highlight'], ['recent', 'operational', 'highlight'], ['recent', 'marketing', 'highlight'], ['very_pleased', 'performance', 'second_quarter', 'first_half', 'year', 'successfully', 'work', 'macro', 'challenge', 'continue', 'execute', 'highlight', 'very', 'strong', 'capital', 'system', 'sale', 'volume', 'improve', 'utilization', 'achieve', 'multiple', 'significant', 'milestone', 'include', 'approval', 'ocd', 'anxious_depression', 'receive', 'multiple', 'favorable', 'reimbursement', 'decision', 'expand', 'number', 'exclusive', 'commercial', 'partnership', 'national', 'account', 'say', 'president_chief_executive_officer', 'neuronetic', 'remainder', 'year', 'look', 'leverage', 'momentum', 'build', 'continue', 'accelerate', 'growth', 'help', 'more', 'patient', 'suffer', 'mental_health', 'disorder', 'get', 'relief', 'deserve'], ['second_quarter_financial', 'operating', 'result', 'month_end'], ['total', 'revenue', 'month_end', 'increase_compare', 'month_end', 'revenue', 'quarter', 'total', 'revenue', 'increase', 'international', 'revenue', 'decrease', 'prior', 'year', 'quarter', 'revenue_growth', 'primarily_drive', 'increase', 'neurostar_advanced', 'therapy', 'system', 'sale', 'decline', 'international', 'revenue', 'primarily_drive', 'decrease', 'international', 'advanced', 'therapy', 'system', 'sale'], ['advanced', 'therapy', 'system', 'revenue', 'month_end', 'increase_compare', 'month_end', 'revenue', 'month_end', 'company', 'sell', 'system', 'respectively', 'recognize', 'neurostar', 'capital', 'revenue', 'period', 'additionally', 'month_end', 'company', 'execute', 'operating', 'lease', 'agreement', 'contribute', 'operate', 'lease', 'revenue'], ['treatment', 'session', 'revenue', 'month_end', 'increase_compare', 'month_end', 'revenue', 'revenue_growth', 'primarily_drive', 'increase', 'number', 'account', 'utilize', 'phq', 'tool', 'result', 'treatment', 'session', 'volume', 'local', 'click', 'account', 'utilize', 'phq', 'tool', 'increase_compare', 'second_quarter'], ['second_quarter', 'treatment', 'session', 'revenue', 'active', 'site', 'compare', 'second_quarter', 'result', 'increase', 'number', 'new', 'account', 'instal', 'system', 'second_quarter'], ['gross_margin', 'second_quarter', 'decrease', 'approximately', 'basis_point', 'second_quarter', 'gross_margin', 'decrease', 'primarily', 'result', 'change', 'product', 'mix', 'compare', 'second_quarter'], ['operating', 'expense', 'second_quarter', 'increase_compare', 'second_quarter', 'increase', 'primarily_drive', 'implementation', 'new', 'marketing', 'initiative', 'personnel', 'cost', 'relate', 'sale', 'force', 'compare', 'prior', 'year', 'quarter'], ['net', 'loss', 'second_quarter', 'share', 'compare', 'second_quarter', 'net', 'loss', 'share', 'net', 'loss', 'share', 'base', 'weight', 'average', 'common_share', 'outstanding', 'second_quarter', 'respectively'], ['ebitda', 'second_quarter', 'compare', 'second_quarter', 'ebitda', 'see', 'accompanying', 'financial', 'table', 'reconcile', 'ebitda', 'non_gaap_financial_measure', 'net', 'loss'], ['cash_cash_equivalent', 'compare', 'cash_cash_equivalent'], ['clearance', 'treatment', 'adult', 'anxious_depression'], [], ['grant', 'clearance', 'neurostar', 'adjunct', 'treatment', 'adult', 'patient', 'suffer', 'initiate', 'limit', 'exclusive', 'launch', 'center', 'expect', 'begin', 'train', 'broad', 'instal', 'base', 'fourth_quarter', 'importantly', 'new', 'indication', 'remotely', 'activate', 'customer', 'exist', 'neurostar', 'hardware', 'enable', 'neurostar', 'treat', 'even', 'more', 'patient', 'suffer', 'debilitate', 'mental_health', 'disorder', 'adult', 'suffer', 'ocd', 'approximately', 'half', 'patient', 'serious', 'impairment'], ['anxious_depression'], ['successfully_leverage', 'real_world', 'datum', 'proprietary', 'database', 'patient', 'outcome', 'gain', 'clearance', 'new', 'indication', 'grant', 'new', 'indication', 'neurostar', 'treat', 'anxiety', 'symptom', 'adult', 'major', 'depressive', 'disorder', 'also', 'know', 'anxious_depression', 'submission', 'utilize', 'datum', 'collect', 'patient', 'treat', 'center', 'country', 'show', 'patient', 'achieve', 'clinically_meaningful', 'reduction', 'anxiety', 'symptom', 'new', 'indication', 'immediately', 'available', 'physician', 'treat', 'patient', 'require', 'new', 'hardware', 'reimburse', 'current', 'cpt', 'code', 'current', 'coverage', 'policy', 'common', 'serious', 'psychiatric', 'diagnosis', 'adult', 'estimate', 'prevalence', 'patient', 'treatment', 'symptom', 'common', 'co', 'morbidity', 'patient', 'commonly', 'call', 'anxious_depression', 'estimate', 'prevalence', 'more', 'mdd', 'patient', 'patient', 'anxious_depression', 'generally', 'regard', 'hard', 'treat', 'currently', 'available', 'pharmaceutical', 'option'], ['long_term', 'commercial', 'partnership'], ['alleviant', 'health', 'center'], ['company', 'initiate', 'commercial', 'partnership', 'alleviant', 'health', 'center', 'base', 'network', 'full', 'service', 'mental_health', 'clinic', 'agreement', 'neuronetic', 'exclusive', 'supplier', 'new', 'equipment', 'alleviant', 'affiliate', 'alleviant', 'use', 'different', 'tms', 'device', 'prior', 'partnership', 'plan', 'expand', 'footprint', 'multiple', 'state', 'choose', 'neurostar', 'ongoing', 'support', 'training', 'marketing', 'initiative', 'integral', 'growth', 'continue', 'success'], ['positive', 'tms', 'coverage', 'policy'], ['company', 'announce', 'series', 'healthcare', 'policy', 'update', 'increase', 'patient', 'access', 'neurostar_advanced', 'therapy', 'contractor', 'propose', 'policy', 'update', 'local', 'coverage', 'determination', 'reduce', 'number', 'prior', 'medication', 'failure', 'eligibility', 'down', 'people', 'suffer', 'major', 'depressive', 'disorder', 'additional', 'propose', 'change', 'remove', 'requirement', 'previous', 'psychotherapy', 'trial', 'coverage', 'area', 'include', 'medicare', 'beneficiary', 'more', 'physician', 'hospital', 'serve', 'patient', 'coverage', 'include', 'cover', 'life'], ['additional', 'positive', 'coverage', 'policy', 'applicable', 'recently', 'issue', 'publish', 'coverage', 'obsessive', 'compulsive', 'disorder', 'ocd', 'affect', 'member', 'select', 'health', 'publish', 'first', 'tms', 'policy', 'impact', 'member', 'would', 'source', 'remove', 'pre', 'authorization', 'requirement', 'medicare', 'advantage', 'plan', 'member', 'would'], ['business'], ['full_year', 'company', 'now', 'expect', 'total', 'worldwide', 'revenue'], ['full_year', 'company', 'now', 'expect', 'total', 'operating', 'expense'], ['third_quarter', 'company', 'expect', 'report', 'total', 'worldwide', 'revenue'], ['conference_call', 'information'], ['management', 'team', 'host_conference_call', 'begin', 'am_eastern', 'time'], ['listen', 'conference_call', 'telephone', 'participant', 'register', 'call', 'link', 'bi', 'ebb', 'ea', 'access', 'live_audio', 'webcast', 'subsequent', 'archive', 'recording', 'visit', 'investor_relation', 'section', 'neuronetic', 'website', 'replay', 'available', 'company', 'website'], ['neuronetic'], ['believe', 'mental_health', 'as', 'important', 'physical', 'health', 'global', 'leader', 'neuroscience', 'large', 'transcranial', 'magnetic', 'stimulation', 'company', 'industry', 'neuronetic', 'redefine', 'patient', 'physician', 'expectation', 'design', 'develop', 'product', 'improve', 'quality_life', 'people', 'suffer', 'neurohealth', 'condition', 'clear', 'non', 'drug', 'noninvasive', 'treatment', 'people', 'depression', 'neuronetic', 'neurostar_advanced', 'therapy', 'system', 'lead', 'tms', 'treatment', 'major', 'depressive', 'disorder', 'adult', 'treatment', 'deliver', 'neurostar', 'widely', 'research', 'back', 'large', 'clinical', 'datum', 'set', 'system', 'depression', 'include', 'world', 'large', 'depression', 'outcome', 'registry', 'neurostar_advanced', 'therapy', 'system', 'also', 'clear', 'treat', 'people', 'suffer', 'obsessive', 'compulsive', 'disorder', 'as_well', 'treatment', 'comorbid', 'anxiety', 'symptom', 'anxious_depression', 'adult', 'suffer', 'anxiety', 'symptom', 'neuronetic', 'commit', 'transform_life', 'offer', 'exceptional', 'treatment_option', 'aim', 'produce', 'extraordinary', 'result', 'safety', 'information', 'indication', 'use', 'visit', 'neurostarcom'], ['statement', 'private_security'], ['statement', 'press_release', 'regard', 'company', 'historical_fact', 'constitute_forward_look', 'statement_meaning', 'private_security_forward_look', 'statement', 'identify', 'term', 'such', 'potential', 'believe', 'expect', 'plan', 'anticipate', 'predict', 'as_well', 'negative', 'term', 'similar_expression', 'statement', 'include', 'relate', 'company', 'business', 'outlook', 'current', 'expectation', 'upcoming', 'quarter', 'fiscal_year', 'include', 'respect', 'revenue', 'operate', 'expense', 'growth', 'statement', 'assumption_underlie', 'foregoing', 'item', 'statement', 'subject', 'significant', 'risk_uncertainty', 'actual_result_differ', 'materially_project', 'company', 'caution', 'investor', 'place_undue_reliance', 'forward_look_statement', 'contain', 'release', 'risk_uncertainty', 'include_limitation', 'risk_uncertainty', 'relate', 'impact', 'company', 'operational', 'budget', 'plan', 'as_well', 'general', 'political_economic', 'condition', 'include', 'result', 'effort', 'governmental', 'authority', 'mitigate', 'such', 'travel', 'restriction', 'third_party', 'business', 'closure', 'related', 'impact', 'resource', 'allocation', 'manufacturing', 'supply_chain', 'patient', 'access', 'commercial', 'product', 'company', 'ability', 'execute', 'business', 'continuity', 'company', 'ability', 'achieve', 'sustain', 'profitable', 'operation', 'history', 'loss', 'company', 'reliance', 'sale', 'usage', 'neurostar_advanced', 'therapy', 'mental_health', 'system', 'generate', 'revenue', 'scale', 'efficacy', 'company', 'as_well', 'company', 'ability', 'retain', 'talent', 'availability', 'coverage', 'reimbursement', 'third_party', 'payor', 'treatment', 'use', 'company', 'product', 'physician', 'patient', 'demand', 'treatment', 'use', 'company', 'product', 'development', 'respect', 'compete', 'technology', 'therapy', 'indication', 'company', 'product', 'treat', 'product', 'defect', 'company', 'ability_obtain', 'maintain', 'intellectual_property', 'protection_technology', 'development', 'clinical_trial', 'regulatory', 'review', 'neurostar_advanced', 'therapy', 'mental_health', 'system', 'additional', 'indication', 'development', 'regulation', 'other', 'applicable', 'jurisdiction', 'discussion', 'other', 'related', 'risk', 'refer', 'company', 'recent', 'filing', 'available', 'website', 'forward_look_statement', 'base', 'company', 'expectation', 'assumption', 'date_press_release', 'require_law', 'company', 'undertake', 'duty', 'obligation_update_forward_look', 'statement_contain_press', 'release', 'result', 'new', 'information', 'future', 'event', 'change', 'company', 'expectation'], ['investor_contact'], [], ['medium_contact'], [], ['statement', 'operation', 'thousand_share', 'datum'], ['balance', 'thousand_share', 'datum'], ['statement', 'cash_flow', 'thousand'], ['non_gaap_financial_measure', 'unaudited'], ['measure', 'financial_performance', 'generally_accept', 'accounting_principle', 'gaap', 'construe', 'substitute', 'superior', 'gaap', 'net', 'loss', 'however', 'management', 'use', 'gaap_non_gaap', 'financial_measure', 'internally', 'evaluate', 'manage', 'company', 'operation', 'well', 'understand', 'business', 'further', 'management_believe', 'addition', 'non_gaap_financial_measure', 'provide', 'meaningful', 'supplementary', 'information', 'facilitate', 'analysis', 'investor', 'evaluate', 'company', 'financial_performance', 'result', 'operation', 'trend', 'company', 'calculation', 'ebitda', 'comparable', 'similarly', 'designate', 'measure', 'report', 'other', 'company', 'company', 'investor', 'differ', 'type', 'event', 'warrant', 'adjustment'], ['follow', 'table', 'reconcile', 'report', 'net', 'loss', 'ebitda'], ['more', 'subject', 'randomize', 'satsuma', 'expect', 'announce', 'summit_trial', 'result'], ['clinical_stage', 'company', 'develop', 'novel', 'investigational', 'therapeutic', 'product_candidate', 'acute', 'treatment', 'migraine', 'today_announce', 'completion', 'subject', 'enrollment', 'company', 'ongoing', 'summit', 'pivotal', 'phase', 'efficacy', 'trial', 'more', 'subject', 'randomize', 'expect', 'announce', 'topline', 'result', 'summit_trial', 'fourth_quarter'], ['pleased', 'report', 'completion', 'subject', 'enrollment', 'summit', 'phase', 'efficacy', 'trial', 'large', 'ever', 'randomize', 'control', 'trial', 'product', 'state', 'president_chief_executive_officer', 'mark_important', 'milestone', 'development', 'program', 'look_forward', 'report', 'summit_trial', 'topline', 'result', 'fourth_quarter', 'interim', 'report', 'further_development', 'program', 'progress', 'clinical', 'datum', 'include', 'topline', 'result', 'ongoing', 'ascend', 'phase_open_label', 'long_term', 'safety', 'trial'], ['summit', 'pivotal', 'phase', 'efficacy', 'trial', 'summit', 'pivotal', 'phase', 'efficacy', 'trial', 'multi_center', 'single_dose', 'randomize_double_blind_placebo', 'control', 'parallel', 'group', 'study', 'more', 'subject', 'migraine', 'conduct', 'state', 'trial', 'design', 'accordance', 'recommendation', 'contain', 'current', 'guidance', 'document', 'industry', 'migraine', 'develop', 'drug', 'acute', 'treatment', 'publish', 'guideline', 'control', 'trial', 'acute', 'treatment', 'migraine', 'attack', 'summit_trial', 'large', 'ever', 'randomize', 'control', 'trial', 'product', 'provide', 'basis', 'become', 'first', 'only', 'product', 'demonstrate', 'efficacy', 'randomize', 'control', 'trial', 'co', 'primary_endpoint', 'freedom', 'pain', 'freedom', 'most', 'bothersome', 'symptom', 'hour', 'post', 'treatment', 'currently', 'recommend', 'base', 'communication', 'include', 'type', 'clinical', 'pre', 'nda', 'meeting', 'hold', 'company', 'believe', 'summit_trial', 'successful', 'support', 'inclusion', 'differentiate', 'efficacy', 'claim', 'prescribe_information', 'presume', 'approve', 'marketing'], ['establish', 'full', 'eligibility', 'summit_trial', 'participant', 'randomize_receive', 'mg', 'match', 'placebo', 'instruct', 'treat', 'next', 'migraine', 'attack', 'least', 'moderate', 'pain', 'severity', 'study', 'medication', 'follow', 'randomization', 'participant', 'day', 'treat', 'qualify', 'migraine', 'attack'], ['co', 'primary_endpoint', 'summit_trial', 'assess', 'hour', 'administration', 'freedom', 'pain', 'freedom', 'most', 'bothersome', 'symptom', 'nausea', 'trial', 'design', 'great', 'statistical', 'power', 'freedom', 'pain', 'endpoint', 'great', 'statistical', 'power', 'freedom', 'most', 'bothersome', 'symptom', 'endpoint', 'addition', 'summit_trial', 'incorporate', 'number', 'secondary_endpoint', 'prospective', 'evaluation', 'clinical', 'performance', 'differentiate', 'clinical', 'profile'], ['expect', 'report', 'topline', 'result', 'summit_trial', 'fourth_quarter'], ['further', 'information', 'regard', 'summit', 'phase', 'efficacy', 'trial', 'see', 'randomize_double_blind_placebo', 'control', 'study', 'assess', 'acute', 'treatment', 'migraine', 'summit'], ['pharmaceutical', 'satsuma', 'pharmaceutical', 'clinical_stage', 'company', 'develop', 'novel', 'therapeutic', 'product', 'acute', 'treatment', 'migraine', 'unique', 'proprietary', 'nasal', 'powder', 'formulation', 'well', 'establish', 'anti', 'migraine', 'drug', 'administer', 'proprietary', 'nasal', 'delivery', 'device', 'design', 'provide', 'significant', 'benefit', 'exist', 'acute', 'treatment', 'migraine', 'include', 'combination', 'quick', 'convenient', 'self', 'administration', 'other', 'clinical', 'advantage', 'current', 'liquid', 'nasal', 'spray', 'product', 'injectable', 'dosage', 'form', 'lack', 'dry', 'powder', 'formulation', 'demonstrate', 'fast', 'absorption', 'rapid', 'achievement', 'high', 'plasma', 'concentration', 'believe', 'necessary', 'early', 'efficacy', 'sustain', 'plasma', 'level', 'time', 'low', 'dose', 'dose', 'variability', 'also', 'now', 'incorporate', 'improved', 'nd', 'generation', 'nasal', 'delivery', 'device', 'design', 'provide', 'more', 'consistent', 'nasal', 'dose', 'irrespective', 'user', 'administration', 'technique', 'long', 'recommend', 'publish', 'migraine', 'treatment', 'guideline', 'first', 'line', 'acute', 'treatment_option', 'migraine', 'significant', 'advantage', 'other', 'anti', 'migraine', 'treatment', 'many', 'patient', 'however', 'disadvantage', 'current', 'nasal', 'spray', 'injectable', 'product', 'include', 'invasive', 'burdensome', 'administration', 'sub', 'optimal', 'clinical', 'performance', 'limit', 'widespread', 'use', 'feature', 'easy', 'carry', 'easy', 'use', 'dosage', 'form', 'design', 'overcome', 'shortcoming', 'provide', 'patient', 'improved', 'therapeutic', 'solution', 'acutely', 'treat', 'migraine', 'consistently', 'deliver', 'robust', 'clinical', 'performance'], ['headquarter', 'operation', 'further', 'information_visit', 'wwwsatsumarxcom'], ['cautionary', 'note', 'forward_look_statement'], ['press_release_contain', 'forward_look_statement', 'concern', 'business_operation', 'financial_performance', 'condition', 'company', 'as_well', 'company', 'plan_objective', 'expectation', 'business_operation', 'financial_performance', 'condition', 'statement', 'contain', 'statement_historical_fact', 'deem', 'forward_look_statement', 'case', 'identify', 'forward_look_statement', 'terminology', 'such', 'anticipate', 'assume', 'believe', 'continue', 'due', 'estimate', 'expect', 'goal', 'intend', 'objective', 'predict', 'potential', 'position', 'seek', 'target', 'other', 'similar_expression', 'prediction', 'indicate', 'future', 'event', 'future', 'trend', 'negative', 'term', 'other', 'comparable', 'terminology', 'forward_look_statement', 'include', 'limit', 'statement', 'company', 'expectation_regard', 'potential', 'safety_efficacy', 'potential', 'result', 'ascend', 'summit_trial', 'timing', 'datum', 'readout', 'ongoing', 'clinical_trial', 'anticipate', 'timing', 'potential', 'nda', 'submission', 'potential', 'important', 'differentiated', 'acute', 'treatment_option', 'expect', 'cash_runway', 'company', 'light', 'risk', 'uncertaintie', 'event_circumstance', 'refer', 'forward_look_statement', 'occur', 'company', 'actual_result_differ', 'materially', 'state', 'imply', 'forward_look_statement', 'number_factor', 'include', 'limit', 'risk', 'detail', 'company', 'quarterly_report_form', 'quarter_end', 'file', 'as_well', 'other', 'document_file', 'company', 'time', 'time', 'particular', 'follow', 'factor', 'other', 'cause', 'result_differ_materially_express', 'imply_such_forward_look', 'statement', 'company', 'ability', 'demonstrate', 'sufficient', 'evidence', 'efficacy_safety', 'clinical_trial', 'result', 'preclinical', 'clinical', 'study', 'predictive_future', 'result', 'risk', 'worldwide', 'pandemic', 'negatively', 'impact', 'company', 'business_operation', 'clinical_trial', 'ability', 'raise', 'capital', 'company', 'believe', 'expectation', 'reflect', 'forward_look_statement', 'reasonable', 'can', 'guarantee', 'event_circumstance', 'reflect', 'forward_look_statement', 'achieve', 'occur', 'timing', 'event_circumstance', 'actual_result_differ', 'materially_project', 'forward_look_statement', 'accordingly', 'place_undue_reliance', 'forward_look_statement', 'such', 'statement', 'speak_only_date', 'make', 'company', 'undertake_obligation', 'update_revise', 'publicly', 'forward_look_statement', 'result', 'new', 'information', 'future', 'event', 'otherwise'], ['press_release', 'discuss', 'product_candidate', 'clinical', 'development', 'yet', 'approve', 'marketing', 'representation', 'make', 'safety', 'effectiveness', 'therapeutic', 'use', 'study'], ['investor', 'corporate', 'contact'], [], ['chief', 'financial', 'officer'], ['diener', 'society', 'control', 'trial', 'acute', 'treatment', 'migraine', 'attack', 'adult'], ['pharmaceutical', 'patient', 'centric', 'healthcare', 'company', 'today_announce', 'approval', 'testosterone', 'undecanoate', 'oral', 'testosterone', 'replacement', 'therapy', 'indicate', 'adult', 'male', 'condition', 'associate', 'deficiency', 'absence', 'endogenous', 'testosterone', 'also', 'know', 'hypogonadism', 'approval', 'provide', 'important', 'option', 'treat', 'hypogonadism', 'more', 'commonly', 'know', 'testosterone_deficiency', 'affect_approximately', 'man', 'old', 'year', 'age', 'man', 'obesity', 'type_diabetes', 'hypogonadism', 'approve', 'dosage_strength', 'mg'], ['like', 'congratulate', 'scientific', 'team', 'major', 'milestone', 'now', 'commercial', 'team', 'make', 'lead', 'therapy', 'go', 'to', 'brand', 'million', 'hypogonadal', 'man', 'low', 'testosterone', 'affect', 'numerous', 'metabolic', 'factor', 'as_well', 'as', 'often', 'overlook', 'true', 'quality_life', 'hence', 'annual', 'testosterone', 'testing', 'mandatory', 'man', 'age', 'remark', 'chairman'], ['proprietary', 'oral', 'softgel', 'capsule', 'absorb', 'primarily', 'lymphatic', 'system', 'avoid', 'liver', 'toxicity', 'oral', 'delivery', 'method', 'eliminate', 'risk', 'application', 'site', 'reaction', 'common', 'intramuscular', 'testosterone', 'injection', 'as_well', 'potential', 'transference', 'woman', 'child', 'occur', 'topical', 'testosterone', 'gel', 'cream', 'daily', 'dosing', 'morning', 'evening', 'food', 'more', 'closely', 'mimic', 'daily', 'rhythm', 'natural', 'testosterone', 'production', 'compare', 'long', 'act', 'therapy'], ['so', 'many', 'man', 'suffer', 'daily', 'effect', 'testosterone_deficiency', 'often', 'abandon', 'elect', 'treatment', 'see', 'approve', 'newly', 'viable', 'oral', 'option', 'demonstrate', 'safety', 'effectiveness', 'further', 'deficiency', 'big', 'blind', 'spot', 'medicine', 'today', 'research', 'continue', 'explore', 'importance', 'testosterone', 'male', 'female', 'health', 'comment'], ['potential', 'become', 'new', 'gold', 'standard_care', 'treat', 'patient', 'hypogonadism', 'least', 'symptomatic', 'man', 'suffer', 'hypogonadism', 'man', 'globally'], ['see', 'additional', 'important', 'safety', 'information'], ['society'], ['about', 'testosterone', 'hypogonadism'], ['often', 'refer', 'testosterone_deficiency', 'condition', 'occur', 'when', 'body', 'produce', 'adequate', 'level', 'testosterone', 'primary', 'hypogonadism', 'testicular', 'failure', 'certain', 'condition', 'hypogonadism', 'result', 'low', 'serum', 'testosterone', 'concentration', 'addition', 'widely', 'accept', 'role', 'sexual', 'reproductive', 'function', 'also', 'important', 'role', 'numerous', 'other', 'metabolic', 'inflammatory', 'process', 'most_common', 'cause', 'secondary', 'osteoporosis', 'man', 'patient', 'hypogonadism', 'experience', 'fatigue', 'low', 'energy', 'decrease', 'muscle', 'mass', 'weight', 'gain', 'low', 'poor', 'cognition', 'difficulty', 'sleep', 'other', 'mood', 'disorder', 'such', 'depression', 'anxiety', 'low', 'level', 'testosterone', 'also', 'increase', 'risk', 'develop', 'type_diabetes', 'obesity', 'hypogonadism', 'common', 'comorbidity', 'broad', 'set', 'condition', 'include', 'type_diabetes', 'non', 'alcoholic', 'steatohepatitis'], [], ['proprietary', 'softgel', 'oral', 'formulation', 'absorb', 'primarily', 'lymphatic', 'system', 'mean', 'toxic', 'liver', 'indicate', 'adult', 'male', 'condition', 'associate', 'deficiency', 'absence', 'endogenous', 'testosterone', 'safety_efficacy', 'demonstrate', 'phase', 'multi_center', 'open_label', 'month', 'study', 'hypogonadal', 'male', 'year', 'age', 'document', 'hypogonadism', 'define', 'normal', 'serum', 'testosterone', 'level', 'ng', 'at_least', 'sign', 'symptom', 'testosterone_deficiency', 'efficacy', 'population', 'percent', 'hypogonadal', 'man', 'treat', 'achieve', 'mean', 'plasma', 'total', 'concentration', 'hour', 'normal', 'range', 'final', 'pharmacokinetic', 'visit', 'study', 'day', 'primary_endpoint', 'base', 'exploratory', 'endpoint', 'patient', 'receive', 'report', 'improvement', 'quality_life', 'energy', 'fatigue', 'erectile', 'function', 'intercourse', 'satisfaction', 'positive', 'mood', 'most_common_side_effect', 'report', 'percent', 'patient', 'increase', 'blood_pressure', 'safety_efficacy', 'male', 'less', 'year_old', 'establish'], ['see', 'additional', 'important', 'safety', 'information', 'include', 'boxed', 'warning', 'potential', 'increase', 'blood_pressure'], ['pharmaceutical'], ['patient', 'centric', 'healthcare', 'company', 'focus', 'therapy', 'design', 'hypogonadism', 'testosterone_deficiency', 'company', 'mission', 'improve', 'functional', 'life', 'patient', 'reduce', 'downstream', 'effect', 'testosterone_deficiency', 'include', 'multiple', 'comorbiditie', 'such', 'type_diabetes', 'obesity', 'more_information_visit'], ['important', 'safety', 'information', 'testosterone', 'undecanoate'], ['use'], ['testosterone', 'prescription', 'drug', 'use', 'treat', 'adult', 'man', 'low', 'testosterone', 'level', 'due', 'certain', 'medical', 'condition', 'control', 'substance', 'contain', 'testosterone', 'know_safe', 'effective', 'male', 'young', 'year_old', 'improper', 'use', 'affect', 'bone', 'growth', 'child', 'mean', 'use', 'woman'], ['important', 'safety', 'information'], ['increase', 'blood_pressure', 'increase', 'risk', 'have', 'heart_attack_stroke', 'increase', 'risk', 'death', 'heart_attack_stroke', 'risk', 'great', 'already', 'have', 'heart_attack_stroke', 'other', 'risk_factor', 'heart_attack_stroke'], ['take', 'breast_cancer', 'prostate_cancer', 'woman', 'pregnant', 'harm_unborn', 'baby', 'allergic', 'ingredient', 'low', 'testosterone', 'certain', 'medical', 'condition', 'take', 'low', 'testosterone', 'age'], ['take', 'tell', 'healthcare_provider', 'medical', 'condition', 'include', 'high', 'blood_pressure', 'treat', 'high', 'blood_pressure', 'history', 'diabetes', 'heart', 'problem', 'high', 'red_blood_cell', 'count', 'high', 'hemoglobin', 'laboratory', 'value', 'urinary', 'problem', 'due', 'enlarged', 'prostate', 'liver', 'kidney_problem', 'problem', 'breathe', 'sleep', 'sleep'], ['tell', 'healthcare_provider', 'medicine', 'take', 'include', 'prescription', 'counter', 'medicine', 'vitamin', 'herbal_supplement', 'take_certain', 'other', 'medicine', 'affect', 'other', 'especially_tell', 'healthcare_provider', 'take', 'insulin', 'medicine', 'decrease', 'blood', 'clotting', 'blood', 'thinner', 'corticosteroid', 'medicine', 'increase', 'blood_pressure', 'such', 'cold', 'medicine', 'pain', 'medicine'], ['cause', 'other', 'serious_side_effect', 'include'], ['call', 'healthcare_provider', 'right_away', 'serious_side_effect', 'list', 'above'], ['most_common_side_effect', 'high', 'blood_pressure', 'other', 'side_effect_include', 'joint', 'back', 'pain', 'diarrhea', 'increase', 'red_blood_cell', 'count', 'anxiety', 'constipation', 'swell', 'leg', 'increase', 'prostate', 'specific', 'level'], ['possible_side_effect', 'more', 'information', 'ask', 'healthcare_provider', 'pharmacist'], ['encourage', 'report', 'negative', 'side_effect', 'prescription', 'drug', 'call', 'also', 'report', 'side_effect', 'marius', 'call'], ['keep', 'medicine', 'reach', 'child', 'see_full', 'prescribing_information', 'medication', 'guide'], [], ['newsroom'], ['newsroom'], ['health', 'lead', 'remote', 'patient', 'monitoring', 'rpm', 'virtual', 'care', 'service', 'provider', 'pleased', 'announce', 'strategic', 'partnership', 'mrhc'], ['extensive', 'search', 'review', 'many', 'prospective', 'solution', 'provider', 'select', 'base', 'experience', 'flexibility', 'solution', 'offering', 'say_chief', 'information', 'officer', 'spend', 'considerable', 'time', 'due', 'diligence', 'find', 'appropriate', 'partner', 'rpm', 'need', 'year', 'leadership', 'rpm', 'space', 'as_well', 'inherent', 'flexibility', 'platform', 'meet', 'only', 'need', 'community', 'health', 'system', 'also', 'disparate', 'need', 'patient', 'community', 'make', 'health', 'right', 'choice', 'mrhc'], ['congestive_heart', 'failure_chf', 'initial', 'focus', 'rpm', 'program', 'goal', 'expand', 'remote', 'care', 'initiative', 'support', 'patient', 'other', 'chronic', 'condition', 'such', 'diabete', 'offer', 'broad', 'offering', 'chronic', 'acute', 'condition', 'monitor', 'rpm', 'leverage', 'clear', 'platform', 'advanced', 'analytic', 'machine_learn', 'technology', 'as_well', 'year', 'experience', 'rpm'], ['rpm', 'program_support', 'chf', 'patient', 'combination', 'monitoring', 'education', 'utilize', 'bluetooth', 'device', 'as_well', 'patient', 'engagement', 'education', 'tool', 'chf', 'rpm', 'program', 'work', 'exist', 'treatment', 'plan', 'improve', 'patient', 'care', 'access', 'care', 'reduce', 'costly', 'readmission', 'improve', 'outcome', 'influence', 'healthy', 'behavior', 'promote', 'self', 'management'], ['believe', 'ability', 'remotely', 'monitor', 'engage', 'patient', 'care', 'become', 'fundamental', 'evolve', 'care', 'model', 'excited', 'work', 'accomplish', 'goal', 'comment', 'professor', 'internal', 'medicine'], ['mhrc', 'care', 'navigator', 'manage', 'chf', 'patient', 'platform', 'allow', 'care', 'navigator', 'provider', 'provide', 'early', 'intervention', 'well', 'care', 'patient'], ['pleased', 'partner', 'agreement', 'utilize', 'rpm', 'apply', 'predictive', 'analytic', 'risk', 'stratification', 'identify', 'patient', 'high', 'risk', 'as_well', 'enable', 'life', 'save', 'clinical', 'intervention', 'say', 'early', 'intervention', 'as_well', 'consideration', 'social', 'determinant', 'health', 'tremendous', 'impact', 'only', 'improve', 'clinical', 'outcome', 'also', 'quality_life', 'patient'], [], ['found', 'virtual', 'care', 'remote', 'patient', 'monitoring', 'suite', 'solution', 'leverage', 'superior', 'analytic', 'platform', 'simple', 'user', 'interface', 'integrate', 'easily', 'clinical', 'workflow', 'advanced', 'real', 'time', 'analytic', 'drive', 'virtual', 'care', 'solution', 'drive', 'outstanding', 'measurable', 'outcome', 'hundred', 'thousand', 'patient', 'healthcare', 'continuum', 'include', 'payer', 'provider', 'system', 'governmental', 'agency'], ['clear', 'clinical', 'decision', 'support', 'platform', 'combine', 'end', 'end', 'clinical', 'support', 'rpm', 'service', 'enable', 'healthcare', 'organization', 'confidently', 'extend', 'service', 'wall', 'hospital', 'ambulatory', 'clinic', 'setting'], ['unparalleled', 'corpus', 'peer', 'review', 'publish', 'study', 'highlight', 'clinical', 'improvement', 'condition', 'include', 'heart_failure', 'diabetes', 'hypertension', 'result', 'reduction', 'hospital', 'admission', 'substantial', 'financial', 'return', 'investment', 'more_information_visit', 'wwwamchealthcom'], [], ['acute', 'care', 'community', 'hospital', 'jointly', 'own', 'city', 'hospital', 'fully', 'accredit', 'joint', 'commission', 'existence', 'time', 'mrhc', 'grow', 'large', 'employer'], [], ['chief', 'marketing', 'officer'], [], [], [], ['director', 'marketing', 'strategic', 'planning'], [], [], ['content', 'issue', 'press_release', 'distribution', 'service'], ['clinical_stage', 'company', 'develop', 'therapy', 'patient', 'cancer', 'need', 'new', 'treatment_option', 'volitionrx', 'multinational', 'epigenetic', 'company', 'today_announce', 'signing', 'research', 'development', 'collaboration', 'advance', 'rapid', 'epigenetic', 'profiling', 'use', 'volition', 'technology', 'support', 'further_development', 'salarius', 'clinical_stage', 'drug', 'seclidemstat'], ['novel', 'oral', 'reversible', 'target', 'lsd', 'inhibitor', 'affect', 'gene', 'expression', 'currently', 'phase', 'clinical', 'study', 'solid', 'hematologic', 'cancer', 'where', 'implicate', 'disease', 'develop', 'simple', 'easy', 'use', 'cost', 'effective', 'blood_test', 'diagnose', 'monitor', 'range', 'life', 'alter', 'disease', 'include', 'cancer', 'human', 'animal'], ['delighted', 'collaborate', 'volition', 'believe', 'technology', 'provide', 'valuable', 'biomarker', 'information', 'seek', 'advance', 'development', 'seclidemstat', 'multiple', 'clinical', 'indication', 'comment', 'chief_executive_officer', 'biomarker', 'allow', 'noninvasive', 'method', 'determine', 'target', 'engagement', 'potential', 'drug', 'activity', 'patient', 'exciting', 'research', 'collaboration', 'volition', 'provide', 'tool', 'aid', 'development', 'seclidemstat', 'clinic'], ['chief', 'commercial', 'officer', 'volition', 'add', 'excited', 'collaborate', 'salarius', 'part', 'discover', 'program', 'offer', 'biopharma', 'company', 'academia', 'access', 'state_art', 'assay', 'rapid', 'epigenetic', 'profiling', 'look_forward', 'support', 'salarius', 'development', 'release', 'groundbreaking', 'seclidemstat', 'therapy', 'directly', 'benefit', 'patient', 'cancer'], ['multinational', 'epigenetic', 'company', 'apply', 'nucleosomics', 'platform', 'subsidiary', 'develop', 'simple', 'easy', 'use', 'cost', 'effective', 'blood_test', 'help', 'diagnose', 'monitor', 'range', 'life', 'alter', 'disease', 'include', 'cancer', 'disease', 'associate', 'netosis', 'such', 'sepsis', 'early', 'diagnosis', 'monitoring', 'potential', 'only', 'prolong', 'life', 'patient', 'also', 'improve', 'quality_life', 'test', 'base', 'science', 'nucleosomic', 'practice', 'identify', 'measure', 'nucleosome', 'bloodstream', 'other', 'bodily', 'fluid', 'indicate', 'disease', 'present', 'volition', 'primarily', 'focus', 'human', 'diagnostic', 'monitoring', 'also', 'subsidiary', 'focus', 'animal', 'diagnostic', 'monitoring'], ['research', 'development', 'activity', 'center', 'belgium', 'innovation', 'laboratory', 'office', 'additional', 'office', 'more_information_visit', 'volition', 'limit', 'website'], ['clinical_stage', 'company', 'develop', 'therapy', 'patient', 'cancer', 'need', 'new', 'treatment_option', 'salarius', 'product', 'portfolio', 'include', 'seclidemstat', 'lead', 'candidate', 'study', 'potential', 'treatment', 'pediatric', 'cancer', 'sarcoma', 'other', 'cancer', 'limited', 'treatment_option', 'sp', 'oral', 'small_molecule', 'protein', 'currently', 'phase', 'clinical_trial', 'relapsed', 'refractory', 'ewing', 'sarcoma', 'certain', 'additional', 'sarcoma', 'share', 'similar', 'biology', 'also', 'refer', 'ewing', 'relate', 'fet', 'rearrange', 'seclidemstat', 'receive', 'fast_track', 'orphan_drug', 'rare_pediatric', 'disease', 'designation', 'ewe', 'sarcoma', 'administration', 'salarius', 'also', 'explore', 'potential', 'several', 'cancer', 'high_unmet', 'medical', 'need', 'investigator', 'initiate', 'phase', 'clinical', 'study', 'hematologic', 'cancer', 'underway', 'receive', 'financial', 'support', 'national', 'advance', 'ewing', 'sarcoma', 'clinical', 'program', 'recipient', 'product', 'development', 'award', 'cancer', 'prevention', 'more_information_visit', 'follow', 'salarius', 'twitter'], ['forward_look_statement', 'press_release_contain', 'forward_look_statement_meaning', 'private_security', 'statement', 'other', 'statement_historical_fact', 'include', 'press_release', 'forward_look_statement', 'forward_look_statement', 'identify', 'term', 'such', 'believe', 'develop', 'potential', 'progress', 'potential', 'similar', 'term', 'expression', 'negative', 'thereof', 'example', 'such', 'statement', 'include', 'limit', 'statement', 'relate', 'follow', 'value', 'benefit', 'collaboration', 'volition', 'ability', 'use', 'biomarker', 'advance', 'salarius', 'product_candidate', 'salarius', 'growth', 'strategy', 'value', 'seclidemstat', 'treatment', 'ewe', 'sarcoma', 'ewe', 'relate', 'sarcoma', 'other', 'cancer', 'expand', 'scope', 'salarius', 'research', 'focus', 'high_unmet', 'need', 'patient', 'population', 'milestone', 'salarius', 'current', 'future', 'clinical_trial', 'include', 'timing', 'datum', 'readout', 'salarius', 'actually', 'achieve', 'plan', 'carry', 'intention', 'meet', 'expectation', 'objective', 'disclose', 'forward_look_statement', 'place_undue_reliance', 'forward_look_statement', 'statement', 'subject', 'risk_uncertainty_cause_actual', 'result', 'performance', 'differ_materially', 'discuss', 'forward_look_statement', 'risk_uncertainty', 'include', 'limit', 'follow', 'sufficiency', 'capital', 'resource', 'ability', 'need', 'salarius', 'raise', 'additional', 'capital', 'meet', 'business', 'operational', 'need', 'achieve', 'business', 'objective', 'strategy', 'future', 'clinical_trial', 'result', 'impact', 'result', 'salarius', 'result', 'study', 'clinical_trial', 'predictive_future', 'clinical_trial', 'result', 'risk', 'relate', 'drug', 'development', 'regulatory_approval', 'process', 'competitive_landscape', 'other', 'industry', 'relate', 'risk', 'other', 'risk', 'describe', 'filing', 'include', 'annual_report_form', 'fiscal_year', 'end', 'revise', 'supplement', 'quarterly_report_form', 'other', 'document_file', 'forward_look_statement', 'contain_press_release', 'speak_only', 'date_press_release', 'base', 'management', 'assumption', 'estimate', 'such', 'date', 'salarius', 'disclaim', 'intent', 'obligation_update_forward_look', 'statement', 'reflect_event_circumstance', 'exist', 'date', 'make'], ['contact'], [], [], ['subcutaneous', 'formulation', 'enhanze', 'reduce', 'treatment', 'time', 'minute', 'compare', 'minute', 'standard', 'intravenous', 'infusion'], ['today_announce', 'phase', 'imscin', 'study', 'evaluate', 'subcutaneous', 'formulation', 'enhanze', 'technology', 'meet', 'co', 'primary_endpoint'], ['study', 'show', 'non', 'inferior', 'level', 'tecentriq', 'blood', 'pharmacokinetic', 'when', 'inject', 'subcutaneously', 'compare', 'intravenous', 'infusion', 'cancer', 'naive', 'patient', 'locally', 'advanced', 'metastatic', 'non', 'small', 'cell', 'lung', 'cancer', 'prior', 'platinum', 'therapy', 'fail', 'safety_profile', 'formulation', 'consistent', 'tecentriq'], ['positive', 'result', 'further', 'demonstrate', 'opportunity', 'coformulation', 'enhanze', 'potentially', 'benefit', 'patient', 'reduce', 'treatment', 'time', 'minute', 'sc', 'delivery', 'minute', 'treatment', 'comment', 'president_chief_executive_officer', 'delighted', 'announce', 'positive', 'result', 'represent', 'second', 'positive', 'phase', 'trial', 'announcement', 'year', 'wave', 'product'], ['share', 'detailed', 'finding', 'imscin', 'study', 'upcoming', 'medical', 'meeting', 'submit', 'datum', 'regulatory_approval', 'health_authority', 'globally', 'include', 'food'], ['proprietary', 'enhanze', 'drug_delivery', 'technology', 'base', 'patent', 'recombinant', 'human', 'hyaluronidase', 'rhuph', 'show', 'remove', 'traditional', 'limitation', 'volume', 'biologic', 'deliver', 'subcutaneously', 'just', 'skin', 'use', 'rhuph', 'biologic', 'compound', 'administer', 'intravenously', 'instead', 'deliver', 'subcutaneously', 'enhanze', 'also', 'benefit', 'subcutaneous', 'biologic', 'reduce', 'need', 'multiple', 'injection'], ['company', 'bring', 'disruptive', 'solution', 'significantly', 'improve', 'patient', 'experience', 'outcome', 'emerge', 'establish', 'therapy', 'innovator', 'enhanze', 'technology', 'proprietary', 'enzyme', 'commercially', 'validate', 'solution', 'use', 'facilitate', 'delivery', 'injected', 'drug', 'fluid', 'order', 'reduce', 'treatment', 'burden', 'patient', 'have', 'touch', 'more', 'patient', 'life', 'post', 'marketing', 'use', 'commercialize', 'product', 'more', 'global', 'market', 'halozyme', 'license', 'enhanze', 'technology', 'lead', 'pharmaceutical', 'biotechnology', 'company', 'include', 'pharmaceutical'], ['also', 'develop', 'manufacture', 'commercialize', 'partner', 'drug', 'device', 'combination', 'product', 'use', 'advanced', 'auto', 'injector', 'technology', 'design', 'provide', 'commercial', 'functional', 'advantage', 'such', 'improve', 'convenience', 'tolerability', 'enhance', 'patient', 'comfort', 'adherence', 'company', 'commercial', 'portfolio', 'proprietary', 'product', 'include', 'xyoste', 'tlando', 'partner', 'commercial', 'product', 'ongoing', 'product', 'development', 'program', 'industry', 'lead', 'pharmaceutical', 'company', 'include', 'pharmaceutical'], ['headquarter', 'office', 'ewe', 'also', 'site', 'operation', 'facility'], ['more_information_visit', 'wwwhalozymecom', 'connect', 'twitter'], ['addition', 'historical', 'information', 'statement', 'set', 'press_release_include', 'forward_look_statement', 'include_limitation', 'statement', 'concern', 'company', 'enhanze', 'drug_delivery', 'technology', 'possible', 'benefit', 'attribute', 'enhanze', 'potential', 'application', 'aid', 'dispersion', 'absorption', 'other', 'injected', 'therapeutic', 'drug', 'facilitate', 'more', 'rapid', 'delivery', 'administration', 'large', 'volume', 'injectable', 'medication', 'subcutaneous', 'delivery', 'forward_look_statement', 'also', 'include', 'statement', 'concern', 'future', 'development', 'effort', 'company', 'collaboration', 'partner', 'include', 'plan_submit', 'clinical_trial', 'datum', 'refer', 'press_release', 'regulatory_approval', 'health_authority', 'forward_look_statement', 'typically', 'always', 'identify', 'use', 'word_believe', 'enable', 'intend', 'estimate', 'anticipate', 'plan', 'predict', 'probable', 'potential', 'possible', 'continue', 'other', 'word', 'similar', 'meaning', 'involve', 'risk_uncertainty_cause_actual', 'result_differ', 'materially', 'forward_look_statement', 'actual_result_differ', 'materially', 'expectation', 'contain_forward_look', 'statement', 'result', 'several', 'factor', 'include', 'unexpected', 'result', 'delay', 'growth', 'company', 'enhanze', 'business', 'development', 'regulatory', 'review', 'approval', 'enhanze', 'product', 'include', 'potential', 'delay', 'cause', 'current', 'global', 'pandemic', 'regulatory_approval', 'requirement', 'unexpecte', 'adverse_event', 'patient', 'outcome', 'competitive', 'condition', 'other', 'factor', 'result', 'difference', 'discuss', 'great', 'detail', 'company', 'most', 'recently', 'file', 'annual_report_form', 'company', 'other', 'periodic', 'report', 'filing', 'company', 'caution', 'investor', 'place_undue_reliance', 'forward_look_statement', 'contain_press_release', 'forward_look_statement', 'base', 'information', 'currently', 'available', 'company', 'date_hereof', 'company', 'undertake_obligation_revise', 'update', 'forward_look_statement', 'reflect_event_circumstance', 'date_press_release', 'require_law'], ['investor_relation', 'corporate_communication', 'tbui'], [], ['view_original_content_download', 'multimedia_news', 'release', 'positive', 'result', 'announce', 'phase', 'evaluate', 'subcutaneous', 'formulation', 'tecentriq', 'enhanze', 'advanced', 'non', 'small', 'cell', 'lung'], [], ['company', 'code'], ['today_announce', 'follow', 'change', 'management', 'structure', 'effective'], ['top', 'management'], ['like', 'express', 'sincere', 'appreciation', 'tremendous', 'contribution', 'say', 'add', 'expect', 'focus', 'accelerate', 'clinical', 'application', 'science', 'enrich', 'clinical', 'portfolio', 'deliver', 'value', 'patient', 'also', 'confident', 'promote', 'realization', 'organizational', 'health', 'goal', 'leverage', 'extensive', 'career', 'area', 'unite', 'new', 'leadership', 'aimimg', 'achieve', 'goal', 'set', 'corporate', 'strategic', 'plan'], ['top', 'management', 'effective'], ['responsibility', 'corporate', 'officer', 'effective'], ['chief_medical_officer', 'current', 'executive', 'adviser'], ['new', 'chief', 'people', 'chief', 'ethic', 'compliance', 'current', 'division', 'head', 'human', 'resource'], ['resignation', 'corporate', 'officer', 'effective'], ['administrative', 'chief', 'ethic', 'compliance', 'officer'], ['chief_medical_officer', 'cmo'], ['reference'], ['name', 'career', 'history'], ['name', 'career', 'history'], ['pharmaceutical', 'company', 'conduct', 'business', 'more', 'country_world', 'promote', 'focus', 'area', 'approach', 'design', 'identify', 'opportunity', 'continuous', 'creation', 'new', 'drug', 'address', 'disease', 'high_unmet', 'medical', 'need', 'focus', 'biology', 'modality', 'furthermore', 'also', 'look', 'foundational', 'focus', 'create', 'healthcare', 'solution', 'combine', 'expertise', 'knowledge', 'cut_edge', 'technology', 'different', 'field', 'external', 'partner', 'effort', 'astella', 'stand', 'forefront', 'healthcare', 'change', 'turn', 'innovative', 'science', 'value', 'patient', 'more_information_visit', 'website'], ['cautionary', 'note', 'press_release_statement', 'make', 'respect', 'current', 'plan', 'estimate', 'strategy', 'belief', 'other', 'statement_historical_fact', 'forward_look_statement', 'future', 'performance', 'statement', 'base', 'management', 'current', 'assumption', 'belief', 'light', 'information', 'currently', 'available', 'involve', 'know_unknown', 'risk_uncertainty', 'number_factor_cause_actual', 'result_differ', 'materially', 'discuss', 'forward_look_statement', 'such', 'factor', 'include', 'limit', 'change', 'general_economic', 'condition', 'law', 'regulation', 'relate', 'pharmaceutical', 'market', 'currency_exchange', 'rate', 'fluctuation', 'delay', 'new', 'product', 'launch', 'inability', 'market', 'exist', 'new', 'product', 'effectively', 'inability', 'continue', 'effectively', 'research', 'develop', 'product', 'accept', 'customer', 'highly', 'competitive', 'market', 'infringement', 'intellectual_property', 'right', 'third_party'], ['information', 'pharmaceutical', 'product', 'include', 'product', 'currently', 'development', 'include', 'press_release', 'intend', 'constitute', 'advertisement', 'medical', 'advice'], ['view_original_content_download', 'multimedia_news', 'release', 'astella', 'announce', 'management', 'structure', 'html'], [], ['company', 'code', 'pink'], ['coherus', 'company', 'today_announce', 'effective', 'company', 'board_director', 'grant', 'option', 'purchase', 'aggregate', 'share', 'common_stock', 'company', 'newly', 'hire', 'employee', 'share', 'exercise', 'price', 'closing', 'trading', 'price', 'grant', 'date', 'newly', 'hire', 'executive_vice', 'president', 'grant', 'option', 'purchase', 'share', 'newly', 'hire', 'senior_vice_president', 'grant', 'option', 'purchase', 'share'], ['stock', 'option', 'grant', 'pursuant', 'commencement', 'incentive', 'plan', 'approve', 'company', 'board_director', 'rule', 'global', 'select', 'market', 'equity', 'grant', 'induce', 'new', 'employee', 'enter', 'employment', 'company'], ['bioscience', 'contact', 'information'], ['investor_relation'], ['pharmaceutical_incorporate', 'today_announce', 'effective', 'director', 'approve', 'grant', 'non', 'qualified', 'stock', 'option', 'award', 'purchase', 'aggregate', 'share', 'common_stock', 'restrict', 'stock', 'unit', 'performance', 'stock', 'unit', 'target', 'level', 'non', 'executive', 'employee', 'option', 'grant', 'grant', 'date', 'rsus', 'psus', 'date', 'ligand', 'file', 'form', 'registration', 'statement', 'register', 'share', 'pursuant', 'ligand', 'employment', 'inducement', 'plan', 'inducement', 'plan'], ['contact'], ['pharmaceutical_incorporate', 'twitter'], [], ['source', 'ligand', 'pharmaceutical_incorporate'], ['view_news', 'release', 'online'], ['fda', 'approve', 'product', 'cocaine_intoxication'], ['grant', 'breakthrough', 'therapy', 'designation'], ['phase', 'single', 'blind_placebo_control', 'potential', 'pivotal', 'study', 'expect', 'start', 'fourth_quarter', 'pende', 'agreement'], ['tnxp', 'tonix', 'company', 'clinical_stage', 'company', 'today_announce', 'receive', 'cooperative', 'agreement', 'grant', 'drug', 'abuse', 'part', 'support', 'development', 'tnx', 'double', 'mutant', 'cocaine', 'mg', 'iv', 'solution', 'treatment', 'cocaine_intoxication', 'tnx', 'recombinant', 'enzyme', 'efficiently', 'degrade', 'metabolize', 'cocaine', 'cocaine_intoxication', 'refer', 'state', 'cocaine', 'deleterious', 'effect', 'several', 'body', 'system', 'especially', 'cardiovascular', 'system', 'tnx', 'demonstrate', 'activity', 'reverse', 'physiological', 'effect', 'cocaine', 'challenge', 'people', 'use', 'cocaine', 'prior', 'phase_randomize_double', 'blind_placebo_control', 'clinical', 'study'], ['grant', 'intend', 'support', 'continued', 'development', 'tnx', 'treatment', 'life_threaten', 'cocaine_intoxication', 'more', 'individual', 'die', 'drug', 'overdose', 'death', 'involve', 'cocaine'], ['grant', 'award', 'underscore', 'unmet_need', 'safe_effective', 'treatment', 'cocaine_intoxication', 'validate', 'progress', 'achieve', 'date', 'tnx', 'say_chief_executive_officer', 'pharmaceutical', 'cocaine_intoxication', 'remain', 'serious', 'issue', 'where', 'currently', 'specific', 'pharmacotherapy', 'indicate', 'treatment', 'target', 'cause', 'rather', 'symptom', 'cocaine_intoxication', 'believe', 'tnx', 'offer', 'significant', 'advantage', 'current', 'standard_care', 'cocaine_intoxication'], ['recently', 'announce', 'design', 'new', 'single', 'blind', 'open_label', 'placebo_control', 'randomized', 'phase', 'clinical_trial', 'tnx', 'treatment', 'cocaine_intoxication', 'phase_study', 'potential', 'serve', 'pivotal', 'trial', 'anticipate', 'start', 'fourth_quarter', 'pende', 'food', 'agreement', 'tnx', 'grant', 'breakthrough', 'therapy', 'designation', 'biologic', 'new', 'molecular', 'entity', 'eligible', 'year', 'market', 'exclusivity', 'approval', 'addition', 'expect', 'patent', 'protection'], ['research', 'tonix', 'pursue', 'bright', 'light', 'shared', 'goal', 'reduce', 'overdose', 'death', 'harm', 'continue', 'battle', 'crisis', 'substance', 'use', 'disorder', 'country', 'only', 'compound', 'pandemic', 'target', 'treatment', 'bring', 'healthcare', 'cost', 'most', 'importantly', 'loss', 'life', 'due', 'say', 'representative', 'federal', 'grant', 'tonix', 'able', 'move', 'step_close', 'authorization', 'get', 'potentially', 'life', 'save', 'treatment', 'hand', 'emergency', 'room', 'doctor', 'nurse', 'as_well', 'em', 'other', 'first', 'responder', 'proud', 'headquarter', 'base', 'here'], ['incredible', 'partner', 'job', 'creator', 'commend', 'effort', 'fight', 'substance', 'use', 'disorder', 'crisis', 'nation', 'continue', 'face', 'kill', 'drug', 'overdose', 'just', 'last', 'year', 'need', 'work_together', 'curb', 'loss', 'set', 'sight', 'prevention', 'harm', 'reduction', 'treatment', 'recovery', 'start', 'medical', 'innovation', 'own', 'community', 'reliable', 'investment', 'country', 'bright', 'leader', 'funding', 'drug', 'abuse', 'just', 'say'], ['research', 'report', 'press_release', 'support', 'drug', 'abuse', 'award', 'number', 'content', 'solely', 'responsibility', 'author', 'necessarily', 'represent', 'official', 'view'], ['tnx'], ['double', 'mutant', 'cocaine', 'mg', 'iv', 'solution', 'develop', 'investigational', 'new', 'drug_application', 'treatment', 'cocaine_intoxication', 'tnx', 'recombinant', 'protein', 'enzyme', 'produce', 'technology', 'non', 'disease', 'produce', 'strain', 'bacteria', 'identify', 'bacteria', 'use', 'cocaine', 'sole', 'source', 'carbon', 'nitrogen', 'grow', 'soil', 'surround', 'coca', 'plants', 'gene', 'encode', 'coce', 'identify', 'protein', 'extensively', 'characterized', 'coce', 'catalyze', 'breakdown', 'cocaine', 'benzoic', 'acid', 'wild', 'type', 'coce', 'unstable', 'body', 'temperature', 'so', 'targeted', 'mutation', 'introduce', 'coce', 'gene', 'result', 'double', 'mutant', 'coce', 'active', 'approximately', 'hour', 'body', 'temperature', 'phase_study', 'tnx', 'mg', 'mg', 'dose', 'well_tolerate', 'rapidly', 'reduce', 'cocaine', 'effect', 'cocaine', 'mg'], ['cocaine_intoxication'], ['cocaine', 'illegal', 'recreational', 'drug', 'take', 'pleasurable', 'effect', 'associate', 'as_well', 'mental', 'alertness', 'case', 'cocaine', 'block', 'reuptake', 'dopamine', 'central_nervous_system', 'synapsis', 'result', 'accumulation', 'dopamine', 'synapse', 'amplification', 'dopamine', 'signal', 'reinforce', 'drug', 'take', 'continue', 'use', 'cocaine', 'however', 'intense', 'cocaine', 'craving', 'occur', 'result', 'high', 'potential', 'continue', 'use', 'addiction', 'as_well', 'risk', 'cocaine_intoxication', 'cocaine_intoxication', 'refer', 'deleterious', 'effect', 'cocaine', 'several', 'body', 'system', 'especially', 'involve', 'cardiovascular', 'system', 'common', 'symptom', 'cocaine_intoxication', 'include', 'tachyarrhythmia', 'elevated', 'blood_pressure', 'life_threaten', 'result', 'individual', 'know', 'suspect', 'cocaine_intoxication', 'send', 'immediately', 'emergency', 'department', 'preferably', 'ambulance', 'case', 'cardiac', 'arrest', 'occur', 'transit', 'accord', 'number', 'overdose', 'death', 'involve', 'cocaine', 'reach', 'individuals', 'also', 'accord', 'recent', 'report', 'cdc', 'drug', 'overdose', 'death', 'approximately', 'nearly', 'involve', 'cocaine', 'black', 'experience', 'high', 'death', 'rate', 'overdose', 'involve', 'cocaine'], ['reference'], ['randomize_double_blind_placebo', 'control', 'trial', 'rbp', 'cocaine', 'abuser', 'pharmacokinetic', 'profile', 'rbp', 'cocaine', 'effect', 'rbp', 'cocaine', 'induce', 'physiological', 'effect'], ['center', 'drug', 'overdose', 'datahtm'], ['rosser', 'basran', 'gene', 'cloning', 'nucleotide', 'sequencing', 'property', 'cocaine', 'esterase'], ['basran', 'lerner', 'structure', 'bacterial', 'cocaine'], ['basran', 'biochemical', 'structural', 'analysis', 'highly', 'proficient', 'cocaine', 'esterase', 'biochemistry'], ['thermostable', 'variant', 'cocaine', 'esterase', 'long', 'time', 'protection', 'cocaine', 'toxicity', 'mol'], ['drug', 'abuse', 'research', 'topic', 'trend', 'statistic', 'overdose', 'death', 'rates', 'text'], [], ['tonix', 'clinical_stage', 'company', 'focus', 'discover', 'licensing', 'acquire', 'develop', 'therapeutic', 'treat', 'prevent', 'human', 'disease', 'alleviate', 'portfolio', 'compose', 'central_nervous_system', 'rare', 'disease', 'immunology', 'infectious_disease', 'product_candidate', 'portfolio', 'include', 'small_molecule', 'biologic', 'treat', 'pain', 'neurologic', 'psychiatric', 'addiction', 'condition', 'candidate', 'cyclobenzaprine', 'mid', 'phase', 'development', 'management', 'fibromyalgia', 'new', 'phase_study', 'launch', 'second_quarter', 'interim', 'datum', 'expect', 'first_quarter', 'also', 'develop', 'treat', 'long_covid', 'chronic', 'post', 'acute', 'condition', 'tonix', 'expect', 'initiate', 'phase_study', 'long_covid', 'third_quarter', 'tnx', 'cocaine', 'esterase', 'biologic', 'design', 'treat', 'cocaine_intoxication', 'mid', 'phase', 'new', 'potentially', 'pivotal', 'phase_study', 'expect', 'initiate', 'fourth_quarter', 'tnx', 'grant', 'breakthrough', 'therapy', 'designation', 'potentiate', 'small_molecule', 'development', 'chronic', 'migraine', 'expect', 'enter', 'clinic', 'phase_study', 'second_half', 'tonix', 'rare', 'disease', 'portfolio', 'include', 'tnx', 'intranasal', 'potentiate', 'treatment', 'prader', 'willi', 'syndrome', 'tnx', 'grant', 'orphan_drug', 'designation', 'immunology', 'portfolio', 'include', 'biologic', 'address', 'organ', 'transplant', 'rejection', 'autoimmunity', 'cancer', 'include', 'tnx', 'humanized', 'monoclonal_antibody', 'target', 'develop', 'prevention', 'rejection', 'treatment', 'autoimmune', 'disease', 'phase_study', 'tnx', 'expect', 'initiate', 'first_half', 'tonix', 'infectious_disease', 'pipeline', 'consist', 'vaccine', 'development', 'prevent', 'smallpox', 'monkeypox', 'next_generation', 'vaccine', 'prevent', 'platform', 'make', 'fully', 'human', 'monoclonal_antibody', 'treat', 'vaccine', 'development', 'prevent', 'smallpox', 'monkeypox', 'also', 'serve', 'live', 'virus', 'vaccine', 'platform', 'recombinant', 'pox', 'vaccine', 'platform', 'other', 'infectious_disease', 'phase_study', 'expect', 'initiate', 'first_half', 'tonix', 'lead', 'vaccine', 'candidate', 'tnx', 'live', 'virus', 'vaccine', 'base', 'recombinant', 'live', 'virus', 'vector', 'vaccine', 'platform', 'phase_study', 'vaccine', 'expect', 'initiate', 'second_half'], ['tonix', 'product_candidate', 'investigational', 'new', 'drug', 'biologic', 'approve', 'indication'], ['press_release', 'further', 'information', 'tonix', 'find'], ['forward_look_statement'], ['certain', 'statement', 'press_release', 'forward_look', 'meaning_private', 'security', 'statement', 'identify', 'use', 'forward_look', 'word', 'such', 'anticipate', 'believe', 'expect', 'intend', 'other', 'forward_look_statement', 'base', 'tonix', 'current', 'expectation', 'actual_result_differ', 'materially', 'number_factor_cause_actual', 'event', 'differ_materially', 'indicate_such', 'forward_look_statement', 'factor', 'include', 'limit', 'risk', 'relate', 'failure', 'obtain', 'clearance', 'approval', 'noncompliance', 'regulation', 'delay', 'uncertainty_cause', 'global', 'pandemic', 'risk', 'relate', 'timing_progress', 'clinical', 'development', 'product_candidate', 'need', 'additional', 'financing', 'uncertainty', 'patent', 'protection', 'litigation', 'uncertainty', 'government', 'third_party', 'payor', 'reimbursement', 'limited', 'research', 'development', 'effort', 'dependence', 'third_party', 'substantial', 'competition', 'pharmaceutical', 'development', 'significant', 'risk', 'development', 'regulatory_approval', 'new', 'product', 'tonix', 'undertake_obligation', 'update_revise', 'forward_look_statement', 'investor', 'read', 'risk_factor', 'set', 'annual_report_form', 'year', 'end', 'file', 'periodic', 'report_file', 'date', 'thereof', 'tonix', 'forward_look_statement', 'expressly', 'qualify', 'such', 'risk_factor', 'other', 'cautionary', 'statement', 'information', 'set', 'speak_only_date', 'thereof'], ['corporate'], [], ['investor'], ['company', 'today_announce', 'strategic', 'alliance', 'advance', 'pipeline', 'rna', 'target', 'oncology', 'therapeutic', 'diagnostic', 'candidate'], ['alliance', 'scientist', 'collaborate', 'preclinical', 'study', 'further', 'validate', 'therapeutic', 'diagnostic', 'candidate', 'expand', 'reach', 'discovery', 'engine', 'result', 'study', 'inform', 'future', 'clinical_trial', 'agent', 'include', 'trial', 'lead'], ['base', 'therapeutic', 'offer', 'exciting', 'possibility', 'treat', 'cancer', 'now', 'examine', 'how', 'regulatory', 'affect', 'signal', 'spatially', 'temporally', 'single', 'cell', 'level', 'tumor', 'cell', 'immune', 'cell', 'stem', 'cell', 'critical', 'tumor', 'progression', 'relapse', 'immune', 'evasion', 'say', 'principal', 'professor', 'translational', 'molecular', 'pathology', 'goal', 'collaborate', 'transcode', 'gain', 'deep_understanding', 'rna', 'target', 'therapy', 'bring', 'innovative', 'new', 'treatment_option', 'patient'], ['collaboration', 'potential', 'inform', 'multiple', 'clinical', 'program', 'pipeline', 'start', 'lead', 'therapeutic', 'candidate', 'design', 'treat', 'multiple', 'metastatic', 'cancer', 'future', 'clinical_trial', 'design', 'lead', 'professor', 'investigational', 'cancer', 'therapeutic'], ['strategic', 'alliance', 'offer', 'opportunity', 'further', 'unlock', 'potential', 'therapeutic', 'pipeline', 'combine', 'promise', 'image', 'capable', 'delivery', 'platform', 'discovery', 'engine', 'unique', 'talent', 'resource', 'find', 'say', 'founder', 'cto', 'transcode'], ['prior', 'phase', 'clinical_trial', 'schedule', 'enter', 'first', 'human', 'phase', 'clinical_trial', 'design', 'demonstrate', 'delivery', 'therapeutic', 'candidate', 'metastatic', 'lesion', 'patient', 'advanced', 'solid_tumor'], ['acutely', 'aware', 'expectation', 'come', 'therapeutic', 'approach', 'potential', 'induce', 'durable', 'regression', 'metastatic', 'disease', 'committed', 'take', 'opportunity', 'fulfill', 'promise', 'rna', 'cancer', 'say', 'founder', 'ceo'], [], ['rna', 'oncology', 'company', 'create', 'belief', 'cancer', 'defeat', 'use', 'therapeutic', 'company', 'create', 'platform', 'drug_candidate', 'design', 'target', 'variety', 'tumor', 'type', 'objective', 'significantly', 'improve', 'patient', 'outcome', 'company', 'lead', 'therapeutic', 'candidate', 'focus', 'treat', 'metastatic', 'cancer', 'believe', 'cause', 'approximately', 'cancer', 'death', 'total', 'year', 'worldwide', 'company', 'believe', 'potential', 'produce', 'regression', 'recurrence', 'range', 'cancer', 'include', 'breast', 'pancreatic', 'colon', 'cancer', 'glioblastoma', 'other', 'company', 'other', 'drug_candidate', 'focus', 'treat', 'tumor', 'target', 'respectively', 'transcode', 'also', 'cancer', 'agnostic', 'program', 'rna', 'base', 'agonist', 'retinoic', 'acid', 'inducible', 'gene', 'rig', 'approach', 'design', 'drive', 'immune_response', 'tumor', 'crispr_cas', 'base', 'therapy', 'platform', 'repair', 'elimination', 'cancer', 'cause', 'gene', 'tumor', 'cell', 'mrna', 'base', 'platform', 'development', 'cancer', 'vaccine', 'design', 'activate', 'cytotoxic', 'immune_response', 'tumor', 'cell'], [], ['rank', 'world', 'most', 'respected', 'center', 'focus', 'cancer', 'patient', 'care', 'research', 'education', 'prevention', 'institution', 'sole', 'mission', 'end', 'cancer', 'patient', 'family', 'only', 'comprehensive', 'cancer', 'center', 'designate', 'cancer', 'good', 'hospital', 'ranking', 'name', 'nation', 'top', 'hospital', 'cancer', 'ranking', 'begin', 'receive', 'cancer', 'center', 'support', 'grant', 'nci'], ['forward_look_statement'], ['release', 'contain_forward_look', 'statement_meaning', 'private_security_include_limitation', 'statement', 'concern', 'result', 'derive', 'therefrom', 'statement', 'concern', 'potential', 'treat', 'cancer', 'therapeutic', 'statement', 'concern', 'timing', 'outcome', 'expect', 'regulatory_filing', 'clinical_trial', 'include', 'filing', 'exploratory', 'investigational', 'new', 'drug_application', 'plan', 'first', 'human', 'study', 'statement', 'concern', 'timing', 'outcome', 'study', 'include', 'study', 'demonstrate', 'proof', 'mechanism', 'statement', 'concern', 'patent', 'application', 'statement', 'concern', 'development', 'program', 'ttx', 'technology_platform', 'generally', 'forward_look_statement', 'press_release_base', 'management', 'current', 'expectation', 'future', 'event', 'subject', 'number_risk_uncertainty', 'cause_actual_result_differ', 'materially_adversely', 'set_forth', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include', 'limit', 'risk_associate', 'drug_discovery', 'development', 'risk', 'result', 'planned', 'clinical_trial', 'consistent', 'pre', 'clinical', 'study', 'expectation', 'risk_associate', 'timing', 'outcome', 'plan', 'regulatory_submission', 'risk_associate', 'plan', 'clinical_trial', 'product_candidate', 'risk_associate', 'obtain_maintain', 'protect', 'intellectual_property', 'risk_associate', 'ability', 'enforce', 'patent', 'infringer', 'defend', 'patent', 'portfolio', 'challenge', 'third_party', 'risk', 'competition', 'other', 'company', 'develop', 'product', 'similar', 'use', 'risk_associate', 'financial', 'condition', 'need', 'obtain', 'additional', 'funding', 'support', 'business', 'activity', 'include', 'ability', 'continue', 'go', 'concern', 'risk_associate', 'dependence', 'third_party', 'risk_associate', 'coronavirus', 'discussion', 'other', 'risk_uncertainty', 'other', 'important_factor', 'cause_actual_result_differ', 'contain', 'imply', 'forward_look_statement', 'see', 'section', 'entitle', 'risk_factor_annual_report', 'form', 'year', 'end', 'as_well', 'discussion', 'potential', 'risk_uncertainty', 'other', 'important_factor', 'subsequent', 'transcode', 'filing', 'information', 'press_release', 'date', 'release', 'transcode', 'undertake', 'duty', 'update_information', 'require_law'], ['more', 'information', 'contact'], ['investor'], ['redchip', 'office', 'cell'], [], [], ['clinical_stage', 'pharmaceutical', 'company', 'focus', 'development', 'therapy', 'patient', 'rare', 'genetic', 'mitochondrial', 'disease', 'today_announce', 'appointment', 'company', 'board_director'], ['accomplished', 'leader', 'industry', 'say', 'chairman', 'pharmaceutical', 'extensive', 'experience', 'healthcare', 'reimbursement', 'policy', 'patient', 'access', 'invaluable', 'addition', 'reneo', 'plan', 'look_forward', 'work', 'come', 'year', 'conclude'], ['thrilled', 'join', 'say', 'reneo', 'extraordinary', 'company', 'novel', 'drug', 'potential', 'treat', 'number', 'mitochondrial', 'disease', 'look_forward', 'work', 'board', 'support', 'management', 'team'], ['more', 'year', 'experience', 'medical', 'device', 'industry', 'president', 'pharmaceutical', 'organization', 'prior', 'founder', 'managing', 'director', 'national', 'health_care', 'consulting', 'firm', 'prior', 'start', 'vice_president', 'strategy', 'planning', 'communication', 'long', 'beach', 'center', 'child', 'hospital', 'first', 'global', 'director', 'health', 'economic', 'reimbursement', 'also', 'hold', 'variety', 'strategic', 'reimbursement', 'position', 'begin', 'pharmaceutical', 'career', 'group', 'work', 'primarily', 'health_care', 'industry', 'graduate', 'where', 'earn', 'ab', 'public', 'international', 'affair', 'hold', 'mba'], ['reneo', 'pharmaceutical'], ['reneo', 'clinical_stage', 'pharmaceutical', 'company', 'focus', 'development', 'therapy', 'patient', 'rare', 'genetic', 'mitochondrial', 'disease', 'often', 'associate', 'inability', 'produce', 'adenosine', 'triphosphate', 'lead', 'product_candidate', 'potent', 'selective', 'agonist', 'peroxisome', 'proliferator', 'activate', 'receptor', 'delta', 'pparÎ´', 'show', 'increase', 'transcription', 'gene', 'involve', 'mitochondrial', 'function', 'increase', 'fatty', 'acid', 'oxidation', 'increase', 'production', 'new', 'mitochondria', 'additional', 'information', 'see'], ['statement_contain_press', 'release', 'regard', 'matter', 'historical_fact', 'forward_look_statement_meaning', 'private_security', 'such_forward_look', 'statement', 'include', 'statement', 'regard', 'other_thing', 'potential', 'development', 'such', 'statement', 'subject', 'risk_uncertainty', 'actual_result_differ', 'materially_express_imply_such', 'forward_look_statement', 'word', 'such', 'plan', 'believe', 'anticipate', 'expect', 'intend', 'goal', 'potential', 'similar_expression_intend_identify', 'forward_look_statement', 'forward_look_statement', 'base', 'reneo', 'current', 'expectation', 'involve', 'assumption', 'never', 'materialize', 'prove', 'incorrect', 'actual_result_differ', 'materially', 'anticipate', 'such_forward_look', 'statement', 'result', 'various', 'risk_uncertainty', 'include_limitation', 'risk_uncertainty', 'associate', 'business', 'general', 'other', 'risk', 'describe', 'reneo', 'filing', 'forward_look_statement', 'contain_press_release', 'speak_only_date', 'make', 'reneo', 'undertake_obligation_update', 'such', 'statement', 'reflect', 'event', 'occur', 'circumstance', 'exist', 'date', 'make', 'require_law'], ['manage', 'director'], ['chief_executive_officer'], ['vaxx', 'company', 'pioneer', 'development', 'new_class', 'vaccine', 'today_announce', 'datum', 'demonstrate_durable', 'lowering', 'low', 'density', 'lipoprotein', 'cholesterol', 'non', 'human', 'primate', 'selection', 'pursue', 'anti', 'pcsk', 'vaccine', 'candidate', 'treat', 'study', 'other', 'ind_enable', 'nonclinical', 'study', 'support', 'progression', 'program', 'phase', 'first', 'human', 'clinical_trial', 'early'], ['mission', 'develop', 'vaccine', 'transform', 'expand', 'treatment', 'chronic', 'disease', 'effective', 'medicine', 'cheap', 'safe', 'more', 'convenient', 'say_chief_executive_officer', 'vaxxinity', 'have', 'make', 'significant', 'progress', 'pipeline', 'successfully', 'generate', 'positive', 'datum', 'multiple', 'clinical_trial', 'scale', 'synthetic', 'peptide', 'manufacture', 'hundred', 'million', 'dose', 'achieve', 'proof_concept', 'well', 'validate', 'target', 'such', 'pcsk', 'meaningful', 'milestone', 'vaxxinity', 'bring_step_close', 'vision', 'vaccinate', 'world', 'heart_attack_stroke'], ['synthetic', 'peptide', 'vaccine', 'target', 'kexin', 'type', 'serine', 'protease', 'pcsk', 'low', 'low', 'density', 'lipoprotein', 'cholesterol', 'mechanism', 'prove', 'reduce', 'risk', 'cardiovascular', 'event', 'high', 'cholesterol', 'major', 'risk_factor', 'coronary', 'heart', 'disease', 'heart_attack_stroke', 'atherosclerotic', 'cardiovascular', 'disease', 'lead', 'cause'], ['target', 'pcsk', 'proven', 'effective', 'approach', 'lower', 'cholesterol', 'reduce', 'risk', 'heart_attack_stroke', 'today', 'approve', 'therapy', 'access', 'administration', 'challenge', 'limit', 'use', 'small', 'subset', 'full', 'population', 'benefit', 'say_chief', 'medical_officer', 'vaxxinity', 'result', 'demonstrate', 'potent', 'durable', 'effect', 'vaccine', 'platform', 'consistent', 'well', 'understand', 'biology', 'further', 'validate', 'technology', 'approach', 'potential', 'safe', 'convenient', 'accessible', 'vaccine', 'heart', 'disease'], ['new', 'datum', 'non', 'human', 'primate', 'demonstrate', 'well_tolerate', 'provide', 'long', 'last', 'significant', 'ldl', 'reduction', 'placebo', 'priming', 'regiman', 'cholesterol', 'progressively', 'drop', 'placebo', 'value', 'healthy', 'monkey', 'steady', 'state', 'reduction', 'cholesterol', 'observe', 'month', 'magnitude', 'reduction', 'similar', 'single_dose', 'comparator', 'monoclonal_antibody', 'level', 'return', 'baseline_week', 'single_dose', 'monoclonal_antibody', 'steady', 'state', 'long', 'last', 'reduction', 'level', 'observe', 'last', 'dose', 'level', 'good', 'high', 'density', 'lipoprotein', 'cholesterol', 'affect', 'treatment', 'remain', 'stable', 'course', 'study', 'datum', 'submit', 'publication', 'peer', 'review', 'journal'], ['renowned', 'serve', 'inaugural', 'clinical', 'director', 'say', 'prospect', 'vaccine', 'lower', 'cholesterol', 'extremely', 'exciting', 'change', 'game', 'cardiovascular', 'health', 'cardiovascular', 'disease', 'still', 'lead', 'cause', 'death', 'world', 'vaccine', 'approach', 'afford', 'solution', 'other', 'medicine', 'can', 'so', 'huge'], [], ['design', 'use', 'vaxxinity', 'proprietary', 'synthetic', 'peptide', 'vaccine', 'platform', 'develop', 'treatment', 'platform', 'design', 'harness', 'immune_system', 'convert', 'body', 'own', 'natural', 'drug', 'factory', 'stimulate', 'production', 'antibody', 'design', 'induce', 'robust', 'long', 'act', 'antibody', 'pcsk', 'lower', 'cholesterol', 'treat', 'coronary', 'heart', 'disease'], ['vaxxinity'], ['purpose', 'drive', 'biotechnology', 'company', 'commit', 'democratize', 'healthcare', 'globe', 'company', 'pioneer', 'new_class', 'synthetic', 'peptide', 'base', 'vaccine', 'aim', 'disrupt', 'exist', 'treatment', 'paradigm', 'chronic', 'disease', 'increasingly', 'dominate', 'monoclonal_antibody', 'suffer', 'prohibitive', 'cost', 'cumbersome', 'administration', 'company', 'proprietary', 'technology_platform', 'enable', 'innovation', 'novel', 'pipeline', 'candidate', 'design', 'bring', 'efficiency', 'vaccine', 'treatment', 'chronic', 'disease', 'include', 'technology', 'also', 'implement', 'part', 'vaccine', 'program', 'vaxxinity', 'optimize', 'pipeline', 'achieve', 'potentially', 'historic', 'global', 'impact', 'human', 'health'], ['more_information_visit', 'follow', 'social_medium', 'vaxxinity'], ['press_release_include', 'forward_look_statement_meaning', 'private_security', 'use', 'certain', 'word', 'include', 'vision', 'potential', 'similar_expression_intend_identify', 'forward_look_statement', 'forward_look_statement', 'involve_substantial_risk_uncertainty', 'base', 'current', 'expectation', 'assumption', 'vaxxinity', 'management', 'forward_look_statement', 'include', 'statement', 'development', 'new_class', 'vaccine', 'innovation', 'efficacy', 'vaxxinity', 'product_candidate', 'anticipate', 'outcome', 'study', 'conduct', 'conduct', 'product_candidate', 'various', 'important_factor', 'cause_actual', 'result', 'event', 'differ_materially', 'express_imply', 'forward_look_statement', 'additional', 'important_factor', 'consider', 'connection', 'forward_look_statement', 'describe', 'risk_factor', 'section', 'vaxxinity', 'annual_report_form', 'file', 'other', 'report_file', 'forward_look_statement', 'make', 'date', 'vaxxinity', 'undertake_obligation_update', 'forward_look_statement', 'result', 'new', 'information', 'future', 'event', 'otherwise', 'require_law'], ['investor'], ['cardiovascular', 'disease', 'news', 'room', 'fact', 'sheet', 'detail', 'cardiovascular', 'diseases', 'cvds'], ['excite', 'announce', 'first', 'human', 'use', 'endovascular', 'retrieval', 'system', 'removal', 'intracardiac', 'tumor', 'intracardiac', 'tumor', 'affect', 'thousand', 'patient', 'world', 'annually', 'prior', 'ono', 'open', 'heart', 'surgery', 'require', 'removal'], ['use', 'ono', 'combination', 'team', 'percutaneously', 'snare', 'resect', 'remove', 'cardiac', 'fibromyxoma', 'right', 'atrium', 'old', 'patient', 'first', 'kind', 'procedure', 'open', 'door', 'new', 'therapeutic', 'strategy', 'patient', 'world', 'suffer', 'cardiac', 'masse'], ['tumor', 'vex', 'problem', 'present', 'management', 'dilemma', 'say', 'interventional', 'cardiology', 'tumor', 'often', 'find', 'incidentally', 'relatively', 'small', 'size', 'however', 'rather', 'subject', 'patient', 'elective', 'surgical', 'removal', 'masse', 'typically', 'follow', 'expectantly', 'increase', 'size', 'point', 'where', 'physiologically', 'problematic', 'point', 'risk', 'open', 'heart', 'surgery', 'deem', 'justifiable', 'say'], ['obviously', 'good', 'remove', 'tumor', 'cause', 'problem', 'now', 'reliable', 'non', 'surgical', 'option', 'continue', 'approach', 'develop', 'here', 'involve', 'use', 'ono', 'secure', 'highly', 'mobile', 'fibromyxoma', 'basket', 'mass', 'separate', 'myocardium', 'mean', 'electrocautery', 'easily', 'compress', 'ono', 'remove', 'body'], ['ono', 'novel', 'device', 'design', 'receive', 'align', 'compress', 'remove', 'material', 'non', 'biologic', 'vascular', 'system', 'ono', 'intuitive', 'use', 'compatible', 'commercially', 'available', 'vascular', 'sheath', 'endovascular', 'snare', 'other', 'grasper', 'ono', 'receive', 'clearance', 'available', 'select', 'site'], ['thrilled', 'able', 'facilitate', 'innovative', 'work', 'say', 'have', 'always', 'believe', 'ono', 'tool', 'help', 'physician', 'safely', 'expand', 'scope', 'minimally', 'invasive', 'procedure', 'think', 'witness', 'here', 'today', 'clear', 'example', 'how', 'new', 'technology', 'such', 'ono', 'potentiate', 'evolution', 'medical', 'therapy'], ['retrieval', 'device', 'indicate', 'use', 'cardiovascular', 'system', 'retrieve', 'foreign', 'object', 'use', 'minimally', 'invasive', 'procedure', 'complete', 'instruction', 'other', 'important', 'safety', 'information', 'refer', 'instruction', 'use'], ['medical', 'technology', 'company', 'dedicate', 'develop', 'essential', 'safety', 'tool', 'other', 'facilitate', 'technology', 'modern', 'day', 'catheterization', 'lab', 'more', 'information', 'go'], ['xenetic', 'company', 'focus', 'advance', 'innovative', 'immune', 'oncology', 'technology', 'address', 'hard', 'treat', 'cancer', 'volitionrx', 'volition', 'multi', 'national', 'epigenetic', 'company', 'today_announce', 'research', 'development', 'collaboration', 'develop', 'neutrophil', 'extracellular', 'trap', 'net', 'target', 'adoptive', 'cell', 'therapy', 'treatment', 'cancer'], ['collaboration', 'early', 'exploratory', 'program', 'evaluate', 'potential', 'combination', 'volition', 'net', 'dnase', 'armored', 'car_platform', 'develop', 'proprietary', 'adoptive', 'cell', 'therapy', 'potentially', 'target', 'multiple', 'type', 'solid', 'cancer'], ['term', 'collaboration', 'agreement', 'volition', 'fund', 'research', 'program', 'party', 'share', 'proceed', 'licensing', 'product', 'arise', 'collaboration'], ['in', 'license', 'dnase', 'base', 'oncology', 'platform', 'year', 'team', 'intently', 'focused', 'drive', 'technology', 'forward', 'goal', 'improve', 'outcome', 'exist', 'therapeutic', 'agent', 'multiple', 'solid_tumor', 'indication', 'pleased', 'enter', 'first', 'industry', 'research', 'development', 'collaboration', 'just', 'few', 'short', 'month', 'acquire', 'technology_platform', 'get', 'know', 'volition', 'team', 'impress', 'technical', 'expertise', 'creativity', 'therefore', 'very', 'excited', 'advance', 'development', 'exciting', 'new', 'technology', 'align', 'strategic', 'partner', 'capability', 'volition', 'comment', 'chief_executive_officer'], ['epigenetically', 'modify', 'nucleosome', 'present', 'tumor', 'cell', 'surface', 'tumor', 'multiple', 'type', 'solid', 'cancer', 'thus', 'nucleosome', 'represent', 'generalizable', 'tumor', 'antigen', 'limit', 'single', 'cancer', 'type', 'volition', 'technology', 'specifically', 'recognize', 'target', 'epigenetically', 'modify', 'nucleosome', 'dnase', 'armored', 'car_platform', 'design_enhance', 'function', 'car', 'cell', 'solid_tumor'], ['chief_scientific', 'officer', 'add', 'elevated', 'level', 'net', 'associate', 'poor', 'patient', 'outcome', 'range', 'disease', 'such', 'sepsis', 'cancer', 'net', 'specifically', 'implicate', 'metastatic', 'cancer', 'remove', 'show', 'prevent', 'spread', 'disease', 'consequently', 'urgent', 'need', 'develop', 'treatment', 'aim', 'reduce', 'production', 'net', 'remove', 'body', 'ce', 'mark', 'net', 'test', 'only', 'analytically', 'validate', 'test', 'detection', 'evaluation', 'net', 'delighted', 'work', 'employ', 'nucleosomics', 'technology', 'measure', 'level', 'net', 'help', 'monitor', 'efficacy', 'pioneering', 'cancer', 'therapy', 'exciting', 'time', 'ahead'], ['bioscience'], ['company', 'focus', 'advance', 'innovative', 'immuno', 'oncology', 'technology', 'address', 'hard', 'treat', 'oncology', 'indication', 'company', 'dnase', 'oncology', 'platform', 'development', 'treatment', 'solid_tumor', 'aim', 'improve', 'outcome', 'exist', 'treatment', 'include', 'immunotherapy', 'target', 'neutrophil', 'extracellular', 'trap', 'net', 'company', 'also', 'develop', 'personalized', 'car_platform', 'technology', 'develop', 'cell', 'base', 'therapeutic', 'target', 'unique', 'cell', 'receptor', 'surface', 'individual', 'patient', 'malignant', 'tumor', 'cell', 'treatment', 'cell', 'lymphomas'], ['additionally', 'leverage', 'polyxen', 'proprietary', 'drug_delivery', 'platform', 'partner', 'biotechnology', 'pharmaceutical', 'company', 'polyxen', 'demonstrate', 'ability', 'improve', 'half', 'life', 'other', 'pharmacological', 'property', 'next_generation', 'biologic', 'drug', 'company', 'receive', 'royalty_payment', 'exclusive', 'license', 'arrangement', 'field', 'blood', 'coagulation', 'disorder', 'more_information_visit', 'company', 'website', 'connect', 'twitter', 'linkedin'], ['volition'], ['volition', 'multi', 'national', 'epigenetic', 'company', 'apply', 'nucleosomics', 'platform', 'subsidiary', 'develop', 'simple', 'easy', 'use', 'cost', 'effective', 'blood_test', 'help', 'diagnose', 'monitor', 'range', 'life', 'alter', 'disease', 'include', 'cancer', 'disease', 'associate', 'netosis', 'such', 'sepsis', 'early', 'diagnosis', 'monitoring', 'potential', 'only', 'prolong', 'life', 'patient', 'also', 'improve', 'quality_life', 'test', 'base', 'science', 'practice', 'identify', 'measure', 'nucleosome', 'bloodstream', 'other', 'bodily', 'fluid', 'indication', 'disease', 'present', 'volition', 'primarily', 'focus', 'human', 'diagnostic', 'monitoring', 'also', 'subsidiary', 'focus', 'animal', 'diagnostic', 'monitoring'], ['research', 'development', 'activity', 'center', 'belgium', 'innovation', 'laboratory', 'office', 'additional', 'office'], ['more', 'information', 'volition', 'visit', 'wwwvolitioncom'], ['forward_look_statement'], ['press_release_contain', 'forward_look_statement', 'intend', 'subject', 'safe_harbor', 'provision', 'private_security', 'statement_contain_press', 'release', 'other', 'statement_historical_fact', 'constitute_forward_look', 'statement_meaning', 'federal', 'security_law', 'statement', 'identify_word', 'such', 'expect', 'plan', 'project', 'anticipate', 'believe', 'intend', 'estimate', 'other', 'word', 'similar', 'meaning', 'include', 'limit', 'statement', 'regard', 'collaboration', 'agreement', 'volition', 'include', 'regard', 'potential', 'combination', 'volition', 'net', 'dnase', 'armored', 'car_platform', 'develop', 'proprietary', 'adoptive', 'cell', 'therapy', 'potentially', 'target', 'multiple', 'type', 'solid', 'cancer', 'expectation_regard', 'advance', 'development', 'exciting', 'new', 'technology', 'align', 'strategic', 'partner', 'capability', 'volition', 'statement', 'regard', 'expectation', 'respect', 'dnase', 'oncology', 'platform', 'include', 'expectation', 'focus', 'drive', 'dnase', 'base', 'oncology', 'platform', 'technology', 'forward', 'goal', 'improve', 'outcome', 'exist', 'therapeutic', 'agent', 'multiple', 'solid_tumor', 'indication', 'expectation', 'improve', 'outcome', 'exist', 'treatment', 'include', 'immunotherapy', 'target', 'net', 'plan', 'regard', 'personalize', 'car_platform', 'technology', 'use', 'develop', 'cell', 'base', 'therapeutic', 'target', 'unique', 'cell', 'receptor', 'surface', 'individual', 'patient', 'malignant', 'tumor', 'cell', 'treatment', 'cell', 'lymphomas', 'plan', 'leverage', 'polyxen', 'proprietary', 'drug_delivery', 'platform', 'partner', 'biotechnology', 'pharmaceutical', 'company', 'expectation_regard', 'receipt', 'royalty_payment', 'exclusive', 'license_agreement', 'field', 'blood', 'coagulation', 'disorder', 'forward_look_statement', 'contain', 'base', 'current', 'expectation', 'subject', 'number', 'risk', 'uncertaintie', 'many', 'factor_cause_actual', 'activity', 'performance_achievement', 'result_differ', 'materially', 'activity', 'result', 'anticipate', 'forward_look_statement', 'important_factor', 'cause_actual', 'activity', 'performance_achievement', 'result_differ', 'materially', 'such', 'plan', 'estimate', 'expectation', 'include', 'other', 'unexpected', 'cost', 'charge', 'expense', 'result', 'collaboration', 'agreement', 'volition', 'unexpected', 'cost', 'charge', 'expense', 'result', 'licensing', 'dnase', 'platform', 'uncertainty', 'expect', 'financial_performance', 'company', 'follow', 'licensing', 'dnase', 'platform', 'failure', 'realize_anticipate', 'potential', 'dnase', 'xcart', 'polyxen', 'technology', 'ability', 'company', 'implement', 'business', 'strategy', 'other', 'risk_factor', 'detail', 'time', 'time', 'company', 'report_file', 'include', 'annual_report_form', 'periodic', 'quarterly_report_form', 'current', 'report_form', 'other', 'document_file', 'forego', 'list', 'important_factor', 'exclusive', 'addition', 'forward_look_statement', 'also', 'adversely_affect', 'general', 'market', 'factor', 'general_economic', 'business', 'condition', 'include', 'potential', 'adverse', 'effect', 'public', 'health', 'issue', 'such', 'outbreak', 'geopolitical', 'event', 'such', 'russian', 'invasion', 'economic', 'activity', 'competitive', 'product', 'development', 'product', 'availability', 'federal', 'state', 'regulation', 'legislation', 'regulatory', 'process', 'new', 'product_candidate', 'indication', 'manufacturing', 'issue', 'arise', 'patent', 'position', 'litigation', 'other', 'factor', 'forward_look_statement', 'contain_press_release', 'speak_only_date', 'statement', 'make', 'company', 'undertake_obligation_update', 'forward_look_statement', 'require_law'], ['xenetic'], [], ['volition', 'contact'], ['volition'], ['source'], ['source_version', 'xenetic', 'bioscience', 'inc', 'volitionrx', 'limit', 'collaborate', 'develop', 'net', 'target', 'adoptive', 'cell', 'therapy', 'treatment', 'cancer'], ['surgery_partner', 'company', 'leading', 'provider', 'surgical', 'service', 'today_announce', 'result', 'second_quarter_end'], ['executive_chairman', 'board', 'partner', 'note', 'second_quarter', 'perform', 'surgical', 'case', 'nearly', 'more', 'second_quarter', 'demonstrate', 'continued', 'operational', 'execution', 'impact', 'strategic', 'physician', 'recruitment', 'acquisition', 'case', 'growth', 'experience', 'quarter', 'reflect', 'growth', 'high', 'acuity', 'procedure', 'bring', 'high', 'overall', 'net', 'revenue', 'case', 'help', 'drive', 'top', 'line', 'revenue_growth', 'adjust_ebitda', 'growth', 'nearly', 'exclude', 'impact', 'grant', 'period', 'very_pleased', 'outcome', 'consider', 'macro', 'economic', 'environment', 'navigate'], ['chief_executive_officer', 'state', 'management', 'team', 'focus', 'core', 'operational', 'excellence', 'rapid', 'integration', 'recent', 'acquisition', 'core', 'strength', 'allow', 'continue', 'report', 'growth', 'surgical', 'case', 'volume', 'revenue', 'yield', 'strong', 'adjusted', 'ebitda', 'performance', 'consistent', 'expectation', 'physician', 'recruitment', 'remain', 'critical', 'component', 'growth', 'engine', 'new', 'physician', 'cohort', 'average', 'high', 'net', 'revenue', 'case', 'cohort', 'contribute', 'high', 'revenue', 'adjust_ebitda', 'margin', 'exclude', 'care', 'grant', 'second_quarter', 'basis_point', 'high', 'first_quarter', 'result', 'demonstrate', 'efficacy', 'team', 'approach', 'labor', 'supply', 'cost', 'management', 'implement', 'sacrifice', 'outstanding', 'clinical', 'quality', 'exceptional', 'service', 'differentiate', 'partnership'], ['chief', 'financial', 'officer', 'comment', 'strong', 'result', 'report', 'today', 'remain', 'confident', 'adjust_ebitda', 'revenue_guidance', 'balance_sheet', 'remain', 'strong', 'ample', 'liquidity', 'support', 'annual', 'capital', 'deployment', 'goal', 'at_least', 'quarter', 'deploy', 'approximately', 'transaction', 'average', 'multiple', 'approximately', 'time', 'maintain', 'robust_pipeline', 'potential', 'acquisition', 'when', 'combine', 'consistent', 'growth', 'accretive', 'acquisition', 'continue', 'give', 'confidence', 'long_term', 'growth', 'opportunity', 'mid', 'teens', 'growth', 'expectation'], ['second_quarter', 'result'], ['revenue', 'second_quarter', 'increase', 'second_quarter', 'day', 'adjust', 'same_facility', 'revenue', 'second_quarter', 'increase', 'same_period', 'last', 'year', 'increase', 'revenue', 'case', 'increase', 'same_facility', 'case', 'second_quarter', 'company', 'net', 'loss_attributable_common_stockholder', 'adjust_ebitda', 'respectively', 'compare', 'same_period', 'last', 'year', 'second_quarter', 'adjust_ebitda', 'benefit', 'recognition', 'care', 'act', 'grant', 'respectively', 'exclude', 'care', 'act', 'grant', 'second_quarter', 'adjust_ebitda', 'respectively'], ['year', 'date', 'result'], ['revenue', 'year', 'date', 'increase', 'period', 'day', 'adjust', 'same_facility', 'revenue', 'year', 'date', 'increase', 'same_period', 'last', 'year', 'increase', 'revenue', 'case', 'increase', 'same_facility', 'case', 'year', 'date', 'company', 'net', 'loss_attributable_common_stockholder', 'adjust_ebitda', 'respectively', 'compare', 'same_period', 'last', 'year', 'year', 'date', 'adjust_ebitda', 'benefit', 'recognition', 'care', 'act', 'grant', 'respectively', 'exclude', 'care', 'act', 'grant', 'year', 'date', 'adjust_ebitda', 'respectively'], ['liquidity'], ['surgery_partner', 'cash_cash_equivalent', 'borrow', 'capacity', 'revolve', 'credit', 'facility', 'cash_flow', 'operate', 'activity', 'second_quarter', 'compare', 'prior', 'year', 'quarter', 'increase', 'primarily_drive', 'payment', 'include', 'interest', 'make', 'prior', 'year', 'quarter', 'connection', 'previously', 'disclose', 'settlement', 'net', 'operate', 'cash', 'inflow', 'define', 'operate', 'cash_flow', 'less', 'distribution', 'non', 'controlling', 'interest', 'second_quarter'], ['year', 'date', 'operate', 'cash_flow', 'compare', 'prior', 'year', 'period', 'increase', 'primarily_drive', 'receipt', 'litigation', 'proceed', 'period', 'settlement', 'payment', 'include', 'interest', 'make', 'period'], ['company', 'ratio', 'total', 'net', 'debt', 'ebitda', 'calculate', 'company', 'credit', 'agreement', 'approximately', 'end', 'second_quarter'], [], ['company', 'continue', 'project', 'adjust_ebitda', 'range', 'revenue', 'range'], ['conference_call', 'information'], ['surgery_partner', 'hold', 'conference_call', 'today', 'am_eastern', 'time', 'conference_call', 'access', 'live', 'phone_dial', 'international_caller', 'replay', 'available', 'hour', 'call', 'access', 'dial_international', 'caller', 'passcode', 'live', 'call', 'replay', 'replay', 'available'], ['interested', 'investor', 'other', 'party', 'also', 'listen', 'simultaneous', 'webcast', 'conference_call', 'log', 'investor_relation', 'section', 'company', 'website', 'replay', 'also', 'available', 'same', 'website', 'limited', 'time', 'follow', 'call'], ['learn_more', 'surgery_partner', 'visit', 'company', 'website', 'surgery_partner', 'use', 'website', 'channel', 'distribution', 'material', 'company', 'information', 'financial', 'other', 'material', 'information', 'regard', 'surgery_partner', 'routinely', 'post', 'company', 'website', 'readily', 'accessible'], ['surgery_partner'], ['headquarter', 'partner', 'lead', 'healthcare', 'service', 'company', 'differentiated', 'outpatient', 'delivery', 'model', 'focus', 'provide', 'high_quality', 'cost', 'effective', 'solution', 'surgical', 'relate', 'ancillary', 'care', 'support', 'patient', 'physician', 'found', 'surgery_partner', 'large', 'fast', 'grow', 'surgical', 'service', 'business', 'country', 'more', 'location', 'state', 'include', 'ambulatory', 'surgery', 'center', 'surgical', 'hospital', 'multi', 'specialty', 'physician', 'practice', 'urgent', 'care', 'facility', 'additional', 'information_visit'], ['press_release_contain', 'forward_look_statement', 'include', 'regard', 'growth', 'anticipate', 'operating', 'result', 'future', 'period', 'other', 'similar', 'statement', 'statement', 'identify', 'use', 'word', 'such', 'believe', 'anticipate', 'expect', 'intend', 'plan', 'continue', 'estimate', 'predict', 'project', 'forecast', 'similar_expression', 'forward', 'looking', 'statement', 'base', 'current', 'expectation', 'belief', 'date', 'release', 'subject', 'risk_uncertainty', 'assumption', 'cause_actual_result_differ', 'materially', 'discuss', 'imply', 'forward_look_statement', 'include', 'limited', 'continue', 'effect', 'ongoing', 'pandemic', 'specifically', 'region', 'operate', 'impact', 'state', 'local', 'economy', 'restrictive', 'order', 'vaccine', 'other', 'mandate', 'pandemic', 'generally', 'ability', 'respond', 'quickly', 'challenge', 'economic_condition', 'include', 'recent', 'inflationary', 'pressure', 'case', 'volume', 'current', 'environment', 'ability', 'preserve', 'raise', 'sufficient_fund', 'continue', 'operation', 'period', 'uncertainty', 'impact', 'cost', 'cut', 'measure', 'future', 'performance', 'ability', 'cause', 'distribution', 'subsidiary', 'responsiveness', 'payor', 'include', 'challenging', 'operating', 'condition', 'include', 'willingness', 'ability', 'continue', 'pay', 'timely_manner', 'advance', 'payment', 'timely_manner', 'at', 'ability', 'execute', 'operational', 'strategic', 'initiative', 'timing', 'impact', 'portfolio', 'optimization', 'effort', 'ability', 'continue', 'improve', 'same_facility', 'volume', 'revenue_growth', 'timeline', 'anticipate', 'at', 'ability', 'successfully', 'integrate', 'acquisition', 'anticipate', 'impact', 'timing', 'ongoing', 'efficiency', 'effort', 'as_well', 'ongoing', 'procurement', 'revenue', 'cycle', 'effort', 'potential', 'reduction', 'payment', 'receive', 'third_party', 'payor', 'include', 'government', 'health_care', 'program', 'private', 'insurance', 'organization', 'impact', 'adverse', 'weather', 'condition', 'other', 'event', 'control', 'other', 'risk', 'identify', 'discuss', 'time', 'time', 'company', 'report_file', 'include', 'item', 'heading_risk', 'factor', 'company', 'annual_report_form', 'year', 'end', 'require_law', 'company', 'undertake_obligation_revise', 'update', 'publicly', 'forward_look_statement', 'reflect_event_circumstance', 'date', 'report', 'reflect', 'occurrence', 'unanticipated', 'event_circumstance'], ['use', 'non_gaap_financial_measure'], ['addition', 'result', 'prepare', 'accordance', 'generally_accept', 'accounting_principle', 'gaap', 'provide', 'press_release', 'surgery_partner', 'present', 'following', 'non_gaap_financial_measure', 'adjust_net_income', 'loss_attributable_common_stockholder', 'adjust_net_income', 'loss', 'share', 'attributable_common', 'stockholder_adjust', 'ebitda_adjust_ebitda', 'exclude', 'grant', 'fund', 'exclude', 'various', 'item', 'detail', 'attach', 'reconciliation_non_gaap', 'financial_measure'], ['non_gaap_financial_measure', 'intend', 'replace', 'financial_performance', 'measure', 'determine', 'accordance_gaap', 'rather', 'present', 'supplemental', 'measure', 'company', 'performance', 'management_believe', 'enhance', 'evaluation', 'company', 'ongoing', 'operating', 'result', 'non_gaap_financial_measure', 'present', 'accordance_gaap', 'company', 'computation', 'non_gaap_financial_measure', 'vary', 'similar', 'measure', 'use', 'other', 'company', 'measure', 'limitation', 'analytical', 'tool', 'consider_isolation', 'substitute', 'alternative', 'revenue', 'net_income', 'loss', 'operating_income', 'loss', 'cash_flow', 'operate', 'activity', 'total', 'indebtedness', 'other', 'measure', 'operate', 'performance', 'liquidity', 'indebtedness', 'derive', 'accordance_gaap'], ['select', 'consolidated_financial', 'datum', 'dollar_million', 'share_amount', 'share', 'thousand'], ['impact', 'potentially', 'dilutive', 'security', 'period', 'present', 'consider', 'effect', 'anti', 'dilutive'], ['select', 'financial', 'operating', 'datum', 'dollar_million', 'case', 'share_amount'], ['reconciliation_non_gaap', 'financial_measure', 'appear', 'define', 'adjust_ebitda', 'revenue', 'define', 'adjust_ebitda', 'exclude', 'grant', 'fund', 'revenue'], ['dollar_million', 'case', 'amount'], ['same_facility', 'information', 'include', 'case', 'revenue', 'consolidated', 'non', 'consolidated', 'surgical', 'facility', 'exclude', 'facility', 'acquire', 'new', 'market', 'divest', 'current', 'prior_period'], ['reconciliation_non_gaap', 'financial_measure', 'dollar_million'], ['follow', 'table', 'reconcile', 'adjust_ebitda', 'income', 'income_taxis', 'report', 'condense_consolidated', 'financial', 'information', 'most', 'directly', 'comparable', 'gaap_financial', 'measure'], ['amount', 'include', 'transaction', 'integration', 'cost', 'month_end', 'respectively', 'amount', 'further', 'include', 'start', 'cost', 'relate', 'surgical', 'hospital', 'month_end'], ['amount', 'include', 'transaction', 'integration', 'cost', 'month_end', 'respectively', 'amount', 'further', 'include', 'start', 'cost', 'relate', 'surgical', 'hospital', 'month_end'], ['amount', 'include', 'other', 'litigation', 'cost', 'month_end', 'respectively'], ['amount', 'include', 'other', 'litigation', 'cost', 'month_end', 'respectively', 'amount', 'also', 'include', 'gain', 'litigation', 'settlement', 'month_end'], ['use', 'adjust_ebitda', 'measure', 'financial_performance', 'adjust_ebitda', 'key', 'measure', 'use', 'management', 'assess', 'operate', 'performance', 'make', 'business', 'decision', 'allocate', 'resource', 'non', 'controlling', 'interest', 'represent', 'interest', 'third_party', 'such', 'physician', 'case', 'healthcare', 'system', 'own', 'interest', 'surgical', 'facility', 'consolidate', 'financial', 'reporting', 'purpose', 'believe_helpful', 'investor', 'present', 'adjust_ebitda', 'define', 'above', 'exclude', 'portion', 'net_income_attributable', 'third_party', 'interest', 'clarifie', 'investor', 'portion', 'adjust_ebitda', 'generate', 'surgical', 'facility', 'other', 'operation', 'adjust_ebitda', 'measurement', 'financial_performance', 'gaap', 'consider_isolation', 'substitute', 'net_income', 'operate', 'income', 'other', 'measure', 'calculate', 'accordance_gaap', 'item', 'exclude', 'adjusted', 'ebitda', 'significant', 'component', 'understanding', 'evaluate', 'financial_performance', 'believe', 'such', 'adjustment', 'appropriate', 'magnitude', 'frequency', 'such', 'item', 'vary', 'significantly', 'relate', 'assessment', 'normal', 'operating', 'performance', 'calculation', 'adjust_ebitda', 'comparable', 'similarly', 'title', 'measure', 'report', 'other', 'company'], ['represent', 'impact', 'grant', 'fund', 'recognize', 'net', 'amount', 'attributable', 'non', 'controlling', 'interest'], ['reconciliation_non_gaap', 'financial_measure', 'dollar_million', 'share_amount', 'share', 'thousand'], ['time', 'time', 'company', 'incur', 'certain', 'non', 'recurring', 'gain_loss', 'normally', 'non', 'operational', 'nature', 'consider', 'relevant', 'assess', 'ongoing', 'operating', 'performance', 'when', 'significant', 'surgery_partner', 'management', 'board_director', 'typically', 'exclude', 'gain_loss', 'when', 'evaluate', 'company', 'operating', 'performance', 'certain', 'instance', 'when', 'evaluate', 'performance', 'incentive', 'compensation', 'purpose', 'additionally', 'company', 'believe', 'certain', 'investor', 'equity', 'analyst', 'exclude', 'similar', 'item', 'when', 'evaluate', 'company', 'current', 'future', 'operate', 'performance', 'make', 'informed', 'investment', 'decision', 'regard', 'company', 'accordingly', 'company', 'provide', 'adjust_net', 'loss_attributable_common_stockholder', 'adjust_net', 'loss', 'share', 'attributable_common', 'stockholder', 'supplement', 'comparable', 'gaap_financial', 'measure', 'adjust_net', 'loss_attributable_common_stockholder', 'adjust_net', 'loss', 'share', 'attributable_common', 'stockholder', 'consider', 'measure', 'financial_performance', 'gaap', 'item', 'exclude', 'such', 'measure', 'significant', 'component', 'understanding', 'assess', 'financial_performance', 'measure', 'consider_isolation', 'alternative', 'comparable', 'gaap_financial', 'measure', 'present', 'consolidated_financial', 'statement'], ['follow', 'table', 'reconcile', 'net_income', 'reflect', 'consolidated', 'statement', 'operation', 'adjust_net', 'loss_attributable_common_stockholder', 'use', 'calculate', 'adjust_net', 'loss', 'share', 'attributable_common', 'stockholder'], ['impact', 'potentially', 'dilutive', 'security', 'period', 'consider', 'effect', 'anti', 'dilutive'], ['contact'], ['surgery_partner', 'investor_relation'], ['elixiron', 'clinical_stage', 'biotech', 'company', 'announce_today', 'grant', 'orphan_drug', 'designation', 'colony', 'stimulate', 'factor', 'receptor', 'inhibitor', 'ei', 'treatment', 'idiopathic_pulmonary_fibrosis'], ['idiopathic_pulmonary_fibrosis', 'devastating', 'impact', 'patient', 'life', 'more', 'effective', 'therapy', 'urgently', 'need', 'drug', 'designation', 'validate', 'potential', 'offer', 'new', 'therapeutic', 'option', 'patient', 'live', 'disease', 'say', 'executive_officer', 'build', 'promising', 'datum', 'preclinical', 'phase_study', 'actively', 'evaluate', 'option', 'accelerate', 'development', 'address_unmet', 'medical', 'need'], ['designation', 'serve', 'support', 'drug_candidate', 'development', 'underserved', 'patient', 'population', 'rare', 'disorder', 'affect', 'few', 'people', 'provide', 'various', 'incentive', 'include', 'tax', 'credit', 'eligible', 'clinical_trial', 'waiver', 'application', 'fee', 'market', 'exclusivity', 'year', 'approval'], ['idiopathic_pulmonary_fibrosis'], ['idiopathic_pulmonary', 'chronic', 'interstitial', 'lung', 'disease', 'characterize', 'tissue', 'fibrosis', 'progressive', 'decline', 'lung_function', 'currently', 'cure', 'ipf', 'only', 'approve', 'drug', 'slow', 'halt', 'disease', 'progression', 'average', 'patient', 'continue', 'live', 'only', 'more', 'year', 'once', 'diagnose', 'ipf'], [], ['orally', 'administer', 'small_molecule', 'inhibitor', 'colony', 'stimulate', 'factor', 'receptor', 'complete', 'phase', 'development', 'signal', 'play', 'important', 'role', 'regulation', 'pulmonary', 'macrophage', 'drive', 'inflammatory', 'damage', 'tissue', 'fibrosis', 'blockade', 'show', 'promise', 'therapeutic', 'effect', 'ameliorate', 'lung', 'fibrosis', 'improve', 'respiratory', 'function', 'preclinical_model', 'inhibit', 'brain', 'microglia', 'mediate', 'preclinical_model', 'disease', 'develop', 'treatment', 'disease', 'funding', 'support', 'part', 'association', 'part', 'cloud', 'program'], [], ['focus', 'development', 'innovative', 'immunotherapy', 'address_unmet', 'need', 'rare', 'immunological', 'disease', 'interferon', 'gamma', 'neutralize', 'antibody', 'currently', 'phase', 'trial', 'develop', 'treatment', 'hemophagocytic', 'vitiligo', 'more_information_visit', 'elixironcom', 'follow', 'company'], ['email', 'media', 'elixironcom'], ['global', 'leader', 'innovation', 'today_announce', 'second_quarter', 'result', 'as_well', 'update', 'companion_animal', 'diagnostic', 'trend'], ['second_quarter', 'result'], ['company', 'report', 'revenue', 'second_quarter', 'increase', 'report', 'organically', 'drive', 'companion_animal', 'group', 'diagnostic', 'recur', 'revenue_growth', 'report', 'organic', 'compare', 'strong', 'prior', 'year', 'performance', 'continue', 'solid', 'companion_animal', 'sector', 'demand', 'benefit', 'idexx', 'execution', 'drive', 'premium', 'instrument', 'placement', 'high', 'prior', 'year', 'period', 'support', 'instrument', 'revenue_growth', 'report', 'organic', 'continue', 'strong', 'momentum', 'cloud', 'base', 'software', 'placement', 'support', 'veterinary', 'software', 'service', 'diagnostic', 'imaging', 'system', 'revenue_growth', 'report', 'organically', 'overall', 'revenue', 'gain', 'quarter', 'also', 'support', 'water', 'revenue_growth', 'report', 'organic'], ['second_quarter', 'earning', 'diluted', 'share', 'decrease', 'report', 'comparable', 'basis', 'compare', 'strong', 'prior', 'year', 'profit', 'level', 'reflect', 'impact', 'discrete', 'investment', 'quarter', 'operate', 'expense', 'growth', 'relate', 'investment', 'commercial', 'capability', 'result', 'include', 'share', 'negative', 'impact', 'currency', 'change', 'share', 'tax', 'benefit', 'share_base_compensation'], ['build', 'strong', 'prior', 'year', 'gain', 'drive', 'continue', 'solid', 'organic', 'growth', 'second_quarter', 'say_chief_executive_officer', 'especially', 'pleased', 'strong', 'execution', 'global', 'team', 'result', 'record', 'premium', 'instrument', 'placement', 'cloud', 'base', 'practice', 'management', 'software', 'adoption', 'idexx', 'innovation', 'never', 'more', 'important', 'help', 'veterinary', 'clinic', 'manage', 'capacity', 'challenge', 'achieve', 'outstanding', 'care', 'patient'], ['companion_animal', 'diagnostic', 'trend', 'update'], ['continue', 'growth', 'demand', 'companion_animal', 'healthcare', 'support', 'solid', 'gain', 'diagnostic', 'product', 'service', 'compare', 'strong', 'prior', 'year', 'demand', 'level', 'average', 'diagnostic', 'revenue', 'grow', 'veterinary', 'practice', 'same', 'store', 'basis', 'second_quarter', 'ahead', 'growth', 'overall', 'clinic', 'revenue', 'reflect', 'continued', 'expansion', 'demand', 'service', 'same', 'store', 'clinical', 'visit', 'veterinary', 'practice', 'decline', 'second_quarter', 'compare', 'prior', 'year', 'period', 'clinical', 'visit', 'growth', 'include', 'benefit', 'increase', 'new', 'pet', 'ownership', 'pandemic', 'growth', 'include', 'diagnostic', 'increase', 'significantly', 'pre', 'pandemic', 'level', 'reflect', 'compound', 'annual', 'growth', 'clinical', 'visit', 'same', 'store', 'diagnostic', 'revenue', 'compare', 'second_quarter'], ['additional', 'companion_animal', 'practice', 'key', 'metric', 'available', 'earning', 'snapshot', 'accessible', 'idexx', 'website', 'investor'], ['second_quarter', 'performance', 'highlight'], ['companion'], ['companion_animal', 'group', 'generate', 'revenue_growth', 'report', 'organically', 'quarter', 'support', 'diagnostic', 'recur', 'revenue_growth', 'report', 'basis', 'organically', 'solid', 'growth', 'achieve', 'major', 'modality', 'build', 'high', 'gain', 'prior', 'year', 'period', 'overall', 'revenue_growth', 'include', 'instrument', 'revenue_growth', 'report', 'organic', 'reflect', 'record', 'second_quarter', 'premium', 'instrument', 'placement'], ['veterinary', 'software', 'service', 'diagnostic', 'imaging', 'system', 'revenue', 'grow', 'report', 'organically', 'support', 'double', 'digit', 'organic', 'gain', 'recur', 'software', 'digital', 'imaging', 'revenue', 'report', 'growth', 'include', 'benefit', 'acquire', 'second_quarter', 'continue', 'show', 'strong', 'momentum', 'customer', 'gain'], ['water'], ['water', 'revenue', 'grow', 'report', 'basis', 'organic', 'basis', 'quarter', 'reflect', 'solid', 'volume', 'growth', 'international', 'region', 'benefit', 'net', 'price', 'gain'], ['livestock', 'poultry', 'dairy'], ['decline', 'report', 'organic', 'basis', 'quarter', 'reflect', 'comparison', 'high', 'prior', 'year', 'revenue', 'level', 'african', 'fever', 'core', 'swine', 'testing', 'impact', 'partially_offset', 'moderate', 'overall', 'organic', 'revenue', 'gain', 'other', 'area', 'business', 'comparison', 'high', 'revenue', 'level', 'african', 'fever', 'testing', 'expect', 'improve', 'second_half'], ['gross_profit', 'operating', 'profit'], ['gross_profit', 'increase', 'report', 'comparable', 'basis', 'gross_margin', 'increase', 'basis_point', 'report', 'flat', 'comparable', 'basis', 'benefit', 'net', 'price', 'gain', 'lab', 'productivity', 'initiative', 'improvement', 'software', 'service', 'gross_margin', 'offset', 'select', 'inflationary', 'effect', 'impact', 'low', 'lpd', 'revenue'], ['operate_margin', 'quarter', 'basis_point', 'low', 'prior', 'year', 'report', 'basis_point', 'lower', 'comparable', 'basis', 'drive', 'year', 'year', 'operate', 'expense', 'growth', 'report', 'comparable', 'basis', 'operate', 'expense', 'include', 'growth', 'impact', 'basis_point', 'operate_margin', 'impact', 'relate', 'discrete', 'investment', 'reflect', 'increase', 'investment', 'support', 'global', 'commercial', 'capability', 'high', 'travel', 'cost', 'inflationary', 'impact'], ['growth', 'financial_performance', 'outlook'], ['company', 'update', 'full_year', 'revenue_growth', 'outlook', 'report', 'organically', 'reduction', 'project', 'full_year', 'revenue_growth', 'range', 'basis_point', 'basis_point', 'respectively', 'outlook', 'range', 'include', 'project', 'full_year', 'diagnostic', 'recur', 'revenue_growth', 'report', 'organic', 'support', 'continue', 'benefit', 'strong', 'idexx', 'execution', 'include', 'additional', 'second_half', 'price', 'gain', 'update', 'outlook', 'also', 'incorporate', 'expectation', 'continue', 'near_term', 'pressure', 'veterinary', 'clinical', 'visit', 'factor', 'include', 'constraint', 'vet', 'clinic', 'capacity', 'lap', 'new', 'patient', 'step', 'benefit', 'as_well', 'additional', 'potential', 'growth', 'impact', 'relate', 'macroeconomic', 'risk'], ['company', 'now', 'project', 'full_year', 'operate_margin', 'reflect', 'basis_point', 'net', 'operate_margin', 'impact', 'relate', 'update', 'revenue_growth', 'estimate'], ['company', 'outlook', 'reflect', 'adjustment', 'midpoint', 'include', 'negative', 'impact', 'high', 'project', 'interest', 'rate', 'negative', 'impact', 'relate', 'strengthen', 'dollar'], ['follow', 'table', 'provide', 'company', 'update', 'outlook', 'annual', 'key', 'financial', 'metric'], ['follow', 'table', 'outline', 'estimate', 'foreign_currency_exchange_rate', 'impact', 'net', 'foreign_currency', 'hedge', 'transaction', 'foreign_currency_exchange_rate', 'assumption', 'reflect', 'above', 'financial_performance', 'outlook'], ['conference_call_webcast', 'information'], ['host_conference_call', 'today', 'am', 'discuss', 'second_quarter', 'result', 'management', 'outlook', 'participate', 'conference_call', 'dial', 'reference', 'pin', 'individual', 'access', 'live_webcast', 'conference_call', 'link', 'idexx', 'website', 'investor', 'archived', 'edition', 'available', 'pm', 'day', 'same', 'link', 'remain', 'available', 'year'], ['investor'], ['host', 'investor', 'day', 'am', 'approximately', 'pm', 'live_audio', 'webcast', 'accompany', 'slide', 'presentation', 'available', 'wwwidexxcom', 'investor', 'archive_webcast', 'replay', 'event', 'available', 'approximately', 'hour', 'follow', 'event', 'investor', 'additional', 'information', 'contact', 'idexxcom'], [], ['global', 'leader', 'healthcare', 'innovation', 'diagnostic', 'software', 'product', 'service', 'create', 'clarity', 'complex', 'constantly', 'evolve', 'world', 'veterinary', 'medicine', 'support', 'long', 'full', 'live', 'pet', 'deliver', 'insight', 'solution', 'help', 'veterinary', 'community', 'world', 'make', 'confident', 'decision', 'advance', 'medical', 'care', 'improve', 'efficiency', 'build', 'thriving', 'practice', 'innovation', 'also', 'help', 'ensure', 'safety', 'milk', 'water', 'world', 'maintain', 'health', 'well', 'being', 'people', 'livestock', 'member', 'index', 'headquarter', 'employ', 'more', 'people', 'offer', 'solution', 'product', 'customer', 'more', 'country', 'more', 'information', 'idexx', 'visit'], ['note_regard', 'forward_look_statement'], ['earning', 'release', 'contain', 'statement', 'company', 'business', 'prospect', 'estimate', 'company', 'financial', 'result', 'future', 'period', 'forward_look_statement_define', 'private_security_forward_look', 'statement', 'include', 'livestock', 'poultry', 'dairy', 'growth', 'financial_performance', 'outlook', 'elsewhere', 'identify', 'use', 'word', 'such', 'expect', 'anticipate', 'intend', 'plan', 'believe', 'estimate', 'project', 'similar', 'word', 'expression', 'forward_look_statement', 'include', 'statement', 'relate', 'expectation_regard', 'financial_performance', 'revenue_growth', 'eps', 'outlook', 'operating', 'free_cash_flow', 'forecast', 'project', 'impact', 'foreign_currency_exchange_rate', 'interest', 'rate', 'project', 'operating', 'margin', 'expense', 'capital_expenditure', 'project', 'tax', 'tax_rate', 'eps', 'benefit', 'share_base_compensation', 'arrangement', 'project', 'effective_tax_rate', 'reduction', 'average', 'share', 'outstanding', 'net', 'interest', 'expense', 'statement', 'intend', 'provide', 'management', 'expectation', 'future', 'event', 'date', 'earning', 'release', 'base', 'management', 'estimate', 'projection', 'belief', 'assumption', 'date', 'earning', 'release', 'guarantee', 'future', 'performance', 'forward_look_statement', 'involve', 'know_unknown', 'risk_uncertainty', 'cause', 'company', 'actual', 'result', 'level', 'activity', 'performance_achievement', 'materially_different', 'express_imply', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'matter', 'describe_heading', 'business', 'risk_factor', 'legal', 'proceeding', 'management', 'discussion', 'analysis', 'financial', 'condition', 'result', 'operation', 'quantitative', 'qualitative', 'disclosure', 'market', 'risk', 'company', 'annual_report_form', 'year', 'end', 'corresponding', 'section', 'company', 'quarterly_report_form', 'quarter_end', 'as_well', 'describe', 'time', 'time', 'company', 'other', 'filing', 'available', 'company', 'specifically', 'disclaim_obligation', 'publicly_update', 'forward_look_statement', 'result', 'new', 'information', 'future', 'event', 'otherwise'], ['statement', 'regard', 'non_gaap_financial_measure'], ['follow', 'define', 'term', 'convention', 'provide', 'reconciliation', 'regard', 'certain', 'measure', 'use', 'earning', 'release', 'accompany', 'earning', 'conference_call', 'require', 'present', 'accordance', 'generally_accept', 'accounting_principle', 'gaap', 'otherwise', 'refer', 'non_gaap_financial_measure', 'supplement', 'company', 'consolidated', 'result', 'present', 'accordance_gaap', 'company', 'disclose', 'non_gaap_financial_measure', 'exclude', 'adjust', 'certain', 'item', 'management_believe', 'non_gaap_financial_measure', 'provide', 'useful', 'supplemental', 'information', 'investor', 'evaluation', 'company', 'business', 'performance', 'liquidity', 'useful', 'period', 'period', 'comparison', 'performance', 'company', 'business', 'liquidity', 'performance', 'liquidity', 'peer', 'management_believe', 'non_gaap_financial_measure', 'useful', 'evaluate', 'company', 'business', 'information', 'consider', 'supplemental', 'nature', 'consider_isolation', 'substitute', 'related', 'financial', 'information', 'prepare', 'accordance_gaap', 'addition', 'non_gaap_financial_measure', 'same', 'similarly', 'title', 'measure', 'report', 'other', 'company'], ['constant_currency', 'constant_currency', 'reference', 'non_gaap_financial_measure', 'exclude', 'impact', 'change_foreign_currency', 'exchange_rate', 'consistent', 'how', 'management', 'evaluate', 'performance', 'comparison', 'prior', 'future', 'period', 'estimate', 'net', 'impact', 'currency', 'revenue', 'gross_profit', 'operating', 'profit', 'eps', 'result', 'restate', 'result', 'average', 'exchange_rate', 'exchange_rate', 'assumption', 'comparative_period', 'include', 'adjust', 'estimate', 'impact', 'foreign_currency', 'hedge', 'transaction', 'certain', 'impact', 'effective_tax_rate', 'estimate', 'currency', 'change', 'impact', 'second_quarter', 'result', 'follow', 'decrease', 'gross_profit', 'growth', 'increase', 'gross_margin', 'growth', 'basis_point', 'decrease', 'operate', 'expense', 'growth', 'decrease', 'operate_profit', 'growth', 'decrease', 'operate_profit', 'margin', 'growth', 'basis_point', 'decrease', 'eps_growth', 'constant_currency', 'revenue_growth', 'represent', 'percentage', 'change', 'revenue', 'applicable', 'period', 'compare', 'prior', 'year', 'period', 'exclude', 'impact', 'change_foreign_currency', 'exchange_rate', 'see', 'supplementary', 'analysis', 'result', 'below', 'revenue', 'percentage', 'change', 'currency', 'month', 'month_end', 'refer', 'growth', 'financial_performance', 'outlook', 'section', 'earning', 'release', 'estimate', 'foreign_currency_exchange_rate', 'impact', 'projection', 'estimate'], ['growth', 'organic', 'revenue_growth', 'reference', 'growth', 'organic', 'growth', 'refer', 'growth', 'compare', 'equivalent', 'prior', 'year', 'period', 'specifically', 'note', 'organic', 'revenue_growth', 'non_gaap_financial_measure', 'exclude', 'impact', 'change_foreign_currency', 'exchange_rate', 'certain', 'business', 'acquisition', 'divestiture', 'management_believe', 'report', 'organic', 'revenue_growth', 'provide', 'useful', 'information', 'investor', 'facilitate', 'easy', 'comparison', 'revenue', 'performance', 'prior', 'future', 'period', 'performance', 'peer', 'organic', 'revenue_growth', 'consider', 'addition', 'replacement', 'superior', 'measure', 'revenue_growth', 'report', 'accordance', 'see', 'supplementary', 'analysis', 'result', 'below', 'reconciliation', 'report', 'revenue_growth', 'organic', 'revenue_growth', 'month', 'month_end', 'refer', 'growth', 'financial_performance', 'outlook', 'section', 'earning', 'release', 'estimate', 'full_year', 'organic', 'revenue_growth', 'company', 'diagnostic', 'recur', 'revenue', 'percentage', 'change', 'revenue', 'result', 'acquisition', 'represent', 'revenue', 'current', 'year', 'period', 'limit', 'initial', 'month', 'date', 'acquisition', 'directly', 'attributable', 'business', 'acquisition', 'revenue', 'acquisition', 'expect', 'increase', 'project', 'full_year', 'revenue_growth', 'basis_point', 'impact', 'project', 'full_year', 'diagnostic', 'recur', 'revenue_growth'], ['comparable', 'growth', 'metric', 'comparable_gross', 'profit_growth', 'comparable_gross', 'margin_gain', 'growth_comparable', 'operate', 'expense', 'growth_comparable', 'operate_profit', 'growth_comparable', 'operate_margin', 'gain', 'growth', 'non_gaap_financial_measure', 'exclude', 'impact', 'change_foreign_currency', 'exchange_rate', 'non', 'recurring', 'unusual', 'item', 'refer', 'constant_currency', 'note', 'above', 'summary', 'foreign_currency_exchange_rate', 'impact', 'management_believe', 'report', 'comparable_gross', 'profit_growth', 'comparable_gross', 'margin_gain', 'growth_comparable', 'operate', 'expense', 'growth_comparable', 'operate_profit', 'growth_comparable', 'operate_margin', 'gain', 'growth', 'provide', 'useful', 'information', 'investor', 'enable', 'well', 'period', 'period', 'comparison', 'fundamental', 'financial', 'result', 'exclude', 'item', 'vary', 'independent', 'performance', 'provide', 'great', 'transparency', 'investor', 'regard', 'key', 'metric', 'use', 'management', 'comparable_gross', 'profit_growth', 'comparable_gross', 'margin_gain', 'growth_comparable', 'operate', 'expense', 'growth_comparable', 'operate_profit', 'growth_comparable', 'operate_margin', 'gain', 'growth', 'consider', 'addition', 'replacement', 'superior', 'measure', 'gross_profit', 'growth', 'gross_margin', 'gain', 'operate', 'expense', 'growth', 'operate_profit', 'growth', 'operate_margin', 'gain', 'report', 'accordance_gaap'], ['reconciliation_non_gaap', 'financial_measure', 'follow'], ['project', 'comparable_operate', 'margin', 'expansion', 'outline', 'growth', 'financial_performance', 'outlook', 'section', 'earning', 'release', 'reflect', 'project', 'full_year', 'report', 'operate_margin', 'adjust', 'estimate', 'positive', 'year', 'year', 'foreign_currency_exchange_rate', 'change', 'impact', 'approximately', 'basis_point'], ['impact', 'describe', 'constant_currency', 'note', 'reconcile', 'report', 'gross_profit', 'growth', 'gross_margin', 'gain', 'operate', 'expense', 'growth', 'operate_profit', 'growth', 'operate_margin', 'gain', 'include', 'project', 'operate_margin', 'expansion', 'comparable_gross', 'profit_growth', 'comparable_gross', 'margin_gain', 'comparable_operate', 'expense', 'growth_comparable', 'operate_profit', 'growth_comparable', 'operate_margin', 'gain', 'company'], ['comparable_eps', 'growth_comparable', 'eps_growth', 'non_gaap_financial_measure', 'represent', 'percentage', 'change', 'earning_share', 'dilute', 'measurement', 'period', 'compare', 'prior', 'base', 'period', 'net', 'impact', 'change_foreign_currency', 'exchange_rate', 'prior', 'base', 'period', 'exclude', 'tax', 'benefit', 'share_base_compensation', 'activity', 'compensation', 'stock', 'compensation', 'topic', 'improvement', 'employee', 'share', 'base', 'payment', 'accounting', 'non', 'recurring', 'unusual', 'item', 'management_believe', 'comparable_eps', 'growth', 'more', 'useful', 'way', 'measure', 'company', 'business', 'performance', 'eps_growth', 'enable', 'well', 'period', 'period', 'comparison', 'fundamental', 'financial', 'result', 'exclude', 'item', 'vary', 'independent', 'performance', 'provide', 'great', 'transparency', 'investor', 'regard', 'key', 'metric', 'use', 'management', 'comparable_eps', 'growth', 'consider', 'addition', 'replacement', 'superior', 'measure', 'eps_growth', 'report', 'accordance', 'refer', 'constant_currency', 'note', 'above', 'summary', 'foreign_currency_exchange_rate', 'impact'], ['reconciliation_non_gaap', 'financial_measure', 'follow'], ['project', 'comparable_eps', 'growth', 'outline', 'growth', 'financial_performance', 'outlook', 'section', 'earning', 'release', 'reflect', 'adjustment', 'include', 'estimate', 'positive', 'share_base_compensation', 'activity', 'estimate', 'negative', 'year', 'year', 'foreign_currency_exchange_rate', 'change', 'impact'], ['impact', 'describe', 'constant_currency', 'note', 'reconcile', 'report', 'eps_growth', 'include', 'project', 'report', 'growth_comparable', 'eps_growth', 'company'], ['free_cash_flow', 'free_cash_flow', 'non_gaap_financial_measure', 'mean', 'respect', 'measurement', 'period', 'cash', 'generate', 'operation', 'period', 'reduce', 'company', 'investment', 'property', 'equipment', 'management_believe', 'free_cash_flow', 'useful', 'measure', 'indicate', 'cash', 'operation', 'business', 'generate', 'appropriate', 'reinvestment', 'recur', 'investment', 'property', 'equipment', 'require', 'operate', 'business', 'free_cash_flow', 'consider', 'addition', 'replacement', 'superior', 'measure', 'net', 'cash', 'provide', 'operate', 'activity', 'see', 'supplementary', 'analysis', 'result', 'below', 'calculation', 'free_cash_flow', 'month_end', 'estimate', 'projected', 'free_cash_flow', 'deduct', 'project', 'purchase', 'property', 'equipment', 'also', 'refer', 'capital_expenditure', 'approximately', 'calculate', 'trail', 'month', 'net_income', 'free_cash_flow', 'ratio', 'month_end', 'deduct', 'purchase', 'property', 'equipment', 'approximately', 'net', 'cash', 'provide', 'operate', 'activity', 'approximately', 'divide', 'net_income', 'approximately'], ['debt', 'adjust_ebitda', 'leverage', 'ratio', 'adjust_ebitda', 'gross', 'debt', 'net', 'debt', 'non_gaap_financial_measure', 'adjust_ebitda', 'non_gaap_financial_measure', 'earning', 'interest', 'taxis', 'depreciation_amortization', 'non_recur', 'transaction', 'expense', 'incur', 'connection', 'acquisition', 'share_base_compensation', 'expense', 'certain', 'other', 'non_cash', 'loss', 'charge', 'management_believe', 'report', 'adjusted', 'ebitda', 'gross', 'debt', 'net', 'debt', 'debt', 'adjust_ebitda', 'ratio', 'provide', 'supplemental', 'analysis', 'help', 'investor', 'further', 'evaluate', 'company', 'business', 'performance', 'available', 'borrowing', 'capacity', 'company', 'credit', 'facility', 'adjust_ebitda', 'gross', 'debt', 'net', 'debt', 'consider', 'addition', 'replacement', 'superior', 'measure', 'net_income', 'total', 'debt', 'report', 'accordance_gaap', 'further', 'information', 'how', 'adjust_ebitda', 'debt', 'adjust_ebitda', 'ratio', 'calculate', 'see', 'company', 'annual_report_form', 'year', 'end', 'quarterly_report_form', 'quarter_end'], ['contact', 'investor_relation'], ['view_original_content_download', 'multimedia_news', 'release', 'idexx', 'laboratory', 'announce', 'second_quarter', 'results', 'html'], [], ['company', 'code'], ['clinical_stage', 'company', 'develop', 'pipeline', 'selective', 'oral', 'immunology', 'therapy', 'focus', 'treat', 'chronic', 'inflammatory', 'autoimmune', 'disease', 'today_announce', 'chief_executive', 'officer_president', 'participate_fireside_chat', 'am', 'et', 'pacgrow', 'virtual', 'healthcare', 'conference', 'take_place'], ['live_webcast', 'presentation', 'available', 'event', 'presentation', 'section', 'website', 'event', 'presentation', 'archive', 'replay', 'available', 'company', 'website', 'period', 'day', 'conference'], [], ['clinical_stage', 'company', 'pipeline', 'selective', 'oral', 'immunology', 'therapy', 'focus', 'treat', 'chronic', 'inflammatory', 'autoimmune', 'disease', 'company', 'develop', 'small_molecule', 'product', 'lead', 'development', 'program', 'calcium', 'selective', 'immune', 'modulator', 'inhibit', 'intracellular', 'metabolism', 'activate', 'immune', 'cell', 'block', 'enzyme', 'dhodh', 'exhibit', 'host', 'base', 'antiviral', 'effect', 'currently', 'develop', 'treatment_option', 'multiple', 'sclerosis', 'primary', 'sclerosing', 'cholangitis', 'imu', 'selective', 'inverse', 'agonist', 'transcription', 'factor', 'target', 'development', 'psoriasis', 'castration', 'resistant', 'prostate_cancer', 'guillain', 'syndrome', 'target', 'restoration', 'intestinal', 'barrier', 'function', 'target', 'development', 'disease', 'involve', 'bowel', 'barrier', 'dysfunction', 'further', 'information_visit'], ['cautionary', 'statement', 'regard_forward_look', 'statement'], ['press_release_contain', 'forward_look_statement', 'involve_substantial_risk_uncertainty', 'purpose', 'safe_harbor', 'provide', 'private_security', 'statement', 'other', 'statement_historical_fact', 'include', 'press_release', 'regard', 'strategy', 'future', 'operation', 'future', 'financial', 'position', 'future', 'revenue', 'project', 'expense', 'expect', 'timing', 'result', 'clinical_trial', 'prospect', 'plan_objective', 'management', 'forward_look_statement', 'example', 'such', 'statement', 'include', 'limit', 'statement', 'relate', 'management', 'participation', 'investor', 'conference', 'immunic', 'actually', 'achieve', 'plan', 'carry', 'intention', 'meet', 'expectation', 'projection', 'disclose', 'forward_look_statement', 'place_undue_reliance', 'forward_look_statement', 'such', 'statement', 'base', 'management', 'current', 'expectation', 'involve_substantial_risk_uncertainty', 'actual', 'result', 'performance', 'differ_materially', 'project', 'forward_look_statement', 'result', 'many', 'factor', 'include_limitation', 'pandemic', 'risk_uncertainty', 'associate', 'ability', 'project', 'future', 'cash', 'utilization', 'reserve', 'need', 'contingent', 'future', 'liability', 'business_operation', 'availability', 'sufficient', 'financial', 'other', 'resource', 'meet', 'business', 'objective', 'operational', 'requirement', 'fact', 'result', 'early', 'preclinical', 'study', 'clinical_trial', 'predictive_future', 'clinical_trial', 'result', 'protection', 'market', 'exclusivity', 'provide', 'intellectual_property', 'risk', 'relate', 'drug', 'development', 'regulatory_approval', 'process', 'impact', 'competitive', 'product', 'technological', 'change', 'further', 'list', 'description', 'risk_uncertainty', 'other', 'factor', 'find', 'section_caption', 'risk_factor', 'company', 'annual_report_form', 'fiscal_year', 'end', 'file', 'company', 'subsequent_filing', 'copy', 'filing', 'available', 'online', 'filing', 'forward_look_statement', 'make', 'release', 'speak_only_date', 'release', 'immunic', 'disclaim', 'intent', 'obligation_update_forward_look', 'statement', 'reflect_event_circumstance', 'exist', 'date', 'make', 'immunic', 'expressly', 'disclaim', 'liability', 'respect', 'action', 'take', 'take', 'base', 'content', 'press_release'], ['contact'], ['head', 'investor_relation', 'communication'], ['group', 'schwartz'], [], ['view_original_content_download', 'multimedia_news', 'release', 'immunic', 'inc', 'participate', 'the', 'wedbush', 'pacgrow', 'virtual', 'healthcare', 'conference', 'html'], [], ['company', 'code'], ['science', 'lead', 'molecular', 'science', 'technology', 'company', 'actively', 'develop', 'deliver', 'innovative', 'solution', 'revolutionize', 'health_care', 'clinical_stage', 'company', 'develop', 'engineer', 'antibody', 'cytokine', 'treatment', 'cancer', 'autoimmune', 'disease', 'announce_today', 'multi', 'year', 'strategic', 'option', 'license_agreement', 'research', 'develop_commercialize', 'bispecific_antibody', 'direct', 'novel', 'target', 'treatment', 'patient', 'cancer'], ['term', 'agreement', 'apply', 'proprietary', 'end', 'end', 'discovery', 'platform', 'discovery', 'identify', 'novel', 'target', 'bispecific_antibody', 'drug_candidate', 'combine', 'insight', 'generate', 'molecular', 'interrogation', 'primary', 'patient', 'tissue', 'use', 'company', 'exclusive', 'aptamer', 'base', 'proteomic', 'profiling', 'platform', 'robust', 'validation', 'pipeline', 'company', 'proprietary', 'real_world', 'datum', 'platform', 'integrate', 'extensive', 'catalog', 'molecular', 'datum', 'cancer', 'treatment', 'information', 'result', 'highly', 'differentiated', 'orthogonal', 'multi', 'omic', 'method', 'target', 'base', 'discovery'], ['critical', 'need', 'address', 'paucity', 'novel', 'therapeutic', 'target', 'oncology', 'say', 'president_chief', 'scientific', 'officer', 'science', 'consequently', 'launch', 'comprehensive', 'platform', 'agnostic', 'therapeutic', 'modality', 'discover', 'validate', 'novel', 'cancer', 'target', 'collaboration', 'combine', 'proprietary', 'multi', 'omics', 'target', 'discovery', 'engine', 'platform', 'design', 'manufacture', 'investigational', 'bispecific_antibody', 'develop', 'first_class', 'therapy', 'patient', 'cancer'], ['collaboration', 'leverage', 'plug', 'play', 'nature', 'platform', 'combine', 'extensive', 'set', 'protein', 'engineering', 'tool', 'capability', 'innovation', 'precision', 'oncology', 'say', 'senior_vice', 'president_chief', 'scientific', 'officer', 'build', 'unique', 'target', 'discovery', 'platform', 'couple', 'deep', 'genomic', 'information', 'enhance', 'ability', 'create', 'evaluate', 'new', 'generation', 'multi', 'specific', 'antibody', 'include', 'cell', 'engager', 'cell', 'engager', 'other', 'modality'], ['part', 'agreement', 'receive', 'exclusive', 'option', 'research', 'develop_commercialize', 'product', 'direct', 'target', 'receive_upfront', 'payment', 'eligible', 'receive', 'approximately', 'license', 'fee', 'discovery', 'development', 'regulatory', 'sale', 'base', 'milestone', 'addition', 'royalty_payment', 'net_sale', 'product', 'commercialize', 'future', 'right', 'molecular', 'profiling', 'companion_diagnostic', 'drug_candidate', 'develop', 'collaboration'], ['register_trademark'], ['science', 'science', 'lead', 'molecular', 'science', 'technology', 'company', 'actively', 'develop', 'deliver', 'innovative', 'solution', 'revolutionize', 'healthcare', 'improve', 'patient', 'outcome', 'comprehensive', 'molecular', 'profiling', 'whole', 'exome', 'whole', 'transcriptome', 'sequencing', 'application', 'advanced', 'artificial', 'intelligence', 'machine_learn', 'create', 'large_scale', 'clinico', 'genomic', 'database', 'cognitive', 'computing', 'need', 'analyze', 'unravel', 'molecular', 'complexity', 'disease', 'information', 'provide', 'unmatched', 'resource', 'ideal', 'path', 'forward', 'conduct', 'basic', 'fundamental', 'research', 'accelerate', 'discovery', 'detection', 'diagnosis', 'monitoring', 'therapy', 'selection', 'drug', 'development', 'improve', 'human', 'condition'], ['primary', 'focus', 'cancer', 'suite', 'market', 'lead', 'molecular', 'profiling', 'offering', 'assesse', 'protein', 'reveal', 'molecular', 'blueprint', 'help', 'patient', 'physician', 'researcher', 'well', 'detect', 'diagnose', 'treat', 'patient', 'late', 'advancement', 'blood', 'base', 'circulate', 'acid', 'sequence', 'combine', 'comprehensive', 'molecular', 'analysis', 'whole', 'exome', 'whole', 'transcriptome', 'sequencing', 'blood', 'serial', 'monitoring', 'make', 'most', 'powerful', 'liquid', 'biopsy', 'assay', 'ever', 'develop'], ['headquarter', 'office', 'provide', 'service', 'other', 'international', 'market', 'learn_more', 'visit', 'follow_twitter'], ['innovative', 'end', 'end', 'discovery', 'platform', 'combine', 'insight', 'generate', 'molecular', 'interrogation', 'primary', 'patient', 'tissue', 'use', 'company', 'exclusive', 'aptamer', 'base', 'proteomic', 'profiling', 'platform', 'company', 'proprietary', 'real_world', 'datum', 'platform', 'integrate', 'extensive', 'catalog', 'molecular', 'datum', 'cancer', 'treatment', 'information', 'result', 'fully', 'integrated', 'proprietary', 'set', 'complementary', 'approach', 'identification', 'novel', 'target', 'agnostic', 'treatment', 'modality', 'validation', 'exist', 'target', 'adapt', 'biotargete', 'system', 'use', 'cancer', 'specific', 'library', 'synthetically', 'manufacture', 'molecule', 'aptamer', 'bind', 'wide_range', 'biological', 'target', 'characterize', 'complex', 'biological', 'system', 'native', 'state', 'enable', 'profile', 'biological', 'sample', 'system', 'wide', 'scale', 'use', 'aptamer', 'library', 'enrich', 'cancer', 'specific', 'protein', 'allow', 'downstream', 'identification', 'novel', 'target', 'directly', 'patient', 'tissue', 'codeai', 'state_art', 'informatic', 'system', 'big', 'datum', 'architecture', 'provide', 'unmatched', 'resource', 'develop', 'well', 'understanding', 'molecular', 'mechanism', 'cancer'], ['clinical_stage', 'company', 'develop', 'engineer', 'antibody', 'cytokine', 'treatment', 'cancer', 'autoimmune', 'disease', 'more', 'candidate', 'engineer', 'technology', 'clinical', 'development', 'medicine', 'market', 'partner', 'engineering', 'technology', 'enable', 'small', 'change', 'protein', 'structure', 'result', 'new', 'mechanism', 'therapeutic', 'action', 'more_information_visit'], ['forward_look_statement', 'certain', 'statement_contain_press', 'release', 'constitute_forward_look', 'statement_meaning', 'applicable', 'security_law', 'forward_look_statement', 'include', 'statement', 'purely', 'statement_historical_fact', 'generally', 'identify', 'use', 'word', 'such', 'potential', 'plan', 'expect', 'anticipate', 'seek', 'look_forward', 'believe', 'commit', 'investigational', 'similar', 'term', 'express_imply', 'discussion', 'relate', 'discovery', 'novel', 'target', 'product_candidate', 'research', 'development', 'product', 'product_candidate', 'quotation', 'senior_vice', 'president_chief', 'scientific', 'officer_president', 'chief_scientific', 'officer', 'other', 'statement', 'purely', 'statement_historical_fact', 'such', 'statement', 'make', 'basis', 'current', 'belief', 'expectation', 'assumption', 'management', 'subject', 'significant', 'known', 'unknown', 'risk_uncertainty', 'other', 'factor_cause_actual', 'result', 'performance_achievement', 'timing', 'event', 'materially_different', 'imply_such', 'statement', 'therefore', 'statement', 'read', 'guarantee', 'future', 'performance', 'result', 'such', 'risk', 'include_limitation', 'risk_associate', 'process', 'discover_develop', 'manufacturing', 'commercialize', 'drug', 'safe_effective', 'use', 'human', 'therapeutic', 'other', 'risk', 'include', 'ability', 'publicly', 'disclose', 'preliminary', 'clinical_trial', 'datum', 'support', 'continue', 'clinical', 'development', 'regulatory_approval', 'specific', 'treatment', 'case', 'describe', 'public', 'security', 'filing', 'discussion', 'other', 'factor', 'refer', 'annual_report_form', 'year', 'end', 'as_well', 'subsequent_filing', 'caution_place_undue_reliance', 'forward_look_statement', 'speak_only', 'date_hereof', 'caution', 'make', 'safe_harbor', 'provision', 'private_security_amend', 'date', 'forward_look_statement', 'qualified', 'entirety', 'cautionary', 'statement', 'undertake_obligation_revise', 'update', 'press_release', 'reflect_event_circumstance', 'date_hereof', 'require_law'], ['science', 'medium_contact'], [], ['spark'], ['view_original_content_download', 'multimedia_news', 'release', 'caris', 'life_science', 'enter', 'target', 'discovery', 'collaboration', 'license_agreement', 'novel', 'xmab', 'bispecific'], ['science'], ['company', 'code'], ['corvel', 'corporation', 'announce', 'result', 'quarter_end', 'earning_share', 'quarter', 'compare', 'same', 'quarter', 'prior', 'year', 'revenue', 'quarter', 'increase', 'same', 'quarter', 'previous', 'year', 'company', 'conservative', 'approach', 'business', 'continue', 'support', 'high', 'return', 'equity', 'current', 'inflation', 'economic', 'dynamic', 'revenue_growth', 'year', 'strong', 'lead', 'payment', 'integrity', 'space', 'result', 'achieve', 'continuation', 'top', 'line', 'growth', 'quarter', 'year', 'prior', 'discount', 'pandemic', 'low'], ['quarter', 'develop', 'optimize', 'system', 'enhance', 'team', 'member', 'efficiency', 'effectiveness', 'remain', 'focus', 'investment', 'result', 'increasingly', 'automate', 'augment', 'workflow', 'increase', 'enhance', 'team', 'throughput', 'as_well', 'result', 'achieve', 'partner'], ['apply', 'technology', 'include', 'artificial', 'intelligence', 'machine', 'learning', 'natural', 'language', 'processing', 'enhance', 'managing', 'episode', 'care', 'related', 'health_care', 'cost', 'partner', 'employer', 'third_party', 'administrator', 'insurance', 'company', 'government', 'agency', 'manage', 'worker', 'compensation', 'health', 'auto', 'liability', 'service', 'diverse', 'suite', 'solution', 'combine', 'integrate', 'technology', 'human', 'touch', 'corvel', 'customize', 'service', 'deliver', 'locally', 'back', 'national', 'team', 'support', 'client', 'as_well', 'customer', 'patient'], ['safe', 'statement', 'private_security'], ['statement', 'include', 'press_release', 'other', 'statement_historical_fact', 'forward_look_statement', 'forward_look_statement', 'base', 'company', 'current', 'expectation', 'estimate', 'projection', 'company', 'management', 'belief', 'certain', 'assumption', 'make', 'company', 'event', 'company', 'control', 'subject', 'change', 'such_forward_look', 'statement', 'include', 'limit', 'statement', 'relate', 'commercial', 'health', 'focus', 'operation', 'improve', 'productivity', 'result', 'automation', 'augmentation', 'enterprise', 'business', 'system', 'expansion', 'ancillary', 'network', 'forward_look_statement', 'guarantee', 'future', 'result', 'subject', 'risk_uncertainty', 'assumption', 'cause', 'company', 'actual_result_differ', 'materially_adversely', 'express', 'forward_look_statement', 'include', 'risk', 'impact', 'pandemic', 'business', 'result', 'operation', 'financial', 'condition', 'great', 'initial', 'assessment'], ['risk_uncertainty', 'refer', 'above', 'include', 'limit', 'factor', 'describe', 'press_release', 'company', 'filing', 'include', 'limit', 'risk_factor', 'company', 'annual_report_form', 'year', 'end', 'company', 'quarterly_report_form', 'quarter_end', 'forward_look_statement', 'press_release', 'speak_only_date', 'make', 'company', 'undertake_obligation_revise', 'update', 'publicly', 'forward_look_statement', 'reason'], ['quarterly', 'result', 'income', 'statement', 'quarter_end', 'unaudited', 'unaudited'], ['quarterly', 'result', 'condense', 'balance', 'unaudited'], [], ['source'], ['view_news', 'release', 'online'], ['synh', 'only', 'fully', 'integrate', 'solution', 'organization', 'today', 'report', 'financial', 'result', 'month_end'], ['second_quarter', 'revenue', 'profitability', 'reflect', 'strength', 'strategy', 'people', 'skill', 'lead', 'product', 'development', 'mindset', 'accelerate', 'customer', 'success', 'bring', 'critical', 'therapy', 'patient', 'say', 'enter', 'next', 'chapter', 'growth', 'syneo', 'focus', 'investment', 'integration', 'clinical', 'medical_affair', 'commercial', 'complex', 'therapeutic', 'area', 'customer', 'streamlining', 'operation', 'drive', 'innovation', 'simplification', 'further', 'digitalization', 'capability', 'use', 'datum', 'insight', 'unlock', 'additional', 'value', 'business', 'stakeholder'], ['refer', 'use', 'non_gaap_financial_measure', 'reconciliation_gaap_non_gaap', 'measure', 'include', 'press_release', 'accompany', 'table', 'important', 'disclosure', 'non_gaap_measure', 'reconciliation', 'measure', 'near', 'gaap', 'measure'], ['revenue', 'increase', 'report_basis_constant', 'currency_basis', 'month_end', 'compare', 'same_period', 'prior', 'year', 'drive', 'growth', 'clinical', 'solution', 'commercial', 'solution', 'segment', 'revenue', 'midpoint', 'company', 'guidance', 'low', 'reimbursable', 'expense', 'clinical', 'solution', 'impact', 'foreign', 'exchange', 'clinical', 'solution', 'revenue', 'increase', 'report_basis_constant', 'currency_basis', 'acquisition', 'contribute', 'approximately', 'basis_point', 'clinical', 'solution', 'report', 'revenue_growth', 'commercial', 'solution', 'revenue', 'increase', 'report_basis_constant', 'currency_basis', 'prior_period', 'segment', 'result', 'recast', 'conform', 'insignificant', 'change', 'management', 'reporting'], ['gaap', 'net_income', 'month_end', 'increase', 'result', 'diluted', 'earning_share', 'compare', 'gaap', 'net_income', 'dilute_earning', 'share', 'month_end', 'adjust_net_income', 'month_end', 'increase', 'result', 'adjust_dilute', 'earning_share', 'compare', 'adjust_net_income', 'adjust_dilute', 'earning_share', 'month_end'], ['adjust_ebitda', 'month_end', 'increase', 'prior', 'year'], ['first', 'result'], ['revenue', 'increase', 'report_basis_constant', 'currency_basis', 'month_end', 'compare', 'same_period', 'prior', 'year', 'clinical', 'solution', 'revenue', 'increase', 'report_basis_constant', 'currency_basis', 'acquisition', 'contribute', 'approximately', 'basis_point', 'clinical', 'solution', 'report', 'revenue_growth', 'commercial', 'solution', 'revenue', 'increase', 'report_basis_constant', 'currency_basis'], ['gaap', 'net_income', 'month_end', 'increase', 'result', 'diluted', 'earning_share', 'compare', 'gaap', 'net_income', 'dilute_earning', 'share', 'month_end', 'adjust_net_income', 'month_end', 'increase', 'result', 'adjust_dilute', 'earning_share', 'compare', 'adjust_net_income', 'adjust', 'diluted', 'eps', 'month_end'], ['adjust_ebitda', 'month_end', 'increase', 'prior', 'year'], ['net', 'new', 'business', 'award', 'backlog'], ['net', 'new', 'business', 'award', 'book', 'bill', 'ratio', 'month_end', 'follow', 'dollar_million'], ['backlog', 'follow', 'dollar_million'], ['net', 'new', 'business', 'award', 'book', 'bill', 'ratio', 'include', 'reimbursable_pocket', 'expense', 'trail', 'month', 'impact', 'adjustment', 'make', 'clinical', 'solution', 'backlog', 'fourth_quarter', 'reflect', 'company', 'expectation', 'reduce', 'reimbursable', 'expense', 'go', 'forward'], ['liquidity', 'capital', 'management', 'update'], ['cash_flow', 'provide', 'operate', 'activity', 'month_end', 'respectively'], ['month_end', 'company', 'repay', 'revolving', 'credit', 'facility', 'leave', 'remain', 'capacity', 'company', 'net', 'leverage', 'ratio', 'trail', 'month', 'adjust_ebitda'], ['month_end', 'company', 'repurchase', 'common_stock', 'month_end', 'company', 'repurchase', 'common_stock', 'remain', 'share', 'repurchase', 'authorization', 'available'], ['full_year', 'business', 'outlook'], ['company', 'update', 'full_year', 'guidance', 'revenue', 'reflect', 'low', 'expect', 'reimbursable', 'expense', 'clinical', 'solution', 'segment', 'increase', 'impact', 'foreign_currency_exchange_rate', 'fluctuation', 'company', 'underlying', 'expectation', 'constant_currency', 'revenue_growth', 'exclude_reimbursable', 'expense', 'remain', 'unchanged', 'prior', 'guidance', 'company', 'update', 'full_year', 'guidance', 'gaap', 'net_income', 'gaap', 'dilute', 'adjust_ebitda', 'adjust_dilute', 'ep', 'reflect', 'accelerated', 'investment', 'operation', 'second_half', 'drive', 'future', 'growth', 'margin', 'expansion'], ['company', 'guidance', 'take', 'account', 'number_factor', 'include', 'exist', 'backlog', 'current', 'sale', 'pipeline', 'trend', 'cancellation', 'delay', 'trend', 'reimbursable_pocket', 'expense', 'company', 'initiative', 'include', 'expansion', 'network', 'process', 'optimization', 'automation', 'initiative', 'addition', 'guidance', 'present', 'represent', 'company', 'good', 'effort', 'estimate', 'economic', 'trend', 'include', 'inflation', 'expect', 'interest', 'rate', 'impact', 'war', 'business', 'furthermore', 'guidance', 'present', 'base', 'foreign_currency_exchange_rate', 'expect', 'interest', 'rate', 'company', 'expect', 'non_gaap', 'effective_tax_rate', 'approximately', 'year', 'end', 'guidance', 'base', 'company', 'estimate', 'number', 'weight', 'average', 'diluted', 'share', 'outstanding', 'take', 'account', 'share', 'repurchase', 'second_quarter', 'company', 'full_year', 'guidance', 'outline', 'below'], ['conference_call', 'detail'], ['host_conference_call', 'am', 'discuss', 'second_quarter_financial', 'result', 'live_webcast', 'available', 'listen', 'only', 'mode', 'event', 'section', 'company', 'investor_relation', 'website', 'participate', 'conference', 'register', 'advance', 'link', 'registration', 'participant', 'receive', 'confirmation', 'email', 'detail', 'how', 'join', 'conference_call', 'include', 'dial', 'number', 'unique', 'passcode', 'would', 'use', 'access', 'call'], ['webcast', 'replay', 'available', 'investor_relation', 'section', 'website', 'pm'], [], ['synh', 'only', 'fully', 'integrate', 'solution', 'organization', 'purpose', 'build', 'accelerate', 'customer', 'success', 'lead', 'product', 'development', 'mindset', 'strategically', 'blend', 'clinical', 'development_medical_affair', 'commercial', 'capability', 'address', 'modern', 'market', 'reality'], ['bring', 'together', 'more', 'mind', 'more', 'country', 'deep_understanding', 'patient', 'physician', 'behavior', 'market', 'dynamic', 'together', 'share', 'insight', 'use', 'late', 'technology', 'apply', 'advanced', 'business', 'practice', 'speed', 'customer', 'delivery', 'important', 'therapy', 'patient'], ['support', 'diverse', 'equitable', 'inclusive', 'culture', 'care', 'colleague', 'customer', 'patient', 'community', 'environment'], ['learn_more', 'how', 'shorten', 'distance', 'lab', 'life', 'visit', 'syneoshealthcom', 'subscribe', 'podcast'], ['historical', 'information', 'statement', 'expectation', 'assumption', 'contain_press_release', 'forward_look_statement', 'term', 'define_private', 'security', 'include', 'future', 'impact', 'pandemic', 'inflation', 'war', 'business', 'financial', 'result', 'financial', 'condition', 'expect', 'interest', 'rate', 'anticipate', 'financial', 'result', 'full_year', 'sale', 'pipeline', 'exist', 'backlog', 'expectation', 'net', 'award', 'expect', 'non_gaap', 'tax_rate', 'trend', 'reimbursable_pocket', 'expense', 'benefit', 'recent', 'acquisition', 'plan', 'capital', 'deployment', 'actual_result_differ', 'materially', 'explicit', 'implicit', 'forward_look_statement', 'important_factor', 'cause_actual_result_differ', 'materially', 'include', 'limit', 'risk_associate', 'pandemic', 'company', 'potential', 'failure', 'generate', 'large', 'number', 'new', 'business', 'award', 'risk', 'delay', 'termination', 'reduction', 'scope', 'failure', 'go', 'contract', 'business', 'award', 'company', 'potential', 'failure', 'convert', 'backlog', 'revenue', 'fluctuation', 'company', 'operating', 'result', 'effective', 'income', 'tax_rate', 'impact', 'potentially', 'underprice', 'company', 'contract', 'overrun', 'cost', 'estimate', 'fail', 'receive', 'approval', 'experience', 'delay', 'documentation', 'change', 'order', 'security', 'other', 'risk_associate', 'company', 'information', 'system', 'infrastructure', 'change', 'cost', 'compliance', 'regulation', 'relate', 'data', 'privacy', 'concentration', 'company', 'customer', 'therapeutic', 'area', 'risk_associate', 'do', 'business', 'internationally', 'include', 'risk', 'relate', 'war', 'challenge', 'tax', 'authority', 'company', 'intercompany', 'transfer', 'pricing', 'policy', 'company', 'potential', 'failure', 'successfully', 'increase', 'market', 'share', 'grow', 'business', 'execute', 'growth', 'strategy', 'company', 'ability', 'effectively', 'upgrade', 'information', 'system', 'company', 'failure', 'perform', 'service', 'accordance', 'contractual', 'requirement', 'regulatory', 'standard', 'ethical', 'consideration', 'risk', 'relate', 'management', 'clinical_trial', 'need', 'hire', 'develop', 'retain', 'key', 'personnel', 'impact', 'unfavorable', 'economic_condition', 'include', 'uncertain', 'international', 'economic', 'environment', 'change_foreign_currency', 'exchange_rate', 'effective', 'income', 'tax_rate', 'fluctuation', 'company', 'ability', 'protect', 'intellectual_property', 'risk', 'relate', 'company', 'acquisition', 'strategy', 'include', 'ability', 'realize', 'synergy', 'company', 'relationship', 'customer', 'competition', 'other', 'failure', 'realize', 'full', 'value', 'company', 'goodwill', 'intangible_asset', 'risk', 'relate', 'restructuring', 'company', 'compliance', 'anti', 'corruption', 'anti', 'bribery', 'law', 'company', 'dependence', 'third_party', 'potential', 'employment', 'liability', 'impact', 'increase', 'focus', 'environmental', 'sustainability', 'social', 'initiative', 'company', 'ability', 'utilize', 'net_operating_loss', 'carryforward', 'other', 'tax', 'attribute', 'downgrade', 'company', 'credit', 'rating', 'competition', 'service', 'industry', 'outsource', 'trend', 'change', 'aggregate', 'spending', 'research', 'development', 'budget', 'impact', 'include', 'change', 'government', 'regulation', 'healthcare', 'reform', 'intense', 'competition', 'face', 'customer', 'low', 'cost', 'generic', 'product', 'other', 'compete', 'product', 'company', 'ability', 'keep', 'pace', 'rapid', 'technological', 'change', 'cost', 'company', 'ability', 'service', 'substantial', 'indebtedness', 'other', 'risk', 'relate', 'ownership', 'company', 'common_stock', 'other', 'risk_factor', 'set', 'company', 'annual_report_form', 'fiscal_year', 'end', 'update', 'company', 'other', 'filing', 'copy', 'available', 'free', 'charge', 'company', 'website', 'company', 'assume', 'obligation', 'intend', 'update', 'forward_look_statement', 'require_law'], ['use', 'non_gaap_financial_measure', 'operate', 'metric'], ['addition', 'financial_measure', 'prepare', 'accordance', 'generally_accept', 'accounting_principle', 'gaap', 'press_release_contain', 'certain', 'non_gaap_financial_measure', 'include', 'adjusted', 'net_income', 'include', 'adjust_dilute', 'earning_share', 'ebitda_adjust_ebitda', 'non_gaap', 'effective', 'income', 'tax_rate', 'also', 'present', 'revenue_growth', 'constant_currency', 'constant_currency', 'revenue_growth', 'define', 'revenue', 'give', 'period', 'restate', 'comparative_period', 'foreign_currency_exchange_rate', 'measure', 'comparative_period', 'revenue', 'constant_currency', 'segment', 'revenue_growth', 'define', 'revenue', 'give', 'period', 'restate', 'comparative_period', 'foreign_currency_exchange_rate', 'measure', 'comparative_period', 'revenue'], ['non_gaap_financial_measure', 'generally', 'define', 'numerical', 'measure', 'company', 'financial_performance', 'exclude', 'include', 'amount', 'most', 'directly', 'comparable', 'measure', 'calculate', 'present', 'accordance_gaap', 'statement', 'operation', 'balance_sheet', 'statement', 'cash_flow', 'company'], ['company', 'define', 'adjust_net_income', 'include', 'adjust_dilute', 'earning_share', 'net_income', 'include', 'dilute_earning', 'share', 'exclude', 'acquisition_relate', 'amortization', 'restructuring', 'other', 'cost', 'transaction', 'integration', 'relate', 'other', 'expense', 'share_base_compensation', 'expense', 'gain_loss', 'extinguishment', 'debt', 'other', 'income', 'expense', 'net_income', 'tax', 'effect', 'above', 'adjustment'], ['represent', 'earning', 'interest', 'taxis', 'depreciation_amortization', 'company', 'define', 'adjust_ebitda', 'ebitda', 'further', 'adjust', 'exclude', 'expense', 'transaction', 'company', 'believe', 'representative', 'core', 'operation', 'namely', 'restructure', 'other', 'cost', 'transaction', 'integration', 'relate', 'other', 'expense', 'share_base_compensation', 'expense', 'other', 'income', 'expense', 'net', 'gain_loss', 'extinguishment', 'debt', 'company', 'present', 'ebitda_adjust_ebitda', 'believe', 'useful', 'metric', 'investor', 'commonly', 'use', 'investor', 'analyst', 'debt', 'holder', 'measure', 'company', 'ability', 'fund', 'capital_expenditure', 'meet', 'work', 'capital', 'requirement'], ['net', 'leverage', 'represent', 'total', 'debt', 'less', 'cash_cash_equivalent', 'divide', 'trail', 'month', 'adjust_ebitda'], ['non_gaap_measure', 'note', 'above', 'use', 'management', 'board', 'evaluate', 'company', 'core', 'operating', 'result', 'exclude', 'certain', 'item', 'fluctuation', 'period', 'period', 'necessarily', 'correspond', 'change', 'core', 'operation', 'business', 'adjust_net_income', 'include', 'adjust_dilute', 'earning_share', 'adjust_ebitda', 'use', 'management', 'board', 'assess', 'performance', 'company', 'business'], ['non_gaap_measure', 'limitation', 'reflect', 'amount', 'associate', 'company', 'result', 'operation', 'determine', 'accordance', 'also', 'other', 'company', 'calculate', 'measure', 'differently', 'investor', 'encourage', 'review', 'reconciliation_non_gaap', 'financial_measure', 'most', 'directly', 'comparable', 'gaap', 'measure', 'include', 'press_release', 'accompany', 'table'], ['also', 'present', 'certain', 'key', 'operate', 'metric', 'include', 'new', 'operate', 'metric', 'segment', 'book', 'bill', 'ratio', 'exclude_reimbursable', 'pocket_expense', 'expectation', 'reimbursable_pocket', 'expense', 'percentage', 'revenue', 'remain', 'lower', 'relative', 'pre', 'pandemic', 'level', 'discuss', 'specifically', 'clinical', 'solution', 'book', 'bill', 'ratio', 'exclude_reimbursable', 'pocket_expense', 'represent', 'clinical', 'solution', 'net', 'new', 'business', 'award', 'exclude_reimbursable', 'pocket_expense', 'divide', 'clinical', 'solution', 'revenue', 'exclude_reimbursable', 'pocket_expense', 'case', 'respective', 'period', 'commercial', 'solution', 'book', 'bill', 'ratio', 'exclude_reimbursable', 'pocket_expense', 'represent', 'commercial', 'solution', 'net', 'new', 'business', 'award', 'exclude_reimbursable', 'pocket_expense', 'divide', 'commercial', 'solution', 'revenue', 'exclude_reimbursable', 'pocket_expense', 'case', 'respective', 'period'], ['subsidiary', 'consolidated', 'statement', 'operation', 'thousand_share', 'datum', 'unaudited'], ['subsidiary', 'consolidated_balance', 'sheet', 'thousand', 'par', 'value', 'unaudited'], ['subsidiary', 'consolidated', 'statement', 'cash_flow', 'thousand_unaudited'], ['subsidiary', 'reconciliation_gaap_non_gaap', 'measure', 'thousand_unaudited'], ['subsidiary', 'reconciliation_gaap_non_gaap', 'measure', 'thousand_share', 'datum', 'unaudited'], ['subsidiary', 'reconciliation_gaap_non_gaap', 'full_year', 'guidance', 'million', 'share', 'datum', 'unaudited'], ['release', 'second_quarter', 'year', 'date', 'financial', 'result', 'management', 'host_conference_call', 'discuss', 'result', 'corporate', 'update', 'pm', 'eastern_time'], ['present', 'company', 'chief_executive_officer', 'chief', 'financial'], ['interested', 'listen', 'conference_call', 'live', 'internet', 'so', 'visit', 'company', 'website', 'news', 'events', 'event'], ['focus', 'development', 'innovative', 'therapeutic', 'product', 'device', 'address', 'serious', 'unmet_medical_need', 'live', 'endocrine', 'orphan', 'lung', 'disease', 'commit', 'help', 'people', 'manage', 'serious', 'health', 'condition', 'such', 'diabete', 'pulmonary', 'arterial', 'idiopathic_pulmonary_fibrosis', 'experience', 'life', 'limit'], ['approach', 'begin', 'signature', 'technology', 'comprise', 'dry', 'powder', 'formulation', 'capability', 'inhalation', 'device', 'engineering', 'offer', 'rapid', 'convenient', 'delivery', 'medicine', 'deep', 'lung', 'where', 'exert', 'effect', 'locally', 'enter', 'systemic', 'circulation'], ['diverse', 'pipeline', 'passionate', 'team', 'mannitarian', 'collaborate', 'nationwide', 'mission', 'give', 'people', 'control', 'health', 'freedom', 'live', 'life'], ['visit', 'learn_more', 'follow', 'instagram'], ['mannkind', 'rise', 'investor', 'email'], ['allarity', 'allarity', 'company', 'clinical_stage', 'pharmaceutical', 'company', 'develop', 'novel', 'oncology', 'therapeutic', 'together', 'drug', 'specific', 'companion_diagnostic', 'personalized', 'cancer', 'care', 'today_announce', 'board_director', 'mandate', 'refocus', 'company', 'oncology', 'pipeline', 'strategy', 'away', 'development', 'monotherapie', 'development', 'more', 'promising', 'clinically', 'relevant', 'combination', 'therapy'], ['follow', 'lengthy', 'depth', 'analysis', 'current', 'pipeline', 'opportunity', 'clinical', 'regulatory', 'risk', 'development', 'cost', 'timeline', 'expect', 'availability', 'funding', 'consultation', 'allarity', 'senior', 'management', 'scientific', 'advisory', 'board', 'external', 'expert', 'board_director', 'conclude', 'refocus', 'company', 'pipeline', 'development', 'combination', 'therapy', 'accomplish', 'following'], ['board', 'decision', 'also', 'take', 'account', 'feedback', 'company', 'recently', 'receive', 'type', 'advisory', 'meeting', 'hold', 'regard', 'potential', 'phase', 'clinical', 'development', 'path', 'monotherapy', 'third', 'line', 'treatment', 'metastatic', 'renal', 'cell', 'carcinoma', 'part', 'feedback', 'indicate', 'recent', 'project', 'optimus', 'guideline', 'relate', 'new', 'optimization', 'therapeutic', 'dosing', 'company', 'likely', 'need', 'conduct', 'new', 'dosing', 'study', 'prior', 'company', 'conduct', 'future', 'phase_study', 'enable', 'submission', 'new', 'conduct', 'new', 'dosing', 'study', 'require', 'further', 'delay', 'initiation_completion', 'future', 'phase_study', 'increase', 'cost', 'time', 'market', 'risk', 'advance', 'dovitinib', 'monotherapy', 'increasingly', 'competitive', 'indication', 'third', 'line', 'view', 'delay', 'increase', 'cost', 'risk', 'company', 'determine', 'advance', 'dovitinib', 'monotherapy', 'adult', 'long', 'commercially', 'viable', 'good', 'interest', 'shareholder', 'however', 'drug', 'continue', 'externally', 'develop', 'partnership', 'oncoheroe', 'bioscience', 'potential', 'monotherapy', 'pediatric', 'cancer'], ['part', 'new', 'strategic', 'pipeline', 'focus', 'company', 'announce', 'expect', 'initiate', 'enrollment', 'phase_study', 'inhibitor', 'combination', 'second', 'line', 'later', 'treatment', 'metastatic', 'ovarian_cancer', 'company', 'plan', 'trial', 'site', 'company', 'currently', 'evaluate', 'other', 'potential', 'phase_study', 'stenoparib', 'dovitinib', 'combine', 'oncology', 'therapeutic', 'include', 'ongoing', 'phase_study', 'monotherapy', 'ovarian_cancer', 'ixempra', 'monotherapy', 'metastatic_breast_cancer', 'continue', 'interim', 'datum', 'readout', 'now', 'anticipate', 'respectively', 'pipeline', 'development', 'activity', 'continue', 'utilize', 'drug', 'specific', 'companion_diagnostic', 'guide', 'patient', 'selection', 'treatment'], ['grateful', 'good', 'path', 'company', 'take', 'advance', 'mission', 'improve', 'cancer', 'patient', 'care', 'realize', 'promise', 'truly', 'personalized', 'medicine', 'say', 'interim', 'chief_executive_officer', 'allarity', 'new', 'therapeutic', 'development', 'recognize', 'very', 'challenging', 'endeavor', 'constantly', 'shift', 'regulatory', 'requirement', 'standard_care', 'improvement', 'new', 'drug', 'come', 'market', 'financial', 'market', 'challengesit', 'become', 'increasingly', 'difficult', 'advance', 'development', 'monotherapie', 'increasingly', 'competitive', 'therapeutic', 'space', 'confident', 'strategic', 'shift', 'focus', 'resource', 'correct', 'path', 'forward', 'allarity', 'give', 'current', 'regulatory', 'market', 'reality', 'well', 'leverage', 'companion_diagnostic', 'match', 'right', 'patient', 'cancer', 'therapeutic', 'most', 'likely', 'benefit'], ['chairman', 'state', 'clear', 'board', 'follow', 'lengthy', 'discussion', 'management', 'team', 'sab', 'additional', 'key', 'opinion', 'leader', 'current', 'future', 'standard_care', 'cancer', 'treatment', 'combination', 'therapy', 'increasingly', 'field', 'market', 'opportunity', 'shift', 'away', 'monotherapy', 'approach', 'view', 'key', 'shift', 'consideration', 'many', 'other', 'market', 'financial', 'factor', 'as_well', 'optimization', 'requirement', 'determine', 'allarity', 'future', 'pipeline', 'focus', 'development', 'promise', 'combination', 'therapy', 'approach', 'utilize', 'current', 'asset', 'together', 'companion_diagnostic', 'remain', 'very', 'enthusiastic', 'company', 'vision', 'mission', 'strategy', 'strategic', 'refocus', 'combination', 'therapy', 'together', 'core', 'technology', 'give', 'allarity', 'good', 'chance', 'success', 'as_well', 'good', 'optimize', 'shareholder', 'return', 'investment'], [], ['develop', 'drug', 'personalized', 'treatment', 'cancer', 'guide', 'proprietary', 'highly', 'validate', 'companion_diagnostic', 'technology_platform', 'company', 'mature', 'portfolio', 'drug_candidate', 'parp', 'inhibitor', 'phase', 'development', 'ovarian_cancer', 'post', 'phase', 'pan', 'tyrosine', 'inhibitor', 'ixempra', 'ixabepilone', 'microtubule', 'inhibitor', 'approve', 'treatment', 'second', 'line', 'metastatic_breast_cancer', 'phase', 'development', 'same', 'indication', 'additionally', 'company', 'right', 'secondary', 'asset', 'liposomal', 'formulation', 'phase', 'development', 'metastatic_breast_cancer', 'subject', 'discussion', 'restructure', 'out', 'license', 'smerud', 'medical', 'research', 'liposomal', 'formulation', 'cisplatin', 'accompany', 'develop', 'partnership', 'affiliate', 'research', 'international', 'late_stage', 'metastatic_breast_cancer', 'company', 'headquarter', 'maintain', 'facility', 'more_information_visit', 'company', 'website'], ['drug', 'response', 'predictor', 'companion_diagnostic'], ['allarity', 'use', 'drug', 'specific', 'select', 'patient', 'genetic', 'signature', 'cancer', 'find', 'high', 'likelihood', 'respond', 'specific', 'drug', 'screen', 'patient', 'treatment', 'only', 'treat', 'patient', 'sufficiently', 'high', 'score', 'therapeutic', 'response', 'rate', 'significantly', 'increase', 'method', 'build', 'comparison', 'sensitive', 'resistant', 'human', 'cancer', 'cell', 'line', 'include', 'transcriptomic', 'information', 'cell', 'line', 'combine', 'clinical', 'tumor', 'biology', 'filter', 'prior', 'clinical_trial', 'outcome', 'base', 'patient', 'biopsy', 'platform', 'prove', 'ability', 'provide', 'statistically_significant', 'prediction', 'clinical', 'outcome', 'drug', 'treatment', 'cancer', 'patient', 'clinical', 'study', 'examine', 'retrospective', 'prospective', 'include', 'ongoing', 'prospective', 'phase', 'trial', 'platform', 'use', 'cancer', 'type', 'patent', 'more', 'anti', 'cancer', 'drug', 'extensively', 'publish', 'review', 'literature'], ['follow', 'allarity', 'social_medium'], ['facebook', 'company', 'twitter', 'allaritytx'], ['press_release_contain', 'forward_look_statement_meaning', 'private_security_forward_look', 'statement', 'provide', 'allarity', 'current', 'expectation', 'forecast', 'future', 'event', 'word', 'anticipate', 'believe', 'continue', 'expect', 'intend', 'plan', 'possible', 'potential', 'predict', 'project', 'similar_expression', 'identify', 'forward_look_statement', 'absence', 'word', 'mean', 'statement', 'forward_look', 'forward_look_statement', 'include', 'limit', 'statement', 'relate', 'company', 'relate', 'expect', 'availability', 'capital', 'fund', 'anticipated', 'clinical_trial', 'statement', 'relate', 'advance', 'dovitinib', 'combination', 'therapeutic', 'candidate', 'other', 'approve', 'drug', 'statement', 'relate', 'ongoing', 'clinical_trial', 'monotherapy', 'combination', 'therapeutic', 'candidate', 'treatment', 'advanced', 'ovarian_cancer', 'ongoing', 'clinical_trial', 'ixempra', 'treatment', 'metastatic_breast_cancer', 'statement', 'relate', 'effectiveness', 'company', 'companion_diagnostic', 'platform', 'predict', 'particular', 'patient', 'likely', 'respond', 'specific', 'drug', 'forward_look_statement', 'press_release_base', 'management', 'current', 'expectation', 'future', 'event', 'subject', 'number_risk_uncertainty', 'cause_actual_result_differ', 'materially_adversely', 'set_forth', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include', 'limit', 'risk', 'result', 'clinical', 'study', 'necessarily', 'predict', 'final', 'result', 'more', 'clinical', 'outcome', 'materially', 'change', 'follow', 'more', 'comprehensive', 'review', 'datum', 'more', 'patient', 'datum', 'become_available', 'risk', 'result', 'clinical', 'study', 'subject', 'interpretation', 'additional', 'analysis', 'need', 'contradict', 'such', 'result', 'receipt', 'regulatory_approval', 'other', 'therapeutic', 'candidate', 'approve', 'successful', 'such', 'product', 'risk', 'cessation', 'delay', 'ongoing', 'plan', 'clinical_trial', 'development', 'product_candidate', 'risk', 'result', 'previously', 'conduct', 'study', 'repeat', 'observe', 'ongoing', 'future', 'study', 'involve', 'therapeutic', 'candidate', 'risk', 'current', 'pandemic', 'impact', 'company', 'current', 'future', 'clinical_trial', 'timing', 'company', 'preclinical', 'study', 'other', 'operation', 'discussion', 'other', 'risk_uncertainty', 'other', 'important_factor', 'cause_actual_result_differ', 'contain_forward_look', 'statement', 'see', 'section', 'entitle', 'risk_factor', 'form', 'registration', 'statement', 'file_available', 'website', 'as_well', 'discussion', 'potential', 'risk_uncertainty', 'other', 'important_factor', 'company', 'subsequent_filing', 'information', 'press_release', 'date', 'release', 'company', 'undertake', 'duty', 'update_information', 'require_law'], [], ['company', 'contact'], ['senior', 'investor'], ['investor_relation'], ['medium_contact'], [], ['contact'], [], ['attachment'], [], ['acquire', 'leading', 'online', 'order', 'platform', 'offer', 'veterinary', 'pharmaceutical', 'other', 'veterinary', 'product', 'veterinary', 'clinic', 'acquisition', 'mark', 'key', 'milestone', 'strategy', 'digitalise', 'global', 'service', 'offering', 'veterinary', 'clinic', 'annual', 'revenue', 'around'], ['veterinary', 'service', 'segment', 'vetfamily', 'acquire', 'found', 'heilandcom', 'family', 'own', 'business', 'rapidly', 'grow', 'become', 'lead', 'online', 'stop', 'shop', 'veterinary', 'pharmaceutical', 'monthly', 'active', 'user', 'more', 'product', 'manufacturer', 'growth', 'rate', 'cent'], ['acquisition', 'gain', 'access', 'lead', 'technology_platform', 'purchase', 'portal', 'veterinary', 'clinic', 'leverage', 'geography', 'drive', 'sale', 'improve', 'offering', 'clinic', 'strategic', 'partner', 'benefit', 'increase', 'efficiency', 'convenience', 'when', 'handle', 'order', 'interface', 'fast', 'grow', 'high', 'margin', 'enjoy', 'attractive', 'market', 'position', 'proprietary', 'technology', 'loyal', 'customer', 'base', 'strong', 'brand', 'say', 'veterinary', 'service', 'segment', 'vetfamily'], ['acquisition', 'marginal', 'impact', 'vimian', 'group', 'earning_share', 'current', 'financial', 'year', 'consolidate', 'vimian', 'veterinary', 'service', 'segment'], ['further', 'information', 'contact'], ['head'], [], ['global', 'fast', 'grow', 'group', 'innovation', 'drive', 'company', 'share', 'passion', 'make', 'positive', 'impact', 'improve', 'animal', 'health', 'together', 'put', 'science', 'technology', 'customer', 'need', 'centre', 'deliver', 'effective', 'solution', 'veterinary', 'professional', 'lab', 'pet', 'parent', 'world', 'bring', 'together', 'pioneering', 'entrepreneurial', 'business', 'animal', 'health', 'aim', 'create', 'uniquely', 'diversified', 'proposition', 'product', 'service', 'high', 'standard', 'group', 'cover', 'essential', 'rapidly', 'evolve', 'area', 'animal', 'health', 'specialty', 'veterinary', 'service', 'provide', 'individual', 'business', 'access', 'network', 'expertise', 'infrastructure', 'capital', 'accelerate', 'innovation', 'growth', 'passionate', 'support', 'leadership', 'exist', 'business', 'welcome', 'new', 'partner', 'vimian', 'family', 'together', 'help', 'make', 'even', 'great', 'impact', 'improve', 'animal', 'health', 'headquarter', 'family', 'company', 'reach', 'customer', 'market', 'employ', 'more', 'people', 'combine', 'annual', 'turnover', 'approximately', 'fnca', 'appoint', 'company', 'certify', 'adviser', 'info', 'fncase', 'more_information_visit'], ['attachment'], ['source'], ['source_version', 'vimian', 'group', 'acquire', 'lead', 'online', 'platform', 'veterinary', 'pharmaceutical'], ['alzecure', 'pharma', 'alzcur', 'fra'], ['publ', 'pharmaceutical', 'company', 'develop', 'broad', 'portfolio', 'small_molecule', 'candidate', 'drug', 'disease', 'affect', 'central_nervous_system', 'project', 'disease', 'pain', 'today_announce', 'company', 'presentation', 'conference', 'regard', 'new', 'clinical', 'datum', 'lead', 'drug_candidate', 'neurorestore', 'develop', 'focus', 'disease', 'now', 'available', 'entirety', 'company', 'website'], ['presentation', 'title', 'result', 'multiple', 'ascending', 'dose', 'study', 'healthy', 'volunteer', 'positive_modulator', 'receptor', 'hold', 'project', 'manager', 'onnestam', 'contain', 'new', 'clinical', 'datum', 'phase', 'mad', 'study', 'lead', 'drug_candidate', 'neurorestore', 'project', 'study', 'placebo', 'administer', 'orally', 'repeatedly', 'week', 'healthy', 'subject', 'divide', 'group', 'incremental', 'dose', 'primary', 'aim', 'evaluate', 'safety_tolerability', 'pharmacokinetic', 'repeat', 'dosing', 'human'], ['result', 'show', 'very', 'good', 'tolerability', 'safety_profile', 'significant', 'safety', 'finding', 'study', 'participant', 'test', 'dose', 'mg', 'substance', 'also', 'show', 'good', 'pharmacokinetic', 'profile', 'high', 'bioavailability', 'clear', 'exposure', 'cerebrospinal', 'fluid', 'show', 'substance', 'cross', 'blood', 'brain', 'barrier', 'highly', 'relevant', 'concentration', 'positive_modulator', 'ngf', 'trka', 'bdnf', 'trkb', 'mediate', 'signaling', 'previous', 'preclinical', 'study', 'show', 'improve', 'cognition', 'memory', 'ability', 'develop', 'primarily', 'treatment', 'disease'], ['follow', 'positive', 'development', 'observe_previous', 'clinical', 'study', 'very', 'good', 'safety_profile', 'now', 'also', 'able', 'verify', 'see', 'dose', 'dependent', 'increase', 'substance', 'cerebrospinal', 'fluid', 'very', 'important', 'brain', 'target', 'organ', 'result', 'bode', 'well', 'future', 'effect', 'study', 'say', 'project', 'leader'], ['positive', 'datum', 'further', 'strengthen', 'continued', 'clinical', 'development', 'base', 'new', 'mechanism_action', 'great', 'potential', 'symptom', 'relief', 'memory', 'enhance', 'effect', 'disease', 'cognitive_impairment', 'such', 'say'], ['abstract', 'write', 'program', 'director', 'alzecure'], ['abstract', 'poster', 'available', 'alzecure', 'website', 'en', 'presentation', 'interviews'], ['more', 'information', 'contact'], ['martinjonsson'], ['publ'], ['swedish', 'pharmaceutical', 'company', 'develop', 'new', 'innovative', 'small_molecule', 'drug', 'therapy', 'treatment', 'severe', 'disease', 'condition', 'affect', 'central_nervous_system', 'such', 'disease', 'pain', 'indication', 'currently', 'available', 'treatment', 'very', 'limited', 'company', 'list', 'growth', 'market', 'develop', 'several', 'parallel', 'drug_candidate', 'base', 'research', 'platform', 'alzstatin', 'consist', 'symptomatic', 'drug_candidate', 'where', 'unique', 'mechanism_action', 'allow', 'multiple', 'indication', 'include', 'disease', 'as_well', 'cognitive', 'disorder', 'associate', 'traumatic', 'brain', 'injury', 'sleep', 'disease', 'platform', 'focus', 'develop', 'disease', 'modify', 'preventive', 'drug_candidate', 'early', 'treatment', 'disease', 'comprise', 'drug_candidate', 'painless', 'company', 'research', 'platform', 'field', 'pain', 'contain', 'project', 'drug_candidate', 'clinical', 'development', 'phase', 'treatment', 'neuropathic_pain', 'target', 'other', 'type', 'severe', 'pain', 'condition', 'such', 'osteoarthritis', 'alzecure', 'aim', 'pursue', 'own', 'project', 'preclinical', 'research', 'development', 'early', 'clinical', 'phase', 'continually', 'work', 'business', 'development', 'find', 'suitable', 'solution', 'license_agreement', 'other', 'pharmaceutical', 'company', 'info', 'fncase', 'company', 'certify', 'adviser', 'more_information_visit'], ['platform', 'symptom', 'relieve', 'drug_candidate', 'cognitive', 'ability', 'impair', 'stimulate', 'several', 'important', 'signal', 'pathway', 'brain', 'other_thing', 'lead', 'improved', 'cognition', 'preclinical', 'study', 'able', 'show', 'drug_candidate', 'enhance', 'communication', 'nerve', 'cell', 'improve', 'cognitive', 'ability', 'neurorestore', 'stimulate', 'specific', 'signal', 'pathway', 'central_nervous_system', 'know', 'neurotrophin', 'most', 'well', 'know', 'being', 'ngf', 'nerve', 'growth', 'factor', 'bdnf', 'brain', 'derive', 'neurotrophic', 'factor', 'level', 'ngf', 'bdnf', 'disturb', 'several', 'disease', 'state', 'signaling', 'reduce', 'impaired', 'function', 'impair', 'communication', 'synapsis', 'contact', 'surface', 'nerve', 'ending', 'as_well', 'reduce', 'possibility', 'survival', 'nerve', 'cell', 'give', 'rise', 'cognitive_impairment', 'neurotrophin', 'play', 'crucial', 'role', 'function', 'nerve', 'cell', 'disturbed', 'function', 'bdnf', 'strong', 'genetic', 'link', 'impair', 'cognitive', 'ability', 'several', 'different', 'disease', 'such', 'injury', 'sleep', 'disorder', 'also', 'link', 'bdnf', 'signaling', 'depression', 'further', 'strengthen', 'recent', 'year'], ['disease', 'most_common', 'form', 'dementia', 'affect_approximately', 'people', 'worldwide', 'disease', 'lethal', 'disorder', 'also', 'large', 'impact', 'relative', 'society', 'today', 'preventive', 'disease', 'modifying', 'treatment', 'miss', 'main', 'risk_factor', 'develop', 'age', 'genetic', 'cause', 'even', 'disease', 'start', 'as_early', 'year', 'age', 'most_common', 'year', 'significant', 'investment', 'research', 'make', 'significant', 'unmet_medical_need', 'large', 'cost', 'disease', 'healthcare', 'society', 'total', 'global', 'cost', 'dementia', 'relate', 'disease', 'estimate', 'usd', 'globally', 'give', 'lack', 'effective', 'symptomatic', 'treatment', 'disease', 'modifying', 'treatment', 'need', 'new', 'effective', 'therapy', 'acutethe', 'few', 'approve', 'drug', 'market', 'today', 'only', 'limit', 'symptomatic', 'effect', 'produce', 'dose', 'limit', 'side_effect', 'disease', 'modify', 'treatment', 'disease', 'estimate', 'reach', 'more', 'annual', 'sale', 'approximately', 'people', 'suffer', 'disease', 'healthcare', 'cost', 'about', 'sek', 'yearly', 'more', 'cancer', 'cardiovascular', 'disease', 'combine'], ['image', 'attachment'], [], ['source', 'pharma'], ['source_version', 'alzecure', 'present', 'new', 'clinical', 'data', 'neurorestore', 'acd', 'at', 'alzheimer', 'conference', 'aaic'], ['biomegrante', 'new', 'crispr', 'phage'], ['company', 'clinical_stage', 'biotechnology', 'company', 'develop', 'crispr', 'base', 'precision_medicine', 'announce_today', 'grant', 'patent', 'number', 'patent', 'trademark', 'uspto', 'further', 'strengthen', 'intellectual_property', 'portfolio', 'now', 'contain', 'more', 'grant', 'patent', 'edit', 'prokaryote', 'use'], ['exclusive', 'worldwide', 'right', 'patent', 'estate', 'medical', 'application', 'support', 'company', 'pipeline', 'lead', 'program', 'crispr', 'arm', 'bacteriophage', 'cocktail', 'target', 'prevention', 'antibiotic', 'resistant', 'coli', 'infection', 'hematological', 'cancer', 'patient', 'experimental', 'medicine', 'currently', 'clinical_trial', 'first', 'company', 'orally', 'dose', 'human', 'crispr', 'therapeutic', 'snipr', 'grant_fast', 'track_designation', 'develop', 'collaboration', 'non', 'profit', 'organization'], ['new', 'patent', 'cover', 'lytic', 'phage', 'arm', 'gene_editing', 'system', 'crispr', 'phage', 'lysis', 'target', 'bacteria', 'potent', 'combination', 'therapeutic', 'patent', 'include', 'use', 'crispr', 'system', 'example', 'cas', 'other', 'nuclease', 'broad', 'application', 'include', 'targeting', 'bacteria', 'medical', 'use'], ['develop', 'technology_platform', 'use', 'precisely', 'target', 'edit', 'prokaryote', 'harm', 'patient', 'cell', 'new', 'patent', 'add', 'company', 'extensive', 'patent', 'estate', 'protect', 'technology', 'include', 'grant', 'patent', 'number', 'fundamental', 'scope', 'protect', 'fast', 'durable', 'action', 'crispr', 'target', 'coli', 'patent', 'uphold', 'several', 'time', 'uspto', 're', 'examination', 'proceeding', 'instigate', 'third_party'], ['co_founder', 'ceo', 'very_pleased', 'uspto', 'grant', 'new', 'patent', 'recognize', 'thecontinue', 'pioneer', 'work', 'snipr', 'scientist', 'innovator', 'editing', 'prokaryotesour', 'broad', 'patent', 'estate', 'underpin', 'clinical', 'development', 'program', 'focus', 'develop', 'crispr', 'base', 'medicine', 'benefit', 'patientssuffere', 'life_threaten', 'disease'], ['end'], [], ['clinical_stage', 'company', 'develop', 'precision_medicine', 'vulnerable', 'patient', 'difficult', 'treat', 'condition', 'pioneer', 'novel', 'use', 'technology', 'well', 'treat', 'prevent', 'human', 'disease', 'precision', 'killing', 'bacteria', 'gene', 'leader', 'area', 'science', 'clinical_trial', 'underway', 'strong', 'ip', 'diverse', 'experienced', 'team', 'first', 'company', 'orally', 'dose', 'human', 'crispr', 'therapeutic', 'first', 'company', 'grant', 'patent', 'use', 'crispr', 'target', 'microbiome', 'addition', 'develop', 'platform', 'use', 'crispr', 'technology', 'achieve', 'gut', 'direct', 'gene', 'therapy', 'headquarter', 'more', 'detail', 'visit', 'follow_twitter'], [], ['research', 'report', 'communication', 'support', 'funding', 'project', 'sponsor', 'other', 'transaction', 'agreement', 'number', 'award', 'wellcome', 'content', 'solely', 'responsibility', 'author', 'necessarily', 'represent', 'official', 'view', 'funder'], [], ['combat', 'antibiotic', 'resistant', 'bacteria', 'accelerator', 'global', 'non', 'profit', 'partnership', 'dedicate', 'accelerate', 'early', 'development', 'antibacterial', 'address', 'rise', 'global', 'threat', 'drug', 'resistant', 'bacteria', 'lead', 'funding', 'provide', 'biomedical', 'advanced', 'research', 'development', 'part', 'office', 'assistant', 'secretary', 'preparedness', 'response', 'human', 'service', 'wellcome', 'global', 'charity', 'work', 'improve', 'health', 'research', 'social', 'care', 'kind', 'support', 'infectious_disease', 'part', 'support', 'world', 'large', 'most', 'innovative', 'pipeline', 'preclinical', 'early_stage', 'development', 'product', 'antibiotic', 'resistant', 'infection', 'headquarter', 'law', 'more', 'information', 'view', 'fact', 'sheet', 'first', 'year', 'annual_report', 'visit', 'follow_twitter', 'carb_x'], ['co_founder', 'ceo', 'mail', 'cg', 'sniprbiomecom', 'mobile', 'follow'], ['tel', 'snipr', 'consilium', 'commscom'], ['announce', 'hold', 'conference_call', 'would', 'pm', 'discuss', 'financial', 'result', 'second_quarter_end', 'financial', 'result', 'report', 'press_release', 'close', 'regular', 'stock', 'market', 'trading', 'hour', 'same', 'day', 'conference_call'], ['chromadex', 'investor_relation', 'contact', 'vice_president', 'finance', 'investor_relation', 'ext', 'briannag', 'chromadexcom'], ['chromadex', 'contact', 'director', 'medium', 'relation', 'ext'], ['source'], ['view_news', 'release', 'online'], ['saint', 'guibert', 'belgium', 'nyxh', 'company', 'medical', 'technology', 'company', 'focus', 'development', 'innovative', 'solution', 'treat', 'obstructive', 'sleep', 'apnea', 'today_announce', 'company', 'enter', 'distribution', 'agreement', 'acurable', 'venture', 'back', 'medical', 'device', 'company', 'develop', 'wearable', 'technology', 'home', 'use', 'provide', 'acupebble', 'home', 'sleep', 'test', 'osa', 'patient'], ['acupebble', 'next_generation', 'wearable', 'home', 'sleep', 'test', 'use', 'acoustic', 'signal', 'diagnose', 'osa', 'patient', 'attach', 'reusable', 'acupebble', 'sensor', 'base', 'neck', 'record', 'sound', 'generate', 'respiratory', 'cardiac', 'function', 'record', 'signal', 'uploaded', 'secure', 'cloud', 'platform', 'smartphone', 'application', 'where', 'patent', 'algorithm', 'extract', 'osa', 'parameter', 'provide', 'automate', 'diagnostic', 'report', 'minute', 'acupebble', 'demonstrate', 'high_level', 'sensitivity', 'specificity', 'hypopnea', 'index', 'oxygen', 'desaturation', 'index', 'compare', 'gold', 'standard', 'polygraphy', 'test', 'clinically', 'validate', 'randomized', 'study', 'publish', 'bmj', 'open', 'system', 'ce', 'mark', 'clearance'], ['acupebble', 'genio', 'nyxoah', 'now', 'offer', 'patient', 'clinician', 'most', 'cut_edge', 'home', 'sleep', 'diagnosis', 'treatment', 'solution', 'comment', 'taelman', 'chief_executive_officer', 'acurable', 'partnership', 'align', 'perfectly', 'patient', 'first', 'mission', 'statement', 'comfort', 'ease', 'use', 'accuracy', 'break', 'barrier', 'osa', 'diagnosis', 'allow', 'more', 'patient', 'receive', 'treatment', 'condition', 'look_forward', 'launch', 'acupebble', 'fourth_quarter'], ['delighted', 'enter', 'highly', 'synergistic', 'collaboration', 'osa', 'technology', 'leader', 'mission', 'align', 'our', 'provide', 'access', 'treatment', 'as', 'many', 'osa', 'patient', 'possible', 'comment', 'pereira', 'co', 'chief_executive_officer', 'acupebble', 'design', 'significantly', 'more', 'patient', 'practitioner', 'friendly', 'polygraphy', 'polysomnography', 'test', 'enable', 'only', 'ease', 'diagnosis', 'also', 'ability', 'patient', 'routinely', 'monitor', 'condition', 'empower', 'patient', 'take', 'great', 'control', 'osa', 'acupebble', 'important', 'new', 'tool', 'improve', 'life', 'suffer', 'debilitate', 'condition'], ['medical', 'technology', 'company', 'focus', 'development', 'innovative', 'solution', 'treat', 'obstructive', 'sleep', 'apnea', 'lead', 'genio', 'system', 'patient', 'center', 'leadless', 'battery', 'free', 'therapy', 'most_common', 'sleep', 'disorder', 'breathing', 'condition', 'associate', 'increase', 'mortality', 'risk', 'cardiovascular', 'comorbiditie', 'drive', 'vision', 'patient', 'enjoy', 'restful', 'night', 'feel', 'enable', 'live', 'life', 'full'], ['follow', 'successful', 'completion', 'blast', 'osa', 'study', 'genio', 'system', 'receive', 'mark', 'complete', 'successful', 'ipos', 'euronext', 'follow', 'positive', 'outcome', 'well', 'sleep', 'study', 'receive', 'approval', 'expansion', 'therapeutic', 'indication', 'complete', 'concentric', 'collapse', 'ccc', 'patient', 'currently', 'contraindicate', 'competitor', 'therapy', 'additionally', 'company', 'currently', 'conduct', 'dream', 'ide', 'pivotal', 'study', 'approval'], ['more_information_visit'], ['caution', 'mark', 'investigational', 'device', 'limit', 'federal', 'law', 'investigational', 'use'], ['contact', 'chief', 'financial', 'officer'], ['corporate_communication'], ['investor', 'stephenmckeon', 'cslcomau'], [], ['pfister', 'irf', 'reputationch'], ['corporate_communication', 'external', 'relation', 'media', 'viforpharmacom'], ['source'], ['view_news', 'release', 'online', 'news'], ['company', 'pleased', 'provide', 'financial', 'result', 'three', 'month', 'period', 'end', 'filing', 'additional', 'information', 'regard', 'available', 'review', 'sedar', 'wwwsedarcom'], ['fiscal', 'financial', 'highlight', 'amount', 'canadian', 'dollar', 'otherwise', 'stated'], ['significant', 'corporate', 'development', 'subsequent', 'end', 'quarter', 'include'], ['believe', 'result', 'demonstrate', 'strength', 'platform', 'challenging', 'time', 'look_forward', 'rest', 'year', 'see', 'great', 'opportunity', 'new', 'product', 'development', 'cosmetic', 'food', 'nutraceutical', 'also', 'anticipate', 'see', 'significant', 'growth', 'enter', 'next', 'phase', 'become', 'first', 'regulated', 'cbd', 'market', 'addition', 'positive', 'outlook', 'core', 'business', 'continue', 'extend', 'service', 'new', 'area', 'such', 'medical', 'device', 'believe', 'subsidiary', 'mining', 'solution', 'poise', 'deliver', 'next_generation', 'lab', 'datum', 'solution', 'mining', 'company', 'say_chief_executive_officer'], [], ['global', 'platform', 'offer', 'integrate', 'suite', 'service', 'assist', 'company', 'product', 'development', 'service', 'include', 'product', 'formulation', 'safety', 'assessment', 'analytical', 'microbiological', 'testing', 'global', 'compliance', 'consumer', 'evaluation', 'offer', 'company', 'range', 'multinational', 'startup', 'particularly', 'cosmetic', 'food', 'wellness', 'industry', 'garner', 'significant', 'expertise', 'development', 'regulatory_approval', 'topical', 'edible', 'cannabis', 'product', 'include', 'preparation', 'support', 'novel', 'food', 'authorization'], ['head', 'locate'], ['further', 'information', 'contact'], ['email', 'investors', 'britannialife'], ['company', 'acquire', 'adsl', 'only', 'begin', 'consolidate', 'financial', 'result', 'time', 'provide', 'comparison', 'financial', 'result', 'prior_period', 'misleading', 'reader'], ['view', 'source_version', 'press_release', 'visit'], ['helenrubinstein', 'sagerxcom'], [], ['source'], ['view_news', 'release', 'online', 'news'], ['medium_contact'], ['advocacy'], ['investor_contact', 'eschli'], ['source', 'genentech'], ['view_news', 'release', 'online', 'news_home'], ['pharmadrug', 'company', 'specialty', 'pharmaceutical', 'company', 'focus', 'research', 'development', 'control', 'substance', 'natural', 'medicine', 'such', 'psychedelic', 'naturally', 'derive', 'approve', 'drug', 'pleased', 'announce', 'raise', 'sale', 'debenture', 'unit', 'unit', 'unit', 'comprise', 'principal', 'amount', 'convertible', 'secured', 'debenture', 'debenture', 'common_share', 'purchase', 'warrant', 'warrant'], ['debenture', 'bear', 'interest', 'rate', 'payable', 'monthly', 'arrear', 'mature', 'year', 'date', 'issue', 'convertible', 'common_share', 'price', 'debenture', 'secure', 'general', 'security', 'agreement', 'company', 'wholly_own', 'subsidiary', 'subscriber', 'entitle', 'closing', 'fee', 'amount', 'aggregate', 'subscription', 'price', 'fee', 'pay', 'way', 'set', 'unit', 'purchase', 'price', 'company', 'agree', 'proceed', 'realize', 'sale', 'consideration', 'receive', 'sale', 'pharmadrug', 'pay', 'holder', 'debenture', 'such', 'time', 'debenture', 'repay', 'previously', 'announce', 'press_release', 'date', 'company', 'agree', 'sell', 'security', 'pharmadrug', 'production', 'gmbh', 'consideration', 'consist', 'common_share', 'capital', 'non', 'interest', 'bear', 'promissory', 'note', 'principal', 'amount', 'note', 'payable', 'year', 'date', 'issue', 'debenture', 'mean', 'serve', 'bridge', 'financing', 'such', 'time', 'transaction', 'close', 'monetize', 'share', 'debenture', 'sale', 'schedule', 'close', 'week'], ['warrant', 'entitle', 'holder', 'acquire', 'common_share', 'price', 'share', 'subject', 'adjustment', 'period', 'year', 'follow', 'issuance', 'thereof', 'net', 'proceed', 'offering', 'use', 'work', 'capital', 'purpose'], ['company', 'also', 'announce_today', 'issue', 'common_share', 'holder', 'convertible', 'debenture', 'agree', 'payment', 'delay', 'current', 'interest', 'payment', 'due', 'month', 'common_share', 'satisfaction', 'outstanding', 'payable', 'share', 'issue', 'deemed', 'price'], ['receive', 'common_share', 'issue', 'satisfaction', 'penalty', 'issuance', 'therefore', 'constitute', 'related', 'party', 'transaction', 'applicable', 'security_law', 'company', 'rely', 'exemption', 'section', 'issuer', 'list', 'specify', 'market', 'fair', 'market', 'value', 'more', 'cent', 'market', 'capitalization', 'multilateral', 'instrument'], ['company', 'believe', 'payment', 'penalty', 'alleviate', 'cash', 'constraint', 'good', 'interest', 'company', 'independent', 'member', 'board_director', 'company', 'review', 'approve', 'term', 'payment'], [], ['specialty', 'pharmaceutical', 'company', 'focus', 'research', 'development', 'control', 'substance', 'natural', 'medicine', 'such', 'psychedelic', 'cannabi', 'naturally', 'derive', 'approve', 'drug', 'own', 'pharmadrug', 'production', 'gmbh', 'pharmadrug', 'production', 'german', 'medical', 'cannabis', 'distributor', 'schedule', 'license', 'german', 'eugmp', 'certification', 'allow', 'importation', 'distribution', 'medical', 'cannabi', 'pharmacy', 'own', 'sairiyo', 'biotech', 'company', 'specialize', 'research', 'reformulate', 'establish', 'natural', 'medicine', 'goal_bring', 'clinical_trial', 'associate', 'regulatory_approval', 'process', 'currently', 'develop', 'patented', 'reformulation', 'cepharanthine', 'drug', 'show', 'substantial', 'third_party', 'validate', 'potential', 'treatment', 'infectious_disease', 'rare', 'cancer', 'sairiyo', 'also', 'conduct', 'psychedelic', 'space', 'treatment', 'non', 'condition', 'company', 'also', 'own', 'smart', 'company', 'build', 'vertically', 'integrate', 'retail', 'business', 'goal', 'elevate', 'use', 'functional', 'mushroom', 'natural', 'base', 'medicine'], [], ['caution', 'regard_forward_look', 'information'], ['exchange', 'review', 'accept', 'responsibility', 'adequacy', 'accuracy', 'release'], ['press_release_contain', 'forward_look', 'information', 'meaning', 'applicable', 'security', 'legislation', 'statement', 'other', 'statement_historical_fact', 'include', 'forward_look', 'information', 'generally', 'forward_look', 'information', 'identify', 'use', 'forward_look', 'terminology', 'such', 'plan', 'expect', 'expect', 'propose', 'expect', 'budget', 'schedule', 'estimate', 'forecast', 'intend', 'anticipate', 'anticipate', 'believe', 'variation', 'such', 'word', 'phrase', 'use', 'word', 'phrase', 'state', 'certain', 'action', 'event', 'result', 'occur', 'achieve', 'particular', 'press_release_contain', 'forward_look', 'information', 'relation', 'use', 'proceed', 'private', 'placement', 'sale', 'pharmadrug', 'development', 'business', 'forward_look', 'information', 'reflect', 'company', 'current', 'belief', 'base', 'information', 'currently', 'available', 'company', 'assumption', 'company', 'believe', 'reasonable_assumption', 'include', 'limit', 'ability', 'company', 'successfully', 'market', 'offering', 'execute', 'plan', 'company', 'affiliated', 'entity', 'ability_obtain', 'require', 'regulatory_approval', 'company', 'continue', 'response', 'ability', 'navigate', 'pandemic', 'consistent', 'well', 'ability', 'response', 'date'], ['forward_look', 'information', 'subject', 'known', 'unknown', 'risk_uncertainty', 'other', 'factor_cause_actual', 'result', 'level', 'activity', 'performance_achievement', 'company', 'materially_different', 'express_imply', 'such_forward_look', 'information', 'such', 'risk', 'other', 'factor', 'include', 'limit', 'general', 'business', 'economic', 'competitive', 'political', 'social', 'uncertainty', 'general', 'capital', 'market', 'condition', 'market', 'price', 'security', 'actual', 'result', 'company', 'future', 'operation', 'competition', 'change', 'legislation', 'affect', 'company', 'ability_obtain', 'maintain', 'required', 'permit', 'approval', 'timing', 'availability', 'external', 'financing', 'acceptable', 'term', 'lack', 'qualified', 'skilled', 'labour', 'loss', 'key', 'individual', 'risk', 'relate', 'pandemic', 'include', 'various', 'recommendation', 'order', 'measure', 'governmental', 'authority', 'try', 'limit', 'pandemic', 'include', 'travel', 'restriction', 'border', 'closure', 'non', 'essential', 'business', 'closure', 'service', 'disruption', 'quarantine', 'self', 'isolation', 'shelter', 'place', 'social', 'distancing', 'disruption', 'market', 'economic', 'activity', 'financing', 'supply_chain', 'sale', 'channel', 'deterioration', 'general_economic', 'condition', 'deterioration', 'financial', 'market', 'limit', 'company', 'ability_obtain', 'external', 'financing'], ['description', 'additional', 'risk_factor', 'cause_actual_result_differ', 'materially', 'forward_look', 'information', 'find', 'company', 'disclosure', 'document', 'sedar', 'website', 'wwwsedarcom', 'company', 'attempt', 'identify', 'important_factor', 'cause_actual_result_differ', 'materially', 'contain_forward_look', 'information', 'other', 'factor', 'cause', 'result', 'as', 'anticipate', 'estimate', 'intend', 'accordingly', 'reader', 'place_undue_reliance', 'forward_look', 'information', 'reader', 'caution', 'foregoing', 'list', 'factor', 'exhaustive', 'reader', 'further', 'caution_place_undue_reliance', 'forward_look', 'information', 'assurance', 'plan', 'intention', 'expectation', 'place', 'occur', 'such', 'information', 'consider', 'reasonable', 'management', 'time', 'preparation', 'prove', 'incorrect', 'actual_result_differ', 'materially', 'anticipate'], ['company', 'security', 'register', 'amend', 'applicable', 'state', 'security_law', 'offer', 'sell', 'account', 'benefit', 'person', 'person', 'such', 'term', 'define', 'regulation', 'registration', 'applicable', 'exemption', 'such', 'registration', 'requirement', 'press_release', 'constitute', 'offer', 'sell', 'solicitation', 'offer', 'buy', 'sale', 'security', 'jurisdiction', 'such', 'offer', 'solicitation', 'sale', 'unlawful'], ['forward_look', 'information_contain_press', 'release', 'expressly', 'qualified', 'cautionary', 'statement', 'forward_look', 'information_contain_press', 'release', 'represent', 'expectation', 'company', 'date_press_release', 'accordingly', 'subject', 'change', 'such', 'date', 'however', 'company', 'expressly', 'disclaim', 'intention', 'obligation_update', 'revise_forward_look', 'information', 'result', 'new', 'information', 'future', 'event', 'otherwise', 'as', 'expressly', 'require_applicable', 'security_law'], ['view', 'source_version', 'press_release', 'visit'], ['implement', 'center', 'prevention', 'diagnosis', 'code', 'accurately', 'identify', 'patient', 'support', 'care', 'research', 'effort'], ['pharme', 'group', 'pharme', 'company', 'announce', 'new', 'diagnosis', 'code', 'report', 'case', 'activate', 'delta', 'syndrome', 'rare', 'primary', 'add', 'international', 'classification', 'disease', 'th', 'revision', 'clinical', 'modification', 'diagnosis', 'activate', 'delta', 'syndrome', 'effective', 'start'], ['chief_medical_officer', 'pharme', 'comment'], ['assign', 'code', 'formally', 'recognize', 'discrete', 'immunological', 'disease', 'make', 'life', 'alter', 'difference', 'people', 'affect', 'condition', 'use', 'unique', 'diagnostic', 'code', 'identify', 'establish', 'new', 'patient', 'increase', 'care', 'option', 'affected', 'individual', 'help', 'boost', 'world', 'understanding', 'prevalence', 'mechanism', 'outcome', 'progressively', 'debilitate', 'disease', 'healthcare', 'practitioner', 'milestone', 'mark', 'opportunity', 'make', 'big', 'difference', 'take', 'simple', 'action'], ['assignment', 'code', 'will', 'first', 'time', 'enable', 'physician', 'payor', 'add', 'diagnosis', 'patient', 'health', 'record', 'help', 'connect', 'individual', 'researcher', 'study', 'prevalence', 'course', 'disease', 'addition', 'allocate', 'specific', 'diagnosis', 'new', 'code', 'help', 'confirm', 'medical', 'necessity', 'individual', 'patient', 'thus', 'improve', 'access', 'relevant', 'care', 'option', 'health', 'insurance', 'plan'], ['cause', 'genetic_variant', 'affect_approximately', 'people', 'cause', 'significant', 'immune', 'dysfunction', 'as_well', 'increase', 'risk', 'lymphoma', 'approve', 'therapy', 'disease', 'treatment', 'generally', 'limit', 'supportive', 'care', 'such_antibiotic', 'replacement', 'physician', 'patient', 'advocacy', 'group', 'specialize', 'disorder', 'pharme', 'expect', 'decision', 'raise', 'awareness', 'rare', 'disease'], ['co_founder', 'comment'], ['excited', 'regulatory_authority', 'assign', 'code', 'foundation', 'dedicate', 'early', 'diagnosis', 'meaningful', 'treatment', 'cure', 'primary', 'aware', 'physical', 'emotional', 'challenge', 'people', 'face', 'misdiagnosis', 'disease', 'increase', 'recognition', 'condition', 'expect', 'new', 'diagnostic', 'code', 'help', 'ensure', 'patient', 'include', 'when', 'come', 'delivery', 'appropriate', 'meaningful', 'treatment'], ['activate', 'syndrome'], ['rare', 'primary', 'affect_approximately', 'people', 'also', 'know', 'pasli', 'cause', 'variant', 'gene', 'regulate', 'maturation', 'white', 'blood', 'cell', 'variant', 'gene', 'lead', 'hyperactivity', 'pi', 'kÎ´', 'delta', 'pathway', 'balance', 'signal', 'essential', 'physiological', 'immune', 'function', 'when', 'pathway', 'hyperactive', 'immune', 'cell', 'fail', 'mature', 'function_properly', 'lead', 'dysregulation', 'characterize', 'severe', 'recurrent', 'sinopulmonary', 'infection', 'autoimmunity', 'enteropathy', 'symptom', 'associate', 'variety', 'condition', 'include', 'other', 'primary', 'people', 'frequently', 'misdiagnose', 'suffer', 'median', 'diagnostic', 'delay', 'progressive', 'disease', 'delay', 'lead', 'accumulation', 'damage', 'time', 'include', 'permanent', 'lung_damage', 'lymphoma', 'only', 'way', 'definitively', 'diagnose', 'condition', 'genetic', 'testing'], ['pharme', 'group'], ['pharme', 'group', 'global', 'company', 'dedicate', 'transform_life', 'patient', 'rare', 'debilitating', 'life_threaten', 'disease', 'pharme', 'commercialize', 'develop', 'innovative', 'portfolio', 'protein', 'replacement', 'therapy', 'precision_medicine', 'include', 'small_molecule', 'biologic', 'gene', 'therapy', 'early', 'late_stage', 'development', 'pharming', 'headquarter', 'leiden', 'employee', 'globe', 'serve', 'patient', 'market'], ['more_information_visit', 'wwwpharmingcom'], [], ['establish', 'memory', 'son', 'die', 'age', 'complication', 'primary', 'pi', 'genetic', 'condition', 'chronic', 'serious', 'often', 'fatal', 'global', 'nonprofit', 'organization', 'dedicate', 'early', 'diagnosis', 'meaningful', 'treatment', 'ultimately', 'cure', 'research', 'physician', 'education', 'public', 'awareness', 'advocacy', 'patient', 'support', 'newborn', 'screening', 'genetic', 'sequencing', 'more_information_visit'], ['press_release_contain', 'forward_look_statement', 'include', 'respect', 'timing_progress', 'pharme', 'preclinical', 'study', 'clinical_trial', 'product_candidate', 'pharme', 'clinical', 'commercial', 'prospect', 'pharme', 'ability', 'overcome', 'challenge', 'pose', 'pandemic', 'conduct', 'business', 'pharme', 'expectation_regard', 'project', 'work', 'capital', 'requirement', 'cash', 'resource', 'statement', 'subject', 'number_risk_uncertainty', 'assumption', 'include', 'limit', 'scope', 'progress', 'expansion', 'pharming', 'clinical_trial', 'ramification', 'cost', 'thereof', 'clinical', 'scientific', 'regulatory', 'technical', 'development', 'light', 'risk_uncertainty', 'other', 'risk_uncertainty', 'describe', 'pharme', 'annual_report', 'annual_report_form', 'year', 'end', 'file', 'event_circumstance', 'discuss', 'such_forward_look', 'statement', 'occur', 'pharme', 'actual_result_differ', 'materially_adversely', 'anticipate', 'imply', 'thereby', 'forward_look_statement', 'speak_only', 'date_press_release', 'base', 'information', 'available', 'pharme', 'date', 'release'], ['inside', 'information'], ['press_release', 'relate', 'disclosure', 'information', 'qualify', 'qualify', 'inside', 'information', 'meaning', 'article', 'market', 'abuse', 'regulation'], ['immunol', 'nune', 'uzel', 'coulter', 'maccari', 'front', 'immunol'], ['logo'], ['view_original_content_download', 'multimedia_news', 'release', 'pharming', 'announce', 'new', 'icd', 'cm', 'code', 'rare', 'primary'], ['source', 'pharme', 'group'], ['company', 'code', 'pharm', 'na', 'pharm', 'ric'], ['independent', 'testing', 'perform', 'innovacell', 'demonstrate', 'dermaprecise', 'control', 'lead', 'unparalleled', 'post', 'injection', 'cell', 'survival', 'viability', 'consistency'], ['repcf', 'tsxv', 'rp', 'fra', 'company', 'company', 'develop', 'next_generation', 'technology', 'aesthetic', 'orthopedic', 'announce_today', 'receive', 'test', 'result', 'show', 'cell', 'inject', 'dermaprecise', 'injector', 'maintain', 'viability'], ['innovacell', 'cell', 'therapy', 'company', 'headquarter', 'manufacturing', 'facility', 'test', 'dermaprecise', 'injection', 'system', 'measure', 'loss', 'cell', 'cell', 'viability', 'when', 'inject', 'system', 'study', 'result', 'show', 'consistent', 'cell', 'viability', 'when', 'cell', 'inject', 'dermaprecise', 'injection', 'system', 'equally', 'important', 'relate', 'clinical', 'practice', 'cell', 'remain', 'viable', 'device', 'minute', 'cell', 'inject', 'dermaprecise', 'injector', 'still', 'maintain', 'viability', 'simple', 'pre', 'injection', 'rotation', 'injector', 'wand', 'reverse', 'sedimentation'], ['alternative', 'dermal', 'injection', 'system', 'manual', 'thus', 'inherently', 'inconsistent', 'involve', 'injection', 'force', 'harmful', 'cell', 'traditional', 'manual', 'injection', 'technique', 'control', 'injection', 'variability', 'shear', 'stress', 'depth', 'dose', 'speed', 'injection', 'force', 'factor', 'know', 'influence', 'cell', 'viability', 'likely', 'impact', 'clinical', 'outcome', 'yet', 'surprisingly', 'remain', 'uncontrolled', 'many', 'clinical', 'cell', 'therapy', 'study'], ['dermaprecise', 'electronically', 'control', 'dermal', 'injector', 'highly', 'precise', 'pre', 'fixed', 'volume', 'depth', 'parameter', 'dictate', 'exact', 'consistency', 'injection', 'additionally', 'dermaprecise', 'system', 'programmable', 'ensure', 'injection', 'delivery', 'speed', 'exceed', 'shear', 'force', 'harmful', 'cell', 'factor', 'cell', 'density', 'needle', 'gauge', 'patient', 'tissue', 'density', 'furthermore', 'dermaprecise', 'inject', 'cell', 'needle', 'withdraw', 'leave', 'cell', 'behind', 'channel', 'create', 'needle', 'thus', 'additionally', 'reduce', 'amount', 'stress', 'impose', 'injected', 'cell'], ['give', 'system', 'control', 'injection', 'depth', 'injection', 'optimize', 'deliver', 'cell', 'where', 'need', 'optimal', 'clinical', 'effect', 'dermaprecise', 'thus', 'assist', 'product', 'developer', 'clinician', 'control', 'delivery', 'variability', 'influence', 'clinical', 'outcome', 'variability'], ['thing', 'always', 'believe', 'rch', 'cell', 'therapy', 'example', 'state', 'buckler', 'president', 'science', 'develop', 'own', 'right', 'dermaprecise', 'product', 'line', 'critical', 'optimize', 'treatment', 'outcome', 'consistently', 'deliver', 'cell', 'entire', 'hair', 'thin', 'region', 'scalp', 'depth', 'hair', 'follicle', 'bulb', 'exist', 'exciting', 'result', 'recent', 'study', 'do', 'monasterium', 'laboratory', 'when', 'combine', 'result', 'innovacell', 'study', 'now', 'clearly', 'show', 'ability', 'consistently', 'inject', 'Î¼l', 'volume', 'use', 'head', 'array', 'maximum', 'needle', 'travel', 'injection', 'perform', 'needle', 'withdrawal', 'image', 'attach', 'release', 'demonstrate', 'ensure', 'deposition', 'mid', 'low', 'upper', 'subcutaneous', 'fat', 'layer', 'depth', 'consistent', 'location', 'hair', 'follicle', 'bulb', 'androgenetic', 'alopecia', 'affect', 'scalp', 'believe', 'enormously', 'valuable', 'rch', 'program', 'eliminate', 'important', 'variable', 'know', 'link', 'success', 'clinical', 'outcome'], ['test', 'result', 'show', 'dermaprecise', 'potential', 'greatly', 'improve', 'consistent', 'post', 'injection', 'cell', 'viability', 'delivery', 'cell', 'inject', 'dermal', 'subcutaneous', 'tissue', 'improve', 'controllable', 'consistent', 'validate', 'cell', 'delivery', 'tool', 'require', 'optimize', 'cell', 'therapy', 'outcome', 'patient', 'company', 'develop', 'valuable', 'therapy', 'state', 'chief', 'science', 'officer'], ['study', 'design'], ['non', 'bulbar', 'dermal', 'sheath', 'cell', 'form', 'basis', 'company', 'rcs', 'rcs', 'product', 'culture', 'place', 'standard', 'injection', 'solution', 'inject', 'dermaprecise', 'injector', 'use', 'system', 'consumable', 'cell', 'collect', 'post', 'injection', 'stain', 'then', 'process', 'flow', 'cytometer', 'count', 'post', 'injection', 'cell', 'survival', 'rate'], ['market', 'demand', 'control', 'delivery', 'system'], ['publication', 'nature', 'medicine', 'author', 'state'], ['exist', 'cell', 'delivery', 'approach', 'show', 'limited', 'success', 'numerous', 'study', 'show', 'few', 'injected', 'cell', 'persist', 'site', 'injection', 'day', 'transplantation'], ['author', 'explore', 'variety', 'reason', 'loss', 'post', 'injection', 'cell', 'viability', 'include', 'variability', 'mechanical', 'injection', 'force', 'use', 'manual', 'injector', 'damage', 'subject', 'cell', 'shear', 'force', 'when', 'injection', 'pressure', 'too', 'high', 'lack', 'focus', 'control', 'cell', 'delivery', 'protocol', 'technology', 'conclude'], ['grow', 'recognition', 'conventional', 'needle', 'base', 'cell', 'transplantation', 'tool', 'considerable', 'inadequacy', 'affect', 'clinical', 'translation'], ['integrated', 'approach', 'evaluation', 'cell', 'delivery', 'success', 'need', 'improve', 'assessment', 'delivery', 'efficacy', 'allow', 'sound', 'interpretation', 'clinical', 'result', 'improve', 'cell', 'delivery', 'tool', 'also', 'require', 'streamline', 'delivery', 'cell', 'base', 'therapeutic', 'donor', 'patient', 'compromise', 'quality', 'finally', 'pre', 'clinical', 'planning', 'testing', 'desire', 'administration', 'protocol', 'cell', 'type', 'specificity', 'essential', 'achieve', 'good', 'clinical_trial', 'design'], ['amer', 'rise', 'translational', 'consideration', 'injectable', 'cell', 'base', 'therapeutic', 'neurological', 'application', 'concept', 'progress', 'challenge', 'me', 'doi', 'pmid', 'pmcid', 'article'], [], ['found', 'subsidiary', 'biotechnology', 'company', 'focus', 'develop', 'produce', 'marketing', 'cell', 'therapy', 'treat', 'fecal', 'urinary', 'incontinence', 'innovacell', 'also', 'develop', 'technology', 'isolate', 'multiplying', 'use', 'deliver', 'muscle', 'cell', 'patent', 'technology', 'already', 'grant', 'application', 'file', 'innovacell', 'aim', 'market', 'product', 'develop', 'key', 'european', 'country', 'as_well', 'goal', 'become', 'global', 'leader', 'field', 'regenerative_medicine', 'focus', 'innovative', 'personalized', 'cell', 'therapy', 'innovacell', 'also', 'perform', 'select', 'contract', 'development', 'manufacturing', 'service', 'client', 'such'], ['dermaprecise', 'injector', 'product', 'line'], ['dermaprecise', 'injector', 'platform', 'electronic', 'injection', 'system', 'bring', 'new', 'level', 'control', 'intra', 'dermal', 'subcutaneous', 'injection', 'where', 'precision', 'depth', 'dose', 'delivery', 'matter'], ['science'], ['regenerative_medicine', 'company', 'focus', 'develop', 'cell', 'therapy', 'aesthetic', 'orthopedic', 'condition', 'affect', 'company', 'believe', 'approximately', 'people', 'industrialize', 'nation', 'include', 'age', 'sun', 'damage', 'skin', 'pattern', 'baldness', 'chronic', 'tendon', 'degeneration', 'condition', 'often', 'associate', 'age', 'cause', 'deficit', 'healthy', 'cell', 'require', 'normal', 'tissue', 'healing', 'function', 'cell', 'therapy', 'product_candidate', 'base', 'innovative', 'technology', 'utilize', 'cell', 'population', 'isolate', 'patient', 'healthy', 'hair', 'follicle'], ['company', 'cell', 'therapy', 'product', 'pipeline', 'comprise', 'rct', 'repair', 'rcs', 'skin', 'rejuvenation', 'rch', 'hair', 'restoration', 'rch', 'subject', 'successful', 'safety', 'dose', 'find', 'clinical', 'study', 'now', 'subject', 'third', 'clinical', 'study', 'evaluate', 'efficacy', 'treatment', 'male', 'female', 'hair', 'loss', 'androgenetic', 'alopecia', 'ongoing', 'study', 'fund', 'shiseido', 'company', 'limit', 'pursuant', 'license_agreement', 'now', 'terminate', 'subject', 'arbitration', 'regard', 'shiseido', 'right', 'product', 'maintain', 'undisputed', 'right', 'rest', 'world', 'exclusively_license', 'great', 'company', 'currently', 'co', 'develop', 'product', 'maintain', 'right', 'product', 'great'], ['also', 'develop', 'proprietary', 'injection', 'device', 'dermaprecise', 'related', 'consumable', 'expect', 'improve', 'administration', 'cell', 'therapy', 'product', 'certain', 'other', 'injectable', 'exclusively_license', 'commercial', 'right', 'dermaprecise', 'device', 'consumable', 'great', 'dermatology', 'application', 'expect', 'first', 'launch', 'product', 'approve', 'market', 'launch', 'visit', 'replicelcom', 'additional', 'information'], ['notable', 'fact'], ['more', 'information', 'contact', 'info', 'replicelcom'], ['venture', 'exchange', 'regulation', 'service', 'provider', 'term', 'define', 'policy', 'venture', 'exchange', 'accept', 'responsibility', 'adequacy', 'accuracy', 'release'], ['source'], ['source_version', 'injection', 'system', 'show', 'produce', 'consistently', 'high', 'cell', 'count', 'viability', 'cell', 'therapy', 'injection'], ['otcqx', 'clinical_stage', 'biotech', 'company', 'dedicate', 'develop', 'first_class', 'neuroreparative', 'drug', 'treat', 'nervous_system', 'damage', 'present', 'study', 'design', 'upcoming', 'phase', 'disease', 'clinical_trial', 'nervgen', 'chief_medical_officer', 'present', 'poster', 'summarize', 'unblinded', 'datum', 'single', 'ascending', 'dose', 'cohort', 'study', 'interim', 'blind', 'datum', 'multiple', 'ascending', 'dose', 'mad', 'portion', 'study', 'first', 'time', 'introduce', 'study', 'design', 'upcoming', 'phase', 'trial', 'lead', 'drug_candidate', 'subject', 'mild', 'cognitive_impairment', 'mild', 'dementia', 'due', 'disease'], ['state', 'very', 'excited', 'share', 'trial', 'design', 'importantly', 'develop', 'substantial', 'input', 'distinguish', 'board', 'comprise', 'lead', 'physician', 'researcher', 'disease'], ['found', 'editor', 'chief', 'disease', 'semme', 'distinguish', 'university', 'chair', 'neurobiology', 'member', 'state', 'believe', 'novel', 'mechanism_action', 'demonstration', 'function', 'improvement', 'several', 'different', 'animal_model', 'nervous_system', 'damage', 'significant', 'interest', 'excited', 'play', 'part', 'test', 'drug', 'patient', 'determine', 'repair', 'mechanism', 'such', 'increase', 'plasticity', 'axonal', 'regeneration', 'remyelination', 'result', 'favorable', 'effect', 'disease', 'patient'], ['state', 'significant', 'potential', 'repair', 'damage', 'relentlessly', 'progressive', 'disease', 'give', 'unique', 'mechanism', 'believe', 'opportunity', 'see', 'change', 'image', 'biomarker', 'trial', 'design', 'give', 'good', 'opportunity', 'detect', 'efficacy', 'patient'], [], ['large', 'most', 'influential', 'international', 'meeting', 'dedicate', 'advance', 'dementia', 'science', 'year', 'aaic', 'convene', 'world', 'lead', 'basic', 'science', 'clinical', 'researcher', 'next_generation', 'investigator', 'clinician', 'care', 'research', 'community', 'share', 'research', 'discovery', 'lead', 'method', 'prevention', 'treatment', 'improvement', 'diagnosis', 'disease'], [], ['otcqx', 'clinical_stage', 'biotech', 'company', 'dedicate', 'develop', 'innovative', 'treatment', 'enable', 'nervous_system', 'repair', 'follow', 'damage', 'injury', 'disease', 'lead', 'drug_candidate', 'currently', 'phase', 'clinical_trial', 'company', 'initial', 'target', 'indication', 'injury', 'multiple', 'sclerosis', 'more', 'information', 'go', 'wwwnervgencom'], [], ['hold', 'exclusive', 'worldwide', 'right', 'develop', 'unique', 'new_class', 'drug', 'technology', 'therapeutic', 'peptide', 'mimic', 'intracellular', 'domain', 'receptor', 'protein', 'cell', 'surface', 'receptor', 'know', 'interact', 'chondroitin', 'sulfate', 'proteoglycan', 'cspgs', 'cspgs', 'show', 'inhibit', 'neural', 'repair', 'mechanism', 'follow', 'nervous_system', 'damage', 'rodent', 'form', 'show', 'promote', 'functional', 'recovery', 'enable', 'nervous_system', 'repair', 'range', 'animal_model', 'include', 'model', 'spinal', 'sclerosis', 'stroke', 'enhanced', 'plasticity', 'axonal', 'regeneration', 'remyelination'], ['tracey', 'corporate_communication'], [], ['follow', 'nervgen', 'twitter', 'facebook', 'late', 'news', 'company'], ['venture', 'exchange', 'regulation', 'service', 'provider', 'term', 'define', 'policy', 'venture', 'exchange', 'accept', 'responsibility', 'adequacy', 'accuracy', 'release'], ['cautionary', 'note_regard', 'forward_look_statement'], ['news', 'release', 'contain_forward_look', 'information', 'forward_look_statement_meaning', 'applicable', 'security', 'legislation', 'such_forward_look', 'statement', 'information', 'include', 'limit', 'company', 'current', 'future', 'plan', 'expectation', 'intention', 'result', 'level', 'activity', 'performance', 'goal', 'achievement', 'other', 'future', 'event', 'development', 'constitute_forward_look', 'statement', 'word', 'expect', 'plan', 'intend', 'trend', 'indication', 'anticipate', 'believe', 'estimate', 'predict', 'likely', 'potential', 'negative', 'other', 'variation', 'word', 'other', 'comparable', 'word', 'phrase', 'intend_identify_forward_look', 'statement', 'forward_look_statement', 'include_limitation', 'statement', 'relate', 'plan', 'present', 'unblinded', 'datum', 'sad', 'cohort', 'study', 'interim', 'blind', 'datum', 'mad', 'portion', 'phase_study', 'timing', 'objective', 'study', 'design', 'clinical', 'development', 'include', 'plan', 'phase', 'clinical_trial', 'disease', 'ongoing', 'phase_study', 'healthy', 'volunteer', 'belief', 'novel', 'mechanism_action', 'demonstration', 'function', 'improvement', 'several', 'different', 'animal_model', 'nervous_system', 'damage', 'significant', 'interest', 'disease', 'field', 'significant', 'potential', 'repair', 'damage', 'disease', 'opportunity', 'see', 'change', 'image', 'biomarker', 'trial', 'design', 'give', 'good', 'opportunity', 'detect', 'efficacy', 'disease', 'patient', 'develop', 'unique', 'new_class', 'drug', 'technology', 'timing', 'requirement', 'remove', 'partial', 'clinical', 'hold', 'initiate', 'clinical', 'development', 'sclerosis', 'spinal', 'cord', 'injury', 'belief', 'inhibit', 'activity', 'promising', 'target', 'reduce', 'clinical', 'effect', 'nervous_system', 'damage', 'multiple', 'mechanism', 'development', 'innovative', 'treatment', 'enable', 'nervous_system', 'repair', 'follow', 'damage'], ['forward_look_statement', 'base', 'estimate', 'assumption', 'make', 'company', 'light', 'management', 'experience', 'perception', 'historical', 'trend', 'current', 'condition', 'expect', 'future', 'development', 'as_well', 'other', 'factor', 'believe', 'appropriate', 'reasonable', 'circumstance', 'make', 'forward_look_statement', 'company', 'rely', 'various', 'assumption', 'include', 'limited', 'company', 'ability', 'manage', 'effect', 'pandemic', 'accuracy', 'company', 'financial', 'projection', 'company', 'obtain', 'positive', 'result', 'clinical', 'other', 'trial', 'company', 'obtain', 'necessary', 'regulatory_approval', 'general', 'business', 'market', 'economic_condition'], ['many', 'factor_cause_actual', 'result', 'level', 'activity', 'performance_achievement', 'future', 'event', 'development', 'differ_materially', 'express_imply', 'forward_look_statement', 'include_limitation', 'lack', 'revenue', 'insufficient', 'fund', 'impact', 'pandemic', 'reliance', 'key', 'personnel', 'uncertainty', 'clinical', 'development', 'process', 'competition', 'other', 'factor', 'set', 'risk_factor', 'section', 'company', 'annual', 'information', 'form', 'prospectus', 'supplement', 'financial', 'statement', 'management', 'discussion', 'analysis', 'find', 'sedarcom', 'clinical', 'development', 'plan', 'subject', 'additional', 'funding'], ['reader', 'place_undue_reliance', 'forward_look_statement', 'make', 'news', 'release', 'furthermore', 'otherwise', 'state', 'forward_look_statement', 'contain', 'news', 'release', 'make', 'date', 'news', 'release', 'intention', 'undertake_obligation', 'update_revise', 'forward_look_statement', 'result', 'new', 'information', 'future', 'event', 'otherwise', 'require_applicable', 'law', 'forward_look_statement', 'contain', 'news', 'release', 'expressly', 'qualified', 'cautionary', 'statement'], ['view', 'source_version', 'press_release', 'visit'], [], ['source', 'idrx'], ['view_news', 'release', 'online'], ['pleased', 'announce', 'tablet', 'nominate', 'good', 'pharmaceutical', 'agent'], ['first', 'only', 'contraceptive', 'pill', 'contain', 'new', 'low', 'impact', 'progestin', 'drospirenone', 'natural', 'produce', 'human', 'body', 'pregnancy', 'derive', 'plant', 'source', 'first', 'new', 'introduce', 'more', 'year'], ['prix', 'create', 'reward', 'innovative', 'treatment', 'technology', 'improve', 'human', 'health', 'see', 'influential', 'event', 'interested', 'pharmaceutical', 'development', 'widely', 'consider', 'industry', 'high', 'accolade', 'pharmaceutical', 'research', 'development'], ['ceremony', 'hold', 'award', 'prize', 'good', 'pharmaceutical', 'agent', 'good', 'biotechnology', 'product', 'good', 'medical', 'technology', 'approve', 'past', 'year', 'prix', 'comprise', 'renowned', 'leader', 'biomedical', 'industry', 'academia', 'include', 'laureate', 'responsible', 'evaluate', 'nominee'], [], ['asx', 'list', 'specialty', 'pharmaceutical', 'company', 'focus', 'commercialize', 'novel', 'generic', 'pharmaceutical', 'offer', 'patient', 'well', 'safe', 'more', 'accessible', 'medicine', 'also', 'provide', 'contract', 'development', 'manufacturing', 'service', 'client', 'worldwide', 'track_record', 'innovation', 'success', 'develop', 'new', 'oral', 'drug_delivery', 'system', 'technology', 'successfully', 'commercialise', 'numerous', 'product', 'continue', 'market', 'facility', 'base', 'expertise', 'formulation', 'complex', 'oral', 'topical', 'dose', 'form', 'include', 'potent', 'compound', 'modify', 'release', 'product', 'poorly', 'soluble', 'compound', 'maynepharmacom'], [], ['belgian', 'biotech', 'company', 'dedicate', 'transform', 'woman', 'health', 'offer', 'new', 'choice', 'innovation', 'particular', 'focus', 'contraception', 'goal', 'develop', 'product', 'offer', 'well', 'efficacy_safety', 'convenience', 'meeting', 'woman', 'need', 'life', 'span', 'explore', 'potential', 'unique', 'estetrol', 'wide_range', 'application', 'woman', 'also', 'develop', 'manufacture', 'complex', 'therapeutic', 'area', 'contraception', 'menopause', 'hormone', 'dependent', 'cancer', 'offer', 'partner', 'complete', 'spectrum', 'research', 'development', 'specialist', 'manufacturing', 'technological', 'platform', 'active', 'more', 'country', 'approximate', 'headcount', 'staff', 'member', 'headquarter'], [], ['foundation', 'foster', 'recognise', 'reward', 'excellence', 'scientific_innovation', 'improve', 'state', 'human', 'health', 'vision', 'catalyst', 'development', 'next_generation', 'innovative', 'treatment', 'technology', 'impact', 'state', 'medical', 'practice', 'save', 'live', 'foundation', 'oversee', 'direct', 'activity', 'prix', 'international', 'award', 'program', 'dedicate', 'progress', 'innovative', 'medicine', 'development', 'chapter', 'country', 'prix', 'create', 'honor', 'medical', 'science', 'modern', 'pharmacology', 'worldwide', 'prix', 'regard', 'equivalent', 'research'], [], ['develop', 'novel', 'patent', 'protect', 'combine', 'oral', 'contraceptive', 'pill', 'contain', 'drospirenone', 'naturally', 'produce', 'pregnancy', 'derive', 'plant', 'source', 'tablet', 'phase', 'clinical', 'study', 'conduct', 'woman', 'show', 'safe_effective', 'meet_primary_endpoint', 'pregnancy', 'prevention', 'also', 'deliver', 'positive', 'result', 'variety', 'secondary_endpoint', 'demonstrate', 'predictable', 'bleeding', 'pattern', 'good', 'safety_tolerability', 'as_well', 'low', 'rate', 'adverse_reaction'], ['register_trademark', 'srl', 'mithra', 'pharmaceutical', 'affiliate', 'company'], ['view_original', 'content', 'news', 'release', 'nextstellis', 'oral', 'contraceptive', 'nominate', 'the', 'prix', 'award', 'good', 'pharmaceutical'], [], ['company', 'code'], ['defence', 'company', 'canadian', 'company', 'specialize', 'development', 'immune', 'oncology', 'vaccine', 'drug_delivery', 'technology', 'pleased', 'report', 'discovery', 'novel', 'dna', 'damaging', 'function', 'trigger', 'lead', 'compound', 'effectively', 'elicit', 'cell', 'death', 'cancer', 'cell'], ['cancer', 'generally', 'describe', 'state', 'uncontrolled', 'cell', 'proliferation', 'mainly', 'due', 'loss', 'ability', 'give', 'cell', 'activate', 'own', 'cell', 'death', 'specific', 'set', 'protein', 'know', 'sense', 'unusual', 'activity', 'difficult', 'reactivate', 'specific', 'pathway', 'elicit', 'cancer', 'cell', 'death', 'address'], ['previously', 'report', 'see', 'press_release', 'discovery', 'accumtm', 'variant', 'capable', 'control', 'cancer', 'growth', 'when', 'inject', 'directly', 'tumor', 'use', 'combination', 'multiple', 'immune', 'checkpoint', 'result', 'survival', 'rate', 'base', 'pre', 'clinical', 'tumor', 'model', 'study', 'mouse', 'mode', 'action', 'approach', 'non', 'biased', 'transcriptomic', 'application', 'reveal', 'compound', 'impair', 'several', 'crucial', 'pathway', 'include', 'replication', 'cell', 'division', 'nuclear', 'integrity', 'multiple', 'modification', 'affect', 'dna', 'activity', 'accumulation', 'exhaustive', 'cell', 'repair', 'mechanism', 'trigger', 'combine', 'build', 'up', 'misfolde', 'protein', 'generation', 'free', 'radical', 'induce', 'irreversible', 'dna', 'damage', 'lead', 'general', 'collapse', 'several', 'cellular', 'pathway', 'result', 'effective', 'cancer', 'cell', 'death'], ['breakthrough', 'discovery', 'accutoxtm', 'formulation', 'novel', 'potent', 'small_molecule', 'capable', 'kill', 'cancer', 'cell', 'significant', 'advancement', 'development', 'oncology', 'cancer', 'treatment', 'application', 'discover', 'behave', 'agent', 'target', 'dna', 'cancer', 'cell', 'immune', 'checkpoint', 'inhibitor', 'booster', 'new', 'discovery', 'highly', 'valuable', 'defence', 'pipeline', 'future', 'potential', 'development', 'present', 'novel', 'discovery', 'platform', 'target', 'multiple', 'cancer', 'novel', 'discovery', 'create', 'significant', 'value', 'application', 'antibody', 'drug', 'conjugate', 'pipeline', 'result', 'convince', 'perfect', 'potent', 'small_molecule', 'use', 'development', 'own', 'adc', 'say', 'therapeutic'], ['defence', 'currently', 'conduct', 'study', 'prior', 'initiate', 'phase', 'trial'], ['defence'], ['defence', 'therapeutic', 'publicly', 'trade', 'biotechnology', 'company', 'work', 'engineer', 'next_generation', 'vaccine', 'adc', 'product', 'use', 'proprietary', 'platform', 'core', 'defence', 'therapeutic', 'platform', 'accumtm', 'technology', 'enable', 'precision', 'delivery', 'vaccine', 'antigen', 'intact', 'form', 'target', 'cell', 'result', 'increase', 'efficacy', 'potency', 'reach', 'catastrophic', 'illness', 'such', 'cancer', 'infectious_disease'], ['further', 'information'], ['cautionary', 'statement', 'regard_forward_look', 'information'], ['release', 'include', 'certain', 'statement', 'deem', 'forward_look_statement', 'statement', 'release', 'other', 'statement_historical_fact', 'address', 'event', 'development', 'company', 'expect', 'occur', 'forward_look_statement', 'forward_look_statement', 'statement_historical_fact', 'generally', 'always', 'identify_word', 'expect', 'plan', 'anticipate', 'believe', 'intend', 'estimate', 'project', 'potential', 'similar_expression', 'event', 'condition', 'occur', 'company', 'believe', 'expectation', 'express', 'such_forward_look', 'statement_base_reasonable', 'assumption', 'such', 'statement', 'guarantee', 'future', 'performance', 'actual_result_differ', 'materially', 'forward_look_statement', 'factor_cause_actual', 'result_differ', 'materially', 'forward_look_statement', 'include', 'regulatory', 'action', 'market', 'price', 'continued', 'availability', 'capital', 'financing', 'general_economic', 'market', 'business', 'condition', 'investor_caution', 'such', 'statement', 'guarantee', 'future', 'performance', 'actual', 'result', 'development', 'differ_materially', 'project', 'forward_look_statement', 'forward_look_statement', 'base', 'belief', 'estimate', 'opinion', 'company', 'management', 'date', 'statement', 'make', 'require_applicable', 'security_law', 'company', 'undertake_obligation_update', 'forward_look_statement', 'event', 'management', 'belief', 'estimate', 'opinion', 'other', 'factor', 'change'], ['cse', 'market', 'regulator', 'term', 'define', 'policy', 'cse', 'accept', 'responsibility', 'adequacy', 'accuracy', 'release'], ['view', 'source_version', 'press_release', 'visit'], ['clinical_stage', 'immunotherapy', 'company', 'develop', 'grow', 'pipeline', 'target', 'cancer', 'immunotherapy', 'infectious_disease', 'vaccine', 'base', 'company', 'proprietary', 'versamune', 'cell', 'activate', 'technology', 'today_announce', 'management', 'participate_fireside_chat', 'meeting', 'biotechnology_conference', 'hybrid', 'event', 'take_place'], ['participate', 'live', 'event', 'schedule', 'meeting', 'management', 'contact', 'btig', 'representative'], ['biotechnology', 'clinical_stage', 'immunotherapy', 'company', 'develop', 'grow', 'pipeline', 'target', 'cancer', 'infectious_disease', 'immunotherapy', 'base', 'company', 'proprietary', 'versamune', 'cell', 'activate', 'technology_platform', 'believe', 'versamune', 'base', 'product', 'demonstrate', 'potential', 'overcome', 'limitation', 'current', 'immunotherapy', 'induce', 'vivo', 'large', 'quantity', 'high_quality', 'highly', 'potent', 'polyfunctional', 'tumor', 'cd', 'helper', 'cell', 'develop', 'multiple', 'therapy', 'base', 'combination', 'versamune', 'disease', 'specific', 'antigen', 'design', 'train', 'immune_system', 'well', 'recognize', 'diseased', 'cell', 'effectively', 'attack', 'destroy', 'company', 'continue', 'advance', 'pipeline', 'preclinical', 'clinical', 'candidate', 'address', 'wide_range', 'cancer', 'include', 'hpv', 'associated', 'cancer', 'anal', 'cervical', 'head', 'vaginal', 'lung', 'prostate', 'ovarian_cancer'], ['infectimune', 'base', 'vaccine', 'demonstrate', 'potential', 'induce', 'only', 'robust', 'durable', 'neutralize', 'antibody', 'response', 'also', 'powerful', 'cell', 'response', 'include', 'long', 'last', 'memory', 'cell', 'response', 'learn_more', 'visit', 'follow_twitter'], ['register_trademark', 'trademark'], ['investor_contact'], ['phone'], ['phone', 'pdsb', 'cgcapital'], ['immuno', 'oncology', 'company', 'extensive', 'pipeline', 'therapeutic', 'design', 'activate', 'immune_response', 'cancer', 'infection', 'today_announce', 'company', 'attend', 'btig', 'biotechnology_conference', 'participate', 'virtually', 'host', 'meeting', 'investor', 'follow', 'second_quarter', 'corporate', 'update', 'morning'], ['clinical_stage', 'immuno', 'oncology', 'company', 'focus', 'discovery', 'development', 'therapy', 'engage', 'body', 'immune_system', 'fight', 'cancer', 'infection', 'company', 'vision', 'expand', 'patient', 'population', 'benefit', 'cancer', 'immunotherapy', 'pursue', 'combination', 'approach', 'leverage', 'broad', 'repertoire', 'antibody', 'therapeutic', 'adoptive', 'cell', 'therapy', 'subsidiary', 'mink', 'therapeutic', 'adjuvant', 'subsidiary', 'saponiqx', 'company', 'equip', 'suite', 'antibody', 'discovery', 'platform', 'state_art', 'gmp', 'manufacturing', 'facility', 'capacity', 'support', 'clinical', 'program', 'headquarter', 'more_information_visit', 'wwwagenusbiocom', 'twitter', 'handle', 'information', 'important', 'investor', 'routinely', 'post', 'website', 'twitter'], ['chief', 'corporate', 'affair', 'officer'], ['clinical_stage', 'company', 'pioneer', 'discovery', 'development', 'allogeneic', 'shelf', 'invariant', 'natural', 'killer', 'cell', 'therapy', 'treat', 'cancer', 'other', 'immune', 'mediate', 'disease', 'announce', 'company', 'attend', 'btig', 'biotechnology_conference', 'mink', 'participate', 'virtually', 'host', 'meeting', 'investor', 'th', 'th'], ['therapeutic', 'clinical_stage', 'company', 'pioneer', 'discovery', 'development', 'allogeneic', 'cell', 'therapy', 'treat', 'cancer', 'other', 'immune', 'mediate', 'disease', 'mink', 'advance', 'pipeline', 'native', 'next_generation', 'engineer', 'inkt', 'program', 'platform', 'design_facilitate', 'scalable', 'reproducible', 'manufacturing', 'shelf', 'delivery', 'company', 'headquarter', 'more_information_visit'], [], ['advisor'], [], [], ['company', 'specialty', 'pharmaceutical', 'company', 'focus', 'development', 'novel', 'treatment', 'rare', 'central_nervous_system', 'lysosomal', 'storage', 'disease', 'today_announce', 'executive_chairman', 'present', 'annual', 'growth', 'conference', 'hold'], ['detail', 'regard', 'presentation', 'follow'], ['management', 'available', 'meeting', 'register', 'attendee', 'live_webcast', 'presentation', 'available', 'event', 'investor_relation', 'section', 'company', 'website'], [], ['specialty', 'pharmaceutical', 'company', 'focus', 'development', 'novel', 'treatment', 'rare', 'central_nervous_system', 'lysosomal', 'storage', 'disease', 'diverse', 'product', 'portfolio', 'combine', 'clinical_stage', 'development', 'pipeline', 'revenue', 'generate', 'nda', 'stage', 'commercial', 'asset', 'pipeline', 'include', 'orally', 'deliver', 'first_class', 'treatment', 'pick', 'disease', 'type', 'company', 'develop', 'treatment', 'idiopathic', 'rare', 'neurological', 'sleep', 'disorder', 'narcolepsy', 'addition', 'food', 'approve', 'once_daily', 'treatment', 'patient', 'age_year_old', 'contain', 'commercialize', 'immediate', 'release', 'combination', 'product', 'contain', 'commercialize', 'more', 'information', 'pipeline', 'product_candidate', 'visit', 'wwwkempharmcom', 'connect', 'twitter'], ['contact'], [], ['company', 'focus', 'develop_commercialize', 'novel', 'cancer', 'therapeutic', 'target', 'dna', 'damage', 'response', 'pathway', 'today_announce', 'chief_executive_officer', 'participate', 'panel_discussion', 'synthetic', 'lethality', 'conference', 'pm', 'panel_discussion', 'host', 'senior', 'pacgrow', 'lifescience'], [], ['company', 'headquarter', 'research', 'facility', 'doylestown', 'focus', 'develop_commercialize', 'novel', 'cancer', 'therapeutic', 'target', 'damage', 'response', 'pathway', 'company', 'lead', 'program', 'phase', 'small_molecule', 'inhibitor', 'develop', 'solid_tumor', 'indication', 'more_information_visit', 'company', 'website', 'wwwapreacom'], ['company', 'use', 'intend', 'use', 'investor_relation', 'website', 'means', 'disclose', 'material', 'nonpublic', 'information', 'comply', 'disclosure', 'obligation', 'regulation'], ['forward_look_statement'], ['certain', 'information_contain_press', 'release', 'include', 'forward_look_statement_meaning', 'section', 'amend', 'section', 'amend', 'related', 'study', 'analysis', 'clinical_trial', 'regulatory_submission', 'project', 'cash', 'position', 'case', 'use', 'term', 'such', 'future', 'predict', 'believe', 'potential', 'continue', 'anticipate', 'estimate', 'expect', 'plan', 'intend', 'target', 'confidence', 'likely', 'other', 'word', 'convey', 'uncertainty', 'future', 'event', 'outcome', 'identify', 'forward_look_statement', 'forward_look_statement', 'base', 'current', 'belief', 'expectation', 'management', 'team', 'involve', 'risk', 'potential', 'change', 'circumstance', 'assumption', 'uncertainty', 'forward_look_statement', 'turn', 'wrong', 'affect', 'inaccurate', 'assumption', 'make', 'know_unknown', 'risk_uncertainty', 'forward_look_statement', 'subject', 'risk_uncertainty', 'include', 'risk', 'relate', 'success', 'timing', 'clinical_trial', 'other', 'study', 'risk_associate', 'other', 'risk', 'set_forth', 'filing', 'reason', 'actual', 'result', 'development', 'materially_different', 'express_imply', 'forward_look_statement', 'caution_place_undue_reliance', 'forward_look_statement', 'make', 'only_date', 'press_release', 'undertake_obligation', 'publicly_update', 'such_forward_look', 'statement', 'reflect', 'subsequent', 'event_circumstance'], ['source'], ['corporate', 'contact'], ['vice_president', 'chief', 'financial', 'officer'], ['gregory', 'vice_president', 'chief', 'operating', 'officer'], ['innovative', 'pharmaceutical', 'company', 'focus', 'develop_commercialize', 'treatment', 'rare', 'disease', 'today_announce', 'report_second_quarter', 'financial', 'result', 'management', 'host_conference_call', 'live_audio', 'webcast', 'discuss', 'result', 'pm', 'pm', 'ct'], ['addition', 'take', 'live', 'question', 'participant', 'conference_call', 'management', 'answer', 'email', 'question', 'investor', 'investor', 'email', 'question', 'live_webcast', 'access', 'investor_section', 'website', 'conference_call', 'access', 'dial', 'domestic', 'international', 'refer', 'conference', 'would', 'archive_webcast', 'available', 'website', 'approximately', 'hour', 'completion', 'event', 'day', 'thereafter'], ['innovative', 'pharmaceutical', 'company', 'focus', 'develop_commercialize', 'treatment', 'rare', 'disease', 'company', 'currently', 'commercialize', 'carglumic', 'acid', 'tablet', 'additional', 'rare', 'disease', 'product', 'development', 'dehydrate', 'alcohol', 'injection', 'autoinjector', 'addition', 'company', 'royalty', 'segment', 'entitle', 'receive', 'milestone_payment', 'royalty', 'different', 'product'], ['investor_contact'], ['clinical_stage', 'company', 'develop', 'proprietary', 'antibody', 'base', 'therapeutic', 'treat', 'cancer', 'today_announce', 'present', 'conference', 'take_place', 'virtually'], ['date'], ['time'], ['wedbush', 'cmpx'], ['virtual', 'replay', 'availability', 'presentation', 'archive', 'day', 'compass', 'event_page'], ['clinical_stage', 'oncology', 'focus', 'company', 'develop', 'proprietary', 'antibody', 'base', 'therapeutic', 'treat', 'multiple', 'human', 'disease', 'compass', 'scientific', 'focus', 'relationship', 'angiogenesis', 'immune_system', 'tumor', 'growth', 'company', 'pipeline', 'novel', 'product_candidate', 'design', 'target', 'multiple', 'critical', 'biological', 'pathway', 'require', 'effective', 'anti', 'tumor', 'response', 'include', 'modulation', 'angiogenesis', 'target', 'agent', 'induction', 'potent', 'immune_response', 'activator', 'effector', 'cell', 'tumor', 'alleviation', 'mechanism', 'use', 'tumor', 'evade', 'immune', 'surveillance', 'compass', 'plan', 'advance', 'product_candidate', 'clinical', 'development', 'standalone', 'therapy', 'combination', 'proprietary', 'pipeline', 'antibody', 'base', 'supportive', 'clinical', 'nonclinical', 'datum', 'company', 'found', 'headquarter', 'more_information_visit', 'compass', 'therapeutic', 'website'], ['forward_look_statement', 'press_release_contain', 'forward_look_statement', 'statement', 'press_release', 'purely', 'historical', 'forward_look_statement', 'such_forward_look', 'statement', 'include_other_thing', 'reference', 'company', 'financial', 'position', 'continue', 'advance', 'product_candidate', 'expectation', 'company', 'cash_runway', 'business', 'development', 'plan', 'statement', 'regard', 'company', 'product_candidate', 'development', 'regulatory', 'plan', 'respect', 'thereto', 'therapeutic', 'potential', 'thereof', 'plan', 'interaction', 'regulatory_authority', 'plan', 'clinical', 'development', 'actual_result_differ', 'project', 'forward_look_statement', 'due', 'numerous', 'factor', 'such', 'factor', 'include', 'other', 'company', 'ability', 'raise', 'additional', 'funding', 'need', 'continue', 'pursue', 'business', 'product', 'development', 'plan', 'inherent', 'uncertainty', 'associate', 'develop', 'product_candidate', 'operate', 'development', 'stage', 'company', 'company', 'ability', 'identify', 'additional', 'product_candidate', 'development', 'company', 'ability', 'develop', 'complete', 'clinical_trial', 'obtain_approval_commercialize', 'product_candidate', 'competition', 'industry', 'company', 'operate', 'market', 'condition', 'forward_look_statement', 'make', 'date_press_release', 'company', 'assume', 'obligation_update_forward_look', 'statement', 'update', 'reason', 'why', 'actual_result_differ', 'project', 'forward_look_statement', 'require_law', 'investor', 'consult', 'information', 'set', 'also', 'refer', 'risk_factor', 'disclosure', 'set_forth', 'report', 'other', 'document_file', 'available', 'include_limitation', 'form', 'year', 'end', 'subsequent_filing'], ['investor', 'executive', 'director', 'head', 'investor_relation'], ['manager'], ['commercial', 'stage', 'pharmaceutical', 'company', 'develop', 'transformative', 'therapy', 'people', 'suffer', 'disease', 'high_unmet', 'medical', 'need', 'initial', 'focus', 'central_nervous_system', 'today_announce', 'chairman', 'chief_executive_officer', 'financial', 'business', 'officer', 'participate_fireside_chat', 'hold', 'virtually', 'pm'], ['live_webcast', 'event', 'available', 'investor_section', 'impel', 'pharmaceutical', 'website', 'replay', 'presentation', 'available', 'website', 'day'], ['pharmaceutical', 'pharmaceutical', 'commercial', 'stage', 'pharmaceutical', 'company', 'develop', 'transformative', 'therapy', 'people', 'suffer', 'disease', 'high_unmet', 'medical', 'need', 'initial', 'focus', 'disease', 'central_nervous_system', 'offer', 'develop', 'treatment', 'pair', 'proprietary', 'pod', 'technology', 'well', 'establish', 'therapeutic', 'addition', 'spray', 'approve', 'acute', 'treatment', 'migraine', 'aura', 'adult', 'impel', 'also', 'develop', 'acute', 'treatment', 'agitation', 'aggression', 'patient', 'autism'], ['additional', 'information_visit'], ['medium', 'relation', 'relation', 'phone', 'email'], ['investor', 'investor_relation', 'phone', 'email'], ['intra', 'cellular', 'company', 'focus', 'development', 'therapeutic', 'central_nervous_system', 'disorder', 'today_announce', 'host_conference_call', 'live_webcast', 'discussion', 'eastern_time', 'provide', 'corporate', 'update', 'discuss', 'detail', 'company', 'financial', 'result', 'quarter_end'], ['access', 'live', 'conference_call', 'phone_dial', 'international', 'dial', 'number'], ['live', 'archived', 'webcast', 'access', 'event', 'presentation', 'investor_relation', 'section', 'company', 'website', 'log', 'approximately', 'minute_prior', 'event', 'register', 'download', 'install', 'necessary', 'software'], ['intra', 'cellular', 'therapy', 'intra', 'cellular', 'therapy', 'company', 'found', 'win', 'research', 'allow', 'understand', 'how', 'therapy', 'affect', 'inner', 'working', 'cell', 'body', 'company', 'leverage', 'intracellular', 'approach', 'develop', 'innovative', 'treatment', 'people', 'live', 'complex', 'psychiatric', 'neurologic', 'disease'], ['contact', 'cellular', 'vice', 'corporate_communication', 'investor_relation'], [], ['clinical_stage', 'biotechnology', 'company', 'develop', 'novel', 'medicine', 'design', 'bring', 'curative', 'power', 'stem', 'cell', 'transplant', 'more', 'patient', 'today_announce', 'company', 'participate', 'gene', 'modulation', 'panel_discussion', 'hold', 'virtually', 'th', 'am'], ['live_webcast', 'panel', 'access', 'website', 'event', 'presentation', 'replay', 'available', 'day', 'follow', 'event'], ['clinical_stage', 'biotechnology', 'company', 'develop', 'medicine', 'design', 'bring', 'curative', 'power', 'stem', 'cell', 'transplant', 'more', 'patient', 'blood', 'cancer', 'genetic', 'disease', 'autoimmune', 'disease', 'combine', 'leadership', 'stem', 'cell', 'biology', 'biotherapeutic', 'development', 'clinical', 'regulatory', 'expertise', 'revolutionize', 'immune', 'blood', 'reset', 'allow', 'more', 'patient', 'take', 'advantage', 'curative', 'potential', 'stem', 'cell', 'transplant', 'as_well', 'potentially', 'improve', 'eligibility', 'future', 'gene', 'therapy'], ['base', 'mass', 'more_information_visit'], ['contact', 'real', 'chemistry', 'advisor', 'jbertotti'], ['company', 'today_announce', 'report', 'financial', 'result', 'quarter_end', 'close', 'financial', 'market', 'announcement', 'follow', 'conference_call_webcast', 'investment', 'community', 'am', 'participate', 'call', 'chairman', 'chief', 'financial', 'officer', 'sue', 'chief', 'commerical', 'officer'], ['access', 'live_webcast', 'update', 'use', 'following', 'link'], ['startherejspei', 'tp_key'], [], ['commercial', 'stage', 'company', 'focus', 'development', 'novel', 'antibody', 'base', 'therapeutic', 'cancer', 'product', 'addition', 'conventional', 'antibody', 'company', 'technology', 'include', 'bispecific_antibody', 'generate', 'use', 'biclone', 'platform', 'platform', 'company', 'broad', 'advanced', 'product', 'pipeline', 'include', 'approve', 'product', 'danyelza', 'target', 'tumor', 'express', 'gd', 'product_candidate', 'registration', 'stage', 'omburtamab', 'target', 'tumor', 'express'], ['statement', 'press_release', 'future', 'expectation', 'plan', 'prospect', 'as_well', 'other', 'statement', 'regard', 'matter', 'historical_fact', 'constitute_forward_look', 'statement_meaning', 'private_security', 'such', 'statement', 'include', 'limit', 'statement', 'business', 'model', 'development', 'product', 'distribution', 'plan', 'current', 'future', 'clinical', 'pre', 'clinical', 'study', 'research', 'development', 'program', 'expectation', 'relate', 'timing', 'initiation_completion', 'regulatory_submission', 'regulatory', 'marketing', 'reimbursement', 'approval', 'rate', 'degree', 'market', 'acceptance', 'clinical', 'utility', 'as_well', 'pricing', 'reimbursement', 'level', 'retain', 'hire', 'key', 'employee', 'marketing', 'manufacturing_capability', 'strategy', 'intellectual_property', 'position', 'strategy', 'additional', 'product_candidate', 'technology', 'collaboration', 'strategic', 'partnership', 'potential', 'benefit', 'thereof', 'expectation', 'relate', 'use', 'cash_cash_equivalent', 'need', 'timing', 'amount', 'future', 'financing', 'transaction', 'financial_performance', 'include', 'estimate', 'regard', 'revenue_expense', 'capital_expenditure', 'requirement', 'development', 'relate', 'competitor', 'industry', 'other', 'statement_historical_fact', 'word', 'such', 'anticipate', 'believe', 'contemplate', 'continue', 'estimate', 'expect', 'intend', 'plan', 'potential', 'predict', 'project', 'target', 'similar_expression_intend_identify', 'forward_look_statement', 'forward_look_statement', 'contain', 'identify_word', 'product_candidate', 'related', 'technology', 'novel', 'approach', 'cancer', 'treatment', 'present', 'significant', 'challenge', 'actual_result_differ', 'materially_indicate_such', 'forward_look_statement', 'result', 'various', 'factor', 'include', 'limited', 'risk_associate', 'financial', 'condition', 'need', 'additional', 'capital', 'risk_associate', 'development', 'work', 'cost', 'success', 'product', 'development', 'activity', 'clinical_trial', 'risk', 'delay', 'timing', 'regulatory_submission', 'failure', 'receive', 'approval', 'drug_candidate', 'risk', 'relate', 'commercialize', 'approve', 'pharmaceutical', 'product', 'include', 'rate', 'degree', 'market', 'acceptance', 'product_candidate', 'development', 'sale', 'marketing', 'capability', 'risk_associate', 'failure', 'obtain', 'sufficient', 'reimbursement', 'product', 'risk', 'relate', 'dependence', 'third_party', 'include', 'conduct', 'clinical', 'testing', 'product', 'manufacture', 'inability', 'enter', 'partnership', 'risk', 'relate', 'government', 'regulation', 'risk', 'relate', 'market', 'approval', 'risk_associate', 'protection', 'intellectual_property', 'right', 'risk', 'relate', 'employee', 'matter', 'manage', 'growth', 'risk', 'relate', 'common_stock', 'risk_associate', 'pandemic', 'risk_associate', 'conflict', 'sanction', 'relate', 'thereto', 'macroeconomic', 'condition', 'include', 'inflation', 'global', 'capital', 'market', 'other', 'risk_uncertainty', 'affect', 'company', 'include', 'describe', 'risk_factor', 'section', 'include', 'annual_report_form', 'year', 'end', 'file', 'other', 'filing', 'forward_look_statement', 'contain_press_release', 'speak_only', 'date_hereof', 'company', 'undertake_obligation_update', 'forward_look_statement', 'result', 'new', 'information', 'future', 'event', 'otherwise', 'require_law'], ['omblastys', 'register_trademark'], ['park'], [], ['mail'], ['yten', 'yield', 'company', 'agricultural', 'bioscience', 'company', 'today_announce', 'company', 'report_second_quarter', 'financial', 'result', 'provide', 'corporate', 'update'], ['management', 'host_conference_call', 'pm', 'review', 'financial', 'result', 'share', 'corporate', 'highlight', 'provide', 'overall', 'business', 'update', 'follow', 'management', 'formal', 'remark', 'question', 'answer', 'session'], ['listen', 'conference_call', 'interested', 'party', 'call', 'international_caller', 'call', 'call', 'also', 'available', 'live_webcast', 'reference', 'slide', 'deck', 'access', 'investor_relation', 'section', 'company', 'website'], ['replay', 'call', 'available', 'approximately', 'hour', 'end', 'call', 'replay', 'access', 'company', 'website', 'investor_relation', 'event_page', 'dial', 'toll', 'free', 'international'], [], ['agricultural', 'bioscience', 'company', 'use', 'differentiated', 'trait', 'gene', 'discovery', 'platform', 'develop', 'improve', 'variety', 'produce', 'proprietary', 'seed', 'product', 'discover', 'high', 'value', 'genetic', 'trait', 'agriculture', 'food', 'industry', 'goal', 'efficiently', 'establish', 'high', 'value', 'seed', 'product', 'business', 'base', 'develop', 'superior', 'variety', 'produce', 'feedstock', 'oil', 'nutritional', 'oil', 'bioplastic', 'license', 'yield', 'trait', 'major', 'seed', 'company', 'major', 'row', 'crop', 'include', 'corn', 'soybean', 'yield', 'headquarter', 'oilseed', 'center', 'excellence'], ['more', 'information', 'company', 'visit', 'follow', 'company', 'twitter'], ['yten'], ['contact', 'lbrum', 'yield', 'biocom'], ['investor_relation', 'brets', 'coreircom', 'manage', 'director', 'core'], ['medium', 'inquiry'], ['dare', 'leader', 'woman', 'health', 'innovation', 'today_announce', 'host_conference_call', 'live_webcast', 'pm', 'eastern_time', 'review', 'financial', 'result', 'quarter_end', 'provide', 'company', 'update'], ['access', 'conference_call', 'phone_dial', 'international', 'conference', 'would', 'number', 'call', 'live_webcast', 'access', 'presentation', 'event', 'investor_section', 'company', 'website', 'log', 'approximately', 'minute_prior', 'call', 'register', 'download', 'install', 'necessary', 'software', 'access', 'replay', 'call', 'international', 'conference', 'would', 'number', 'replay', 'call_webcast', 'replay', 'available'], ['bioscience'], ['company', 'commit', 'advance', 'innovative', 'product', 'woman', 'health', 'company', 'mission', 'identify', 'develop', 'bring', 'market', 'diverse', 'portfolio', 'differentiated', 'therapy', 'prioritize', 'woman', 'health', 'well', 'expand', 'treatment_option', 'improve', 'outcome', 'primarily', 'area', 'contraception', 'fertility', 'vaginal', 'sexual', 'health'], ['approve', 'product', 'vaginal', 'gel', 'lincosamide', 'antibacterial', 'indicate', 'treatment', 'bacterial', 'vaginosis', 'female', 'patient', 'year', 'age_old', 'global', 'license_agreement', 'clear', 'colorless', 'viscous', 'gel', 'administer', 'once', 'intravaginally', 'single_dose', 'portfolio', 'also', 'include', 'potential', 'first', 'category', 'candidate', 'clinical', 'development', 'ovaprene', 'novel', 'hormone', 'free', 'monthly', 'contraceptive', 'commercial', 'right', 'license_agreement', 'bayer', 'cream', 'novel', 'cream', 'formulation', 'treat', 'female', 'sexual', 'arousal', 'disorder', 'utilize', 'active', 'ingredient', 'viagra', 'dare', 'hrt', 'combination', 'bio', 'identical', 'estradiol', 'progesterone', 'intravaginal', 'ring', 'hormone', 'therapy', 'follow', 'menopause', 'learn_more', 'full', 'portfolio', 'woman', 'health', 'product_candidate', 'mission', 'deliver', 'differentiated', 'therapy', 'woman', 'visit'], ['announce', 'material', 'information', 'finance', 'product', 'product_candidate', 'clinical_trial', 'other', 'matter', 'use', 'investor_section', 'website', 'filing', 'press_release', 'public', 'conference_call_webcast', 'dare', 'use', 'channel', 'distribute', 'material', 'information', 'company', 'also', 'use', 'social_medium', 'communicate', 'important', 'information', 'company', 'finance', 'product', 'product_candidate', 'clinical_trial', 'other', 'matter', 'information', 'dare', 'post', 'investor_relation', 'website', 'social_medium', 'channel', 'deem', 'material', 'information', 'dare', 'encourage', 'investor_medium', 'other', 'interested', 'company', 'review', 'information', 'dare', 'post', 'investor_section', 'website', 'follow_twitter', 'account', 'darebioscience', 'update', 'list', 'social_medium', 'channel', 'company', 'use', 'communicate', 'information', 'post', 'investor_section', 'website'], ['investor'], ['medium', 'behalf'], ['source'], ['conference_call_webcast', 'hold'], ['developer', 'prevention', 'stent', 'system', 'device', 'treatment', 'artery', 'disease', 'announce_today', 'report_second_quarter', 'financial', 'result', 'th', 'financial', 'market', 'open'], ['management', 'host_conference_call_webcast', 'investment', 'community', 'am', 'same', 'day', 'review', 'financial', 'result', 'provide', 'update', 'corporate', 'development'], ['access', 'minute_prior', 'conference_call', 'start', 'time', 'replay', 'webcast', 'available', 'follow', 'conclusion', 'live', 'broadcast', 'accessible', 'company', 'website'], [], ['seek', 'utilize', 'proprietary', 'micronet', 'technology', 'make', 'product', 'industry', 'standard', 'carotid', 'stente', 'provide', 'outstanding', 'acute', 'result', 'durable', 'stroke', 'free', 'long_term', 'outcome'], ['press_release_contain', 'forward_look_statement', 'such', 'statement', 'precede', 'word', 'intend', 'plan', 'expect', 'anticipate', 'project', 'predict', 'estimate', 'aim', 'believe', 'hope', 'potential', 'schedule', 'similar', 'word', 'forward_look_statement', 'guarantee', 'future', 'performance', 'base', 'certain', 'assumption', 'subject', 'various', 'know_unknown', 'risk_uncertainty', 'many', 'company', 'control', 'can', 'predict', 'quantify', 'consequently', 'actual_result_differ', 'materially_express_imply_such', 'forward_look_statement', 'example', 'company', 'use', 'forward_look_statement', 'when', 'discuss', 'expansion', 'portfolio', 'potential', 'indication', 'cguard', 'provide', 'foundational', 'advantage', 'improved', 'patient', 'outcome', 'prevention', 'stroke', 'such', 'risk_uncertainty', 'include_limitation', 'risk_uncertainty', 'associate', 'market', 'acceptance', 'existing', 'new', 'product', 'negative', 'clinical_trial', 'result', 'lengthy', 'product', 'delay', 'key', 'market', 'inability', 'secure', 'regulatory_approval', 'sale', 'product', 'intense', 'competition', 'medical', 'device', 'industry', 'much', 'large', 'multinational', 'company', 'product', 'liability', 'claim', 'product', 'malfunction', 'limited', 'manufacturing_capability', 'reliance', 'subcontractor', 'assistance', 'insufficient', 'inadequate', 'reimbursement', 'governmental', 'other', 'third_party', 'payer', 'product', 'effort', 'successfully', 'obtain_maintain', 'intellectual_property', 'protection', 'cover', 'product', 'successful', 'legislative', 'regulatory', 'reform', 'healthcare', 'system', 'foreign', 'jurisdiction', 'reliance', 'single', 'supplier', 'certain', 'product', 'component', 'fact', 'need', 'raise', 'additional', 'capital', 'meet', 'business', 'requirement', 'future', 'such', 'capital', 'raising', 'costly', 'dilutive', 'difficult', 'obtain', 'fact', 'conduct', 'business', 'multiple', 'foreign', 'jurisdiction', 'expose', 'foreign_currency_exchange_rate', 'fluctuation', 'logistical', 'communication', 'challenge', 'burden', 'cost', 'compliance', 'foreign', 'law', 'political_economic', 'instability', 'jurisdiction', 'more', 'detailed', 'information', 'company', 'risk_factor', 'affect', 'realization', 'forward_look_statement', 'set_forth', 'company', 'filing', 'include', 'company', 'annual_report_form', 'quarterly_report_form', 'investor', 'security', 'holder', 'urge', 'read', 'document', 'free', 'charge', 'web', 'site', 'company', 'assume', 'obligation', 'publicly_update', 'revise_forward_look', 'statement', 'result', 'new', 'information', 'future', 'event', 'otherwise'], ['investor_contact', 'chief', 'financial'], ['director', 'investor', 'relations', 'inspiremdcom'], ['clinical_stage', 'biotechnology', 'company', 'focus', 'discover_develop', 'novel', 'therapeutic', 'treatment', 'today_announce', 'chief_executive_officer', 'participate', 'panel_discussion', 'biotechnology_conference'], ['live', 'replay', 'session', 'panel_discussion', 'available', 'conference', 'registrant', 'biotechnology_conference', 'portal'], [], ['pliant', 'clinical_stage', 'company', 'focus', 'discover_develop', 'novel', 'therapy', 'treatment', 'lead', 'product_candidate', 'pln', 'oral', 'small_molecule', 'dual', 'selective_inhibitor', 'integrin', 'development', 'lead', 'indication', 'treatment', 'idiopathic_pulmonary_fibrosis', 'primary', 'sclerosing', 'cholangitis', 'pln', 'receive', 'fast_track_designation', 'orphan_drug', 'designation', 'psc', 'drug', 'designation', 'currently', 'conduct', 'phase', 'trial', 'pln', 'lead', 'indication', 'ipf', 'psc', 'also', 'develop', 'pln', 'small_molecule', 'selective_inhibitor', 'treatment', 'liver', 'fibrosis', 'transfer', 'novartis', 'pursuant', 'development', 'partnership', 'addition', 'clinical_stage', 'program', 'pliant', 'currently', 'preclinical', 'program', 'target', 'oncology', 'muscular_dystrophy', 'additional', 'information', 'pliant', 'therapeutic', 'visit', 'wwwpliantrxcom', 'follow_twitter'], ['investor_medium', 'contact'], ['vice', 'investor_relation', 'corporate_communication'], ['acquire', 'company', 'focus', 'transform', 'medicine', 'transform_life', 'announce_today', 'host_conference_call', 'live_webcast', 'am', 'provide', 'corporate', 'update', 'discuss', 'company', 'financial', 'result', 'second_quarter_end'], ['access', 'conference_call', 'investor', 'invite', 'dial_international', 'when', 'join', 'call', 'ask', 'join', 'pharmaceutical', 'call', 'live_audio', 'webcast', 'access', 'visit', 'investor_relation', 'section', 'company', 'website', 'wwwavadelcom', 'replay', 'webcast_archive', 'website', 'day', 'follow', 'event'], ['company', 'focus', 'transform', 'medicine', 'transform', 'live', 'approach', 'include', 'apply', 'innovative', 'solution', 'development', 'medication', 'address', 'challenge', 'patient', 'face', 'current', 'treatment_option', 'current', 'lead', 'drug_candidate', 'lumryz', 'investigational', 'formulation', 'sodium', 'oxybate', 'leverage', 'proprietary', 'drug_delivery', 'technology', 'design', 'take', 'once', 'bedtime', 'treatment', 'eds', 'cataplexy', 'adult', 'narcolepsy', 'more_information_visit', 'wwwavadelcom'], ['investor_contact'], ['medium_contact', 'greig', 'real', 'chemistry'], ['global', 'clinical_stage', 'biotechnology', 'company', 'focus', 'development', 'conditionally', 'active', 'antibody', 'therapeutic', 'treatment', 'solid_tumor', 'today_announce', 'plan', 'host_conference_call_webcast', 'pm', 'discuss', 'financial', 'result', 'quarter_end', 'provide', 'business', 'highlight'], ['conference_call_webcast', 'information', 'date', 'time', 'pm', 'bioatla', 'second_quarter', 'earning', 'conference_call', 'dial', 'number', 'domestic', 'international', 'would'], ['press_release', 'financial', 'result', 'accessible', 'prior', 'conference_call', 'news', 'release', 'news', 'event', 'section', 'company', 'website', 'replay', 'call', 'also', 'available', 'event', 'presentation', 'investor_section', 'company', 'website'], ['global', 'clinical_stage', 'biotechnology', 'company', 'operation', 'contractual', 'relationship', 'provider', 'preclinical', 'development', 'service', 'utilize', 'proprietary', 'conditionally', 'active', 'biologic', 'technology', 'develop', 'novel', 'reversibly', 'active', 'monoclonal_antibody', 'other', 'protein', 'therapeutic', 'product_candidate', 'cab', 'product_candidate', 'design', 'more', 'selective', 'target', 'great', 'efficacy', 'low', 'toxicity', 'more', 'cost', 'efficient', 'predictable', 'manufacturing', 'traditional', 'antibody', 'bioatla', 'extensive', 'worldwide', 'patent', 'coverage', 'cab', 'technology', 'product', 'more', 'patent', 'include', 'issue', 'broad', 'patent', 'coverage', 'major', 'market', 'include', 'method', 'make', 'screening', 'manufacture', 'cab', 'product_candidate', 'wide_range', 'format', 'composition', 'matter', 'coverage', 'specific', 'product', 'bioatla', 'first_class', 'cab', 'program', 'currently', 'phase', 'clinical', 'testing', 'vedotin', 'novel', 'conditionally', 'active', 'axl', 'target', 'antibody', 'drug', 'conjugate', 'adc', 'ozuriftamab', 'vedotin', 'novel', 'conditionally', 'active', 'ror', 'targeted', 'antibody', 'drug', 'conjugate', 'addition', 'company', 'advance', 'phase', 'cab', 'antibody', 'novel', 'inhibitor', 'design', 'reduce', 'systemic', 'toxicity', 'potentially', 'enable', 'safe', 'combination', 'therapy', 'checkpoint', 'inhibitor', 'such', 'anti', 'pd', 'antibody', 'learn_more'], ['internal', 'contact', 'chief', 'financial'], ['external', 'contact'], ['company', 'tsx', 'company', 'focus', 'development', 'innovative', 'therapy', 'today_announce', 'levesque', 'president_chief_executive_officer', 'participate_fireside_chat', 'annual', 'growth', 'conference', 'pm'], ['live_webcast', 'event', 'access', 'here', 'investor_relation', 'section', 'company', 'website', 'event', 'archive', 'also', 'available', 'day', 'follow', 'conference'], [], ['tsx', 'company', 'focus', 'development', 'innovative', 'therapy', 'address_unmet', 'medical', 'need', 'further', 'information', 'available', 'company', 'website', 'edgar'], ['clinical_stage', 'company', 'focus', 'develop', 'life', 'change', 'medicine', 'patient', 'severe', 'rare', 'disease', 'cancer', 'today_announce', 'management', 'participate_fireside_chat', 'th', 'am'], ['access', 'live_webcast', 'visit', 'event', 'presentation', 'page', 'investor_medium', 'section', 'company', 'website', 'replay', 'webcast', 'available', 'springwork', 'website', 'limited', 'time', 'follow', 'conference'], ['clinical_stage', 'company', 'apply', 'precision_medicine', 'approach', 'acquire', 'develop_commercialize', 'life', 'change', 'medicine', 'patient', 'live', 'severe', 'rare', 'disease', 'cancer', 'springwork', 'differentiate', 'target', 'oncology', 'pipeline', 'span', 'solid_tumor', 'hematological', 'cancer', 'include', 'potentially', 'registrational', 'clinical_trial', 'rare', 'tumor', 'type', 'as_well', 'several', 'program', 'address', 'highly', 'prevalent', 'genetically', 'define', 'cancer', 'springwork', 'strategic', 'approach', 'operational', 'excellence', 'clinical', 'development', 'enable', 'rapidly', 'advance', 'lead', 'product_candidate', 'late_stage', 'clinical_trial', 'simultaneously', 'enter', 'multiple', 'share', 'value', 'partnership', 'innovator', 'industry', 'academia', 'unlock', 'full', 'potential', 'portfolio', 'create', 'more', 'solution', 'patient', 'cancer', 'more_information_visit', 'follow_twitter'], ['contact', 'vice', 'communication', 'investor_relation', 'phone', 'email'], ['director', 'investor_relation', 'phone', 'email'], ['second_quarter', 'net_sale', 'reflect', 'double', 'digit', 'revenue', 'increase', 'fourth', 'consecutive', 'quarter', 'company', 'continue', 'portfolio', 'product'], ['achieve', 'strong', 'year', 'year', 'revenue_growth', 'key', 'focus', 'area', 'surgical', 'recovery'], ['company', 'reaffirm', 'revenue_growth', 'outlook', 'continue', 'portfolio', 'product'], ['management', 'host_conference_call', 'am'], ['company', 'placental', 'biologic', 'company', 'today_announce', 'operate', 'financial', 'result', 'second_quarter_end'], ['chief_executive_officer', 'comment', 'continue', 'execute', 'strategy', 'deliver', 'growth', 'expand', 'market', 'innovative', 'product', 'portfolio', 'drive', 'shareholder', 'value', 'fourth', 'consecutive', 'quarter', 'achieve', 'double', 'digit', 'revenue_growth', 'continue', 'portfolio', 'product', 'include', 'strong', 'year', 'year', 'increase', 'key', 'focus', 'area', 'surgical', 'recovery', 'sale', 'professional', 'successfully', 'engage', 'broad_range', 'physician', 'specialty', 'hospital', 'surgeon', 'incorporate', 'product', 'biologically', 'enhance', 'procedure', 'where', 'patient', 'risk', 'potential', 'complication', 'delay', 'healing', 'initiate', 'limited', 'market', 'release', 'amnioeffect', 'remain', 'track', 'full', 'launch', 'third_quarter', 'amnioeffect', 'first', 'new', 'product', 'bring', 'market', 'year', 'penetrate', 'surgical', 'recovery', 'market', 'expand', 'customer', 'base', 'strengthen', 'portfolio', 'lead', 'placental', 'base', 'technology', 'provide', 'meaningful', 'benefit', 'patient'], ['continue', 'look', 'ahead', 'keenly', 'focus', 'optimize', 'value', 'placental', 'pipeline', 'asset', 'track', 'enroll', 'first', 'knee', 'osteoarthritis', 'patient', 'later', 'year', 'end', 'upcoming', 'type', 'regenerative_medicine', 'advanced', 'therapy', 'rmat', 'meeting', 'schedule', 'food', 'review', 'result', 'phase', 'clinical_trial', 'micronized', 'dehydrated', 'human', 'chorion', 'membrane', 'mdhacm', 'drug', 'propose', 'protocol', 'next', 'study', 'believe', 'mdhacm', 'platform', 'represent', 'significant', 'future', 'year', 'growth', 'opportunity', 'accomplish', 'number', 'critical', 'milestone', 'increase', 'overall', 'probability', 'successful', 'drug', 'registration'], ['recent', 'operating', 'financial', 'highlight'], ['key', 'second_quarter_financial', 'metric'], ['report', 'net_sale', 'month_end', 'compare', 'month_end', 'decrease', 'net_sale', 'second_quarter', 'include', 'section', 'product', 'compare', 'second_quarter', 'reflect', 'end', 'period', 'enforcement', 'discretion', 'company', 'no', 'long', 'able', 'market', 'section', 'product'], ['second_quarter', 'net_sale', 'company', 'continue', 'portfolio', 'tissue', 'cord', 'product', 'increase_compare', 'same_period', 'last', 'year', 'reflect', 'company', 'focus', 'application', 'product', 'area', 'surgical', 'recovery', 'as_well', 'result', 'prior', 'initiative', 'expand', 'train', 'realign', 'sale', 'team'], ['primary', 'class', 'product', 'advanced', 'wound', 'care', 'section', 'product', 'consist', 'tissue', 'cord', 'sheet', 'allograft', 'product', 'section', 'product', 'consist', 'company', 'micronize', 'particulate', 'product', 'advance', 'wound', 'care', 'further', 'disaggregate', 'company', 'tissue', 'other', 'cord', 'product', 'summary', 'company', 'revenue', 'most_recent', 'quarter', 'comparative_period', 'prior', 'year', 'include', 'revenue', 'derive', 'section', 'product', 'include', 'table', 'below', 'amount', 'thousand'], ['summary', 'company', 'year', 'date', 'revenue', 'compare', 'same_period', 'prior', 'year', 'include', 'revenue', 'derive', 'section', 'product', 'include', 'table', 'below', 'amount', 'thousand'], ['gross_profit', 'margin', 'month_end', 'compare', 'month_end'], ['sell', 'general_administrative', 'expense', 'month_end', 'compare', 'month_end', 'increase', 'reflect', 'increase', 'travel', 'expense', 'follow', 'removal', 'travel', 'relate', 'restriction', 'place', 'pandemic', 'bad', 'debt', 'expense', 'result', 'deterioration', 'credit', 'certain', 'specific', 'customer', 'inflationary', 'pressure', 'commission', 'due', 'company', 'focus', 'sale', 'product', 'area', 'surgical', 'recovery', 'result', 'proportional', 'increase', 'sale', 'sale', 'agent'], ['company', 'expense', 'negatively', 'impact', 'respectively', 'result', 'shareholder', 'activist', 'action', 'relate', 'company', 'annual_meeting', 'shareholder', 'net', 'effect', 'reduction', 'period'], ['research', 'development', 'expense', 'month_end', 'compare', 'month_end', 'increase', 'reflect', 'clinical', 'research', 'effort', 'connect', 'company', 'wound', 'care', 'surgical', 'regenerative', 'innovation', 'pipeline', 'offset', 'year', 'year', 'decrease', 'professional', 'service', 'expense', 'clinical_trial', 'expense', 'company', 'incur', 'month_end', 'close', 'analyze', 'result', 'clinical_trial'], ['investigation', 'restatement', 'related', 'expense', 'month_end', 'compare', 'benefit', 'month_end', 'prior', 'year', 'benefit', 'primarily', 'result', 'fund', 'receive', 'certain', 'director', 'officer', 'insurance', 'policy', 'as_well', 'negotiate', 'reduction', 'previously', 'recognize', 'legal', 'expense', 'advance', 'behalf', 'certain', 'former', 'member', 'management'], ['net', 'loss', 'month_end', 'compare', 'net', 'loss', 'month_end'], ['company', 'cash_cash_equivalent', 'compare', 'decrease', 'month_end', 'reflect', 'payment', 'accrue', 'compensation', 'include', 'payment', 'annual', 'employee', 'incentive', 'payment', 'payroll', 'taxis', 'defer', 'coronavirus', 'aid', 'relief', 'economic'], ['outlook', 'company', 'maintain', 'outlook', 'disclose', 'earning', 'release', 'year', 'end', 'include', 'expect', 'net_sale', 'continue', 'portfolio', 'advanced', 'wound', 'care', 'product', 'grow', 'expectation', 'reflect', 'company', 'plan', 'launch', 'amnioeffect', 'placental', 'collagen', 'matrix', 'product', 'as_well', 'launch', 'epifix', 'later', 'year'], ['conference_call', 'host_conference_call_webcast', 'review', 'second_quarter', 'result', 'begin', 'am_eastern', 'time', 'call', 'access', 'use', 'follow', 'information'], ['click_here', 'investor', 'international', 'investor', 'would'], ['replay', 'webcast', 'available', 'approximately', 'day', 'company', 'website', 'follow', 'conclusion', 'event'], ['important', 'cautionary', 'statement', 'press_release_include', 'forward_look_statement', 'statement', 'regard', 'future', 'sale', 'sale', 'growth', 'financial', 'outlook', 'expectation', 'future', 'financial', 'result', 'include', 'net_sale', 'level', 'sell', 'general_administrative', 'expense', 'expectation_regard', 'timing', 'clinical', 'program', 'trial', 'expectation_regard', 'timing', 'new', 'product', 'launch', 'effectiveness', 'amniotic', 'tissue', 'therapy', 'particular', 'indication', 'condition', 'additional', 'forward_look_statement', 'identify_word', 'such', 'believe', 'expect', 'plan', 'goal', 'potential', 'preliminary', 'similar_expression', 'base', 'management', 'current', 'belief', 'expectation'], ['forward_look_statement', 'subject', 'risk_uncertainty', 'company', 'caution', 'investor', 'place_undue_reliance', 'such', 'statement', 'actual_result_differ', 'materially', 'set_forth', 'forward_look_statement', 'factor_cause_actual', 'result_differ', 'expectation', 'include', 'future', 'sale', 'uncertain', 'affect', 'competition', 'access', 'customer', 'patient', 'access', 'healthcare_provider', 'many', 'other', 'factor', 'status', 'timing', 'result', 'expect', 'result', 'company', 'clinical_trial', 'plan', 'regulatory_submission', 'expectation_regard', 'ability', 'potentially', 'accelerate', 'timing', 'trial', 'regulatory_submission', 'depend', 'number_factor', 'include', 'favorable', 'trial', 'result', 'patient', 'access', 'ability', 'manufacture', 'accordance', 'current', 'good_manufacturing_practice', 'appropriate', 'chemistry', 'manufacturing', 'control', 'company', 'change', 'plan', 'unforeseen', 'circumstance', 'delay', 'analyze', 'auditing', 'result', 'delay', 'alter', 'timeline', 'future', 'trial', 'analysis', 'public', 'announcement', 'access', 'hospital', 'health_care', 'provider', 'facility', 'restrict', 'result', 'ongoing', 'pandemic', 'other', 'factor', 'result', 'scientific', 'research', 'uncertain', 'little', 'value', 'ability', 'sell', 'product', 'other', 'country', 'depend', 'number_factor', 'include', 'adequate', 'level', 'reimbursement', 'market', 'acceptance', 'novel', 'therapy', 'ability', 'build', 'manage', 'direct', 'sale', 'force', 'third_party', 'distribution', 'relationship', 'effectiveness', 'amniotic', 'tissue', 'therapy', 'particular', 'indication', 'condition', 'subject', 'further', 'scientific', 'clinical', 'study', 'alter', 'timing', 'amount', 'plan', 'expenditure', 'research', 'development', 'base', 'result', 'clinical_trial', 'other', 'regulatory', 'development', 'company', 'describe', 'additional', 'risk_uncertainty', 'risk_factor', 'section', 'most_recent', 'annual_report_quarterly_report', 'file', 'forward_look_statement', 'speak_only', 'date_press_release', 'company', 'assume', 'obligation_update_forward_look', 'statement'], ['placental', 'biologic', 'company', 'develop', 'distribute', 'placental', 'tissue', 'allograft', 'patent', 'protect', 'proprietary', 'process', 'multiple', 'sector', 'pioneer', 'placental', 'tissue', 'engineering', 'commercial', 'business', 'focus', 'address', 'need', 'patient', 'acute', 'chronic', 'non', 'healing', 'wound', 'promising', 'late_stage', 'pipeline', 'target', 'decrease', 'pain', 'improve', 'function', 'patient', 'degenerative', 'musculoskeletal', 'condition', 'derive', 'product', 'human', 'placental', 'tissue', 'process', 'tissue', 'use', 'proprietary', 'method', 'include', 'purion', 'process', 'employ', 'current', 'good', 'tissue', 'practice', 'current', 'good_manufacturing_practice', 'terminal', 'sterilization', 'produce', 'allograft', 'supply', 'allograft', 'direct', 'consignment', 'shipment', 'additional', 'information_visit', 'wwwmimedxcom'], ['contact', 'investor', 'investor_relation'], ['medium', 'corporate', 'strategic'], ['select', 'unaudited', 'financial', 'information'], ['condense_consolidated_balance_sheet', 'thousand_unaudited'], ['condense_consolidated_statement', 'operation', 'thousand_unaudited'], ['condense_consolidated_statement', 'cash_flow', 'thousand_unaudited'], ['reconciliation_non_gaap', 'measure'], ['addition', 'gaap', 'result', 'provide', 'certain', 'non_gaap', 'metric', 'include', 'earning', 'interest', 'taxis', 'depreciation_amortization', 'ebitda_adjust_ebitda', 'believe', 'presentation', 'measure', 'provide', 'important', 'supplemental', 'information', 'management', 'investor', 'regard', 'performance', 'measurement', 'substitute', 'gaap', 'measurement', 'company', 'management', 'use', 'non_gaap', 'measurement', 'aid', 'monitor', 'ongoing', 'financial_performance', 'quarter', 'quarter', 'year', 'year', 'regular', 'basis', 'benchmarke', 'comparable', 'company'], ['intend', 'provide', 'measure', 'company', 'operating', 'performance', 'eliminate', 'effect', 'financing', 'capital_expenditure', 'ebitda', 'consist', 'gaap', 'net', 'loss', 'exclude', 'depreciation_amortization', 'intangible', 'interest', 'expense', 'net_income', 'tax_provision', 'adjust_ebitda', 'intend', 'provide', 'normalized', 'view', 'ebitda', 'broad', 'business_operation', 'expect', 'experience', 'ongoing', 'basis', 'remove', 'certain', 'non_cash', 'item', 'item', 'irregular', 'time', 'non_recur', 'ebitda', 'enable', 'identify', 'underlie_trend', 'business', 'otherwise', 'mask', 'such', 'item', 'adjust_ebitda', 'consist', 'gaap', 'net', 'loss', 'exclude', 'depreciation_amortization', 'intangible', 'interest', 'expense', 'net_income', 'tax_provision', 'cost', 'incur', 'connection', 'investigation', 'restatement', 'share_base_compensation'], ['reconciliation_gaap', 'net', 'loss', 'ebitda_adjust_ebitda', 'appear', 'table', 'below', 'thousand'], ['company', 'apply', 'precision_medicine', 'approach', 'develop', 'genetically', 'target', 'therapy', 'cardiovascular', 'disease', 'today', 'report_second_quarter', 'financial', 'result', 'provide', 'corporate', 'update'], ['president_chief_executive_officer', 'comment', 'process', 'evaluate', 'option', 'create', 'stockholder', 'value', 'include', 'potential', 'development', 'asset', 'partner', 'other', 'strategic', 'option'], ['company', 'retain', 'act', 'financial', 'advisor', 'explore', 'evaluate', 'strategic', 'option', 'maximize', 'stockholder', 'value', 'potential', 'strategic', 'alternative', 'explore', 'evaluate', 'part', 'process', 'include', 'potential', 'acquisition', 'merger', 'business', 'combination', 'other', 'strategic', 'transaction', 'involve', 'company', 'board', 'set', 'timetable', 'conclusion', 'review', 'make', 'decision', 'relate', 'further', 'action', 'potential', 'strategic', 'option', 'time', 'assurance', 'however', 'process', 'result', 'such', 'transaction'], ['second_quarter', 'summary', 'financial', 'result'], ['cash_cash_equivalent', 'compare', 'believe', 'current', 'cash_cash_equivalent', 'sufficient_fund', 'operation', 'current', 'level', 'least', 'end', 'company', 'review', 'strategic', 'option', 'impact', 'projection'], ['research', 'development', 'expense', 'quarter_end', 'compare', 'corresponding', 'period', 'decrease', 'expense', 'second_quarter', 'primarily_relate', 'completion_enrollment', 'rnapc', 'phase', 'clinical_trial', 'fourth_quarter', 'expense', 'expect', 'low'], ['general_administrative', 'expense', 'quarter_end', 'compare', 'corresponding', 'period', 'increase', 'primarily', 'result', 'increase', 'professional', 'fee', 'consulting', 'cost', 'expense', 'expect', 'consistent', 'company', 'maintain', 'administrative', 'activity', 'support', 'ongoing', 'operation'], ['total', 'operating', 'expense', 'quarter_end', 'compare', 'second_quarter'], ['net', 'loss', 'quarter_end', 'basic', 'diluted', 'share', 'compare', 'basic', 'diluted', 'share', 'second_quarter'], ['dedicate', 'develop', 'genetically', 'other', 'target', 'therapy', 'cardiovascular', 'disease', 'precision_medicine', 'approach', 'drug', 'development', 'present', 'arca', 'evaluate', 'option', 'development', 'asset', 'include', 'partner', 'other', 'strategic', 'option', 'more_information_visit', 'follow', 'company'], ['statement', 'press_release_contain', 'forward_look_statement', 'purpose', 'safe_harbor', 'provide', 'private_security', 'statement', 'include', 'limit', 'statement', 'regard', 'potential', 'future', 'development', 'plan', 'gencaro', 'rnapc', 'company', 'review', 'strategic', 'option', 'such', 'statement', 'base', 'management', 'current', 'expectation', 'involve', 'risk_uncertainty', 'actual', 'result', 'performance', 'differ_materially', 'project', 'forward_look_statement', 'result', 'many', 'factor', 'include_limitation', 'risk_uncertainty', 'associate', 'financial', 'resource', 'sufficient', 'meet', 'business', 'objective', 'operational', 'requirement', 'arca', 'able', 'raise', 'sufficient', 'capital', 'acceptable', 'term', 'at_all', 'continue', 'development', 'rnapc', 'gencaro', 'otherwise', 'continue', 'operation', 'future', 'result', 'early', 'clinical_trial', 'confirm', 'future', 'clinical_trial', 'protection', 'market', 'exclusivity', 'provide', 'intellectual_property', 'risk', 'relate', 'drug_discovery', 'regulatory_approval', 'process', 'company', 'ability', 'complete', 'strategic', 'transaction', 'impact', 'competitive', 'product', 'technological', 'change', 'other', 'factor', 'identify', 'describe', 'more', 'detail', 'filing', 'include_limitation', 'annual_report_form', 'year', 'end', 'subsequent_filing', 'arca', 'disclaim', 'intent', 'obligation_update_forward_look', 'statement'], ['investor_contact'], ['table', 'follow'], ['generation', 'biotechnology', 'company', 'innovate', 'genetic', 'medicine', 'people', 'live', 'rare', 'prevalent', 'disease', 'announce', 'company', 'participate', 'panel', 'virtual', 'conference', 'th', 'am'], ['live_webcast', 'presentation', 'available', 'investor_section', 'company', 'website', 'replay', 'available', 'there', 'day', 'follow', 'event'], ['generation', 'generation', 'innovate', 'genetic', 'medicine', 'provide', 'durable', 'redosable', 'treatment', 'people', 'live', 'rare', 'prevalent', 'disease', 'company', 'non', 'viral', 'genetic', 'medicine', 'platform', 'incorporate', 'novel', 'dna', 'construct', 'call', 'closed', 'end', 'dna', 'unique', 'cell', 'target', 'lipid', 'nanoparticle', 'delivery', 'system', 'ctlnp', 'highly', 'scalable', 'capsid', 'free', 'manufacturing', 'process', 'use', 'proprietary', 'cell', 'free', 'rapid', 'enzymatic', 'synthesis', 're', 'produce', 'platform', 'design', 'enable', 'multi', 'year', 'durability', 'single_dose', 'deliver', 'large', 'genetic', 'payload', 'include', 'multiple', 'gene', 'specific', 'cell', 'type', 'allow', 'titration', 'redose', 'adjust', 'extend', 'expression', 'level', 'patient', 'res', 'potential', 'expand', 'generation', 'manufacturing', 'scale', 'hundred', 'million', 'dose', 'support', 'mission', 'extend', 'reach', 'genetic', 'medicine', 'more', 'people', 'live', 'more', 'disease', 'world'], ['more_information_visit'], ['investor_medium', 'contact', 'generation'], ['call', 'hold', 'th', 'pm', 'eastern_time'], ['company', 'today_announce', 'host_conference_call', 'pm', 'eastern_time', 'discuss', 'company', 'corporate', 'progress', 'other', 'development', 'as_well', 'financial', 'result', 'first_quarter', 'end'], ['conference_call', 'available', 'telephone', 'dial', 'toll', 'free', 'caller', 'international_caller', 'webcast', 'call', 'access', 'https', 'appwebinarnet', 'kwk', 'obmy', 'company', 'investor_relation', 'section', 'website'], ['webcast', 'replay', 'available', 'company', 'investor', 'news', 'event', 'section', 'website', 'telephone', 'replay', 'call', 'available', 'approximately', 'hour', 'follow', 'call', 'access', 'dial', 'caller', 'international_caller', 'enter', 'replay', 'access', 'code'], ['late_stage', 'specialty', 'pharma', 'company', 'drug_delivery', 'technology', 'drug_candidate', 'address', 'rare', 'orphan', 'disease', 'novel', 'drug_delivery', 'technology', 'potential', 'improve', 'performance', 'currently', 'market', 'drug', 'achieve', 'fast', 'onset', 'action', 'enhance', 'efficacy', 'reduce', 'side_effect', 'more', 'convenient', 'drug_delivery', 'help', 'increase', 'treatment', 'compliance', 'improve', 'patient', 'outcome'], ['lead', 'clinical', 'asset', 'grant', 'orphan_drug', 'designation', 'provide', 'asset', 'year', 'marketing', 'exclusivity', 'post', 'launch', 'additional', 'intellectual_property', 'protection', 'grant', 'pende', 'patent', 'lead', 'clinical', 'asset', 'target', 'underserved', 'orphan', 'disease', 'gtx', 'intravenous', 'infusion', 'target', 'subarachnoid', 'hemorrhage', 'rare_life', 'threaten', 'medical', 'emergency', 'bleed', 'occur', 'surface', 'brain', 'subarachnoid', 'space', 'brain', 'skull', 'oral', 'mucosal', 'spray', 'target', 'progressive', 'genetic', 'disease', 'primarily', 'affect', 'child', 'cause', 'severe', 'disability', 'treatment', 'currently', 'exist', 'gtx', 'topical', 'spray', 'target', 'postherpetic', 'persistent', 'often', 'debilitate', 'neuropathic_pain', 'cause', 'nerve', 'damage', 'virus', 'shingle', 'persist', 'month', 'even', 'year', 'more_information_visit'], ['forward_look_statement', 'statement', 'press_release_statement', 'historical', 'current', 'fact', 'constitute_forward_look', 'information', 'meaning', 'canadian', 'security_law', 'forward_look_statement_meaning', 'private_security_amend', 'section', 'amend', 'section', 'amend', 'collectively', 'forward_look_statement', 'such_forward_look', 'statement', 'involve', 'know_unknown', 'risk_uncertainty', 'other', 'unknown', 'factor_cause_actual', 'result', 'acasti', 'materially_different', 'historical', 'result', 'future', 'result', 'express_imply', 'such_forward_look', 'statement', 'addition', 'statement', 'explicitly', 'describe', 'such', 'risk_uncertainty', 'reader', 'urge', 'consider', 'statement', 'label', 'term', 'believe', 'belief', 'expect', 'intend', 'anticipate', 'estimate', 'potential', 'plan', 'continue', 'target', 'other', 'similar_expression', 'uncertain', 'forward_look', 'reader', 'caution_place_undue_reliance', 'forward_look_statement', 'speak_only', 'date_press_release'], ['forward_look_statement', 'base', 'current', 'expectation', 'involve', 'assumption', 'never', 'materialize', 'prove', 'incorrect', 'actual', 'result', 'timing', 'event', 'differ_materially', 'anticipate', 'such_forward_look', 'statement', 'result', 'various', 'risk_uncertainty', 'include_limitation', 'success', 'timing', 'regulatory_submission', 'plan', 'phase', 'safety', 'study', 'other', 'pre', 'clinical', 'clinical_trial', 'regulatory', 'requirement', 'development', 'outcome', 'meeting', 'change', 'clinical_trial', 'design', 'regulatory', 'pathway', 'legislative', 'regulatory', 'political_economic', 'development', 'cost_associate', 'clinical_trial', 'effect', 'clinical', 'program', 'business', 'success', 'timing', 'regulatory_submission', 'pre', 'clinical', 'clinical_trial', 'regulatory', 'requirement', 'development', 'iii', 'change', 'clinical_trial', 'design', 'regulatory', 'pathway', 'legislative', 'regulatory', 'political_economic', 'development', 'effect', 'clinical', 'program', 'business_operation', 'forego', 'review', 'important_factor', 'cause_actual_event', 'differ', 'expectation', 'construe', 'exhaustive', 'read', 'conjunction', 'statement', 'include', 'elsewhere', 'include', 'risk_factor', 'detail', 'document_file', 'acasti', 'time', 'time', 'forward_look_statement', 'contain_press_release', 'speak_only_date', 'make', 'acasti', 'undertake_obligation_update', 'such', 'statement', 'reflect', 'event', 'occur', 'circumstance', 'exist', 'date', 'make'], ['tsxv', 'regulation', 'service', 'provider', 'term', 'define', 'policy', 'tsxv', 'accept', 'responsibility', 'adequacy', 'accuracy', 'release'], ['contact', 'chief_executive_officer', 'email'], ['investor_contact', 'email'], ['fosgo', 'active', 'metabolite', 'demonstrate', 'neuroprotective', 'effect', 'primary', 'culture', 'new', 'orally', 'available', 'small_molecule', 'positive_modulator', 'meet', 'reverse', 'memory', 'deficit', 'preclinical_model'], ['late', 'clinical_stage', 'company', 'focus', 'develop', 'small_molecule', 'restore', 'neuronal', 'health', 'slow', 'today_announce', 'detail', 'preclinical', 'poster_presentation'], ['continue', 'develop', 'advance', 'pipeline', 'small_molecule', 'positive_modulator', 'meet', 'signal', 'pathway', 'repair', 'restore', 'say_executive_vice', 'president', 'research', 'presentation', 'support', 'potential', 'unique', 'mechanism_action', 'positively', 'impact', 'disorder'], ['first', 'poster_presentation', 'novel_small_molecule', 'positive_modulator', 'meet', 'system', 'neuroprotective', 'primary', 'culture', 'poster', 'demonstrate', 'fosgo', 'active', 'metabolite', 'pipeline', 'candidate', 'promote', 'neurotrophic', 'effect', 'offer', 'protection', 'neurological', 'insult', 'central', 'primary', 'culture', 'cortical', 'neuron', 'treatment', 'fosgo', 'increase', 'number', 'neuron', 'enhance', 'neurite', 'outgrowth', 'cortical', 'neuron', 'treat', 'fosgo', 'exhibit', 'significant', 'protection', 'neurotoxic', 'insult', 'implicate', 'mitochondrial', 'dysfunction', 'excitotoxicity', 'inflammation', 'oxidative', 'stress', 'neuroprotective', 'effect', 'highlight', 'therapeutic', 'potential', 'restore', 'neuronal', 'health', 'slow'], ['second', 'poster_presentation', 'development', 'stable', 'orally', 'bioavailable', 'small_molecule', 'positive_modulator', 'meet', 'signal', 'treatment', 'cognitive_impairment', 'poster', 'focus', 'identification', 'preclinical', 'validation', 'panel', 'novel_small_molecule', 'meet', 'positive_modulator', 'orally', 'available', 'molecule', 'significantly', 'reverse', 'scopolamine', 'induce', 'spatial', 'memory', 'deficit', 'rat', 'also', 'demonstrate', 'favorable', 'pharmacokinetic', 'include', 'efficient', 'distribution', 'brain', 'follow', 'administration', 'base', 'promising', 'preclinical', 'datum', 'athira', 'intend', 'continue', 'develop', 'compound', 'potential', 'treatment', 'disease', 'other', 'disorder'], ['poster', 'available', 'scientific', 'publication', 'presentation', 'page', 'website'], ['area', 'late', 'clinical_stage', 'company', 'focus', 'develop', 'small_molecule', 'restore', 'neuronal', 'health', 'slow', 'athira', 'aim', 'provide', 'rapid', 'cognitive', 'improvement', 'alter', 'course', 'neurological', 'disease', 'novel', 'mechanism_action', 'currently', 'advance', 'pipeline', 'therapeutic', 'candidate', 'target', 'meet', 'neurotrophic', 'system', 'dementia', 'lewy', 'body', 'indication', 'more_information_visit', 'wwwathiracom', 'also', 'follow', 'athira', 'twitter', 'instagram'], ['forward_look_statement', 'communication', 'contain_forward_look', 'statement_meaning', 'section', 'section', 'private_security_forward_look', 'statement', 'base', 'historical_fact', 'include', 'statement', 'regard', 'potential', 'treatment', 'dementia', 'lewy', 'body', 'other', 'dementia', 'neurological', 'disorder', 'indication', 'platform', 'technology', 'potential', 'therapy', 'future', 'development', 'plan', 'clinical', 'regulatory', 'objective', 'timing_thereof', 'expectation_regard', 'potential', 'efficacy', 'commercial', 'potential', 'product_candidate', 'anticipate', 'reporting', 'datum', 'ability', 'advance', 'product_candidate', 'later', 'stage', 'development', 'forward_look_statement', 'generally', 'include', 'statement', 'predictive', 'nature', 'depend', 'refer', 'future', 'event', 'condition', 'include', 'word', 'such', 'track', 'expect', 'plan', 'believe', 'intend', 'pursue', 'continue', 'other', 'similar_expression', 'other', 'forward_look_statement', 'base', 'management', 'current', 'expectation', 'future', 'event', 'subject', 'number_risk_uncertainty', 'cause_actual_result_differ', 'materially_adversely', 'set_forth', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include', 'limit', 'preliminary_datum', 'product_candidate', 'phase', 'phase', 'act', 'ad', 'trial', 'continue', 'persist', 'current', 'plan', 'clinical_trial', 'cessation', 'delay', 'ongoing', 'clinical_trial', 'development', 'other', 'product_candidate', 'occur', 'future', 'potential', 'regulatory', 'milestone', 'other', 'product_candidate', 'include', 'relate', 'current', 'plan', 'clinical', 'study', 'insufficient', 'support', 'regulatory_submission', 'approval', 'impact', 'pandemic', 'business', 'research', 'clinical', 'development', 'plan', 'timeline', 'regulatory', 'process', 'athira', 'product_candidate', 'able', 'recruit', 'sufficient', 'patient', 'clinical_trial', 'outcome', 'legal', 'proceeding', 'future', 'institute', 'certain', 'director', 'officer', 'clinical_trial', 'demonstrate', 'safety_efficacy', 'product_candidate', 'possible', 'negative', 'interaction', 'product_candidate', 'other', 'treatment', 'assumption', 'regard', 'sufficiency_cash', 'cash_equivalent', 'investment', 'fund', 'plan', 'operation', 'incorrect', 'research', 'development', 'effort', 'ability', 'advance', 'product_candidate', 'later', 'stage', 'development', 'fail', 'more', 'product_candidate', 'successfully', 'develop', 'approve', 'commercialize', 'adverse', 'condition', 'general', 'domestic', 'global', 'economic', 'market', 'impact', 'competition', 'latency', 'functional', 'measure', 'highly', 'correlate', 'cognition', 'athira', 'successfully', 'establish', 'connection', 'latency', 'result', 'improve', 'cognition', 'regulatory_agency', 'delay', 'review', 'comment', 'approve', 'athira', 'clinical', 'development', 'plan', 'result', 'pandemic', 'further', 'delay', 'development', 'timeline', 'impact', 'expand', 'product', 'development', 'clinical', 'activity', 'operating', 'expense', 'impact', 'new', 'change', 'law', 'regulation', 'as_well', 'other', 'risk', 'detail', 'filing', 'forward_look_statement', 'speak_only', 'date_hereof', 'athira', 'undertake_obligation_update', 'forward_look_statement', 'athira', 'actually', 'achieve', 'plan', 'intention', 'expectation', 'disclose', 'forward_look_statement', 'place_undue_reliance', 'forward_look_statement'], ['investor_contact'], [], ['schedule', 'regular', 'earning', 'conference_call', 'cover', 'second_quarter_financial', 'result', 'certain', 'business', 'development', 'pm', 'pm'], ['schedule'], ['second_quarter_financial', 'result', 'press_release', 'distribute'], ['pm', 'participate', 'conference_call', 'dial', 'conference', 'would'], ['pm', 'et', 'conference_call', 'simultaneous', 'webcast', 'begin'], ['conference_call', 'also', 'available', 'access', 'investor_relation', 'page', 'orasure', 'website', 'click', 'link', 'follow', 'prompt', 'registration', 'access', 'minute_prior', 'call'], ['unable', 'participate', 'replay', 'call', 'archive', 'orasure', 'website', 'shortly', 'call', 'end', 'available', 'day'], ['ilit', 'rewalk', 'company', 'lead', 'manufacturer', 'robotic', 'medical', 'technology', 'people', 'low', 'extremity', 'disability', 'today_announce', 'result', 'company', 'annual_meeting', 'shareholder', 'annual_meeting', 'base', 'final', 'tabulation', 'vote', 'certify', 'independent', 'inspector', 'election', 'annual_meeting', 'shareholder', 'vote', 'reelect', 'chief_executive_officer', 'board_director', 'shareholder', 'vote', 'approve', 'proposal', 'put', 'creative', 'value', 'capital', 'limited', 'partnership', 'cvc'], ['advance', 'shareholder', 'interest', 'board', 'decide', 'appoint', 'hadar', 'board', 'additive', 'experience', 'corporate', 'finance', 'broad', 'healthcare', 'sector', 'agree', 'immediately', 'join', 'director', 'board', 'thank', 'cvc', 'put', 'candidate', 'next', 'year', 'company', 'also', 'intend', 'reduce', 'size', 'board', 'continue', 'evaluate', 'director', 'refreshment', 'opportunity'], ['chairman', 'board', 'comment'], ['grateful', 'shareholder', 'support', 'annual_meeting', 'appreciate', 'constructive', 'dialogue', 'have', 'many', 'precede', 'month', 'addition', 'hadar', 'believe', 'board', 'possess', 'right', 'mix', 'essential', 'skill', 'set', 'background', 'directly', 'applicable', 'company', 'need', 'approach', 'key', 'milestone', 'near_term', 'look_forward', 'continue', 'engagement', 'shareholder', 'remain', 'committed', 'enhance', 'shareholder', 'value', 'pursue', 'increase', 'access', 'wearable', 'robotic', 'exoskeleton', 'expand', 'reimbursement', 'coverage', 'provide', 'update', 'appropriate'], ['comment'], ['improve', 'people', 'life', 'commercialize', 'novel', 'technology', 'always', 'drive', 'force', 'career', 'rewalk', 'do', 'excellent', 'job', 'develop', 'obtain', 'regulatory', 'clearance', 'innovative', 'product', 'honor', 'join', 'company', 'board', 'look_forward', 'work', 'fellow', 'director', 'executive', 'management', 'team', 'order', 'achieve', 'company', 'long_term', 'strategic', 'objective', 'enhance', 'shareholder', 'value'], ['final', 'result', 'annual_meeting', 'relevant', 'information', 'report_form', 'file'], [], ['start', 'career', 'then', 'have', 'extensive', 'career', 'medical', 'device', 'industry', 'serve', 'key', 'position', 'where', 'lead', 'financial', 'activity', 'oversee', 'implementation', 'growth', 'development', 'key', 'product', 'hold', 'accounting', 'economic', 'degree', 'bar', 'certify', 'public', 'accountant'], [], ['develop', 'manufacture', 'market', 'wearable', 'robotic', 'exoskeleton', 'individual', 'low', 'limb', 'disability', 'result', 'spinal', 'cord', 'injury', 'stroke', 'mission', 'fundamentally', 'change', 'quality_life', 'individual', 'low', 'limb', 'disability', 'creation', 'development', 'market', 'lead', 'robotic', 'technology', 'found', 'rewalk', 'headquarters', 'more', 'information', 'rewalk', 'system', 'visit', 'rewalkcom'], ['rewalk', 'restore', 'register_trademark', 'other', 'jurisdiction'], ['addition', 'historical', 'information', 'press_release_contain', 'forward_look_statement_meaning', 'private_security', 'section', 'section', 'such_forward_look', 'statement', 'include', 'projection', 'regard', 'future', 'performance', 'other', 'statement', 'statement_historical_fact', 'case', 'identify_word', 'anticipate', 'assume', 'believe', 'continue', 'estimate', 'expect', 'intend', 'plan', 'potential', 'predict', 'project', 'future', 'seek', 'similar', 'term', 'phrase', 'forward_look_statement', 'contain_press_release', 'base', 'management', 'current', 'expectation', 'subject', 'uncertainty', 'risk', 'change', 'circumstance', 'difficult', 'predict', 'many', 'outside', 'control', 'important_factor', 'cause_actual_result_differ', 'materially_indicate', 'forward_look_statement', 'include', 'other', 'uncertainty', 'associate', 'future', 'clinical_trial', 'clinical', 'development', 'process', 'product', 'development', 'process', 'regulatory_submission', 'review', 'approval', 'process', 'adverse', 'effect', 'pandemic', 'have', 'continue', 'company', 'business', 'result', 'operation', 'ability', 'sufficient_fund', 'meet', 'certain', 'future', 'capital', 'requirement', 'impair', 'company', 'effort', 'develop_commercialize', 'exist', 'new', 'product', 'ability', 'maintain', 'compliance', 'continue', 'listing', 'requirement', 'capital', 'market', 'risk', 'ordinary', 'share', 'delist', 'can', 'so', 'ability', 'maintain', 'grow', 'reputation', 'market', 'acceptance', 'product', 'ability', 'achieve', 'reimbursement', 'third_party', 'payor', 'include', 'cms', 'product', 'limited', 'operating', 'history', 'ability', 'leverage', 'sale', 'marketing', 'training', 'infrastructure', 'expectation', 'clinical', 'research', 'program', 'clinical', 'result', 'expectation_regard', 'future', 'growth', 'include', 'ability', 'increase', 'sale', 'exist', 'geographic', 'market', 'expand', 'new', 'market', 'ability_obtain', 'certain', 'component', 'product', 'third_party', 'supplier', 'continue', 'access', 'product', 'manufacturer', 'ability', 'improve', 'product', 'develop', 'new', 'product', 'compliance', 'medical', 'device', 'report', 'regulation', 'report', 'adverse_event', 'involve', 'company', 'product', 'result', 'voluntary', 'corrective', 'action', 'enforcement', 'action', 'such', 'mandatory', 'recall', 'potential', 'impact', 'such', 'adverse_event', 'ability', 'market', 'sell', 'product', 'ability', 'gain', 'maintain', 'regulatory_approval', 'ability', 'maintain', 'adequate', 'protection', 'intellectual_property', 'avoid', 'violation', 'intellectual_property', 'right', 'other', 'risk', 'cybersecurity', 'attack', 'breach', 'company', 'system', 'significantly', 'disrupt', 'business_operation', 'ability', 'use', 'effectively', 'proceed', 'offering', 'security', 'other', 'factor', 'discuss', 'heading_risk', 'factor_annual', 'report_form', 'year', 'end', 'file', 'other', 'document', 'subsequently', 'file', 'furnish', 'forward_look_statement', 'make', 'press_release', 'speak_only', 'date_hereof', 'factor', 'event', 'cause_actual_result_differ', 'statement', 'contain', 'emerge', 'time', 'time', 'possible', 'rewalk', 'predict', 'require_law', 'rewalk', 'undertake_obligation', 'publicly_update', 'forward_look_statement', 'result', 'new', 'information', 'future', 'development', 'otherwise'], ['investor'], [], ['medium'], ['dreingold'], ['receive', 'approval', 'imcivree', 'setmelanotide', 'first', 'ever', 'therapy', 'patient', 'bardet', 'biedl', 'syndrome'], ['launch', 'strong', 'start', 'more', 'imcivree', 'prescription', 'write', 'patient', 'first', 'week', 'approval'], ['chmp', 'recommend', 'expansion', 'imcivree', 'marketing_authorization', 'include', 'treatment', 'obesity', 'control', 'hunger', 'patient', 'genetically', 'confirm', 'approval', 'anticipate', 'fourth_quarter'], ['announce', 'positive', 'interim', 'result', 'phase', 'trial', 'hypothalamic', 'obesity', 'plan', 'initiate', 'phase', 'trial', 'early'], ['enter', 'non', 'dilutive', 'revenue', 'interest', 'financing', 'agreement', 'partner', 'extend', 'cash_runway', 'second_half'], ['management', 'host_conference_call', 'today', 'am'], ['today', 'report', 'financial', 'result', 'provide', 'business', 'update', 'second_quarter_end'], ['execute', 'global', 'mission', 'transform_life', 'patient', 'family', 'live', 'severe', 'obesity', 'cause', 'rare', 'pathway', 'disease', 'say', 'chair', 'president_chief_executive_officer', 'rhythm', 'commercial', 'launch', 'imcivree', 'setmelanotide', 'biedl', 'syndrome', 'strong', 'start', 'continue', 'make', 'meaningful', 'progress', 'secure', 'market', 'access', 'initial', 'indication', 'more', 'recently', 'bbs'], ['meeker', 'add', 'highly', 'encourage', 'interim', 'datum', 'phase', 'trial', 'evaluate', 'setmelanotide', 'hypothalamic', 'obesity', 'potential', 'role', 'play', 'transform', 'how', 'disease', 'treat', 'look_forward', 'review', 'datum', 'food', 'seek', 'input', 'pivotal', 'phase', 'trial', 'plan', 'initiate', 'first_half', 'excited', 'add', 'potential', 'phase', 'trial', 'hypothalamic', 'obesity', 'broad', 'setmelanotide', 'clinical', 'development', 'program', 'also', 'include', 'ongoing', 'phase', 'emanate', 'trial', 'phase', 'daybreak', 'trial', 'phase', 'switch', 'study', 'evaluate', 'weekly', 'formulation', 'setmelanotide', 'phase', 'pediatric', 'trial', 'complete_enrollment'], ['second_quarter', 'recent', 'business', 'highlight'], ['regulatory', 'commercial', 'update', 'syndrome'], ['lepr', 'deficiency', 'obesity'], ['clinical', 'development', 'update'], ['corporate'], ['key', 'upcoming', 'milestone', 'second_half', 'rhythm', 'expect'], ['year', 'date', 'financial', 'result'], ['financial_guidance', 'base', 'current', 'operating', 'plan', 'rhythm', 'expect', 'exist', 'cash_cash_equivalent', 'short', 'term', 'investment', 'sufficient_fund', 'operation', 'such', 'exist', 'cash_cash_equivalent', 'short', 'term', 'investment', 'together', 'second', 'investment', 'tranche', 'rifa', 'royalty', 'partner', 'expect', 'second_half', 'sufficient_fund', 'operating', 'expense', 'capital_expenditure', 'requirement', 'least', 'second_half'], ['conference_call', 'pharmaceutical', 'host', 'live', 'conference_call_webcast', 'am', 'today', 'review', 'second_quarter_financial', 'result', 'recent', 'business', 'activity', 'participant', 'register', 'conference_call', 'here', 'require', 'recommend', 'participant', 'join', 'call', 'minute_prior', 'schedule', 'start'], ['live_webcast', 'call', 'also', 'available', 'event', 'presentation', 'investor_relation', 'section', 'rhythm', 'pharmaceutical', 'website', 'archive_webcast', 'available', 'rhythm', 'pharmaceutical', 'website', 'approximately', 'hour', 'conference_call', 'available', 'day', 'follow', 'call'], ['pharmaceutical', 'rhythm', 'commercial', 'stage', 'company', 'commit', 'transform_life', 'patient', 'family', 'live', 'severe', 'obesity', 'cause', 'rare', 'receptor', 'pathway', 'disease', 'imcivree', 'setmelanotide', 'approve', 'chronic', 'weight', 'management', 'adult_pediatric', 'patient', 'year', 'age_old', 'monogenic', 'syndromic', 'obesity', 'due', 'lepr', 'deficiency', 'confirm', 'genetic', 'testing', 'patient', 'clinical', 'diagnosis', 'bardet', 'biedl', 'syndrome', 'product', 'regulatory_agency', 'authorize', 'imcivree', 'treatment', 'obesity', 'control', 'hunger', 'associate', 'genetically', 'confirm', 'loss', 'function', 'include', 'deficiency', 'biallelic', 'lepr', 'deficiency', 'adult', 'child', 'year', 'age', 'imcivree', 'first', 'ever', 'fda', 'approve', 'mhra', 'authorize', 'therapy', 'patient', 'rare', 'genetic', 'disease', 'obesity', 'rhythm', 'receive', 'positive', 'committee_medicinal_product', 'human_use_chmp', 'opinion', 'type', 'variation', 'application', 'agency', 'seek', 'regulatory_approval', 'authorization', 'setmelanotide', 'treat', 'obesity', 'control', 'hunger', 'adult_pediatric', 'patient', 'year', 'age_old', 'decision', 'expect', 'fourth_quarter', 'additionally', 'advance', 'broad', 'clinical', 'development', 'program', 'setmelanotide', 'other', 'rare', 'genetic', 'disease', 'obesity', 'leverage', 'rhythm', 'engine', 'large', 'know', 'obesity', 'dna', 'database', 'now', 'approximately', 'sequencing', 'sample', 'improve', 'understand', 'diagnosis', 'care', 'people', 'live', 'severe', 'obesity', 'certain', 'genetic', 'deficiency', 'headquarters'], ['receptor', 'mc', 'agonist', 'part', 'key', 'biological', 'pathway', 'regulate', 'hunger', 'caloric', 'intake', 'energy', 'expenditure', 'variant', 'gene', 'impair', 'function', 'pathway', 'potentially', 'lead', 'early', 'onset', 'severe', 'obesity', 'rhythm', 'develop', 'setmelanotide', 'target', 'therapy', 'potentially', 'restore', 'function', 'impaired', 'pathway', 'so', 'do', 'potentially', 'reduce', 'hunger', 'weight', 'patient', 'rare', 'genetic', 'disease', 'obesity'], ['indicate', 'treatment', 'obesity', 'control', 'hunger', 'associate', 'genetically', 'confirm', 'loss', 'function', 'include', 'deficiency', 'biallelic', 'lepr', 'deficiency', 'adult', 'child', 'year', 'age', 'imcivree', 'prescribe', 'supervise', 'physician', 'expertise', 'obesity', 'underlie', 'genetic', 'etiology'], ['variation', 'application', 'treatment', 'obesity', 'control', 'adult_pediatric', 'patient', 'year', 'age_old', 'review', 'company', 'also', 'continue', 'advance', 'most', 'comprehensive', 'clinical', 'research', 'program', 'ever', 'initiate', 'pathway', 'disease', 'include', 'pivotal', 'phase', 'emanate', 'clinical_trial', 'evaluate', 'setmelanotide', 'independent', 'sub', 'study', 'patient', 'obesity', 'cause', 'heterozygous', 'variant', 'gene', 'lepr', 'insufficiency', 'cause', 'heterozygous', 'variant', 'lepr', 'gene', 'src', 'deficiency', 'cause', 'variant', 'ncoa', 'gene', 'deficiency', 'cause', 'variant', 'sh', 'gene', 'deletion', 'encompass', 'sh', 'gene', 'phase', 'daybreak', 'trial', 'evaluate', 'setmelanotide', 'patient', 'severe', 'obesity', 'cause', 'rare', 'variant', 'associate', 'prioritize', 'mc', 'relevant', 'gene', 'rhythm', 'also', 'initiate', 'phase', 'pediatric', 'trial', 'phase', 'trial', 'evaluate', 'weekly', 'formulation', 'setmelanotide'], ['setmelanotide', 'indication', 'indicate', 'chronic', 'weight', 'management', 'adult_pediatric', 'patient', 'year', 'age_old', 'monogenic', 'syndromic', 'obesity'], ['limitation', 'use', 'imcivree', 'indicate', 'treatment', 'patient', 'follow', 'condition', 'imcivree', 'expect', 'effective'], ['warning', 'precaution'], ['disturbance', 'sexual', 'arousal', 'spontaneous', 'penile', 'erection', 'male', 'sexual', 'adverse_reaction', 'female', 'occur', 'inform', 'patient', 'event', 'occur', 'instruct', 'patient', 'erection', 'last', 'long', 'hour', 'seek', 'emergency', 'medical', 'attention'], ['depression', 'suicidal', 'ideation', 'depression', 'suicidal', 'ideation', 'occur', 'monitor', 'patient', 'new', 'onset', 'worsen', 'depression', 'suicidal', 'thought', 'behavior', 'consider', 'discontinue', 'imcivree', 'patient', 'experience', 'suicidal', 'thought', 'behavior', 'clinically', 'significant', 'persistent', 'depression', 'symptom', 'occur'], ['skin', 'pigmentation', 'darkening', 'pre', 'existing', 'nevi', 'generalize', 'increase', 'skin', 'pigmentation', 'darkening', 'pre', 'existing', 'occur', 'perform', 'full', 'body', 'skin', 'examination', 'prior', 'initiation', 'periodically', 'treatment', 'monitor', 'pre', 'existing', 'new', 'pigmentary', 'lesion'], ['risk', 'serious_adverse', 'reaction', 'preservative', 'neonate', 'low', 'birth', 'weight', 'infant', 'imcivree', 'approve', 'use', 'neonate', 'infant', 'serious', 'fatal', 'adverse_reaction', 'include', 'gasp', 'syndrome', 'occur', 'neonate', 'low', 'birth', 'weight', 'infant', 'treat', 'alcohol', 'preserve', 'drug'], ['adverse_reaction'], ['use', 'specific', 'population', 'treatment', 'imcivree', 'recommend', 'when', 'breastfeed', 'discontinue', 'imcivree', 'when', 'pregnancy', 'recognize', 'benefit', 'therapy', 'outweigh', 'potential', 'risk', 'fetus'], ['report', 'suspect', 'adverse_reaction', 'contact', 'rhythm', 'pharmaceutical'], ['see_full', 'prescribing_information', 'additional', 'important', 'safety', 'information'], ['forward_look_statement', 'press_release_contain', 'forward_look_statement_meaning', 'private_security', 'statement_contain_press', 'release', 'relate', 'matter', 'historical_fact', 'consider', 'forward_look_statement', 'include_limitation', 'statement', 'regard', 'potential', 'safety_efficacy', 'regulatory', 'clinical', 'progress', 'setmelanotide', 'include', 'anticipate', 'timing', 'initiation', 'clinical_trial', 'release', 'clinical_trial', 'datum', 'expectation', 'surround', 'potential', 'regulatory_submission', 'approval', 'timing_thereof', 'include', 'business', 'strategy', 'plan', 'include', 'regard', 'setmelanotide', 'sale', 'lead', 'product_candidate', 'imcivree', 'participation', 'upcoming', 'event', 'presentation', 'sufficiency_cash', 'cash_equivalent', 'short', 'term', 'investment', 'fund', 'operation', 'statement', 'use', 'word', 'such', 'expect', 'anticipate', 'believe', 'similar', 'term', 'also', 'forward_look_statement', 'such', 'statement', 'subject', 'numerous', 'risk_uncertainty', 'include', 'limited', 'ability', 'enroll', 'patient', 'clinical_trial', 'design', 'outcome', 'clinical_trial', 'impact', 'competition', 'ability', 'achieve', 'obtain', 'necessary', 'regulatory_approval', 'risk_associate', 'datum', 'analysis', 'report', 'liquidity', 'expense', 'impact', 'pandemic', 'business_operation', 'include', 'preclinical', 'study', 'clinical_trial', 'prospect', 'general_economic', 'condition', 'other', 'important_factor', 'discuss', 'caption', 'risk_factor', 'quarterly_report_form', 'quarter_end', 'other', 'filing', 'require_law', 'undertake_obligation', 'make', 'revision', 'forward_look_statement', 'contain', 'release', 'update', 'reflect_event_circumstance', 'occur', 'date', 'release', 'result', 'new', 'information', 'future', 'development', 'otherwise'], ['condense_consolidated_statement', 'operation', 'comprehensive', 'loss', 'income', 'thousand_share', 'share', 'datum', 'unaudited'], ['condense_consolidated_balance_sheet', 'thousand_share', 'share', 'datum', 'unaudited'], ['corporate', 'contact', 'head', 'investor_relation', 'corporate_communication', 'dconnolly', 'rhythmtxcom'], ['investor_contact', 'deresiewicz'], ['medium_contact', 'public', 'relation'], ['clinical_stage', 'company', 'focus', 'development', 'novel', 'oncology', 'therapy', 'today_announce', 'report_second_quarter', 'financial', 'result', 'financial', 'market', 'close', 'management', 'host', 'webcast_pm', 'pm', 'provide', 'comprehensive', 'business', 'update', 'discuss', 'company', 'financial', 'result'], ['live_webcast', 'call', 'available', 'online', 'call', 'archive', 'there', 'at_least', 'day'], ['clinical_stage', 'company', 'focus', 'development', 'novel', 'oncology', 'therapy', 'treatment', 'patient', 'cancer', 'critical', 'unmet_medical_need', 'pursue', 'drug', 'development', 'target', 'promising', 'untapped', 'biological', 'pathway', 'implicate', 'cancer', 'generation', 'progression', 'focus', 'hematological', 'malignancy', 'prostate_cancer', 'clinical', 'pipeline', 'include', 'investigational', 'monoclonal_antibody', 'design', 'inhibit', 'ror', 'type', 'tyrosine', 'kinase', 'like', 'orphan', 'receptor', 'evaluate', 'phase', 'clinical_trial', 'combination', 'ibrutinib', 'treatment', 'patient', 'mantle', 'cell', 'lymphoma', 'chronic', 'lymphocytic', 'leukemia', 'investigator', 'initiate', 'study', 'include', 'phase', 'clinical_trial', 'combination', 'paclitaxel', 'treatment', 'woman', 'metastatic', 'locally', 'advanced', 'unresectable', 'breast_cancer', 'phase', 'clinical_trial', 'combination', 'venetoclax', 'inhibitor', 'patient', 'relapse', 'refractory', 'cll', 'phase_study', 'combination', 'docetaxel', 'patient', 'metastatic', 'castration', 'resistant', 'prostate_cancer', 'oncternal', 'also', 'develop', 'onct', 'chimeric', 'receptor', 'cell', 'car', 'therapy', 'target', 'ror', 'currently', 'preclinical', 'development', 'potential', 'treatment', 'hematologic', 'cancer', 'solid_tumor', 'early_stage', 'pipeline', 'also', 'include', 'onct', 'dual', 'action', 'androgen', 'receptor', 'inhibitor', 'preclinical', 'development', 'potential', 'treatment', 'castration', 'resistant', 'prostate_cancer', 'include', 'clinically', 'important', 'resistance', 'approve', 'receptor', 'inhibitor', 'more', 'information', 'available'], ['contact', 'information'], ['rvincent', 'oncternalcom'], [], ['company', 'pioneer', 'single', 'molecule', 'proteome', 'analysis', 'today', 'report', 'financial', 'result', 'second_quarter_end'], ['recent', 'highlight'], ['continue', 'see', 'solid', 'progress', 'development', 'goal', 'second_quarter', 'remain', 'confident', 'overarching', 'strategy', 'say', 'light', 'current', 'macroeconomic', 'condition', 'financially', 'manage', 'business', 'way', 'give', 'maximum', 'opportunity', 'build', 'launch', 'commercialize', 'platform', 'anticipate', 'cash_runway', 'extend', 'well', 'remain', 'singularly', 'focused', 'drive', 'scientific', 'development', 'effort', 'forward', 'most', 'efficient', 'most', 'predictable', 'way', 'possible', 'make', 'choice', 'focus', 'intently', 'development', 'time', 'believe', 'position', 'maximize', 'impact', 'marketplace', 'biological', 'science'], ['operating', 'expense', 'second_quarter', 'increase', 'month_end', 'increase', 'operating', 'expense', 'drive', 'primarily', 'increase', 'headcount', 'support', 'ongoing', 'development', 'product', 'as_well', 'cost_associate', 'public', 'company'], ['net', 'loss', 'second_quarter', 'compare', 'net', 'loss', 'corresponding', 'prior', 'year', 'period'], ['cash_cash_equivalent', 'investment'], ['host_conference_call', 'discuss', 'second_quarter_financial', 'result', 'business', 'development', 'outlook', 'market', 'open', 'am', 'pacific', 'time', 'eastern_time', 'live_audio', 'available', 'investor_section', 'company', 'website', 'wwwnautilusbio'], [], ['base', 'development', 'stage', 'life_science', 'company', 'create', 'platform', 'technology', 'quantify', 'unlock', 'complexity', 'mission', 'transform', 'field', 'proteomic', 'democratize', 'access', 'proteome', 'enable', 'fundamental', 'advancement', 'human', 'health', 'medicine', 'learn_more', 'visit'], ['special_note_regard', 'forward_look_statement'], ['press_release_contain', 'forward_look_statement_meaning', 'federal', 'security_law', 'forward_look_statement', 'press_release_include', 'limit', 'statement', 'regard', 'expectation_regard', 'company', 'business_operation', 'financial_performance', 'result', 'operation', 'expectation', 'respect', 'revenue', 'timing', 'projection', 'expectation', 'respect', 'timing', 'launch', 'nautilus', 'product', 'platform', 'functionality', 'performance', 'product', 'platform', 'potential', 'impact', 'provide', 'proteome', 'access', 'pharmaceutical', 'development', 'drug_discovery', 'expand', 'research', 'horizon', 'enable', 'scientific', 'exploration', 'discovery', 'present', 'future', 'capability', 'limitation', 'emerge', 'proteomic', 'technology', 'statement', 'base', 'numerous', 'assumption', 'concern', 'development', 'product', 'target', 'market', 'other', 'current', 'emerge', 'proteomic', 'technology', 'involve_substantial_risk_uncertainty', 'other', 'factor_cause_actual', 'result', 'materially_different', 'information', 'express_imply', 'forward_look_statement', 'risk_uncertainty', 'materially', 'affect', 'accuracy', 'assumption', 'ability', 'achieve', 'forward_look_statement', 'set', 'press_release', 'include_limitation', 'follow', 'product', 'platform', 'yet', 'commercially', 'available', 'remain', 'subject', 'significant', 'scientific', 'technical', 'development', 'inherently', 'challenging', 'difficult', 'predict', 'particularly', 'respect', 'highly', 'novel', 'complex', 'product', 'such', 'develop', 'even', 'development', 'effort', 'successful', 'product', 'platform', 'require', 'substantial', 'validation', 'functionality', 'utility', 'life_science', 'research', 'course', 'scientific', 'technical', 'development', 'associate', 'product', 'validation', 'experience', 'material', 'delay', 'result', 'unanticipated', 'event', 'can', 'provide', 'guarantee', 'assurance', 'respect', 'outcome', 'development', 'collaboration', 'initiative', 'respect', 'associate', 'timeline', 'more', 'detailed', 'description', 'additional', 'risk_uncertainty', 'face', 'development', 'effort', 'investor', 'refer', 'information', 'caption', 'risk_factor_annual_report', 'form', 'as_well', 'quarterly_report_form', 'file', 'quarter_end', 'other', 'filing', 'forward_look_statement', 'press_release', 'date_press_release', 'as', 'otherwise', 'require_applicable', 'law', 'disclaim', 'duty', 'update', 'forward_look_statement', 'therefore', 'rely', 'forward_look_statement_represent', 'view', 'date', 'subsequent', 'date_press_release'], ['disclosure', 'information'], ['use', 'filing', 'website', 'wwwnautilusbio', 'press_release', 'public', 'conference_call', 'public', 'webcast', 'social_medium', 'account', 'mean', 'disclose', 'material', 'non', 'public', 'information', 'comply', 'regulation', 'therefore', 'encourage', 'investor_medium', 'other', 'interested', 'review', 'information', 'make', 'public', 'location', 'such', 'information', 'deem', 'material', 'information'], ['biotechnology'], ['investor'], ['condense_consolidated_balance_sheet', 'unaudited'], ['condense_consolidated_statement', 'operation', 'month_end', 'unaudited'], ['weight', 'average', 'number', 'share', 'common_stock', 'outstanding', 'prior', 'business', 'combination', 'retroactively', 'restate', 'reflect', 'exchange', 'ratio', 'approximately', 'establish', 'business', 'combination'], ['condense_consolidated_statement', 'cash_flow', 'month_end', 'unaudited'], ['pharmaceutical', 'tsx', 'otcqx', 'medxf', 'plan', 'host_conference_call', 'am_eastern', 'time', 'discuss', 'result', 'first_quarter', 'end', 'expect', 'file', 'financial', 'statement', 'market', 'close'], ['participate', 'call_dial', 'follow', 'number'], ['live_webcast', 'call', 'available', 'investor', 'news', 'event', 'calendar', 'section', 'corporate', 'website', 'following', 'link'], ['replay', 'call', 'available', 'approximately', 'hour', 'follow', 'end', 'call', 'access', 'replay', 'dial', 'follow', 'number'], ['replay', 'webcast', 'available', 'investor', 'news', 'event', 'calendar', 'section', 'corporate', 'website'], [], ['leader', 'innovative', 'rare', 'disease', 'treatment', 'solution', 'strong', 'north', 'american', 'commercial', 'platform', 'portfolio', 'prove', 'well', 'class', 'product', 'current', 'focus', 'therapeutic', 'area', 'hematology', 'auto', 'immune', 'disease', 'allergy', 'continue', 'build', 'highly', 'differentiated', 'company', 'grow', 'portfolio', 'innovative', 'high', 'value', 'orphan', 'rare', 'disease', 'product', 'underpin', 'growth', 'next', 'decade'], ['current', 'lead', 'product', 'rasuvo', 'metoject', 'unique', 'formulation', 'methotrexate', 'auto', 'pen', 'pre', 'fill', 'syringe', 'design', 'treat', 'rheumatoid', 'arthritis', 'other', 'auto', 'immune', 'disease', 'ixinity', 'intravenous', 'recombinant', 'factor', 'therapeutic', 'use', 'patient', 'year', 'age_old', 'hereditary', 'bleeding', 'disorder', 'characterize', 'deficiency', 'clot', 'factor', 'blood', 'necessary', 'control', 'bleed', 'rupall', 'innovative', 'prescription', 'allergy', 'medication', 'unique', 'mode', 'action', 'also', 'hold', 'exclusive', 'canadian', 'right', 'commercialize', 'aminolevulinic', 'acid', 'hydrochloride', 'approve', 'drug', 'designate', 'optical', 'image', 'agent', 'currently', 'indicate', 'patient', 'suspect', 'grade', 'iv', 'preoperative', 'imaging', 'adjunct', 'visualization', 'malignant', 'tissue', 'surgery'], ['also', 'license', 'treosulfan', 'part', 'preparative', 'regimen', 'allogeneic', 'hematopoietic_stem', 'cell', 'transplantation', 'use', 'combination', 'approve', 'market', 'treosulfan', 'currently', 'subject', 'regulatory', 'review', 'process', 'food'], ['mission', 'provide', 'good', 'healthcare', 'product', 'healthcare', 'professional', 'patient', 'strive', 'deliver', 'mission', 'act', 'core', 'value', 'quality', 'innovation', 'customer', 'service', 'collaboration'], ['more', 'information', 'contact', 'following'], [], ['chief_executive_officer', 'email'], ['chief', 'financial', 'email'], ['investor_relation'], ['email', 'victoria', 'adcapca'], ['certain', 'statement', 'make', 'press_release_contain', 'forward_look', 'information', 'meaning', 'applicable', 'security_law', 'forward_look_statement', 'word', 'anticipate', 'believe', 'expect', 'plan', 'potential', 'similar', 'word', 'expression', 'often', 'intend_identify_forward_look', 'statement', 'forward_look_statement', 'contain', 'identify_word', 'statement', 'base', 'factor', 'assumption', 'apply', 'draw', 'conclusion', 'make', 'forecast', 'projection', 'include', 'assumption', 'base', 'historical', 'trend', 'current', 'condition', 'expect', 'future', 'development', 'forward_look_statement', 'relate', 'future', 'event', 'condition', 'very', 'nature', 'require', 'make', 'assumption', 'involve', 'inherent', 'risk', 'uncertaintie', 'medexus', 'caution', 'believe', 'assumption', 'reasonable', 'circumstance', 'risk_uncertainty', 'give', 'rise', 'possibility', 'actual_result_differ', 'materially', 'expectation', 'set', 'forward_look_statement', 'material', 'risk_factor', 'include', 'set', 'material', 'file', 'canadian', 'security', 'regulatory_authority', 'time', 'time', 'include', 'most_recent', 'annual', 'information', 'form', 'management', 'discussion', 'analysis', 'future', 'capital', 'requirement', 'dilution', 'intellectual_property', 'protection', 'infringement', 'risk', 'competition', 'include', 'potential', 'generic', 'competition', 'reliance', 'key', 'management', 'personnel', 'ability', 'implement', 'business', 'plan', 'ability', 'leverage', 'canadian', 'infrastructure', 'promote', 'additional', 'growth', 'regulatory_approval', 'relevant', 'health_authority', 'include', 'product', 'reimbursement', 'third_party', 'payer', 'litigation', 'expiry', 'respect', 'patent', 'other', 'intellectual_property', 'right', 'litigation', 'risk', 'stock', 'price', 'volatility', 'government', 'regulation', 'potential', 'third_party', 'claim', 'give', 'risk', 'undue_reliance', 'place', 'forward_look_statement', 'make', 'only_date', 'hereof', 'other', 'as', 'specifically', 'require_law', 'undertake_obligation_update', 'forward_look_statement', 'reflect', 'new', 'information', 'subsequent', 'otherwise'], ['company', 'vieme', 'vmd', 'national', 'leader', 'respiratory', 'care', 'technology', 'enable', 'home', 'medical', 'equipment', 'service', 'announce_today', 'report', 'financial', 'result', 'month_end'], ['operational', 'highlight', 'dollar', 'amount', 'usd'], ['extremely', 'proud', 'robust', 'growth', 'line', 'product', 'service', 'highlight', 'synergy', 'offering', 'say', 'ceo', 'see', 'release', 'pen', 'demand', 'health_care', 'system', 're', 'enforce', 'critical', 'need', 'cost', 'effective', 'home', 'base', 'treatment', 'solution', 'keep', 'patient', 'hospital', 'facility'], ['conference_call', 'detail'], ['company', 'host_conference_call', 'discuss', 'second_quarter', 'result', 'am'], ['interested', 'party', 'participate', 'call', 'dialing'], ['toll', 'free', 'international'], ['live', 'mediaframe'], ['follow', 'conclusion', 'call', 'audio', 'recording', 'transcript', 'call', 'access', 'company', 'website'], [], ['provider', 'home', 'medical', 'equipment', 'post', 'acute', 'respiratory', 'healthcare', 'service', 'service', 'offering', 'focus', 'effective', 'home', 'treatment', 'clinical', 'practitioner', 'provide', 'therapy', 'counseling', 'patient', 'home', 'use', 'cut_edge', 'technology', 'visit', 'website'], ['glen', 'bristolircom'], ['chief', 'operate', 'officer', 'investorinfo', 'viemedcom'], ['certain', 'statement_contain_press', 'release', 'constitute_forward_look', 'statement_meaning', 'private_security_forward_look', 'information', 'such', 'term', 'define', 'applicable', 'canadian', 'security', 'legislation', 'collectively', 'forward_look_statement', 'often', 'always', 'forward_look_statement', 'identify', 'use', 'word', 'such', 'plan', 'expect', 'expect', 'budget', 'potential', 'schedule', 'estimate', 'forecast', 'intend', 'anticipate', 'believe', 'project', 'negative', 'thereof', 'variation', 'such', 'word', 'phrase', 'statement', 'certain', 'action', 'event', 'result', 'take', 'occur', 'achieve', 'negative', 'term', 'comparable', 'terminology', 'statement', 'other', 'statement_historical_fact', 'include', 'express', 'involve', 'discussion', 'expectation', 'belief', 'plan_objective', 'assumption', 'future', 'event', 'performance', 'include', 'company', 'net', 'revenue_guidance', 'third_quarter', 'historical_fact', 'forward_look_statement', 'involve', 'estimate', 'assumption', 'uncertainty_cause', 'actual', 'result', 'outcome', 'differ_materially', 'express', 'forward_look_statement', 'such', 'statement', 'reflect', 'company', 'current', 'view', 'intention', 'respect', 'future', 'event', 'current', 'information', 'available', 'company', 'subject', 'certain', 'risk_uncertainty', 'assumption', 'many', 'factor_cause_actual', 'result', 'performance_achievement', 'express_imply', 'such_forward_look', 'statement', 'vary', 'describe', 'more', 'risk_uncertainty', 'materialize', 'factor', 'include_limitation', 'general', 'business', 'market', 'economic_condition', 'region', 'company', 'operate', 'impact', 'pandemic', 'action', 'take', 'governmental', 'authority', 'individual', 'company', 'response', 'pandemic', 'business', 'financial', 'condition', 'result', 'operation', 'include', 'company', 'patient', 'base', 'revenue', 'employee', 'equipment', 'supply', 'significant', 'capital', 'requirement', 'operate', 'risk', 'company', 'subject', 'ability', 'company', 'implement', 'business', 'strategy', 'pursue', 'business', 'opportunity', 'volatility', 'market', 'price', 'company', 'common_share', 'company', 'novel', 'business', 'model', 'risk', 'clinical', 'application', 'treatment', 'demonstrate', 'positive', 'result', 'study', 'positively', 'replicate', 'such', 'test', 'result', 'predictive', 'actual', 'treatment', 'result', 'result', 'adoption', 'such', 'treatment', 'provider', 'state', 'capital', 'market', 'availability', 'fund', 'resource', 'pursue', 'operation', 'reduction', 'reimbursement', 'rate', 'audits', 'reimbursement', 'claim', 'various', 'governmental', 'private', 'payor', 'entity', 'dependence', 'few', 'payor', 'possible', 'new', 'drug_discovery', 'dependence', 'key', 'supplier', 'recall', 'certain', 'royal', 'philip', 'bipap', 'cpap', 'device', 'ventilator', 'distribute', 'sell', 'granting', 'permit', 'license', 'highly', 'regulated', 'business', 'competition', 'low', 'profit', 'market', 'segment', 'disruption', 'attack', 'include', 'attack', 'company', 'information', 'technology', 'internet', 'network', 'access', 'other', 'voice', 'datum', 'communication', 'system', 'service', 'evolution', 'various', 'type', 'fraud', 'other', 'criminal', 'behavior', 'company', 'expose', 'failure', 'third_party', 'comply', 'obligation', 'difficulty', 'integrate', 'newly', 'acquire', 'business', 'impact', 'new', 'change', 'application', 'current', 'law', 'regulation', 'overall', 'difficult', 'litigation', 'regulatory', 'environment', 'increase', 'competition', 'change_foreign_currency', 'rate', 'increase', 'funding', 'cost', 'market', 'volatility', 'market', 'illiquidity', 'competition', 'funding', 'critical', 'accounting', 'estimate', 'change', 'accounting', 'standard', 'policy', 'method', 'use', 'company', 'company', 'status', 'emerge', 'growth', 'company', 'small', 'reporting', 'company', 'occurrence', 'natural', 'unnatural', 'catastrophic', 'event', 'health', 'epidemic', 'concern', 'such', 'pandemic', 'claim', 'result', 'such', 'event', 'concern', 'as_well', 'risk_factor', 'discuss', 'refer', 'company', 'disclosure', 'document_file', 'available', 'website', 'include', 'company', 'most_recent', 'annual_report_form', 'quarterly_report_form', 'security', 'regulatory_authority', 'certain', 'province', 'available', 'wwwsedarcom', 'factor', 'affect', 'company', 'unexpected', 'manner', 'assumption_underlie', 'forward_look_statement', 'prove', 'incorrect', 'actual', 'result', 'event', 'differ_materially', 'result', 'event', 'predict', 'such_forward_look', 'statement', 'expressly', 'qualified', 'entirety', 'cautionary', 'statement', 'moreover', 'company', 'assume', 'responsibility', 'accuracy', 'completeness', 'such_forward_look', 'statement', 'forward_look_statement', 'include', 'press_release', 'make', 'date_press_release', 'company', 'undertake_obligation', 'publicly_update', 'revise_forward_look', 'statement', 'other', 'require_applicable', 'law'], ['condense_consolidated_balance_sheet', 'express', 'thousand', 'dollar', 'share_amount', 'unaudited'], ['condense_consolidated_statement', 'income', 'comprehensive', 'income', 'express', 'thousand', 'dollar', 'outstanding', 'share', 'share_amount', 'unaudited'], ['condense_consolidated_statement', 'cash_flow', 'express', 'thousand', 'dollar', 'unaudited'], ['non_gaap_financial_measure'], ['press_release', 'refer', 'adjust_ebitda', 'non_gaap_financial_measure', 'standardized', 'meaning', 'prescribe', 'company', 'presentation', 'financial_measure', 'comparable', 'similarly', 'title', 'measure', 'use', 'other', 'company', 'adjust_ebitda', 'define', 'net_income', 'loss', 'interest', 'expense', 'income_tax', 'expense', 'benefit', 'depreciation', 'stock_base_compensation', 'management_believe', 'adjust_ebitda', 'provide', 'helpful', 'information', 'respect', 'company', 'operating', 'performance', 'view', 'management', 'include', 'view', 'company', 'business', 'dependent', 'impact', 'company', 'capitalization', 'structure', 'item', 'part', 'company', 'day', 'day', 'operation', 'management', 'use', 'adjust_ebitda', 'compare', 'company', 'operate', 'performance', 'consistent', 'basis', 'calculate', 'incentive', 'compensation', 'company', 'employee', 'planning', 'purpose', 'include', 'preparation', 'company', 'internal', 'annual', 'operating', 'budget', 'evaluate', 'performance', 'effectiveness', 'company', 'operational', 'strategy', 'accordingly', 'management_believe', 'adjust_ebitda', 'provide', 'useful', 'information', 'understanding', 'evaluate', 'company', 'operate', 'performance', 'same', 'manner', 'management', 'follow', 'table', 'reconciliation', 'net_income', 'loss', 'most', 'directly', 'comparable', 'gaap', 'measure', 'adjust_ebitda', 'historical', 'basis', 'period', 'indicate'], ['reconciliation', 'net_income', 'non_gaap', 'adjust_ebitda', 'express', 'thousand', 'dollar', 'unaudited'], ['adjust_ebitda', 'consider', 'addition', 'substitute', 'superior', 'financial_measure', 'calculate', 'accordance_gaap', 'measurement', 'company', 'financial_performance', 'gaap', 'consider', 'alternative', 'revenue', 'net_income', 'applicable', 'other', 'performance', 'measure', 'derive', 'accordance_gaap', 'comparable', 'other', 'similarly', 'title', 'measure', 'other', 'business', 'adjust_ebitda', 'limitation', 'analytical', 'tool', 'consider_isolation', 'substitute', 'analysis', 'company', 'operating', 'result', 'report', 'gaap', 'adjust_ebitda', 'reflect', 'impact', 'certain', 'cash_charge', 'result', 'matter', 'company', 'consider', 'indicative', 'ongoing', 'operation', 'other', 'company', 'company', 'industry', 'calculate', 'adjusted', 'ebitda', 'differently', 'limit', 'usefulness', 'comparative', 'measure'], ['key', 'financial', 'operational', 'information', 'express', 'thousand', 'dollar', 'vent', 'patient', 'unaudited'], ['non_gaap_financial_measure', 'section', 'definition', 'adjust_ebitda'], ['patient', 'represent', 'number', 'active', 'ventilator', 'patient', 'recur', 'billing', 'service', 'end', 'calendar', 'quarter'], ['laser', 'therapy', 'modality', 'form', 'valuable', 'tool', 'repertoire', 'veterinary', 'practitioner', 'surgical', 'therapeutic', 'purpose', 'popularity', 'stem', 'fact', 'reduce', 'pain', 'inflammation', 'further', 'facilitate', 'tissue', 'heal', 'wide', 'spectrum', 'disease', 'various', 'animal', 'include', 'pet', 'recent', 'year', 'modality', 'make', 'way', 'veterinary', 'dental', 'use', 'treat', 'tumor', 'canine', 'application', 'laser', 'technique', 'enable', 'veterinarian', 'treat', 'common', 'cutaneous', 'tumor', 'dog', 'such', 'laser', 'typically', 'utilize', 'property', 'carbon', 'dioxide'], ['efficacy', 'treatment', 'attribute', 'several', 'attractive', 'benefit', 'such', 'non', 'contact', 'dissection', 'well', 'hemostasis', 'reduce', 'chance', 'intraoperative', 'wound', 'contamination', 'such', 'type', 'veterinary_laser', 'find', 'extensive', 'use', 'perform', 'oncologic', 'surgery', 'skin', 'lesion', 'regard', 'low', 'level', 'laser', 'therapy', 'mainly', 'use', 'red', 'near', 'infrared', 'light', 'function', 'principle', 'occupy', 'promising', 'role'], ['grow', 'number', 'study', 'regard', 'efficacy', 'laser', 'modality', 'different', 'animal', 'surgical', 'therapeutic', 'purpose', 'impart', 'sustained', 'momentum', 'growth', 'market', 'however', 'result', 'suffer', 'crucial', 'setback', 'lack', 'uniformity', 'study', 'result', 'different', 'animal_model', 'such', 'mouse', 'horse', 'porcine', 'model', 'vital', 'factor', 'limit', 'application', 'furthermore', 'lack', 'standard', 'experimental', 'protocol', 'confound', 'problem', 'however', 'effort', 'device', 'maker', 'confront', 'challenge', 'create', 'technologically', 'advance', 'laser', 'product', 'open', 'new', 'exciting', 'avenue', 'veterinary_laser', 'market', 'rise', 'number', 'pet', 'ownership', 'develop', 'country', 'also', 'help', 'market', 'expand', 'rapidly', 'year', 'come', 'market', 'witness', 'rise', 'number', 'clinical', 'study', 'involve', 'pet', 'evaluation', 'therapeutic', 'efficacy', 'laser', 'such', 'development', 'bode', 'well', 'market', 'global', 'veterinary_laser', 'market', 'veterinary_laser', 'find', 'application', 'treatment', 'pet', 'laser', 'therapy', 'light', 'particular', 'wavelength', 'make', 'penetrate', 'injure', 'cell', 'bring', 'recovery', 'laser', 'therapy', 'serve', 'lessen', 'pain', 'up', 'vascular', 'metabolic', 'activity', 'bring', 'fast', 'healing', 'wound', 'swift', 'tissue', 'repair', 'overall', 'market', 'veterinary_laser', 'see', 'make', 'healthy', 'progress', 'effort', 'savvy', 'player', 'build', 'well', 'product', 'shine', 'example', 'direction', 'development', 'series', 'market', 'player', 'biolase', 'product', 'series', 'cut', 'fast', 'consume', 'less', 'power', 'give', 'less', 'heat', 'bring', 'trauma', 'cause', 'pet', 'treat', 'also', 'improve', 'rate', 'heal', 'brochure', 'report', 'global', 'veterinary_laser', 'market', 'key', 'trend', 'global', 'market', 'veterinary_laser', 'expect', 'rise', 'significant', 'pace', 'next', 'couple', 'year', 'back', 'growth', 'pet', 'adoption', 'people', 'account', 'rise', 'disposable', 'income', 'couple', 'rise', 'awareness', 'pet', 'care', 'solid', 'network', 'healthcare', 'center', 'particularly', 'advanced', 'western', 'country', 'have', 'major', 'positive', 'impact', 'market', 'reason', 'swift', 'adoption', 'veterinary_laser', 'non_invasive', 'nature', 'swift', 'healing', 'bring', 'about', 'post', 'surgery', 'recovery', 'time', 'apply', 'range', 'pet', 'namely', 'avian', 'feline', 'canine', 'other', 'factor', 'propel', 'growth', 'veterinary_laser', 'however', 'high', 'cost', 'veterinary_laser', 'factor', 'pose', 'challenge', 'sale', 'inadequate', 'number', 'train', 'professional', 'carry', 'complex', 'procedure', 'also', 'affect', 'market', 'growth', 'global', 'veterinary_laser', 'market', 'market', 'different_type', 'veterinary_laser', 'use', 'market', 'therapeutic', 'laser', 'low', 'level', 'laser', 'therapy', 'surgical', 'laser', 'high', 'energy', 'laser', 'depend', 'configuration', 'key', 'segment', 'market', 'compact', 'portable', 'bench', 'top', 'veterinary_laser', 'primarily', 'find', 'application', 'pain', 'therapy', 'soft', 'tissue', 'surgery', 'key', 'end', 'use', 'segment', 'market', 'veterinary', 'hospital', 'veterinary', 'clinic', 'veterinary', 'hospital', 'other', 'get', 'table', 'content', 'report', 'global', 'veterinary_laser', 'market', 'regional', 'geographically', 'report', 'divide', 'market', 'veterinary_laser', 'purpose', 'study', 'find', 'key', 'market', 'account', 'high_degree', 'awareness', 'pet', 'owner', 'region', 'health', 'pet', 'also', 'benefit', 'procedure', 'apart', 'high', 'income', 'people', 'region', 'enable', 'adopt', 'such', 'costly', 'treatment', 'well', 'other', 'hand', 'expect', 'rise', 'moderate', 'pace', 'grow', 'number', 'local', 'manufacturer', 'continue', 'thrust', 'product', 'development', 'popularity', 'non_invasive', 'treatment', 'method', 'global', 'veterinary_laser', 'market', 'competitive', 'dynamic', 'key', 'player', 'global', 'market', 'veterinary_laser', 'vb', 'direct', 'limited', 'aspen', 'laser', 'system', 'laser', 'technology', 'laser', 'global', 'veterinary_laser', 'market', 'segment', 'follow', 'veterinary', 'market', 'regional', 'segment', 'analysis'], ['discount', 'late', 'report', 'rich', 'experience', 'develop', 'state_art', 'report', 'wide', 'array', 'market', 'sector', 'brilliance', 'expert', 'research', 'alacrity', 'conduct', 'thorough', 'research', 'create', 'phenomenal', 'report', 'make', 'tmr', 'research', 'well', 'other', 'growth_formula', 'growth_formula', 'develop', 'research', 'provide', 'insight', 'stakeholder_cxo', 'current', 'situation', 'market', 'growth_formula', 'make', 'report', 'perfect', 'companion', 'stakeholder_cxo', 'growth_formula', 'include', 'follow', 'point'], ['current', 'future', 'threat', 'study', 'opportunity', 'necessary', 'growth', 'threat', 'also', 'important', 'aspect', 'look', 'company', 'stakeholder', 'specific', 'sector', 'tmr', 'research', 'study', 'negative', 'aspect', 'hinder', 'growth', 'specific', 'area', 'business', 'include', 'report', 'stakeholder_cxo', 'benefit', 'assess', 'threat', 'take', 'necessary', 'step', 'prevent', 'hindrance', 'cause', 'threat', 'accurate', 'trend', 'analysis', 'keep', 'late', 'trend', 'crucial', 'business', 'sector', 'stakeholder', 'aware', 'trend', 'surface', 'tmr', 'researcher', 'find', 'trend', 'deeply', 'entrenched', 'particular', 'market', 'sector', 'report', 'constantly', 'update', 'late', 'trend', 'stakeholder_cxo', 'derive', 'benefit', 'trend', 'generate', 'good', 'revenue', 'regional', 'assessment', 'demography', 'form', 'important', 'part', 'growth', 'pattern', 'market', 'dive', 'deep', 'demographic', 'enable', 'maximum', 'output', 'specific', 'area', 'research', 'team', 'assess', 'region', 'pick', 'vital', 'point', 'large', 'impact', 'growth', 'market', 'analogy', 'analyst', 'research', 'conduct', 'all', 'round', 'analysis', 'competitive_landscape', 'market', 'observation', 'record', 'analyst', 'add', 'report', 'stakeholder', 'get', 'glimpse', 'competitive', 'scenario', 'frame', 'business', 'plan', 'accord', 'situation', 'impact', 'outbreak', 'change', 'growth', 'projection', 'numerous', 'sector', 'business', 'analyst', 'conduct', 'conscientious', 'survey', 'market', 'pandemic', 'strike', 'analyst', 'put', 'brilliant', 'well', 'research', 'opinion', 'report', 'opinion', 'help', 'stakeholder', 'plan', 'strategy', 'accordingly', 'report', 'offer', 'answer', 'top', 'question', 'revolve', 'growth', 'market'], ['premier', 'provider', 'customize', 'market', 'research', 'consulting', 'service', 'business', 'entity', 'keen', 'succeed', 'today', 'supercharged', 'economic', 'climate', 'arm', 'experienced', 'dedicated', 'dynamic', 'team', 'analyst', 'redefine', 'way', 'client', 'conduct', 'business', 'provide', 'authoritative', 'trusted', 'research', 'study', 'tune', 'late', 'methodology', 'market', 'trend', 'contact', 'balboa', 'visit', 'site'], ['accord', 'transparency_market', 'late', 'report', 'global_teleradiology', 'market', 'historical', 'period', 'forecast_period', 'advancement', 'digital', 'technology', 'rise', 'number', 'radiology', 'imaging', 'procedure', 'project', 'drive', 'global_teleradiology', 'market'], ['accord', 'report', 'global_teleradiology', 'market', 'value_bn', 'project', 'expand_cagr'], ['advancement', 'digital', 'technology', 'adoption', 'outsource', 'developed', 'country', 'key_driver'], ['rapid', 'development', 'digital', 'image', 'processing', 'technology', 'ensure', 'effective', 'image', 'distribution', 'regional', 'local', 'global', 'level', 'vastly', 'improve', 'capacity', 'internet', 'speed', 'transmission', 'permit', 'much', 'wide', 'use', 'teleradiology', 'center', 'world', 'provide', 'day', 'time', 'reporting', 'hour', 'image', 'service', 'other', 'country', 'different', 'time', 'zone'], ['sample', 'report_sample_samplephpflag'], ['emergence', 'acceptance', 'mobile', 'technology', 'mhealth', 'visualize', 'interpret', 'image', 'further', 'fuel', 'growth', 'teleradiology_market', 'develop', 'nation', 'such', 'widespread', 'use', 'smart', 'connectivity', 'device', 'related', 'solution', 'confirm', 'effective', 'interpretation', 'medical', 'image', 'thereby', 'reduce', 'treatment', 'time', 'hence', 'advancement', 'digital', 'technology', 'enhance', 'remote', 'patient', 'monitoring', 'methodology', 'accessibility', 'radiologist', 'interpretation', 'consultation'], ['outsource', 'radiology', 'service', 'well', 'train', 'radiologist', 'work', 'relatively', 'low', 'fraction', 'cost', 'profitable', 'health_care', 'provider', 'accord', 'macroeconomic', 'principle', 'hub', 'therefore', 'emerge', 'price', 'sensitive', 'country', 'handle', 'bulk', 'radiology', 'reporting', 'requirement', 'radiologist', 'provide', 'service', 'rich', 'developed', 'country', 'focus', 'more', 'improve', 'role', 'image', 'consultant', 'consider', 'value', 'addition', 'patient', 'care', 'certain', 'case'], ['request_custom_research', 'sample_samplephpflag'], ['focus', 'geographic', 'expansion'], ['company', 'global_teleradiology', 'market', 'undergo', 'strategic', 'acquisition', 'various', 'product', 'launch', 'enable', 'product', 'distribution', 'various', 'region', 'also', 'strengthen', 'market', 'share', 'global', 'market'], ['acquire', 'several', 'company', 'last', 'year', 'expand', 'several', 'other', 'service', 'geographical', 'presence', 'instance', 'company', 'acquire', 'sunshine', 'radiology', 'expand', 'radiology', 'business', 'acquire', 'image', 'advantage', 'acquisition', 'also', 'intend', 'expand', 'radiology', 'business'], ['ask_reference_sample_samplephpflag'], ['high', 'cost', 'technology', 'lack', 'image', 'datum', 'security', 'hamper', 'market'], ['high', 'cost', 'involve', 'initial', 'set', 'installation', 'image', 'equipment', 'broadband', 'technology', 'remote', 'location', 'challenging', 'factor', 'teleradiology_market', 'moreover', 'chance', 'recover', 'cost', 'solely', 'depend', 'number', 'scan', 'arrive', 'day', 'introduction', 'subsequent', 'implementation', 'hi', 'tech', 'medical', 'device', 'imaging', 'technology', 'demand', 'gradation', 'infrastructure', 'change', 'seek', 'huge', 'cost', 'hamper', 'growth', 'market', 'least', 'profit', 'margin'], ['teleradiology', 'practice', 'involve', 'transfer', 'image', 'datum', 'globe', 'maintenance', 'datum', 'confidentiality', 'security', 'crucial', 'also', 'susceptible', 'crime', 'hack', 'need', 'development', 'virtual', 'private', 'network', 'datum', 'encryption', 'safeguard', 'datum', 'theft', 'reduce', 'further', 'ambiguity', 'hospital', 'clinician', 'patient', 'lack', 'robust', 'datum', 'security', 'tool', 'technology', 'hamper', 'growth', 'acceptance', 'teleradiology', 'technology', 'service'], ['make_enquiry', 'buy_sample_samplephpflag'], ['global_teleradiology', 'market', 'competitive_landscape'], ['report', 'profile', 'major', 'player', 'global_teleradiology', 'market', 'base', 'various', 'attribute', 'such', 'company', 'overview', 'financial', 'overview', 'product', 'portfolio', 'business', 'strategy', 'recent', 'development'], ['global_teleradiology', 'market', 'fragment', 'presence', 'number', 'international', 'as_well', 'regional', 'player'], ['various', 'player_operate', 'global_teleradiology', 'market'], ['more', 'trending', 'report', 'transparency_market', 'research'], ['home', 'diagnostic', 'market', 'global', 'home', 'diagnostic', 'market', 'project', 'expand_cagr'], ['control', 'unit', 'market', 'global', 'laboratory', 'temperature', 'control', 'unit', 'market', 'value', 'mn', 'project', 'expand', 'moderate', 'cagr'], ['single', 'use', 'cystoscope', 'market', 'global', 'single', 'use', 'cystoscope', 'market', 'value', 'mn', 'anticipate', 'expand_cagr'], ['informatic', 'market', 'healthcare', 'informatic', 'market', 'project', 'advance', 'robust', 'cagr_forecast_period'], ['suture', 'anchor', 'market', 'global', 'suture', 'anchor', 'market', 'value_bn', 'anticipate', 'expand_cagr'], ['system', 'market', 'global', 'laboratory', 'information', 'system', 'market', 'anticipate', 'reach', 'more', 'bn_end'], ['wind', 'irrigation', 'system', 'market', 'global', 'wound', 'irrigation', 'system', 'market', 'anticipate', 'reach', 'more', 'end'], ['market', 'grow', 'awareness', 'benefit', 'smart', 'digital', 'inhaler', 'patient', 'key', 'underpin', 'propel', 'evolution', 'inhaler', 'market'], [], ['transparency_market', 'research', 'global', 'market', 'research', 'company', 'register', 'provide', 'custom_research', 'consulting', 'service', 'exclusive', 'blend', 'quantitative', 'forecasting', 'trend', 'analysis', 'provide', 'forward_look', 'insight', 'thousand', 'decision', 'maker', 'experienced', 'team', 'analyst', 'researcher', 'consultant', 'use', 'proprietary', 'datum', 'source', 'various', 'tool', 'technique', 'gather', 'analyze', 'information'], ['datum', 'repository', 'continuously', 'update_revise', 'team', 'research', 'expert', 'always', 'reflect', 'late', 'trend', 'information', 'broad', 'research', 'analysis', 'transparency_market', 'research', 'employ', 'rigorous', 'primary', 'secondary', 'research', 'technique', 'develop', 'distinctive', 'datum', 'set', 'research', 'material', 'business', 'report'], ['more', 'research', 'insight', 'lead', 'industry', 'visit', 'youtube', 'hit', 'subscribe', 'future', 'update', 'https', 'wwwyoutubecom', 'tddmuodil', 'bkq'], ['transparency', 'corporate', 'downtown', 'suite', 'website', 'blog', 'email'], ['also', 'know', 'telemedicine', 'health', 'healthcare', 'service', 'delivery', 'remote', 'setting', 'solution', 'global_telemedicine', 'market', 'cover', 'consultation', 'exam', 'infrastructure', 'late', 'research', 'majority', 'healthcare', 'organization', 'implement', 'start', 'implementation', 'telemedicine', 'program', 'organization', 'trend', 'expect', 'positively', 'influence', 'demand', 'dynamic', 'global_telemedicine', 'market', 'next_few', 'year', 'as_well'], ['rise', 'trend', 'adopt', 'service', 'solution', 'global_telemedicine', 'market', 'also', 'penetrate', 'small', 'individual', 'healthcare', 'practitioner', 'period', 'pandemic', 'solution', 'global_telemedicine', 'market', 'aid', 'reduction', 'medical', 'cost', 'provide', 'enhance', 'patient', 'access', 'healthcare', 'professional', 'medical', 'service', 'improve', 'profitability', 'as_well', 'efficiency', 'medical', 'practitioner'], ['time', 'pandemic', 'solution', 'global_telemedicine', 'market', 'widely', 'use', 'gather', 'information', 'treat', 'patient', 'provide', 'accurate', 'diagnostic', 'connect', 'patient', 'eligible', 'medical', 'professional', 'service', 'global_telemedicine', 'market', 'also', 'utilize', 'several', 'government', 'large_scale', 'pandemic', 'order', 'reassure', 'spread', 'awareness', 'population', 'rise', 'demand', 'radiological', 'service', 'due', 'increase', 'prevalence', 'chronic', 'health', 'condition', 'such', 'orthopedic', 'injury', 'congestive_heart', 'failure', 'major', 'driving', 'factor', 'service', 'global_telemedicine', 'market'], ['sample', 'report_sample_samplephpflag'], ['furthermore', 'substantial', 'rise', 'government', 'spending', 'healthcare', 'information', 'sector', 'hcit', 'sector', 'as_well', 'increase', 'focus', 'player', 'global_telemedicine', 'market', 'innovate', 'digital', 'diagnostic', 'method', 'also', 'fuel', 'demand', 'global_telemedicine', 'market'], ['moreover', 'advancement', 'medical', 'diagnostic', 'technology', 'also', 'anticipate', 'create', 'new', 'avenue', 'expansion', 'global_telemedicine', 'market', 'come', 'year', 'increase', 'develop', 'prospect', 'emerge', 'establish', 'economy', 'also', 'expect', 'further_development', 'trajectory', 'global_telemedicine', 'market', 'next_few', 'year', 'high', 'demand', 'physician', 'virtual', 'consultation', 'service', 'also', 'positively', 'influence', 'growth', 'global_telemedicine', 'market'], ['accord', 'transparency_market', 'late', 'report', 'telemedicine_market', 'historical', 'period', 'forecast_period', 'increase', 'incidence', 'chronic', 'other', 'acute', 'disease', 'age', 'baby', 'boomer', 'population', 'technological_advancement', 'awareness', 'telehealth', 'service', 'increase', 'healthcare', 'expenditure', 'project', 'drive', 'telemedicine_market', 'forecast_period'], ['accord', 'report', 'telemedicine_market', 'value_bn', 'anticipate', 'expand_cagr'], ['request_custom_research', 'sample_samplephpflag'], ['increase', 'government', 'spending', 'reimbursement', 'policy', 'increase', 'age', 'population', 'boost', 'telemedicine', 'preference', 'key_driver'], ['government', 'world', 'increase', 'spending', 'healthcare', 'related', 'service', 'due', 'grow', 'health', 'concern', 'rise', 'non', 'infectious_disease', 'accord', 'research', 'conduct', 'institute', 'fiscal', 'study', 'government', 'spending', 'healthcare', 'national', 'income', 'increase', 'public', 'spending', 'health', 'increase', 'moreover', 'real', 'spending', 'healthcare', 'grow', 'fast', 'rate', 'reportedly', 'high', 'national', 'income', 'growth', 'rate'], ['continuous', 'growth', 'geriatric', 'population', 'expect', 'potential', 'driver', 'telemedicine_market', 'forecast_period', 'accord', 'estimate', 'global', 'geriatric', 'population', 'likely', 'reach', 'around', 'global', 'population', 'further', 'expect', 'further', 'drive', 'telemedicine_market', 'forecast_period', 'age', 'population', 'prone', 'long_term', 'care', 'other', 'chronic', 'disease', 'include', 'cardiology', 'orthopedic', 'other', 'condition', 'major', 'factor', 'drive', 'demand', 'telemedicine', 'service'], ['ask_reference_sample_samplephpflag'], ['nursing', 'remote', 'care', 'handle', 'solution', 'handle', 'large', 'patient', 'pool'], ['increase', 'patient', 'pool', 'create', 'huge', 'burden', 'exist', 'healthcare', 'system', 'world', 'patient', 'complaint', 'infection', 'create', 'mild', 'panic', 'situation', 'developed', 'develop', 'country', 'large', 'percentage', 'patient', 'represent', 'normal', 'situation', 'false', 'alarm', 'many', 'case', 'arise', 'due', 'misinformation', 'regard', 'medical', 'application', 'unnecessary', 'confusion', 'panic', 'problem', 'effectively', 'filter', 'train', 'front', 'level', 'medical', 'practitioner', 'nursing', 'staff', 'practice', 'doctor', 'filtering', 'efficiently', 'implement', 'decrease', 'workload', 'increase', 'effectiveness', 'productivity', 'experienced', 'medical', 'practitioner', 'scarce', 'many', 'region', 'also', 'improve', 'patient', 'care', 'pave', 'way', 'provide', 'increase', 'attention', 'more', 'serious', 'case', 'highly', 'time', 'bind', 'emergency', 'case'], ['nurse', 'often', 'well', 'informed', 'appropriate', 'expert', 'medical', 'practitioner', 'specialize', 'particular', 'case', 'accord', 'stroke', 'account', 'death', 'more', 'people', 'die', 'injury', 'accident', 'globally', 'year', 'such', 'emergency', 'case', 'highly', 'benefit', 'timely', 'accurate', 'organize', 'telemedicine', 'service', 'thereby', 'reduce', 'global', 'fatality'], ['make_enquiry', 'buy_sample_samplephpflag'], ['increase', 'demand', 'personal', 'healthcare', 'privacy', 'boost', 'market', 'telemedicine'], ['pocket', 'capita', 'spending', 'increase', 'past', 'few', 'year', 'people', 'thus', 'huge', 'demand', 'personal', 'healthcare', 'service', 'grow', 'patient', 'burden', 'outpatient', 'shift', 'other', 'form', 'patient', 'care', 'telemedicine', 'witness', 'constant', 'growth', 'rate'], ['demonstrate', 'people', 'favor', 'telemedicine', 'personal', 'healthcare', 'hospital', 'visit', 'trend', 'expect', 'continue', 'future', 'telemedicine', 'likely', 'replace', 'outpatient', 'hospital', 'visit', 'individual', 'consider', 'hospital', 'infection', 'convenience', 'maintenance', 'privacy', 'primary', 'factor', 'prefer', 'home', 'telemedicine', 'solution', 'telemedicine', 'usage', 'therefore', 'expect', 'rise', 'increase', 'demand', 'personal', 'healthcare'], ['telemedicine_market', 'competitive_landscape'], ['report', 'profile', 'major', 'player', 'telemedicine_market', 'base', 'various', 'attribute', 'such', 'company', 'overview', 'financial', 'overview', 'product', 'portfolio', 'business', 'strategy', 'recent', 'development'], ['telemedicine_market', 'highly', 'fragment', 'due', 'presence', 'various', 'player', 'offer', 'telemedicine', 'service', 'grow', 'patient', 'population'], ['prominent', 'player_operate', 'telemedicine_market'], ['blood', 'purification', 'equipment', 'market', 'global', 'blood', 'purification', 'equipment', 'market', 'expect', 'expand', 'healthy', 'cagr_forecast_period'], ['epileptic', 'seizure', 'treatment', 'market', 'global', 'epileptic', 'seizure', 'treatment', 'market', 'course', 'surpass', 'bn', 'mark', 'end'], ['serum', 'free', 'medium', 'market', 'global', 'serum', 'free', 'medium', 'market', 'project', 'reach', 'mn', 'manufacturer', 'increase', 'output', 'capacity', 'customize', 'cell', 'culture', 'medium'], ['skincare', 'product', 'market', 'global', 'skincare', 'product', 'market', 'project', 'grow', 'cagr_forecast_period'], ['ai', 'drug_discovery', 'market', 'drug_discovery', 'market', 'estimate', 'expand_cagr', 'forecast_period'], ['self', 'sample', 'blood', 'collection', 'storage', 'device', 'market', 'self', 'sample', 'blood', 'collection', 'storage', 'device', 'market', 'slate', 'clock', 'cagr'], ['home', 'diagnostic', 'market', 'rise', 'consumer', 'awareness', 'enhance', 'lifestyle', 'project', 'regional', 'market', 'grow', 'high', 'cagr_forecast_period'], ['pressure', 'ulcer', 'treatment', 'market', 'pressure', 'ulcer', 'treatment', 'market', 'size', 'project', 'cross_value', 'bn', 'technological_advancement', 'wound', 'care', 'solution', 'expand', 'growth', 'frontier', 'pressure', 'ulcer', 'treatment'], ['plasmon', 'phenomenon', 'squeeze', 'light', 'tiny', 'volume', 'cause', 'biomolecule', 'trap', 'surface', 'turn', 'enable', 'study', 'microscope', 'recent', 'past', 'sprs', 'use', 'drug_discovery', 'material', 'science', 'development', 'biosensor', 'now', 'researcher', 'suggest', 'tool', 'also', 'know', 'lab', 'chip', 'pave', 'new', 'way', 'detection', 'diagnosis', 'cancer', 'virus', 'other', 'ailment', 'cause', 'biomolecule', 'add', 'whole', 'new', 'revenue', 'vendor', 'operate', 'surface_plasmon_resonance', 'market'], ['formally', 'name', 'nanotweezer', 'novel', 'spr', 'device', 'ability', 'function', 'reduced', 'amount', 'laser', 'power', 'trap', 'stabilize', 'molecule', 'allow', 'study', 'high', 'resolution', 'possible', 'previous', 'version', 'addition', 'new', 'device', 'also', 'potentially', 'utilize', 'broadband', 'light', 'wavelength', 'aggregate', 'silicon', 'gold', 'nanoparticle', 'turn', 'expand', 'application', 'permanent', 'non', 'fading', 'color', 'print', 'researcher', 'use', 'plasmonic', 'order', 'construct', 'kind', 'spr', 'device', 'exceptionally', 'fast', 'term', 'trap', 'detect', 'virus', 'molecule', 'dna'], ['apart', 'innovation', 'field', 'market', 'surface_plasmon_resonance', 'gain', 'traction', 'increase', 'public', 'private', 'investment', 'clinical', 'research', 'order', 'formulate', 'drug', 'therapy', 'number', 'chronic', 'disease', 'gain', 'strong', 'prevalence', 'pass', 'year', 'addition', 'increase', 'adoption', 'microfluidic', 'technology', 'order', 'reduce', 'usage', 'reagent', 'introduction', 'advanced', 'imaging', 'software', 'order', 'analyze', 'result', 'also', 'expect', 'create', 'new', 'opportunity', 'market', 'near', 'future'], ['global', 'plasmon', 'market', 'overview'], ['plasmon', 'label', 'free', 'detection', 'technique', 'use', 'analyze', 'kinetic', 'interaction', 'biomolecule', 'late', 'witness', 'high', 'traction', 'account', 'benefit', 'technique', 'offer', 'include', 'sensitivity', 'high', 'specificity', 'demand', 'surface_plasmon_resonance', 'extremely', 'high', 'biotechnology', 'sector', 'pharmaceutical', 'sector', 'clinical', 'research', 'organization', 'food', 'beverage', 'industry', 'drug_discovery', 'biosensor', 'material', 'science', 'plasmon_resonance', 'technology', 'use', 'determine', 'affinity', 'reaction', 'identify', 'bind', 'specificity', 'more', 'molecule', 'as_well', 'measure', 'dissociation', 'as_well', 'association', 'rate', 'therefore', 'surprising', 'growth', 'surface_plasmon_resonance', 'market', 'witness', 'positive', 'outlook', 'year', 'come'], ['application', 'surface_plasmon_resonance', 'development', 'point', 'care', 'device', 'long', 'focus', 'market', 'player', 'player', 'however', 'meet', 'challenge', 'such', 'difficulty', 'mass', 'fabrication', 'durable', 'metal', 'nanostructure', 'substrate', 'high', 'cost'], ['brochure', 'report'], ['global', 'plasmon', 'market', 'driver', 'trend'], ['key', 'trend', 'see', 'surface_plasmon_resonance', 'market', 'grow', 'adoption', 'microfluidic', 'technique', 'lower', 'consumption', 'reagent', 'friend', 'influence', 'market', 'introduction', 'advanced', 'imaging', 'software', 'analysis', 'surface_plasmon_resonance', 'extensive', 'investment', 'carry', 'consistently', 'research', 'development', 'surface_plasmon_resonance', 'system', 'also', 'market', 'grow', 'region'], ['chief', 'factor', 'boost', 'growth', 'market', 'rise', 'adoption', 'label', 'free', 'detection', 'technique', 'oppose', 'label', 'detection', 'technique', 'majorly', 'due', 'cost', 'effectiveness', 'label', 'free', 'detection', 'technique', 'availability', 'versatile', 'surface_plasmon_resonance', 'system', 'factor', 'growth', 'market', 'other', 'hand', 'emergence', 'alternative', 'technique', 'detection', 'protein', 'act', 'threat', 'hamper', 'growth', 'market', 'addition', 'high', 'cost', 'product', 'also', 'deter', 'surface_plasmon_resonance', 'system', 'adopt', 'large_scale'], ['table', 'content', 'report'], ['global', 'plasmon', 'market', 'geographic', 'analysis'], ['geographically', 'report', 'split', 'surface_plasmon_resonance', 'market', 'region', 'report', 'mention', 'region', 'witness', 'maximum', 'growth', 'witness', 'sluggish', 'growth', 'fast', 'grow', 'regional', 'segment', 'also', 'reveal'], ['global', 'plasmon_resonance', 'market', 'company', 'mention'], ['biosense', 'instrument', 'bio', 'rad', 'laboratory', 'key', 'player_operate', 'plasmon_resonance', 'market', 'business', 'financial', 'overview', 'company', 'information', 'merger', 'acquisition', 'give', 'challenge', 'face', 'as_well', 'strategy', 'adopt', 'player', 'reveal', 'report'], ['discount', 'late', 'report'], ['rich', 'experience', 'develop', 'state_art', 'report', 'wide', 'array', 'market', 'sector', 'brilliance', 'expert', 'research', 'alacrity', 'conduct', 'thorough', 'research', 'create', 'phenomenal', 'report', 'make', 'tmr', 'research', 'well', 'other'], ['growth_formula'], ['growth_formula', 'develop', 'research', 'provide', 'insight', 'stakeholder_cxo', 'current', 'situation', 'market', 'growth_formula', 'make', 'report', 'perfect', 'companion', 'stakeholder_cxo'], ['growth_formula', 'include', 'follow', 'point'], ['current', 'future', 'threat'], ['study', 'opportunity', 'necessary', 'growth', 'threat', 'also', 'important', 'aspect', 'look', 'company', 'stakeholder', 'specific', 'sector', 'tmr', 'research', 'study', 'negative', 'aspect', 'hinder', 'growth', 'specific', 'area', 'business', 'include', 'report', 'stakeholder_cxo', 'benefit', 'assess', 'threat', 'take', 'necessary', 'step', 'prevent', 'hindrance', 'cause', 'threat'], ['accurate', 'trend', 'analysis'], ['keep', 'late', 'trend', 'crucial', 'business', 'sector', 'stakeholder', 'aware', 'trend', 'surface', 'tmr', 'researcher', 'find', 'trend', 'deeply', 'entrenched', 'particular', 'market', 'sector', 'report', 'constantly', 'update', 'late', 'trend', 'stakeholder_cxo', 'derive', 'benefit', 'trend', 'generate', 'good', 'revenue'], ['regional', 'assessment'], ['demography', 'form', 'important', 'part', 'growth', 'pattern', 'market', 'dive', 'deep', 'demographic', 'enable', 'maximum', 'output', 'specific', 'area', 'research', 'team', 'assess', 'region', 'pick', 'vital', 'point', 'large', 'impact', 'growth', 'market'], ['industrial', 'analogy'], ['analyst', 'research', 'conduct', 'all', 'round', 'analysis', 'competitive_landscape', 'market', 'observation', 'record', 'analyst', 'add', 'report', 'stakeholder', 'get', 'glimpse', 'competitive', 'scenario', 'frame', 'business', 'plan', 'accord', 'situation'], ['impact'], ['outbreak', 'change', 'growth', 'projection', 'numerous', 'sector', 'business', 'analyst', 'conduct', 'conscientious', 'survey', 'market', 'pandemic', 'strike', 'analyst', 'put', 'brilliant', 'well', 'research', 'opinion', 'report', 'opinion', 'help', 'stakeholder', 'plan', 'strategy', 'accordingly'], ['report', 'offer', 'answer', 'top', 'question', 'revolve', 'growth', 'market'], [], ['premier', 'provider', 'customize', 'market', 'research', 'consulting', 'service', 'business', 'entity', 'keen', 'succeed', 'today', 'supercharged', 'economic', 'climate', 'arm', 'experienced', 'dedicated', 'dynamic', 'team', 'analyst', 'redefine', 'way', 'client', 'conduct', 'business', 'provide', 'authoritative', 'trusted', 'research', 'study', 'tune', 'late', 'methodology', 'market', 'trend'], ['balboa', 'visit', 'site'], ['safety_needle', 'characterize', 'empty', 'bore', 'needle', 'consider', 'decrease', 'lessen', 'likelihood', 'skin', 'cut', 'harm', 'specialist', 'medication', 'organization', 'safety_needle', 'simply', 'annul', 'principle', 'pass', 'absorption', 'medication', 'oral', 'movement', 'yet', 'also', 'save', 'medication', 'change', 'enzymatic', 'activity', 'patient', 'body', 'make', 'corruption', 'pharmaceutical', 'variable', 'section', 'time', 'side_effect', 'account', 'medication', 'metabolite', 'sole', 'motivation', 'plan', 'safety_needle', 'evade', 'needlestick', 'wound', 'gather', 'liquid', 'convey', 'medication', 'body'], ['wound', 'support', 'debased', 'needle', 'achieve', 'pollution', 'various', 'dangerous', 'blood', 'bear', 'infection', 'diverse', 'government', 'look', 'norm', 'instance', 'usage', 'exchange', 'program', 'safety', 'execution', 'develop', 'mindfulness', 'people', 'connection', 'illness', 'inferable', 'use', 'tainted', 'needle', 'perspective', 'presumably', 'go', 'drive', 'prerequisite', 'well', 'quality', 'safety_needle', 'rise', 'awareness', 'nsis', 'human', 'service', 'specialist', 'hcws', 'impel', 'development', 'safety_needle', 'advertise', 'district', 'anticipate', 'period'], ['key', 'factor', 'fuel', 'growth', 'global', 'safety_needle', 'market', 'ascend', 'requirement', 'precise', 'organization', 'additionally', 'point', 'interest', 'offer', 'safety_needle', 'example', 'counteractive', 'action', 'change', 'enzymatic', 'movement', 'drug', 'organization', 'impel', 'market', 'development'], ['global', 'safety_needle', 'market', 'overview'], ['demand', 'product', 'capable', 'arrest', 'rise', 'number', 'gravity', 'injury', 'key', 'factor', 'help', 'global', 'safety_needle', 'market', 'expand', 'healthy', 'pace', 'recent', 'year', 'rise', 'participation', 'manufacturer', 'healthcare', 'organization', 'government', 'non', 'government', 'body', 'activity', 'program', 'aim', 'raise', 'awareness', 'regard', 'safety', 'hazard', 'induce', 'reusable', 'needle', 'patient', 'as_well', 'healthcare_provider', 'expect', 'key', 'factor', 'drive', 'market', 'near', 'future'], ['market', 'also', 'expect', 'drive', 'rise', 'use', 'prefille', 'syrinx', 'number', 'application', 'number', 'pharmaceutical', 'company', 'adopt', 'prefille', 'syrinx', 'rise', 'steady', 'pace', 'market', 'prefille', 'syrinx', 'consecutively', 'safety_needle', 'expect', 'rise', 'near', 'future', 'market', 'also', 'expect', 'benefit', 'massively', 'rise', 'prevalence', 'number', 'chronic', 'disease', 'infection', 'resultant', 'rise', 'demand', 'disease', 'diagnosis', 'treatment', 'activity'], ['global', 'safety_needle', 'market', 'segmentation'], ['basis', 'distribution', 'channel', 'report', 'segment', 'global', 'safety_needle', 'market', 'private', 'clinic', 'hospital', 'pharmacy', 'retail', 'pharmacy', 'drug', 'store', 'segment', 'hospital', 'pharmacy', 'expect', 'account', 'consumption', 'lion', 'share', 'total', 'number', 'safety_needle', 'sell', 'globe', 'report', 'forecast_period', 'segment', 'private', 'clinic', 'expect', 'expand', 'healthy', 'rate'], ['key', 'application', 'safety_needle', 'cover', 'report', 'include', 'drug_delivery', 'sample', 'collection', 'segment', 'drug_delivery', 'presently', 'account', 'dominant', 'share', 'global', 'market', 'expect', 'retain', 'dominant', 'stance', 'forecast_period', 'expand', 'healthy', 'pace'], ['report', 'segment', 'global', 'safety_needle', 'market', 'basis', 'product', 'type', 'fine', 'aspirating', 'needle', 'biopsy', 'needle', 'pen', 'needle', 'hypodermic', 'needle', 'suture', 'needle', 'blood', 'collection', 'needle', 'prefille', 'needle', 'catheter', 'needle', 'epidural', 'needle', 'spinal', 'needle', 'cannula', 'needle', 'needle', 'blood', 'collection', 'needle', 'huber', 'needle', 'segment', 'needle', 'presently', 'lead', 'contributor', 'revenue', 'global', 'market', 'however', 'segment', 'needle', 'expect', 'expand', 'fast', 'pace', 'forecast_period'], ['global', 'safety_needle', 'market', 'regional', 'competitive', 'dynamic'], ['regional', 'point', 'view', 'report', 'cover', 'market', 'safety_needle', 'region', 'such', 'presently', 'market', 'most', 'developed', 'regional', 'market', 'expect', 'remain', 'key', 'contributor', 'revenue', 'as_well', 'new', 'product', 'variety', 'owe', 'presence', 'lead', 'medical', 'device', 'company', 'region', 'market', 'expect', 'expand', 'highly', 'promising', 'pace', 'owe', 'rise', 'awareness', 'stabilize', 'economy', 'rapid', 'development', 'healthcare', 'industry', 'rise', 'prevalence', 'number', 'chronic', 'condition'], ['market', 'safety_needle', 'witness', 'entry', 'large', 'number', 'player', 'past', 'few', 'year', 'owe', 'vast', 'rise', 'demand', 'globally', 'lead', 'company', 'market', 'medical', 'medtronic', 'retractable', 'technology', 'safety', 'product', 'surgery', 'simply', 'surgical', 'medical', 'hi', 'tech', 'device', 'sanxin', 'vigme'], ['nurse_call_system', 'innovative', 'highly', 'useful', 'product', 'give', 'dependable', 'service', 'patient', 'nurse_call_system', 'ensure', 'guarantee', 'service', 'patient', 'ward', 'addition', 'wireless', 'wired', 'model', 'ease', 'product', 'installation', 'hospital', 'prophesize', 'influence', 'growth', 'global', 'nurse_call_system', 'market', 'timeline', 'forecast'], ['several', 'factor', 'contribute', 'growth', 'global', 'nurse_call_system', 'market', 'rise', 'need', 'integrated', 'diversified', 'platform', 'grow', 'preference', 'mobility', 'equipment', 'likely', 'drive', 'demand', 'nurse_call_system', 'change', 'scenario', 'reimbursement', 'estimate', 'trigger', 'market', 'growth', 'as_well'], ['rise', 'home', 'healthcare', 'nursing', 'home', 'facility', 'push', 'market', 'demand'], ['modern', 'day', 'nurse_call_system', 'come', 'several', 'different', 'option', 'feature', 'most', 'usual', 'important', 'component', 'nurse_call_system', 'comprise', 'below', 'mention'], ['augment', 'adoption', 'real', 'time', 'location', 'system', 'incorporate', 'wireless', 'technology', 'many', 'healthcare', 'facility', 'likely', 'fuel', 'global', 'nurse_call_system', 'market', 'real', 'time', 'location', 'system', 'enable', 'healthcare', 'facility', 'track', 'attendant', 'movement', 'movement', 'equipment', 'improve', 'productivity', 'feature', 'likely', 'work', 'favor', 'global', 'nurse_call_system', 'market', 'year', 'come'], ['sample', 'report_sample_samplephpflag'], ['rise', 'nursing', 'home', 'home', 'healthcare', 'facility', 'many', 'lead', 'player', 'healthcare', 'industry', 'emphasize', 'need', 'improve', 'time', 'patient', 'response', 'together', 'reduce', 'tiredness', 'nurse', 'many', 'market', 'player', 'differentiate', 'product', 'offering', 'incorporation', 'device', 'various', 'technology', 'diagnostic', 'solution', 'such', 'factor', 'likely', 'support', 'expansion', 'global', 'nurse_call_system', 'market', 'future'], ['accord', 'transparency_market', 'late', 'report', 'global', 'nurse_call_system', 'market', 'historical', 'period', 'forecast_period', 'increase', 'need', 'efficient', 'responsive', 'health_care', 'communication', 'increase', 'budget', 'allocation', 'health_care', 'elderly', 'population', 'rise', 'number', 'people', 'suffer', 'various', 'disability', 'reduce', 'redundant', 'nursing', 'activity', 'age', 'population', 'nursing', 'shortage', 'factor', 'project', 'drive', 'global', 'nurse_call_system', 'market', 'forecast_period'], ['accord', 'report', 'global', 'nurse_call_system', 'market', 'value_bn', 'anticipate', 'expand_cagr'], ['request_custom_research', 'sample_samplephpflag'], ['increase', 'need', 'efficient', 'responsive', 'health_care', 'communication', 'key_driver'], ['increase', 'budget', 'allocation', 'health_care', 'elderly', 'population', 'boost', 'market', 'growth'], ['government', 'regulation', 'manufacture', 'distribution', 'nurse_call_system', 'hamper', 'market'], ['make_enquiry', 'buy_sample_samplephpflag', 'eb', 'rep_id'], ['global', 'nurse_call_system', 'market', 'competitive_landscape'], ['lead', 'player_operate', 'global', 'nurse_call_system', 'market'], ['ambulance', 'service', 'market', 'global', 'ambulance', 'service', 'market', 'anticipate', 'reach', 'more', 'bn_end'], ['depth', 'monitoring', 'device', 'market', 'global', 'depth', 'monitoring', 'device', 'market', 'anticipate', 'reach', 'mn', 'end'], ['mhealth', 'service', 'market', 'global', 'mhealth', 'service', 'market', 'anticipate', 'reach', 'bn_end', 'global', 'market', 'estimate', 'grow', 'cagr'], ['market', 'global', 'healthcare', 'erp', 'market', 'expect', 'reach_value_bn_end', 'estimate', 'expand_cagr'], ['diabetes', 'supplement', 'market', 'global', 'diabetes', 'supplement', 'market', 'expect', 'reach_value_bn_end'], ['management_solution', 'market', 'management_solution', 'market', 'expect', 'reach_value_bn_end'], ['outsourcing', 'market', 'contract', 'research', 'outsourcing', 'market', 'expect', 'reach_value_bn_end'], ['negative', 'pressure', 'wound', 'therapy', 'device', 'market', 'global', 'negative', 'pressure', 'wound', 'therapy', 'npwt', 'device', 'market', 'estimate', 'register', 'growth', 'cagr_forecast_period'], ['gene', 'therapy', 'good', 'treatment_option', 'most', 'chronic', 'disease', 'involve', 'insert', 'functional', 'copy', 'gene', 'defective', 'cell', 'gene', 'therapy', 'useful', 'treatment', 'cancer', 'inherit', 'disorder', 'cardiovascular', 'disease', 'infectious', 'pathogen', 'neurological', 'disorder'], ['read', 'viral_vector', 'manufacturing', 'markethtml'], ['viral', 'non', 'viral_vector', 'method', 'use', 'efficient', 'transfer', 'therapeutic', 'gene', 'target', 'cell', 'viral_vector', 'use', 'gene', 'therapy', 'include', 'associate', 'viral', 'non', 'viral_vector', 'generally', 'depend', 'delivery', 'plasmid'], ['development', 'quality', 'vector', 'term', 'formulation', 'physical', 'size', 'cost', 'delivery', 'function', 'quite', 'challenging', 'minimize', 'problem', 'manufacturer', 'use', 'various', 'approach', 'such', 'development', 'cell', 'line', 'culture', 'current', 'good_manufacturing_practice', 'cell', 'culture', 'system', 'expression', 'system', 'use', 'development', 'vector', 'project', 'boost', 'growth', 'global', 'viral_vector_manufacture', 'market'], ['request', 'brochure', 'report_sample_samplephpflag', 'rep_id'], ['additionally', 'increase', 'number', 'gene', 'therapy', 'candidate', 'due', 'rapid', 'development', 'disease', 'rise', 'funding', 'gene', 'therapy', 'expect', 'fuel', 'growth', 'global', 'viral_vector_manufacture', 'market', 'alliance', 'cancer', 'gene', 'therapy', 'public', 'charity', 'foundation', 'fund', 'advancement', 'cancer', 'gene', 'therapy', 'laboratory', 'clinical_trial', 'however', 'high', 'cost', 'gene', 'therapy', 'possible', 'mutagenesis', 'restrain', 'market'], ['global', 'viral_vector_manufacture', 'market', 'segment', 'base', 'type', 'disease', 'application', 'region', 'term', 'type', 'global', 'market', 'divide', 'adenoviral', 'vector', 'retroviral', 'associate', 'viral_vector', 'other', 'retroviral', 'vector', 'segment', 'dominate', 'global', 'viral_vector_manufacture', 'market', 'due', 'ease', 'application', 'major', 'target', 'disease', 'such', 'cancer', 'genetic', 'disorder', 'base', 'disease', 'global', 'viral_vector_manufacture', 'market', 'classify', 'cancer', 'infectious_disease', 'genetic', 'disorder', 'other', 'disease'], ['request_custom_research', 'sample_samplephpflag', 'cr', 'rep_id'], ['genetic', 'disorder', 'segment', 'anticipate', 'dominate', 'market', 'increase', 'research', 'activity', 'various', 'genetic', 'disorder', 'such_sickle', 'cell', 'anemia', 'disease', 'strong', 'gene', 'therapy', 'pipeline', 'last', 'phase', 'drug', 'development', 'term', 'application', 'global', 'market', 'bifurcate', 'gene', 'therapy', 'vaccinology', 'gene', 'therapy', 'segment', 'expect', 'account', 'large', 'share', 'market', 'due', 'increase', 'number', 'gene', 'therapy', 'clinical_trial', 'conduct', 'chronic', 'disease', 'such', 'cancer', 'cardiovascular', 'disease', 'disease', 'globally'], ['geographically', 'global', 'viral_vector_manufacture', 'market', 'segment', 'region', 'divide', 'specific', 'country', 'sub', 'region', 'such', 'country', 'dominate', 'global', 'viral_vector_manufacture', 'market', 'increase', 'research', 'activity', 'large', 'number', 'regenerative_medicine', 'company', 'rise', 'prevalence', 'target', 'disease', 'availability', 'fund', 'expect', 'most', 'attractive', 'market', 'forecast_period', 'due', 'increase', 'health', 'awareness', 'demand', 'advanced', 'medical', 'technology'], ['make_enquiry', 'buy_sample_samplephpflag'], ['key', 'player_operate', 'global', 'viral_vector_manufacture', 'market', 'biologic', 'uniqure', 'diosynth', 'biotechnology', 'spark', 'therapeutic', 'other', 'player', 'adopt', 'various', 'strategy', 'such', 'collaboration', 'agreement', 'partnership', 'launch', 'new', 'product', 'gain', 'competitive', 'advantage', 'market'], ['coronary', 'stent', 'market', 'global', 'coronary', 'stent', 'market', 'expect', 'reach_value', 'end'], ['market', 'global', 'hyperbaric', 'therapy', 'market', 'expect', 'reach_value_bn_end'], ['treatment', 'market', 'global', 'treatment', 'market', 'expect', 'reach_value_bn_end'], ['pain', 'management', 'device', 'market', 'global', 'pain', 'management', 'device', 'market', 'expect', 'reach_value_bn_end'], ['traditional', 'chinese', 'herbal', 'medicine', 'face', 'care', 'market', 'traditional', 'herbal', 'medicine', 'face', 'care', 'market', 'expect', 'exceed', 'value_bn', 'end'], ['drug', 'device', 'combination', 'product', 'market', 'global', 'drug', 'device', 'combination', 'product', 'market', 'expect', 'reach_value_bn_end'], ['knee', 'prosthesis', 'market', 'global', 'knee', 'prosthesis', 'market', 'expect', 'reach_value_bn_end'], ['cell', 'separation', 'technology', 'market', 'market', 'value', 'global', 'cell', 'separation', 'technology', 'market', 'estimate', 'bn', 'accord', 'research', 'report', 'transparency_market'], ['drive', 'hospital_capacity_management_solution', 'mainly', 'stem', 'potential', 'need', 'well', 'hospital_capacity', 'planning', 'method', 'strategy', 'world', 'unsuccessful', 'management', 'hospital_capacity', 'asset', 'invariably', 'lead', 'significant', 'loss', 'revenue', 'hospital', 'lack', 'patient', 'care', 'coordination', 'factor', 'throw', 'challenge', 'hospital_capacity', 'management', 'crucial', 'only', 'reduce', 'downstream', 'bottleneck', 'hospital', 'also', 'play', 'vital', 'role', 'revenue', 'management', 'cycle', 'range', 'operational', 'end', 'need', 'well', 'scheduling', 'responsive', 'method', 'ensure', 'smooth', 'flow', 'patient', 'department', 'notably', 'emergency', 'critical_care', 'unit', 'bolster', 'demand', 'hospital_capacity_management_solution', 'also', 'critical', 'enhance', 'satisfaction', 'patient'], ['rise', 'demand', 'assortment', 'analytical', 'tool', 'hospital_capacity', 'management', 'notable', 'trend', 'boost', 'market', 'launch', 'advanced', 'analytic', 'tool', 'developer', 'healthcare', 'particularly', 'allow', 'dynamic', 'scheduling', 'forecasting', 'promising', 'trend', 'expect', 'substantially', 'expand', 'market', 'potential', 'come', 'year', 'grow', 'adoption', 'robust', 'forecasting', 'reporting', 'method', 'also', 'accentuate', 'market', 'revenue', 'rise', 'number', 'analytic', 'solution', 'tailor', 'make', 'meet', 'varied', 'hospital_capacity', 'management', 'need', 'important', 'trend', 'augur', 'well', 'global', 'market'], ['recent', 'year', 'grow', 'number', 'provider', 'focus', 'hospital_capacity_management_solution', 'more', 'comprehensive', 'metric', 'apart', 'bed', 'occupancy', 'act', 'well', 'index', 'hospital_capacity', 'management', 'rise', 'need', 'well', 'supply_chain', 're', 'engineer', 'method', 'workflow', 'hospital', 'also', 'expect', 'augur', 'well', 'market', 'grow', 'number', 'research', 'discover', 'well', 'methodology', 'capacity', 'plan', 'especially', 'numerous', 'developing', 'develop', 'nation', 'increasingly', 'benefit', 'market', 'player', 'globe'], ['global', 'hospital_capacity_management_solution', 'market', 'overview'], ['capacity_management', 'solution', 'enable', 'executive', 'administrator', 'clinical', 'staff', 'work', 'hospital', 'more', 'effectively', 'manage', 'capacity', 'tracking', 'when', 'come', 'planning', 'track', 'bring', 'improve', 'resource', 'planning', 'utilization', 'up', 'efficiency', 'productivity', 'also', 'bring', 'visibility', 'forecast', 'improved', 'tracking', 'metric', 'addition', 'help', 'stem', 'revenue', 'loss', 'reduce', 'cost', 'seamless', 'operation', 'well', 'visibility', 'account', 'so', 'many', 'benefit', 'market', 'expect', 'make', 'steady', 'progress', 'near_term'], ['global', 'hospital_capacity_management_solution', 'market', 'driver', 'restraint'], ['majorly', 'fuel', 'demand', 'hospital_capacity_management_solution', 'surge', 'demand', 'well', 'healthcare', 'facility', 'emergence', 'more', 'evolved', 'version', 'continued', 'technological_advancement', 'further', 'demand', 'also', 'boost', 'rise', 'spend', 'healthcare', 'company', 'increase', 'demand', 'integrated', 'healthcare', 'solution', 'proliferate', 'hospital', 'myriad', 'benefit', 'such', 'solution', 'offer', 'such', 'efficiency', 'workflow', 'lessen', 'hospital', 'expense'], ['flipside', 'however', 'strict', 'rule', 'pertain', 'implementation', 'capacity_management', 'solution', 'pose', 'challenge', 'market', 'far', 'such', 'system', 'costly', 'install', 'maintain', 'factor', 'hamper', 'demand', 'dearth', 'well', 'train', 'highly', 'skilled', 'professional', 'particularly', 'develop', 'nation', 'crimp', 'market', 'growth', 'too'], ['global', 'hospital_capacity_management_solution', 'market', 'trend', 'opportunity'], ['noticeable', 'trend', 'global', 'market', 'hospital_capacity_management_solution', 'grow', 'number', 'merger', 'acquisition', 'player', 'indulge', 'tap', 'synergy', 'apart', 'soar', 'uptake', 'mobile', 'health', 'key', 'trend', 'observe', 'market', 'different_type', 'solution', 'available', 'market', 'bed', 'management_solution', 'quality', 'patient', 'care', 'solution', 'asset', 'management_solution', 'flow', 'management_solution', 'workflow', 'management_solution'], ['global', 'hospital_capacity_management_solution', 'market', 'regional', 'analysis'], ['geographical', 'standpoint', 'key', 'region', 'global', 'market', 'hospital_capacity_management_solution', 'mainly', 'account', 'alarming', 'increase', 'chronic', 'disease', 'state_art', 'healthcare', 'region', 'addition', 'emergence', 'more', 'evolved', 'version', 'hospital_capacity_management_solution', 'rise', 'knowledge', 'potential', 'also', 'serve', 'drive', 'market', 'region', 'nation', 'forefront', 'drive', 'growth', 'market', 'hospital_capacity_management_solution', 'region', 'promising', 'market', 'mushroom', 'healthcare', 'center', 'region', 'particularly', 'large', 'populous', 'economy'], ['global', 'hospital_capacity_management_solution', 'market', 'competitive_landscape'], ['prominent', 'player_operate', 'global', 'market', 'hospital_capacity_management_solution', 'profile', 'report', 'teletracke', 'central', 'logic', 'alcidion', 'corporation'], ['farm_animal_drug', 'medicine', 'mainly', 'use', 'healthcare', 'base', 'practice', 'diagnosis', 'cure', 'mitigation', 'treatment', 'prevention', 'disease', 'affect', 'livestock', 'medicine', 'need', 'use', 'strict', 'requirement', 'base', 'essentiality', 'maintain', 'well', 'being', 'farm_animal', 'simply', 'say', 'farm_animal_drug', 'key', 'factor', 'support', 'growth', 'livestock', 'industry', 'all', 'globe'], ['farm', 'drug', 'include', 'wide', 'variety', 'medical', 'substance', 'such', 'anti', 'infective', 'drug', 'hormone', 'analgesic', 'parasiticide', 'anti', 'inflammatory', 'medicine', 'anesthetic', 'antibiotic', 'manufacturing', 'distribution', 'use', 'safety', 'drug', 'control', 'specific', 'administration', 'most', 'region', 'drug', 'roll', 'commercial', 'use', 'need', 'approve', 'administration', 'sponsor', 'manufacturer', 'drug', 'document', 'scientific', 'testing', 'substance', 'label', 'safe_effective', 'testing', 'datum', 'also', 'show', 'methodology', 'available', 'detect', 'measure', 'residue', 'leave', 'edible', 'animal', 'product', 'need', 'do', 'analyze', 'how', 'much', 'drug', 'remain', 'animal', 'body', 'consequence'], ['apart', 'farmer', 'veterinary', 'doctor', 'need', 'strictly', 'adhere', 'guideline', 'how', 'much', 'time', 'elapse', 'treat', 'animal', 'slaughter', 'drug', 'sell', 'also', 'carry', 'relevant', 'warning', 'constraint', 'other', 'important', 'information', 'label', 'drug', 'farm_animal_drug', 'category', 'vaccination', 'most', 'commonly', 'use', 'medical', 'substance', 'several', 'decade', 'extensive', 'use', 'vaccine', 'now', 'able', 'eradicate', 'several', 'disease', 'affect', 'farm_animal', 'vaccine', 'need', 'keep', 'chill', 'freeze', 'container', 'deteriorate', 'rapidly', 'expose', 'warm', 'condition', 'farmer', 'other', 'involve', 'animal', 'husbandry', 'practice', 'need', 'gain', 'thorough', 'knowledge', 'veterinary', 'practice', 'regard', 'treatment', 'farm_animal', 'way', 'become', 'aware', 'associate', 'aspect', 'context', 'animal_drug'], ['global', 'farm_animal_drug', 'market', 'overview'], ['farm_animal_drug', 'veterinary', 'product', 'use', 'prevention', 'treatment', 'wide_range', 'disease', 'disorder', 'livestock', 'usage', 'product', 'essential', 'well', 'being', 'key', 'factor', 'support', 'growth', 'livestock', 'industry', 'world', 'wide', 'variety', 'farm_animal_drug', 'comprise', 'anti', 'infective', 'parasiticide', 'anti', 'inflammatory', 'analgesic', 'hormone', 'antibiotic', 'rise', 'number', 'pet', 'ownership', 'couple', 'grow', 'population', 'companion_animal', 'foster', 'demand', 'food', 'feed', 'pharmaceutical', 'product', 'year', 'rise', 'uptake', 'farm_animal_drug', 'drive', 'role', 'reduce', 'burden', 'number', 'livestock', 'disease'], ['global', 'farm_animal_drug', 'market', 'key', 'trend'], ['drug', 'farm_animal', 'gain', 'immense', 'significance', 'meet', 'nutritional', 'requirement', 'livestock', 'globe', 'rise', 'demand', 'meat', 'dairy', 'product', 'various', 'part', 'world', 'lead', 'farm', 'owner', 'livestock', 'manager', 'spend', 'substantial', 'sum', 'keep', 'animal', 'healthy', 'extensive', 'demand', 'drug', 'prevent', 'variety', 'infectious_disease', 'animal', 'also', 'positively', 'drive', 'growth', 'market', 'end', 'market', 'recent', 'year', 'witness', 'burgeon', 'production', 'anti', 'infective', 'drug', 'emergence', 'new', 'disease', 'notably', 'avian', 'influenza', 'cause', 'considerable', 'concern', 'industry', 'player', 'government', 'alike', 'favor', 'growth', 'market'], ['global', 'farm_animal_drug', 'market', 'market', 'potential'], ['substantial', 'consumption', 'meat', 'dairy', 'product', 'human', 'lead', 'emergent', 'condition', 'antimicrobial', 'resistance', 'find', 'indiscriminate', 'use', 'antibiotic', 'farm_animal', 'confirm', 'several', 'regulatory_agency', 'recent', 'year', 'accord', 'organization', 'overuse', 'antibiotic', 'animal', 'recent', 'decade', 'find', 'contribute', 'grow', 'drug', 'resistance', 'human', 'serious', 'health', 'repercussion', 'antimicrobial', 'resistance', 'genuine', 'concern', 'recently', 'generate', 'widespread', 'attention', 'develop', 'country', 'such', 'several', 'european', 'country', 'bid', 'curb', 'routine', 'use', 'antibiotic', 'boost', 'health', 'prevent', 'disease', 'recently', 'draft', 'new', 'guideline', 'farmer', 'harp', 'more', 'stringent', 'implementation', 'country', 'where', 'overuse', 'prominent'], ['backdrop', 'rise', 'antimicrobial', 'resistant', 'infection', 'world', 'draft', 'framework', 'urge', 'livestock', 'farmer', 'prevent', 'overuse', 'antibiotic', 'start', 'farm', 'owner', 'require', 'prescription', 'veterinarian', 'buy', 'score', 'common', 'veterinary', 'antibiotic', 'such', 'stringent', 'regulation', 'likely', 'wide', 'impact', 'market', 'potential', 'forecast_period'], ['global', 'farm_animal_drug', 'market', 'regional', 'outlook'], ['study', 'offer', 'critical', 'insight', 'outlook', 'various', 'regional', 'market', 'highlight', 'promising', 'avenue', 'key', 'investment', 'trend', 'region', 'develop', 'develop', 'region', 'expect', 'potentially', 'prominent', 'regional', 'market', 'farm_animal_drug', 'contribute', 'attractive', 'revenue', 'global', 'market', 'drive', 'burgeon', 'demand', 'anticipate', 'emerge', 'vastly', 'lucrative', 'market', 'burgeon', 'demand', 'farm_animal_drug', 'attribute', 'rapidly', 'rise', 'livestock', 'industry', 'key', 'economy'], ['global', 'farm_animal_drug', 'market', 'competitive', 'outlook'], ['report', 'take', 'detailed', 'look', 'prevail', 'competitive', 'dynamic', 'various', 'part', 'globe', 'analyze', 'regulatory', 'framework', 'likely', 'shape', 'dynamic', 'come', 'year', 'several', 'player', 'focus', 'new', 'product', 'launch', 'spend', 'copious', 'fund', 'research', 'development', 'activity', 'clinical_trial', 'pertain', 'efficacy', 'veterinary', 'drug', 'medicine', 'player', 'hold', 'prominent', 'position', 'farm_animal_drug', 'market', 'include', 'alembic', 'animal'], ['prescription', 'type', 'electronic', 'prescribing', 'technology', 'enable', 'doctor', 'become', 'paperless', 'transmit', 'prescription', 'digital', 'format', 'rather', 'handwrite', 'doctor', 'increasingly', 'favor', 'prescription', 'order', 'provide', 'patient', 'convenient', 'access', 'drug', 'country', 'invest', 'great', 'effort', 'prescription', 'adoption'], ['read', 'epharmacies', 'markethtml'], ['year', 'hospital', 'intend', 'paperless', 'lead', 'significant', 'growth', 'demand', 'prescription', 'technology', 'future', 'main', 'benefit', 'prescription', 'allow', 'effortlessly', 'submit', 'prescription', 'pharmacy', 'website', 'drug', 'hassle', 'result', 'grow', 'use', 'prescription', 'post', 'prescription', 'internet', 'become', 'simple', 'time', 'saving', 'result', 'aforementioned', 'variable', 'contribute', 'expansion', 'global', 'epharmacy', 'market'], ['counter', 'drug', 'expect', 'rise', 'healthy', 'clip', 'next_few', 'year', 'major', 'industry', 'trend', 'pharmaceutical', 'manufacturer', 'switch', 'grow', 'tendency', 'individual', 'develop', 'country', 'self', 'medicate', 'increase', 'burden', 'pain', 'preference', 'internet', 'pharmacy', 'drive', 'segmental', 'expansion', 'global', 'epharmacy', 'market'], ['sample', 'report_sample_samplephpflag'], ['result', 'rise', 'incidence', 'patent', 'expiration', 'firm', 'transition', 'counter', 'strategy', 'furthermore', 'saving', 'prescription', 'cost', 'cost', 'clinical', 'visit', 'link', 'drug', 'use', 'economic', 'benefit', 'emerge', 'nation', 'element', 'considerable', 'impact', 'vertical', 'expansion'], ['addition', 'convenience', 'order', 'medication', 'comfort', 'own', 'home', 'predict', 'propel', 'pharmacy', 'industry', 'particularly', 'addition', 'market', 'predict', 'rise', 'high', 'concentration', 'market', 'participant', 'region', 'use', 'modern', 'technology', 'major', 'company', 'improve', 'consumer', 'experience', 'online', 'medication', 'buying', 'drive', 'regional', 'market'], ['epharmacy', 'refer', 'intermediate', 'seller', 'consumer', 'purpose', 'selling', 'medicine', 'online', 'platform', 'sale', 'medicine', 'also', 'widely', 'know', 'mail', 'order', 'pharmacy', 'internet', 'pharmacy', 'main', 'benefit', 'epharmacy', 'consumer', 'enable', 'consumer', 'order', 'medicine', 'hassle', 'free', 'convenient', 'fashion', 'right', 'form', 'computer', 'mobile', 'phone', 'likely', 'assist', 'patient', 'kind', 'sickness', 'condition', 'go', 'buy', 'medicine', 'pharmacy'], ['request_custom_research', 'sample_samplephpflag', 'cr', 'rep_id'], ['addition', 'online', 'platform', 'aggregate', 'supply', 'difficult', 'find', 'otherwise', 'make', 'available', 'consumer', 'country', 'offline', 'pharmacy', 'able', 'stock', 'limited', 'supply', 'result', 'consumer', 'have', 'visit', 'several', 'store', 'benefit', 'likely', 'support', 'growth', 'global', 'epharmacy', 'market', 'year', 'come'], ['expand', 'growth', 'rate', 'cagr', 'projection', 'period', 'valuation', 'market', 'expect', 'touch', 'end', 'period'], ['key', 'player', 'global', 'epharmacy', 'market', 'comprise', 'rowland', 'pharmacy'], ['ask_reference_sample_samplephpflag'], ['convenience', 'prescription', 'shoot', 'demand', 'market'], ['growth', 'global', 'pharmacy', 'market', 'mainly', 'augment', 'access', 'online', 'web', 'base', 'service', 'increase', 'use', 'prescription', 'various', 'healthcare', 'hospital', 'facility', 'widespread', 'use', 'internet'], ['prescription', 'refer', 'technology', 'electronic', 'prescribing', 'enable', 'healthcare', 'professional', 'send', 'prescription', 'electronically', 'lieu', 'handwritten', 'one', 'doctor', 'now', 'opt', 'prescription', 'attempt', 'enable', 'patient', 'hassle', 'free', 'access', 'medication', 'prescription', 'various', 'country', 'increase', 'effort', 'make', 'accelerate', 'use', 'prescription', 'nhs', 'hospital', 'already', 'way', 'go', 'paperless', 'end'], ['primary', 'benefit', 'prescription', 'easy', 'upload', 'prescription', 'website', 'epharmacy', 'order', 'medicine', 'internet', 'likely', 'increase', 'popularity', 'prescription', 'technology', 'year', 'come', 'thereby', 'drive', 'growth', 'global', 'pharmacy', 'market'], ['addition', 'ease', 'convenience', 'price', 'medicine', 'online', 'pharmacy', 'substantially', 'low', 'so', 'need', 'spend', 'money', 'rent', 'warehouse', 'premise', 'maintenance', 'large', 'workforce', 'factor', 'lower', 'price', 'medicine', 'likely', 'encourage', 'expansion', 'global', 'pharmacy', 'market', 'projection', 'period', 'commerce', 'company', 'try', 'figure', 'new', 'strategy', 'meet', 'demand', 'consumer', 'much', 'efficacious', 'well', 'way'], ['make_enquiry', 'buy_sample_samplephpflag'], ['high', 'penetration', 'internet', 'propel', 'growth', 'market'], ['global', 'pharmacy', 'market', 'estimate', 'exert', 'dominance', 'market', 'sizeable', 'share', 'market', 'such', 'territorial', 'dominance', 'region', 'owe', 'shift', 'consumer', 'preference', 'online', 'purchase', 'medicine', 'augment', 'penetration', 'high', 'speed', 'internet', 'furthermore', 'rapid', 'growth', 'commerce', 'sector', 'together', 'rapid', 'expansion', 'pool', 'elderly', 'population', 'likely', 'influence', 'growth', 'pharmacy', 'market', 'region', 'likely', 'trail', 'term', 'revnue', 'market', 'share'], ['phenomenal', 'rise', 'commerce', 'industry', 'likely', 'remain', 'forefront', 'rapid', 'growth', 'pharmacy', 'market', 'projection', 'period', 'large', 'base', 'population', 'together', 'presence', 'high', 'medical', 'need', 'expect', 'open', 'new', 'growth', 'avenue', 'market', 'region'], ['outsourcing', 'market', 'contract', 'research', 'outsourcing', 'market', 'expect', 'reach_value_bn_end'], ['market', 'biometric', 'market', 'expect', 'reach_value_bn_end'], ['cloud', 'compute', 'market', 'healthcare', 'industry', 'global', 'cloud', 'compute', 'market', 'healthcare', 'industry', 'expect', 'reach_value_bn_end'], ['management', 'market', 'global', 'population', 'health', 'management', 'market', 'expect', 'cross_value', 'bn_end'], ['medical', 'transcription', 'service', 'market', 'global', 'medical', 'transcription', 'service', 'market', 'expect', 'cross_value', 'bn_end'], ['corporate', 'wellness', 'market', 'global', 'corporate', 'wellness', 'market', 'expect', 'cross_value', 'bn_end'], ['print_medical', 'application', 'market', 'global', 'printing_medical_application', 'market', 'expect', 'cross_value', 'end'], ['empty', 'capsule', 'market', 'empty', 'capsule', 'market', 'projection', 'estimate', 'market', 'rise', 'cagr_forecast_period', 'global', 'empty', 'capsule', 'market', 'size', 'likely', 'attain', 'valuation', 'bn'], ['transparency_market', 'research', 'global', 'market', 'intelligence', 'company', 'provide', 'market', 'research', 'report', 'service', 'exclusive', 'blend', 'quantitative', 'forecasting', 'trend', 'analysis', 'provide', 'forward_look', 'insight', 'thousand', 'decision', 'maker', 'experienced', 'team', 'analyst', 'researcher', 'consultant', 'use', 'proprietary', 'datum', 'source', 'various', 'tool', 'technique', 'gather', 'analyze', 'information'], ['contact'], ['rohit'], [], ['corporate', 'headquarter', 'downtown'], [], [], [], [], ['email'], ['website'], ['rise', 'geriatric', 'population', 'inclination', 'various', 'chronic', 'acute', 'disease', 'especially', 'heart', 'prognosticate', 'propel', 'growth', 'global', 'congestive_heart', 'failure', 'treatment', 'device', 'market', 'growth', 'forecast_period', 'most', 'cardiac', 'arrest', 'case', 'ventricular', 'assist', 'device', 'use', 'nowadays', 'ventricular', 'assist', 'device', 'append', 'heart', 'help', 'debilitated', 'ventricle', 'blood', 'all', 'body'], ['report', 'base', 'comprehensive', 'overview', 'global', 'congestive_heart', 'failure', 'treatment', 'device', 'market', 'offer', 'subjective', 'quantitative', 'investigation', 'market', 'development', 'boundary', 'incorporate', 'component', 'test', 'market', 'make', 'development', 'open', 'door', 'market', 'estimate', 'time', 'frame', 'intricate', 'diagram', 'tmr', 'trend', 'manufacturer', 'region', 'carve', 'worldwide', 'cheddar', 'concentrate', 'market', 'offer', 'report'], ['request', 'brochure', 'report_sample_samplephpflag'], ['current', 'circumstance', 'congestive_heart', 'failure', 'treatment', 'device', 'market', 'midst', 'pandemic', 'additionally', 'give', 'report', 'help', 'financial', 'specialist', 'intrigue', 'possibility', 'comprehend', 'upside', 'downside', 'likewise', 'put', 'resource', 'gauge', 'time', 'frame'], ['global', 'market', 'congestive_heart', 'failure', 'treatment', 'device', 'market', 'group', 'category', 'product', 'end', 'user', 'geography', 'base', 'product', 'market', 'group', 'pacemaker', 'cular', 'assist', 'device', 'vad', 'implantable', 'cardioverter', 'defibrillator', 'icd', 'pulsation', 'device', 'cardiac', 'therapy', 'hospital', 'section', 'further', 'categorize', 'ambulatory', 'surgical', 'center', 'specialize', 'cardiovascular', 'disease', 'treatment', 'center', 'hospital'], ['request_custom_research', 'sample_samplephpflag', 'cr', 'rep_id'], ['congestive_heart', 'failure', 'treatment', 'device', 'market', 'nature', 'competition'], ['work', 'methodology', 'embrace', 'player', 'work', 'worldwide', 'congestive_cardiovascular', 'breakdown', 'treatment', 'gadget', 'market', 'incorporate', 'new', 'item', 'dispatch', 'local', 'development', 'example', 'dispatch', 'biomonitor', 'implantable', 'heart', 'distant', 'screen', 'item', 'dispatch', 'foresee', 'assist', 'organization', 'extend', 'current', 'item', 'portfolio', 'additionally', 'dispatch', 'arrangement', 'framework', 'post', 'fda', 'endorsement', 'treatment', 'atrial', 'fibrillation', 'item', 'dispatch', 'help', 'biotronik', 'grow', 'cardiovascular', 'cadence', 'board', 'item', 'contribution'], ['player', 'function', 'global', 'congestive_heart', 'failure', 'treatment', 'device', 'market', 'include', 'other'], ['ask_reference_sample_samplephpflag'], ['congestive_heart', 'failure', 'treatment', 'device', 'market', 'current', 'trend'], ['congestive_cardiovascular', 'failure', 'treatment', 'device', 'normal', 'show', 'critical', 'development', 'seek', 'figure', 'period', 'attributable', 'rise', 'occurrence', 'cardiovascular', 'infection', 'congestive_cardiovascular', 'breakdown', 'most', 'well', 'know', 'ailment', 'liable', 'passing', 'individual', 'universally', 'expand', 'pervasiveness', 'cardiovascular', 'sickness', 'district', 'main', 'consideration', 'drive', 'income', 'development', 'congestive_cardiovascular', 'breakdown', 'therapy', 'gadget', 'worldwide'], ['way', 'life', 'relate', 'variable', 'rely', 'add', 'develop', 'illness', 'rate', 'cvds', 'manner', 'raise', 'selection', 'medicine', 'quick', 'track', 'endorsement', 'gadget', 'combine', 'innovative', 'headway', 'create', 'nation', 'move', 'market', 'income', 'further', 'tremendous', 'neglect', 'treatment', 'interest', 'congestive_cardiovascular', 'breakdown', 'rely', 'note', 'create', 'market', 'significant', 'expense', 'gadget', 'negative', 'repayment', 'approach', 'many', 'component', 'prevent', 'income', 'development', 'congestive_cardiovascular', 'breakdown', 'treatment', 'market'], ['make_enquiry', 'buy_sample_samplephpflag', 'eb', 'rep_id'], ['congestive_heart', 'failure', 'treatment', 'device', 'market', 'regional', 'analysis'], ['currently', 'dominate', 'market', 'owe', 'presence', 'large', 'population', 'chronic', 'heart', 'issue', 'couple', 'presence', 'well', 'therapeutic', 'help', 'aid', 'expansion', 'north', 'american', 'region', 'forecast_period', 'other', 'side', 'market', 'witness', 'significant', 'growth', 'account', 'rapid', 'development', 'medical', 'healthcare', 'infrastructure'], ['dermal', 'filler', 'market', 'dermal', 'filler', 'market', 'anticipate', 'reach', 'bn_end', 'market', 'country', 'project', 'expand_cagr'], ['particle', 'therapy', 'market', 'global', 'particle', 'therapy', 'market', 'expect', 'drive', 'rise', 'prevalence', 'cancer', 'low', 'risk', 'treatment', 'induce', 'disorder', 'increase', 'number', 'particle', 'therapy', 'center', 'world'], ['physician', 'dispense', 'cosmeceutical', 'market', 'global', 'physician', 'dispense', 'cosmeceutical', 'market', 'expect', 'reach_value_bn_end'], ['insulin', 'market', 'global', 'insulin', 'market', 'drive', 'technological_advancement', 'surge', 'funding', 'increase', 'government', 'support', 'rise', 'prevalence', 'diabetes'], ['market', 'global', 'biosimilar', 'market', 'potential', 'grow', 'rapid', 'pace', 'large', 'number', 'biological', 'drug', 'likely', 'go', 'patent'], ['allergy', 'human', 'market', 'global', 'cat', 'allergy', 'human', 'market', 'anticipate', 'exceed', 'bn', 'global', 'market', 'project', 'grow', 'cagr'], ['device', 'market', 'global', 'repair', 'device', 'market', 'expect', 'reach_value', 'end'], ['life', 'solution', 'service', 'market', 'significance', 'preventive', 'maintenance', 'approach', 'medical', 'equipment', 'avoid', 'medical', 'device', 'relate', 'accident', 'prevent', 'large', 'repair', 'propel', 'life', 'care', 'solution', 'service', 'market'], ['increase', 'infectious_disease', 'world', 'as_well', 'technological_advancement', 'method', 'clinical', 'diagnosis', 'lead', 'driving', 'factor', 'development', 'global', 'clinical', 'laboratory_service', 'market', 'clinical', 'laboratory', 'essential', 'component', 'healthcare', 'medical', 'sector', 'laboratory', 'use', 'worldwide', 'conduct', 'various', 'diagnostic', 'test', 'way', 'simple', 'blood_test', 'complex', 'genetic', 'analysis', 'testing'], ['solution', 'global', 'clinical', 'laboratory_service', 'market', 'offer', 'resource', 'datum', 'management', 'capability', 'optimize', 'necessary', 'distribution', 'various', 'healthcare', 'system', 'solution', 'global', 'clinical', 'laboratory_service', 'market', 'enable', 'clinician', 'begin', 'adapt', 'stop', 'treatment', 'hamper', 'absence', 'medical', 'lab', 'facility'], ['solution', 'offer', 'global', 'clinical', 'laboratory_service', 'market', 'include', 'drug', 'development', 'toxicology', 'test', 'clinical', 'preclinical', 'trial', 'relate', 'service', 'lab', 'bioanalytical', 'chemistry', 'gene', 'cell', 'therapy', 'increase', 'demand', 'accurate', 'as_well', 'rapid', 'early', 'diagnosis', 'various', 'disease', 'yet', 'major', 'driving', 'factor', 'development', 'expansion', 'global', 'clinical', 'laboratory_service', 'market', 'come', 'year'], ['sample', 'report_sample_samplephpflag'], ['furthermore', 'other', 'significant', 'driver', 'global', 'clinical', 'laboratory_service', 'market', 'include', 'increase', 'adoption', 'digital', 'pathology', 'portal', 'rise', 'preference', 'comprehensive', 'health', 'checkup', 'offer', 'clinical', 'laboratory', 'global', 'population'], ['however', 'lack', 'favorable', 'reimbursement', 'policy', 'part', 'world', 'especially', 'develop', 'develop', 'economy', 'as_well', 'risk', 'inaccurate', 'result', 'hamper', 'growth', 'global', 'clinical', 'laboratory_service', 'market', 'next_few', 'year'], ['furthermore', 'increase', 'consumer', 'preference', 'point', 'care', 'home', 'base', 'testing', 'procedure', 'as_well', 'increase', 'pricing', 'pressure', 'encounter', 'healthcare', 'payer', 'also', 'create', 'challenge', 'expansion', 'global', 'clinical', 'laboratory_service', 'market', 'next_few', 'year', 'other', 'hand', 'increase', 'demand', 'hospital', 'base', 'laboratory', 'as_well', 'physician', 'office', 'base', 'laboratory', 'anticipate', 'aid', 'expansion', 'global', 'clinical', 'laboratory_service', 'market', 'come', 'year'], ['request_custom_research', 'sample_samplephpflag'], ['surge', 'incidence', 'chronic', 'infectious_disease', 'drive', 'demand', 'clinical', 'laboratory_service', 'key_driver'], ['ask_reference_sample_samplephpflag'], ['grow', 'medical', 'tourism', 'boost', 'market', 'growth'], ['make_enquiry', 'buy_sample_samplephpflag'], ['stringent', 'regulatory', 'scenario', 'hamper', 'market'], ['global', 'clinical', 'laboratory_service', 'market', 'competitive_landscape'], ['report', 'profile', 'major', 'player', 'global', 'clinical', 'laboratory_service', 'market', 'base', 'various', 'attribute', 'such', 'company', 'overview', 'financial', 'overview', 'product', 'portfolio', 'business', 'strategy', 'recent', 'development'], ['lead', 'player_operate', 'global', 'clinical', 'laboratory_service', 'market'], ['market', 'global', 'healthcare', 'erp', 'market', 'expect', 'reach_value_bn_end'], ['thoracic', 'drainage', 'device', 'market', 'global', 'thoracic', 'drainage', 'device', 'market', 'likely', 'drive', 'rise', 'demand', 'cardiovascular', 'disease', 'medication', 'technical', 'development', 'different', 'surgical', 'field'], ['accord', 'transparency_market', 'late', 'report', 'global', 'printing_medical_application', 'market', 'historical', 'period', 'forecast_period', 'increase', 'demand', 'customized', 'printing_medical_application', 'project', 'drive', 'global', 'printing_medical_application', 'market', 'forecast_period'], ['increase', 'demand', 'customize', 'print', 'accelerate', 'market', 'growth', 'key_driver'], ['rise', 'trend', 'customize', 'print_medical', 'product', 'increase', 'number', 'medical', 'application', 'expect', 'boost', 'growth', 'global', 'printing_medical_application', 'market', 'next_few', 'year'], ['increase', 'trend', 'customize', 'print_medical', 'product', 'high', 'funding', 'government', 'private', 'organization', 'likely', 'accelerate', 'market', 'growth', 'next_few', 'year'], ['printing', 'use', 'create', 'new', 'surgical', 'cutting', 'drill', 'guide', 'prosthetics', 'patient', 'specific', 'replica', 'bone', 'organ', 'blood', 'vessel', 'recent', 'printing', 'advancement', 'result', 'light', 'strong', 'safe', 'product', 'as_well', 'short', 'lead', 'time', 'low', 'cost'], ['sample', 'report_sample_samplephpflag'], ['create', 'patient', 'specific', 'organ', 'replica', 'drive', 'market'], ['printing', 'use', 'create', 'patient', 'specific', 'organ', 'surgeon', 'use', 'practice', 'perform', 'complex', 'operation', 'technique', 'expedite', 'procedure', 'minimize', 'patient', 'trauma'], ['type', 'procedure', 'use', 'successfully', 'surgery', 'range', 'full', 'face', 'transplant', 'spinal', 'procedure', 'become', 'more', 'common', 'moreover', 'market', 'project', 'propel', 'technological', 'revolution', 'print_medical', 'application'], ['usage', 'print', 'medicine', 'provide', 'numerous', 'advantage', 'include', 'customization', 'personalization', 'medical', 'product', 'drug', 'equipment', 'cost', 'effectiveness', 'increase', 'productivity', 'democratization', 'design', 'manufacturing', 'improved', 'collaboration'], ['request_custom_research', 'sample_samplephpflag'], ['shortage', 'skilled', 'workforce', 'limit', 'specialized', 'training', 'additive', 'manufacturing'], ['skilled', 'most', 'significant', 'barrier', 'adoption', 'additive', 'manufacturing', 'print', 'limited', 'resource', 'pool', 'available', 'staff', 'well', 'verse', 'printing', 'process', 'exacerbate', 'rapid', 'pace', 'evolution', 'print_medical', 'device', 'market', 'term', 'technology', 'material'], ['shortage', 'additive', 'manufacturing', 'training', 'program', 'wide', 'gap', 'exist', 'academia', 'practical', 'application', 'industry', 'difficult', 'bridge', 'lack', 'workforce', 'thorough', 'understanding', 'design', 'process', 'production', 'cycle', 'additive', 'manufacturing', 'impact', 'final', 'product', 'quality'], ['make_enquiry', 'buying', 'sample_samplephpflag'], ['print_medical', 'application', 'market', 'competition', 'landscape'], ['report', 'profile', 'major', 'player', 'global', 'printing_medical_application', 'market', 'base', 'various', 'attribute', 'such', 'company', 'overview', 'financial', 'overview', 'product', 'portfolio', 'business', 'strategy', 'recent', 'development'], ['global', 'printing_medical_application', 'market', 'highly', 'fragment', 'presence', 'large', 'number', 'international', 'as_well', 'regional', 'player'], ['lead', 'player_operate', 'global', 'printing_medical_application', 'market'], ['scanner', 'market', 'global', 'pet', 'scanner', 'market', 'project', 'cross', 'market', 'value_bn', 'end'], ['ethylene', 'vinyl', 'acetate', 'infusion', 'bag', 'market', 'global', 'ethylene', 'vinyl', 'acetate', 'infusion', 'bag', 'market', 'course', 'reach', 'market', 'value', 'mn', 'end'], ['bone', 'graft', 'substitute', 'market', 'global', 'bone', 'graft', 'substitute', 'market', 'expect', 'attain', 'market', 'value_bn', 'end'], ['corporate', 'wellness', 'market', 'corporate', 'wellness', 'market', 'expect', 'cross_value', 'bn_end'], ['aseptic', 'transfer', 'system', 'market', 'global', 'aseptic', 'transfer', 'system', 'market', 'expect', 'cross_value', 'bn_end'], ['direct', 'consumer', 'laboratory', 'testing', 'market', 'direct', 'consumer', 'laboratory', 'testing', 'market', 'expect', 'expand_cagr', 'forecast_period'], ['glycomic', 'market', 'global', 'glycomic', 'market', 'project', 'cross', 'bn', 'increase', 'demand', 'treatment', 'various', 'chronic', 'disease', 'fuel', 'growth', 'global', 'glycomic', 'market'], ['robotic', 'rehabilitation', 'assistive', 'technology', 'market', 'globally', 'size', 'robotic', 'rehabilitation', 'assistive', 'technology', 'market', 'project', 'reach', 'more', 'bn', 'advance', 'cagr_forecast_period'], ['rise', 'use', 'augment', 'reality', 'healthcare', 'sector', 'various', 'activity', 'such', 'surgical', 'simulation', 'diagnostic', 'image', 'patient', 'care', 'management', 'rehabilitation', 'boost', 'sale', 'opportunity', 'global', 'healthcare', 'market'], ['upcoming', 'report', 'transparency_market', 'research', 'provide', 'comprehensive', 'assessment', 'major', 'factor', 'drive', 'growth', 'global', 'healthcare', 'market', 'present', 'historical', 'trend', 'driver', 'growth', 'opportunity', 'restraint', 'challenge', 'market', 'prime', 'facet', 'cover', 'research', 'report', 'therefore', 'study', 'document', 'work', 'dependable', 'guide', 'gain', 'thorough', 'insight', 'healthcare', 'market', 'forecast_period'], ['research', 'analyst', 'present', 'datum', 'global', 'market', 'base', 'several', 'important', 'parameter', 'such', 'product', 'end', 'user', 'technology', 'region', 'basis', 'end', 'user', 'market', 'divide', 'research', 'laboratory', 'hospital', 'clinic', 'other'], ['request', 'brochure', 'report_sample_samplephpflag'], ['key_driver', 'healthcare', 'market', 'growth'], ['augment', 'reality', 'refer', 'utilization', 'display', 'sensor', 'camera', 'superimpose', 'digital', 'datum', 'real_world', 'technology', 'let', 'user', 'take', 'most', 'useful', 'information', 'perception', 'environment', 'technological_advancement', 'sensor', 'display', 'technology', 'together', 'different', 'software', 'result', 'revolution', 'healthcare', 'sector', 'technology', 'help', 'healthcare', 'professional', 'interact', 'patient', 'use', 'wide_range', 'prime', 'feature', 'application', 'ability', 'offer', 'healthcare', 'professional', 'power', 'visualize', 'as_well', 'interact', 'body', 'representation'], ['period', 'past', 'few', 'year', 'surge', 'number', 'base', 'startup', 'addition', 'notable', 'growth', 'investment', 'such', 'technology', 'factor', 'project', 'drive', 'expansion', 'opportunity', 'global', 'healthcare', 'market', 'year', 'ahead', 'moreover', 'rise', 'private', 'as_well', 'government', 'investment', 'integration', 'healthcare', 'system', 'project', 'result', 'lucrative', 'avenue', 'company', 'operate', 'global', 'healthcare', 'market', 'upcoming', 'year'], ['request_custom_research', 'sample_samplephpflag'], ['competition', 'landscape', 'market'], ['global', 'healthcare', 'market', 'moderately', 'fragment', 'nature', 'presence', 'several', 'well', 'establish', 'player', 'make', 'competition', 'level', 'market', 'extremely', 'fierce', 'thus', 'company', 'operate', 'market', 'execute', 'diverse', 'strategic', 'move', 'expand', 'business', 'maintain', 'leading', 'position', 'prominent', 'market', 'strategy', 'include', 'activity', 'new', 'product', 'launch', 'partnership', 'merger', 'acquisition', 'collaboration'], ['key', 'player_operate', 'global', 'healthcare', 'market'], ['make_enquiry', 'buying', 'sample_samplephpflag'], ['regional', 'market'], ['global', 'healthcare', 'market', 'show', 'presence', 'several', 'region', 'such', 'seem', 'lucrative', 'market', 'region'], ['enterprise', 'operate', 'market', 'project', 'gather', 'noticeable', 'growth', 'prospect', 'due', 'many', 'factor', 'such', 'surge', 'funding', 'regional', 'government', 'private', 'organization', 'advanced', 'technology', 'development', 'healthcare', 'sector', 'presence', 'advanced', 'healthcare', 'infrastructure', 'region'], ['ai', 'drug_discovery', 'market', 'drug_discovery', 'market', 'estimate', 'expand_cagr', 'forecast_period', 'global', 'market', 'project', 'cross', 'bn'], ['control', 'unit', 'market', 'global', 'laboratory', 'temperature', 'control', 'unit', 'market', 'project', 'expand', 'moderate', 'cagr'], ['substance', 'abuse', 'treatment', 'market', 'value', 'global', 'substance', 'abuse', 'treatment', 'market', 'stand', 'bn', 'market', 'likely', 'develop', 'cagr_forecast_period'], ['increase', 'maternal_age', 'main', 'reason', 'grow', 'case', 'child', 'bear', 'chromosomal', 'abnormality', 'such', 'down', 'syndrome', 'syndrome', 'non_invasive', 'prenatal_diagnostic', 'enable', 'medical', 'professional', 'diagnose', 'such', 'condition', 'beforehand', 'hence', 'widely', 'adopt', 'hospital', 'diagnostic', 'center'], ['read', 'noninvasive', 'prenatal_diagnostic', 'markethtml'], ['detection', 'diagnosis', 'genetic', 'condition', 'niche', 'non_invasive', 'prenatal_diagnostic', 'manufacturer', 'market', 'analyst', 'project', 'present', 'lucrative', 'growth', 'opportunity', 'non_invasive', 'prenatal_diagnostic', 'market', 'country', 'reportedly', 'case', 'annually', 'qualify', 'category', 'high', 'risk', 'pregnancy'], ['rise', 'awareness', 'consumer', 'key', 'factor', 'likely', 'drive', 'growth', 'market', 'come', 'year', 'woman', 'have', 'high', 'risk', 'pregnancy', 'tend', 'go', 'prenatal_testing'], ['ease', 'process', 'major', 'factor', 'diagnosis', 'process', 'minimally', 'invasive', 'hence', 'process', 'pose', 'minimal', 'risk', 'mother', 'fetus', 'further', 'advantage', 'test', 'result', 'substantial', 'decline', 'number', 'costly', 'chorionic', 'villus', 'sampling', 'cvs', 'invasive', 'amniocentesis', 'procedure'], ['sample', 'report_sample_samplephpflag', 'rep_id'], ['result', 'volumetric', 'capability', 'enhance', 'globe', 'explicitly', 'boost', 'growth', 'non_invasive', 'prenatal_diagnostic', 'market', 'term', 'revenue'], ['moreover', 'non_invasive', 'prenatal_diagnostic', 'middle', 'step', 'screen', 'procedure', 'invasive', 'test_check', 'fetal', 'abnormality', 'turn', 'likely', 'drive', 'growth', 'reproductive', 'genetic', 'sector', 'as_well'], ['moreover', 'favorable', 're', 'imbursement', 'policy', 'several', 'region', 'act', 'catalyst', 'turn', 'anticipate', 'accelerate', 'growth', 'market', 'come', 'year'], ['non_invasive_prenatal_testing', 'market', 'overview'], ['accord', 'transparency_market', 'late', 'market', 'report', 'non_invasive_prenatal_testing', 'market', 'historical', 'period', 'forecast_period', 'increase', 'maternal_age', 'increase', 'demand', 'early', 'non_invasive', 'fetal', 'testing', 'procedure', 'anticipate', 'drive', 'global', 'non_invasive_prenatal_testing', 'market'], ['accord', 'report', 'global', 'non_invasive_prenatal_testing', 'market', 'value_bn', 'non_invasive_prenatal_testing', 'market', 'project', 'expand_cagr'], ['request_custom_research', 'sample_samplephpflag', 'cr', 'rep_id'], ['rise', 'maternal_age', 'propel', 'market', 'key_driver'], ['average', 'age', 'first', 'time', 'mother', 'increase', 'especially', 'develop', 'country', 'such', 'financial', 'stability', 'rise', 'literacy', 'rate', 'social', 'factor', 'key', 'factor', 'responsible', 'advance', 'maternal_age'], ['risk', 'fetal', 'chromosomal', 'aneuploidy', 'directly', 'relate', 'rise', 'maternal_age', 'accord', 'publication', 'family', 'risk', 'fetal', 'chromosomal', 'abnormality', 'increase', 'gradually', 'age', 'increase', 'exponentially'], ['risk', 'syndrome', 'baby', 'year', 'maternal_age', 'risk', 'pregnant', 'woman', 'year', 'age', 'increase', 'year'], ['rise', 'average', 'maternal_age', 'likely', 'result', 'increase', 'incidence', 'chromosomal', 'aneuploidy', 'lead', 'increase', 'demand', 'non_invasive_prenatal_testing'], ['ask_reference_sample_samplephpflag'], ['increase', 'number', 'chromosomal', 'abnormality'], ['high', 'incidence', 'rate', 'baby', 'bear', 'down', 'syndrome', 'turner', 'syndrome', 'globe', 'likely', 'drive', 'demand', 'primarily', 'high_level', 'accuracy', 'safety', 'offer', 'conventional', 'screening', 'invasive', 'diagnostic', 'method'], ['accord', 'source', 'syndrome', 'prevalence', 'syndrome', 'range', 'baby', 'bear', 'different', 'country', 'further', 'state', 'nearly', 'baby', 'bear', 'down', 'syndrome', 'globally', 'year'], ['accord', 'center', 'incidence', 'rate', 'syndrome', 'child', 'birth', 'annually', 'other', 'hand', 'live', 'birth', 'detect', 'down', 'syndrome', 'reveal'], ['high', 'incidence', 'rate', 'genetic', 'mutation', 'result', 'various', 'syndrome', 'globe', 'likely', 'trigger', 'demand', 'non_invasive', 'prenatal', 'test'], ['change', 'dietary', 'habit', 'exposure', 'mutagenic', 'agent', 'poise', 'cause', 'spontaneous', 'mutation', 'expect', 'mother', 'likely', 'lead', 'increase', 'incidence', 'hereditary', 'congenital', 'disease', 'factor', 'anticipate', 'drive', 'demand', 'non_invasive', 'prenatal', 'test', 'forecast_period'], ['strict', 'regulatory', 'guideline', 'hamper', 'global', 'non_invasive_prenatal_testing', 'market'], ['various', 'regulatory', 'body', 'world', 'believe', 'implementation', 'non_invasive', 'prenatal', 'test', 'subsequent', 'rise', 'uptake', 'prenatal_testing', 'likely', 'increase', 'incidence', 'abortion', 'therefore', 'professional', 'group', 'such', 'gynecologist', 'acog', 'international', 'society', 'prenatal', 'diagnosis', 'national', 'society', 'genetic', 'counselor', 'society', 'obstetric', 'gynecology', 'set', 'guideline', 'limit', 'use', 'non_invasive_prenatal_testing', 'only', 'pregnant', 'woman', 'high', 'risk', 'chromosomal', 'aneuploidy'], ['make_enquiry', 'buy_sample_samplephpflag', 'eb', 'rep_id'], ['global', 'non_invasive_prenatal_testing', 'market', 'competition', 'landscape'], ['report', 'profile', 'major', 'player', 'global', 'non_invasive_prenatal_testing', 'market', 'base', 'various', 'attribute', 'such', 'company', 'overview', 'financial', 'overview', 'product', 'portfolio', 'business', 'strategy', 'recent', 'development'], ['non_invasive_prenatal_testing', 'market', 'moderately', 'fragment', 'presence', 'few', 'large_scale', 'player', 'present', 'international', 'market', 'top', 'player', 'hold', 'majority', 'share', 'global', 'non_invasive_prenatal_testing', 'market'], ['prominent', 'player_operate', 'global', 'non_invasive_prenatal_testing', 'market', 'include'], ['bovine', 'base', 'collagen', 'biomedical', 'application', 'market', 'global', 'bovine', 'base', 'collagen', 'biomedical', 'application', 'market', 'value', 'approximately', 'mn', 'anticipate', 'register', 'cagr', 'about', 'reach_value', 'nearly', 'mn'], ['diagnostic', 'market', 'global', 'diagnostic', 'market', 'value', 'approximately', 'mn', 'anticipate', 'reach', 'approximately', 'mn', 'expand_cagr', 'more'], ['diagnostic', 'specialty', 'enzyme', 'market', 'global', 'diagnostic', 'specialty', 'enzyme', 'market', 'value', 'mn', 'anticipate', 'expand_cagr', 'reach'], ['immunoassay', 'market', 'grow', 'geriatric', 'population', 'world', 'anticipate', 'key', 'driving', 'factor', 'immunoassay', 'market', 'global', 'level'], ['filter', 'market', 'global', 'membrane', 'filter', 'market', 'value', 'mn', 'project', 'expand_cagr'], ['fermentation', 'system', 'market', 'accord', 'report', 'market', 'project', 'witness', 'substantial', 'cagr', 'moreover', 'report', 'also', 'state', 'market', 'reach_value', 'end', 'duration'], ['assays', 'market', 'global', 'multiplex', 'assay', 'market', 'anticipate', 'reach', 'mn', 'expand_cagr'], ['prostate_cancer', 'therapeutic', 'market', 'global', 'prostate_cancer', 'therapeutic', 'market', 'estimate', 'register', 'growth', 'cagr_forecast_period', 'hence', 'market', 'prognosticate', 'gain', 'valuation', 'bn'], ['late', 'market', 'analysis', 'report', 'publish', 'report', 'datum', 'title', 'global', 'ptosis', 'market', 'forecast', 'thoroughly', 'examine', 'ptosis', 'industry', 'provide', 'essential', 'datum', 'information', 'target', 'reader', 'report', 'consist', 'quantitative', 'qualitative', 'research', 'market', 'perform', 'market', 'expert', 'ptosis', 'industry', 'report', 'emphasize', 'current', 'upcoming', 'market', 'revenue_growth', 'opportunity', 'trend', 'moreover', 'report', 'offer', 'key', 'information', 'industry', 'statistic', 'as_well', 'wide_range', 'dynamic', 'factor', 'include', 'driver', 'restraint', 'challenge', 'supply', 'demand', 'ratio', 'production', 'manufacturing', 'capacitie', 'sale', 'distribution', 'network', 'cost', 'demand', 'volatility', 'import', 'export', 'ratio', 'profit', 'margin', 'macro', 'economic', 'micro', 'economic', 'factor', 'report', 'inclusive', 'product', 'type', 'outlook', 'application', 'end', 'use', 'outlook', 'technology', 'landscape', 'regional', 'market', 'analysis', 'competitive', 'overview', 'market', 'expert', 'determine', 'current', 'financial', 'position', 'lead', 'industry', 'player', 'report', 'leverage', 'advanced', 'analytical', 'tool', 'such', 'porter', 'force', 'analysis', 'analysis', 'investment', 'assessment'], ['access', 'free', 'sample', 'copy', 'report', 'sample', 'enquiry', 'form'], ['market'], ['global', 'ptosis', 'market', 'significantly', 'grow', 'recent', 'past', 'expect', 'register', 'rapid', 'growth', 'forecast_period', 'pharma', 'healthcare', 'sector', 'rapidly', 'evolve', 'innovation', 'technology', 'increase', 'healthcare', 'spending', 'improve', 'healthcare', 'facility', 'system', 'many', 'hospital', 'ambulatory', 'surgical', 'care', 'center', 'clinic', 'globe', 'adopt', 'advanced', 'device', 'equipment', 'revenue_growth', 'global', 'ptosis', 'market', 'significantly', 'drive', 'factor', 'such', 'increase', 'prevalence', 'chronic', 'disease', 'rapid', 'advancement', 'healthcare', 'medical', 'sector', 'high', 'adoption', 'late', 'tool', 'technique', 'grow', 'fund', 'several', 'public', 'private', 'sector', 'addition', 'rise', 'focus', 'drug', 'development', 'increase', 'demand', 'precision_medicine', 'high', 'adoption', 'home', 'care', 'setting', 'point', 'care', 'diagnostic', 'increase', 'investment', 'research', 'development', 'activity', 'expect', 'drive', 'global', 'market', 'revenue_growth', 'forecast_period'], ['ongoing', 'pandemic', 'significantly', 'change', 'dynamic', 'pharma', 'healthcare', 'sector', 'various', 'country', 'face', 'challenge', 'such', 'shortage', 'medicine', 'device', 'hospital', 'expect', 'open', 'lucrative', 'growth', 'opportunity', 'market', 'player', 'come', 'year'], ['competitive_landscape'], ['global', 'market', 'comprise', 'various', 'market', 'player_operate', 'regional', 'global', 'level', 'key', 'player', 'adopt', 'various', 'strategy', 'such', 'investment', 'license_agreement', 'partnership', 'merger', 'acquisition', 'collaboration', 'joint', 'venture', 'gain', 'robust', 'footing', 'market'], ['top', 'company', 'profile', 'report'], ['know', 'more', 'report', 'visit', 'report', 'detail', 'ptosis', 'market'], ['ptosis', 'market', 'segmentation'], ['medication', 'revenue'], ['product', 'type', 'outlook', 'revenue'], ['route', 'administration', 'revenue'], ['distribution', 'channel', 'outlook', 'revenue'], ['end', 'user', 'outlook', 'revenue'], ['regional', 'outlook'], ['ask', 'customize', 'research', 'report', 'request', 'customization'], ['study', 'aim', 'define', 'market', 'size', 'forecast', 'value', 'different', 'segment', 'country', 'come', 'year', 'study', 'aim', 'include', 'qualitative', 'quantitative', 'perspective', 'industry', 'region', 'country', 'cover', 'report', 'report', 'also', 'outline', 'significant', 'factor', 'such', 'drive', 'factor', 'challenge', 'determine', 'market', 'future', 'growth'], ['explore', 'late', 'trending', 'research', 'report', 'report', 'datum'], ['therapy', 'device', 'market', 'size', 'share', 'analysis', 'product', 'type', 'mono', 'place', 'hbot', 'device', 'multi', 'place', 'hbot', 'device', 'topical', 'hbot', 'device', 'application', 'wind', 'heal', 'decompression', 'sickness', 'infection', 'gas', 'embolism', 'other', 'region', 'forecast', 'download', 'pdf', 'brochure'], ['market', 'analysis', 'product', 'equipment', 'service', 'other', 'type', 'single', 'room', 'system', 'multi', 'room', 'system', 'other', 'application', 'region', 'forecast', 'download', 'pdf', 'brochure'], ['surgical', 'blade', 'market', 'size', 'share', 'analysis', 'material', 'stainless', 'steel', 'high', 'grade', 'carbon', 'steel', 'product', 'type', 'sterile', 'non', 'sterile', 'end', 'user', 'hospital', 'surgical', 'center', 'region', 'forecast', 'download', 'pdf', 'brochure'], ['report', 'datum'], ['report', 'datum', 'market', 'research', 'consult', 'company', 'provide', 'syndicate', 'research', 'report', 'customize', 'research', 'report', 'consult', 'service', 'solution', 'purely', 'focus', 'purpose', 'locate', 'target', 'analyze', 'consumer', 'behavior', 'shift', 'demographic', 'industry', 'help', 'client', 'make', 'smart', 'business', 'decision', 'offer', 'market', 'intelligence', 'study', 'ensure', 'relevant', 'fact', 'base', 'research', 'multiple', 'industry', 'include', 'healthcare', 'touch', 'point', 'chemical', 'product', 'energy', 'consistently', 'update', 'research', 'offering', 'ensure', 'client', 'aware', 'late', 'trend', 'existent', 'market', 'report', 'datum', 'strong', 'base', 'experienced', 'analyst', 'varied', 'area', 'expertise', 'industry', 'experience', 'ability', 'develop', 'concrete', 'solution', 'research', 'problem', 'provide', 'client', 'ability', 'secure', 'edge', 'respective', 'competitor'], ['contact'], ['head', 'business', 'report', 'datum', 'web', 'direct', 'line', 'mail', 'twitter'], ['when', 'particle', 'move'], ['persistent', 'infection', 'novel', 'coronavirus', 'cause', 'infected', 'host'], ['new', 'research', 'lead', 'simple', 'blood_test', 'brain', 'tumour'], ['why', 'bird', 'more', 'intelligent', 'other'], ['brazilian', 'scientist', 'reveal', 'method', 'convert', 'methane', 'gas', 'liquid', 'methanol'], ['bacteria', 'power', 'truly', 'green', 'revolution', 'personal', 'electronic'], ['new', 'study', 'use', 'marine', 'monitor', 'radar', 'system', 'monitor', 'protect', 'area'], ['capture', 'stellar', 'gymnastic', 'cartwheel', 'galaxy'], ['health', 'risk', 'spur', 'more', 'smoker', 'quit'], ['award', 'reveal', 'cancer', 'target', 'atomic', 'resolution', 'imaging'], ['award', 'study', 'well', 'know', 'gene', 'link', 'disease'], ['computer', 'modelling', 'aim', 'inform', 'restoration', 'conservation', 'coral', 'reef'], ['chemoradiation', 'induce', 'alteration', 'program', 'death', 'ligand', 'cd', 'tumor', 'infiltrate', 'lymphocyte', 'expression', 'rectal', 'cancer'], ['rensselaer', 'researcher', 'propose', 'affordable', 'sustainable', 'alternative', 'lithium', 'ion', 'battery'], ['use', 'artificial', 'intelligence', 'control', 'digital', 'manufacturing'], ['invest', 'brain', 'research'], ['algorithm', 'teach', 'scientist', 'write', 'well', 'quantum', 'computer', 'program'], ['name', 'new', 'content', 'provider', 'learning', 'platform'], ['researcher', 'create', 'biosensor', 'turn', 'spider', 'silk', 'optical', 'fiber'], ['coolant', 'puff', 'electronic', 'cigarette', 'present'], ['professor', 'appoint'], ['scientist', 'uncover', 'new', 'therapeutic', 'target', 'treat', 'colorectal', 'tumor'], ['resolution', 'molecular', 'orchestra'], ['spotlight', 'program', 'focus', 'fusion', 'energy'], ['warn', 'promise', 'peril', 'simulation', 'technology'], ['research', 'show', 'short', 'term', 'debt', 'make', 'capital', 'more', 'costly'], ['use', 'light', 'restore', 'cell', 'function'], ['small', 'increase', 'risk', 'woman'], ['cancer', 'research', 'repurpose', 'expose', 'age', 'relate', 'blood', 'disease'], ['novel', 'cell', 'bispecific_antibody', 'show', 'potent', 'anti', 'tumor', 'activity', 'preclinical_model', 'epidermal', 'growth', 'factor', 'receptor'], ['environment', 'measure', 'boost', 'wildlife', 'population', 'long_term', 'farm', 'study'], ['light', 'tool', 'synthesis', 'complex', 'molecule'], ['scientist', 'find', 'solution', 'building', 'superconductor', 'transform', 'technology'], ['remote', 'surgery', 'robot', 'test', 'international', 'space', 'station'], ['researcher', 'design', 'cheap', 'most', 'efficient', 'squid', 'aquaculture', 'system', 'date'], ['investment', 'accelerate', 'construction', 'giant'], ['diagnosis', 'increase', 'percent', 'rural', 'area', 'past', 'year', 'accord', 'private', 'insurance', 'claim'], ['researcher', 'improve', 'cement', 'shrimp', 'shell', 'nanoparticle'], ['how', 'mutation', 'lead', 'self', 'destructive', 'inflammation'], ['disease', 'brain', 'white', 'matter', 'associate', 'bad', 'cognition'], ['buy', 'net', 'carbon', 'home'], ['unleash', 'limb', 'regeneration', 'need', 'metamorphosis', 'body', 'growth'], ['destroy', 'tumor', 'cell', 'target', 'immunotherapy', 'use', 'injectable', 'material'], ['flexible', 'device', 'harvest', 'thermal', 'energy', 'power', 'wearable', 'electronic'], ['model', 'brain', 'tumor', 'environment', 'aid', 'personalized', 'treatment'], ['discover', 'cause', 'drug', 'sensitivity'], ['signal', 'stress', 'out', 'plant'], ['study', 'show', 'few', 'people', 'try', 'quit', 'smoking', 'pandemic'], ['study', 'asexual', 'reproduction', 'lead', 'harmful', 'genetic', 'mutation'], ['legacy', 'ancient', 'ice', 'age', 'shape', 'how', 'seagrasse', 'respond', 'environmental', 'threat', 'today'], ['lining', 'child', 'nose', 'provide', 'protection', 'infection'], ['study', 'examine', 'black', 'boxing', 'breast_cancer', 'survivorship', 'care'], ['age', 'age', 'brain', 'multi', 'region', 'methylation', 'principal', 'component', 'base', 'clock', 'context'], ['new', 'cell', 'biology', 'ai', 'reveal', 'just', 'look', 'image', 'lot'], ['medicine', 'shed', 'light', 'challenge', 'medical', 'practice'], ['child', 'lack', 'sleep', 'experience', 'detrimental', 'impact', 'brain', 'cognitive', 'development', 'persist', 'time'], ['common', 'virus', 'trigger', 'onset', 'disease'], ['researcher', 'develop', 'new', 'breath', 'drive', 'concept', 'set', 'transform', 'access', 'hand', 'prosthetics'], ['new', 'clip', 'detect', 'virus', 'blood', 'sample'], ['gut', 'patrol'], ['electrical', 'engineering', 'professor', 'work', 'make', 'real', 'time', 'artificial', 'intelligence'], ['take', 'time', 'make', 'difference', 'brain', 'development', 'differ', 'neanderthal', 'modern', 'human'], ['communication', 'make', 'hunt', 'easy', 'chimpanzee'], ['project', 'build', 'innovation'], ['advanced', 'imaging', 'reveal', 'mire', 'migration', 'neuron', 'lab', 'model'], ['pathogenic', 'microbe', 'dry', 'soil', 'present', 'public', 'health', 'threat'], ['matter', 'much', 'fiber', 'choose', 'just', 'more', 'fiber'], ['grant', 'help', 'build', 'well', 'muscle', 'synthetic', 'biology'], ['promising', 'friendly', 'plug', 'treat', 'nosebleed'], ['wfirm', 'researcher', 'create', 'specific', 'cancer', 'organoid', 'system', 'study', 'bacterial', 'effect', 'immunotherapy'], ['prenatal', 'exposure', 'trigger', 'neurological', 'behavioral', 'change', 'later', 'life'], ['increase', 'oil', 'price', 'lead', 'decrease', 'development', 'green', 'energy'], ['new', 'nsf', 'fund', 'institute', 'core', 'datum', 'science'], ['flexible', 'hybrid', 'capacitor', 'base', 'transition', 'metal', 'composite', 'electrode'], ['common', 'table', 'sugar', 'key', 'allay', 'safety', 'concern', 'aqueous', 'zinc', 'battery'], ['spim', 'wgs', 'high', 'performance', 'waveguide', 'device', 'next_generation', 'photonic', 'chip'], ['help', 'insect', 'grip'], ['listen', 'people', 'result', 'more', 'sustainable', 'future', 'energy', 'system'], ['benefit', 'cultural', 'landscape', 'approach'], ['safe', 'space', 'key', 'ocean', 'specie'], ['scientist', 'fabricate', 'high', 'performance', 'large', 'area', 'perovskite', 'submodule', 'solar', 'cell'], ['lur', 'find', 'old', 'world'], ['scientist', 'part', 'team', 'win', 'end', 'early', 'death', 'killer', 'heart', 'disease', 'global', 'british', 'heart', 'challenge'], ['ai', 'researcher', 'help', 'manufacturer', 'reduce', 'energy', 'use'], ['vaccine', 'distribution'], ['new', 'social_medium', 'tool', 'help', 'public', 'assess', 'viral', 'post', 'check', 'bot'], ['how', 'help', 'assembly', 'line', 'robot', 'shift', 'gear', 'pick', 'almost'], ['progress', 'stem', 'cell', 'base', 'therapy', 'blindness'], ['receive', 'grant', 'study', 'emerge', 'technology', 'old', 'adult'], ['animal', 'role', 'identify'], ['science', 'publication', 'first', 'describe', 'novel', 'approach', 'fight', 'cancer', 'cell', 'modification'], ['new', 'study', 'give', 'important', 'understanding', 'how', 'molecular', 'motor', 'protein', 'involve', 'malaria', 'transmission'], ['early', 'vaccine', 'roll', 'health', 'facility', 'metropolitan', 'area', 'high', 'proportion', 'black', 'citizen', 'less', 'likely', 'administer', 'immunization', 'indicate', 'possible', 'vaccine', 'access', 'barrier'], ['idotea', 'sea', 'bee'], ['specialized', 'brain', 'region', 'recognize', 'vocal', 'cue', 'involve', 'speech'], ['researcher', 'take', 'first', 'ever', 'cryo', 'em', 'image', 'nitrogenase', 'action'], ['engineer', 'develop', 'sticker', 'see', 'body'], ['research', 'importance', 'teach', 'physician', 'advocacy', 'medical', 'student'], ['computer', 'science', 'physics', 'department', 'appoint', 'new', 'leader'], ['novel', 'target', 'therapy', 'effective', 'treatment_option', 'deadly', 'childhood', 'cancer'], ['gene', 'cause', 'deadly', 'brain', 'tumor', 'also', 'cause', 'childhood', 'cancer', 'new', 'research', 'show'], ['age', 'age', 'relate', 'neuroendocrine', 'cognitive', 'behavioral', 'co', 'morbidity', 'promote', 'tat', 'expression', 'male', 'mouse'], ['announce', 'scientific', 'symposium'], ['technique', 'base', 'artificial', 'intelligence', 'detect', 'disease', 'use', 'image', 'take', 'smartphone'], ['brain', 'imaging', 'reveal', 'how', 'mindfulness', 'program', 'boost', 'pain', 'regulation'], ['datum', 'elephant', 'seal', 'reveal', 'new', 'feature', 'marine', 'heatwave', 'blob'], ['researcher', 'discover', 'sophisticated', 'mechanism', 'bacteria', 'use', 'resist', 'antibiotic'], ['then', 'stop', 'brain', 'wire', 'math', 'make', 'happen'], ['chemotherapy', 'drug', 'online', 'pharmacy', 'endanger', 'leukemia', 'patient', 'suggest', 'research'], ['study', 'novel', 'drug', 'promote', 'nervous_system', 'repair', 'animal_model', 'stroke'], ['new', 'method', 'control', 'qubit', 'advance', 'quantum', 'computer'], ['prove', 'safe_effective', 'smoking', 'cessation', 'therapy'], ['organoid', 'production', 'breakthrough', 'help', 'accelerate', 'disease', 'drug', 'research'], ['novel', 'permeable', 'reactive', 'barrier', 'situ', 'groundwater', 'remediation'], ['chip', 'scale', 'metamicroscope', 'high', 'performance', 'imaging'], ['high', 'tech', 'imaging', 'reveal', 'detail', 'rare', 'eye', 'disorder'], ['researcher', 'invent', 'rapid', 'antibody', 'level', 'test'], ['molecular', 'electronic', 'possible', 'solution', 'law'], ['when', 'medical', 'care', 'collapse'], ['online', 'chair', 'yoga', 'viable', 'exercise', 'isolated', 'old', 'adult', 'dementia'], ['medicine', 'scientist', 'create', 'nanobody', 'punch', 'tough', 'brain', 'cell', 'potentially', 'treat', 'disease'], ['study', 'look', 'female', 'athlete', 'mental', 'physical', 'resilience'], ['appoint', 'meyer', 'director', 'center'], ['teach', 'old', 'drug', 'new', 'trick'], ['live', 'close', 'community', 'pharmacy'], ['new', 'energy', 'flag', 'immune', 'cell'], ['advanced', 'benefit', 'patient', 'heart', 'stiffen', 'disease'], ['cell', 'cell', 'scientist', 'build', 'high', 'resolution', 'map', 'brain', 'change', 'disease'], ['city', 'life', 'farm', 'life', 'when', 'elephant', 'adapt', 'different', 'human', 'development'], ['miniaturization', 'thermoelectric', 'device', 'capable', 'power', 'iot', 'product'], ['perform', 'as_well', 'medical', 'specialist', 'analyze', 'lung', 'disease'], ['fight', 'variant', 'well', 'needle'], ['past'], ['magnetic', 'material', 'platform', 'probe', 'next', 'gen', 'information', 'technology'], ['smoke', 'western', 'wildfire', 'influence', 'sea', 'ice', 'researcher', 'find'], ['scientist', 'capture', 'first', 'image', 'atom', 'swimming', 'liquid'], ['bat', 'teach', 'stop', 'next', 'pandemic'], ['reveal', 'role', 'genetic_variant', 'psychedelic', 'therapeutic', 'effect'], ['lactate', 'pass', 'common', 'antimicrobial', 'pup', 'initiate', 'liver', 'damage'], ['high', 'status', 'danish', 'viking', 'wear', 'exotic', 'beaver', 'fur'], ['new', 'endoscope', 'fit', 'needle'], ['ancient', 'clarify', 'early', 'history', 'american', 'colonial', 'horse'], ['explore', 'factor', 'underlie', 'how', 'domestic', 'cat', 'live', 'group'], ['methodological', 'leap', 'exploration', 'memory'], ['prehistoric', 'root', 'cold', 'sore', 'virus', 'trace', 'ancient', 'herpe'], ['how', 'service', 'dog', 'reduce', 'ptsd', 'symptom', 'factor', 'mechanism'], ['human', 'like', 'feature', 'robot', 'behavior', 'response', 'time', 'variability', 'perceive', 'human', 'like'], ['harm', 'blue', 'light', 'exposure', 'increase', 'age', 'research', 'suggest'], ['blood', 'brain', 'barrier', 'get', 'funding', 'boost'], ['western', 'smoke', 'plume', 'get', 'tall'], ['researcher', 'print', 'sensor', 'satellite'], ['study', 'reveal', 'insight', 'enzyme', 'combat', 'common', 'greenhouse', 'gas'], ['single', 'multiple', 'architectural', 'distortion', 'digital', 'breast', 'tomosynthesis'], ['work', 'memory', 'depend', 'reciprocal', 'interaction', 'brain'], ['key', 'role', 'entanglement'], ['new', 'research', 'propose', 'local', 'biological', 'control', 'agent', 'hub', 'fight', 'fall', 'armyworm'], ['new', 'insight', 'latent', 'cell', 'yield', 'potential', 'cure', 'target'], ['fossil', 'find', 'suggest', 'just', 'marine', 'animal'], ['skin', 'clinical', 'grade', 'collagen', 'chronic', 'wound', 'skin', 'healing'], ['partner', 'sit', 'establish', 'campus', 'composite', 'printing', 'ecosystem'], ['study', 'identifie', 'region', 'genome', 'link', 'virus', 'replication', 'transmission'], ['researcher', 'regulate', 'pore', 'size', 'distribution', 'improve', 'nanofiltration', 'membrane'], ['early', 'hunting', 'farm', 'homogenize', 'mammal', 'community'], ['publish', 'new', 'patient', 'guideline', 'breast_cancer', 'screening', 'diagnosis', 'emphasize', 'annual', 'mammogram', 'average', 'risk', 'woman'], ['lifegate', 'new', 'interactive', 'map', 'show', 'full', 'diversity', 'life'], ['like', 'hot', 'thermal', 'conductivity', 'switch', 'bottleneck', 'resolve'], ['bring', 'child', 'close', 'nature', 'help', 'improve', 'lung', 'health'], ['improve', 'heat', 'shield', 'wind', 'tunnel'], ['emerge', 'technology', 'help', 'extract', 'lithium', 'new', 'source'], ['rare', 'plant', 'attract', 'rare', 'bee', 'bird', 'urban', 'garden'], ['lose', 'translation', 'new', 'approach', 'ai', 'navigate', 'world', 'literature'], ['discover', 'alternative', 'physics'], ['anti', 'butterfly', 'effect', 'enable', 'new', 'benchmarking', 'quantum', 'computer', 'performance'], ['first', 'time', 'scientist', 'systematize', 'halo', 'discover', 'thousand', 'year', 'observation'], ['research', 'rigor', 'transparency', 'index', 'large_scale', 'analysis', 'scientific', 'reporting', 'quality'], ['call', 'action', 'consistent', 'measurement', 'social', 'determinant', 'health'], ['dynamic', 'building', 'facade', 'inspire', 'marine', 'organism', 'reduce', 'heating', 'cooling', 'lighting', 'cost'], ['enthusiasm', 'green', 'energy', 'varie', 'few', 'willing', 'pay', 'more'], ['researcher', 'develop', 'novel', 'atomic', 'force', 'microscopy', 'probe'], ['marmoset', 'practise', 'call', 'mother', 'womb'], ['see', 'light', 'researcher', 'develop', 'new', 'system', 'use', 'light', 'learn', 'associatively'], ['cudc', 'promote', 'apoptosis', 'cell'], ['new', 'glass', 'ceramic', 'emit', 'light', 'when', 'mechanical', 'stress'], ['natural', 'clean', 'up', 'bacteria', 'remove', 'plastic', 'pollution', 'lake'], ['space', 'study', 'offer', 'clear', 'understanding', 'yet', 'life', 'cycle', 'supermassive', 'black', 'hole'], ['scientist', 'find', 'surprising', 'link', 'mitochondrial', 'dna', 'increase', 'atherosclerosis', 'risk'], ['improve', 'image', 'sensor', 'machine', 'vision'], ['split', 'merger', 'investigate', 'role', 'policy', 'disagreement', 'party', 'switching', 'use', 'japanese', 'example'], ['good', 'medium', 'reputation', 'save', 'job', 'reveal', 'new', 'study'], ['cancer', 'team', 'halt', 'growth', 'multiple', 'diffuse', 'large', 'cell', 'lymphoma', 'mouse', 'custom', 'molecule', 'fc'], ['special', 'report', 'outline', 'actionable', 'step', 'address', 'racial', 'ethnic', 'linguistic', 'socioeconomic', 'disparity', 'telehealth', 'model', 'care'], ['public', 'health', 'researcher', 'develop', 'web', 'base', 'guide', 'help', 'family', 'physician', 'address', 'vaccine', 'hesitancy'], ['researcher', 'recycle', 'cd', 'flexible', 'biosensor'], ['practice', 'leverage', 'telehealth', 'enhance', 'access', 'abortion', 'service'], ['date', 'black', 'widow', 'eat', 'mate'], ['marine', 'conservation', 'effort', 'key', 'fish', 'specie', 'state', 'research', 'find'], ['genetic', 'clue', 'age', 'relate_macular_degeneration', 'reveal'], ['virtual', 'co', 'embodiment', 'joint', 'body', 'left', 'right', 'limb', 'control', 'person'], ['work', 'scale', 'paper', 'thin', 'solar', 'technology'], ['ribbon', 'cut', 'ceremony', 'spotlight', 'advanced', 'source', 'game', 'change', 'long', 'beamline'], ['industry', 'partner', 'discover', 'treatment', 'rare', 'genetic', 'liver', 'disease'], ['small', 'strong', 'magnet', 'improve', 'device', 'harness', 'fusion', 'power', 'sun', 'star'], ['honor', 'compute', 'construction', 'thorpe', 'medal'], ['implicit', 'bias', 'concern', 'appear', 'racist', 'predict', 'teacher', 'reluctance', 'discuss', 'race', 'racism', 'classroom'], ['how', 'earth', 'avoid', 'like', 'fate', 'ancient', 'rock', 'hold', 'clue'], ['bioinspire', 'protein', 'create', 'stretchable', 'material'], ['how', 'turn', 'muscle', 'protein', 'factory', 'advanced', 'gene', 'therapy'], ['design', 'root', 'reach', 'new', 'depth', 'help', 'carbon', 'storage', 'soil'], ['straighten', 'kinky', 'root', 'capture', 'carbon', 'avoid', 'drought', 'stress'], ['study', 'advance', 'cell', 'age', 'childhood', 'poverty'], ['neuromorphic', 'compute', 'optically', 'drive', 'nonlinear', 'fluid', 'dynamic'], ['lab', 'professional', 'disabled', 'employee', 'year'], ['wine', 'drinker', 'world', 'rejoice', 'new', 'research', 'lead', 'find', 'key', 'dollar', 'problem'], ['black', 'patient', 'find', 'time', 'more', 'likely', 'advance', 'vision', 'loss', 'glaucoma', 'diagnosis', 'white', 'patient'], ['severity', 'symptom', 'link', 'decrease', 'activity'], ['wood', 'heating', 'pollute', 'air', 'mountain', 'area', 'more', 'previously', 'assume'], ['twitter', 'health', 'amplifier', 'combat', 'misinformation'], ['new', 'leap', 'understand', 'nickel', 'oxide', 'superconductor'], ['use', 'train', 'team', 'robot', 'work_together'], ['machine_learn', 'fable'], ['clusters', 'future', 'approval', 'organic', 'synthesis'], ['hijack', 'nanotube', 'neuron', 'infect'], ['structure', 'small', 'semiconductor', 'elucidate'], ['damage', 'genome'], ['common', 'mechanism', 'cancer', 'metastasis', 'atherosclerosis'], ['rapid', 'test', 'technology', 'perform', 'pcr', 'fast', 'similar', 'test', 'market'], ['fine', 'print', 'study', 'shed', 'light', 'mechanism', 'drive', 'induce', 'cancer', 'printing', 'industry'], ['study', 'refute', 'claim', 'separate', 'specie'], ['heed', 'heat', 'desert', 'region', 'well', 'inform', 'future', 'global', 'temperate', 'zone', 'drive', 'climate', 'change'], ['how', 'cell', 'zip', 'sticki', 'mucus'], ['researcher', 'identify', 'how', 'cell', 'move', 'fast', 'mucus', 'blood'], ['mode', 'action', 'cell', 'immunotherapy', 'focus'], ['research', 'decarbonize', 'cement', 'manufacturing'], ['dairy', 'farmer', 'where', 'time', 'go'], ['particle', 'phase', 'chemistry', 'enable', 'soot', 'well', 'seed', 'cloud', 'new', 'study', 'challenge', 'current', 'understanding', 'formation', 'mechanism'], ['when', 'invasive', 'fish', 'native'], ['name', 'co', 'chair', 'solar', 'space', 'physics', 'decadal'], ['mass', 'mortality', 'event', 'link', 'marine', 'heatwave', 'become', 'new', 'norm'], ['tetrahedron', 'assemble', 'sided', 'pyramid', 'form', 'structure'], ['study', 'warn', 'flirt', 'online', 'beware', 'ruin', 'relationship'], ['rice', 'engineer', 'get', 'grip', 'necrobotic', 'spider'], ['new', 'study', 'challenge', 'old', 'view', 'primitive', 'mammalian', 'reproduction'], ['decode', 'structure', 'property', 'near', 'infrare', 'reflective', 'pigment'], ['high_quality', 'manganese', 'oxide', 'catalyst', 'large', 'surface', 'area'], ['change', 'power', 'usage', 'nuclear', 'power', 'plant', 'closure'], ['cell', 'surface', 'trace', 'subcellular', 'glycoprotein', 'transport', 'use', 'modify', 'toxin'], ['new', 'study', 'researcher', 'explore', 'prevalence', 'heatwave'], ['fish', 'suffer', 'oxygen', 'starvation'], ['control', 'life', 'death', 'hair', 'follicle'], ['develop', 'core', 'technology', 'aqueous', 'zinc', 'battery'], ['select', 'inaugural', 'dean', 'health'], ['scientist', 'find', 'molecular', 'clue', 'acute', 'chronic', 'phase', 'traumatic', 'brain', 'injury'], ['research', 'examine', 'effect', 'embryonic', 'exposure', 'environmental', 'pollutant', 'risk', 'diabetes'], ['research', 'chemist', 'unlock', 'secret', 'molten', 'salt'], ['research', 'team', 'win', 'prize', 'plan', 'accelerate', 'advance', 'spinal', 'stimulation', 'autonomic', 'neuromodulation'], ['colony', 'behave', 'neural', 'network', 'when', 'make', 'decision'], ['how', 'intestine', 'replace', 'repair'], ['colorectal', 'cancer', 'tumor', 'help', 'hinder', 'cell'], ['genetic', 'defect', 'lead', 'motor', 'disorder', 'fly'], ['wong', 'award', 'prize', 'creativity', 'organic', 'synthesis'], ['international', 'study', 'identifie', 'risk', 'long_covid', 'child'], ['light', 'polarization', 'create', 'art', 'explain', 'mathematical', 'concept'], ['porous', 'crystal', 'fluorine', 'contain', 'greenhouse', 'gas'], ['strengthen', 'immune_response', 'cancer'], ['venomous', 'new', 'pit', 'viper', 'discover'], ['nonthermal', 'plasma', 'promote', 'hydrogenation', 'presence', 'alloy', 'catalyst'], ['scientist', 'expand', 'entomological', 'research', 'use', 'genome_editing'], ['unravel', 'mystery', 'anisotropic', 'effect', 'surround', 'gas'], ['scientist', 'develop', 'new', 'biomimetic', 'formulation', 'treat'], ['human', 'activity', 'increase', 'likelihood', 'more', 'extreme', 'heatwave', 'researcher', 'find'], ['develop', 'key', 'technology', 'cryptography'], ['physicist', 'find', 'signature', 'highly', 'entangle', 'quantum', 'matter'], ['wildfire', 'smoke', 'observation', 'fill', 'gap', 'estimate', 'role', 'climate', 'change'], ['spray', 'coating', 'shield', 'surface', 'virus', 'bacteria'], ['elect'], ['body', 'remember', 'common_cold', 'coronaviruse', 'childhood', 'how', 'same', 'immunity'], ['demonstration', 'potent', 'universal', 'therapy', 'variant'], ['emerge', 'offshore', 'wind', 'workforce', 'training', 'leader', 'new', 'award'], ['researcher', 'report', 'major', 'advance', 'semiconductor', 'material'], ['inspire', 'nature', 'artificial', 'microtubule', 'work', 'current', 'transport', 'tiny', 'cargo'], ['novel', 'vaccine', 'use', 'modify', 'bacterial', 'dna'], ['taste', 'sensor', 'keep', 'protein', 'order', 'fly'], ['competition', 'limit', 'range', 'mountain', 'bird'], ['northeast', 'region', 'high', 'childhood', 'cancer', 'rate', 're', 'examine'], ['anti', 'amyloid', 'drug', 'disease'], ['good', 'semiconductor'], ['fast', 'biosensor', 'development'], ['silk', 'offer', 'alternative', 'microplastic'], ['new', 'section', 'effective', 'disease', 'oat', 'discover'], ['buckyball', 'gold', 'less', 'exotic', 'graphene'], ['craft', 'coffee', 'everywhere', 'research', 'explain', 'how', 'get', 'there'], ['work', 'more'], ['researcher', 'chart', 'advance', 'ancient', 'dna', 'technology'], ['research', 'waste', 'ecology', 'call', 'urgent', 'action'], ['advance_pivotal', 'development', 'people', 'acute_pain', 'phase', 'program', 'initiate'], ['phase', 'dose_range', 'trial', 'neuropathic_pain', 'expect', 'initiate', 'year', 'end'], ['therapy', 'designation', 'grant'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'follow', 'positive', 'phase', 'result', 'early', 'year', 'have', 'reach', 'agreement', 'design', 'pivotal', 'development', 'program', 'food', 'plan', 'advance', 'selective_inhibitor', 'phase', 'clinical_trial', 'fourth_quarter', 'vertex', 'also', 'intend', 'initiate', 'phase', 'dose_range', 'study', 'neuropathic_pain', 'end', 'year', 'addition', 'grant', 'breakthrough', 'therapy', 'designation', 'treatment', 'moderate_severe', 'acute_pain'], ['phase', 'program', 'include', 'randomize_double_blind_placebo', 'control', 'study', 'evaluate', 'efficacy_safety', 'moderate_severe', 'acute_pain_follow_bunionectomy', 'abdominoplasty_surgery', 'study', 'also', 'include', 'hydrocodone', 'bitartrate', 'acetaminophen', 'treatment', 'arm', 'third', 'single_arm', 'study', 'evaluate', 'safety', 'effectiveness', 'day', 'multiple', 'other', 'type', 'moderate_severe', 'acute_pain'], ['very_pleased', 'complete', 'discussion', 'reach', 'agreement', 'design', 'pivotal', 'development', 'program', 'acute_pain', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'demonstrate', 'positive', 'benefit', 'risk', 'profile', 'phase', 'work', 'urgency', 'bring', 'forward', 'medicine', 'deliver', 'effective', 'pain', 'control', 'addictive', 'potential', 'patient', 'wait'], ['pivotal', 'program', 'acute_pain', 'phase', 'program', 'consist', 'randomize_double_blind_placebo', 'control', 'study', 'evaluate', 'efficacy_safety', 'follow', 'mg_hour', 'acute_pain', 'bunionectomy', 'abdominoplasty', 'primary_endpoint', 'study', 'time_weight_sum', 'pain_intensity', 'difference', 'first', 'hour', 'treatment', 'spid', 'record', 'numeric', 'pain', 'rating_scale', 'nprs', 'compare_placebo', 'key_secondary_endpoint', 'study', 'spid', 'compare'], ['phase', 'program', 'also', 'include', 'single_arm', 'study', 'evaluate', 'safety', 'effectiveness', 'multiple', 'other', 'type', 'moderate_severe', 'acute_pain', 'study', 'patient', 'treat', 'day'], ['phase_study', 'neuropathic_pain', 'phase_study', 'randomize_double_blind', 'active', 'control', 'dose_range', 'study', 'evaluate', 'efficacy_safety', 'people', 'painful', 'diabetic', 'peripheral', 'neuropathy', 'primary_endpoint', 'change_baseline', 'weekly', 'average_daily', 'pain_intensity', 'numeric', 'pain', 'rating_scale', 'nprs', 'week'], ['breakthrough', 'therapy', 'designation', 'intend', 'expedite', 'development', 'review', 'medicine', 'aim', 'address', 'serious', 'condition', 'preliminary', 'clinical', 'evidence', 'indicate', 'drug', 'demonstrate', 'substantial_improvement', 'exist', 'treatment', 'more', 'clinically', 'significant', 'endpoint', 'breakthrough', 'therapy', 'designation', 'grant', 'base', 'clinical', 'evidence', 'phase_proof_concept', 'study', 'demonstrate', 'potential', 'treat', 'moderate_severe', 'acute_pain'], ['oral', 'selective_inhibitor', 'highly', 'selective', 'relative', 'other', 'channel', 'voltage', 'gate', 'sodium', 'channel', 'play', 'critical', 'role', 'pain', 'signal', 'peripheral', 'nervous_system', 'genetically', 'validate', 'target', 'treatment', 'pain', 'vertex', 'previously', 'demonstrate', 'clinical_proof_concept', 'small_molecule', 'investigational', 'treatment', 'target', 'nav', 'multiple', 'pain', 'indication', 'include', 'acute_pain', 'neuropathic_pain', 'musculoskeletal', 'approach', 'selectively', 'inhibit', 'use', 'small_molecule', 'objective', 'create_new_class', 'medicine', 'potential', 'provide', 'superior', 'relief', 'acute_pain', 'limitation_opioid', 'include', 'addictive', 'potential', 'most_recent', 'molecule', 'enter', 'clinical', 'development', 'portfolio', 'inhibitor'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'cell', 'genetic', 'therapy', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'sickle', 'cell', 'disease_beta_thalassemia', 'kidney_disease', 'pain', 'type_diabetes', 'deficiency_muscular', 'dystrophy'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'seramount', 'formerly', 'work', 'mother', 'medium', 'good', 'company', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow'], ['special_note_regard', 'forward_look_statement'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'advancement', 'pivotal', 'development', 'acute_pain', 'initiate', 'phase_study', 'neuropathic_pain', 'potential', 'benefit', 'anticipate_timeline', 'dosing', 'associate', 'ongoing', 'future', 'clinical_trial', 'study', 'design', 'include', 'expectation', 'patient', 'enrollment', 'expectation_regard', 'efficacy_endpoint', 'expedite', 'development', 'result', 'therapy', 'designation', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'trial', 'complete', 'expect', 'timeframe', 'at_all_datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], [], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['source', 'pharmaceutical_incorporate'], ['verve', 'receive_upfront', 'payment', 'equity_investment', 'as_well', 'potential', 'milestone_royalty'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'exclusive', 'year', 'global', 'research', 'collaboration', 'focus', 'discover_develop', 'vivo', 'gene_editing', 'program', 'single', 'undisclosed', 'liver', 'disease'], ['term', 'collaboration', 'verve', 'advance', 'discovery', 'research', 'certain', 'preclinical', 'development', 'novel', 'vivo', 'gene_editing', 'program', 'target', 'interest', 'program', 'cost', 'fund', 'vertex', 'vertex', 'responsible', 'subsequent', 'development', 'manufacturing', 'program', 'stem', 'research', 'effort'], ['partnership', 'vertex', 'enable', 'important', 'step', 'forward', 'verve', 'build', 'lead', 'gene_edit', 'capability', 'pipeline', 'vivo_gene_edit', 'medicine', 'address', 'serious_disease', 'say', 'co_founder', 'chief_executive_officer', 'agreement', 'validate', 'pioneering', 'work', 'verve', 'develop', 'liver', 'direct', 'gene_edit', 'medicine', 'expand', 'reach', 'capability', 'breadth', 'pipeline', 'thrilled', 'partner', 'vertex', 'advance', 'important', 'research', 'development', 'program'], ['commit', 'discover_develop', 'transformative_medicine_people', 'serious_disease', 'say', 'executive', 'research', 'chief_scientific', 'officer', 'vertex', 'impressed', 'progress', 'verve', 'make', 'look_forward', 'combine', 'expertise', 'gene_editing', 'drug', 'development', 'company', 'serve', 'more', 'patient', 'need'], ['transaction', 'term', 'term', 'agreement', 'verve', 'receive_upfront', 'payment', 'include', 'equity_investment', 'also', 'eligible', 'receive', 'success', 'payment', 'development', 'commercial_milestone', 'tiere', 'royalty_future_net', 'sale', 'product', 'result', 'collaboration', 'agreement'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'seramount', 'formerly', 'work', 'mother', 'medium', 'good', 'company', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow'], ['clinical_stage', 'genetic', 'medicine', 'company', 'pioneer', 'new', 'approach', 'care', 'cardiovascular', 'disease', 'transform', 'treatment', 'chronic', 'management', 'single', 'course', 'gene_editing', 'medicine', 'company', 'initial', 'program', 'target', 'pcsk', 'angptl', 'gene', 'extensively', 'validate', 'target', 'lower', 'blood', 'lipid', 'such', 'low', 'density', 'lipoprotein', 'cholesterol', 'root', 'cause', 'cardiovascular', 'lead', 'product_candidate', 'design', 'permanently', 'turn', 'pcsk', 'gene', 'liver', 'order', 'disrupt', 'blood', 'pcsk', 'protein', 'production', 'thereby', 'durably', 'reduce', 'blood', 'ldl', 'level', 'goal', 'reduce', 'patient', 'risk', 'cardiovascular', 'disease', 'develop', 'initially', 'treatment', 'patient', 'heterozygous', 'familial', 'potentially', 'fatal', 'genetic', 'heart', 'disease', 'more_information_visit'], ['forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'press_release_statement', 'potential', 'benefit', 'result', 'achieve', 'collaboration', 'include', 'gene_editing', 'capability', 'delivery', 'technology', 'statement', 'regard', 'upfront_milestone_payment', 'potential', 'royalty_future_sale', 'expectation', 'ability', 'ultimately', 'bring', 'therapy', 'patient', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'anticipate', 'benefit', 'potential', 'collaboration', 'verve', 'achieve', 'anticipated', 'timeline_at_all', 'datum', 'support', 'further_development', 'therapy', 'subject', 'collaboration', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_annual', 'report_file', 'available', 'website_wwwvrtxcom_website_place', 'undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['forward_look_statement', 'press_release_contain', 'forward_look_statement_meaning', 'private_security', 'involve_substantial_risk_uncertainty', 'include', 'statement', 'regard', 'potential', 'benefit', 'result', 'achieve', 'collaboration', 'vertex', 'forward_look_statement', 'word', 'anticipate', 'believe', 'continue', 'expect', 'intend', 'plan', 'potential', 'predict', 'project', 'target', 'similar_expression_intend_identify', 'forward_look_statement', 'forward_look_statement', 'contain', 'identify_word', 'forward_look_statement', 'base', 'management', 'current', 'expectation', 'future', 'event', 'subject', 'number_risk_uncertainty', 'cause_actual_result_differ', 'materially_adversely', 'set_forth', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include', 'limit', 'risk_associate', 'company', 'limited', 'operate', 'history', 'timing', 'company', 'ability', 'submit', 'application', 'product_candidate', 'advance', 'product_candidate', 'clinical_trial', 'initiate', 'enroll', 'clinical_trial', 'timeline', 'expect', 'at_all', 'correctly', 'estimate', 'potential', 'patient', 'population', 'market', 'company', 'product_candidate', 'replicate', 'clinical_trial', 'positive', 'result', 'find', 'preclinical', 'study', 'early_stage', 'clinical_trial', 'other', 'product_candidate', 'advance', 'development', 'product_candidate', 'timeline', 'anticipate', 'current', 'future', 'clinical_trial', 'obtain_maintain', 'protect', 'intellectual_property', 'right', 'relate', 'product_candidate', 'manage', 'expense', 'raise', 'substantial', 'additional', 'capital', 'need', 'achieve', 'business', 'objective', 'discussion', 'other', 'risk_uncertainty', 'other', 'important_factor', 'cause', 'company', 'actual_result_differ', 'contain_forward_look', 'statement', 'see', 'risk_factor', 'section', 'as_well', 'discussion', 'potential', 'risk_uncertainty', 'other', 'important_factor', 'company', 'most_recent', 'filing', 'other', 'filing', 'company', 'make', 'future', 'addition', 'forward_look_statement', 'include', 'press_release', 'represent', 'company', 'view', 'date_hereof', 'rely', 'represent', 'company', 'view', 'date', 'subsequent', 'date_hereof', 'company', 'anticipate', 'subsequent', 'event', 'development', 'cause', 'company', 'view', 'change', 'however', 'company', 'elect', 'update', 'forward_look_statement', 'point', 'future', 'company', 'specifically', 'disclaim_obligation', 'so'], ['pharmaceutical_incorporate_investor'], ['medium'], ['investor_contact'], ['contact'], ['vertex_pharmaceutical_incorporate', 'report_second_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international', 'reference', 'pharmaceutical', 'second_quarter', 'earning', 'call'], ['conference_call_webcast', 'live_link', 'webcast', 'access', 'website_wwwvrtxcom_investor_section', 'ensure_timely_connection_recommend', 'participant', 'register_least', 'minute_prior', 'schedule_webcast', 'archive_webcast', 'available', 'company', 'website'], [], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'cell', 'genetic', 'therapy', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'sickle', 'cell', 'disease_beta_thalassemia', 'kidney_disease', 'pain', 'type_diabetes', 'deficiency_muscular', 'dystrophy'], ['vrtx', 'web'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['viacyte', 'bring', 'tool', 'technology', 'asset', 'potential', 'accelerate', 'development', 'fully_differentiate', 'insulin_produce', 'stem', 'cell', 'derive_islet'], ['acquire', 'cash'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'company', 'enter', 'definitive', 'agreement', 'acquire', 'privately', 'hold', 'biotechnology', 'company', 'focus', 'deliver', 'novel', 'stem', 'cell', 'derive', 'cell', 'replacement', 'therapy', 'functional_cure', 'type_diabetes', 'cash'], ['successfully', 'demonstrate', 'clinical_proof_concept', 'acquisition', 'accelerate', 'goal', 'transform', 'cure', 'expand', 'capability', 'bring', 'additional', 'tool', 'technology', 'asset', 'current', 'stem', 'cell', 'base', 'program', 'say_chief_executive_officer', 'president'], ['investigational_allogeneic', 'stem', 'cell', 'derive_fully_differentiate_insulin', 'produce_islet', 'cell', 'therapy', 'already', 'achieve', 'proof_concept', 'highly', 'promising', 'safety_efficacy', 'result', 'ongoing', 'phase_study', 'continue', 'enroll', 'dose', 'patient', 'acquisition', 'provide', 'vertex', 'complementary', 'asset', 'capability', 'technology', 'include', 'additional', 'human', 'stem', 'cell', 'line', 'intellectual_property', 'stem', 'cell', 'differentiation', 'good_manufacturing_practice', 'manufacturing', 'facility', 'cell', 'base', 'therapy', 'accelerate', 'ongoing', 'program', 'acquisition', 'also', 'provide', 'access', 'novel', 'hypoimmune', 'stem', 'cell', 'asset', 'viacyte', 'collaboration'], ['commitment', 'find', 'functional_cure', 'share', 'vertex', 'acquisition', 'allow', 'vertex', 'deploy', 'tool', 'technology', 'asset', 'development', 'multiple', 'cell', 'replacement', 'therapy', 'approach', 'design', 'reduce', 'burden', 'million', 'people', 'live', 'worldwide', 'say_chief_executive_officer', 'viacyte'], ['transaction', 'term', 'term', 'acquisition', 'vertex', 'acquire', 'viacyte', 'cash', 'vertex', 'anticipate', 'acquisition', 'close', 'later', 'year', 'subject', 'certain', 'condition', 'include', 'expiration_waiting_period_antitrust', 'improvement', 'other', 'customary', 'condition'], ['viacyte', 'viacyte', 'private', 'cellular', 'therapy', 'company', 'clinical_stage', 'stem', 'cell', 'platform', 'deliver', 'therapeutic', 'protein', 'restore', 'health', 'people', 'company', 'significant', 'clinical', 'experience', 'patient', 'include', 'first_class', 'gene_edit', 'immune', 'evasive', 'investigational', 'islet', 'cell', 'replacement', 'therapy', 'diabetes', 'potentially', 'eliminate', 'need', 'exogenous_insulin', 'require', 'viacyte', 'receive', 'support', 'research', 'medicine', 'establish', 'collaborative', 'partnership', 'lead', 'company', 'include', 'advance', 'therapy'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'status', 'clinical', 'progress', 'expect', 'therapeutic', 'benefit', 'potential', 'impact', 'other', 'program', 'include', 'potential', 'program', 'transform', 'cure', 'future', 'activity', 'potential', 'benefit', 'acquisition', 'include', 'potential', 'acceleration', 'other', 'program', 'expansion', 'capability', 'tool', 'use', 'stem', 'cell', 'base', 'program', 'potential', 'reduce', 'burden', 'disease', 'people', 'live', 'worldwide', 'potential', 'closing', 'acquisition', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'transaction', 'subject', 'certain', 'condition', 'include', 'expiration_waiting_period_antitrust', 'improvement', 'act', 'vertex', 'realize', 'potential', 'benefit', 'transaction', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program', 'include', 'program_support_registration_further', 'development', 'potential', 'medicine_timely_manner', 'at_all_safety_efficacy', 'other_reason', 'other_risk_list', 'heading_risk', 'factor_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['pharmaceutical_incorporate_investor'], ['medium'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'lift', 'clinical', 'hold', 'place', 'phase', 'clinical_trial', 'investigational', 'stem', 'cell', 'derive_fully_differentiate_pancreatic', 'islet', 'cell', 'replacement', 'therapy', 'people', 'type_diabetes', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'result', 'phase', 'trial', 'reopen', 'screen', 'enrollment', 'dosing', 'multiple', 'site'], ['date', 'patient', 'dose', 'phase_study', 'patient', 'receive', 'target', 'dose', 'cell', 'part', 'study', 'third', 'patient', 'receive', 'full', 'target', 'dose', 'part', 'study', 'part', 'evaluate', 'safety_efficacy', 'patient', 'target', 'dose', 'expand', 'additional', 'patient', 'part'], [], ['investigational_allogeneic', 'stem', 'cell', 'derive_fully_differentiate_insulin', 'produce_islet', 'cell', 'therapy', 'manufacture', 'use', 'proprietary', 'technology', 'evaluate', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'potential', 'restore_body_ability_regulate', 'glucose_level_restore_pancreatic', 'islet', 'cell', 'function', 'include', 'glucose_responsive_insulin_production', 'deliver', 'infusion', 'hepatic_portal_vein', 'require', 'maintenance', 'therapy', 'protect_islet', 'cell', 'immune_rejection'], ['phase', 'clinical_trial'], ['clinical_trial', 'phase', 'multi_center', 'single_arm_open_label', 'study', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'study', 'design', 'sequential_multi', 'part', 'clinical_trial', 'evaluate', 'safety_efficacy', 'part', 'first', 'patient', 'receive', 'target', 'dose', 'part', 'patient', 'receive', 'target', 'dose', 'concurrent_dosing', 'full', 'target', 'dose', 'occur', 'part', 'approximately', 'patient', 'enrol', 'clinical_trial', 'enrollment', 'ongoing', 'study'], ['type_diabetes'], ['result', 'autoimmune', 'destruction', 'insulin_produce_islet', 'cell', 'pancrea', 'lead', 'loss', 'insulin_production', 'impairment', 'blood_glucose', 'control', 'absence', 'insulin', 'lead', 'abnormality', 'how', 'body', 'process', 'nutrient', 'lead', 'high', 'blood_glucose', 'level', 'high', 'blood_glucose', 'lead', 'diabetic', 'ketoacidosis', 'time', 'complication', 'such', 'kidney_disease', 'failure', 'eye', 'disease', 'include', 'vision', 'loss', 'heart', 'disease', 'nerve', 'damage', 'even', 'death'], ['limitation', 'complexity', 'insulin', 'delivery', 'system', 'difficult', 'achieve', 'maintain', 'balance', 'glucose', 'control', 'people', 'hypoglycemia', 'often', 'result', 'difficulty', 'balance', 'different', 'factor', 'impact', 'glucose_level', 'include', 'insulin', 'diet', 'exercise', 'hypoglycemia', 'remain', 'critical', 'limit', 'factor', 'glycemic', 'management', 'severe_hypoglycemia', 'cause', 'loss', 'consciousness', 'seizure', 'injury', 'fatal', 'time', 'patient', 'develop', 'impair', 'awareness', 'hypoglycemia', 'meaning', 'no', 'long', 'able', 'perceive', 'early', 'sign', 'hypoglycemic', 'event', 'dangerous', 'result', 'life_threaten', 'event'], ['current', 'standard_care', 'address_underlie', 'cause', 'disease', 'limit', 'treatment_option', 'insulin', 'management'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'press_release_ii', 'plan', 'expectation', 'potential', 'benefit', 'plan', 'continue', 'progress', 'phase', 'program', 'plan', 'dosing', 'enrollment', 'patient', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'research', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['datum', 'patient', 'transfusion_dependent_beta_thalassemia', 'severe_sickle', 'cell', 'disease', 'follow_up', 'month', 'continue', 'demonstrate', 'exa', 'potential', 'time', 'functional_cure'], ['safety_profile', 'generally_consistent', 'myeloablative_conditioning', 'autologous', 'stem', 'cell', 'transplant'], ['vertex_pharmaceutical_incorporate', 'announce', 'presentation', 'new', 'datum', 'exa_cel', 'formerly_know', 'highlight', 'potentially_transformative', 'profile', 'investigational', 'therapy', 'people', 'transfusion_dependent_beta_thalassemia', 'severe_sickle', 'cell', 'disease', 'provide', 'additional', 'program', 'update'], ['new', 'datum', 'exa_cel', 'climb', 'clinical', 'study', 'datum', 'present', 'patient', 'tdt_scd', 'follow_up', 'range', 'month', 'exa_cel', 'dosing'], ['patient', 'beta', 'beta', 'other', 'beta', 'like', 'severe', 'genotype', 'patient', 'transfusion', 'free', 'follow_up', 'range', 'month', 'exa_cel_infusion', 'patient', 'yet', 'transfusion', 'free', 'reduction', 'transfusion', 'volume', 'patient', 'substantial', 'mean', 'increase', 'fetal_hemoglobin', 'corresponding', 'increase', 'mean', 'total_hemoglobin', 'mean', 'total', 'level', 'increase', 'month', 'maintain', 'thereafter'], ['patient', 'severe_scd', 'characterize_recurrent', 'vaso_occlusive', 'crisis', 'mean', 'vocs', 'year', 'prior', 'year', 'free', 'exa_cel_infusion', 'duration', 'follow_up', 'follow_up', 'range', 'month', 'scd', 'patient', 'mean', 'proportion', 'total', 'hb', 'approximately', 'month', 'maintain', 'thereafter'], ['safety', 'generally_consistent', 'myeloablative_conditioning', 'busulfan', 'autologous', 'stem', 'cell', 'transplant', 'patient', 'engraft', 'neutrophil', 'platelet', 'exa_cel_infusion', 'patient', 'patient', 'serious_adverse_event', 'sae_consider_related', 'exa_cel', 'previously', 'report', 'patient', 'sae_consider_related', 'exa_cel', 'hemophagocytic', 'distress', 'syndrome', 'headache', 'sae', 'idiopathic', 'pneumonia', 'syndrome', 'consider_related', 'exa_cel', 'busulfan', 'sae_occur', 'context', 'resolve', 'patient', 'sae', 'delay', 'consider_related', 'exa_cel', 'busulfan', 'sae', 'resolve', 'patient', 'scd', 'sae_consider_related', 'exa_cel'], ['additional', 'detail', 'present', 'medium', 'briefing', 'find', 'publish', 'abstract', 'presentation'], ['late', 'break', 'abstract', 'entitle', 'efficacy_safety', 'single_dose', 'transfusion_dependent', 'Î²eta', 'thalassemia_severe', 'sickle', 'cell', 'disease', 'oral_presentation', 'cest'], ['robust', 'datum', 'patient', 'year', 'more', 'follow_up', 'exa_cel_infusion', 'further', 'demonstrate', 'potential', 'investigational', 'therapy', 'time', 'functional_cure', 'patient', 'transfusion_dependent_beta_thalassemia', 'severe_sickle', 'cell', 'disease', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer'], ['reactivate', 'naturally_occur', 'developmental', 'process', 'exa', 'restore', 'fetal_hemoglobin', 'production', 'thereby', 'ameliorate', 'course', 'disease', 'say', 'director', 'pediatric_hematology_oncology', 'child', 'hospital', 'remarkable', 'result', 'base', 'approach', 'give', 'great', 'optimism', 'confidence', 'potential', 'treatment', 'patient'], ['see', 'first', 'hand', 'impact', 'investigational', 'therapy', 'have', 'patient', 'clinical_trial', 'continue', 'impress', 'totality', 'datum', 'say', 'pediatric', 'director', 'hematology_oncology', 'hospital', 'give', 'urgency', 'highly', 'effective', 'curative', 'therapy', 'patient', 'excited', 'part', 'team', 'work', 'goal', 'address_unmet', 'need'], ['exa_cel', 'study', 'update', 'follow', 'ongoing', 'discussion', 'regulator', 'clinical_trial', 'protocol', 'amend', 'incorporate', 'feedback', 'primary_endpoint', 'regulatory_submission', 'specifically', 'primary_endpoint', 'amend', 'proportion', 'subject', 'achieve', 'transfusion', 'reduction', 'exa_cel_infusion', 'proportion', 'subject', 'maintain', 'weight', 'average', 'red_blood_cell', 'rbc', 'transfusion', 'at_least', 'consecutive', 'month', 'exa_cel_infusion'], ['primary_endpoint', 'scd', 'update', 'proportion', 'subject', 'cel_infusion', 'proportion', 'subject', 'experience', 'severe', 'vocs', 'at_least', 'consecutive', 'month', 'exa_cel_infusion'], ['clinical_trial', 'now', 'phase', 'fully', 'enrol', 'patient', 'opportunity', 'join', 'long_term', 'follow', 'study', 'complete', 'participation', 'initial', 'study'], ['additional', 'pediatric', 'study', 'line', 'company', 'strategy', 'develop', 'therapy', 'patient', 'age', 'additional', 'phase_study', 'exa', 'begin', 'early', 'year', 'independent', 'meet', 'review', 'datum', 'adult', 'adolescent', 'endorse', 'expand', 'young', 'pediatric', 'patient', 'phase_open_label', 'trial', 'design_assess', 'safety_efficacy', 'single_dose', 'exa_cel', 'patient', 'age_year', 'tdt_scd', 'respectively', 'trial', 'now', 'open', 'enrollment', 'currently', 'enrol', 'patient', 'age_year', 'plan', 'extend', 'patient', 'less', 'year', 'age', 'later', 'date', 'trial', 'enroll', 'approximately', 'patient', 'patient', 'follow', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'follow', 'trial'], ['also', 'present', 'additional', 'abstract', 'burden', 'disease', 'sickle', 'cell', 'disease_beta_thalassemia'], ['exa', 'formerly_know', 'investigational_autologous', 'cas', 'gene', 'edite', 'therapy', 'evaluate', 'patient', 'tdt_scd_characterize_recurrent', 'patient', 'own', 'hematopoietic_stem', 'cell', 'edit', 'produce_high', 'level_fetal', 'hemoglobin_red', 'blood', 'cell', 'form_oxygen', 'carrying', 'hemoglobin_naturally', 'present', 'fetal', 'development', 'then_switch', 'adult_form', 'hemoglobin', 'birth', 'elevation_hbf_potential_alleviate', 'transfusion_requirement', 'patient', 'tdt', 'reduce_painful', 'debilitate_sickle_crisis', 'patient', 'scd', 'early', 'result', 'ongoing', 'trial', 'publish'], ['base', 'progress', 'program', 'date_grant_regenerative', 'medicine', 'advanced', 'therapy', 'rmat', 'fast_track', 'orphan_drug', 'rare_pediatric', 'disease', 'designation_tdt_scd', 'exa', 'also', 'grant', 'drug', 'designation', 'as_well', 'priority', 'medicine', 'designation_tdt_scd'], ['gene_editing', 'approach', 'evaluate', 'tdt_scd', 'furthest', 'advanced', 'clinical', 'development'], ['ongoing_phase_open', 'label_trial', 'design_assess', 'safety_efficacy', 'single_dose', 'patient', 'age_year', 'tdt_scd_characterize_recurrent', 'respectively', 'trial', 'now', 'close', 'enrollment', 'patient', 'follow', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'trial'], ['long_term', 'open_label', 'trial', 'evaluate', 'safety_efficacy', 'patient', 'receive', 'trial', 'design', 'follow', 'participant', 'year', 'infusion'], ['ongoing_phase_open', 'label_trial', 'design_assess', 'safety_efficacy', 'single_dose', 'patient', 'age_year', 'tdt_scd_characterize_recurrent', 'respectively', 'trial', 'now', 'open', 'enrollment', 'currently', 'enrol', 'patient', 'age_year', 'age', 'plan', 'extend', 'patient', 'less', 'year', 'age', 'later', 'date', 'trial', 'enroll', 'approximately', 'patient', 'patient', 'follow', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'trial'], ['gene_editing', 'process', 'trial', 'patient', 'enroll', 'trial', 'own', 'hematopoietic_stem', 'progenitor', 'cell', 'collect', 'peripheral', 'blood', 'patient', 'cell', 'edit', 'use', 'crispr', 'technology', 'edit', 'cell', 'then', 'infuse', 'back', 'patient', 'part', 'autologous', 'hematopoietic_stem', 'cell', 'transplant', 'process', 'involve', 'patient', 'treat', 'myeloablative_busulfan', 'conditioning', 'patient', 'undergo', 'hsct', 'also', 'encounter', 'side_effect', 'range', 'mild', 'severe', 'unrelated', 'administration', 'patient', 'initially', 'monitor', 'determine', 'when', 'edit', 'cell', 'begin', 'produce', 'mature', 'blood', 'cell', 'process', 'know', 'engraftment', 'engraftment', 'patient', 'continue', 'monitor', 'track', 'impact', 'multiple', 'measure', 'disease', 'safety'], ['enter_strategic', 'research', 'collaboration', 'focus', 'use', 'cas', 'discover_develop', 'potential', 'new', 'treatment', 'aim', 'underlying_genetic', 'cause', 'human', 'disease', 'represent', 'first', 'potential', 'treatment', 'emerge_joint', 'research', 'program', 'amend', 'collaboration', 'agreement', 'vertex', 'now', 'lead', 'global', 'development', 'manufacturing', 'split', 'program', 'cost', 'profit_worldwide'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'cell', 'genetic', 'therapy', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'sickle', 'cell', 'disease', 'apol', 'mediate', 'type_diabete', 'alpha', 'deficiency_muscular', 'dystrophy'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'press_release_ii', 'plan', 'expectation', 'present', 'clinical', 'datum', 'ongoing', 'exa_cel', 'clinical_trial', 'progress', 'ongoing', 'exa_cel', 'clinical_trial', 'include', 'expectation_regard', 'abstract', 'make', 'available', 'virtual', 'platform', 'include', 'anticipate', 'projection', 'estimate', 'relate', 'various', 'economic', 'impact', 'scd', 'potential', 'benefit', 'efficacy_safety', 'exa', 'include', 'potentially_transformative', 'nature', 'therapy', 'potential', 'treatment', 'patient', 'plan', 'expectation', 'clinical_trial', 'pipeline', 'product', 'status_clinical_trial', 'product_candidate', 'development', 'collaborator', 'include', 'activity', 'clinical_trial', 'site', 'patient', 'enrollment', 'expectation_regard', 'clinical_trial', 'follow_up', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program', 'include', 'program', 'collaborator_support_registration', 'further_development', 'compound_safety_efficacy', 'other_reason', 'internal_external', 'factor', 'delay', 'divert', 'change', 'plan_objective', 'respect', 'research', 'development', 'program', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'exa_cel', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], [], ['lead', 'gene_edit', 'company', 'focus', 'develop', 'transformative', 'gene', 'base', 'medicine', 'serious_disease', 'use', 'proprietary', 'crispr', 'platform', 'cas', 'revolutionary', 'gene_edit', 'technology', 'allow', 'precise', 'direct', 'change', 'establish', 'portfolio', 'therapeutic', 'program', 'broad_range', 'disease', 'area', 'include', 'oncology', 'regenerative_medicine', 'rare', 'disease', 'accelerate', 'expand', 'effort', 'establish', 'strategic', 'collaboration', 'lead', 'company', 'include', 'bayer', 'vertex_pharmaceutical', 'headquarter', 'wholly_own', 'subsidiary', 'operation', 'base', 'business', 'office', 'more_information_visit', 'wwwcrisprtxcom'], ['word', 'mark', 'design', 'logo', 'trademark', 'register_trademark', 'other', 'trademark', 'register_trademark', 'property', 'respective', 'owner'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security', 'as', 'amend', 'as_well', 'statement', 'make', 'press_release', 'as_well', 'statement', 'regard', 'expectation', 'follow', 'safety_efficacy', 'clinical', 'progress', 'ongoing', 'exa_cel', 'clinical_trial', 'include', 'expectation_regard', 'abstract', 'make', 'available', 'virtual', 'platform', 'plan', 'expectation', 'present', 'clinical', 'datum', 'present', 'as_well', 'potentially_transformative', 'nature', 'exa', 'potential', 'treatment', 'patient', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'exist', 'prospective_investor', 'caution_forward_look', 'statement_inherently_uncertain', 'promise_guarantee', 'place_undue_reliance', 'such', 'statement', 'speak_only_date', 'make', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'initial_preliminary', 'datum', 'clinical_trial', 'initial_datum_limited', 'number', 'patient', 'case', 'exa_cel', 'time_indicative', 'final', 'future', 'trial', 'result', 'potential', 'exa_cel', 'clinical_trial', 'result', 'favorable', 'support_registration', 'further_development', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'exa', 'realize', 'potential', 'benefit', 'collaboration', 'vertex', 'potential', 'impact_due_coronavirus', 'pandemic', 'such', 'timing_progress', 'clinical_trial', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'quarterly_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available', 'website_disclaim', 'obligation_undertaking', 'update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['source_version'], ['investor'], ['medium'], ['trikafta', 'ivacaftor', 'ivacaftor', 'real_world', 'safety', 'effectiveness', 'interim', 'result', 'show', 'improved', 'lung_function', 'significant', 'reduction', 'risk', 'pulmonary_exacerbation', 'lung', 'transplant', 'death', 'people_cystic_fibrosis'], ['study', 'people', 'genotype', 'treat', 'trikafta', 'show', 'mean', 'loss', 'lung_function', 'year', 'compare', 'treat', 'cftr_modulator'], ['long_term', 'real_world', 'study', 'result', 'show', 'significant', 'benefit', 'initiate', 'ivacaftor', 'young', 'age'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'scientific', 'abstract', 'company', 'portfolio', 'cystic_fibrosis', 'medicine', 'present', 'th', 'european', 'hold'], ['present', 'first', 'analysis', 'datum', 'collect', 'patient', 'registry', 'cffpr', 'people', 'treat', 'trikafta', 'ivacaftor', 'ivacaftor', 'average', 'month', 'first', 'interim_analysis', 'ongoing', 'year', 'post', 'authorization', 'study', 'abstract', 'show', 'real_world', 'treatment', 'trikafta', 'associate', 'improved', 'lung_function', 'reduce', 'risk', 'pulmonary_exacerbation', 'compare', 'pre', 'trikafta', 'baseline', 'as_well', 'low', 'risk', 'lung', 'transplant', 'low', 'risk', 'death', 'compare', 'historical', 'cffpr', 'population', 'new', 'safety', 'concern', 'identify'], ['also', 'present', 'datum', 'compare', 'annual', 'rate', 'lung_function', 'change', 'people', 'age_year_old', 'del_mutation', 'mutation_minimal', 'function_mutation', 'treat', 'trikafta', 'pivotal', 'study', 'open_label_extension', 'study', 'compare', 'propensity', 'score', 'match', 'historical', 'cftr_modulator', 'untreated', 'control', 'cffpr', 'abstract', 'ws', 'result', 'show', 'trikafta', 'demonstrate', 'average', 'decrease', 'ppfev', 'year', 'period', 'population', 'contrast', 'decline', 'see', 'match', 'control', 'analysis', 'indicate', 'treatment', 'trikafta', 'significant', 'impact', 'trajectory'], ['additionally', 'present', 'datum', 'long_term', 'real_world', 'study', 'demonstrate', 'initiate', 'ivacaftor', 'early', 'life', 'age_year', 'preserve', 'lung_function', 'great', 'extent', 'initiate', 'old', 'age', 'abstract', 'result', 'show', 'importance', 'early', 'initiation', 'eligible', 'patient'], ['long_term', 'real_world', 'study', 'show', 'potentially_transformative', 'benefit', 'treatment', 'cftr_modulator', 'add', 'substantial', 'body', 'evidence', 'support', 'treatment', 'as_early', 'life', 'possible', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'continue', 'make', 'rapid', 'progress', 'develop', 'medicine_treat_underlying', 'cause', 'today', 'close', 'goal', 'develop', 'highly', 'effective', 'therapy', 'patient', 'ever'], ['additional', 'presentation'], ['addition', 'study', 'note', 'other', 'vertex', 'presentation', 'conference', 'year', 'support', 'long_term', 'early', 'use', 'cftr_modulator'], ['cystic_fibrosis'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect', 'more', 'people', 'globally_cf_progressive_multi', 'organ', 'disease', 'affect_lung', 'pancrea', 'tract_sinus', 'sweat_gland', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'mutation', 'identify', 'genetic_test', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_mutation', 'cftr', 'mutation', 'lead', 'cause', 'cftr_protein', 'defective', 'lead', 'shortage', 'absence_cftr', 'protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'lung_infection', 'progressive_lung', 'damage', 'eventually_lead', 'death', 'many', 'patient', 'median_age', 'death_early'], ['trikafta', 'ivacaftor', 'ivacaftor'], ['people', 'certain', 'type', 'mutation', 'cftr', 'gene', 'cftr_protein_process_fold', 'normally', 'cell', 'prevent', 'cftr_protein', 'reach', 'cell', 'surface', 'function_properly', 'trikafta', 'ivacaftor', 'ivacaftor', 'oral', 'medicine', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'elexacaftor_tezacaftor', 'work_together', 'increase_amount', 'mature_protein', 'cell', 'surface', 'bind', 'different', 'site', 'protein', 'ivacaftor', 'know_cftr_potentiator', 'design_facilitate', 'ability', 'cftr_protein_transport_salt', 'water', 'cell', 'membrane', 'combine', 'action', 'elexacaftor', 'help_hydrate', 'clear_mucus', 'airway'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'mutation', 'responsive', 'trikafta', 'cftr', 'gene', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'trikafta', 'safe_effective_child', 'year', 'age'], ['see', 'important', 'safety', 'information', 'below', 'click_here', 'full_prescribe', 'information'], ['ivacaftor'], ['people', 'certain', 'type', 'mutation', 'cftr', 'gene', 'cftr_protein', 'cell', 'surface', 'function_properly', 'know_cftr_potentiator', 'ivacaftor', 'oral', 'medicine', 'design_facilitate', 'ability', 'cftr_protein_transport_salt', 'water', 'cell', 'membrane_help_hydrate_clear', 'mucus', 'ivacaftor', 'first', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'people', 'specific', 'mutation', 'cftr', 'gene'], ['prescription_medicine_use', 'treatment', 'patient', 'aged_month', 'old_at_least', 'mutation', 'gene_responsive', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know_safe', 'effective_child', 'month', 'age'], ['lumacaftor_ivacaftor'], ['people', 'copy_mutation', 'cftr_protein', 'process', 'traffic', 'normally', 'cell', 'result', 'little', 'cftr_protein', 'cell', 'surface'], ['lumacaftor_ivacaftor', 'oral', 'medicine', 'combination', 'lumacaftor_ivacaftor', 'lumacaftor_design', 'increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'cftr_protein', 'ivacaftor', 'know_cftr_potentiator', 'design_facilitate', 'ability', 'cftr_protein_transport_salt', 'water', 'cell', 'membrane', 'combine', 'action', 'lumacaftor_ivacaftor', 'help_hydrate', 'clear_mucus', 'airway'], ['prescription_medicine_use', 'treatment', 'patient', 'age_year_old_copy', 'mutation', 'cftr', 'gene', 'orkambi', 'only', 'use', 'patient', 'know', 'orkambi', 'safe_effective', 'patient', 'year', 'age'], ['important', 'safety', 'information', 'trikafta', 'ivacaftor', 'ivacaftor', 'ivacaftor', 'lumacaftor_ivacaftor'], ['patient', 'take', 'kalydeco', 'trikafta', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medicine_such_phenobarbital', 'carbamazepine_phenytoin'], ['patient', 'take_orkambi', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medicine', 'phenobarbital_carbamazepine', 'phenytoin', 'sedative', 'anti', 'anxiety', 'medicine', 'medicine', 'cyclosporine', 'sirolimus', 'tacrolimus'], ['take_orkambi', 'trikafta', 'patient', 'tell_doctor_medical', 'condition', 'include', 'have_liver', 'problem', 'kidney_problem', 'pregnant_plan_become_pregnant', 'know', 'kalydeco', 'orkambi', 'trikafta', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'kalydeco', 'orkambi', 'trikafta', 'pass_breast_milk', 'take_orkambi', 'patient', 'tell_doctor', 'have', 'organ', 'transplant', 'use', 'hormonal_contraceptive', 'include', 'oral', 'injectable', 'transdermal', 'implantable', 'form', 'use', 'method', 'birth', 'control', 'when_take', 'orkambi'], ['trikafta', 'affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'kalydeco', 'orkambi', 'trikafta', 'work_therefore', 'dose', 'trikafta', 'need', 'adjust_when_take_certain', 'medication', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medication', 'such_voriconazole', 'fluconazole_antibiotic', 'such'], ['cause_dizziness', 'people', 'take', 'patient', 'drive_car', 'use', 'machinery', 'need', 'alert', 'know', 'how', 'trikafta', 'affect'], ['when_take', 'orkambi', 'patient', 'tell_doctor', 'stop', 'take_orkambi', 'more', 'week', 'doctor', 'need', 'change', 'dose', 'orkambi', 'other', 'medicine', 'patient', 'take'], ['patient', 'avoid_food_drink_contain', 'grapefruit', 'take', 'kalydeco', 'trikafta'], ['cause', 'serious_side_effect', 'such'], ['liver', 'damage', 'worsening', 'liver', 'function', 'people', 'take', 'trikafta', 'severe', 'liver', 'disease', 'serious', 'require', 'transplantation', 'liver', 'damage', 'also', 'happen', 'people', 'liver', 'disease'], ['high_liver', 'enzyme_blood', 'report', 'patient', 'receive', 'kalydeco', 'orkambi', 'trikafta', 'patient', 'doctor_blood_test_check', 'liver_start', 'treatment', 'orkambi', 'trikafta', 'month', 'first', 'year', 'treatment', 'year', 'treatment', 'patient', 'have', 'high_liver', 'enzyme', 'past', 'doctor_blood_test_check', 'liver', 'more', 'often', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['worsen', 'liver', 'function', 'people', 'severe', 'liver', 'disease', 'take_orkambi', 'worsening', 'liver', 'function', 'serious', 'cause', 'death', 'talk_doctor', 'tell', 'liver', 'disease', 'doctor', 'need', 'adjust', 'dose', 'orkambi'], ['breathing', 'problem', 'such', 'shortness', 'breath', 'chest', 'tightness', 'patient', 'when', 'start', 'orkambi', 'especially', 'patient', 'poor', 'lung_function', 'patient', 'poor', 'lung_function', 'doctor', 'monitor', 'more', 'closely', 'when', 'start', 'orkambi'], ['increase', 'blood_pressure', 'people', 'receive', 'orkambi', 'patient', 'doctor', 'monitor', 'blood_pressure', 'treatment', 'orkambi'], ['abnormality_eye_lens_cataract', 'child_adolescent', 'treat', 'orkambi', 'trikafta', 'patient', 'child_adolescent', 'doctor_perform_eye_examination', 'treatment', 'orkambi', 'trikafta', 'look_cataract'], ['most_common_side_effect', 'include', 'respiratory_tract_infection', 'common_cold', 'include', 'sore_throat', 'nasal', 'sinus', 'congestion', 'runny_nose', 'stomach_abdominal', 'pain', 'diarrhea', 'rash', 'nausea', 'dizziness'], ['most_common_side_effect', 'orkambi', 'include', 'breathing', 'problem', 'such', 'shortness', 'breath', 'chest', 'tightness', 'nausea', 'diarrhea', 'fatigue', 'increase', 'certain', 'blood', 'enzyme', 'call', 'phosphokinase', 'rash', 'gas', 'common_cold', 'include', 'sore_throat', 'stuffy_runny', 'nose', 'flu', 'flu', 'like', 'symptom', 'irregular', 'missed', 'abnormal', 'period', 'mense', 'increase_amount', 'menstrual', 'bleed', 'additional', 'side_effect', 'see', 'child', 'include', 'cough', 'sputum', 'stomach', 'pain', 'increase', 'sputum'], ['most_common_side_effect', 'include', 'diarrhea', 'respiratory_tract_infection', 'common_cold', 'include', 'stuffy_runny', 'nose_stomach', 'abdominal_pain', 'inflamed', 'sinus', 'increase', 'liver_enzyme', 'increase', 'certain', 'blood', 'enzyme', 'call', 'creatine', 'phosphokinase', 'rash', 'flu', 'increase', 'blood', 'bilirubin'], ['possible_side_effect', 'orkambi', 'trikafta', 'click', 'product', 'link', 'see_full', 'prescribe_information', 'orkambi', 'trikafta'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'make', 'bozic', 'press_release_statement', 'regard', 'potential', 'benefit', 'safety_efficacy', 'product', 'plan', 'present', 'datum', 'portfolio', 'product', 'conference', 'include', 'analysis', 'datum', 'ongoing', 'year', 'post', 'authorization', 'safety', 'study', 'datum', 'compare', 'annual', 'rate', 'lung_function', 'change', 'certain', 'individual', 'assessment', 'impact', 'such', 'data', 'datum', 'regard', 'early', 'initiation', 'assessment', 'impact', 'such', 'datum', 'additional', 'scientific', 'presentation', 'regard', 'market', 'product', 'include', 'expectation_regard', 'abstract', 'make', 'available', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support', 'registration', 'approval', 'further_development', 'compound_safety_efficacy', 'other_reason', 'risk', 'relate', 'approval', 'medicine', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['medium'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'company', 'participate_fireside_chat', 'annual', 'global', 'healthcare', 'conference', 'pm'], ['live_webcast', 'management', 'remark', 'available', 'website_wwwvrtxcom_investor_section', 'news', 'event_page', 'replay', 'conference', 'webcast_archive', 'company', 'website'], ['source_version'], ['pharmaceutical_incorporate_investor', 'miroslava'], ['name'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'grant', 'inaxaplin', 'breakthrough', 'therapy', 'designation', 'apol_mediated', 'focal', 'segmental', 'grant', 'priority', 'medicine', 'designation', 'chronic', 'kidney_disease', 'first', 'investigational', 'therapy', 'aim', 'treat_underlying_cause', 'amkd'], ['breakthrough', 'therapy', 'designation', 'intend', 'expedite', 'development', 'review', 'medicine', 'aim', 'address', 'serious', 'condition', 'preliminary', 'clinical', 'evidence', 'indicate', 'drug', 'demonstrate', 'substantial_improvement', 'exist', 'treatment', 'more', 'clinically', 'significant', 'endpoint', 'breakthrough', 'therapy', 'designation', 'grant', 'base', 'phase', 'clinical', 'study', 'inaxaplin', 'patient', 'fsgs', 'form', 'amkd'], ['prime_designation', 'regulatory', 'mechanism', 'provide', 'early', 'proactive', 'support', 'developer', 'promise', 'medicine', 'optimize', 'generation', 'robust', 'datum', 'enable', 'accelerated', 'assessment', 'medicine', 'potentially', 'reach', 'patient', 'fast', 'goal', 'help', 'patient', 'benefit', 'as_early_possible', 'innovative', 'new', 'therapy', 'potential', 'significantly', 'address_unmet', 'medical', 'need', 'prime_designation', 'grant', 'base', 'clinical_proof_concept', 'datum', 'phase_study', 'inaxaplin', 'fsgs', 'inaxaplin', 'only', 'second', 'nephrology', 'product', 'grant', 'prime_designation'], ['now', 'hold', 'approximately', 'non', 'oncological', 'prime_designation', 'grant', 'date', 'include', 'prime_designation', 'exa', 'formerly_know', 'transfusion_dependent_beta_thalassemia', 'sickle', 'cell', 'disease', 'ninth', 'breakthrough', 'designation', 'grant', 'vertex', 'portfolio', 'program'], ['inaxaplin', 'pivotal', 'program', 'randomize_double_blind_placebo', 'control', 'phase', 'adaptive', 'study', 'ongoing', 'first', 'evaluate', 'dose', 'inaxaplin', 'week', 'select', 'dose', 'phase', 'subsequently', 'evaluate', 'efficacy_safety', 'single', 'select', 'dose', 'phase', 'portion', 'study'], ['patient', 'age_year', 'apol', 'mutation', 'urine', 'protein', 'ratio', 'estimate', 'glomerular', 'filtration', 'rate', 'stable', 'dose', 'standard_care', 'medication', 'eligible', 'enroll', 'approximately', 'patient', 'plan', 'enrol', 'phase', 'dose_range', 'portion', 'study', 'approximately', 'additional', 'patient', 'plan', 'enrol', 'phase', 'portion', 'study'], ['primary_efficacy', 'endpoint', 'final', 'analysis', 'egfr_slope', 'patient', 'receive', 'select', 'compare_placebo', 'secondary', 'efficacy_endpoint', 'time', 'composite', 'clinical', 'outcome', 'also', 'assess', 'final', 'analysis', 'define', 'sustained', 'decline', 'baseline', 'onset', 'end', 'stage', 'kidney_disease', 'maintenance', 'dialysis', 'day', 'kidney', 'transplantation', 'sustained', 'egfr', 'death', 'final', 'study', 'analysis', 'occur', 'when', 'subject', 'at_least', 'year', 'egfr', 'datum', 'when', 'approximately', 'composite', 'clinical', 'outcome', 'occur'], ['study', 'also', 'design', 'pre', 'plan', 'interim_analysis', 'week', 'evaluate', 'egfr_slope', 'support', 'percent', 'change_baseline', 'arm_placebo', 'positive', 'interim_analysis', 'serve', 'basis', 'vertex', 'seek', 'accelerated_approval', 'patient', 'amkd'], ['kidney_disease', 'kidney_disease', 'form', 'chronic', 'kidney_disease', 'cause', 'mutation', 'apol', 'gene', 'approximately', 'people', 'apol', 'genetic', 'mutation', 'proteinuric', 'disease', 'people', 'inherit', 'mutation', 'apol', 'gene', 'course', 'disease', 'far', 'more', 'aggressive', 'absence', 'genetic', 'mutation', 'inherit', 'apol', 'genetic', 'mutation', 'kidney_disease', 'toxic', 'gain', 'function', 'lead', 'podocyte', 'injury', 'injury', 'disrupt', 'filtration', 'result', 'rapidly', 'progressive', 'result', 'dialysis', 'kidney', 'transplant', 'death'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'regard', 'expedite', 'development', 'result', 'therapy', 'designation', 'prime_designation', 'potential', 'benefit', 'anticipate_timeline', 'dosing', 'associate', 'ongoing', 'future', 'clinical_trial', 'study', 'design', 'include', 'expectation', 'patient', 'enrollment', 'expectation_regard', 'efficacy_endpoint', 'plan', 'interim', 'evaluation', 'plan', 'submission', 'regulatory_approval', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'trial', 'complete', 'expect', 'timeframe', 'at_all_datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news_home'], ['pharmaceutical_incorporate_investor'], ['patient', 'show', 'blood_glucose', 'time', 'range', 'change', 'unit', 'day', 'exogenous_insulin', 'baseline', 'insulin_independence', 'day'], ['patient', 'show', 'blood_glucose', 'time', 'range', 'change', 'unit', 'day', 'exogenous_insulin', 'baseline', 'reduction', 'exogenous_insulin', 'use', 'day'], ['previously', 'report', 'proof_concept', 'achieve', 'first', 'patient', 'treat', 'target', 'dose', 'demonstrate', 'glucose_responsive', 'insulin', 'secretion', 'improvement', 'reduction', 'exogenous_insulin'], ['generally_well_tolerate', 'patient', 'dose', 'date', 'majority_adverse_event_mild', 'moderate'], ['additional', 'abstract', 'also', 'accept', 'presentation'], ['vertex_pharmaceutical_incorporate_today', 'provide', 'additional', 'datum', 'patient', 'dose', 'part', 'phase', 'clinical_trial', 'investigational', 'stem', 'cell', 'derive_fully_differentiate_pancreatic', 'islet', 'cell', 'replacement', 'therapy', 'people', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'report', 'last', 'month', 'patient', 'treat', 'target', 'dose', 'achieve', 'glucose_responsive_insulin_production', 'improvement', 'glycemic_control', 'reduction', 'exogenous_insulin', 'requirement', 'datum', 'present', 'today', 'show', 'significant', 'increase', 'blood_glucose', 'time', 'range', 'compare', 'baseline', 'follow', 'treatment', 'time', 'spend', 'target', 'range', 'clinically', 'important', 'metric', 'diabetes', 'management', 'reflect', 'amount', 'time', 'patient', 'blood_glucose', 'level', 'measure', 'desire', 'target', 'blood', 'sugar', 'range', 'accept', 'association', 'study', 'diabetes', 'target', 'time', 'range', 'blood_glucose'], ['datum', 'present', 'nd', 'scientific', 'session', 'conference', 'am', 'cdt', 'oral', 'abstract', 'presentation', 'stem', 'cell', 'derive_fully', 'differentiate', 'islet', 'cell', 'type_diabetes', 'abstract', 'publication', 'link', 'presentation', 'include', 'here'], ['presentation', 'include', 'datum', 'patient', 'dose', 'part', 'study', 'design_assess', 'safety_profile', 'target', 'dose', 'patient', 'show', 'blood_glucose', 'time', 'range', 'increase', 'baseline', 'day', 'insulin', 'independent', 'patient', 'show', 'time', 'range', 'increase', 'baseline', 'day', 'reduction', 'exogenous_insulin', 'use'], ['generally_well_tolerate', 'patient', 'dose', 'date', 'majority_adverse_event_mild', 'moderate'], ['glucose', 'time', 'range', 'datum', 'present', 'today', 'demonstrate', 'remarkable', 'glycemic_control', 'achieve', 'treatment', 'say_executive_vice', 'president_chief', 'cell', 'genetic', 'therapy', 'vertex', 'elevation', 'blood', 'sugar', 'important', 'control', 'fluctuation', 'time', 'increase', 'risk', 'complication', 'patient', 'first', 'patient', 'treat', 'only', 'achieve', 'improved', 'decrease', 'insulin', 'requirement', 'also', 'high', 'time', 'range', 'take', 'altogether', 'datum', 'provide', 'further', 'evidence', 'potential', 'functional_cure', 'people', 'live'], ['treat', 'physician', 'see', 'profound', 'burden', 'disease', 'patient', 'especially', 'experience', 'severe_hypoglycemia', 'ability', 'restore', 'patient', 'islet', 'function', 'improve', 'glycemic_control', 'subsequently', 'reduce', 'exogenous_insulin', 'dependence', 'significant', 'potential', 'improve', 'patient', 'life', 'say', 'ricordi', 'professor', 'surgery', 'director', 'cell', 'transplant', 'center', 'committee', 'chair', 'clinical_trial', 'result', 'first', 'patient', 'treat', 'half', 'target', 'remarkable', 'encouraging', 'continue', 'investigate', 'treat', 'patient', 'type_diabetes', 'stem', 'cell', 'derive', 'therapy'], ['potential', 'impact', 'treatment', 'patient', 'can', 'overstate', 'say', 'professor', 'surgery', 'chief', 'division', 'transplant', 'surgery', 'treat', 'patient', 'study', 'show', 'significant', 'leap', 'forward', 'potential', 'treatment', 'patient', 'type_diabetes'], ['additional', 'vertex', 'presentation', 'ada', 'year', 'include', 'oral_presentation', 'persistence', 'impaired', 'awareness', 'hypoglycemia', 'severe', 'hypoglycemic', 'event', 'suboptimal', 'glycemic_control', 'advanced', 'diabetes', 'technology', 'abstract', 'publication', 'poster', 'gap', 'remain', 'achieve', 'target', 'glycemic', 'goal', 'advanced', 'technology', 'poster'], ['date', 'patient', 'dose', 'phase_study', 'patient', 'receive', 'target', 'dose', 'cell', 'part', 'study', 'third', 'patient', 'receive', 'full', 'target', 'dose', 'part', 'study'], ['encapsulate', 'cell', 'hypoimmune', 'cell'], ['also', 'pursue', 'additional', 'program', 'include', 'same', 'stem', 'cell', 'derive_islet', 'encapsulate', 'device', 'surgically', 'implant', 'use', 'concomitant', 'program', 'where', 'cell', 'modify', 'produce', 'hypoimmune', 'stem', 'cell', 'derive_islet', 'ind_enable', 'study', 'encapsulated', 'cell', 'program', 'underway', 'company', 'remain', 'track', 'submit_ind'], ['investigational_allogeneic', 'stem', 'cell', 'derive_fully_differentiate_insulin', 'produce_islet', 'cell', 'therapy', 'manufacture', 'use', 'proprietary', 'technology', 'evaluate', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'potential', 'restore_body_ability_regulate', 'glucose_level_restore_pancreatic', 'islet', 'cell', 'function', 'include', 'glucose_responsive_insulin_production', 'deliver', 'infusion', 'hepatic_portal_vein', 'require', 'maintenance', 'therapy', 'protect_islet', 'cell', 'immune_rejection'], ['clinical_trial', 'phase', 'multi_center', 'single_arm_open_label', 'study', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'study', 'design', 'sequential_multi', 'part', 'clinical_trial', 'evaluate', 'safety_efficacy', 'part', 'first', 'patient', 'receive', 'target', 'dose', 'part', 'patient', 'receive', 'full', 'target', 'dose', 'concurrent_dosing', 'full', 'target', 'dose', 'occur', 'part', 'approximately', 'patient', 'enrol', 'clinical_trial', 'phase_study', 'clinical', 'hold', 'ongoing'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'ricordi', 'press_release_ii', 'plan', 'expectation', 'potential', 'benefit', 'plan', 'continue', 'progress', 'phase', 'program', 'ind_enable', 'study', 'encapsulate', 'islet', 'cell', 'program', 'include', 'anticipate_regulatory_filing', 'plan', 'dosing', 'enrollment', 'patient', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'research', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'new', 'late', 'break', 'clinical', 'datum', 'accept', 'oral_presentation', 'also', 'announce', 'abstract', 'accept', 'poster_presentation'], ['late', 'break', 'abstract', 'entitle', 'efficacy_safety', 'single_dose', 'transfusion_dependent', 'Î²eta', 'thalassemia_severe', 'sickle', 'cell', 'disease', 'oral_presentation', 'abstract', 'vertex', 'include', 'datum', 'patient', 'treat', 'follow', 'now', 'know', 'exa', 'abstract', 'select', 'medium', 'briefing', 'program', 'therefore', 'embargo', 'am'], ['addition', 'real_world', 'evidence', 'health', 'economic', 'abstract', 'vertex', 'accept', 'poster_presentation'], ['accept', 'abstract', 'now', 'available', 'online', 'website'], ['investigate', 'multiple', 'ongoing', 'clinical_trial', 'potential', 'time', 'therapy', 'patient', 'tdt_scd'], ['exa_cel'], ['formerly_know', 'investigational_autologous', 'cas', 'gene', 'edite', 'therapy', 'evaluate', 'patient', 'tdt_scd_characterize_recurrent', 'patient', 'own', 'hematopoietic_stem', 'cell', 'edit', 'produce_high', 'level_fetal', 'hemoglobin_red', 'blood', 'cell', 'form_oxygen', 'carrying', 'hemoglobin_naturally', 'present', 'fetal', 'development', 'then_switch', 'adult_form', 'hemoglobin', 'birth', 'elevation_hbf_potential_alleviate', 'transfusion_requirement', 'patient', 'tdt', 'reduce_painful', 'debilitate_sickle_crisis', 'patient', 'scd', 'early', 'result', 'ongoing', 'trial', 'publish'], [], ['ongoing_phase_open', 'label_trial', 'design_assess', 'safety_efficacy', 'single_dose', 'patient', 'age_year', 'tdt_scd_characterize_recurrent', 'respectively', 'trial', 'now', 'close', 'enrollment', 'patient', 'follow', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'trial'], ['climb'], ['long_term', 'open_label', 'trial', 'evaluate', 'safety_efficacy', 'patient', 'receive', 'trial', 'design', 'follow', 'participant', 'year', 'infusion'], [], ['ongoing_phase_open', 'label_trial', 'design_assess', 'safety_efficacy', 'single_dose', 'patient', 'age_year', 'tdt_scd_characterize_recurrent', 'respectively', 'trial', 'now', 'open', 'enrollment', 'currently', 'enrol', 'patient', 'age_year', 'age', 'plan', 'extend', 'age', 'less', 'year', 'age', 'later', 'date', 'trial', 'enroll', 'patient', 'patient', 'follow', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'trial'], ['gene_editing', 'process', 'trial'], ['patient', 'enroll', 'trial', 'own', 'hematopoietic_stem', 'progenitor', 'cell', 'collect', 'peripheral', 'blood', 'patient', 'cell', 'edit', 'use', 'crispr', 'technology', 'edit', 'cell', 'then', 'infuse', 'back', 'patient', 'part', 'autologous', 'hematopoietic_stem', 'cell', 'transplant', 'process', 'involve', 'patient', 'treat', 'myeloablative_busulfan', 'conditioning', 'patient', 'undergo', 'hsct', 'also', 'encounter', 'side_effect', 'range', 'mild', 'severe', 'unrelated', 'administration', 'patient', 'initially', 'monitor', 'determine', 'when', 'edit', 'cell', 'begin', 'produce', 'mature', 'blood', 'cell', 'process', 'know', 'engraftment', 'engraftment', 'patient', 'continue', 'monitor', 'track', 'impact', 'multiple', 'measure', 'disease', 'safety'], ['collaboration'], ['enter_strategic', 'research', 'collaboration', 'focus', 'use', 'cas', 'discover_develop', 'potential', 'new', 'treatment', 'aim', 'underlying_genetic', 'cause', 'human', 'disease', 'represent', 'first', 'potential', 'treatment', 'emerge_joint', 'research', 'program', 'amend', 'collaboration', 'agreement', 'vertex', 'now', 'lead', 'global', 'development', 'manufacturing', 'split', 'program', 'cost', 'profit_worldwide'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'cell', 'genetic', 'therapy', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'sickle', 'cell', 'disease', 'apol', 'mediate', 'type_diabete', 'alpha', 'deficiency_muscular', 'dystrophy'], ['special_note_regard', 'forward_look_statement'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'plan', 'expectation', 'present', 'clinical', 'datum', 'ongoing', 'exa_cel', 'clinical_trial', 'expectation_regard', 'abstract', 'make', 'available', 'virtual', 'platform', 'clinical', 'datum', 'present', 'include', 'anticipate', 'projection', 'estimate', 'relate', 'various', 'economic', 'impact', 'scd', 'tdt', 'potential', 'benefit', 'efficacy_safety', 'exa', 'include', 'potentially_transformative', 'nature', 'therapy', 'potential', 'treatment', 'patient', 'plan', 'expectation', 'clinical_trial', 'pipeline', 'product', 'status_clinical_trial', 'product_candidate', 'development', 'collaborator', 'include', 'activity', 'clinical_trial', 'site', 'patient', 'enrollment', 'expectation_regard', 'clinical_trial', 'follow_up', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program', 'include', 'program', 'collaborator_support_registration', 'further_development', 'compound_safety_efficacy', 'other_reason', 'internal_external', 'factor', 'delay', 'divert', 'change', 'plan_objective', 'respect', 'research', 'development', 'program', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'exa_cel', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], [], ['lead', 'gene_edit', 'company', 'focus', 'develop', 'transformative', 'gene', 'base', 'medicine', 'serious_disease', 'use', 'proprietary', 'crispr', 'platform', 'cas', 'revolutionary', 'gene_edit', 'technology', 'allow', 'precise', 'direct', 'change', 'establish', 'portfolio', 'therapeutic', 'program', 'broad_range', 'disease', 'area', 'include', 'oncology', 'regenerative_medicine', 'rare', 'disease', 'accelerate', 'expand', 'effort', 'establish', 'strategic', 'collaboration', 'lead', 'company', 'include', 'bayer', 'vertex_pharmaceutical', 'headquarter', 'wholly_own', 'subsidiary', 'operation', 'base', 'business', 'office', 'more_information_visit', 'wwwcrisprtxcom'], ['forward_look_statement'], ['press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security', 'as', 'amend', 'as_well', 'statement', 'regard', 'expectation', 'follow', 'safety_efficacy', 'clinical', 'progress', 'ongoing', 'exa_cel', 'clinical_trial', 'include', 'expectation_regard', 'abstract', 'make', 'available', 'virtual', 'platform', 'plan', 'present', 'clinical', 'datum', 'present', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'exist', 'prospective_investor', 'caution_forward_look', 'statement_inherently_uncertain', 'promise_guarantee', 'place_undue_reliance', 'such', 'statement', 'speak_only_date', 'make', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'initial_preliminary', 'datum', 'clinical_trial', 'initial_datum_limited', 'number', 'patient', 'case', 'exa_cel', 'time_indicative', 'final', 'future', 'trial', 'result', 'potential', 'exa_cel', 'clinical_trial', 'result', 'favorable', 'support_registration', 'further_development', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'exa', 'realize', 'potential', 'benefit', 'collaboration', 'vertex', 'potential', 'impact_due_coronavirus', 'pandemic', 'such', 'timing_progress', 'clinical_trial', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'quarterly_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available', 'website_disclaim', 'obligation_undertaking', 'update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['source_version_home'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'abstract', 'include', 'oral_presentation', 'poster', 'detail', 'datum', 'type_diabetes', 'phase', 'trial', 'stem', 'cell', 'derive_fully_differentiate_pancreatic', 'islet', 'cell', 'replacement', 'therapy', 'accept', 'presentation', 'nd', 'annual', 'scientific', 'session', 'conference', 'hold'], ['abstract', 'publication', 'entitled', 'stem', 'cell', 'derive_fully', 'differentiate', 'islet', 'cell', 'type_diabetes', 'present', 'am', 'cdt', 'oral_presentation', 'session', 'other', 'therapeutic', 'agent', 'run', 'am', 'abstract', 'post', 'today', 'detail', 'result', 'phase', 'clinical_trial', 'demonstrate', 'restore', 'insulin_production', 'glucose', 'control', 'datum', 'update', 'additional', 'information', 'present', 'conference'], ['abstract', 'publication', 'or', 'entitle', 'persistence', 'impaired', 'awareness', 'hypoglycemia', 'severe', 'hypoglycemic', 'event', 'suboptimal', 'glycemic_control', 'advanced', 'diabetes', 'technology', 'present', 'pm', 'cdt', 'oral_presentation', 'session', 'glucose', 'monitoring', 'sensing', 'run', 'pm', 'abstract', 'post', 'today', 'describe', 'online', 'survey', 'adult', 'exchange', 'registry', 'online', 'community', 'show', 'patient', 'high', 'rate', 'diabetes', 'technology', 'adoption', 'such', 'continuous', 'glucose', 'monitor', 'insulin', 'pump', 'closed', 'system', 'impair', 'awareness', 'hypoglycemia', 'severe', 'hypoglycemic', 'event', 'persist', 'substantial', 'proportion', 'patient', 'achieve', 'target', 'glycemic_control', 'indicate', 'need', 'novel', 'treatment'], ['abstract', 'poster', 'entitle', 'gap', 'remain', 'achieve', 'target', 'glycemic', 'goal', 'advanced', 'technology', 'available', 'part', 'general', 'poster', 'session', 'hold', 'am', 'pm', 'abstract', 'post', 'today', 'highlight', 'improvement', 'glycemic_control', 'diabetes', 'technology', 'many', 'patient', 'still', 'unable', 'achieve', 'clinical', 'target', 'experience', 'severe_hypoglycemia', 'emphasize', 'need', 'novel', 'treatment'], ['accept', 'abstract', 'now', 'available', 'ada', 'website'], ['investigational_allogeneic', 'stem', 'cell', 'derive_fully_differentiate_insulin', 'produce_islet', 'cell', 'therapy', 'manufacture', 'use', 'proprietary', 'technology', 'evaluate', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'potential', 'restore_body_ability_regulate', 'glucose_level_restore_pancreatic', 'islet', 'cell', 'function', 'include', 'glucose_responsive_insulin_production', 'deliver', 'infusion', 'hepatic_portal_vein', 'require', 'maintenance', 'therapy', 'protect_islet', 'cell', 'immune_rejection'], ['clinical_trial', 'phase', 'multi_center', 'single_arm_open_label', 'study', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'study', 'design', 'sequential_multi', 'part', 'clinical_trial', 'evaluate', 'safety_efficacy', 'part', 'first', 'patient', 'receive', 'target', 'dose', 'part', 'patient', 'receive', 'full', 'target', 'dose', 'concurrent_dosing', 'full', 'target', 'dose', 'occur', 'part', 'approximately', 'patient', 'enrol', 'clinical_trial', 'phase_study', 'clinical', 'hold', 'ongoing'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'regard', 'potential', 'benefit', 'safety_efficacy', 'vx', 'plan', 'present', 'datum', 'vx', 'conference', 'include', 'datum', 'clinical_trial', 'additional', 'scientific', 'presentation', 'regard', 'vx', 'plan', 'continue', 'progress', 'phase', 'program', 'vx', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'research', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'suketu', 'elect', 'board_director', 'independent', 'director', 'global', 'business', 'executive', 'more', 'year', 'experience', 'pharmaceutical', 'medical', 'technology', 'sector', 'serve', 'financial', 'strategy', 'role', 'cover', 'multiple', 'area', 'life_science', 'sector', 'currently', 'executive_vice_president_chief', 'financial', 'officer', 'lead', 'global', 'innovator', 'manufacturer', 'orthopedic', 'solution', 'position', 'hold'], ['delighted', 'join', 'board', 'extensive', 'financial', 'strategic', 'experience', 'health_care', 'pair', 'leadership', 'expertise', 'make', 'valuable', 'addition', 'board_director', 'say_chief_executive_officer', 'president'], ['honor', 'join', 'company', 'focus', 'serial_innovation', 'industry', 'lead', 'track_record', 'discover_develop', 'commercialize', 'transformative_medicine', 'treat', 'serious_disease', 'particularly', 'exciting', 'join', 'pivotal', 'time', 'when', 'company', 'process', 'transform', 'treatment', 'multiple', 'serious_disease', 'do', 'cystic_fibrosis', 'say'], ['prior', 'join', 'serve', 'senior_vice_president', 'global', 'financial', 'operation', 'where', 'responsible', 'strategic', 'operational', 'initiative', 'supply_chain', 'commercial', 'operation', 'business', 'development', 'prior', 'serve', 'executive_vice_president_chief', 'financial', 'officer', 'executive', 'various', 'global', 'finance', 'strategy', 'leadership', 'role', 'include', 'interim', 'chief', 'financial', 'officer', 'chief', 'accounting', 'officer', 'cfo', 'addition', 'also', 'hold', 'several', 'global', 'finance', 'strategy', 'role', 'hold', 'bachelor', 'science', 'finance', 'mba', 'business'], ['addition', 'bring', 'director', 'member', 'independent'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['medium'], ['square', 'cell', 'genetic', 'therapy', 'research', 'manufacturing', 'facility', 'built'], ['support', 'continued'], ['dedication', 'today', 'new', 'cell', 'genetic', 'therapy', 'pharmaceutical_incorporate', 'announce', 'plan', 'build', 'square', 'foot', 'facility', 'seaport', 'support', 'company', 'continue', 'rapid', 'growth', 'particular', 'expansion', 'cell', 'genetic', 'therapy', 'program', 'completion', 'new', 'site', 'expect', 'vertex', 'occupy', 'square', 'foot', 'real', 'estate', 'seaport', 'site', 'make', 'large', 'biotech', 'term', 'square', 'footage'], ['cell', 'genetic', 'therapy'], ['today', 'vertex', 'dedicate', 'site', 'northern', 'avenue', 'honor', 'company', 'executive_chairman', 'former', 'new', 'state_art', 'cell', 'genetic', 'therapy', 'research', 'clinical', 'manufacturing', 'site', 'accommodate', 'more', 'employee', 'percent', 'facility', 'dedicate', 'lab', 'research', 'space', 'cell', 'genetic', 'therapy', 'rapidly', 'emerge', 'therapeutic', 'modality', 'potential', 'treat_underlying_cause', 'even', 'cure', 'several', 'serious_disease', 'vertex', 'work', 'include', 'sickle', 'cell', 'disease', 'thalassemia', 'type_diabetes', 'duchenne', 'muscular_dystrophy'], ['center', 'expansion', 'drydock', 'avenue'], ['further', 'expansion', 'develop', 'partnership', 'related', 'beal', 'real', 'advisory', 'group', 'new', 'square', 'foot', 'facility', 'locate', 'drydock', 'avenue', 'facility', 'complete', 'building', 'know', 'leiden', 'campus', 'help', 'support', 'company', 'continue', 'growth', 'multiple', 'disease', 'area', 'span', 'multiple', 'modality', 'further', 'enable', 'research', 'development', 'team', 'bring', 'transformative', 'therapy', 'patient', 'new', 'building', 'house', 'lab', 'office', 'manufacturing_capability', 'approximately', 'additional', 'employee'], ['name', 'campus', 'fitting', 'tribute', 'visionary', 'leadership', 'enormous', 'contribution', 'make', 'vertex', 'company', 'today', 'say_chief_executive_officer', 'president', 'building', 'achievement', 'cystic_fibrosis', 'vertex', 'new', 'inflection', 'point', 'continue', 'expansion', 'enable', 'continue', 'growth', 'work', 'bring', 'many', 'more', 'transformative', 'curative', 'medicine', 'patient', 'wait'], ['expansion', 'sign', 'deep', 'commitment', 'large', 'innovation', 'say', 'chairman', 'building', 'represent', 'so', 'much', 'more', 'have', 'good', 'equipment', 'lab', 'great', 'amenity', 'as', 'important', 'thing', 'building', 'represent', 'further', 'significant', 'investment', 'unique', 'strategy', 'transform_life', 'people', 'serious_disease', 'sickle', 'cell', 'disease', 'type_diabetes', 'use', 'cut_edge', 'genetic', 'cell', 'base', 'therapy'], ['addition', 'expansion', 'vertex', 'also', 'announce', 'commitment', 'health', 'equity', 'focus', 'clinical_trial', 'diversity', 'access', 'quality', 'care', 'education', 'local', 'health_care'], ['source_version_news'], ['medium'], ['grant', 'support', 'effort', 'improve', 'clinical_trial', 'diversity', 'type_diabete'], ['foundation', 'grant', 'support', 'general', 'comprehensive', 'sickle', 'cell', 'disease'], ['additional', 'foundation', 'grant', 'year', 'support', 'health_care', 'training'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'vertex', 'foundation_nonprofit_charitable_foundation', 'commit', 'year', 'clinical_trial', 'diversity', 'access', 'quality', 'care', 'education', 'health_care', 'workforce', 'donation', 'extension', 'long_stand', 'commitment', 'inclusion', 'diversity', 'equity', 'exist', 'work', 'foundation', 'promote', 'value', 'education_innovation', 'various', 'health', 'program'], ['be', 'delighted', 'work', 'year', 'number', 'other', 'extraordinary', 'organization', 'advance', 'collective', 'goal', 'have', 'more', 'equitable', 'society', 'whole', 'more', 'equitable', 'health_care', 'system', 'particular', 'say_chief_executive_officer', 'president', 'conjunction', 'announcement', 'today', 'expansion', 'cell', 'genetic', 'therapy', 'footprint', 'commitment', 'reflect', 'ongoing', 'commitment', 'close', 'gap', 'health_care', 'research', 'access', 'quality', 'patient', 'outcome', 'community'], ['clinical_trial', 'diversity'], ['lead', 'global', 'type_diabetes', 'research', 'advocacy', 'organization', 'broaden', 'understanding', 'awareness', 'get', 'more', 'people', 'involve', 'clinical_trial', 'screen', 'monitoring', 'research', 'vertex', 'support', 'effort', 'improve', 'clinical_trial', 'diversity', 'help', 'champion', 'advanced', 'care', 'clinical_trial', 'education', 'awareness', 'recruitment', 'effort', 'include', 'diverse', 'representation'], ['dedicate', 'support', 'individual', 'diagnose', 'type_diabetes', 'support', 'allow', 'expand', 'effort', 'ensure', 'understanding', 'disease', 'knowledge', 'most', 'up', 'date', 'treatment_option', 'alleviate', 'daily', 'burden', 'say', 'continue', 'drive', 'cure', 'understand', 'importance', 'expansive', 'diverse', 'clinical_trial', 'part', 'research', 'process', 'thankful', 'vertex', 'commitment', 'increase', 'education', 'enrollment', 'clinical_trial', 'accelerate', 'research', 'progress', 'ultimately', 'drive', 'well', 'outcome', 'more', 'people', 'diabetes'], ['access', 'quality', 'care'], ['approximately', 'percent', 'patient', 'sickle', 'cell', 'disease', 'black', 'african', 'rate', 'scd', 'also', 'high', 'latinx', 'other', 'ethnicity', 'white', 'population', 'lack', 'access', 'quality', 'health_care', 'disease', 'couple', 'issue', 'associate', 'poverty', 'lack', 'nutritional', 'food', 'stable', 'housing', 'steady', 'employment', 'lead', 'poor', 'health', 'outcome', 'foundation', 'support', 'general', 'comprehensive', 'sickle', 'cell', 'disease', 'center', 'provide', 'integrate', 'care', 'patient', 'population', 'receive', 'focused', 'attention', 'deserve', 'order', 'help', 'center', 'provide', 'good', 'care', 'disease', 'funding', 'advance', 'center', 'ability', 'provide', 'holistic', 'support', 'improve', 'patient', 'care', 'expansion', 'social', 'worker', 'patient', 'coordinator', 'nurse', 'navigator', 'addition', 'support', 'expand', 'programmatic', 'effort', 'such', 'athletic', 'training', 'survivorship', 'program'], ['long', 'dedicated', 'identify', 'address', 'racial', 'ethnic', 'disparity', 'achieve', 'equity', 'quality', 'care', 'say', 'senior_vice_president', 'equity', 'community', 'health', 'comprehensive', 'sickle', 'cell', 'center', 'represent', 'long', 'overdue', 'step', 'forward', 'care', 'treatment', 'serious', 'disorder', 'impact', 'primarily', 'african', 'community', 'color'], ['want', 'patient', 'feel', 'corner', 'disease', 'affect', 'facet', 'life', 'say', 'medical', 'director', 'general', 'comprehensive', 'sickle', 'cell', 'disease', 'want', 'provide', 'welcome', 'place', 'where', 'patient', 'feel', 'safe', 'trusted', 'hear', 'connect', 'well', 'care', 'true', 'medical', 'home'], ['education', 'health_care', 'workforce'], ['order', 'address', 'health_care', 'workforce', 'talent', 'shortage', 'state', 'foundation', 'partner', 'year', 'up', 'headquartered', 'development', 'nonprofit', 'funding', 'support', 'curriculum', 'prepare', 'young', 'adult', 'future', 'career', 'community', 'health', 'pay', 'internship', 'opportunity', 'source', 'skilled', 'train', 'professional', 'reflect', 'population', 'serve'], ['access', 'quality', 'health_care', 'financial', 'sustainability', 'come', 'good', 'job', 'go', 'hand', 'hand', 'build', 'equitable', 'just', 'society', 'say', 'ceo', 'year', 'up', 'proud', 'partner', 'foundation', 'develop', 'career', 'pathway', 'health_care', 'service', 'community'], [], ['nonprofit_charitable', 'foundation', 'seek', 'improve', 'life', 'people', 'serious_disease', 'community', 'education_innovation', 'health', 'program', 'establish', 'foundation', 'long_term', 'source', 'charitable', 'giving', 'part', 'vertex_pharmaceutical', 'corporate', 'give', 'commitment', 'learn_more', 'foundation', 'visit', 'responsibility', 'vertex', 'foundation'], ['source_version'], ['pharmaceutical_incorporate'], ['investor'], ['source', 'pharmaceutical'], ['product_revenue', 'increase_compare'], ['company', 'reiterate_full_year', 'product_revenue', 'guidance'], ['late_stage', 'clinical', 'pipeline', 'now', 'span', 'disease', 'area'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'first_quarter', 'end', 'reiterate_full_year', 'product_revenue', 'guidance'], ['follow', 'success', 'transform', 'treatment', 'cystic', 'unique', 'differentiated', 'strategy', 'continue', 'deliver', 'positive', 'phase_proof_concept', 'study', 'multiple', 'disease', 'area', 'wave', 'therapy', 'set', 'enter', 'clinic', 'second_half', 'year', 'say_chief_executive_officer', 'president', 'yet', 'quarter', 'strong', 'revenue', 'performance', 'characterize', 'year', 'year', 'growth', 'well', 'position', 'continue', 'innovation', 'sustained', 'growth', 'work', 'bring', 'additional', 'transformative_medicine', 'more', 'patient', 'globe'], ['first_quarter', 'financial', 'highlight'], ['month_end'], [], ['change'], ['million', 'share_amount'], ['product_revenue', 'net'], ['start', 'first_quarter', 'vertex', 'no', 'longer', 'exclude', 'research', 'development', 'charge', 'result', 'upfront', 'contingent', 'milestone_payment', 'connection', 'collaboration', 'asset_acquisition', 'licensing', 'third_party', 'intellectual_property', 'right', 'non_gaap_financial_measure', 'non_gaap_financial_measure', 'first_quarter', 'recast', 'reflect', 'change'], ['product_revenue', 'increase_compare', 'first_quarter', 'primarily_drive', 'strong', 'launch', 'multiple', 'country', 'internationally', 'strong', 'performance', 'trikafta', 'include', 'launch', 'trikafta', 'child', 'year_old', 'net_product_revenue', 'first_quarter', 'increase', 'increase_compare', 'first_quarter'], ['gaap_non_gaap', 'net_income', 'increase_compare', 'first_quarter', 'drive_strong', 'product_revenue', 'growth'], ['cash_cash', 'equivalent_marketable_security', 'increase', 'approximately', 'compare', 'increase', 'primarily_drive', 'strong', 'revenue_growth', 'operate', 'cash_flow'], ['first_quarter', 'expense'], ['million'], ['combine_gaap_non_gaap', 'expense', 'increase_compare', 'first_quarter', 'primarily', 'progression', 'multiple', 'product_candidate', 'mid_late', 'stage', 'clinical', 'development', 'incremental_investment_support', 'launch', 'vertex', 'therapy', 'globally'], ['gaap_non_gaap', 'income_taxis', 'increase_compare', 'first_quarter', 'primarily', 'increase', 'operating_income'], ['full_year_financial_guidance'], ['today', 'reiterate_full_year', 'product_revenue', 'guidance', 'guidance_summarize', 'below'], ['current'], ['previous', 'fy'], ['product_revenue'], ['unchanged'], [], ['combine_gaap_expense'], [], ['combined_non_gaap', 'expense'], [], [], [], ['start', 'first_quarter', 'vertex', 'no', 'longer', 'exclude', 'research', 'development', 'charge', 'result', 'upfront', 'contingent', 'milestone_payment', 'connection', 'collaboration', 'asset_acquisition', 'licensing', 'third_party', 'intellectual_property', 'right', 'non_gaap_financial_measure'], ['key', 'business', 'highlight'], ['cystic', 'market', 'product'], ['anticipate', 'number', 'patient', 'treat', 'medicine', 'continue', 'grow', 'uptake', 'trikafta', 'launch', 'continue', 'enter', 'additional', 'reimbursement_agreement', 'achieve', 'new', 'approval', 'treatment', 'young', 'patient', 'recent', 'progress', 'include'], ['now', 'approve', 'reimburse', 'accessible', 'more', 'country'], ['pipeline'], ['deliver', 'diversified', 'pipeline', 'potentially_transformative', 'small_molecule', 'cell', 'genetic', 'therapy', 'aim', 'serious_disease', 'recent', 'anticipated', 'progress', 'key', 'pipeline', 'program', 'summarize'], ['cystic'], ['continue', 'pursue', 'next_class', 'small_molecule', 'cftr_modulator', 'therapy', 'as_well', 'new', 'treatment_option', 'approximately', 'patient', 'can', 'benefit_cftr_modulator', 'alone'], ['beta_thalassemia_sickle', 'cell', 'disease', 'scd'], ['program', 'employ', 'non', 'viral', 'vivo_gene_edit', 'therapy', 'develop', 'potential', 'functional_cure', 'transfusion_dependent', 'thalassemia_severe', 'sickle', 'cell', 'disease', 'develop', 'collaboration'], ['apol_mediated', 'kidney_disease', 'amkd'], ['discover', 'multiple', 'oral', 'small_molecule', 'inhibitor', 'apol', 'function', 'pioneer', 'new_class', 'medicine', 'target', 'underlying_genetic', 'driver', 'kidney_disease'], ['pain'], ['discover', 'multiple', 'selective', 'small_molecule', 'inhibitor', 'objective', 'create_new_class', 'pain', 'medicine', 'potential', 'provide', 'effective', 'pain', 'relief', 'limitation_opioid'], ['type_diabetes'], ['evaluate', 'cell', 'therapy', 'use', 'stem', 'cell', 'derive_islet', 'replace', 'endogenous', 'insulin_produce_islet', 'cell', 'destroy', 'people', 'goal', 'develop', 'potential', 'functional_cure', 'disease'], ['expect', 'share', 'additional', 'datum', 'medical', 'conference', 'year'], ['aat', 'deficiency'], ['work', 'address_underlie', 'genetic', 'cause', 'aat', 'deficiency', 'develop', 'novel_small_molecule', 'corrector', 'aat', 'protein', 'fold', 'goal', 'increase', 'secretion', 'functional', 'aat', 'blood', 'address', 'lung', 'liver', 'aspect', 'aat', 'deficiency'], ['dystrophy'], ['investigate', 'novel', 'approach', 'treat', 'dmd', 'deliver', 'gene_edit', 'technology', 'muscle', 'cell', 'goal', 'restore', 'near', 'full', 'length', 'dystrophin', 'protein', 'expression', 'target', 'specific', 'mutation', 'dystrophin', 'gene', 'cause', 'disease'], ['consistent', 'overall', 'strategy', 'vertex', 'take', 'portfolio', 'approach', 'program', 'additional', 'asset', 'thalassemia', 'pain', 'aatd', 'early_stage', 'development'], ['non_gaap_financial_measure'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'increase_decrease_fair', 'value_contingent_consideration', 'acquisition_relate_cost', 'other', 'adjustment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe_certain_discrete', 'item', 'result', 'view_substitute', 'company', 'gaap', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'company', 'believe_helpful', 'understanding', 'ongoing', 'business', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'calculation', 'non_gaap_financial_measure', 'likely_differ', 'calculation', 'use', 'other', 'company', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['company', 'provide', 'guidance_regard_combine', 'expense_effective_tax', 'rate', 'non_gaap_basis', 'guidance_regard', 'combine_gaap_non_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'transaction', 'include', 'collaboration', 'asset_acquisition', 'licensing', 'third_party', 'intellectual_property', 'right', 'company', 'provide', 'guidance_regard', 'gaap', 'effective_tax_rate', 'unable', 'forecast', 'reasonable', 'certainty', 'impact', 'excess_tax_benefit', 'relate_stock_base_compensation', 'possibility', 'certain_discrete_item', 'material'], ['pharmaceutical_incorporate', 'consolidated', 'statement', 'operation', 'million', 'share_amount', 'unaudited'], ['revenue'], [], [], ['other', 'revenue'], [], [], ['total', 'revenue'], [], ['cost', 'expense'], ['cost_sale'], [], [], ['research', 'development', 'expense'], [], ['sell', 'general_administrative', 'expense'], [], [], ['change_fair_value_contingent', 'consideration'], [], [], [], ['total', 'cost', 'expense'], [], [], ['income', 'operation'], [], [], ['interest', 'income'], [], [], ['interest', 'expense'], [], [], ['other', 'expense', 'net'], [], [], ['income', 'provision_income_taxis'], [], [], ['provision_income_taxis'], [], [], ['net_income'], [], [], ['net_income', 'common_share'], [], [], [], ['dilute'], ['share', 'use', 'share', 'calculation'], [], [], [], [], ['pharmaceutical_incorporate', 'reconciliation_gaap_non_gaap', 'net_income', 'operating_income', 'million', 'share_amount', 'unaudited'], ['stock_base_compensation_expense'], [], [], ['fair_value', 'strategic_investment'], [], [], ['fair_value_contingent_consideration'], ['acquisition_relate_cost'], [], ['total', 'non_gaap_adjustment_pre', 'tax_income'], [], [], ['tax_adjustment'], [], [], [], [], ['net_income', 'diluted', 'common_share'], [], ['non_gaap'], ['share', 'use', 'dilute', 'share', 'calculation'], ['gaap_non_gaap'], [], [], ['pharmaceutical_incorporate', 'reconciliation_gaap_non_gaap', 'expense', 'million', 'percentage', 'unaudited'], ['gaap', 'cost_sale'], [], [], ['non_gaap', 'cost_sale'], [], [], ['research', 'development', 'expense'], [], [], ['non_gaap', 'research', 'development', 'expense'], [], [], ['gaap', 'sell', 'general_administrative', 'expense'], [], [], ['non_gaap', 'selling', 'general_administrative', 'expense'], [], [], [], [], ['gaap', 'other', 'expense', 'net'], ['non_gaap', 'other', 'income', 'expense', 'net'], [], ['gaap', 'provision_income_taxis'], [], [], ['non_gaap', 'provision_income_taxis'], [], ['gaap', 'effective_tax_rate'], [], [], ['pharmaceutical_incorporate', 'condense_consolidated_balance_sheet', 'million', 'unaudited'], [], [], ['asset'], ['cash_cash', 'equivalent_marketable_security'], [], [], ['account', 'receivable', 'net'], [], [], ['inventory'], [], [], ['property', 'equipment', 'net'], [], [], ['goodwill', 'intangible_asset'], [], ['defer_tax_asset'], [], [], ['other', 'asset'], [], [], ['total', 'asset'], [], [], ['liability', 'shareholder', 'equity'], ['account', 'payable', 'accrued', 'expense'], [], [], ['finance', 'lease', 'liability'], [], [], ['contingent_consideration'], [], [], ['other', 'liability'], [], [], ['shareholder', 'equity'], [], [], ['total', 'liability', 'shareholder', 'equity'], ['common_share', 'outstanding'], [], [], ['note', 'explanation'], ['month_end_tax_adjustment', 'include', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment', 'company', 'pre_tax_income', 'excess_tax_benefit', 'relate_stock_base_compensation'], ['difference', 'company', 'full_year', 'combined', 'gaap', 'expense', 'combine', 'non_gaap', 'expense', 'guidance', 'relate', 'primarily', 'stock_base_compensation_expense', 'guidance_regard', 'combine_gaap_non_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'transaction', 'include', 'collaboration', 'asset_acquisition', 'licensing', 'third_party', 'intellectual_property', 'right'], ['other', 'expense', 'net', 'include', 'net', 'gain_loss_relate', 'change_fair_value', 'company', 'strategic_investment'], ['month_end', 'change_fair_value_contingent', 'consideration_relate', 'potential', 'payment_exonic', 'therapeutic', 'former_equity_holder'], ['acquisition_relate_cost', 'month_end', 'relate_cost', 'associate', 'company', 'acquisition_exonic', 'therapeutic'], ['note', 'amount', 'foot', 'due', 'round'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'cell', 'genetic', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'operation_section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'anticipate', 'regulatory', 'discussion', 'filing', 'data', 'availability_timing_thereof', 'expectation', 'development', 'plan', 'anticipate_timeline', 'company', 'product', 'product_candidate', 'pipeline', 'program', 'include', 'study', 'design', 'patient', 'enrollment', 'datum', 'availability_timing_thereof', 'iii', 'expectation', 'continued_growth', 'number', 'patient', 'treat', 'medicine', 'include', 'number', 'child', 'newly_eligible', 'trikafta', 'expand', 'access', 'company', 'medicine', 'additional', 'reimbursement_agreement', 'new', 'approval', 'include', 'market', 'authorization', 'label_extension', 'expansion', 'treatment_option', 'patient', 'can', 'benefit_cftr_modulator', 'expectation_regard', 'collaboration', 'develop', 'mrna', 'therapeutic', 'include', 'plan_submit', 'ind', 'program', 'anticipate', 'presentation', 'datum', 'global', 'regulatory_filing', 'late', 'expectation_regard', 'potential', 'benefit', 'pain', 'program', 'product', 'plan', 'advancement', 'pivotal', 'development', 'acute_pain', 'second_half', 'potential', 'benefit', 'safety', 'plan', 'expectation_regard', 'interaction', 'include', 'ability', 'resume', 'phase', 'program', 'site', 'plan', 'continue', 'progress', 'phase', 'program', 'viii', 'plan', 'expectation_regard', 'additional', 'program', 'include', 'completion', 'ind_enable', 'study', 'encapsulate', 'islet', 'cell', 'program', 'anticipate_regulatory_filing', 'plan', 'advance', 'more', 'novel_small_molecule', 'zaat', 'corrector', 'clinic', 'plan', 'regard', 'phase_study', 'amkd', 'belief', 'regard', 'anticipate', 'result', 'study', 'possibility', 'accelerated_approval', 'plan', 'regard', 'program', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'company', 'able', 'submit', 'anticipate_regulatory_filing', 'expect', 'timeline_at_all', 'external', 'factor', 'different', 'more', 'significant', 'impact', 'company', 'business_operation', 'company', 'currently', 'expect', 'datum', 'preclinical_testing', 'clinical_trial', 'especially', 'base', 'limited_number', 'patient', 'indicative_final_result', 'available', 'anticipate_timeline', 'company', 'realize_anticipate_benefit', 'collaboration', 'third_party', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine_timely_manner', 'at_all_safety_efficacy', 'other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['conference_call_webcast'], ['company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international', 'reference', 'pharmaceutical', 'first_quarter', 'earning', 'call'], [], ['source_version'], ['investor'], ['medium'], ['clinical_proof_concept', 'achieve', 'base', 'positive', 'datum', 'first', 'patient', 'dose', 'target', 'dose', 'cell', 'part', 'phase_study'], ['first', 'patient', 'achieve', 'insulin_independence', 'day', 'positive', 'datum', 'second', 'patient', 'third', 'patient', 'receive', 'full', 'target', 'dose', 'initiation', 'part'], ['generally_well_tolerate', 'patient', 'dose', 'date'], ['phase_study', 'clinical', 'hold', 'us'], ['pharmaceutical_incorporate', 'today', 'provide', 'update', 'phase', 'clinical_trial', 'investigational', 'stem', 'cell', 'derive_fully_differentiate_pancreatic', 'islet', 'cell', 'replacement', 'therapy', 'people', 'type_diabetes', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'patient', 'part', 'receive', 'target', 'first', 'patient', 'dose', 'part', 'study', 'achieve', 'insulin_independence', 'day', 'hba', 'second', 'patient', 'dose', 'part', 'show', 'robust', 'increase', 'fast', 'stimulate_peptide', 'reduction', 'exogenous_insulin', 'requirement', 'day', 'take', 'together', 'datum', 'first', 'patient', 'part', 'establish', 'proof_concept_study', 'protocol', 'independent', 'datum', 'review', 'totality', 'safety_efficacy', 'datum', 'first', 'patient', 'dose', 'part', 'study', 'recommend', 'advancement', 'part', 'where', 'patient', 'receive', 'full', 'target', 'dose', 'first', 'patient', 'receive', 'full', 'target', 'dose', 'achieve', 'day', 'follow_up', 'milestone'], ['program', 'generally_well_tolerate', 'date', 'serious_adverse_event', 'sae_consider_related', 'majority_adverse_event_mild', 'moderate', 'patient', 'treat', 'date', 'safety_profile', 'generally_consistent', 'regiman', 'use', 'study', 'perioperative', 'period'], ['company', 'also', 'announce', 'phase_study', 'place', 'clinical', 'hold', 'food', 'determination', 'insufficient', 'information', 'support', 'escalation', 'product'], ['surprised', 'clinical', 'hold', 'place', 'study', 'result', 'first', 'patient', 'treat', 'target', 'dose', 'establish', 'proof_concept', 'demonstrate', 'restore', 'glucose', 'regulate', 'insulin_production', 'improve', 'glycemic_control', 'indeed', 'achievement', 'insulin_independence', 'first', 'patient', 'landmark', 'milestone', 'further', 'totality', 'safety_efficacy', 'datum', 'patient', 'dose', 'date', 'give', 'high', 'confidence', 'benefit', 'risk', 'assessment', 'potentially_transformative', 'profile', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'commit', 'work', 'understand', 'address', 'question', 'trial', 'resume', 'site', 'as_soon', 'possible'], ['safety_efficacy', 'result'], ['patient'], ['result', 'day', 'day', 'previously', 'report', 'patient', 'achieve', 'insulin_independence', 'day', 'hba', 'level', 'study', 'define', 'insulin_independence', 'exogenous_insulin', 'use', 'at_least', 'week', 'fast', 'serum', 'post', 'prandial', 'serum', 'glucose', 'fast', 'stimulate_peptide', 'pmol'], ['day', 'sae_consider_related', 'sae', 'rash', 'dehydration', 'consider_related', 'majority', 'consider_mild_moderate', 'most_common_ae', 'severe', 'hypoglycemic', 'event', 'relate', 'occur', 'perioperative', 'period'], [], ['islet', 'cell', 'function', 'evaluate', 'baseline', 'day', 'infusion', 'use', 'mixed', 'meal', 'tolerance', 'test', 'quantification', 'peptide', 'level', 'direct', 'marker', 'endogenous', 'insulin_production', 'baseline', 'prior', 'infusion', 'fast', 'stimulate_peptide', 'level', 'undetectable', 'indicate', 'endogenous', 'insulin_production', 'day', 'stimulate_peptide', 'increase', 'peak', 'pmol', 'indicate', 'restore', 'glucose_responsive_insulin_production', 'day', 'decrease', 'compare', 'baseline', 'exogenous_insulin', 'use', 'decrease'], ['day', 'sae', 'ae', 'consider_mild_moderate', 'most_common', 'headache', 'hypomagnesemia', 'consider_related'], ['patient'], ['third', 'patient', 'receive', 'full', 'target', 'dose', 'reach', 'day', 'follow', 'visit'], ['early', 'datum', 'show', 'increase', 'fast', 'peptide', 'improve', 'glycemic_control', 'day', 'comprehensive', 'evaluation', 'islet', 'cell', 'function', 'evaluate', 'base', 'mmtt', 'day', 'visit'], ['day', 'sae_consider_related', 'patient', 'sae_consider_related', 'majority', 'consider_mild_moderate', 'most_common_ae', 'nausea', 'consider_related'], ['cell', 'device', 'program'], ['investigational_allogeneic', 'stem', 'cell', 'derive_fully_differentiate_insulin', 'produce_islet', 'cell', 'therapy', 'manufacture', 'use', 'proprietary', 'technology', 'evaluate', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'potential', 'restore_body_ability_regulate', 'glucose_level_restore_pancreatic', 'islet', 'cell', 'function', 'include', 'glucose_responsive_insulin_production', 'deliver', 'infusion', 'hepatic_portal_vein', 'require', 'chronic', 'therapy', 'protect_islet', 'cell', 'immune_rejection'], ['clinical_trial', 'phase', 'multi_center', 'single_arm_open_label', 'study', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'study', 'design', 'sequential_multi', 'part', 'clinical_trial', 'evaluate', 'safety_efficacy', 'part', 'first', 'patient', 'receive', 'target', 'dose', 'part', 'patient', 'receive', 'full', 'target', 'dose', 'concurrent_dosing', 'full', 'target', 'dose', 'occur', 'part', 'approximately', 'patient', 'enrol', 'clinical_trial', 'phase_study', 'clinical', 'hold'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'press_release_statement', 'regard', 'potential', 'benefit', 'safety', 'plan', 'expectation_regard', 'interaction', 'include', 'ability', 'resume', 'phase', 'program', 'site', 'plan', 'continue', 'progress', 'phase', 'program', 'plan', 'expectation_regard', 'additional', 'program', 'include', 'completion', 'ind_enable', 'study', 'encapsulate', 'islet', 'cell', 'program', 'include', 'anticipate_regulatory_filing', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'small', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'research', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy', 'internal_external', 'factor', 'delay', 'divert', 'change', 'plan_objective', 'respect', 'research', 'development', 'program', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['pharmaceutical_incorporate_investor'], ['vertex_pharmaceutical_incorporate', 'report', 'first_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international', 'reference', 'pharmaceutical', 'first_quarter', 'earning', 'call'], ['source_version'], ['approximately', 'canadian', 'age', 'now', 'eligible', 'trikafta'], ['submit', 'indication', 'cadth', 'health', 'technology'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant_marketing_authorization', 'expand', 'use', 'trikafta', 'ivacaftor', 'ivacaftor', 'include', 'child_cystic_fibrosis', 'age_year', 'at_least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'announcement', 'approximately', 'canadian', 'now', 'eligible', 'trikafta', 'result', 'approval', 'additional', 'dosage_strength', 'trikafta', 'tablet', 'now', 'available', 'elexacaftor', 'mg'], ['delighted', 'trikafta', 'now', 'available', 'young', 'patient', 'provide', 'new', 'treatment_option', 'at_least_mutation', 'first_class', 'treatment_option', 'approximately', 'old', 'newly_eligible', 'medicine', 'treat', 'underlie', 'cause', 'disease', 'say_chief_executive_officer', 'president', 'important_milestone', 'bring_step_close', 'ultimate_goal', 'develop', 'treatment', 'patient', 'live', 'now', 'work_closely', 'province', 'territory', 'secure_access_eligible', 'patient', 'as_quickly_possible'], ['complete', 'phase_open_label', 'multicenter', 'study', 'enrol', 'child', 'age_year_old_copy', 'mutation', 'copy_mutation', 'minimal_function_mutation', 'evaluate', 'safety', 'pharmacokinetic', 'efficacy', 'trikafta', 'generally_well_tolerate', 'safety', 'datum', 'consistent_observe', 'previous', 'study', 'patient', 'age_year_old'], ['trial', 'investigator', 'see', 'firsthand', 'demonstrated', 'efficacy', 'trikafta', 'people', 'age', 'live_cystic_fibrosis', 'say', 'land', 'medicine', 'pediatric', 'cystic', 'clinic', 'pediatric', 'pulmonary', 'function', 'laboratory', 'exciting', 'next_step', 'allow', 'eligible', 'patient', 'begin', 'treatment', 'early'], ['also', 'submit', 'indication', 'canadian', 'agency', 'drug', 'technology', 'health', 'service', 'health', 'technology', 'assessment'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect', 'more', 'people', 'globally_cf_progressive_multi', 'organ', 'disease', 'affect_lung', 'pancrea', 'tract_sinus', 'sweat_gland', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'mutation', 'identify', 'genetic_test', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_mutation', 'cftr', 'mutation', 'lead', 'cause', 'cftr_protein', 'defective', 'lead', 'shortage', 'absence_cftr', 'protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'lung_infection', 'progressive_lung', 'damage', 'eventually_lead', 'death', 'many', 'patient', 'median_age', 'death_early'], ['people', 'certain', 'type', 'mutation', 'cftr', 'gene', 'cftr_protein_process_fold', 'normally', 'cell', 'prevent', 'cftr_protein', 'reach', 'cell', 'surface', 'function_properly', 'trikafta', 'ivacaftor', 'ivacaftor', 'oral', 'medicine', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'elexacaftor_tezacaftor', 'work_together', 'increase_amount', 'mature_protein', 'cell', 'surface', 'bind', 'different', 'site', 'protein', 'ivacaftor', 'know_cftr_potentiator', 'design_facilitate', 'ability', 'cftr_protein_transport_salt', 'water', 'cell', 'membrane', 'combine', 'action', 'elexacaftor', 'help_hydrate', 'clear_mucus', 'trikafta', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'cell', 'genetic', 'therapy', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'sickle', 'cell', 'disease_beta_thalassemia', 'kidney_disease', 'pain', 'type_diabetes', 'deficiency_muscular', 'dystrophy'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'make', 'land', 'press_release_statement', 'regard', 'estimate', 'number', 'child', 'eligible', 'trikafta', 'first', 'time', 'belief', 'regard', 'benefit', 'medicine', 'anticipate', 'patient', 'access', 'trikafta', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['treatment', 'inhibitor', 'meet_primary_endpoint', 'phase_proof_concept', 'acute_pain', 'study', 'follow', 'abdominoplasty', 'bunionectomy_surgery'], ['generally_well_tolerate'], ['result', 'further', 'highlight', 'new', 'mechanism', 'create', 'alternative', 'opioid', 'treatment', 'pain'], ['company', 'plan', 'advance_pivotal', 'development', 'acute_pain', 'follow', 'discussion', 'regulator'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'positive', 'result', 'phase_proof_concept', 'poc', 'study', 'investigate', 'treatment', 'selective_inhibitor', 'acute_pain', 'follow', 'abdominoplasty_surgery', 'bunionectomy_surgery', 'treatment', 'initial', 'dose', 'mg', 'follow', 'mg_hour', 'high', 'dose', 'compare_placebo', 'result', 'rapid', 'statistically_significant', 'clinically_meaningful', 'improvement', 'primary_endpoint', 'time_weight_sum', 'pain_intensity', 'difference', 'hour', 'spid', 'consistent', 'trial', 'study', 'also', 'include', 'active', 'reference_arm', 'opioid', 'support', 'evaluation', 'treatment', 'effect'], ['generally_well_tolerate', 'study', 'most', 'adverse_event_mild_moderate', 'serious_adverse_event', 'sae', 'relate', 'few', 'patient', 'discontinue', 'treatment', 'mid', 'high', 'dose', 'arm_placebo', 'group', 'apap', 'reference_arm'], ['base', 'positive', 'proof_concept', 'efficacy', 'result', 'safety_tolerability', 'profile', 'abdominoplasty', 'bunionectomy', 'plan', 'advance_pivotal', 'development', 'second_half', 'follow', 'discussion', 'regulator'], ['result', 'patient', 'undergo', 'bunionectomy'], ['efficacy', 'result'], ['study', 'meet_primary_endpoint', 'show_statistically', 'significant_improvement', 'spid', 'record', 'numeric', 'pain', 'rating_scale', 'nprs', 'treat', 'high', 'dose', 'compare_placebo', 'high', 'spid', 'value', 'represent', 'great', 'improvement', 'pain', 'relief', 'onset', 'action', 'rapid', 'sustain', 'duration', 'assessment'], ['primary_efficacy', 'outcome'], ['treatment', 'group'], [], ['high', 'dose', 'first', 'hour'], [], ['mid', 'dose', 'mg', 'first', 'hour'], [], ['low', 'dose', 'hour'], [], ['reference_arm'], ['hour'], ['mean'], [], [], [], [], [], ['mean', 'spid', 'difference', 'placebo'], ['value', 'placebo'], [], [], [], [], [], ['patient', 'enrol', 'value', 'base', 'comparison', 'placebo'], ['safety', 'result'], ['generally_well_tolerate', 'study', 'discontinuation', 'rate', 'include', 'discontinuation', 'due', 'lack', 'efficacy', 'low', 'vx', 'treated', 'mid', 'high', 'dose', 'arm_placebo', 'group', 'apap', 'reference_arm', 'patient', 'discontinue', 'treatment', 'patient', 'sae', 'ae', 'mild_moderate', 'most_common', 'aes', 'incidence', 'high', 'dose', 'group', 'respectively', 'nausea'], ['result', 'patient', 'undergo', 'abdominoplasty'], ['study', 'meet_primary_endpoint', 'show_statistically', 'significant_improvement', 'spid', 'record', 'nprs', 'treat', 'high', 'dose', 'compare_placebo', 'similar', 'pain', 'relief', 'bunionectomy', 'study', 'onset', 'action', 'rapid', 'sustain', 'assessment', 'period'], [], [], [], [], [], [], [], [], [], [], [], ['patient', 'enrol', 'value', 'base', 'comparison', 'placebo'], ['generally_well_tolerate', 'study', 'discontinuation', 'rate', 'include', 'discontinuation', 'due', 'lack', 'efficacy', 'low', 'vx', 'treate', 'arm_placebo', 'group', 'apap', 'reference_arm', 'patient', 'mid', 'dose', 'arm', 'discontinue', 'treatment', 'none', 'relate', 'treatment', 'patient', 'experience', 'sae', 'patient', 'placebo', 'arm', 'patient', 'apap', 'arm', 'patient', 'mid', 'dose', 'treatment', 'arm', 'none', 'relate', 'treatment', 'majority', 'mild_moderate', 'most_common', 'aes', 'incidence', 'apap', 'high', 'dose', 'group', 'respectively', 'nausea', 'constipation', 'dizziness', 'vomiting'], ['high', 'expectation', 'achieve', 'therapeutic', 'pain', 'control', 'inhibit', 'channel', 'meet', 'result', 'acute_pain', 'study', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'remarkable', 'consistency', 'safety_tolerability', 'efficacy', 'result', 'study', 'demonstrate', 'potential', 'first_class', 'non', 'opioid', 'treatment', 'acute_pain', 'work', 'urgency', 'advance', 'program', 'phase', 'goal_bring', 'first', 'novel', 'pain', 'treatment', 'decade', 'address_unmet', 'need', 'patient', 'suffer', 'acute_pain'], ['tremendous', 'need', 'innovation', 'treatment', 'pain', 'specifically', 'non', 'opioid', 'therapy', 'result', 'provide', 'hope', 'advance', 'horizon', 'say', 'former', 'professor', 'distinguished', 'chair', 'department', 'consultant', 'department', 'cedar', 'new', 'approach', 'pain', 'addictive', 'quality', 'opioid', 'relate', 'side_effect', 'transformative', 'impact', 'field', 'pain', 'management', 'million', 'patient', 'experience', 'acute_pain'], ['next_step'], ['result', 'positive', 'datum', 'vertex', 'plan', 'advance_pivotal', 'development', 'second_half', 'follow', 'discussion', 'regulator', 'full', 'datum', 'set', 'study', 'present', 'future', 'medical', 'meeting'], ['phase_study', 'patient', 'undergo', 'bunionectomy'], ['phase_study', 'randomized_double', 'blind_placebo_control', 'dose_range', 'trial', 'evaluate', 'different', 'dose', 'administer', 'orally', 'hour', 'patient', 'acute_pain_follow_bunionectomy', 'surgery', 'study', 'also', 'include', 'hydrocodone', 'bitartrate', 'reference_arm', 'administer', 'orally', 'hour_hour', 'primary_endpoint', 'time_weight_sum', 'pain_intensity', 'difference', 'first', 'hour', 'treatment', 'record', 'numeric', 'pain', 'rating_scale', 'nprs', 'compare_placebo', 'study', 'evaluate', 'dose', 'regimen', 'high', 'dose', 'follow', 'mg_hour', 'hour', 'first', 'dose', 'mid', 'dose', 'follow', 'mg_hour', 'hour', 'first', 'dose', 'low', 'dose', 'follow', 'mg_hour', 'hour', 'first', 'dose'], ['phase_study', 'patient', 'undergo', 'abdominoplasty'], ['phase_study', 'randomized_double', 'blind_placebo_control', 'arm', 'trial', 'evaluate', 'different', 'dose', 'administer', 'orally', 'hour', 'patient', 'acute_pain', 'follow', 'abdominoplasty_surgery', 'study', 'also', 'include', 'hydrocodone', 'bitartrate', 'reference_arm', 'administer', 'orally', 'hour_hour', 'primary_endpoint', 'time_weight_sum', 'pain_intensity', 'difference', 'first', 'hour', 'treatment', 'record', 'numeric', 'pain', 'rating_scale', 'nprs', 'compare_placebo', 'study', 'evaluate', 'dose', 'regimen', 'high', 'dose', 'follow', 'mg_hour', 'hour', 'first', 'dose', 'mid', 'dose', 'follow', 'mg_hour', 'hour', 'first', 'dose'], [], ['oral', 'selective_inhibitor', 'highly', 'selective', 'relative', 'other', 'channel', 'voltage', 'gate', 'sodium', 'channel', 'play', 'critical', 'role', 'pain', 'signal', 'peripheral', 'nervous_system', 'genetically', 'validate', 'target', 'treatment', 'pain', 'vertex', 'previously', 'demonstrate', 'clinical_proof_concept', 'small_molecule', 'investigational', 'treatment', 'target', 'nav', 'multiple', 'pain', 'indication', 'include', 'acute_pain', 'neuropathic_pain', 'musculoskeletal', 'approach', 'selectively', 'inhibit', 'use', 'small_molecule', 'objective', 'create_new_class', 'medicine', 'potential', 'provide', 'superior', 'relief', 'acute_pain', 'limitation_opioid', 'include', 'addictive', 'potential', 'most_recent', 'molecule', 'enter', 'clinical', 'development', 'portfolio', 'inhibitor'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'press_release_statement', 'regard', 'potential', 'benefit', 'treatment', 'patient', 'acute_pain', 'plan', 'advance_pivotal', 'development', 'second_half', 'expectation', 'transformative', 'impact', 'field', 'pain', 'management', 'patient', 'experience', 'acute_pain', 'expectation_regard', 'number', 'patient', 'experience', 'acute_pain', 'expectation', 'anticipate_timeline', 'upcoming', 'clinical', 'study', 'discussion', 'regulator', 'plan', 'present', 'datum', 'future', 'medical', 'meeting', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'potential', 'future', 'clinical_trial', 'design', 'regulatory', 'review', 'datum', 'company', 'poc', 'study', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'filing', 'file_available_company', 'website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['pharmaceutical_incorporate_investor'], ['reimbursement_agreement', 'place', 'more', 'people', 'pbs', 'fund', 'access', 'trikafta', 'include', 'more', 'now', 'access_cftr_modulator', 'therapy', 'first', 'time'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'trikafta', 'ivacaftor', 'ivacaftor', 'reimburse', 'australian', 'pharmaceutical', 'benefit', 'scheme', 'treatment_cystic_fibrosis', 'people', 'age_year_old_at', 'least_mutation', 'cftr', 'gene', 'most_common', 'cf', 'cause', 'mutation', 'worldwide'], ['today_announcement', 'significant', 'milestone', 'ensure', 'live', 'receive', 'timely', 'sustainable', 'access', 'trikafta', 'say_fenaux_senior_vice', 'fourth', 'treatment', 'bring', 'last', 'year', 'work', 'tirelessly', 'patient', 'clinical', 'community', 'thank', 'australian', 'government', 'recognize', 'significant', 'need', 'trikafta', 'value', 'bring'], ['ivacaftor', 'ivacaftor', 'approve', 'australian', 'therapeutic', 'good', 'base', 'result', 'global', 'phase', 'clinical_trial', 'include', 'multiple', 'australian', 'trial', 'site', 'patient'], ['rare_life_shorten_genetic', 'disease', 'affect_approximately', 'people', 'cause_defective', 'miss_cftr_protein', 'result', 'mutation', 'cftr', 'gene', 'percent', 'people', 'live', 'at_least_mutation'], ['genetic', 'disease', 'cystic', 'prime', 'candidate', 'precision_medicine', 'now', 'list', 'eligible', 'live', 'age_year_old', 'broadly', 'access', 'therapy', 'treat', 'underlie', 'cause', 'disease', 'clinician', 'excite', 'most', 'welcome', 'news', 'say'], ['now', 'join', 'list', 'country', 'where', 'triple_combination_therapy', 'approve', 'reimburse', 'include', 'country'], ['complete', 'product', 'information', 'see', 'summary_product_characteristic', 'find', 'https', 'wwwtgagovau', 'apm', 'summary'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'seramount', 'formerly', 'work', 'mother', 'medium', 'good', 'company', 'company_update_learn', 'more_history', 'innovation_visit', 'follow_twitter'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'ludovic', 'fenaux_senior_vice', 'press_release_statement', 'regard', 'reimbursement', 'access', 'trikafta', 'certain', 'patient', 'estimate', 'number', 'patient', 'eligible', 'cftr_modulator', 'therapy', 'include', 'patient', 'now', 'access_cftr_modulator', 'therapy', 'first', 'time', 'belief', 'benefit', 'medicine', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_indicate', 'such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'obtain_approval_commercialize', 'medicine', 'other_risk_list', 'heading_risk', 'factor_annual', 'report_file', 'available', 'company', 'website', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['investor'], ['medium'], ['single', 'pivotal', 'trial', 'initiate', 'later', 'month', 'target', 'broad', 'patient', 'population', 'apol', 'mutation', 'proteinuric', 'disease'], ['accelerated_approval', 'use', 'interim_analysis', 'week', 'slope', 'support', 'reduction'], ['final', 'analysis', 'evaluate', 'egfr_slope', 'approximately', 'year', 'serve', 'basis', 'approval'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'company', 'advance_pivotal', 'development', 'people', 'live', 'proteinuric', 'kidney_disease', 'mediate', 'mutation', 'apol', 'gene', 'affect_approximately', 'people', 'first', 'investigational', 'therapy', 'aim', 'treat_underlying_cause', 'amkd', 'pivotal', 'study', 'open', 'enrollment', 'later', 'month'], ['company', 'evaluate', 'safety_efficacy', 'single', 'pivotal', 'clinical_trial', 'design_assess', 'impact', 'top', 'standard_care', 'kidney', 'function', 'proteinuria', 'people', 'amkd', 'primary_endpoint', 'study', 'reduction', 'rate', 'decline', 'kidney', 'function', 'measure', 'estimate', 'glomerular', 'filtration', 'rate', 'slope', 'placebo', 'approximately', 'year', 'study', 'also', 'design', 'pre', 'plan', 'interim_analysis', 'week', 'evaluate', 'egfr_slope', 'placebo', 'support', 'percent', 'change_baseline', 'positive', 'interim_analysis', 'serve', 'basis', 'vertex', 'seek', 'accelerated_approval', 'patient', 'amkd'], ['hold', 'potential', 'first_class', 'good', 'class', 'treatment', 'patient', 'base', 'phase', 'result', 'demonstrate', 'reduction', 'apol_mediated', 'focal', 'segmental', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'very_pleased', 'conclude', 'discussion', 'enable', 'initiate', 'pivotal', 'development', 'program', 'evaluate', 'broad', 'patient', 'population', 'amkd', 'clear', 'path', 'forward', 'potential', 'accelerated_approval'], ['pivotal', 'program', 'randomize_double_blind_placebo', 'control', 'phase', 'adaptive', 'study', 'first', 'evaluate', 'dose', 'week', 'select', 'dose', 'phase', 'subsequently', 'evaluate', 'efficacy_safety', 'single', 'select', 'dose', 'phase', 'portion', 'study'], ['patient', 'age_year', 'apol', 'mutation', 'urine', 'protein', 'ratio', 'egfr', 'stable', 'dose', 'standard_care', 'medication', 'eligible', 'enroll', 'approximately', 'patient', 'plan', 'enrol', 'phase', 'dose_range', 'portion', 'study', 'approximately', 'additional', 'patient', 'plan', 'enrol', 'phase', 'portion', 'study'], ['primary_efficacy', 'endpoint', 'final', 'analysis', 'egfr_slope', 'patient', 'receive', 'select', 'dose', 'compare_placebo', 'secondary', 'efficacy_endpoint', 'time', 'composite', 'clinical', 'outcome', 'also', 'assess', 'final', 'analysis', 'define', 'sustained', 'decline', 'baseline', 'onset', 'end', 'stage', 'kidney_disease', 'maintenance', 'dialysis', 'day', 'kidney', 'transplantation', 'sustained', 'egfr', 'death', 'final', 'study', 'analysis', 'occur', 'when', 'subject', 'at_least', 'year', 'egfr', 'datum', 'when', 'approximately', 'composite', 'clinical', 'outcome', 'occur'], ['study', 'also', 'design', 'pre', 'plan', 'interim_analysis', 'week', 'evaluate', 'egfr_slope', 'support', 'percent', 'change_baseline', 'arm_placebo', 'positive', 'interim_analysis', 'serve', 'basis', 'vertex', 'seek', 'accelerated_approval', 'patient', 'amkd'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'press_release_statement', 'regard', 'advancement', 'single', 'pivotal', 'clinical', 'study', 'potential', 'benefit', 'plan', 'expectation', 'anticipate_timeline', 'clinical_trial', 'include', 'enrollment', 'study', 'design', 'interim_analysis', 'submission', 'regulatory_approval', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'trial', 'complete', 'expect', 'timeframe', 'at_all_datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'health_care', 'conference', 'pm'], ['source_version'], ['year', 'product_revenue', 'increase_compare', 'full_year'], ['provide', 'full_year', 'product_revenue', 'guidance', 'billion'], ['advance', 'broad', 'clinical', 'pipeline', 'disease', 'area', 'multiple', 'program', 'mid_late', 'stage', 'development', 'clinical', 'readout', 'expect'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'fourth_quarter_full_year', 'end', 'provide', 'full_year_financial_guidance'], ['vertex', 'deliver', 'exceptional', 'financial_performance', 'include', 'revenue_growth', 'couple', 'important', 'progress', 'business', 'expand', 'leadership', 'cystic', 'treat', 'more', 'patient', 'ever', 'before', 'advance', 'next_class', 'triple', 'regiman', 'pivotal', 'study', 'addition', 'pipeline', 'accelerate', 'deliver', 'important', 'clinical', 'datum', 'new', 'disease', 'area', 'say_chief_executive_officer', 'president', 'move', 'multiple', 'program', 'mid_late', 'stage', 'development', 'important_milestone', 'ahead', 'continue', 'innovation', 'progress', 'pipeline', 'poise', 'serve', 'many', 'more', 'patient', 'drive', 'revenue', 'earning', 'growth', 'many', 'year', 'future'], ['fourth_quarter_full_year', 'financial', 'highlight'], ['month_end'], [], ['month_end'], ['combine_gaap_expense', 'increase_compare', 'primarily', 'payment', 'second_quarter'], ['combined_non_gaap', 'expense', 'increase_compare', 'primarily', 'advancement', 'expansion_pipeline', 'incremental_investment_support', 'launch', 'medicine', 'globally'], ['gaap', 'income_taxis', 'decrease', 'compare', 'primarily', 'income_tax', 'impact', 'payment', 'impact', 'discrete', 'tax', 'event', 'compare', 'note'], ['non_gaap_income_taxis', 'increase_compare', 'primarily', 'increase', 'operating_income'], ['fourth_quarter', 'result'], ['product_revenue', 'increase_compare', 'fourth_quarter', 'primarily_drive', 'strong', 'launch', 'performance', 'trikafta', 'net_product_revenue', 'fourth_quarter', 'increase', 'increase_compare', 'fourth_quarter'], ['gaap_non_gaap', 'net_income', 'increase_compare', 'fourth_quarter', 'drive_strong', 'product_revenue', 'growth'], ['fourth_quarter', 'expense'], ['month_end'], ['combined_non_gaap', 'expense', 'increase_compare', 'fourth_quarter_primarily', 'advancement', 'expansion_pipeline', 'incremental_investment_support', 'launch', 'medicine', 'globally'], ['gaap', 'income_taxis', 'decrease', 'compare', 'fourth_quarter_primarily', 'impact', 'discrete', 'tax', 'event', 'recognize', 'fourth_quarter', 'note', 'income_tax', 'impact', 'sale', 'certain', 'strategic_investment', 'fourth_quarter'], ['non_gaap_income_taxis', 'increase_compare', 'fourth_quarter_primarily', 'due', 'increase', 'operating_income'], ['today', 'provide', 'full_year', 'financial', 'product_revenue', 'guidance', 'primarily', 'base', 'expectation', 'continued', 'strong', 'performance', 'trikafta', 'product_revenue', 'guidance', 'reflect', 'management', 'expectation', 'approve', 'product', 'country', 'where', 'vertex', 'already', 'secure', 'reimbursement'], ['guidance_summarize', 'below'], [], ['combined_non_gaap', 'expense'], ['anticipate', 'number', 'patient', 'treat', 'medicine', 'continue', 'grow', 'uptake', 'trikafta', 'launch', 'continue', 'enter', 'additional', 'reimbursement_agreement', 'achieve', 'new', 'approval', 'treatment', 'young', 'patient', 'recent', 'progress', 'include'], ['now', 'approve', 'reimburse', 'accessible', 'more', 'country'], ['deliver', 'diversified', 'pipeline', 'potentially_transformative', 'small_molecule', 'cell', 'genetic', 'therapy', 'aim', 'serious_disease', 'recent', 'anticipated', 'progress', 'key', 'pipeline', 'program', 'note'], ['continue', 'pursue', 'next_class', 'cftr_modulator', 'therapy', 'as_well', 'new', 'treatment_option', 'approximately', 'patient', 'can', 'benefit_cftr_modulator', 'alone'], ['program', 'employ', 'non', 'viral', 'vivo_gene_edit', 'therapy', 'develop', 'potential', 'functional_cure', 'transfusion_dependent', 'thalassemia_severe', 'sickle', 'cell', 'disease', 'scd'], ['evaluate', 'potential', 'oral', 'small_molecule', 'inhibitor', 'apol', 'function', 'treat', 'people', 'amkd'], ['evaluate', 'cell', 'therapy', 'design', 'replace', 'insulin_produce_islet', 'cell', 'destroy', 'people', 'goal', 'develop', 'potential', 'functional_cure', 'disease'], ['discover', 'multiple', 'selective', 'small_molecule', 'inhibitor', 'objective', 'create_new_class', 'medicine', 'potential', 'highly', 'effective', 'acute', 'chronic', 'pain', 'limitation_opioid', 'other', 'exist', 'pain', 'medication'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'revenue_expense', 'relate_collaborative', 'upfront_milestone_payment', 'include', 'upfront_payment', 'therapeutic', 'certain', 'other', 'business', 'development', 'activity', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'increase_decrease_fair', 'value_contingent_consideration', 'acquisition_relate_cost', 'other', 'adjustment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe_certain_discrete', 'item', 'result', 'view_substitute', 'company', 'gaap', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'company', 'believe_helpful', 'understanding', 'ongoing', 'business', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'calculation', 'non_gaap_financial_measure', 'likely_differ', 'calculation', 'use', 'other', 'company', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['company', 'provide', 'guidance_regard_combine', 'expense_effective_tax', 'rate', 'non_gaap_basis', 'guidance_regard', 'combine_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity', 'company', 'provide', 'guidance_regard', 'gaap', 'effective_tax_rate', 'unable', 'forecast', 'reasonable', 'certainty', 'impact', 'excess_tax_benefit', 'relate_stock_base_compensation', 'possibility', 'certain_discrete_item', 'material'], ['fourth_quarter_full_year', 'result'], ['consolidated', 'statement', 'operation'], ['month_end_tax_adjustment', 'include', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment', 'company', 'pre_tax_income', 'non_recur', 'discrete_benefit', 'company', 'provision_income_taxis', 'tax_adjustment', 'month_end', 'include', 'discrete_benefit', 'result', 'conclusion', 'tax', 'credit', 'study', 'month_end', 'also', 'include', 'discrete_benefit_relate', 'increase', 'corporate', 'tax_rate', 'enact', 'become', 'effective_tax', 'adjustment', 'month_end', 'include', 'discrete_benefit_relate', 'transfer', 'intellectual_property', 'right', 'company', 'relate', 'write', 'off', 'long_term', 'intercompany', 'receivable', 'relate', 'increase', 'corporate', 'tax_rate', 'enact', 'become', 'effective'], ['difference', 'company', 'full_year', 'combined', 'gaap', 'expense', 'combine', 'non_gaap', 'expense', 'guidance', 'relate', 'primarily', 'collaborative', 'milestone_payment', 'certain', 'other', 'business', 'development', 'activity', 'relate', 'exist', 'business', 'development', 'agreement', 'stock_base_compensation_expense', 'guidance_regard', 'combine_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity'], ['research', 'development', 'expense', 'include', 'upfront_payment', 'month_end'], ['other', 'income', 'net', 'include', 'net', 'gain_loss_relate', 'change_fair_value', 'company', 'strategic_investment', 'sale', 'certain', 'investment'], ['month_end', 'change_fair_value_contingent', 'consideration_relate', 'potential', 'payment_exonic', 'therapeutic', 'former_equity_holder'], ['collaborative_revenue_expense', 'month_end', 'relate_collaborative', 'upfront_milestone_payment', 'certain', 'other', 'business', 'development', 'activity', 'company', 'upfront_payment', 'include', 'collaborative_revenue_expense', 'month_end'], ['acquisition_relate_cost', 'month_end', 'relate_cost', 'associate', 'company', 'acquisition_exonic', 'therapeutic'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'seramount', 'formerly', 'work', 'mother', 'medium', 'good', 'company', 'good', 'place_work', 'lgbtq_equality', 'human_right_campaign', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'operation_section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'anticipate_regulatory_filing', 'data', 'availability_timing_thereof', 'expectation', 'development', 'plan', 'anticipate_timeline', 'company', 'medicine', 'drug_candidate', 'pipeline', 'program', 'include', 'study', 'design', 'patient', 'enrollment', 'datum', 'availability_timing_thereof', 'iii', 'anticipate', 'global', 'regulatory_filing', 'late', 'expectation', 'continued_growth', 'number', 'patient', 'treat', 'medicine', 'include', 'number', 'child', 'newly_eligible', 'uptake', 'expand', 'access', 'company', 'medicine', 'additional', 'reimbursement_agreement', 'new', 'approval', 'expansion', 'treatment_option', 'patient', 'can', 'benefit_cftr_modulator', 'expectation', 'pain', 'program', 'include', 'expectation', 'obtain', 'datum', 'bunionectomy', 'abdominoplasty', 'study', 'first_quarter', 'plan', 'enroll', 'dose', 'more', 'patient', 'report', 'long_term', 'follow', 'program', 'expectation', 'submission', 'cell', 'device', 'program', 'plan', 'advance', 'more', 'novel_small_molecule', 'zaat', 'corrector', 'clinic', 'expectation', 'collaboration', 'evaluate', 'therapeutic', 'include', 'plan_submit', 'ind', 'program', 'plan', 'complete', 'end', 'phase', 'meeting', 'regulator', 'initiation', 'pivotal', 'development', 'amkd', 'first_quarter', 'plan_submit', 'regulatory_filing', 'orkambi', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'company', 'able', 'submit', 'anticipate_regulatory_filing', 'expect', 'timeline_at_all', 'different', 'more', 'significant', 'impact', 'company', 'business_operation', 'company', 'currently', 'expect', 'datum', 'preclinical_testing', 'clinical_trial', 'especially', 'base', 'limited_number', 'patient', 'indicative_final_result', 'available', 'anticipate_timeline', 'company', 'realize_anticipate_benefit', 'collaboration', 'third_party', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine_timely_manner', 'at_all_safety_efficacy', 'other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['company', 'host_conference_call_webcast', 'today', 'pm_access_call_dial', 'international', 'conference_call_webcast', 'live_link', 'webcast', 'access', 'website_wwwvrtxcom_investor_section', 'event', 'presentation_ensure_timely', 'connection_recommend_user_register', 'least_minute_prior_schedule', 'webcast_archive_webcast', 'available', 'company', 'website'], ['source_version'], ['contact', 'investor'], ['vertex_pharmaceutical_incorporate', 'report', 'fourth_quarter_full_year', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['source_version_home'], ['more', 'child', 'now', 'eligible', 'receive', 'treatment', 'target', 'underlying_cause', 'cystic_fibrosis', 'first', 'time'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant', 'approval', 'label_extension', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene'], ['delighted', 'elexacaftor_combination', 'regimen_ivacaftor', 'now', 'approve', 'young', 'patient', 'provide', 'new', 'treatment_option', 'physician', 'help', 'treat_underlying_cause', 'devastating', 'disease', 'early', 'life', 'say_chief_executive_officer', 'president', 'important_milestone', 'bring_step_close', 'ultimate_goal', 'develop', 'treatment', 'patient', 'live'], ['elexacaftor_ivacaftor', 'show', 'clinical', 'benefit', 'availability', 'last', 'year', 'people', 'age', 'above', 'say', 'head', 'respiratory', 'medicine', 'immunology', 'critical_care', 'medicine', 'progressive', 'disease', 'symptom', 'organ', 'damage', 'manifest', 'very', 'early', 'life', 'physician', 'welcome', 'approval', 'medicine', 'young', 'age', 'group', 'help', 'treat', 'eligible', 'child', 'as_early', 'year_old'], ['result', 'long_term', 'reimbursement_agreement', 'provision', 'access', 'health_care', 'system', 'such', 'eligible', 'patient', 'country', 'access', 'expand', 'indication', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'shortly', 'follow', 'regulatory_approval', 'continue', 'work', 'reimbursement', 'body', 'ensure', 'access', 'eligible', 'patient'], ['medicine', 'also', 'approve', 'regulatory_authority', 'where', 'know', 'trikafta', 'ivacaftor', 'ivacaftor', 'people', 'age', 'above', 'continue', 'work_closely', 'reimbursement', 'body', 'country', 'ensure', 'access', 'eligible', 'patient'], ['ivacaftor_elexacaftor_combination_regimen', 'ivacaftor'], ['people', 'certain', 'type', 'mutation', 'cftr', 'gene', 'cftr_protein_process_fold', 'normally', 'cell', 'prevent', 'cftr_protein', 'reach', 'cell', 'surface', 'function_properly', 'ivacaftor_elexacaftor', 'combination', 'ivacaftor', 'oral', 'medicine', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'elexacaftor_tezacaftor', 'work_together', 'increase_amount', 'mature_protein', 'cell', 'surface', 'bind', 'different', 'site', 'protein', 'ivacaftor', 'know_cftr_potentiator', 'design_facilitate', 'ability', 'cftr_protein_transport_salt', 'water', 'cell', 'membrane', 'combine', 'action', 'ivacaftor', 'tezacaftor_elexacaftor', 'help_hydrate', 'clear_mucus', 'airway'], ['complete', 'product', 'information', 'see', 'summary_product_characteristic', 'find', 'wwwemaeuropaeu'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'seramount', 'formerly', 'work', 'mother', 'medium', 'good', 'company', 'good', 'place_work', 'lgbtq_equality', 'human_right_campaign', 'company_update_learn', 'more_history', 'innovation_visit', 'follow_twitter'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'chief_executive', 'officer_president', 'professor', 'head', 'respiratory', 'medicine', 'immunology', 'critical_care', 'medicine', 'press_release_statement', 'regard', 'estimate', 'number', 'child', 'eligible', 'medicine_treat_underlying', 'cause', 'disease', 'first', 'time', 'belief', 'regard', 'benefit', 'medicine', 'anticipate', 'patient', 'access', 'combination', 'ivacaftor', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include', 'risk_list_heading_risk', 'factor_annual_report_subsequent', 'filing', 'file_available_company', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'th', 'annual', 'conference', 'am'], ['source_version'], ['treatment', 'lead', 'statistically_significant', 'substantial', 'clinically_meaningful', 'mean', 'reduction', 'proteinuria', 'week', 'compare', 'baseline', 'well_tolerate'], ['result', 'provide', 'clinical_proof_concept', 'first', 'genetically', 'target', 'approach', 'treat', 'kidney_disease'], ['vertex', 'advance_pivotal', 'development'], ['vertex', 'hold', 'conference_call', 'result', 'today', 'am'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'phase_proof_concept', 'poc', 'study', 'patient', 'apol_mediated', 'focal', 'segmental', 'fsgs', 'vx', 'top', 'standard_care', 'achieve', 'statistically_significant', 'substantial', 'clinically_meaningful', 'mean', 'reduction', 'urine', 'protein', 'ratio', 'week', 'compare', 'baseline', 'well_tolerate', 'result', 'provide', 'first', 'clinical', 'evidence', 'poc', 'oral', 'small_molecule', 'apol', 'inhibitor', 'decrease', 'patient', 'apol_mediated', 'kidney_disease', 'base', 'result', 'vertex', 'plan', 'advance_pivotal', 'development', 'kidney_disease', 'include', 'fsgs'], ['press_release_feature_view', 'full', 'release', 'here', 'news_home'], ['figure', 'primary_endpoint', 'result', 'mean', 'percent', 'change_baseline', 'week', 'graphic', 'business', 'wire'], ['total', 'patient', 'enrol', 'study', 'accord', 'pre_specified', 'statistical', 'analysis', 'plan', 'patient', 'noncompliant', 'treatment', 'include', 'primary_efficacy', 'analysis', 'evaluable', 'patient', 'treatment', 'top', 'standard_care', 'result', 'rapid', 'statistically_significant', 'clinically_meaningful', 'mean', 'change_baseline', 'follow', 'week', 'treatment', 'reduction', 'observe', 'early', 'continue', 'treatment', 'period', 'result', 'consistent', 'regardless', 'baseline', 'proteinuria', 'background', 'therapy'], ['treatment', 'discontinuation', 'due', 'adverse_event', 'serious_adverse_event', 'consider_related', 'study', 'drug', 'ae', 'mild_moderate_severity', 'most_common', 'aes', 'occur', 'subject', 'pain', 'nausea'], ['first', 'investigational', 'treatment', 'target', 'underlying_cause', 'kidney_disease', 'result', 'demonstrate', 'inhibition', 'apol', 'protein', 'substantially', 'reduce', 'proteinuria', 'patient', 'apol', 'genetic_variant', 'fsgs', 'significant', 'proteinuria', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'work', 'urgency', 'advance', 'molecule', 'pivotal', 'development', 'goal_bring', 'first_class', 'therapy', 'more', 'patient', 'live', 'kidney_disease'], ['result', 'very', 'promising', 'decade', 'care', 'patient', 'suffer', 'rapid', 'onset', 'kidney_disease', 'progress', 'quickly', 'kidney', 'failure', 'now', 'know', 'cause', 'gene', 'variant', 'say', 'professor', 'medicine', 'chair', 'program', 'approach', 'tremendous', 'potential', 'target', 'underlie', 'genetic', 'driver', 'kidney_disease', 'patient', 'datum', 'demonstrate', 'potential', 'target', 'treatment', 'patient', 'population', 'unusually', 'high', 'risk', 'progression', 'kidney', 'failure'], ['base', 'datum', 'vertex', 'plan', 'advance_pivotal', 'development', 'potential', 'first_class', 'therapy', 'more', 'patient', 'proteinuric', 'kidney_disease', 'mediate', 'variant', 'apol', 'gene', 'include', 'limit', 'fsgs', 'consistent', 'company', 'serial_innovation', 'strategy', 'vertex', 'also', 'continue', 'investigate', 'additional', 'small_molecule', 'apol', 'inhibitor', 'clinic'], ['phase_study'], ['phase_open_label', 'single_arm', 'study', 'evaluate', 'efficacy_safety', 'pharmacokinetic', 'patient', 'apol_mediated', 'fsgs', 'patient', 'biopsy', 'confirm', 'fsgs', 'genetic_variant', 'define', 'at_least', 'upcr', 'estimate', 'glomerular', 'filtration', 'rate', 'at_least', 'ml', 'min', 'eligible', 'enrollment', 'study', 'patient', 'stable', 'standard_care', 'regiman', 'include', 'angiotensin', 'convert', 'enzyme', 'inhibitor', 'receptor', 'blocker', 'low', 'dose', 'corticosteroid', 'patient', 'treat', 'total', 'week', 'primary_endpoint', 'percent', 'change_baseline', 'week', 'secondary_endpoint', 'safety', 'pharmacokinetic', 'addition', 'safety', 'follow', 'period', 'last', 'dose', 'treatment', 'optional', 'treatment', 'follow', 'period', 'week', 'last', 'dose', 'treatment', 'study', 'ongoing', 'follow', 'period'], ['kidney_disease'], ['apol_mediated', 'kidney_disease', 'form', 'chronic', 'kidney_disease', 'cause', 'variant', 'apol', 'gene', 'people', 'apol', 'genetic_variant', 'proteinuric', 'people', 'inherit', 'risk', 'variant', 'apol', 'gene', 'course', 'disease', 'far', 'more', 'aggressive', 'absence', 'genetic_variant', 'inherit', 'apol', 'genetic_variant', 'kidney_disease', 'toxic', 'gain', 'function', 'lead', 'podocyte', 'injury', 'injury', 'disrupt', 'filtration', 'result', 'rapidly', 'progressive', 'result', 'dialysis', 'kidney', 'transplant', 'death'], ['company', 'host_conference_call_webcast', 'today', 'am', 'access', 'call_dial_international', 'conference_call_webcast', 'live_link', 'webcast', 'access', 'website_wwwvrtxcom_investor_section', 'event', 'presentation_ensure_timely', 'connection_recommend_user_register', 'least_minute_prior_schedule', 'webcast_archive_webcast', 'available', 'company', 'website'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'chertow', 'press_release_ii', 'plan', 'advance_pivotal', 'development', 'expectation', 'potential', 'benefit', 'treatment', 'patient', 'apol_mediated', 'kidney_disease', 'expectation', 'potential', 'first_class', 'therapy', 'more', 'patient', 'live', 'mediate', 'kidney_disease', 'statement', 'regard', 'plan', 'investigate', 'additional', 'small_molecule', 'apol', 'inhibitor', 'clinic', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'company', 'research', 'development', 'program', 'include', 'potential', 'future', 'clinical_trial', 'design', 'regulatory', 'review', 'datum', 'company', 'research', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news_home'], ['reimbursement_agreement', 'approximately', 'people_cystic_fibrosis', 'now', 'access_cftr_modulator', 'therapy', 'first', 'time'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'spanish', 'government', 'approve', 'term', 'national_reimbursement', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'treatment_cystic_fibrosis', 'eligible', 'patient', 'agreement', 'cover', 'people', 'age_year_old_at', 'least_copy_mutation', 'regardless', 'other', 'mutation', 'type', 'cftr', 'gene', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'prescribe', 'eligible', 'patient', 'treat', 'physician', 'medicine', 'list', 'national'], ['formalize', 'agreement', 'important_milestone', 'people', 'live_cystic_fibrosis', 'pleased', 'recognize', 'value', 'elexacaftor_combination', 'regimen_ivacaftor', 'today_announcement', 'mean', 'medicine', 'prescribe', 'eligible', 'patient', 'when', 'list', 'say_fenaux_senior_vice', 'like_thank', 'collaborative', 'approach', 'as_well', 'community', 'important', 'input', 'process'], ['agreement', 'join', 'group', 'country', 'such', 'where', 'eligible', 'patient', 'access', 'triple_combination_therapy'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect', 'more', 'people', 'globally_cf_progressive_multi', 'organ', 'disease', 'affect_lung', 'pancrea', 'tract_sinus', 'sweat_gland', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'mutation', 'identify', 'genetic_test', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_mutation', 'cftr', 'mutation', 'lead', 'cause', 'cftr_protein', 'defective', 'lead', 'shortage', 'absence_cftr', 'protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'lung_infection', 'progressive_lung', 'damage', 'eventually_lead', 'death', 'many', 'patient', 'median_age', 'death_early'], ['ivacaftor_elexacaftor', 'combination', 'ivacaftor', 'approve', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cftr', 'gene'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'cell', 'genetic', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'ludovic', 'fenaux_senior_vice', 'press_release_statement', 'regard', 'belief', 'eligible', 'patient', 'population', 'access', 'combination', 'ivacaftor', 'include', 'patient', 'now', 'access_cftr_modulator', 'therapy', 'first', 'time', 'belief', 'regard', 'benefit', 'medicine', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_indicate', 'such_forward_look', 'statement', 'risk_list_heading_risk', 'factor_annual_report_subsequent', 'filing', 'file_available_company', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news_home'], ['pharmaceutical_incorporate_investor_medium'], ['approve', 'more', 'child', 'eligible', 'medicine_treat_underlying', 'cause', 'disease', 'first', 'time'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'committee_medicinal_product', 'human_use_chmp', 'adopt_positive_opinion', 'label_extension', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene'], ['today', 'mark_important', 'milestone', 'treatment', 'child', 'approve', 'elexacaftor_combination', 'regimen_ivacaftor', 'offer', 'physician', 'new', 'treatment_option', 'young', 'patient', 'help', 'combat', 'life_shorten', 'condition', 'as_early_possible', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer'], ['clinical', 'datum', 'ivacaftor', 'tezacaftor_elexacaftor', 'ivacaftor', 'people', 'age', 'eligible', 'genotype', 'demonstrate', 'improvement_lung_function', 'sweat_chloride', 'respiratory', 'symptom', 'safety_tolerability', 'profile_consistent', 'observe', 'patient', 'age_year_old', 'say', 'head', 'respiratory', 'medicine', 'immunology', 'critical_care', 'medicine', 'medicine', 'already', 'make', 'big', 'impact', 'life', 'eligible', 'people', 'age_year', 'above', 'community', 'now', 'look_forward', 'available', 'young', 'patient', 'too', 'enable', 'treatment', 'as_early_possible', 'life'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect', 'more', 'people', 'globally_cf_progressive_multi', 'organ', 'disease', 'affect_lung', 'pancrea', 'tract_sinus', 'sweat_gland', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'mutation', 'identify', 'genetic_test', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_mutation', 'cftr', 'mutation', 'lead', 'cause', 'cftr_protein', 'defective', 'lead', 'shortage', 'absence_cftr', 'protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'lung_infection', 'progressive_lung', 'damage', 'eventually_lead', 'death', 'many', 'patient', 'median_age', 'death_early'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'professor', 'head', 'respiratory', 'medicine', 'immunology', 'critical_care', 'medicine', 'press_release_statement', 'regard', 'expectation', 'regulatory_approval', 'label_extension', 'combination', 'ivacaftor', 'estimate', 'number', 'child', 'eligible', 'medicine_treat_underlying', 'cause', 'disease', 'first', 'time', 'belief', 'regard', 'benefit', 'medicine', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support', 'label_extension', 'combination', 'ivacaftor', 'approve', 'company', 'post', 'marketing', 'application', 'combination', 'ivacaftor', 'timely_basis', 'at', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'filing', 'file_available_company', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['revenue', 'increase_compare'], ['raise', 'full_year', 'guidance', 'product_revenue', 'billion'], ['pipeline', 'advance', 'recent', 'progress', 'mark', 'unprecedented', 'clinical', 'result', 'phase', 'clinical', 'result', 'expect', 'quarter'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'third_quarter', 'end', 'raise', 'full_year', 'product_revenue', 'guidance'], ['financial_performance', 'third_quarter', 'outstanding', 'mark', 'exceptional', 'continued_growth', 'base', 'result', 'again', 'raise', 'product_revenue', 'guidance', 'see', 'significant', 'additional', 'growth', 'ahead', 'continue', 'deliver', 'medicine', 'more', 'people', 'say_chief_executive_officer', 'president', 'last', 'quarter', 'also', 'significantly', 'expand', 'advance', 'pipeline', 'announce', 'unprecedented', 'datum', 'first', 'type_diabete', 'patient', 'dosed', 'stem', 'cell', 'derive', 'allogeneic', 'islet', 'cell', 'complete_enrollment', 'phase_proof_concept', 'study', 'fsgs', 'report', 'result', 'later', 'quarter', 'also', 'achieve', 'target', 'enrollment', 'pivotal', 'study', 'support', 'regulatory_submission', 'year', 'finally', 'make', 'important', 'advancement', 'early_stage', 'pipeline', 'expect', 'submit_ind', 'program', 'type_diabetes', 'cell', 'device', 'program'], ['third_quarter', 'financial', 'highlight'], ['month_end'], ['product_revenue', 'increase_compare', 'third_quarter', 'primarily_drive', 'strong', 'launch', 'performance', 'trikafta', 'include', 'rapid', 'uptake', 'trikafta', 'child', 'year_old', 'net_product_revenue', 'third_quarter', 'increase', 'increase_compare', 'third_quarter'], ['gaap_non_gaap', 'net_income', 'increase_compare', 'third_quarter', 'drive_strong', 'product_revenue', 'growth'], ['cash_cash', 'equivalent_marketable_security', 'increase_compare', 'increase', 'primarily_drive', 'strong', 'operate', 'cash_flow', 'partially_offset', 'repurchase', 'common_stock', 'authorize', 'share', 'repurchase', 'program', 'payment', 'second_quarter', 'connection', 'amendment', 'collaboration'], ['third_quarter', 'expense'], ['combine_gaap_non_gaap', 'expense', 'increase_compare', 'third_quarter', 'primarily', 'expansion_pipeline', 'cystic_fibrosis', 'other', 'disease', 'area', 'incremental_investment_support', 'launch', 'medicine', 'globally'], ['gaap', 'income_taxis', 'increase_compare', 'third_quarter', 'primarily_due', 'increase', 'operating_income', 'impact', 'certain_discrete', 'tax', 'event', 'note'], ['non_gaap_income_taxis', 'increase_compare', 'third_quarter', 'primarily_due', 'increase', 'operating_income'], ['full_year_financial_guidance'], ['today', 'increase', 'full_year', 'product_revenue', 'guidance', 'base', 'strong', 'year', 'date', 'performance', 'vertex', 'guidance_summarize', 'below'], ['current', 'fy'], ['previous', 'fy'], [], [], [], [], ['anticipate', 'number', 'patient', 'treat', 'medicine', 'continue', 'grow', 'enter', 'additional', 'reimbursement_agreement', 'achieve', 'new', 'approval', 'treatment', 'young', 'patient', 'expand', 'treatment_option', 'approximately', 'percent', 'patient', 'benefit', 'cystic_fibrosis', 'conductance_regulator', 'cftr_modulator', 'lead', 'continued_growth', 'business', 'year', 'ahead', 'recent', 'progress', 'include'], ['now', 'approve', 'reimburse', 'accessible', 'more', 'country', 'include'], ['deliver', 'diversified', 'pipeline', 'potentially_transformative', 'small_molecule', 'cell', 'genetic', 'therapy', 'aim', 'serious_disease', 'recent', 'anticipated', 'progress', 'key', 'pipeline', 'program', 'note', 'below'], ['apol_mediated', 'kidney_disease', 'amkd'], ['investment', 'external', 'innovation'], ['further', 'expand', 'capability', 'gene_editing', 'vertex', 'recently', 'announce', 'new', 'collaboration'], ['third_quarter', 'result'], ['thousand_share', 'amount'], ['month_end'], ['month_end_tax_adjustment', 'include', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment', 'company', 'pre_tax_income', 'non_recur', 'discrete_benefit', 'company', 'provision_income', 'taxis_estimate', 'income_taxis', 'relate_non_gaap', 'adjustment', 'company', 'pre_tax_income', 'include', 'adjustment', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'change_fair_value', 'company', 'strategic_investment', 'collaborative_upfront_milestone_payment', 'certain', 'other', 'business', 'development', 'activity', 'other', 'adjustment', 'tax_adjustment', 'month_end', 'also', 'include', 'discrete_benefit_relate', 'increase', 'corporate', 'tax_rate', 'enact', 'become', 'effective_tax', 'adjustment', 'month_end', 'also', 'include', 'discrete_benefit_relate', 'transfer', 'intellectual_property', 'right', 'company', 'discrete_benefit_relate', 'write', 'off', 'long_term', 'intercompany', 'receivable', 'discrete_benefit_relate', 'increase', 'corporate', 'tax_rate', 'enact', 'become', 'effective'], ['difference', 'company', 'full_year', 'combine_gaap_expense', 'combine', 'non_gaap', 'expense', 'guidance', 'relate', 'primarily', 'collaborative_upfront_milestone_payment', 'certain', 'other', 'business', 'development', 'activity', 'relate', 'exist', 'business', 'development', 'agreement', 'stock_base_compensation_expense', 'guidance_regard', 'combine_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity'], ['research', 'development', 'expense', 'include', 'upfront_payment', 'month_end'], ['other', 'income', 'expense', 'net', 'include', 'net', 'gain', 'relate_change_fair', 'value', 'company', 'strategic_investment', 'sale', 'certain', 'investment'], ['month_end', 'change_fair_value_contingent', 'consideration_relate', 'potential', 'payment_exonic', 'therapeutic', 'former_equity_holder'], ['collaborative_revenue_expense', 'month_end', 'relate_collaborative', 'upfront_milestone_payment', 'certain', 'other', 'business', 'development', 'activity', 'company', 'upfront_payment', 'include', 'collaborative_revenue_expense', 'month_end'], ['acquisition_relate_cost', 'month_end', 'relate_cost', 'associate', 'company', 'acquisition_exonic', 'therapeutic'], ['company', 'release', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'company', 'utilize', 'substantially', 'remain', 'federal_net_operating_loss', 'result', 'large', 'portion', 'company', 'tax_provision_represent', 'cash', 'tax', 'payable', 'subject', 'continued', 'utilization', 'certain', 'tax', 'credit'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'operation_section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'anticipate_regulatory_filing', 'data', 'availability', 'new', 'approval', 'timing_thereof', 'anticipate', 'future', 'label_expansion', 'expectation', 'development', 'plan', 'anticipate_timeline', 'company', 'medicine', 'drug_candidate', 'pipeline', 'program', 'include', 'study', 'design', 'patient', 'enrollment', 'datum', 'availability_timing_thereof', 'expectation', 'collaboration', 'include', 'anticipate', 'benefit', 'collaboration', 'potential', 'time', 'functional_cure', 'patient', 'tdt_scd', 'expectation', 'regulatory_filing', 'year', 'expectation', 'uptake', 'expand', 'access', 'company', 'medicine', 'include', 'additional', 'reimbursement_agreement', 'expectation', 'continued_growth', 'number', 'patient', 'treat', 'medicine', 'include', 'expansion', 'treatment_option', 'patient', 'benefit_cftr_modulator', 'expectation', 'pain', 'program', 'include', 'expectation', 'available', 'datum', 'bunionectomy', 'abdominoplasty', 'trial', 'first_quarter', 'expectation', 'submission', 'cell', 'device', 'program', 'plan', 'advance', 'more', 'novel_small_molecule', 'zaat', 'corrector', 'clinic', 'expectation', 'anticipate', 'benefit', 'collaboration', 'evaluate', 'therapeutic', 'include', 'plan_submit', 'ind', 'program', 'plan', 'report', 'result', 'phase_study', 'evaluate', 'fourth_quarter', 'potential', 'progression', 'pivotal', 'study', 'broad', 'population', 'people', 'expectation', 'new', 'collaboration', 'arbor', 'expectation', 'datum', 'present', 'american', 'society', 'nephrology', 'annual_meeting', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'company', 'able', 'submit', 'anticipate_regulatory_filing', 'expect', 'timeline_at_all', 'different', 'more', 'significant', 'impact', 'company', 'business_operation', 'company', 'currently', 'expect', 'datum', 'preclinical_testing', 'early', 'clinical_trial', 'especially', 'base', 'limited_number', 'patient', 'indicative_final_result', 'available', 'anticipate_timeline', 'company', 'realize_anticipate_benefit', 'collaboration', 'third_party', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine_timely_manner', 'at_all_safety_efficacy', 'other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['investor'], ['vertex', 'use', 'proprietary', 'ultra', 'small', 'crispr', 'system', 'discover_develop', 'novel', 'vivo_gene_edit', 'therapy'], ['vertex_pharmaceutical_incorporate', 'bioscience', 'biotech', 'company', 'build', 'next_generation', 'crispr', 'product', 'cure', 'detect', 'disease', 'today_announce', 'new', 'partnership', 'develop', 'vivo_gene_edit', 'therapy', 'genetic', 'disease', 'use', 'next_generation', 'crispr', 'system'], ['press_release_feature_view', 'full', 'release', 'here'], ['believe', 'novel', 'ultra', 'small', 'crispr', 'system', 'potential', 'game', 'changer', 'when', 'come', 'systemic', 'target', 'delivery', 'vivo_gene_edit', 'therapy', 'say', 'business', 'officer', 'head', 'therapeutic', 'strategy', 'mammoth', 'bioscience', 'combination', 'unique', 'technology', 'unmatched', 'experience', 'serious_disease', 'research', 'development', 'only', 'accelerate', 'program', 'goal', 'reach', 'patient', 'high_unmet', 'medical', 'need'], ['drive', 'unique', 'protein', 'engine', 'platform', 'consist', 'proprietary', 'toolbox', 'novel', 'ultracompact', 'enzyme', 'include', 'casÉ¸', 'small', 'size', 'mammoth', 'system', 'together', 'further', 'optimize', 'parameter', 'potential', 'facilitate', 'advanced', 'delivery', 'increase', 'scope', 'vivo_gene_edit', 'genetic', 'disease'], ['mammoth', 'share', 'same', 'commitment', 'develop', 'therapy', 'potential', 'transformative', 'people', 'serious_disease', 'say_chief', 'scientific', 'officer', 'pharmaceutical', 'look_forward', 'expand', 'cell', 'genetic', 'therapy', 'capabilitie', 'addition', 'ultra', 'small', 'crispr', 'system', 'vivo', 'genome_editing', 'provide', 'set', 'tool', 'tackle', 'many', 'disease', 'be', 'interested'], ['collaboration'], ['term', 'agreement', 'mammoth', 'bioscience', 'receive_upfront', 'payment', 'include', 'investment', 'form', 'convertible', 'note', 'eligible', 'receive', 'potential', 'future', 'payment', 'base', 'successful_achievement', 'prespecifie', 'research', 'development', 'commercial_milestone', 'potential', 'program', 'addition', 'vertex', 'pay_tiered', 'royalty_future_net', 'sale', 'product', 'result', 'collaboration'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'good', 'place_work', 'lgbtq_equality', 'human_right_campaign', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow'], ['bioscience', 'harness', 'diversity', 'life', 'power', 'next_generation', 'crispr', 'product', 'discovery', 'engineering', 'novel', 'crispr', 'system', 'company', 'enable', 'full', 'potential', 'platform', 'read', 'write', 'code', 'life', 'aim', 'develop', 'permanent', 'genetic', 'cure', 'well', 'class', 'vivo', 'ex', 'vivo', 'therapy', 'democratize', 'disease', 'detection', 'demand', 'diagnostic', 'leverage', 'internal', 'research', 'development', 'exclusive', 'licensing', 'casÉ¸', 'provide', 'enhanced', 'diagnostic', 'genome_editing', 'life', 'agriculture', 'more', 'base', 'bioscience', 'co', 'found', 'firm', 'back', 'top', 'institutional', 'investor', 'include', 'foresite', 'vc', 'along', 'lead', 'individual', 'investor', 'include', 'byer'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'press_release_statement', 'potential', 'benefit', 'result', 'achieve', 'collaboration', 'mammoth', 'statement', 'regard', 'future', 'activity_party', 'pursuant_collaboration', 'statement', 'regard', 'upfront_milestone_payment', 'potential', 'royalty_future_sale', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'anticipate', 'benefit', 'potential', 'collaboration', 'achieve', 'datum', 'support', 'further_development', 'therapy', 'subject', 'collaboration', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'website_wwwvrtxcom_website_place', 'undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['contact', 'investor'], ['mammoth', 'bioscience', 'medium_contact', 'email', 'phone'], ['source', 'bioscience'], ['vertex_pharmaceutical_incorporate', 'report', 'third_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['interim', 'result', 'trikafta', 'ivacaftor', 'ivacaftor', 'study', 'show', 'loss', 'pulmonary', 'function', 'people', 'at_least', 'first', 'cftr_modulator'], ['real_world', 'datum', 'people', 'treat', 'ivacaftor', 'approximately', 'year', 'show', 'low', 'rate', 'mortality', 'lung', 'transplant', 'pulmonary_exacerbation', 'comparator', 'cohort'], ['additional', 'presentation', 'highlight', 'safety_efficacy', 'profile', 'trikafta'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'scientific', 'abstract', 'company', 'portfolio', 'cystic_fibrosis', 'medicine', 'present', 'north', 'take_place', 'virtually'], ['key', 'datum', 'present', 'include', 'interim', 'result', 'ongoing', 'trikafta', 'open_label_extension', 'study', 'people', 'age_year_old', 'minimal_function', 'genotype', 'show', 'favorable', 'safety_profile', 'clinically_meaningful', 'improvement_lung_function', 'respiratory', 'symptom', 'cftr', 'function', 'measure', 'sweat_chloride', 'observe', 'phase', 'pivotal', 'study', 'maintain', 'additional', 'week', 'treatment', 'poster', 'additionally', 'analysis', 'annualize', 'mean', 'rate', 'change', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'show', 'loss', 'pulmonary', 'function', 'week', 'population', 'first', 'cftr_modulator', 'date'], ['also', 'present', 'year', 'conference', 'datum', 'result', 'retrospective', 'study', 'patient', 'gate', 'mutation', 'age_year_old', 'treat', 'show', 'people', 'treat', 'approximately', 'year', 'follow', 'significantly', 'low', 'rate', 'mortality', 'lung', 'transplant', 'pulmonary_exacerbation', 'compare', 'cohort', 'patient', 'eligible', 'receive', 'treatment', 'poster'], ['datum', 'be', 'present', 'year', 'clearly', 'demonstrate', 'portfolio', 'cftr_modulator', 'truly', 'transform', 'landscape', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'long_term', 'follow', 'datum', 'trikafta', 'particular', 'demonstrate', 'unprecedented', 'treatment', 'effect', 'medicine', 'reinforce', 'high', 'bar', 'set', 'safety_efficacy', 'be', 'committed', 'continue', 'serially', 'innovate', 'program', 'reach', 'goal_bring', 'transformative_medicine', 'disease'], ['addition', 'study', 'note', 'other', 'presentation', 'include'], ['people', 'certain', 'type', 'mutation', 'cftr', 'gene', 'cftr_protein', 'cell', 'surface', 'function_properly', 'know_cftr_potentiator', 'ivacaftor', 'oral', 'medicine', 'design_facilitate', 'ability', 'cftr_protein_transport_salt', 'water', 'cell', 'membrane', 'ivacaftor', 'first', 'medicine_treat_underlying', 'cause', 'people', 'specific', 'mutation', 'cftr', 'gene'], ['indication_important_safety', 'information', 'ivacaftor'], ['ivacaftor', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_month', 'old_at_least', 'mutation', 'gene_responsive', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know_safe', 'effective_child', 'month', 'age'], ['patient', 'take', 'kalydeco', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medication', 'such_phenobarbital_carbamazepine_phenytoin'], ['take', 'patient', 'tell_doctor', 'liver', 'kidney_problem', 'drink', 'grapefruit', 'juice', 'eat', 'grapefruit', 'pregnant_plan_become_pregnant', 'know', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'pass_breast_milk'], ['affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'work_therefore', 'dose', 'need', 'adjust_when_take_certain', 'medication', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medication', 'such_voriconazole', 'fluconazole_antibiotic', 'such'], ['cause_dizziness', 'people', 'take', 'patient', 'drive_car', 'use', 'machinery', 'need', 'alert', 'know', 'how', 'affect'], ['patient', 'avoid_food', 'contain_grapefruit', 'take'], ['cause', 'serious_side_effect'], ['high_liver', 'enzyme_blood', 'report', 'patient', 'receive', 'patient', 'doctor_blood_test_check', 'liver_start', 'month', 'first', 'year', 'take', 'kalydeco', 'year', 'take', 'patient', 'have', 'high_liver', 'enzyme', 'past', 'doctor_blood_test_check', 'liver', 'more', 'often', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['abnormality_eye_lens_cataract', 'note', 'child_adolescent', 'receive', 'patient', 'doctor_perform_eye_examination', 'prior', 'treatment', 'kalydeco', 'look_cataract'], ['most_common_side_effect', 'include', 'respiratory_tract_infection', 'common_cold', 'include', 'sore_throat', 'nasal', 'sinus', 'congestion', 'runny_nose', 'stomach_abdominal', 'pain', 'diarrhea', 'rash', 'nausea', 'dizziness'], ['possible_side_effect', 'kalydeco', 'click_here_see_full', 'prescribing_information'], ['indication_important_safety', 'information', 'trikafta'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'mutation', 'responsive', 'treatment', 'trikafta', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'trikafta', 'safe_effective_child', 'year', 'age'], ['patient', 'take', 'trikafta', 'take_certain_medicine_herbal', 'supplement_such', 'antibiotic', 'such', 'rifampin_rifabutin', 'seizure', 'medicine_such_phenobarbital', 'carbamazepine_phenytoin'], ['take', 'trikafta', 'patient', 'tell_doctor_medical', 'condition', 'include', 'kidney_problem', 'have_liver', 'problem_pregnant', 'plan', 'become_pregnant', 'know', 'trikafta', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'trikafta', 'pass_breast_milk'], ['trikafta', 'affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'trikafta', 'work_therefore', 'dose', 'trikafta', 'need', 'adjust_when_take_certain', 'medicine', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medicine', 'include', 'posaconazole', 'voriconazole_fluconazole', 'antibiotic', 'include'], ['trikafta', 'cause_dizziness', 'people', 'take', 'patient', 'drive_car', 'operate', 'machinery', 'require', 'alertness', 'know', 'how', 'trikafta', 'affect'], ['patient', 'avoid_food_drink_contain', 'grapefruit', 'take', 'trikafta'], ['trikafta', 'cause', 'serious_side_effect', 'include'], ['liver', 'damage', 'worsening', 'liver', 'function', 'people', 'severe', 'liver', 'disease', 'serious', 'require', 'transplantation', 'liver', 'damage', 'also', 'happen', 'people', 'liver', 'disease'], ['high_liver', 'enzyme_blood', 'common_side', 'effect', 'people', 'treat', 'trikafta', 'serious', 'sign', 'liver', 'injury', 'patient', 'doctor_blood_test_check', 'liver_start', 'trikafta', 'month', 'first', 'year', 'take', 'trikafta', 'year', 'take', 'trikafta', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['abnormality_eye_lens_cataract', 'happen', 'child_adolescent', 'treat', 'trikafta', 'patient', 'child_adolescent', 'doctor_perform_eye_examination', 'treatment', 'trikafta', 'look_cataract'], ['most_common_side_effect', 'include', 'tract_infection', 'common_cold', 'include', 'stuffy_runny', 'nose_stomach', 'abdominal_pain', 'diarrhea', 'rash', 'increase', 'liver_enzyme', 'increase', 'certain', 'blood', 'enzyme', 'call', 'creatine', 'phosphokinase', 'inflame', 'sinus', 'increase', 'blood', 'bilirubin'], ['possible_side_effect', 'trikafta', 'click_here_see_full', 'prescribing_information', 'trikafta'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'potential', 'benefit', 'safety_efficacy', 'trikafta', 'plan', 'present', 'datum', 'portfolio', 'medicine', 'include', 'datum', 'trikafa', 'open_label_extension', 'study', 'retrospective', 'study', 'patient', 'treat', 'additional', 'scientific', 'presentation', 'regard', 'trikafta', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support', 'registration', 'approval', 'further_development', 'compound_safety_efficacy', 'other_reason', 'risk', 'relate', 'approval', 'medicine', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['first', 'patient', 'dose', 'demonstrate', 'restoration', 'insulin_production', 'achieve', 'peptide', 'pmol', 'response', 'mixed', 'meal', 'tolerance', 'test', 'day', 'visit'], ['decrease', 'daily', 'insulin', 'requirement', 'simultaneous', 'robust', 'improvement', 'glucose', 'control', 'measure'], ['treatment', 'generally_well_tolerate'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'positive', 'day', 'datum', 'first', 'patient', 'phase', 'clinical_trial', 'investigational', 'stem', 'cell', 'derive_fully_differentiate_pancreatic', 'islet', 'cell', 'replacement', 'therapy', 'people', 'type_diabetes', 'first', 'demonstration', 'patient', 'achieve', 'robust', 'restoration', 'islet', 'cell', 'function', 'cell', 'therapy'], ['patient', 'treat', 'single', 'infusion', 'target', 'dose', 'conjunction', 'therapy', 'patient', 'achieve', 'successful', 'engraftment', 'demonstrate', 'rapid', 'robust', 'improvement', 'multiple', 'measure', 'include', 'increase', 'fast', 'stimulate_peptide', 'improvement', 'glycemic_control', 'include', 'decrease', 'exogenous_insulin', 'requirement', 'generally_well_tolerate'], ['result', 'first', 'patient', 'treat', 'unprecedented', 'make', 'result', 'truly', 'remarkable', 'achieve', 'treatment', 'target', 'dose', 'say_executive_vice', 'president_chief', 'cell', 'genetic', 'therapy', 'still', 'early', 'result', 'support', 'continued', 'progression', 'clinical', 'study', 'as_well', 'future', 'study', 'use', 'encapsulate', 'islet', 'cell', 'hold', 'potential', 'use', 'need'], ['surgeon', 'work', 'field', 'islet', 'cell', 'transplantation', 'decade', 'approach', 'obviate', 'need', 'organ', 'donor', 'game', 'changer', 'say', 'professor', 'surgery', 'chief', 'division', 'transplant', 'surgery', 'excited', 'progress', 'unique', 'potentially_transformative', 'medicine', 'clinical_trial', 'patient'], ['more', 'decade', 'lab', 'vision', 'develop', 'islet', 'cell', 'replacement', 'therapy', 'provide', 'functional_cure', 'people', 'suffer', 'say', 'professor', 'investigator', 'promising', 'result', 'bring', 'great', 'hope', 'stem', 'cell', 'derive_fully', 'differentiate', 'islet', 'cell', 'deliver', 'life', 'change', 'therapy', 'people', 'suffer', 'relentless', 'life', 'long', 'burden'], ['patient', 'diagnose', 'approximately', 'year', 'ago', 'dependent', 'exogenous_insulin', 'year', 'prior', 'treatment', 'patient', 'experience', 'severe', 'potentially', 'life_threaten', 'hypoglycemic', 'episode', 'prior', 'treatment', 'patient', 'insulin', 'unit', 'day', 'fasting', 'stimulate_peptide', 'level', 'undetectable', 'indicate', 'patient', 'make', 'own', 'insulin', 'study', 'protocol', 'patient', 'receive', 'target', 'dose', 'hepatic_portal_vein', 'infusion', 'combination', 'standard', 'regimen', 'agent'], ['fast', 'peptide', 'hba', 'average_daily', 'insulin', 'dose', 'measure', 'various', 'interval', 'treatment', 'day', 'fast', 'peptide', 'detect', 'early', 'treatment', 'increase', 'rapidly', 'day', 'parallel', 'daily', 'insulin', 'decrease', 'time'], ['islet', 'cell', 'function', 'evaluate', 'baseline', 'day', 'use', 'mixed', 'meal', 'tolerance', 'test', 'quantification', 'peptide', 'level', 'direct', 'marker', 'insulin_production', 'baseline', 'prior', 'treatment', 'fast', 'stimulate_peptide', 'level', 'undetectable', 'indicate', 'endogenous', 'insulin_production', 'day', 'treatment', 'fast', 'peptide', 'pmol', 'reflect', 'restore', 'basal', 'insulin_production', 'increase', 'mmtt', 'stimulation', 'peak', 'pmol', 'indicate', 'restore', 'glucose_responsive_insulin_production', 'also', 'day', 'hba', 'improve', 'baseline', 'daily', 'insulin', 'decrease', 'unit', 'day', 'prior', 'treatment', 'average', 'dose', 'unit', 'day', 'period', 'day', 'visit', 'reflect', 'decrease', 'daily', 'exogenous_insulin', 'use'], ['baseline', 'day', 'measure', 'islet', 'cell', 'function', 'patient'], ['before'], ['infusion'], ['day'], ['fast', 'peptide'], ['first', 'patient', 'safety', 'generally_consistent', 'regiman', 'use', 'study', 'serious_adverse_event', 'sae_consider_related', 'majority_adverse', 'event', 'consider_mild_moderate', 'most_common', 'adverse_event', 'severe', 'hypoglycemic', 'event', 'non', 'serious', 'relate', 'occur', 'perioperative', 'period', 'day', 'patient', 'sae', 'rash', 'mild', 'severity', 'relate', 'resolve'], ['base', 'datum', 'vertex', 'plan', 'continue', 'progress', 'phase', 'program', 'multiple', 'active', 'site', 'clinical_trial', 'application', 'approve', 'also', 'progress', 'ind_enable', 'study', 'encapsulated', 'islet', 'cell', 'program', 'potentially', 'eliminate', 'requirement', 'plan', 'file', 'ind', 'program'], ['investigational_allogeneic', 'stem', 'cell', 'derive_fully_differentiate_insulin', 'produce_islet', 'cell', 'therapy', 'manufacture', 'use', 'proprietary', 'technology', 'evaluate', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'potential', 'restore_body_ability_regulate', 'glucose_level_restore_pancreatic', 'islet', 'cell', 'function', 'include', 'glucose_responsive_insulin_production', 'deliver', 'infusion', 'hepatic_portal_vein', 'require', 'chronic', 'therapy', 'protect_islet', 'cell', 'immune_rejection'], ['clinical_trial', 'phase', 'multi_center', 'single_arm_open_label', 'study', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'study', 'design', 'sequential_multi', 'part', 'clinical_trial', 'evaluate', 'safety_efficacy', 'first', 'patient', 'treat', 'target', 'dose', 'follow', 'escalation', 'target', 'dose', 'subsequent', 'patient', 'approximately', 'patient', 'enrol', 'clinical_trial', 'enrollment', 'ongoing', 'study'], ['limitation', 'complexity', 'insulin', 'delivery', 'system', 'difficult', 'achieve', 'maintain', 'balance', 'glucose', 'control', 'patient', 'hypoglycemia', 'often', 'result', 'difficulty', 'balance', 'different', 'factor', 'impact', 'glucose_level', 'include', 'insulin', 'diet', 'exercise', 'hypoglycemia', 'remain', 'critical', 'limit', 'factor', 'glycemic', 'management', 'severe_hypoglycemia', 'cause', 'loss', 'consciousness', 'seizure', 'injury', 'fatal', 'time', 'patient', 'develop', 'impair', 'awareness', 'hypoglycemia', 'meaning', 'no', 'long', 'able', 'perceive', 'early', 'sign', 'hypoglycemic', 'event', 'dangerous', 'result', 'life_threaten', 'event'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'press_release_ii', 'plan', 'expectation', 'potential', 'benefit', 'plan', 'continue', 'progress', 'phase', 'program', 'ind_enable', 'study', 'encapsulate', 'islet', 'cell', 'program', 'include', 'anticipate_regulatory_filing', 'plan', 'dosing', 'enrollment', 'patient', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'data', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'research', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news_home'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'virtual', 'th', 'annual', 'global', 'healthcare', 'conference', 'th', 'am'], ['audio', 'portion', 'management', 'remark', 'available', 'live', 'website_wwwvrtxcom_investor_section', 'news', 'event_page', 'replay', 'conference', 'webcast_archive', 'company', 'website'], ['source_version'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'publication', 'result', 'phase_study', 'trikafta', 'ivacaftor', 'ivacaftor', 'people_cystic_fibrosis', 'age_year_old_copy', 'mutation', 'gating_residual', 'function_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'manuscript', 'include', 'datum', 'primary', 'key_secondary_endpoint', 'previously', 'report', 'show_statistically', 'significant_clinically', 'meaningful_improvement', 'lung_function', 'sweat_chloride', 'when', 'compare', 'active', 'control', 'ivacaftor', 'tezacaftor_ivacaftor', 'as_well', 'more', 'detailed', 'efficacy_safety', 'datum', 'include', 'subgroup', 'efficacy', 'analysis'], ['study', 'third', 'phase', 'clinical_trial', 'trikafta', 'program', 'year_old', 'age', 'group', 'consistent', 'prior', 'outcome', 'result', 'show', 'clinically_meaningful', 'improvement', 'pulmonary', 'function', 'sweat_chloride', 'cystic_revise', 'respiratory_domain_score', 'say_vice_president_chief', 'medical_officer', 'vertex', 'result', 'especially', 'notable', 'give', 'patient', 'treat', 'cftr_modulator', 'prior', 'initiate', 'trikafta'], ['outcome', 'study', 'particular', 'subgroup', 'efficacy', 'analysis', 'remarkable', 'demonstrate', 'additional', 'benefit', 'top', 'standard_care', 'build', 'further', 'confidence', 'clinician', 'treat', 'people', 'mutation', 'say'], ['study'], ['datum', 'publish', 'today', 'global', 'phase_randomize_double', 'blind', 'parallel', 'group', 'study', 'patient', 'run', 'period', 'ivacaftor', 'tezacaftor_ivacaftor', 'follow', 'run', 'patient', 'randomize_receive', 'trikafta', 'remain', 'prior', 'regiman', 'ivacaftor', 'tezacaftor_ivacaftor', 'week', 'baseline', 'measure', 'end', 'run', 'period', 'prior', 'start', 'treatment', 'period', 'trikafta', 'improve', 'percent_predict', 'force_expiratory_volume_second', 'ppfev_percentage_point_baseline', 'percentage_point', 'active', 'control', 'improved', 'sweat_chloride', 'concentration', 'liter', 'baseline', 'liter', 'active', 'control', 'change', 'respiratory_domain_score', 'point_baseline', 'point', 'active', 'control', 'subgroup', 'analysis', 'patient', 'rf', 'genotype', 'also', 'include', 'manuscript', 'safety', 'datum', 'consistent_observe', 'previous_phase', 'study', 'trikafta'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect', 'more', 'people', 'globally_cf_progressive_multi', 'system', 'disease', 'affect_lung_liver_tract', 'sinus_sweat_gland_pancrea', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['indication_important_safety', 'information', 'trikafta', 'ivacaftor', 'ivacaftor', 'tablet'], ['trikafta'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'mutation', 'responsive', 'treatment', 'trikafta', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'trikafta', 'safe_effective_child', 'year', 'age'], ['take', 'trikafta', 'patient', 'tell_doctor_medical', 'condition', 'include', 'kidney_problem', 'have_liver', 'problem_pregnant', 'plan', 'become_pregnant', 'know', 'trikafta', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'trikafta', 'pass_breast_milk'], ['trikafta', 'affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'trikafta', 'work_therefore', 'dose', 'trikafta', 'need', 'adjust_when_take_certain', 'medicine', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medicine', 'such_voriconazole', 'fluconazole_antibiotic', 'include'], ['high_liver', 'enzyme_blood', 'common_side', 'effect', 'people', 'treat', 'trikafta', 'serious', 'sign', 'liver', 'injury', 'patient', 'doctor_blood_test_check', 'liver_start', 'trikafta', 'month', 'first', 'year', 'take', 'trikafta', 'year', 'take', 'trikafta', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['possible_side_effect', 'trikafta', 'click', 'product', 'link', 'see_full', 'prescribing_information', 'trikafta'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'potential', 'benefit', 'trikafta', 'anticipate', 'effort', 'expand', 'indication', 'trikafta', 'globally', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program', 'include', 'program', 'collaborator_support_registration', 'further_development', 'compound_safety_efficacy', 'other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['vertex', 'use', 'gene_edit', 'technology', 'enhance', 'effort', 'develop', 'novel', 'cell', 'therapy', 'treatment', 'serious_disease'], ['pharmaceutical_incorporate', 'arbor', 'biotechnology', 'today_announce', 'new', 'collaboration', 'enhance', 'effort', 'develop', 'ex', 'vivo', 'engineer', 'cell', 'therapy', 'use', 'proprietary', 'gene_edit', 'technology', 'select', 'disease'], ['new', 'agreement', 'build', 'company', 'first', 'partnership', 'establish', 'new', 'partnership', 'vertex', 'receive', 'right', 'use', 'technology', 'research', 'develop', 'vivo', 'engineer', 'cell', 'therapy', 'goal', 'generate', 'fully_differentiate', 'insulin_produce', 'hypoimmune', 'islet', 'cell', 'treatment', 'type_diabetes', 'next_generation', 'approach', 'sickle', 'cell', 'disease_beta_thalassemia', 'treatment', 'other', 'disease'], ['new', 'collaboration', 'further', 'expand', 'toolkit', 'cell', 'genetic', 'therapy', 'specifically', 'work', 'discover_develop', 'cell', 'therapy', 'treatment', 'multiple', 'serious_disease', 'say_executive_vice', 'president_chief', 'cell', 'genetic', 'therapy', 'vertex', 'excited', 'bring', 'technology', 'together', 'ongoing', 'program', 'capability', 'diabetes', 'other', 'disease', 'create', 'improved', 'cell', 'replacement', 'therapy', 'broad', 'population', 'patient'], ['arbor', 'vertex', 'share', 'common', 'goal', 'improve', 'life', 'people', 'life_threaten', 'disease', 'discovery', 'development', 'innovative', 'therapy', 'vertex', 'prove', 'ideal', 'partner', 'effort', 'say', 'agreement', 'demonstrate', 'versatility', 'strength', 'platform', 'reinforce', 'strategic', 'vision', 'expand', 'engineer', 'cell', 'therapy', 'capability', 'partnership', 'lead', 'organization', 'industry', 'focus', 'internal', 'portfolio', 'effort', 'genetic', 'medicine'], ['term', 'agreement', 'arbor', 'receive_upfront', 'cash', 'payment', 'eligible', 'receive', 'potential', 'payment', 'base', 'successful_achievement_specify', 'research', 'development', 'regulatory', 'commercial_milestone', 'potential', 'program', 'addition', 'vertex', 'pay_tiered', 'royalty_future_net', 'sale', 'product', 'result', 'collaboration', 'vertex', 'also', 'make', 'investment', 'arbor', 'form', 'convertible', 'note'], ['biotechnology', 'early_stage', 'life_science', 'company', 'discover_develop', 'next_generation', 'genetic', 'medicine', 'co', 'found', 'use', 'proprietary', 'discovery', 'engine', 'discover', 'unique', 'wholly_own', 'base', 'genetic', 'modifier', 'differentiated', 'genetic', 'editing', 'capability', 'portfolio', 'gene', 'editor', 'custom', 'tailor', 'address_underlie', 'pathology', 'genetic', 'disease', 'pipeline', 'genetic', 'medicine', 'focus', 'bring', 'curative', 'therapy', 'patient', 'genetic', 'disease', 'follow', 'strategic', 'partnership', 'vertex_pharmaceutical', 'accelerate', 'path', 'clinic', 'arbor', 'recently', 'announce', 'agreement', 'lonza', 'partnership', 'further', 'validate', 'breadth', 'application', 'gene_edit', 'platform', 'more', 'information', 'technology', 'innovation_visit'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'press_release_statement', 'potential', 'benefit', 'result', 'achieve', 'collaboration', 'arbor', 'statement', 'regard', 'future', 'activity_party', 'pursuant_collaboration', 'statement', 'regard', 'upfront_milestone_payment', 'potential', 'royalty_future_sale', 'investment', 'arbor', 'form', 'convertible', 'note', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'anticipate', 'benefit', 'potential', 'collaboration', 'arbor', 'achieve', 'datum', 'support', 'further_development', 'therapy', 'subject', 'collaboration', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'quarterly_report_file_available', 'website_wwwvrtxcom_website_place', 'undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['contact'], ['investor_medium'], ['contact'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'arbuckle', 'appoint', 'company', 'executive_vice_president_chief', 'operating', 'officer', 'effective', 'immediately', 'serve', 'executive_vice_president_chief', 'commercial', 'officer', 'expand', 'role', 'include', 'oversight', 'operation', 'early', 'year'], ['exciting', 'time', 'vertex', 'continue', 'expand', 'access', 'cystic_fibrosis', 'portfolio', 'world', 'prepare', 'bring', 'forward', 'new', 'therapy', 'potential', 'transform', 'treatment', 'multiple', 'serious_disease', 'say_chief_executive_officer', 'president', 'build', 'world', 'class', 'commercial', 'team', 'international', 'lead', 'effort', 'secure', 'reimbursement', 'medicine', 'world', 'also', 'play', 'key', 'role', 'evolve', 'operating', 'model', 'ready', 'continued', 'expansion', 'new', 'disease', 'geographic', 'area', 'new', 'role', 'stuart', 'ensure', 'best', 'position', 'maximize', 'potential', 'innovative', 'therapy', 'secure_access', 'patient', 'drive', 'continue', 'growth', 'vertex'], ['global', 'commercial', 'team', 'responsible', 'company', 'reimbursement', 'access', 'sale', 'marketing', 'patient', 'support', 'market', 'research', 'as_well', 'commercial', 'manufacturing', 'supply_chain', 'other', 'activity', 'support', 'approve', 'use', 'market', 'medicine', 'also', 'oversee', 'human', 'resource', 'corporate_communication', 'function'], ['more', 'year', 'experience', 'lead', 'global', 'sale', 'marketing', 'effort', 'company', 'include', 'currently', 'serve', 'member', 'rhythm', 'pharmaceutical', 'board_director', 'member', 'cancer', 'support', 'community', 'biotechnology', 'innovation', 'also', 'co', 'chair', 'access', 'value'], ['earn', 'degree', 'pharmacology', 'physiology', 'leed'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'cell', 'genetic', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate_forward_look', 'statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'risk_list_heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['product_revenue', 'increase_compare'], ['company', 'raise', 'full_year', 'guidance', 'product_revenue'], ['phase_study', 'next_class', 'triple_combination', 'begin', 'second_half', 'multiple', 'additional', 'clinical', 'milestone', 'pipeline', 'expect', 'next', 'month'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'second_quarter_end', 'raise', 'full_year', 'guidance', 'product_revenue'], ['second_quarter', 'see', 'continue', 'significant', 'growth', 'strong', 'business', 'performance', 'cystic_fibrosis', 'franchise', 'now', 'secure', 'reimbursement_agreement', 'triple_combination', 'more', 'country', 'start', 'expansion', 'young', 'age', 'group', 'approval', 'patient', 'year', 'age', 'last', 'month', 'advancement', 'poise', 'reach', 'more', 'patient', 'previously', 'forecast', 'therefore', 'raise', 'revenue_guidance', 'look_forward', 'continue', 'see', 'significant', 'growth', 'ahead', 'more', 'patient', 'benefit', 'triple_combination', 'yet', 'treat', 'say_chief_executive_officer', 'president'], ['also', 'make', 'important', 'progress', 'pipeline', 'program', 'first_half', 'year', 'pipeline', 'program', 'advance', 'quickly', 'program', 'mid_late', 'stage', 'clinical_trial', 'continue', 'see', 'impressive', 'clinical', 'result', 'most', 'advanced', 'program', 'now', 'dose', 'more', 'patient', 'pre', 'commercial', 'effort', 'program', 'underway', 'prepare', 'serve', 'patient', 'sickle', 'cell', 'disease_beta_thalassemia', 'address', 'significant', 'market', 'opportunity', 'look_forward', 'multiple', 'milestone', 'datum', 'readout', 'come', 'month', 'say'], ['second_quarter_financial', 'highlight'], ['combined_non_gaap', 'expense', 'increase_compare', 'second_quarter', 'primarily', 'expansion_pipeline', 'other', 'disease', 'area', 'incremental_investment_support', 'global', 'launch', 'medicine'], ['gaap', 'income_taxis', 'reflect', 'increase', 'benefit', 'compare', 'second_quarter', 'primarily', 'income_tax', 'impact', 'payment', 'partially_offset', 'decrease', 'discrete', 'tax', 'benefit', 'refer', 'note', 'further', 'detail'], ['non_gaap_income_taxis', 'increase_compare', 'second_quarter', 'primarily_due', 'increase', 'operating_income'], ['today', 'increase', 'full_year', 'product_revenue', 'guidance', 'base', 'strong', 'year', 'date', 'performance', 'expect', 'impact', 'recent', 'reimbursement_agreement', 'guidance_summarize', 'below'], [], ['combine_gaap_expense'], ['combined_non_gaap', 'expense'], ['anticipate', 'number', 'patient', 'treat', 'medicine', 'continue', 'grow', 'enter', 'additional', 'reimbursement_agreement', 'achieve', 'new', 'approval', 'treatment', 'young', 'patient', 'expand', 'treatment_option', 'approximately', 'percent', 'patient', 'benefit_cftr_modulator', 'lead', 'continued_growth', 'business', 'year', 'ahead'], ['approve', 'expansion', 'indication', 'trikafta', 'ivacaftor', 'ivacaftor', 'include', 'child', 'age_year', 'grant_marketing_authorization', 'trikafta', 'people', 'age_year_old_at', 'least_mutation', 'now', 'approve', 'reimburse', 'accessible', 'more', 'country', 'include'], ['continue', 'progress', 'broad', 'pipeline', 'potentially_transformative', 'small_molecule', 'cell', 'genetic', 'therapy', 'aim', 'serious_disease', 'recent', 'anticipated', 'progress', 'key', 'pipeline', 'program', 'note', 'below'], ['phase', 'program', 'consist', 'trial', 'evaluate', 'safety_efficacy', 'new', 'combination', 'relative', 'trikafta', 'total', 'patient', 'study', 'measure', 'regulatory', 'enable', 'endpoint', 'absolute_change', 'ppfev', 'measure', 'lung_function', 'analyze', 'non', 'inferiority', 'trikafta', 'study', 'also', 'assess', 'absolute_change', 'baseline', 'ppfev', 'sweat_chloride', 'superiority', 'trikafta'], ['beta_thalassemia_sickle', 'cell', 'disease'], ['apol_mediated', 'kidney_disease'], ['pain'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'revenue_expense', 'relate_collaborative', 'milestone', 'upfront_payment', 'include', 'upfront_payment', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'increase_decrease_fair', 'value_contingent_consideration', 'acquisition_relate_cost', 'other', 'adjustment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe_certain_discrete', 'item', 'result', 'view_substitute', 'company', 'gaap', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'company', 'believe_helpful', 'understanding', 'ongoing', 'business', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'calculation', 'non_gaap_financial_measure', 'likely_differ', 'calculation', 'use', 'other', 'company', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['pharmaceutical_incorporate', 'second_quarter', 'result', 'consolidated', 'statement', 'operation', 'thousand_share_amount_unaudited'], ['month_end'], ['research', 'development', 'expense', 'include', 'company', 'upfront_payment', 'month_end'], ['month_end_tax_adjustment', 'include', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment', 'company', 'pre_tax_income', 'loss', 'non_recur', 'discrete_benefit', 'company', 'provision_income', 'taxis_estimate', 'income_taxis', 'relate_non_gaap', 'adjustment', 'company', 'pre_tax_income', 'loss', 'include', 'adjustment', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'change_fair_value', 'company', 'strategic_investment', 'collaborative_upfront_milestone_payment', 'other', 'adjustment', 'also', 'include', 'tax_adjustment', 'discrete_benefit_relate', 'increase', 'corporate', 'tax_rate', 'month_end', 'discrete_benefit_relate', 'transfer', 'intellectual_property', 'right', 'company', 'month_end', 'discrete_benefit', 'first_quarter', 'relate', 'write', 'off', 'long_term', 'intercompany', 'receivable', 'include', 'month_end'], ['difference', 'company', 'full_year', 'combine_gaap_expense', 'combine', 'non_gaap', 'expense', 'guidance', 'relate', 'primarily', 'collaborative_upfront_milestone_payment', 'relate', 'exist', 'collaboration', 'agreement', 'stock_base_compensation_expense', 'guidance_regard', 'combine_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity'], ['other', 'income', 'expense', 'net', 'include', 'gain_loss_relate', 'change_fair_value', 'company', 'strategic_investment', 'sale', 'certain', 'investment'], ['month_end', 'change_fair_value_contingent', 'consideration_relate', 'potential', 'payment_exonic', 'therapeutic', 'former_equity_holder'], ['collaborative_revenue_expense', 'month_end', 'relate_collaborative', 'upfront_milestone_payment', 'include', 'company', 'upfront_payment', 'month_end'], ['acquisition_relate_cost', 'month_end', 'relate_cost', 'associate', 'company', 'acquisition_exonic', 'therapeutic'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'operation_section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'anticipate_regulatory_filing', 'data', 'availability', 'new', 'approval', 'timing_thereof', 'anticipate', 'future', 'label_expansion', 'expectation', 'development', 'plan', 'anticipate_timeline', 'company', 'medicine', 'drug_candidate', 'pipeline', 'program', 'include', 'study', 'design', 'clinical', 'site', 'activation', 'patient', 'enrollment', 'datum', 'availability_timing_thereof', 'expectation', 'collaboration', 'crispr', 'include', 'expectation_regard', 'achievement', 'target', 'enrollment', 'clinical', 'study', 'anticipate', 'benefit', 'collaboration', 'potential', 'time', 'functional_cure', 'patient', 'tdt_scd', 'possibility', 'regulatory_filing', 'next', 'month', 'expectation', 'uptake', 'expand', 'access', 'company', 'medicine', 'include', 'additional', 'reimbursement_agreement', 'expectation', 'continued_growth', 'number', 'patient', 'treat', 'medicine', 'include', 'belief', 'reach', 'more', 'patient', 'previously', 'forecast', 'expectation', 'pain', 'program', 'include', 'creation', 'new_class', 'non', 'opioid', 'medicine', 'potential', 'provide', 'superior', 'relief', 'acute_pain', 'plan', 'commence', 'abdominoplasty', 'study', 'come', 'week', 'expectation', 'available', 'datum', 'trial', 'expectation', 'pipeline', 'program', 'include', 'plan', 'initiate', 'phase_study', 'next_class', 'once_daily', 'triple_combination', 'potential', 'new', 'triple_combination', 'provide', 'enhanced', 'benefit', 'people', 'expectation', 'availability', 'initial', 'datum', 'study', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'different', 'more', 'significant', 'impact', 'company', 'business_operation', 'company', 'currently', 'expect', 'datum', 'preclinical_testing', 'early', 'clinical_trial', 'especially', 'base', 'limited_number', 'patient', 'indicative_final_result', 'available', 'anticipate_timeline', 'company', 'realize_anticipate_benefit', 'collaboration', 'third_party', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine_timely_manner', 'at_all_safety_efficacy', 'other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['company', 'host_conference_call_webcast', 'today', 'pm_access_call_dial', 'international', 'conference_call_webcast', 'live_link', 'webcast', 'access', 'website_wwwvrtxcom_investor_section', 'event', 'presentation_ensure_timely', 'connection_recommend_user_register', 'least_minute_prior_schedule', 'webcast_archive_webcast', 'available', 'company', 'website'], ['source_version_news'], ['contact', 'investor_medium'], ['phase_study', 'meet_primary_endpoint', 'secondary_endpoint'], ['phase', 'datum', 'demonstrate', 'once_daily', 'triple_combination', 'potential', 'enhanced', 'clinical', 'benefit', 'compare', 'trikafta', 'ivacaftor', 'ivacaftor'], ['initiation', 'phase', 'program', 'expect', 'second_half'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'company', 'initiate', 'phase', 'development', 'program', 'new', 'once_daily', 'investigational', 'triple_combination', 'deutivacaftor', 'second_half', 'combination', 'first', 'identify', 'have', 'potential', 'increase', 'efficacy', 'base', 'ability', 'drive', 'high_level', 'chloride', 'transport', 'compare', 'trikafta', 'ivacaftor', 'ivacaftor', 'human', 'bronchial', 'epithelial', 'cell', 'combination', 'evaluate', 'phase_study', 'people_cystic_fibrosis', 'age_old', 'mutation_minimal', 'function_mutation', 'people', 'age_old', 'del_mutation', 'generally_well_tolerate', 'study', 'meet_primary', 'efficacy_endpoint', 'absolute_change', 'baseline', 'secondary', 'efficacy_endpoint', 'include', 'absolute_change', 'baseline', 'sweat_chloride', 'concentration', 'patient', 'population', 'take', 'together', 'datum', 'suggest', 'triple_combination', 'hold', 'potential', 'restore', 'cystic_fibrosis_regulator_cftr', 'function', 'people', 'even', 'high_level', 'see', 'other', 'vertex', 'cftr_modulator', 'thereby', 'provide', 'enhance', 'clinical', 'benefit'], ['demonstrate', 'high_level', 'efficacy', 'people', 'at_least_mutation', 'however', 'remain', 'committed', 'continue', 'effort', 'maximize', 'benefit', 'convenience', 'deliver', 'patient', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'once_daily', 'next_class', 'triple_combination_regimen', 'goal', 'develop', 'more', 'effective', 'treatment', 'regiman', 'potential', 'restore', 'cftr', 'function', 'people', 'even', 'high_level', 'currently', 'achievable'], ['phase_study', 'result'], ['result', 'phase_study', 'adult', 'del', 'minimal_function_mutation', 'result', 'show', 'mean_absolute_group', 'change_baseline', 'day'], [], ['primary_efficacy', 'analysis', 'mean_absolute_group', 'change_baseline', 'day', 'dose', 'group'], ['also', 'evaluate', 'dose_range', 'monotherapy', 'study', 'complete', 'datum', 'phase', 'clinical', 'study', 'phase', 'monotherapy', 'study', 'present', 'later', 'date'], ['phase', 'program'], ['phase', 'program', 'consist', 'randomize_double_blind', 'active', 'control', 'trial', 'evaluate', 'safety_efficacy', 'mg', 'tezacaftor', 'mg', 'comparison', 'trikafta', 'ivacaftor', 'ivacaftor', 'first', 'study', 'enroll', 'approximately', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation', 'second', 'study', 'enroll', 'approximately', 'people', 'age_year_old', 'del_mutation', 'mutation', 'second', 'mutation', 'responsive', 'cftr_modulator', 'primary_endpoint', 'study', 'absolute_change', 'baseline', 'analyze', 'non', 'inferiority', 'trikafta', 'study', 'also', 'assess', 'absolute_change', 'baseline', 'ppfev', 'sweat_chloride', 'superiority', 'trikafta'], [], ['people', 'certain', 'type', 'mutation', 'cftr', 'gene', 'cftr_protein', 'process', 'can', 'move', 'cell', 'normally', 'result', 'little', 'protein', 'cell', 'surface', 'tezacaftor', 'design_increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'cftr_protein', 'deutivacaftor', 'investigational', 'potentiator', 'design_keep', 'cftr_protein', 'cell', 'surface_open', 'long', 'improve', 'flow_salt_water', 'cell', 'membrane_help_hydrate_clear', 'mucus', 'program', 'grant_fast', 'track_orphan', 'drug', 'designation', 'administration', 'treatment_cystic_fibrosis'], ['patient', 'take', 'trikafta', 'take_certain_medicine_herbal', 'supplement_such', 'antibiotic', 'such', 'rifampin_rifabutin', 'seizure', 'medicine_such_phenobarbital', 'carbamazepine_phenytoin'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'expectation', 'plan', 'phase', 'development', 'program', 'new', 'once_daily', 'triple_combination', 'include', 'timing', 'program', 'initiation', 'patient', 'enrollment', 'expectation', 'benefit', 'potential', 'new', 'triple_combination', 'include', 'belief', 'enhanced', 'clinical', 'benefit', 'compare', 'trikafta', 'expectation', 'datum', 'phase_study', 'present', 'later', 'date', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'phase', 'development', 'program', 'evaluate', 'new', 'triple_combination', 'initiate', 'complete', 'anticipated', 'timeline_at_all', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'filing', 'file_available_company', 'website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['proof_concept_study', 'acute_pain_follow_bunionectomy', 'surgery', 'open', 'enrollment'], ['second', 'phase_study', 'acute_pain', 'follow', 'abdominoplasty_surgery', 'begin', 'come', 'week'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'begin', 'phase_proof_concept', 'poc', 'study', 'acute_pain_follow_bunionectomy', 'surgery', 'selective_inhibitor', 'expect', 'commence', 'second', 'phase_study', 'acute_pain', 'follow', 'abdominoplasty_surgery', 'come', 'week'], ['base', 'favorable', 'phase', 'datum', 'advance', 'program', 'phase', 'initiation', 'dose_range', 'poc', 'study', 'patient', 'acute_pain', 'bunionectomy_surgery', 'follow', 'quickly', 'second', 'study', 'patient', 'undergo', 'abdominoplasty_surgery', 'expect', 'see', 'result', 'bunionectomy', 'study', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'genetically', 'validate', 'target', 'excited', 'potential', 'new_class', 'effective', 'pain', 'treatment', 'limitation', 'current', 'therapy', 'include', 'addictive', 'potential', 'opioid'], ['phase_study', 'randomize_double_blind_placebo', 'control', 'trial', 'evaluate', 'multiple', 'dose', 'patient', 'acute_pain_follow_bunionectomy', 'surgery', 'abdominoplasty_surgery', 'study', 'also', 'include', 'hydrocodone', 'bitartrate', 'reference_arm', 'primary_endpoint', 'study', 'time_weight_sum', 'pain_intensity', 'difference', 'first', 'hour', 'treatment', 'spid'], ['oral', 'selective_inhibitor', 'complete', 'phase_study', 'healthy', 'volunteer', 'base', 'favorable', 'pharmacokinetic', 'safety_tolerability', 'profile', 'advance', 'phase_study'], ['voltage', 'gate', 'sodium', 'channel', 'play', 'critical', 'role', 'pain', 'signal', 'peripheral', 'nervous_system', 'genetically', 'validate', 'novel', 'target', 'treatment', 'pain', 'vertex', 'previously', 'demonstrate', 'clinical_proof_concept', 'small_molecule', 'investigational', 'treatment', 'target', 'nav', 'multiple', 'pain', 'indication', 'include', 'acute_pain', 'neuropathic_pain', 'musculoskeletal', 'pain'], ['approach', 'selectively', 'inhibit', 'use', 'small_molecule', 'objective', 'create_new_class', 'medicine', 'potential', 'provide', 'superior', 'relief', 'acute_pain', 'limitation_opioid', 'include', 'addictive', 'potential', 'most_recent', 'molecule', 'enter', 'clinical', 'development', 'portfolio', 'inhibitor'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'press_release_statement', 'regard', 'plan', 'begin', 'phase_study', 'evaluate', 'acute_pain', 'follow', 'abdominoplasty_surgery', 'potential', 'benefit', 'treatment', 'acute_pain', 'plan', 'expectation', 'anticipate_timeline', 'phase', 'clinical', 'study', 'include', 'expectation', 'available', 'datum', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'either', 'study', 'complete', 'expect', 'timeframe', 'at_all_datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'filing', 'file_available_company', 'website_wwwvrtxcom', 'place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['vertex_pharmaceutical_incorporate', 'report_second_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['source_version'], ['reimbursement_agreement', 'more', 'patient', 'now', 'access_cftr_modulator', 'therapy', 'first', 'time'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'national_reimbursement', 'agreement', 'french', 'health_authority', 'cystic_fibrosis', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'ivacaftor', 'combination', 'ivacaftor', 'medicine', 'available', 'eligible', 'patient', 'agreement', 'publish', 'french', 'official', 'journal'], ['today_announcement', 'represent', 'major', 'milestone', 'patient', 'national_reimbursement', 'agreement', 'eligible', 'patient', 'year_old', 'now', 'access', 'live', 'delighted', 'reach', 'agreement', 'so', 'quickly', 'french', 'health_authority', 'recognize', 'value', 'medicine', 'say_fenaux_senior_vice'], ['reimbursement_agreement', 'enable', 'broad', 'access', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation', 'triple_combination_therapy', 'also', 'reimburse', 'patient', 'homozygous', 'mutation', 'cftr', 'gene', 'represent', 'new', 'therapeutic', 'option', 'treat', 'physician', 'health', 'grant', 'asmr', 'rating', 'indicate', 'significant_improvement', 'medical', 'service', 'render', 'first', 'time', 'list', 'medicine', 'issue', 'tc', 'only', 'receive', 'rating'], ['term', 'new', 'reimbursement_agreement', 'reimburse', 'people', 'age_year_old', 'mutation', 'mutation', 'result', 'residual', 'activity', 'cftr_protein', 'list', 'summary_product_characteristic', 'smpc', 'also', 'fund', 'patient', 'homozygous', 'mutation', 'cftr', 'gene'], ['ivacaftor_elexacaftor', 'combination', 'ivacaftor'], ['ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'develop', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'tezacaftor_elexacaftor', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'late', 'approve', 'license', 'indication', 'ivacaftor', 'tezacaftor_elexacaftor', 'support', 'positive', 'result', 'global', 'phase_study', 'people', 'age_year_old', 'phase_study', 'study', 'people_mutation_minimal', 'function_mutation', 'week', 'phase_study', 'study', 'people_del', 'mutation', 'phase_study', 'study', 'people', 'heterozygous', 'cftr', 'mutation', 'cftr', 'gating_mutation', 'residual_function_mutation', 'rf'], ['ivacaftor', 'combination', 'ivacaftor'], ['mutation', 'result', 'cftr_protein_process_fold', 'normally', 'cell', 'generally_reach', 'cell', 'surface', 'tezacaftor', 'design', 'address_trafficking_processing_defect', 'cftr_protein', 'enable', 'reach', 'cell', 'surface', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface'], ['complete', 'product', 'information', 'include', 'dose', 'guidance', 'see', 'summary_product_characteristic', 'find', 'wwwemaeuropaeu'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'good', 'place_work', 'lgbtq_equality', 'human_right_campaign'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'ludovic', 'fenaux_senior_vice', 'press_release_statement', 'regard', 'reimbursement', 'availability', 'access', 'certain', 'patient', 'estimate', 'number', 'patient', 'eligible', 'cftr_modulator', 'therapy', 'belief', 'regard', 'benefit', 'medicine', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'filing', 'file_available_company', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news_home'], ['medium'], ['reimbursement_agreement', 'also', 'include', 'certain', 'future', 'indication', 'extension', 'vertex', 'medicine'], ['approximately', 'patient', 'now', 'access_cftr_modulator', 'first', 'time'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'reach', 'new', 'portfolio', 'agreement', 'italian', 'medicine', 'agency', 'reimbursement', 'approve', 'medicine', 'treatment_cystic_fibrosis', 'include', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor'], ['italian', 'patient', 'age_year_old', 'mutation_minimal', 'function_mutation', 'del_mutation_cystic_fibrosis', 'regulator_cftr_gene', 'now', 'access', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'additionally', 'term', 'agreement', 'eligible', 'patient', 'age_year_old_copy', 'mutation', 'cftr', 'gene', 'now', 'access_orkambi_lumacaftor', 'ivacaftor', 'eligible', 'patient', 'age_year_old_copy', 'copy_mutation_responsive', 'residual_function_mutation', 'cftr', 'gene', 'broad', 'access', 'ivacaftor', 'combination', 'ivacaftor', 'agreement', 'also', 'expand', 'access', 'ivacaftor', 'eligible', 'patient', 'age_year_old', 'addition', 'agreement', 'cover', 'new', 'approve', 'indication', 'extension', 'submit', 'approve', 'reimbursement', 'term', 'contract'], ['fenaux_senior_vice', 'comment', 'agreement', 'important_milestone', 'cystic_fibrosis', 'patient', 'medicine', 'fundamentally', 'change', 'way', 'treat', 'delighted', 'broad', 'portfolio', 'agreement', 'include', 'access', 'young', 'patient', 'orkambi', 'kalydeco', 'access', 'patient', 'year_old', 'like_thank', 'party', 'involve', 'collaboration', 'commitment', 'engagement', 'quickly', 'reach', 'agreement'], ['first', 'reimburse', 'follow', 'patient', 'year_old', 'vertex', 'medicine', 'reimburse', 'country_world', 'include', 'sweden'], ['lumacaftor_ivacaftor', 'mutation'], ['people', 'copy_mutation', 'cftr_protein', 'process', 'traffic', 'normally', 'cell', 'result', 'little', 'cftr_protein', 'cell', 'surface', 'patient', 'copy_mutation', 'easily', 'identify', 'simple', 'genetic_test'], ['lumacaftor_ivacaftor', 'combination_lumacaftor', 'design_increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'cftr_protein', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface'], ['ivacaftor', 'first', 'medicine_treat_underlying', 'cause', 'people', 'specific', 'mutation', 'cftr', 'gene', 'know_cftr_potentiator', 'ivacaftor', 'oral', 'medicine', 'design_keep', 'cftr_protein', 'cell', 'surface_open', 'long_improve_transport', 'salt_water_cell', 'membrane_help_hydrate_clear', 'mucus_airway'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'ludovic', 'fenaux_senior_vice', 'press_release_statement', 'regard', 'belief', 'eligible', 'patient', 'population', 'access', 'medicine', 'include', 'patient', 'now', 'access_cftr_modulator', 'first', 'time', 'reimbursement', 'coverage', 'future', 'approve', 'indication', 'extension', 'medicine', 'belief', 'regard', 'benefit', 'medicine', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_indicate', 'such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support', 'extended', 'indication', 'medicine', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'filing', 'file_available_company', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['patient', 'now', 'eligible', 'cftr_modulator', 'treat_underlying_cause', 'disease'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant_marketing_authorization', 'trikafta', 'ivacaftor', 'ivacaftor', 'treatment_cystic_fibrosis', 'people', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'most_common', 'cf', 'cause', 'mutation', 'approval', 'first', 'time', 'approximately', 'eligible', 'patient', 'age_year_old_at', 'least_mutation', 'medicine', 'target', 'underlying_cause', 'cf'], ['approval', 'trikafta', 'mark', 'significant', 'milestone', 'canadian', 'family', 'vertex', 'say_chief_executive_officer', 'like_thank', 'people', 'participate', 'clinical_trial', 'dedicated', 'scientist', 'investigator', 'enable', 'innovative', 'medicine', 'approve', 'today', 'commitment', 'milestone', 'possible'], ['see', 'substantial_improvement', 'patient', 'treat', 'trikafta', 'clinical', 'practice', 'include', 'improve', 'lung_function', 'say', 'director', 'be', 'excite', 'more', 'canadian', 'able', 'benefit_cftr_modulator', 'look_forward', 'see', 'impact', 'medicine', 'patient', 'benefit'], ['trikafta'], ['ivacaftor', 'ivacaftor', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'trikafta', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'approval', 'support', 'positive', 'result', 'global', 'phase_study', 'people', 'age_year_old', 'phase_study', 'study', 'people_mutation_minimal', 'function_mutation', 'week', 'phase_study', 'study', 'people_del', 'mutation', 'phase_study', 'study', 'people', 'heterozygous', 'cftr', 'mutation', 'cftr', 'gating_mutation', 'residual_function_mutation', 'rf'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'good', 'place_work', 'lgbtq_equality', 'human_right_campaign', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'expectation', 'eligible', 'patient', 'population', 'access', 'trikafta', 'belief', 'regard', 'benefit', 'medicine', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['beta_thalassemia', 'patient', 'transfusion_independent', 'infusion', 'sickle', 'cell', 'disease', 'patient', 'free_vaso_occlusive_crisis', 'infusion'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'new', 'datum', 'patient', 'follow_up', 'least', 'month', 'range', 'month', 'month', 'treat', 'investigational', 'crispr_cas', 'base', 'gene_edit', 'therapy', 'show', 'consistent', 'sustained', 'response', 'treatment', 'investigate', 'ongoing', 'phase', 'clinical_trial', 'potential', 'time', 'therapy', 'patient', 'suffer', 'transfusion_dependent_beta_thalassemia', 'severe_sickle', 'cell', 'disease', 'total', 'more', 'patient', 'dose', 'study', 'date'], ['press_release_feature_view', 'full', 'release', 'here', 'home'], ['patient', 'include', 'beta', 'beta', 'other', 'severe', 'genotype', 'transfusion', 'free', 'last', 'follow_up', 'patient', 'severe_scd', 'free_vaso_occlusive_crisis', 'infusion', 'last', 'follow', 'patient', 'tdt', 'patient', 'scd', 'now', 'follow_up', 'great', 'year', 'demonstrate', 'stable', 'durable', 'response', 'treatment', 'datum', 'available', 'poster', 'begin', 'partial', 'presentation', 'datum', 'present', 'joint', 'symposium', 'cest', 'summary', 'result', 'phase', 'clinical_trial', 'provide'], ['datum', 'present', 'today', 'patient', 'impressive', 'consistency', 'durability', 'effect', 'result', 'add', 'grow', 'body', 'evidence', 'hold', 'promise', 'time', 'functional_cure', 'sickle', 'cell', 'disease_beta_thalassemia', 'work', 'urgency', 'complete_enrollment', 'look_forward', 'finalize', 'regulatory', 'discussion', 'move', 'filing', 'say_chief_executive_officer', 'president'], ['continue', 'progress', 'momentum', 'validate', 'role', 'gene_edit', 'technology', 'future', 'therapeutic', 'add', 'chief_executive_officer', 'excited', 'result', 'look_forward', 'additional', 'long_term', 'datum', 'move', 'investigational', 'medicine', 'forward', 'large', 'population', 'patient', 'devastating', 'disease'], ['physician', 'care', 'patient', 'suffer', 'beta_thalassemia', 'high', 'sense', 'urgency', 'novel', 'efficacious', 'treatment', 'say', 'professor', 'pediatric', 'director', 'hematology_oncology', 'hospital', 'result', 'suggest', 'potential', 'durable', 'benefit', 'patient', 'transfusion_dependent_beta_thalassemia'], ['thrill', 'work', 'groundbreaking', 'program', 'say_chief', 'cellular', 'therapy', 'transplant', 'division', 'oncology', 'child', 'hospital', 'approach', 'use', 'gene_edit', 'enable', 'patient', 'own', 'cell', 'produce', 'fetal_hemoglobin', 'see', 'result', 'demonstrate', 'potential', 'treatment', 'transform_life', 'many', 'patient', 'exciting', 'time', 'team'], ['climb', 'trial', 'update', 'result', 'patient', 'report', 'patient', 'reach', 'at_least_month', 'follow_up', 'dosing', 'therefore', 'assess', 'initial', 'safety_efficacy', 'patient', 'show', 'similar', 'pattern', 'response', 'rapid', 'sustained', 'increase', 'total_hemoglobin', 'hemoglobin', 'transfusion', 'independence'], ['patient', 'transfusion_independent', 'follow_up', 'range', 'month', 'infusion', 'clinically_meaningful', 'improvement', 'total_hemoglobin_fetal_hemoglobin', 'last', 'visit'], ['datum', 'collect', 'patient', 'at_least_month', 'follow_up', 'patient', 'at_least_month', 'follow_up', 'patient', 'at_least_month', 'follow_up', 'demonstrate_durable', 'effect'], ['safety', 'datum', 'patient', 'generally_consistent', 'autologous', 'stem', 'cell', 'transplant', 'myeloablative_conditioning', 'previously', 'report', 'serious_adverse_event', 'sae_consider_related', 'possibly', 'relate', 'report', 'patient', 'distress', 'syndrome', 'idiopathic', 'pneumonia', 'syndrome', 'sae_occur', 'context', 'resolve', 'majority', 'non', 'serious_adverse_event', 'consider_mild_moderate'], ['presentation', 'datum', 'summarize', 'press_release', 'cover', 'patient', 'dose', 'more', 'month_follow_up', 'datum', 'cut', 'addition', 'datum', 'present', 'tdt', 'patient', 'less_month', 'follow_up', 'therefore', 'include', 'datum', 'cut', 'experience', 'sae', 'sae', 'cerebellar', 'hemorrhage', 'consider_related', 'busulfan_conditioning', 'resolve'], ['enrollment', 'dosing', 'ongoing'], ['trial', 'severe_scd', 'update', 'result', 'patient', 'report', 'patient', 'reach', 'at_least_month', 'follow_up', 'dosing', 'therefore', 'assess', 'initial', 'safety_efficacy', 'patient', 'show', 'similar', 'pattern', 'response', 'rapid', 'sustained', 'increase', 'total_hemoglobin_fetal_hemoglobin', 'as_well', 'elimination'], ['patient', 'remain', 'voc', 'free', 'follow_up', 'range', 'month', 'infusion', 'clinically_meaningful', 'improvement', 'total_hemoglobin_fetal_hemoglobin', 'level', 'last', 'visit'], ['datum', 'collect', 'patient', 'least', 'month_follow_up', 'month_follow_up', 'demonstrate_durable', 'effect'], ['safety', 'datum', 'patient', 'generally_consistent', 'autologous', 'stem', 'cell', 'transplant', 'myeloablative_conditioning', 'sae_consider_related', 'majority', 'non', 'serious_adverse_event', 'consider_mild_moderate'], ['investigational_autologous_gene_edit', 'therapy', 'evaluate', 'patient', 'suffer_severe_scd', 'patient', 'hematopoietic_stem', 'cell', 'edit', 'produce_high', 'level_fetal', 'hemoglobin_red', 'blood', 'cell', 'form_oxygen_carry_hemoglobin', 'naturally_present_birth_then', 'switch_adult', 'form_hemoglobin', 'elevation_hbf_potential_alleviate', 'eliminate', 'transfusion_requirement', 'patient', 'tdt', 'reduce', 'eliminate', 'painful_debilitate_sickle_crisis', 'patient', 'scd', 'early', 'result', 'ongoing', 'trial', 'publish', 'brief', 'report'], ['base', 'progress', 'program', 'date_grant_regenerative', 'medicine', 'advanced', 'therapy', 'rmat', 'fast_track', 'orphan_drug', 'rare_pediatric', 'disease', 'designation_tdt_scd', 'also', 'grant', 'drug', 'designation', 'as_well', 'priority', 'medicine', 'designation_tdt_scd'], ['gene_edit', 'approach', 'investigate', 'evaluate', 'tdt_scd', 'furthest', 'advanced', 'clinical', 'development'], ['ongoing_phase_open', 'label_trial', 'climb_design_assess_safety', 'efficacy_single', 'dose', 'patient', 'age', 'trial', 'enroll', 'patient', 'follow', 'patient', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'follow', 'trial'], ['ongoing_phase_open', 'label_trial', 'climb_design_assess_safety', 'efficacy_single', 'dose', 'patient', 'age', 'severe_scd', 'trial', 'enroll', 'patient', 'follow', 'patient', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'follow', 'trial'], ['long_term', 'open_label', 'trial', 'evaluate', 'safety_efficacy', 'patient', 'receive', 'trial', 'design', 'follow', 'participant', 'year', 'infusion'], ['gene_edit', 'process', 'trial', 'patient', 'enroll', 'trial', 'own', 'hematopoietic_stem', 'progenitor', 'cell', 'collect', 'peripheral', 'blood', 'patient', 'cell', 'edit', 'use', 'crispr', 'technology', 'edit', 'cell', 'then', 'infuse', 'back', 'patient', 'part', 'stem', 'cell', 'transplant', 'process', 'involve', 'other_thing', 'patient', 'treat', 'myeloablative_busulfan', 'conditioning', 'patient', 'undergo', 'stem', 'cell', 'transplant', 'also', 'encounter', 'side_effect', 'range', 'mild', 'severe', 'unrelated', 'administration', 'patient', 'initially', 'monitor', 'determine', 'when', 'edit', 'cell', 'begin', 'produce', 'mature', 'blood', 'cell', 'process', 'know', 'engraftment', 'engraftment', 'patient', 'continue', 'monitor', 'track', 'impact', 'multiple', 'measure', 'disease', 'safety'], ['vertex', 'crispr', 'collaboration', 'enter_strategic', 'research', 'collaboration', 'focus', 'use', 'cas', 'discover_develop', 'potential', 'new', 'treatment', 'aim', 'underlying_genetic', 'cause', 'human', 'disease', 'represent', 'first', 'potential', 'treatment', 'emerge_joint', 'research', 'program', 'recently', 'amend', 'collaboration', 'agreement', 'vertex', 'lead', 'global', 'development', 'manufacturing', 'split', 'program', 'cost', 'profit_worldwide'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'statement', 'regard', 'expectation', 'datum', 'present', 'available', 'poster', 'begin', 'potential', 'benefit', 'potential', 'benefit', 'collaboration', 'gene_edit', 'technology', 'plan', 'expectation', 'clinical_trial', 'include', 'expectation', 'gene_edit', 'process', 'clinical_trial', 'status_clinical_trial', 'product_candidate', 'development', 'collaborator', 'include', 'activity', 'clinical_trial', 'site', 'patient', 'enrollment', 'expectation', 'plan', 'regard', 'regulatory', 'discussion', 'future', 'regulatory_filing', 'expectation_regard', 'future', 'activity_party', 'pursuant', 'amend', 'collaboration', 'agreement', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program', 'include', 'program', 'collaborator_support_registration', 'further_development', 'compound_safety_efficacy', 'other_reason', 'pandemic', 'impact', 'status', 'progress', 'clinical_trial', 'clinical_trial', 'site', 'clinical_trial', 'clinical_trial', 'site', 'collaborator', 'include', 'patient', 'enrollment', 'other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security_amend', 'include', 'statement', 'make', 'press_release', 'as_well', 'statement', 'regard', 'expectation', 'follow', 'safety_efficacy', 'clinical', 'progress', 'various', 'clinical', 'program', 'include', 'include', 'expectation_regard', 'datum', 'present', 'available', 'poster', 'begin', 'partial', 'presentation', 'such', 'datum', 'joint', 'symposium', 'potential', 'expected', 'benefit', 'collaboration', 'vertex', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'exist', 'prospective_investor', 'caution_forward_look', 'statement_inherently_uncertain', 'promise_guarantee', 'place_undue_reliance', 'such', 'statement', 'speak_only_date', 'make', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'initial_preliminary', 'datum', 'clinical_trial', 'initial_datum_limited', 'number', 'patient', 'case_time_indicative', 'final', 'future', 'trial', 'result', 'potential', 'clinical_trial', 'result', 'favorable', 'support_registration', 'further_development', 'potential', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'realize', 'potential', 'benefit', 'collaboration', 'vertex', 'potential', 'impact_due_coronavirus', 'pandemic', 'such', 'timing_progress', 'clinical_trial', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'quarterly_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available', 'website_disclaim', 'obligation_undertaking', 'update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['source_version_home'], ['medium'], ['treatment', 'lead', 'statistically_significant', 'increase', 'baseline', 'plasma', 'functional', 'aat', 'level', 'compare_placebo', 'generally_well_tolerate'], ['result', 'provide', 'proof', 'mechanism', 'magnitude', 'treatment', 'effect', 'observe', 'unlikely', 'translate', 'substantial', 'clinical', 'benefit', 'advance', 'late_stage', 'development'], ['vertex', 'advance', 'additional', 'novel', 'small', 'potential', 'great', 'clinical', 'efficacy', 'clinic'], ['host', 'investor', 'conference_call', 'today', 'pm'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'phase_proof_concept', 'study', 'achieve', 'rapid', 'consistent', 'statistically_significant', 'increase', 'mean', 'functional', 'faat', 'level', 'micromolar', 'baseline', 'people', 'deficiency', 'genotype', 'dose', 'group', 'compare_placebo', 'generally_well_tolerate', 'phase_study', 'datum', 'provide', 'clear', 'evidence', 'oral', 'small_molecule_corrector', 'design', 'promote', 'proper', 'folding', 'mutant', 'aat', 'protein', 'increase', 'plasma', 'level', 'faat', 'patient', 'result', 'provide', 'proof', 'mechanism', 'magnitude', 'treatment', 'effect', 'observe', 'study', 'unlikely', 'translate', 'substantial', 'clinical', 'benefit', 'such', 'vertex', 'advance', 'late_stage', 'development', 'instead', 'advance', 'additional', 'novel_small_molecule', 'corrector', 'potential', 'increased', 'clinical', 'efficacy', 'clinic'], ['press_release_feature_view', 'full', 'release', 'here'], ['figure', 'statistically_significant', 'increase', 'mean', 'functional', 'antigenic', 'aat', 'observe', 'day', 'compare_placebo', 'business', 'wire'], ['first', 'time', 'dose', 'small_molecule_corrector', 'aat', 'protein', 'result', 'significant', 'elevation', 'functional', 'antigenic', 'level', 'aat', 'people', 'encourage', 'clear', 'separation', 'aat', 'level', 'treat', 'group', 'placebo', 'favorable', 'safety_profile', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'base', 'finding', 'remain', 'committed', 'develop', 'transformative', 'treatment', 'work', 'urgency', 'translate', 'learning', 'study', 'optimize', 'next', 'set', 'small_molecule_corrector', 'fully', 'realize', 'potential', 'class', 'molecule', 'hold', 'people', 'live', 'disease'], ['study', 'meet_primary_endpoint', 'dose', 'group', 'demonstrate', 'highly', 'statistically_significant', 'increase', 'plasma', 'faat', 'level', 'baseline', 'compare_placebo', 'day', 'treatment', 'treatment', 'result', 'mean', 'increase', 'micromolar', 'faat', 'level', 'group', 'study', 'compare_placebo', 'dose', 'group', 'show', 'rapid', 'increase', 'faat', 'day', 'sustain', 'day', 'treatment', 'similar', 'statistically_significant', 'increase', 'antigenic', 'aat', 'level', 'observe', 'compare_placebo', 'mean', 'increase', 'micromolar', 'group', 'study', 'plasma', 'faat', 'level', 'return', 'baseline', 'safety', 'follow', 'period', 'follow', 'discontinuation', 'consistent', 'half', 'life', 'native', 'aat', 'protein', 'further', 'confirm', 'biological', 'activity'], ['study', 'generally_well_tolerate', 'patient', 'complete', 'treatment', 'discontinuation', 'due', 'adverse_event', 'serious_adverse_event', 'sae_consider', 'relate', 'study', 'drug', 'majority', 'mild_moderate_severity', 'treatment', 'limit', 'most_common_ae', 'treat', 'patient', 'diarrhea', 'nausea', 'liver', 'function', 'test', 'result', 'similar', 'placebo', 'treat', 'group', 'evidence', 'impact', 'result'], ['result', 'study', 'demonstrate', 'proof', 'mechanism', 'rapid', 'consistent', 'clear', 'effect', 'functional', 'antigenic', 'aat', 'level', 'safety_profile', 'consistent', 'mechanism', 'relate', 'toxicity', 'datum', 'collect', 'anticipate', 'enable', 'optimization', 'small_molecule_corrector', 'approach', 'rapid', 'progression', 'portfolio', 'new', 'molecule', 'potential', 'great', 'clinical', 'efficacy', 'clinic', 'addition', 'learning', 'study', 'expect', 'enable', 'efficiency', 'clinical_trial', 'design', 'enrollment', 'execution', 'future', 'asset'], ['phase_study', 'people'], ['phase_study', 'randomized_double', 'blind_placebo_control', 'study', 'efficacy_safety', 'people', 'people', 'randomize', 'dose', 'group', 'placebo', 'day', 'addition', 'follow', 'period', 'last', 'dose', 'treatment', 'primary', 'outcome', 'measure', 'mean', 'change_baseline', 'plasma', 'faat', 'level', 'day', 'compare_placebo', 'as_well', 'safety_tolerability'], ['deficiency'], ['rare', 'genetic', 'disease', 'characterize', 'protein', 'fold', 'defect', 'lead', 'liver', 'lung', 'cause', 'change', 'serpina', 'gene', 'encode', 'aat', 'protein', 'most_common', 'form', 'occur', 'people', 'pizz', 'genotype', 'change', 'serpina', 'body', 'produce', 'misfolde', 'aat', 'protein', 'get', 'trap', 'liver', 'where', 'most', 'aat', 'make', 'lead', 'low', 'level', 'aat', 'protein', 'blood', 'low', 'blood', 'level', 'aat', 'allow', 'inflammation', 'proceed', 'unchecked', 'damage', 'lung', 'accumulation', 'defective', 'aat', 'liver', 'also', 'lead', 'liver', 'disease', 'currently', 'cure', 'aatd', 'also', 'treatment', 'target', 'underlie', 'protein', 'fold', 'defect', 'cause', 'disease'], ['investor'], ['conference_call_webcast', 'live_link', 'webcast', 'access', 'vertex', 'website_wwwvrtxcom_investor_section', 'access', 'call', 'phone_dial', 'international', 'ensure_timely_connection_recommend', 'user_register_least_minute', 'prior_schedule_webcast_archive', 'webcast', 'available', 'company', 'website', 'approximately', 'day'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'press_release_ii', 'statement', 'regard', 'company', 'plan', 'advance', 'additional', 'novel', 'small', 'clinic', 'statement', 'set', 'caption', 'next_step', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate_forward_look', 'statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'company', 'research', 'program', 'datum', 'company', 'research', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['approval', 'approximately', 'child', 'minimal_function_mutation', 'mutation', 'medicine_treat_underlying', 'cause', 'disease', 'first', 'time'], ['first', 'paragraph', 'third', 'sentence', 'release', 'read', 'additional', 'dosage_strength', 'trikafta', 'tablet', 'now', 'available', 'elexacaftor', 'mg', 'ivacaftor', 'mg', 'instead', 'additional', 'dosage_strength', 'trikafta', 'tablet', 'now', 'available', 'elexacaftor', 'mg', 'mg'], ['update', 'release', 'read'], ['announce', 'approval', 'trikafta', 'ivacaftor', 'ivacaftor', 'child_cystic_fibrosis', 'age', 'certain', 'mutation'], ['pharmaceutical_incorporate', 'today_announce', 'food', 'approve', 'expand', 'use', 'trikafta', 'ivacaftor', 'ivacaftor', 'include', 'child_cystic_fibrosis', 'age_year', 'at_least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'mutation', 'cftr', 'gene_responsive', 'trikafta', 'base', 'datum', 'trikafta', 'previously', 'approve', 'use', 'people_cystic_fibrosis', 'year_old', 'at_least', 'copy_mutation', 'copy_mutation_responsive', 'additional', 'dosage_strength', 'trikafta', 'tablet', 'now', 'available', 'elexacaftor', 'connection', 'approval'], ['today', 'approval', 'critical', 'milestone', 'effort', 'deliver', 'medicine', 'help', 'treat_underlying_cause', 'devastating', 'disease', 'as_early', 'life', 'possible', 'say_chief_executive_officer', 'now', 'reach', 'approximately', 'newly_eligible', 'child', 'continue', 'pursue', 'approval', 'expand', 'indication', 'other', 'country'], ['complete', 'phase_open_label', 'multicenter', 'study', 'enrol', 'child', 'age_year_old', 'cystic_fibrosis', 'copy_mutation', 'copy_mutation', 'minimal_function_mutation', 'evaluate', 'safety', 'pharmacokinetic', 'efficacy', 'trikafta', 'generally_well_tolerate', 'safety', 'datum', 'similar_observe', 'previous', 'study', 'patient', 'age_year_old', 'full', 'datum', 'study', 'recently', 'publish', 'critical_care', 'medicine'], ['clinical', 'experience', 'trikafta', 'patient', 'old', 'past', 'month', 'demonstrate', 'medicine', 'meaningful', 'unprecedented', 'clinical', 'benefit', 'patient', 'look_forward', 'now', 'able', 'treat', 'young', 'patient', 'breakthrough', 'medicine', 'include', 'present', 'major', 'signal', 'say', 'director', 'division', 'head', 'addition', 'bring', 'trikafta', 'young', 'patient', 'population', 'patient', 'previously', 'eligible', 'cftr_modulator', 'now', 'able', 'access', 'treatment', 'target', 'underlying_cause', 'disease'], ['already_approve', 'treatment', 'patient', 'age_year_old', 'certain', 'mutation', 'as_well', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'submit', 'application', 'use', 'trikafta', 'child', 'age_year', 'product', 'regulatory_agency', 'plan', 'file', 'expand', 'use', 'year'], ['more', 'information', 'trikafta', 'patient', 'assistance', 'program', 'find', 'additional', 'eligibility', 'detail', 'visit', 'trikaftacom', 'vertexgpscom'], ['trikafta', 'cause_dizziness', 'people', 'take', 'patient', 'drive_car', 'operate', 'machinery', 'require', 'alertness', 'know', 'how', 'trikafta', 'affect'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'laguna', 'press_release_statement', 'regard', 'expectation', 'number', 'patient', 'newly_eligible', 'trikafta', 'statement', 'regard', 'potential', 'benefit', 'trikafta', 'expectation_regard', 'global', 'regulatory_filing', 'expand', 'use', 'trikafta', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'regulatory_filing', 'approve_timely', 'basis', 'at_all_datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['medium'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'approve', 'expand', 'use', 'trikafta', 'ivacaftor', 'ivacaftor', 'include', 'child_cystic_fibrosis', 'age_year', 'at_least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'mutation', 'cftr', 'gene_responsive', 'trikafta', 'base', 'datum', 'trikafta', 'previously', 'approve', 'use', 'people_cystic_fibrosis', 'year_old', 'at_least', 'copy_mutation', 'copy_mutation_responsive', 'additional', 'dosage_strength', 'trikafta', 'tablet', 'now', 'available', 'elexacaftor', 'mg', 'connection', 'approval'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'securitie', 'virtual', 'health_care', 'conference', 'am'], ['source_version'], ['revenue', 'increase_compare'], ['company', 'advance', 'clinical', 'program', 'additional', 'disease', 'cystic_fibrosis'], ['phase_proof_concept', 'study', 'result', 'expect'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'first_quarter', 'end', 'reiterate_full_year', 'guidance', 'product_revenue'], ['goal', 'eligible', 'patient', 'access', 'benefit_cftr_modulator', 'first_quarter', 'continue', 'make', 'significant', 'progress', 'goal', 'so', 'do', 'again', 'deliver', 'strong', 'revenue', 'earning', 'growth', 'say_chief_executive_officer', 'president', 'also', 'see', 'continue', 'significant', 'progress', 'broad', 'pipeline', 'include', 'advancement', 'phase', 'acute_pain', 'initiation', 'phase', 'clinical_trial', 'type_diabetes', 'completion_enrollment', 'dosing', 'phase_proof_concept', 'study', 'aat', 'corrector', 'recent', 'amendment', 'agreement', 'program', 'further', 'enhance', 'leadership', 'position', 'cell', 'genetic', 'therapy', 'look_forward', 'complete_enrollment', 'ongoing', 'trial', 'sickle', 'cell', 'disease_beta_thalassemia', 'year', 'bring', 'first_class', 'treatment', 'patient', 'devastating', 'disease', 'as_soon', 'possible'], ['first_quarter', 'financial', 'highlight'], ['product_revenue', 'increase_compare', 'first_quarter', 'primarily_drive', 'uptake', 'continue', 'performance', 'trikafta', 'net_product_revenue', 'first_quarter', 'increase', 'increase_compare', 'prior', 'year'], ['gaap_non_gaap', 'net_income', 'increase_compare', 'first_quarter', 'largely_drive', 'strong', 'growth', 'total_product_revenue'], ['cash_cash', 'equivalent_marketable_security', 'increase_compare', 'primarily_drive', 'strong', 'revenue', 'profitability', 'offset', 'repurchase', 'common_stock', 'authorize', 'stock', 'repurchase', 'plan'], ['first_quarter', 'expense'], ['non_gaap', 'effective_tax_rate'], ['combine_gaap_non_gaap', 'expense', 'increase_compare', 'first_quarter', 'primarily', 'expansion_pipeline', 'other', 'disease', 'area', 'incremental_investment_support', 'global', 'launch', 'medicine'], ['gaap', 'income_taxis', 'gaap', 'effective_tax_rate', 'increase_compare', 'first_quarter', 'non_recur', 'discrete', 'tax', 'benefit', 'recognize', 'first_quarter', 'increase', 'operating_income'], ['non_gaap_income_taxis', 'increase_compare', 'first_quarter', 'primarily_due', 'increase', 'operating_income'], ['today', 'reiterate_full_year', 'financial_guidance', 'expectation', 'combine_gaap_expense', 'increase', 'result', 'amend', 'collaboration', 'announce', 'vertex', 'guidance_summarize', 'below'], [], ['cystic'], ['anticipate', 'achieve', 'new', 'approval', 'enter', 'additional', 'reimbursement_agreement', 'current', 'cftr_modulator', 'increase', 'number', 'patient', 'treat', 'medicine', 'continue', 'grow', 'business', 'year', 'ahead'], ['key', 'progress', 'include'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'revenue_expense', 'relate_collaborative', 'milestone', 'upfront_payment', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'increase_decrease_fair', 'value_contingent_consideration', 'acquisition_relate_cost', 'other', 'adjustment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe_certain_discrete', 'item', 'result', 'view_substitute', 'company', 'gaap', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'company', 'believe_helpful', 'understanding', 'ongoing', 'business', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'calculation', 'non_gaap_financial_measure', 'likely_differ', 'calculation', 'use', 'other', 'company', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['first_quarter', 'result'], ['month_end_tax_adjustment', 'primarily_relate', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'include', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'decrease_fair', 'value', 'company', 'strategic_investment', 'collaborative', 'milestone_payment', 'month_end_tax_adjustment', 'also', 'include', 'non_recur', 'discrete_benefit', 'company', 'provision_income', 'taxis_relate', 'write', 'off', 'long_term', 'intercompany', 'receivable', 'company', 'exclude', 'non_gaap_measure'], ['company', 'increase', 'combine_gaap_expense', 'guidance', 'reflect', 'expect', 'effect', 'closing', 'company', 'contemplate', 'transaction', 'announce', 'difference', 'company', 'full_year', 'combine_gaap_expense', 'combine', 'non_gaap', 'expense', 'guidance', 'relate', 'primarily', 'expense', 'relate', 'exist', 'contemplated', 'collaboration', 'agreement', 'stock_base_compensation_expense', 'guidance_regard', 'combine_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity', 'other', 'company', 'contemplate', 'transaction'], ['other', 'expense', 'net', 'include', 'net', 'loss', 'relate_change_fair', 'value', 'company', 'strategic_investment', 'sale', 'certain', 'investment'], ['month_end', 'change_fair_value_contingent', 'consideration_relate', 'potential', 'payment_exonic', 'therapeutic', 'former_equity_holder'], ['collaborative_revenue_expense', 'month_end', 'primarily_relate', 'collaborative', 'milestone_payment'], ['acquisition_relate_cost', 'month_end', 'relate_cost', 'associate', 'company', 'acquisition_exonic', 'therapeutic'], ['company', 'release', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'company', 'utilize', 'substantially', 'remain', 'federal_net_operating_loss', 'result', 'large', 'portion', 'company', 'tax_provision_represent', 'cash', 'tax', 'payable', 'beginning', 'subject', 'continued', 'utilization', 'certain', 'tax', 'credit'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'operation_section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'anticipate_regulatory_filing', 'datum', 'submission', 'approval', 'anticipate', 'future', 'label_expansion', 'expectation', 'development', 'plan', 'anticipate_timeline', 'company', 'medicine', 'drug_candidate', 'pipeline', 'program', 'include', 'clinical', 'site', 'activation', 'patient', 'enrollment', 'data', 'availability', 'expectation', 'collaboration', 'crispr', 'include', 'expectation_regard', 'completion_enrollment', 'clinical', 'study', 'anticipated', 'benefit', 'collaboration', 'expectation', 'uptake', 'expand', 'access', 'company', 'medicine', 'include', 'additional', 'reimbursement_agreement', 'expectation', 'increase', 'number', 'patient', 'treat', 'medicine', 'expectation', 'include', 'plan', 'advance', 'phase_proof_concept', 'study', 'second_half', 'expectation', 'transaction', 'contemplate', 'amend', 'collaboration', 'include', 'satisfaction', 'close', 'condition', 'antitrust', 'clearance', 'anticipate', 'upfront_milestone_payment', 'anticipate', 'future', 'activity_party', 'expect', 'effect', 'expense', 'closing_transaction', 'contemplate', 'amend', 'collaboration', 'anticipate', 'investment', 'internal_external', 'innovation', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'different', 'more', 'significant', 'impact', 'company', 'business_operation', 'company', 'currently', 'expect', 'closing_transaction', 'contemplate', 'amend', 'collaboration', 'crispr', 'occur', 'timely_manner_at_all', 'datum', 'preclinical_testing', 'early', 'clinical_trial', 'especially', 'base', 'limited_number', 'patient', 'indicative_final_result', 'company', 'realize_anticipate_benefit', 'collaboration', 'third_party', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine_timely_manner', 'at_all_safety_efficacy', 'other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['new', 'indication', 'include', 'people', 'age_year_old_copy', 'mutation', 'regardless', 'other', 'mutation', 'type'], ['people', 'residual_function', 'rf', 'mutation', 'now', 'eligible', 'triple_combination_therapy'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant', 'approval', 'label_extension', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'extension', 'indication', 'patient', 'year_old', 'heterozygous', 'cftr', 'mutation', 'residual_function', 'gate', 'mutation', 'eligible', 'triple_combination_therapy', 'first', 'time', 'majority', 'people', 'age_year_old', 'now', 'eligible'], ['indication', 'extension', 'important', 'patient', 'gating_residual', 'function_mutation', 'access', 'first', 'time', 'say_chief_executive_officer', 'president', 'look_forward', 'work', 'health_authority', 'government', 'ensure', 'eligible', 'patient', 'benefit', 'medicine', 'access', 'as_soon', 'possible'], ['where', 'triple_combination_therapy', 'know', 'trikafta', 'ivacaftor', 'ivacaftor', 'already', 'license', 'treatment', 'people', 'age_year_old_at', 'least_copy_mutation', 'cftr', 'gene', 'regardless', 'other', 'mutation', 'type'], ['clinical_trial', 'ivacaftor_elexacaftor', 'ivacaftor', 'show', 'positive', 'significant', 'result', 'people_cystic_fibrosis', 'age_year_old_at', 'least_copy', 'most_common', 'gene', 'mutation', 'late', 'result', 'show', 'clinical', 'benefit', 'individual', 'additional', 'gating_residual', 'function', 'gene', 'mutation', 'welcome', 'news', 'community', 'extend', 'licensed', 'indication', 'therapy', 'base', 'late', 'trial', 'result', 'mean', 'additional', 'patient', 'gain', 'access', 'medication', 'say', 'honorary', 'senior', 'lecturer'], ['result', 'long_term', 'reimbursement_agreement', 'provision', 'access', 'health_care', 'system', 'such', 'eligible', 'patient', 'country', 'access', 'expand', 'indication', 'triple_combination_regiman', 'shortly', 'follow', 'regulatory_approval'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect', 'more', 'people', 'progressive_multi_system', 'disease', 'affect_lung', 'tract_sinus', 'sweat_gland', 'pancrea_reproductive', 'tract_cause', 'defective_miss', 'cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'develop', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'tezacaftor_elexacaftor', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'late', 'approve', 'license', 'indication', 'ivacaftor', 'tezacaftor_elexacaftor', 'support', 'positive', 'result', 'global', 'phase_study', 'people', 'age_year_old', 'phase_study', 'study', 'people_mutation_minimal', 'function_mutation', 'week', 'phase_study', 'study', 'people_del', 'mutation', 'phase_study', 'study', 'people', 'heterozygous', 'cftr', 'mutation', 'cftr', 'gating_mutation', 'residual_function_mutation'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'eligible', 'patient', 'population', 'expectation_regard', 'timing', 'access', 'combination', 'ivacaftor', 'eligible', 'patient', 'age_year_old', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'commercialize', 'combination', 'ivacaftor', 'other_risk_list', 'heading_risk', 'factor_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['vertex', 'datum', 'file', 'global', 'summary_product_characteristic', 'limit', 'available', 'en', 'document', 'product', 'information', 'product', 'last', 'access'], ['source_version'], ['proof_concept_study', 'acute_pain', 'initiate', 'second_half', 'year'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'advance', 'selective_inhibitor', 'phase', 'clinical', 'development', 'clinical_trial', 'patient', 'visceral', 'non', 'visceral', 'type', 'acute_pain', 'decision', 'move', 'phase', 'base', 'supportive', 'phase', 'datum', 'healthy', 'volunteer', 'include', 'safety_tolerability', 'pharmacokinetic', 'study', 'molecule', 'exhibit', 'favorable', 'profile', 'dose', 'considerably', 'low', 'require', 'previous', 'inhibitor'], ['voltage', 'gate', 'sodium', 'channel', 'play', 'critical', 'role', 'pain', 'signal', 'peripheral', 'nervous_system', 'genetically', 'validate', 'novel', 'target', 'treatment', 'pain', 'vertex', 'previously', 'demonstrate', 'clinical_proof_concept', 'small_molecule', 'investigational', 'treatment', 'target', 'nav', 'multiple', 'pain', 'indication', 'include', 'acute_pain', 'neuropathic_pain', 'musculoskeletal', 'pain'], ['approach', 'selectively', 'inhibit', 'use', 'small_molecule', 'objective', 'create_new_class', 'medicine', 'potential', 'provide', 'superior', 'relief', 'acute_pain', 'limitation_opioid', 'include', 'addictive', 'potential', 'most_recent', 'molecule', 'enter', 'clinical', 'development', 'portfolio', 'inhibitor'], ['previously', 'validate', 'potential', 'role', 'inhibitor', 'positive', 'proof_concept', 'result', 'variety', 'pain', 'condition', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'excited', 'potent', 'inhibitor', 'move', 'forward', 'phase_proof_concept', 'trial', 'urgency', 'study', 'key', 'next_step', 'ultimate_goal', 'develop', 'transformative_medicine', 'treatment', 'pain'], ['oral', 'selective_inhibitor', 'complete', 'phase_study', 'base', 'favorable', 'pharmacokinetic', 'safety_tolerability', 'profile', 'advance', 'phase_study', 'second_half'], ['plan', 'phase_study', 'acute_pain'], ['plan', 'phase_study', 'randomize_double_blind_placebo', 'control', 'trial', 'evaluate', 'multiple', 'dose', 'patient', 'acute_pain_follow_bunionectomy', 'surgery', 'abdominoplasty', 'study', 'also', 'include', 'hydrocodone', 'arm', 'primary_endpoint', 'plan', 'study', 'time_weight_sum', 'pain_intensity', 'difference', 'first', 'hour', 'treatment', 'spid'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include_limitation', 'statement', 'press_release_statement', 'regard', 'plan', 'advance', 'phase', 'clinical', 'study', 'second_half', 'potential', 'benefit', 'plan', 'expectation', 'anticipate_timeline', 'clinical_trial', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'pandemic', 'impact', 'status', 'progress', 'clinical_trial', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['multi', 'year', 'strategic', 'research', 'collaboration', 'leverage', 'proprietary', 'cytodrive', 'platform', 'discover', 'controllable', 'genetic', 'therapy', 'treat', 'serious_disease'], ['vertex', 'pay', 'obsidian', 'equity', 'upfront_payment', 'potential', 'research', 'milestone'], ['vertex_pharmaceutical_incorporate', 'obsidian', 'therapeutic', 'announce_today', 'company', 'enter_strategic', 'research', 'collaboration', 'licensing_agreement', 'focus', 'discovery', 'novel', 'therapy', 'regulate', 'gene_edit', 'treatment', 'serious_disease', 'collaboration', 'leverage', 'cytodrive', 'platform', 'technology', 'discover', 'gene_edit', 'medicine', 'therapeutic', 'activity', 'precisely', 'control', 'use', 'small_molecule', 'establish', 'scientific', 'clinical', 'capability', 'small_molecule', 'cell', 'genetic', 'therapy', 'more', 'rapidly', 'bring', 'approach', 'patient'], ['press_release_feature_view', 'full', 'release', 'here'], ['collaboration', 'obsidian', 'build', 'expand', 'leadership', 'small_molecule', 'genetic', 'therapy', 'be', 'excited', 'partner', 'team', 'explore', 'capability', 'technology', 'say', 'executive', 'research', 'chief_scientific', 'officer', 'ability', 'tune', 'gene_edit', 'activity', 'specific', 'level', 'important', 'innovation', 'potential', 'address', 'several', 'serious_disease'], ['be', 'use', 'cytodrive', 'technology', 'pioneer', 'new', 'generation', 'engineer', 'cell', 'gene', 'therapy', 'patient', 'serious_disease', 'say', 'executive_officer', 'obsidian', 'therapeutic', 'partner', 'vertex', 'establish', 'leader', 'forefront', 'genetic', 'therapy', 'further', 'advance', 'technology', 'gene', 'therapy', 'field', 'accelerate', 'development', 'controllable', 'gene_editing', 'therapy', 'patient'], ['term', 'agreement', 'obsidian', 'use', 'cytodrive', 'technology', 'develop', 'novel', 'regulated', 'gene_edit', 'therapy', 'candidate', 'multiple', 'serious_disease', 'obsidian', 'grant', 'vertex', 'exclusive', 'option', 'license', 'worldwide', 'right', 'candidate', 'discover_develop', 'collaboration', 'follow', 'exercise', 'option', 'vertex', 'responsible', 'further', 'preclinical', 'clinical', 'development'], ['pay', 'obsidian', 'upfront_payment', 'research', 'milestone', 'pay', 'research', 'term', 'include', 'equity_investment', 'obsidian', 'obsidian', 'eligible', 'receive', 'potential', 'payment', 'base', 'successful_achievement_specify', 'research', 'development', 'regulatory', 'commercial_milestone', 'potential', 'program', 'addition', 'vertex', 'pay_tiered', 'royalty_future_net', 'sale', 'product', 'result', 'collaboration', 'specific', 'disease', 'subject', 'collaboration', 'disclose'], ['obsidian', 'therapeutic'], ['biotechnology', 'company', 'pioneer', 'engineer', 'cell', 'gene', 'therapy', 'deliver', 'transformative', 'outcome', 'patient', 'intractable', 'disease', 'company', 'expect', 'submit_ind', 'mid', 'lead', 'program', 'novel', 'engineer', 'tumor', 'infiltrate', 'lymphocyte', 'therapy', 'armor', 'regulated', 'membrane', 'bind', 'require', 'patient', 'receive', 'toxic', 'proprietary', 'cytodrive', 'technology', 'provide', 'way', 'control', 'protein_degradation', 'use', 'approve', 'small_molecule', 'permit', 'precise', 'control', 'timing', 'level', 'protein', 'expression', 'headquarter', 'mass', 'more_information_visit'], ['pharmaceutical'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'press_release_statement', 'potential', 'benefit', 'result', 'achieve', 'collaboration', 'include', 'cytodrive', 'platform', 'technology', 'statement', 'regard', 'upfront_milestone_payment', 'potential', 'royalty_future_sale', 'expectation', 'ability', 'rapidly', 'bring', 'therapy', 'patient', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'anticipate', 'benefit', 'potential', 'collaboration', 'achieve', 'anticipated', 'timeline_at_all', 'datum', 'support', 'further_development', 'therapy', 'subject', 'collaboration', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_annual', 'report_file', 'available', 'website_wwwvrtxcom_website_place', 'undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['contact', 'investor'], ['medium'], ['obsidian', 'therapeutic', 'contact'], ['vertex_pharmaceutical_incorporate', 'report', 'first_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['source_version'], ['approve', 'people', 'age_year_old_copy', 'mutation', 'gating_residual', 'function_mutation', 'now', 'eligible', 'triple_combination_therapy'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'committee_medicinal_product', 'human_use_chmp', 'adopt_positive_opinion', 'label_extension', 'ivacaftor_elexacaftor', 'combination', 'ivacaftor', 'tablet', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'most_common', 'cf', 'cause', 'mutation', 'worldwide', 'follow', 'recommendation', 'majority', 'people', 'eligible', 'medicine'], ['positive_opinion', 'base', 'result', 'global', 'phase_study', 'study', 'evaluate', 'triple_combination_therapy', 'patient', 'age_year_old', 'heterozygous', 'cftr', 'mutation', 'cftr', 'gating_mutation', 'residual_function_mutation', 'study', 'conduct', 'vertex', 'complement', 'prior', 'phase', 'trial', 'show', 'positive', 'result', 'ivacaftor', 'tezacaftor_elexacaftor', 'combination', 'ivacaftor', 'people', 'age_year_old', 'del_mutation', 'mutation_minimal', 'function_mutation', 'genotype', 'show_statistically', 'significant_clinically', 'meaningful_improvement', 'primary', 'key_secondary_endpoint', 'include', 'lung_function', 'patient', 'treat', 'ivacaftor', 'tezacaftor_elexacaftor', 'combination', 'ivacaftor'], ['today', 'opinion', 'important', 'step', 'bring', 'medicine', 'patient', 'at_least_mutation', 'include', 'gating_residual', 'function_mutation', 'previously', 'eligible', 'triple_combination_therapy', 'say', 'executive', 'president_chief', 'regulatory', 'quality', 'officer'], ['ivacaftor_elexacaftor', 'combination', 'ivacaftor', 'currently', 'license', 'treatment', 'people', 'age_year_old'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect', 'more', 'people', 'globally_cf_progressive_multi', 'system', 'disease', 'affect_lung_liver_tract', 'sinus_sweat_gland_pancrea', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'develop', 'treatment_cystic_fibrosis', 'patient', 'age_year_old', 'del_mutation', 'mutation_minimal', 'function_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'tezacaftor_elexacaftor', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'current', 'approve', 'license', 'indication', 'ivacaftor', 'tezacaftor_elexacaftor', 'support', 'positive', 'result', 'global', 'phase_study', 'people', 'age_year_old', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'week', 'phase_study_people_del', 'mutation'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'expectation', 'potential', 'benefit', 'combination', 'ivacaftor', 'approval', 'label_extension', 'availability', 'combination', 'ivacaftor', 'eligible', 'patient', 'population', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support', 'label_extension', 'combination', 'ivacaftor', 'approve', 'label_extension', 'other_risk_list', 'heading_risk', 'factor_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['approval', 'approximately', 'people', 'live_cystic_fibrosis', 'newly_eligible', 'cftr_modulator', 'therapy'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'australian', 'therapeutic', 'good', 'approve', 'use', 'trikafta', 'ivacaftor', 'ivacaftor', 'people_cystic_fibrosis', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'most_common', 'cf', 'cause', 'mutation', 'worldwide', 'people', 'live', 'worldwide', 'at_least_mutation'], ['delighted', 'tga', 'approve', 'trikafta', 'eligible', 'people', 'live', 'continue', 'work', 'australian', 'government', 'bring', 'important', 'medicine', 'patient', 'as_quickly_possible', 'say_chief_executive_officer', 'goal', 'develop', 'provide', 'treatment', 'people', 'world', 'today', 'significant', 'milestone', 'journey'], ['affect_approximately', 'people', 'cause_defective', 'miss_cftr_protein', 'result', 'mutation', 'cftr', 'gene'], ['cystic', 'complex', 'progressive', 'devastating', 'disease', 'cause', 'severe', 'damage', 'lung', 'digestive', 'system', 'other', 'organ', 'body', 'condition', 'significantly', 'affect', 'only', 'patient', 'also', 'care', 'people', 'live_cystic_fibrosis', 'spend', 'multiple', 'hour', 'day', 'treatment', 'require', 'daily', 'care', 'family', 'member', 'love', 'say', 'approval', 'new', 'treatment_option', 'people', 'live_cystic_fibrosis', 'always', 'welcome', 'news', 'new', 'treatment', 'patient', 'age_year_old_at', 'least_mutation', 'mean', 'more', 'patient', 'potentially', 'benefit', 'medicine', 'target', 'underlying_cause', 'disease', 'first', 'time'], ['tga', 'approval', 'trikafta', 'base', 'result', 'global', 'phase_study', 'include', 'multiple', 'trial', 'site', 'patient'], ['indicate', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene'], ['complete', 'product', 'information', 'pi', 'find', 'wwwtgagovau'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'good', 'place_work', 'lgbtq_equality', 'human_right_campaign'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'reshma', 'press_release_statement', 'regard', 'expectation', 'eligible', 'patient', 'population', 'include', 'patient', 'previously', 'eligible', 'treatment', 'cftr_modulator', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support', 'license', 'extension', 'trikafta', 'other_risk_list', 'heading_risk', 'factor_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['first', 'investigational', 'stem', 'cell', 'derive', 'therapy', 'utilize', 'fully_differentiate', 'insulin_produce', 'pancreatic_islet', 'cell', 'treatment', 'type_diabetes'], ['first', 'only', 'pancreatic_islet', 'replacement', 'therapy', 'know', 'receive', 'fast_track_designation'], [], ['pharmaceutical_incorporate', 'today_announce', 'food', 'grant_fast', 'track_designation', 'company', 'initiate', 'clinical_trial', 'patient', 'type_diabetes', 'severe_hypoglycemia', 'impair_hypoglycemic', 'awareness'], ['program', 'root', 'groundbreaking', 'work', 'begin', 'lab', 'progress', 'therapeutic', 'accelerate', 'bring', 'clinic', 'team', 'say_executive_vice', 'president_chief', 'cell', 'genetic', 'therapy', 'our', 'only', 'approach', 'produce', 'fully', 'differentiated', 'fully', 'functional', 'insulin', 'secrete', 'pancreatic_islet', 'very_pleased', 'receive', 'fast_track_designation', 'facilitate', 'development', 'expedite', 'review', 'drug', 'treat', 'serious', 'condition', 'fill', 'unmet_medical_need', 'continue', 'work', 'urgency', 'bring', 'innovative', 'therapy', 'patient'], ['remarkable', 'time', 'research', 'effort', 'worldwide', 'investigational', 'treatment', 'enter', 'clinic', 'say', 'ricordi', 'professor', 'surgery', 'director', 'cell', 'transplant', 'center', 'committee', 'chair', 'clinical_trial', 'field', 'experience', 'limited', 'cadaveric', 'islet', 'transplant', 'available', 'where', 'patient', 'experience', 'prolong', 'insulin_independence', 'year', 'provide', 'important', 'proof_concept', 'potential', 'cell', 'therapy', 'transformative', 'patient', 'live'], ['first', 'clinical_trial', 'site', 'system', 'open', 'enrollment', 'additional', 'site', 'activate', 'year', 'learn_more', 'visit'], ['formerly_know', 'investigational_allogeneic', 'human', 'stem', 'cell', 'derive_islet', 'cell', 'therapy', 'evaluate', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'potential', 'restore_body_ability_regulate', 'glucose_level_restore_pancreatic', 'islet', 'cell', 'function', 'include', 'insulin_production'], ['clinical_trial', 'involve', 'infusion', 'fully_differentiate', 'functional', 'islet', 'cell', 'as_well', 'chronic', 'administration', 'concomitant', 'therapy', 'protect_islet', 'cell', 'immune_rejection'], ['clinical_trial', 'phase', 'single_arm_open_label', 'study', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'sequential_multi', 'part', 'clinical_trial', 'evaluate', 'safety_efficacy', 'different', 'dose', 'approximately', 'patient', 'enrol', 'clinical_trial'], ['currently', 'limit', 'treatment_option', 'insulin', 'management'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'ricordi', 'press_release_statement', 'regard', 'development', 'plan', 'expectation', 'pipeline', 'program', 'include', 'phase', 'clinical_trial', 'people', 'statement', 'regard', 'patient', 'enrollment', 'dosing', 'activation', 'new', 'site', 'statement', 'regard', 'potential', 'clinical_trial', 'result', 'anticipate', 'benefit', 'plan', 'provide', 'further', 'update', 'pipeline', 'program', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'approve', 'ind', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'safety_efficacy_other_reason', 'pandemic', 'impact', 'status', 'progress', 'clinical_trial', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_file', 'available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'care', 'conference', 'am'], ['source_version'], ['full_year', 'gaap', 'product_revenue', 'billion'], ['year', 'non_gaap', 'product_revenue', 'increase_compare', 'full_year'], ['provide', 'full_year', 'product_revenue', 'guidance', 'billion'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'full_year_fourth_quarter', 'end', 'provide', 'full_year_financial_guidance'], ['achievement', 'mark', 'significant', 'increase', 'number', 'people', 'treat', 'triple_combination', 'also', 'year', 'mark', 'meaningful', 'pipeline', 'advancement', 'now', 'clinical', 'program', 'disease', 'area', 'span', 'multiple', 'modality', 'include', 'small_molecule', 'deficiency_kidney', 'disease', 'gene_edit', 'sickle', 'cell', 'disease_beta_thalassemia', 'cell', 'therapy', 'type_diabetes', 'say_chief_executive_officer', 'president', 'enter', 'look_forward', 'treat', 'more', 'patient', 'reach', 'important_milestone', 'multiple', 'additional', 'disease', 'fuel', 'growth', 'year', 'many', 'year', 'come'], ['fourth_quarter_full_year', 'financial', 'highlight'], ['combine_gaap_expense', 'similar', 'fourth_quarter'], ['combined_non_gaap', 'expense', 'increase_compare', 'fourth_quarter', 'primarily_incremental', 'investment', 'support', 'global', 'use', 'vertex', 'medicine', 'expansion_pipeline', 'other', 'disease', 'area'], ['gaap_non_gaap', 'income_taxis', 'increase_compare', 'fourth_quarter_primarily', 'due', 'increase', 'operate', 'income', 'refer_supplemental', 'income_tax', 'information', 'section', 'discussion_cash', 'non_cash_component', 'provision_income_taxis'], ['today', 'provide', 'full_year_financial_guidance', 'product_revenue', 'guidance', 'primarily', 'base'], [], ['cystic', 'pipeline'], ['expect', 'increase', 'number', 'patient', 'eligible', 'take', 'medicine', 'thereby', 'continue', 'grow', 'business', 'important', 'progress', 'make', 'increase', 'number', 'eligible', 'patient', 'expand', 'approval', 'access', 'medicine', 'additional', 'geography', 'age', 'group'], ['ivacaftor'], ['tezacaftor_ivacaftor'], ['ivacaftor'], ['pipeline'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'adjustment', 'product_revenue', 'related', 'cost_sale', 'reflect', 'conclusion', 'early', 'access', 'program', 'orkambi', 'fourth_quarter', 'iii', 'revenue_expense', 'relate', 'collaboration', 'agreement', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'increase_decrease_fair', 'value_contingent_consideration', 'acquisition_relate_cost', 'other', 'adjustment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe_certain_discrete', 'item', 'result', 'view_substitute', 'company', 'gaap', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'company', 'believe_helpful', 'understanding', 'ongoing', 'business', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'calculation', 'non_gaap_financial_measure', 'likely_differ', 'calculation', 'use', 'other', 'company', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['company', 'provide', 'guidance_regard_combine', 'expense_effective_tax', 'rate', 'non_gaap_basis', 'guidance_regard', 'combine_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity', 'company', 'provide', 'gaap', 'effective_tax_rate', 'unable', 'forecast', 'reasonable', 'certainty', 'impact', 'excess_tax_benefit', 'relate_stock_base_compensation', 'possibility', 'certain_discrete_item', 'material'], ['supplemental_income', 'tax', 'information'], ['thousand', 'percentage'], ['component_provision', 'income_taxis', 'relate'], ['cash', 'pay', 'accrue', 'income_taxis'], [], [], [], [], ['benefit_income_taxis', 'due', 'discrete', 'tax', 'item'], [], [], ['provision_income_taxis', 'offset', 'net_operating', 'loss_credit'], [], [], [], [], ['gaap', 'provision_income_taxis'], ['adjustment_pre_tax_income'], [], [], ['effective_tax_rate', 'reconciliation'], ['impact', 'gaap_non_gaap', 'adjustment'], [], [], ['orkambi', 'adjustment', 'company', 'reconciliation_gaap_non_gaap', 'net_income', 'month_end', 'include', 'adjustment', 'net_product_revenue', 'cost_sale', 'relate', 'conclusion', 'early', 'access', 'program', 'orkambi', 'fourth_quarter', 'company', 'previously', 'recognize', 'portion', 'net_product_revenue', 'relate', 'orkambi', 'distribute', 'early', 'access', 'program', 'result', 'company', 'recognize', 'adjustment', 'increase', 'net_product_revenue', 'cost_sale', 'relate', 'prior_period', 'shipment', 'orkambi', 'distribute', 'early', 'access', 'program', 'company', 'exclude', 'adjustment', 'net_product_revenue', 'cost_sale', 'non_gaap_measure', 'month_end'], ['month_end_tax_adjustment', 'primarily_relate', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'include', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'increase_decrease_fair', 'value', 'company', 'strategic_investment', 'collaborative', 'payment', 'month_end_tax_adjustment', 'also', 'include', 'non_recur', 'discrete_benefit', 'company', 'provision_income_taxis', 'such', 'transfer', 'intellectual_property', 'right', 'company', 'approximately', 'company', 'exclude', 'non_gaap_measure'], ['difference', 'company', 'full_year', 'combine_gaap_expense', 'combine', 'non_gaap', 'expense', 'guidance', 'relate', 'primarily', 'stock_base_compensation_expense', 'expense', 'relate', 'exist', 'collaboration', 'agreement', 'guidance_regard', 'combine_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity'], ['other', 'income', 'net', 'include', 'gain', 'relate_change_fair', 'value', 'company', 'strategic_investment', 'sale', 'certain', 'investment'], ['month_end', 'increase', 'fair_value_contingent_consideration', 'relate', 'potential', 'payment_exonic', 'therapeutic', 'former_equity_holder'], ['collaborative_revenue_expense', 'month_end', 'primarily_relate_collaborative_upfront', 'milestone_payment'], ['acquisition_relate_cost', 'month_end', 'relate_cost', 'associate', 'company', 'acquisition', 'therapeutic', 'exonic'], ['company', 'record_provision_income_taxis', 'pre_tax_income', 'use', 'effective_tax_rate_approximate', 'statutory_rate', 'company', 'release', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'tax_provision', 'include', 'significant', 'non_cash_charge', 'company', 'ability_offset', 'pre_tax_income', 'previously', 'benefit', 'net_operating', 'loss_credit', 'company', 'federal_net_operating_loss', 'credit', 'available', 'offset', 'future', 'pre_tax_income', 'company', 'utilize', 'substantially', 'remain', 'federal_net_operating_loss', 'result', 'large', 'portion', 'company', 'tax_provision_represent', 'cash', 'expense', 'future', 'period', 'subject', 'continued', 'utilization', 'certain', 'tax', 'credit'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'operation_section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'anticipate_regulatory_filing', 'datum', 'submission', 'anticipate', 'future', 'label_expansion', 'expectation', 'development', 'plan', 'anticipate_timeline', 'company', 'medicine', 'drug_candidate', 'pipeline', 'program', 'include', 'collaboration', 'third_party', 'expectation', 'collaboration', 'crispr', 'include', 'expectation_regard', 'completion_enrollment', 'expectation', 'uptake', 'expand', 'access', 'company', 'medicine', 'include', 'additional', 'reimbursement_agreement', 'anticipate', 'investment', 'internal_external', 'innovation', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'different', 'more', 'significant', 'impact', 'company', 'business_operation', 'company', 'currently', 'expect', 'datum', 'preclinical_testing', 'early', 'clinical_trial', 'especially', 'base', 'limited_number', 'patient', 'indicative_final_result', 'approve_timely', 'basis', 'at_all_datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine_timely_manner', 'at_all_safety_efficacy', 'other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['contact', 'investor'], ['vertex', 'initiate', 'phase', 'clinical_trial', 'first_half'], ['first', 'stem', 'cell', 'derive', 'therapy', 'evaluate', 'fully_differentiate', 'pancreatic_islet', 'cell', 'treatment'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'clear', 'ind_enable', 'company', 'proceed', 'initiate', 'clinical_trial', 'investigational', 'stem', 'cell', 'derive_fully_differentiate_pancreatic', 'islet', 'cell', 'therapy', 'treat', 'vertex', 'plan', 'initiate', 'phase', 'clinical_trial', 'first_half', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia'], ['celebrate', 'th', 'anniversary', 'discovery', 'insulin', 'year', 'excited', 'bring', 'first_class', 'cell', 'therapy', 'clinic', 'potential', 'meaningfully', 'impact', 'people', 'live', 'say_executive_vice', 'president_chief', 'cell', 'genetic', 'therapy', 'vertex', 'look_forward', 'get', 'clinical', 'program', 'underway', 'test', 'unique', 'approach', 'replace', 'pancreatic_islet', 'cell', 'destroy', 'people', 'type_diabetes', 'stem', 'cell', 'derive_fully_differentiate_insulin', 'produce', 'pancreatic_islet', 'cell'], ['formerly_know', 'investigational_allogeneic', 'human', 'stem', 'cell', 'derive_islet', 'cell', 'therapy', 'evaluate', 'patient', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'potential', 'restore_body_ability_regulate', 'glucose_level_restore_pancreatic', 'islet', 'cell', 'function', 'include', 'insulin_production'], ['phase', 'clinical_trial', 'clinical_trial', 'phase', 'single_arm_open_label', 'study', 'subject', 'impair_hypoglycemic_awareness_severe', 'hypoglycemia', 'sequential_multi', 'part', 'clinical_trial', 'evaluate', 'safety_efficacy', 'different', 'dose', 'approximately', 'patient', 'enrol', 'clinical_trial'], ['type_diabetes', 'result', 'autoimmune', 'destruction', 'insulin_produce_islet', 'cell', 'pancrea', 'lead', 'loss', 'insulin_production', 'impairment', 'blood_glucose', 'control', 'absence', 'insulin', 'lead', 'abnormality', 'how', 'body', 'process', 'nutrient', 'lead', 'high', 'blood_glucose', 'level', 'high', 'blood_glucose', 'lead', 'diabetic', 'ketoacidosis', 'time', 'complication', 'such', 'kidney_disease', 'failure', 'eye', 'disease', 'include', 'vision', 'loss', 'heart', 'disease', 'nerve', 'damage', 'even', 'death', 'limitation', 'complexity', 'insulin', 'delivery', 'system', 'difficult', 'achieve', 'maintain', 'balance', 'glucose', 'control', 'patient', 'hypoglycemia', 'remain', 'critical', 'limit', 'factor', 'glycemic', 'management', 'severe_hypoglycemia', 'cause', 'loss', 'consciousness', 'seizure', 'injury', 'fatal'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'development', 'plan', 'expectation', 'pipeline', 'program', 'include', 'plan', 'initiate', 'phase', 'clinical_trial', 'people', 'expect', 'timeline', 'clinical_trial', 'statement', 'regard', 'patient', 'enrollment', 'dose', 'statement', 'regard', 'potential', 'clinical_trial', 'result', 'anticipate', 'benefit', 'plan', 'provide', 'further', 'update', 'pipeline', 'program', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'approve', 'ind', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'safety_efficacy_other_reason', 'pandemic', 'impact', 'status', 'progress', 'clinical_trial', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['grant', 'priority_review', 'application', 'set', 'pdufa_target_action', 'date'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'accept', 'supplemental', 'new', 'drug_application', 'expand', 'use', 'trikafta', 'ivacaftor', 'ivacaftor', 'include', 'child', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'mutation', 'cftr', 'gene_responsive', 'base', 'grant', 'priority_review', 'snda', 'assign', 'prescription', 'drug', 'user', 'pdufa_target_action', 'date', 'submission', 'support', 'datum', 'global', 'phase_study', 'trikafta', 'child', 'age_year_old', 'cystic_fibrosis', 'copy_mutation', 'copy_mutation', 'minimal_function_mutation'], ['approve', 'expand', 'use', 'opportunity', 'treat_underlying_cause', 'disease', 'early', 'life', 'trikafta', 'potentially', 'benefit', 'approximately', 'additional', 'child', 'say_vice_president_chief', 'medical_officer', 'initial', 'approval', 'trikafta', 'continue', 'work', 'tirelessly', 'bring', 'medicine', 'wait', 'as_quickly_possible', 'look_forward', 'work', 'agency', 'review', 'application', 'course', 'coming', 'month'], ['plan_submit', 'marketing_authorization_application', 'variation', 'triple_combination', 'first_half', 'child', 'age', 'global', 'regulatory_filing', 'additional', 'market', 'include', 'plan', 'coming', 'month', 'age', 'group'], ['indication_important_safety', 'information', 'trikafta', 'ivacaftor', 'ivacaftor'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'mutation', 'responsive', 'treatment', 'trikafta', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'trikafta', 'safe_effective_child', 'year', 'age'], ['patient', 'take', 'trikafta', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medication', 'such_phenobarbital_carbamazepine_phenytoin'], ['trikafta', 'affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'trikafta', 'work_therefore', 'dose', 'trikafta', 'need', 'adjust_when_take_certain', 'medication', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medication', 'such_voriconazole', 'fluconazole_antibiotic', 'such'], ['trikafta', 'cause_dizziness', 'people', 'take', 'patient', 'drive_car', 'operate', 'machinery', 'need', 'alert', 'know', 'how', 'trikafta', 'affect'], ['high_liver', 'enzyme_blood', 'common_side', 'effect', 'people', 'treat', 'trikafta', 'patient', 'doctor_blood_test_check', 'liver_start', 'trikafta', 'month', 'first', 'year', 'take', 'trikafta', 'year', 'take', 'trikafta', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['abnormality_eye_lens_cataract', 'child_adolescent', 'treat', 'trikafta', 'patient', 'child_adolescent', 'doctor_perform_eye_examination', 'treatment', 'trikafta', 'look_cataract'], ['most_common_side_effect', 'include', 'tract_infection', 'common_cold', 'include', 'stuffy_runny', 'nose_stomach', 'abdominal_pain', 'inflame', 'sinus', 'increase', 'liver_enzyme', 'increase', 'certain', 'blood', 'enzyme', 'call', 'creatine', 'increase', 'blood', 'bilirubin'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'plan_submit', 'maa', 'other', 'global', 'regulatory_filing', 'additional', 'market', 'expectation_regard', 'number', 'patient', 'newly_eligible', 'trikafta', 'statement', 'regard', 'potential', 'benefit', 'trikafta', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'snda', 'expand', 'use', 'trikafta', 'include', 'child', 'age', 'approve_timely', 'basis', 'at_all_datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news'], ['vertex_pharmaceutical_incorporate', 'report', 'fourth_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'conference', 'am', 'am', 'pt'], ['audio', 'portion', 'management', 'remark', 'access', 'live', 'website_wwwvrtxcom_investor_section', 'news', 'event_page', 'replay', 'conference', 'webcast_archive', 'company', 'website'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'medicine', 'people', 'serious_disease', 'company', 'multiple_approve', 'medicine', 'treat_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'good', 'place_work', 'lgbtq_equality', 'human_right_campaign', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'new', 'drug', 'submission', 'trikafta', 'investigational', 'triple_combination', 'medicine', 'accept', 'priority_review', 'treatment_cystic_fibrosis', 'people', 'age_year_old'], ['pleased', 'submission', 'accept', 'priority_review', 'anticipate', 'accelerated', 'review', 'process', 'enable', 'access', 'patient', 'as_early_possible', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer'], ['priority_review', 'conventional', 'review', 'timeline', 'day', 'reduce', 'day', 'expected', 'approval', 'target', 'first_half'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people', 'worldwide_cf_progressive_multi', 'system', 'disease', 'affect_lung_liver_tract', 'sinus_sweat_gland_pancrea', 'reproductive_tract_cause_defective', 'miss', 'cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr', 'protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_include', 'expectation', 'patient', 'access', 'medicine', 'statement', 'regard', 'anticipate', 'timing', 'expect', 'approval', 'target', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'new', 'drug', 'submission', 'approve', 'expect', 'timeline_at_all', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source'], ['receive', 'exclusive', 'option', 'license', 'number', 'product_candidate', 'direct', 'serious_disease'], ['receive_upfront', 'as_well', 'potential', 'milestone_royalty', 'payment', 'future', 'sale'], ['pharmaceutical_incorporate', 'announce_today', 'strategic', 'research', 'collaboration', 'licensing_agreement', 'aim', 'discovery', 'development', 'novel_small_molecule', 'modulate', 'rna', 'splicing', 'treatment', 'serious_disease'], ['press_release_feature_view', 'full', 'release', 'here', 'home'], ['believe', 'splice', 'site', 'modulation', 'hold', 'significant', 'promise', 'treatment', 'disease', 'today', 'limit', 'therapeutic', 'option', 'say', 'dphil', 'senior_vice_president', 'site', 'research', 'collaboration', 'bring', 'innovative', 'technology', 'together', 'research', 'development', 'experience', 'fit', 'perfectly', 'strategy', 'invest', 'new', 'technology', 'help', 'transform', 'multiple', 'serious_disease'], ['excited', 'enter', 'collaboration', 'vertex', 'global', 'leader', 'create_transformative', 'medicine', 'serial_innovation', 'say', 'executive_officer', 'skyhawk', 'collaboration', 'vertex', 'team', 'look_forward', 'use', 'platform', 'discover_develop', 'novel_small_molecule', 'therapeutic', 'modulate', 'rna', 'splicing', 'potential', 'transform_life', 'patient', 'serious_disease'], ['collaboration', 'agreement', 'vertex', 'pay', 'skyhawk', 'upfront', 'skyhawk', 'grant', 'vertex', 'option', 'exclusively_license', 'worldwide', 'intellectual_property', 'right', 'candidate', 'discover_develop', 'collaboration', 'direct', 'program', 'target', 'follow', 'vertex', 'exercise', 'option', 'vertex', 'responsible', 'further_development', 'skyhawk', 'also', 'eligible', 'receive', 'potential', 'milestone_payment', 'as_well', 'potential', 'royalty_future_sale'], ['therapeutic'], ['skyhawk', 'develop_commercialize', 'therapy', 'use', 'novel', 'platform', 'build', 'small_molecule', 'provide', 'breakthrough', 'treatment', 'patient', 'skyhawk', 'productive', 'collaboration', 'broad_range', 'disease', 'area', 'range', 'disease', 'oncology'], ['more_information_visit', 'company', 'skyhawk', 'therapeutics'], ['skyhawk', 'forward_look_statement'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'press_release_statement', 'potential', 'benefit', 'result', 'achieve', 'collaboration', 'skyhawk', 'statement', 'regard', 'upfront_milestone_payment', 'potential', 'royalty_future_sale', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'anticipate', 'benefit', 'potential', 'collaboration', 'skyhawk', 'achieve', 'datum', 'support', 'further_development', 'therapy', 'subject', 'collaboration', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'quarterly_report_file_available', 'website_wwwvrtxcom_website_place', 'undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['medium'], ['pharmaceutical_incorporate_investor'], ['more', 'people', 'certain', 'rare', 'mutation', 'now', 'eligible', 'trikafta', 'kalydeco'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'expand', 'eligibility', 'ivacaftor', 'ivacaftor', 'include', 'people_cystic_fibrosis', 'age_year_old', 'certain', 'mutation_cystic_fibrosis', 'regulator_cftr_gene', 'responsive', 'trikafta', 'base', 'ivacaftor', 'ivacaftor', 'ivacaftor', 'also', 'receive', 'approval', 'include', 'additional', 'responsive', 'mutation', 'people', 'age_year_old', 'age_month', 'old', 'respectively', 'approval', 'allow', 'more', 'people', 'cf', 'previously', 'eligible', 'medicine', 'opportunity', 'potentially', 'benefit', 'treatment', 'target', 'underlying_cause', 'disease'], ['approval', 'expand', 'use', 'medicine', 'base', 'well', 'establish', 'model', 'testament', 'relentless', 'commitment', 'scientist', 'reach', 'goal', 'develop', 'treatment', 'people', 'say_chief_executive_officer', 'remain', 'commit', 'today', 'reach', 'patient', 'benefit', 'medicine', 'when', 'first', 'start', 'journey', 'year', 'ago', 'important_milestone', 'now', 'enable', 'hundred', 'people', 'access', 'treatment_option', 'address_underlie', 'cause', 'disease', 'many', 'first', 'time'], ['previously', 'approve', 'people', 'at_least_mutation', 'now', 'approve', 'additional', 'mutation', 'symdeko', 'now', 'approve', 'additional', 'mutation', 'total', 'symdeko', 'responsive', 'mutation', 'now', 'approve', 'additional', 'mutation', 'total', 'kalydeco', 'responsive', 'mutation', 'addition', 'certain', 'people', 'currently', 'eligible', 'kalydeco', 'approval', 'allow', 'also', 'eligible', 'symdeko', 'trikafta', 'similarly', 'currently', 'eligible', 'symdeko', 'approval', 'allow', 'also', 'eligible', 'trikafta'], ['full', 'list', 'mutation', 'trikafta', 'find', 'update', 'full_prescribing', 'information', 'respective', 'product', 'addition', 'people', 'family', 'search', 'eligibility', 'medicine'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people', 'worldwide_cf_progressive_multi', 'system', 'disease', 'affect_lung_liver_tract', 'sinus_sweat_gland_pancrea', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['indication_important_safety', 'information', 'ivacaftor', 'symdeko', 'ivacaftor', 'ivacaftor', 'trikafta', 'ivacaftor', 'ivacaftor'], [], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient'], ['age_month', 'old_at_least', 'mutation', 'gene_responsive', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know_safe', 'effective_child', 'month', 'age'], ['symdeko'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_copy', 'mutation', 'at_least_mutation', 'gene_responsive', 'treatment', 'symdeko', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'symdeko', 'safe_effective_child', 'year', 'age'], ['patient', 'take', 'symdeko', 'trikafta', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medication', 'such_phenobarbital_carbamazepine_phenytoin'], ['take', 'trikafta', 'patient', 'tell_doctor_medical', 'condition', 'include', 'kidney_problem', 'have_liver', 'problem_pregnant', 'plan', 'become_pregnant', 'know', 'trikafta', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'trikafta', 'pass_breast_milk', 'take', 'patient', 'tell_doctor', 'drink', 'grapefruit', 'juice', 'eat', 'grapefruit'], ['trikafta', 'affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'trikafta', 'work_therefore', 'dose', 'trikafta', 'need', 'adjust_when_take_certain', 'medication', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medication', 'such_voriconazole', 'fluconazole_antibiotic', 'such'], ['trikafta', 'cause_dizziness', 'people', 'take', 'patient', 'drive_car', 'use', 'machinery', 'need', 'alert', 'know', 'how', 'trikafta', 'affect'], ['patient', 'avoid_food_drink_contain', 'grapefruit', 'take', 'trikafta'], ['cause', 'serious_side_effect', 'such'], ['high_liver', 'enzyme_blood', 'report', 'patient', 'receive', 'trikafta', 'patient', 'doctor_blood_test_check', 'liver_start', 'treatment', 'trikafta', 'month', 'first', 'year', 'treatment', 'year', 'treatment', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['abnormality_eye_lens_cataract', 'child_adolescent', 'treat', 'trikafta', 'patient', 'child_adolescent', 'doctor_perform_eye_examination', 'treatment', 'trikafta', 'look_cataract'], ['most_common_side_effect', 'include', 'sinus', 'congestion', 'dizziness'], ['possible_side_effect', 'trikafta', 'click', 'product', 'link', 'see_full', 'prescribing_information', 'trikafta'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'eligible', 'patient', 'population', 'trikafta', 'kalydeco', 'expectation_regard', 'number', 'patient', 'newly_eligible', 'trikafta', 'kalydeco', 'statement', 'regard', 'potential', 'benefit', 'trikafta', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'website_place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['beta_thalassemia', 'patient', 'transfusion_independent', 'month_follow_up', 'infusion'], ['sickle', 'cell', 'disease', 'patient', 'free_vaso_occlusive_crisis', 'month_follow_up', 'infusion'], ['patient', 'dose', 'program'], ['publish', 'manuscript', 'contain', 'first', 'report', 'investigational', 'use', 'cas', 'base', 'gene_edit', 'treat', 'inherited', 'disease', 'human'], ['pharmaceutical_incorporate', 'today_announce', 'new', 'datum', 'total', 'patient', 'treat', 'investigational', 'crispr_cas', 'base', 'gene_edit', 'therapy', 'show', 'consistent', 'sustained', 'response', 'treatment', 'patient', 'transfusion_dependent_beta_thalassemia', 'include', 'severe', 'genotype', 'transfusion_independent', 'last', 'follow_up', 'patient', 'sickle', 'cell', 'disease', 'free_vaso_occlusive_crisis', 'infusion', 'last', 'follow', 'datum', 'present', 'scientific', 'plenary', 'annual_ash', 'meeting_exposition', 'summary', 'result', 'phase', 'clinical', 'study', 'provide'], ['company', 'also', 'announce', 'publish', 'independently', 'peer', 'review', 'article', 'entitle', 'gene_edit', 'sickle', 'cell', 'disease', 'thalassemia', 'article', 'include', 'detailed', 'information', 'first', 'patient', 'tdt', 'enrol', 'first', 'patient', 'severe_scd', 'enrol', 'month_follow_up', 'respectively'], ['investigate', 'ongoing', 'phase', 'clinical_trial', 'potential', 'time', 'curative', 'therapy', 'patient', 'suffer_severe_scd'], ['pleased', 'datum', 'present', 'ash', 'demonstrate', 'potential', 'benefit', 'durability', 'large', 'population', 'patient', 'transfusion_dependent_beta_thalassemia', 'sickle', 'cell', 'disease', 'say_chief_executive_officer', 'additionally', 'case', 'study', 'first', 'peer', 'review', 'journal', 'publication', 'crispr_cas', 'gene', 'therapy', 'together', 'further', 'validation', 'potential', 'become', 'good', 'class', 'therapy', 'plan', 'continue', 'rapid', 'advancement', 'clinical_trial', 'bring', 'much', 'need', 'therapy', 'patient'], ['first', 'publish', 'result', 'therapy', 'people', 'genetic', 'disease', 'represent', 'important_milestone', 'medicine', 'collaboration', 'most', 'importantly', 'datum', 'represent', 'critical', 'step', 'effort', 'bring', 'transformative', 'potentially', 'curative', 'therapy', 'patient', 'say_chief_executive_officer', 'clinical_proof_concept', 'beta_thalassemia_sickle', 'cell', 'disease', 'patient', 'dose', 'look_forward', 'continue', 'effort', 'bring', 'investigational', 'treatment', 'patient', 'live', 'tdt_scd', 'as_quickly'], ['vision', 'approach', 'use', 'patient', 'own', 'stem', 'cell', 'provide', 'transformative', 'treatment', 'disease', 'almost', 'unimaginable', 'few', 'year', 'ago', 'say', 'director', 'pediatric_hematology_oncology', 'datum', 'patient', 'see', 'potential', 'fulfill', 'vision', 'more', 'datum', 'long', 'duration', 'follow_up', 'hopefully', 'confirm', 'durable', 'therapy', 'transform_life', 'many', 'patient'], ['climb', 'trial', 'update', 'result', 'total', 'patient', 'dose', 'include', 'additional', 'patient', 'last', 'update'], ['patient', 'report', 'ash', 'patient', 'reach', 'at_least_month', 'follow_up', 'dosing', 'therefore', 'assess', 'initial', 'safety_efficacy', 'patient', 'show', 'similar', 'pattern', 'response', 'rapid', 'sustained', 'increase', 'total_hemoglobin', 'hemoglobin', 'transfusion', 'independence', 'last', 'analysis'], ['patient', 'transfusion_independent', 'follow_up', 'range', 'month', 'infusion', 'normal', 'normal', 'total_hemoglobin', 'level', 'last', 'visit', 'include', 'total_hemoglobin_fetal_hemoglobin'], ['datum', 'collect', 'patient', 'month_follow_up', 'patient', 'month_follow_up', 'infusion', 'demonstrate_durable', 'effect'], ['safety', 'datum', 'patient', 'generally_consistent', 'autologous', 'stem', 'cell', 'transplant', 'myeloablative_conditioning', 'serious_adverse_event', 'sae_consider_related', 'possibly', 'relate', 'report', 'patient', 'distress', 'syndrome', 'idiopathic', 'pneumonia', 'syndrome', 'sae_occur', 'context', 'resolve', 'majority', 'non', 'serious_adverse_event', 'consider_mild_moderate'], ['trial', 'severe_scd', 'update', 'result', 'total', 'patient', 'scd', 'dose', 'include', 'additional', 'patient', 'last', 'update'], ['patient', 'report', 'ash', 'patient', 'reach', 'at_least_month', 'follow_up', 'dosing', 'therefore', 'assess', 'initial', 'safety_efficacy', 'patient', 'show', 'similar', 'pattern', 'response', 'rapid', 'sustained', 'increase', 'total_hemoglobin_fetal_hemoglobin', 'as_well', 'elimination', 'last', 'analysis'], ['patient', 'remain', 'voc', 'free', 'follow_up', 'range', 'month', 'infusion', 'hemoglobin_level', 'normal', 'normal', 'range', 'last', 'visit', 'include', 'total_hemoglobin_fetal_hemoglobin', 'level'], ['datum', 'collect', 'patient', 'month_follow_up', 'patient', 'month_follow_up', 'infusion', 'demonstrate_durable', 'effect'], ['safety', 'datum', 'patient', 'generally_consistent', 'autologous', 'stem', 'cell', 'transplant', 'myeloablative_conditioning', 'sae_consider_related', 'majority', 'non', 'serious_adverse_event', 'consider_mild_moderate'], ['investigational_autologous_gene_edit', 'therapy', 'evaluate', 'patient', 'suffer_severe_scd', 'patient', 'hematopoietic_stem', 'cell', 'edit', 'produce_high', 'level_fetal', 'hemoglobin_red', 'blood', 'cell', 'form_oxygen_carry_hemoglobin', 'naturally_present_birth_then', 'switch_adult', 'form_hemoglobin', 'elevation_hbf_potential_alleviate', 'transfusion_requirement', 'patient', 'tdt', 'reduce_painful', 'debilitate_sickle_crisis', 'patient', 'scd'], ['base', 'progress', 'program', 'date_grant_regenerative', 'medicine', 'advanced', 'therapy', 'rmat', 'fast_track', 'orphan_drug', 'rare_pediatric', 'disease', 'designation_tdt_scd', 'also', 'grant', 'drug', 'designation_tdt_scd', 'as_well', 'priority', 'medicine', 'designation', 'scd'], ['develop', 'co', 'development', 'co', 'agreement', 'vertex', 'gene_edit', 'approach', 'investigate', 'evaluate', 'tdt_scd', 'furthest', 'advanced', 'clinical', 'development'], ['crispr', 'vertex', 'collaboration', 'vertex', 'enter_strategic', 'research', 'collaboration', 'focus', 'use', 'cas', 'discover_develop', 'potential', 'new', 'treatment', 'aim', 'underlying_genetic', 'cause', 'human', 'disease', 'represent', 'first', 'potential', 'treatment', 'emerge_joint', 'research', 'program', 'vertex', 'jointly', 'develop_commercialize', 'equally', 'share', 'research', 'development', 'cost', 'profit_worldwide'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security_amend', 'include', 'statement', 'make', 'frangoul', 'press_release', 'as_well', 'statement', 'regard', 'expectation', 'follow', 'safety_efficacy', 'clinical', 'progress', 'various', 'clinical', 'program', 'include', 'status_clinical_trial', 'include_limitation', 'expect', 'timing', 'datum', 'release', 'relate', 'product_candidate', 'development', 'collaborator', 'include', 'expectation_regard', 'datum', 'present', 'press_release', 'annual_ash', 'meeting_exposition', 'article', 'expect', 'benefit', 'collaboration', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'exist', 'prospective_investor', 'caution_forward_look', 'statement_inherently_uncertain', 'promise_guarantee', 'place_undue_reliance', 'such', 'statement', 'speak_only_date', 'make', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'preliminary_datum', 'clinical_trial', 'initial_datum_limited', 'number', 'patient', 'case_time_indicative', 'final', 'future', 'trial', 'result', 'clinical_trial', 'result', 'favorable', 'support_registration', 'further_development', 'potential', 'impact_due_coronavirus', 'pandemic', 'such', 'timing_progress', 'clinical_trial', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'uncertainty', 'regard_intellectual_property', 'protection_technology', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'quarterly_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available', 'website_disclaim', 'obligation_undertaking', 'update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'expectation', 'plan', 'present', 'datum', 'annual_ash', 'meeting_exposition', 'development', 'include', 'expect', 'timeline', 'development', 'update', 'datum', 'patient', 'treat', 'date', 'new', 'datum', 'additional', 'patient', 'potential', 'benefit', 'curative', 'therapy', 'plan', 'expectation', 'clinical_trial', 'clinical_trial', 'site', 'include', 'statement', 'regard', 'patient', 'enrollment', 'status_clinical_trial', 'product_candidate', 'development', 'collaborator', 'include', 'activity', 'clinical_trial', 'site', 'potential', 'outcome', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program', 'include', 'program', 'collaborator_support_registration', 'further_development', 'compound_safety_efficacy', 'other_reason', 'pandemic', 'impact', 'status', 'progress', 'clinical_trial', 'clinical_trial', 'site', 'clinical_trial', 'clinical_trial', 'site', 'collaborator', 'include', 'patient', 'enrollment', 'other_risk_list', 'heading_risk', 'factor_most_recent_annual', 'report_subsequent', 'quarterly_report_file_available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['investor_contact'], ['contact', 'wcg', 'behalf', 'reides', 'wcgworldcom'], [], ['pharmaceutical_incorporate', 'today_announce', 'company', 'host', 'investor', 'webcast', 'am', 'review', 'clinical', 'datum', 'present', 'plenary', 'scientific', 'session', 'annual_ash', 'meeting_exposition', 'ongoing', 'phase', 'clinical_trial', 'investigational', 'crispr_gene_edit', 'therapy', 'patient', 'sickle', 'cell', 'disease_beta_thalassemia', 'presentation', 'include', 'speaker', 'vertex', 'crispr', 'as_well', 'director', 'pediatric_hematology_oncology', 'principal', 'investigator', 'clinical', 'study'], ['conference_call_webcast', 'live_link', 'webcast', 'access', 'therapeutic', 'website', 'webcom', 'event', 'investor_section', 'event', 'presentation', 'vertex', 'website_wwwvrtxcom_investor_section', 'access', 'call', 'phone_dial', 'international', 'ensure_timely_connection_recommend', 'user_register_least_minute', 'prior_schedule_webcast_archive', 'webcast', 'available', 'company', 'website', 'approximately', 'day'], ['meeting', 'official', 'program', 'ash', 'annual_meeting'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security_amend', 'include', 'statement', 'regard', 'expectation', 'plan', 'review', 'datum', 'present', 'annual_ash', 'meeting_exposition', 'ongoing', 'phase', 'clinical_trial', 'patient', 'sickle', 'cell', 'disease_beta_thalassemia', 'as_well', 'anticipate', 'speaker', 'participate', 'investor', 'webcast', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'exist', 'prospective_investor', 'caution_forward_look', 'statement_inherently_uncertain', 'place_undue_reliance', 'such', 'statement', 'speak_only_date', 'make', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'preliminary_datum', 'clinical_trial', 'indicative_final', 'trial', 'result', 'potential', 'clinical_trial', 'result', 'support_registration', 'further_development', 'uncertainty', 'regard_intellectual_property', 'protection_technology', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'quarterly_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available', 'website_disclaim', 'obligation_undertaking', 'update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'regard', 'expectation', 'plan', 'review', 'datum', 'present', 'annual_ash', 'meeting_exposition', 'ongoing', 'phase', 'clinical_trial', 'investigational', 'crispr_gene_edit', 'therapy', 'patient', 'sickle', 'cell', 'disease_beta_thalassemia', 'anticipated', 'speaker', 'participate', 'investor', 'webcast', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'potential', 'datum_limited', 'number', 'patient', 'indicative_final_clinical_trial', 'result', 'datum', 'company', 'development', 'program', 'include', 'program', 'collaborator_support_registration', 'further_development', 'compound_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_most_recent', 'annual_report_subsequent_quarterly', 'report_file', 'available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source'], ['combination', 'therapy', 'new', 'treatment_option', 'patient', 'homozygous'], ['only', 'medicine_treat_underlying', 'cause', 'age', 'group', 'mutation', 'residual_function_mutation'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant', 'approval', 'label_extension', 'ivacaftor', 'ivacaftor', 'include', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_copy', 'mutation_cystic_fibrosis', 'regulator_cftr_gene', 'copy_mutation', 'copy_mutation', 'cftr', 'gene', 'result', 'residual', 'cftr', 'activity'], ['approval', 'child', 'age_year', 'most_common', 'mutation', 'new', 'treatment_option', 'child', 'certain', 'residual_function_mutation', 'first', 'time', 'treatment_option', 'available', 'address_underlie', 'cause', 'cf', 'say_chief_executive_officer', 'president', 'today', 'approval', 'bring', 'close', 'ultimate_goal', 'provide', 'medicine', 'people'], ['ivacaftor', 'ivacaftor', 'immediately', 'available', 'additional', 'eligible', 'patient', 'available', 'shortly', 'country', 'enter', 'innovative', 'long_term', 'reimbursement_agreement', 'vertex', 'include', 'other', 'country', 'vertex', 'work_closely', 'relevant', 'authority', 'secure_access_eligible', 'patient'], ['ivacaftor', 'ivacaftor', 'already_approve', 'treatment', 'people', 'age_year_old_copy', 'mutation', 'cftr', 'gene', 'copy_mutation_copy', 'following', 'mutation', 'cftr', 'gene', 'result', 'residual', 'cftr_protein', 'activity'], ['combination'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'eligible', 'patient', 'population', 'expectation_regard', 'timing', 'access', 'combination', 'kalydeco', 'eligible', 'patient', 'age_year', 'country', 'plan', 'secure_access', 'combination', 'additional', 'eligible', 'patient', 'age_year', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'commercialize', 'symkevi', 'combination', 'other_risk_list', 'risk_factor_most_recent', 'annual_report_subsequent_quarterly', 'report_file', 'available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'notify', 'unsolicited', 'mini_tender', 'offer', 'date', 'make', 'purchase', 'share', 'vertex', 'common_stock', 'unsolicite', 'mini_tender', 'offer', 'price', 'share', 'approximately', 'share', 'closing', 'price', 'common_stock', 'last', 'trading', 'day', 'prior', 'commencement', 'offer'], ['endorse', 'offer', 'recommend', 'vertex', 'shareholder', 'reject', 'offer', 'tender', 'share', 'response', 'unsolicited', 'offer', 'mini_tender', 'offer', 'price', 'market', 'price', 'share', 'common_stock', 'today', 'date', 'subject', 'numerous', 'condition', 'include', 'ability_obtain', 'financing', 'necessary', 'consummate', 'offer', 'vertex', 'affiliate', 'way', 'trc', 'capital', 'offer', 'offer', 'documentation'], ['make', 'many', 'similar', 'mini_tender', 'offer', 'share', 'other', 'company', 'mini_tender', 'offer', 'design', 'seek', 'less', 'percent', 'company', 'outstanding', 'share', 'thereby', 'avoid', 'many', 'disclosure', 'procedural', 'requirement', 'threshold', 'provide', 'such', 'disclosure', 'procedural', 'protection', 'investor'], ['caution', 'investor', 'mini_tender', 'offer', 'investor', 'alert', 'note', 'offer', 'increasingly', 'use', 'catch', 'investor', 'guard', 'many', 'investor', 'hear', 'mini_tender', 'offer', 'surrender', 'security', 'investigate', 'offer', 'assume', 'price', 'offer', 'include', 'premium', 'usually', 'present', 'large', 'traditional', 'tender_offer'], ['read', 'more', 'risk', 'mini_tender', 'offer', 'review', 'alert', 'website', 'investor', 'pub', 'minitendhtm'], ['other', 'offer', 'mini_tender', 'put', 'individual', 'investor', 'risk', 'sell', 'share', 'discount', 'so', 'realize', 'vertex', 'urge', 'shareholder', 'obtain', 'current', 'stock', 'quote', 'share', 'common_stock', 'review', 'term', 'condition', 'offer', 'consult', 'broker', 'financial', 'adviser', 'exercise', 'caution', 'respect', 'mini_tender', 'offer', 'shareholder', 'already', 'tender', 'consider', 'advisability', 'withdraw', 'share', 'permit', 'offer', 'purchase', 'document'], ['shareholder', 'already', 'tender', 'share', 'withdraw', 'time', 'prior', 'expiration', 'offer', 'capital', 'accept', 'shareholder', 'share', 'payment', 'pursuant', 'offer', 'shareholder', 'withdraw', 'time', 'trc', 'capital', 'accept', 'shareholder', 'share', 'payment', 'accordance', 'offering', 'document', 'accord', 'offer', 'document', 'offer', 'currently', 'schedule', 'expire', 'am', 'time'], ['encourage', 'broker', 'dealer', 'as_well', 'other', 'market', 'participant', 'review', 'letter', 'regard', 'broker', 'dealer', 'mini_tender', 'offer', 'dissemination', 'disclosure', 'division', 'minitender', 'sia', 'htm', 'nasd', 'notice', 'member', 'regard', 'guidance', 'member', 'forward', 'mini_tender', 'offer', 'customer', 'find', 'site', 'default', 'file', 'noticedocument'], ['request', 'copy', 'news', 'release', 'include', 'distribution', 'material', 'relate', 'mini_tender', 'offer', 'relate', 'share', 'common_stock'], ['source_version'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'jefferie', 'care', 'conference', 'am', 'pm', 'gmt'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list', 'good', 'place_work', 'lgbtq_equality', 'human_right_campaign', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow', 'vrtx', 'web'], ['source_version'], ['approval', 'provide', 'opportunity', 'treat_underlying_cause', 'cystic_fibrosis', 'early', 'ever', 'before'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant', 'approval', 'label_extension', 'ivacaftor', 'granule', 'include', 'treatment', 'infant', 'cystic_fibrosis_age', 'month_old_weigh', 'least_kg', 'mutation', 'follow', 'gating', 'class', 'iii', 'mutation_cystic_fibrosis', 'regulator_cftr_gene'], ['very', 'first', 'first', 'approve', 'year', 'ago', 'certain', 'patient', 'age_year_old', 'today', 'approval', 'baby', 'young', 'month', 'eligible', 'believe', 'early', 'treatment', 'important', 'manage', 'say_chief_executive_officer', 'today', 'approval', 'testament', 'commitment', 'keep', 'go', 'people', 'treatment_option'], ['label', 'update', 'base', 'datum', 'cohort', 'phase_open_label', 'safety', 'study', 'arrival', 'consist', 'child', 'age_month', 'less_month', 'eligible', 'gating_mutation'], ['ivacaftor', 'now', 'available', 'additional', 'eligible', 'patient', 'available', 'shortly', 'country', 'enter', 'innovative', 'long_term', 'reimbursement_agreement', 'vertex', 'include', 'other', 'country', 'vertex', 'work_closely', 'relevant', 'authority', 'secure_access_eligible', 'patient'], ['ivacaftor', 'already_approve', 'people', 'age_month', 'old_weigh_least_kg', 'follow', 'mutation', 'cftr', 'gene'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'eligible', 'patient', 'population', 'expectation_regard', 'timing', 'access', 'eligible', 'patient', 'month', 'age_old', 'country', 'plan', 'secure_access', 'additional', 'eligible', 'patient', 'month', 'age_old', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'commercialize', 'other_risk_list', 'risk_factor_most_recent', 'annual_report_subsequent_quarterly', 'report_file', 'available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['pharmaceutical_incorporate', 'today_announce', 'datum', 'patient', 'ongoing', 'phase', 'clinical_trial', 'investigational', 'crispr_gene_edit', 'therapy', 'severe', 'accept', 'oral_presentation', 'plenary', 'scientific', 'session', 'annual_ash', 'meeting_exposition', 'take_place', 'virtually', 'director', 'pediatric_hematology_oncology', 'medical', 'deliver', 'presentation', 'behalf', 'author'], ['abstract', 'post', 'online', 'today', 'include', 'datum', 'patient', 'month', 'month_follow_up', 'infusion', 'ongoing', 'phase', 'trial', 'transfusion_dependent_beta_thalassemia', 'datum', 'patient', 'month', 'month_follow_up', 'ongoing', 'phase', 'trial', 'severe_sickle', 'cell', 'disease', 'additional', 'datum', 'present', 'ash', 'include', 'long', 'duration', 'follow', 'datum', 'patient', 'include', 'abstract', 'datum', 'additional', 'patient', 'great', 'month_follow_up'], ['investigate', 'ongoing', 'clinical_trial', 'potential', 'time', 'curative', 'therapy', 'patient', 'suffer_severe_scd'], ['accept', 'abstract', 'now', 'available', 'ash', 'conference', 'website'], ['investigational_autologous_gene_edit', 'therapy', 'evaluate', 'patient', 'suffer_severe_scd', 'patient', 'hematopoietic_stem', 'cell', 'engineer_produce_high_level', 'fetal_hemoglobin_red_blood', 'cell', 'form_oxygen_carry_hemoglobin', 'naturally_present_birth_then', 'switch_adult', 'form_hemoglobin', 'elevation_hbf_potential_alleviate', 'transfusion_requirement', 'patient', 'reduce_painful', 'debilitate_sickle_crisis', 'scd', 'patient'], ['base', 'progress', 'program', 'date_grant_regenerative', 'medicine', 'advanced', 'therapy', 'rmat', 'fast_track', 'orphan_drug', 'rare_pediatric', 'disease', 'designation', 'also', 'grant', 'drug', 'designation_tdt_scd', 'as_well', 'priority', 'medicine', 'designation', 'scd'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security', 'as', 'amend', 'as_well', 'statement', 'regard', 'expectation', 'follow', 'status_clinical_trial', 'include_limitation', 'expect', 'timing', 'datum', 'release', 'relate', 'product_candidate', 'development', 'collaborator', 'include', 'expectation_regard', 'datum', 'plan', 'present', 'datum', 'annual_ash', 'meeting_exposition', 'expect', 'benefit', 'collaboration', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'forward_look_statement', 'promise_guarantee_necessarily_subject', 'high_degree', 'uncertainty', 'risk', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'initial_preliminary', 'datum', 'clinical_trial', 'initial_datum_limited', 'number', 'patient', 'case_time_indicative', 'final', 'trial', 'result', 'potential', 'clinical_trial', 'result', 'favorable', 'potential', 'impact_due_coronavirus', 'pandemic', 'such', 'timing_progress', 'clinical_trial', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party_outcome_proceeding', 'such', 'interference_opposition_similar_proceeding', 'involve_portion', 'such', 'intellectual_property', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'quarterly_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available_website_existing', 'prospective_investor_caution_place', 'undue_reliance', 'forward_look_statement', 'speak_only_date', 'make_disclaim_obligation', 'undertaking_update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'regard', 'expectation', 'plan', 'present', 'datum', 'annual_ash', 'meeting_exposition', 'development', 'include', 'expect', 'timeline', 'development', 'potential', 'benefit', 'plan', 'expectation', 'clinical_trial', 'clinical_trial', 'site', 'status_clinical_trial', 'product_candidate', 'development', 'collaborator', 'include', 'activity', 'clinical_trial', 'site', 'potential', 'outcome', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program', 'include', 'program', 'collaborator_support_registration', 'further_development', 'compound_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_most_recent', 'annual_report_subsequent_quarterly', 'report_file', 'available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['revenue', 'increase_compare'], ['raise', 'revenue_guidance', 'now', 'expect', 'product_revenue', 'billion'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'third_quarter', 'end', 'revise', 'upward', 'full_year_financial_guidance', 'product_revenue'], ['very', 'strong', 'quarter', 'vertex', 'execution', 'business', 'continue', 'earning', 'revenue_growth', 'say_chief_executive_officer', 'president', 'pleased', 'progress', 'treat', 'people_cystic_fibrosis', 'highlight', 'several', 'recent', 'milestone', 'early', 'approval', 'encouraging', 'start', 'launch', 'positive', 'datum', 'child', 'age', 'continued', 'expansion', 'medicine', 'label', 'recent', 'approval', 'infant', 'as', 'young', 'month', 'age'], ['extend', 'leadership', 'also', 'advance', 'broad', 'pipeline', 'innovative', 'therapy', 'continue', 'strategy', 'contemplate', 'high', 'risk', 'nature', 'drug', 'development', 'therefore', 'include', 'portfolio', 'approach', 'disease', 'area', 'interest', 'disappoint', 'outcome', 'look_forward', 'phase_proof_concept', 'datum', 'first_half', 'pipeline', 'span', 'multiple', 'disease', 'multiple', 'important', 'clinical', 'readout', 'expect', 'now', 'end', 'expect', 'hold', 'transformative', 'potential', 'patient', 'further', 'growth', 'vertex'], ['third_quarter', 'financial', 'highlight'], ['product_revenue', 'increase_compare', 'third_quarter', 'primarily_drive', 'uptake', 'trikafta', 'uptake', 'medicine', 'follow', 'completion', 'several', 'significant', 'reimbursement_agreement'], ['gaap_non_gaap', 'net_income', 'increase_compare', 'third_quarter', 'largely_drive', 'strong', 'growth', 'total_product_revenue'], ['cash_cash', 'equivalent_marketable_security', 'increase', 'approximately', 'compare', 'drive_strong', 'revenue', 'profitability'], ['third_quarter', 'expense'], ['combine_gaap_expense', 'decrease', 'compare_third', 'quarter', 'decrease', 'collaboration', 'payment'], ['combined_non_gaap', 'expense', 'increase_compare', 'third_quarter', 'primarily_incremental', 'investment', 'support', 'global', 'use', 'vertex', 'medicine', 'expansion_pipeline', 'other', 'disease', 'area'], ['gaap_non_gaap', 'income_taxis', 'increase_compare', 'third_quarter', 'primarily_due', 'increase', 'operate', 'income', 'refer_supplemental', 'income_tax', 'information', 'section', 'discussion_cash', 'non_cash_component', 'provision_income_taxis'], ['full_year_financial_guidance'], ['today', 'revise', 'upward', 'guidance', 'full_year', 'product_revenue', 'company', 'also', 'adjust', 'expectation', 'combine_gaap_expense', 'non_gaap', 'effective_tax_rate', 'vertex', 'guidance_summarize', 'below'], ['current', 'fy'], ['previous', 'fy'], ['total_product_revenue'], [], [], ['combine_gaap_expense'], [], [], [], [], ['key', 'business', 'highlight'], ['cystic', 'pipeline'], ['expect', 'increase', 'number', 'patient', 'eligible', 'take', 'medicine', 'thereby', 'continue', 'grow', 'business', 'important', 'progress', 'make', 'support', 'extension', 'eligible', 'patient', 'population', 'expansion', 'additional', 'geography', 'age', 'group'], ['genetic', 'therapy'], ['pipeline'], ['beta_thalassemia_sickle', 'cell', 'disease'], ['aat', 'deficiency'], ['apol_mediated', 'kidney_disease'], ['type_diabetes'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'revenue_expense', 'relate', 'collaboration', 'agreement', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'increase_decrease_fair', 'value_contingent_consideration', 'acquisition_relate_cost', 'other', 'adjustment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe_certain_discrete', 'item', 'result', 'view_substitute', 'company', 'gaap', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'company', 'believe_helpful', 'understanding', 'ongoing', 'business', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'calculation', 'non_gaap_financial_measure', 'likely_differ', 'calculation', 'use', 'other', 'company', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['company', 'provide', 'guidance_regard_combine', 'expense_effective_tax', 'rate', 'non_gaap_basis', 'guidance_regard', 'combine_gaap', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity', 'company', 'provide', 'forward_look', 'reconciliation', 'measure', 'most', 'directly', 'comparable', 'gaap_financial', 'measure', 'unable', 'unreasonable', 'effort', 'calculate', 'gaap', 'measure', 'reasonable', 'certainty'], [], ['month_end'], ['company', 'increase', 'combine_gaap_expense', 'guidance', 'reflect', 'effect', 'new', 'collaboration', 'agreement', 'third_quarter', 'company', 'adjusted', 'non_gaap', 'effective_tax_rate', 'guidance', 'include', 'change', 'utilization', 'certain', 'tax_asset'], ['other', 'income', 'expense', 'net', 'include', 'gain_loss_relate', 'change_fair_value', 'company', 'strategic_investment'], ['month_end', 'increase', 'fair_value_contingent_consideration', 'relate', 'potential', 'payment_exonic', 'former_equity_holder'], ['collaborative_revenue_expense', 'month_end', 'primarily_relate_collaborative_upfront', 'milestone_payment'], ['acquisition_relate_cost', 'month_end', 'relate_cost', 'associate', 'company', 'acquisition_exonic'], ['month_end_tax_adjustment', 'primarily_relate', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'include', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'increase_decrease_fair', 'value', 'company', 'strategic_investment', 'collaborative', 'payment', 'month_end_tax_adjustment', 'also', 'include', 'non_recur', 'discrete_benefit', 'company', 'provision_income_taxis', 'approximately', 'respectively', 'company', 'exclude', 'non_gaap_measure'], ['company', 'record_provision_income_taxis', 'pre_tax_income', 'use', 'effective_tax_rate_approximate', 'statutory_rate', 'company', 'release', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'tax_provision', 'include', 'significant', 'non_cash_charge', 'company', 'ability_offset', 'pre_tax_income', 'previously', 'benefit', 'net_operating', 'loss_credit', 'company', 'federal_net_operating_loss', 'credit', 'available', 'offset', 'future', 'pre_tax_income', 'approximately', 'company', 'expect', 'utilize', 'remain', 'federal_net_operating_loss', 'result', 'large', 'portion', 'company', 'tax_provision_represent', 'cash', 'expense', 'future', 'period', 'subject', 'continued', 'utilization', 'certain', 'tax', 'credit'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'regulatory_filing', 'datum', 'submission', 'anticipate', 'future', 'label_expansion', 'expectation', 'development', 'plan', 'anticipate_timeline', 'company', 'medicine', 'drug_candidate', 'pipeline', 'program', 'include', 'collaboration', 'third_party', 'expectation', 'collaboration', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'different', 'more', 'significant', 'impact', 'company', 'business_operation', 'company', 'currently', 'expect', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine_timely_manner', 'at_all_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['contact', 'investor'], [], ['pharmaceutical_incorporate', 'report', 'third_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow'], ['source_version_news'], ['phase_study', 'patient', 'deficiency', 'discontinue', 'base', 'safety', 'pharmacokinetic', 'datum'], ['phase_study', 'continue', 'enroll', 'dose', 'patient', 'datum', 'expect'], ['research', 'program', 'continue', 'progress'], ['vertex_pharmaceutical_incorporate_today', 'provide', 'update', 'clinical', 'program', 'target', 'small_molecule', 'correction', 'deficiency'], ['vx', 'phase_proof_concept', 'study'], ['base', 'safety', 'pharmacokinetic', 'profile', 'observe', 'date', 'phase', 'trial', 'decide', 'stop', 'dose', 'trial', 'discontinue', 'development', 'randomize_double_blind_placebo', 'control', 'phase_study', 'approximately', 'patient', 'design', 'evaluate', 'safety', 'pk', 'ability', 'increase', 'functional', 'level', 'antitrypsin', 'day', 'dose', 'elevated', 'liver_enzyme', 'observe', 'several', 'patient', 'patient', 'different', 'dose', 'study', 'elevation', 'great', 'time', 'upper', 'limit', 'normal', 'note', 'elevated', 'liver_enzyme', 'resolve', 'resolve', 'patient', 'concomitant', 'elevation', 'bilirubin', 'level', 'patient', 'asymptomatic', 'analysis', 'datum', 'study', 'indicate', 'exposure', 'achieve', 'low', 'base', 'datum', 'vertex', 'conclude', 'feasible', 'safely', 'reach', 'targeted', 'exposure', 'level', 'thus', 'meaningful', 'increase', 'aat', 'level', 'study', 'stop'], ['base', 'liver_enzyme', 'elevation', 'observe', 'determination', 'able', 'safely', 'achieve', 'target', 'exposure', 'level', 'discontinue', 'further_development', 'molecule', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'grateful', 'aatd', 'patient', 'investigator', 'participate', 'study', 'remain', 'committed', 'transform', 'treatment', 'disease', 'look_forward', 'continue', 'clinical', 'study', 'other', 'molecule', 'target', 'underlying_cause', 'aatd'], ['phase_proof_concept', 'study'], ['phase', 'trial', 'structurally', 'distinct', 'initiate', 'ongoing', 'randomize_double_blind_placebo', 'control', 'study', 'approximately', 'patient', 'design', 'evaluate', 'safety', 'pharmacokinetic', 'ability', 'increase', 'functional', 'level', 'antitrypsin', 'day', 'dose', 'patient', 'continue', 'enroll', 'dose', 'study', 'clinical', 'datum', 'study', 'anticipate', 'first_half'], [], ['also', 'continue', 'advance', 'multiple', 'small_molecule_corrector', 'late_stage', 'research', 'goal', 'advance', 'at_least', 'additional', 'molecule', 'development'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'regard', 'plan', 'expectation', 'clinical_trial', 'evaluate', 'program', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'research', 'development', 'program_support', 'development', 'registration', 'compound_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news_home'], ['provide', 'opportunity', 'treat_underlying_cause', 'early', 'ever', 'before'], ['datum', 'cohort', 'phase', 'arrival', 'study', 'support', 'treatment', 'kalydeco', 'child', 'age_month', 'eligible', 'mutations'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'approve', 'ivacaftor', 'use', 'child_cystic_fibrosis', 'age_month', 'less_month', 'old_at_least', 'mutation_cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr_gene', 'responsive', 'base', 'clinical', 'already_approve', 'treatment', 'patient', 'age_month', 'old'], ['initial', 'approval', 'more', 'year', 'ago', 'continue', 'advance', 'clinical', 'development', 'program', 'goal', 'treat_underlying_cause', 'cystic_fibrosis', 'as_early', 'life', 'possible', 'say_chief_executive_officer', 'today', 'approval', 'testament', 'relentless', 'effort', 'clinical', 'scientific', 'community', 'reach', 'people', 'benefit', 'medicine'], ['approval', 'base', 'datum', 'cohort', 'phase_open_label', 'safety', 'cohort', 'arrival', 'consist', 'child', 'age_month', 'less_month', 'mutation', 'cftr', 'gene', 'cohort', 'demonstrate', 'safety_profile', 'similar_observe', 'old_child_adult'], ['initiate', 'therapy', 'treat_underlying_cause', 'cystic_fibrosis', 'as_early', 'month', 'age', 'potential', 'modify', 'course', 'disease', 'say'], ['first', 'approve', 'now', 'available', 'more', 'country', 'more', 'information', 'kalydeco', 'prescribe_information', 'patient', 'assistance', 'program', 'visit'], ['take', 'patient', 'tell_doctor', 'liver', 'kidney_problem', 'drink', 'grapefruit', 'juice', 'eat', 'grapefruit', 'pregnant_plan_become_pregnant', 'know', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'pass_breast_milk'], ['affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'work_therefore', 'dose', 'need', 'adjust_when_take_certain', 'medication', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medication', 'such_voriconazole', 'fluconazole_antibiotic', 'such'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'quote', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['oral_presentation', 'interim', 'result', 'trikafta', 'ivacaftor', 'ivacaftor', 'open_label', 'safety', 'extension', 'study', 'present', 'conference'], ['presentation', 'highlight', 'datum', 'ivacaftor', 'lumacaftor_ivacaftor', 'trikafta', 'present', 'virtual', 'conference'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'datum', 'company', 'portfolio', 'cystic_fibrosis', 'medicine', 'present', 'rd', 'european', 'hold', 'american', 'conference', 'take_place', 'oral_presentation', 'highlight', 'first', 'time', 'interim', 'result', 'trikafta', 'open_label_extension', 'study', 'show', 'safety_efficacy', 'consistent', 'result', 'phase', 'pivotal', 'study', 'patient', 'age_old', 'minimal_function', 'genotype', 'additional', 'scientific', 'abstract', 'publish', 'cystic', 'part', 'addition', 'scientific', 'presentation', 'occur', 'regard', 'orkambi', 'trikafta', 'include', 'new', 'datum', 'infant', 'age', 'less_month', 'old'], ['continue', 'reach', 'additional', 'people', 'medicine', 'gain', 'well', 'understanding', 'long_term', 'real_world', 'impact', 'become', 'even', 'more', 'important', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'pleased', 'report', 'first', 'long_term', 'datum', 'trikafta', 'show', 'significant', 'benefit', 'see', 'early', 'maintain', 'year', 'treatment'], ['datum', 'highlight', 'interim', 'result', 'ongoing', 'trikafta', 'open_label_extension', 'study', 'evaluate', 'long_term', 'safety_efficacy', 'people', 'age_old', 'minimal_function', 'genotype', 'complete', 'pivotal', 'study', 'present', 'interim_analysis', 'trikafta', 'generally_well_tolerate', 'new', 'safety', 'concern', 'datum', 'show', 'mark', 'improvement', 'observe', 'prior', 'pivotal', 'study', 'multiple', 'efficacy_endpoint', 'include', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'sweat_chloride', 'swcl', 'cystic_revise', 'respiratory_domain_score', 'body', 'mass', 'index', 'sustain', 'continue', 'treatment', 'trikafta'], ['full', 'listing', 'vertex', 'scientific', 'presentation', 'below'], ['abstract', 'title'], ['presentation', 'type'], ['present', 'author'], ['time'], ['iva'], ['phase_open', 'label_extension', 'study', 'ivacaftor', 'interim_analysis', 'safety_efficacy', 'people_cystic_fibrosis', 'minimal_function', 'genotype'], ['oral_presentation'], [], [], ['am', 'cet'], ['impact', 'ivacaftor', 'triple_combination_therapy', 'health', 'relate', 'quality_life', 'people', 'cystic', 'heterozygous', 'minimal_function_mutation', 'result', 'phase', 'clinical', 'study'], ['publish'], ['poster_presentation'], [], [], ['impact', 'ivacaftor', 'triple_combination_therapy', 'health', 'relate', 'quality_life', 'people', 'cystic', 'homozygous', 'result', 'phase', 'clinical', 'study'], ['publish'], ['poster_presentation'], [], ['iva'], ['observational', 'study', 'ivacaftor', 'people_cystic_fibrosis', 'select', 'non', 'gating_mutation', 'outcome', 'third', 'interim_analysis', 'vocal', 'study'], ['poster_presentation'], [], [], ['ivacaftor', 'old', 'infant', 'gating_mutation', 'result', 'single_arm', 'phase_study'], [], [], ['real_world', 'outcome', 'child', 'age', 'cf', 'treat', 'ivacaftor'], [], [], ['iva'], ['long_term', 'safety', 'lumacaftor_ivacaftor', 'person', 'cystic_fibrosis', 'age_year', 'homozygous', 'cftr', 'mutation'], ['publish', 'abstract'], [], ['person', 'cystic_fibrosis', 'treat', 'lumacaftor_ivacaftor', 'iva', 'interim', 'result', 'long_term', 'safety', 'study', 'use', 'datum', 'patient', 'registry', 'cffpr'], [], [], [], ['indication_important_safety', 'information', 'ivacaftor', 'ivacaftor', 'ivacaftor', 'lumacaftor_ivacaftor'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_month', 'old_at_least', 'mutation', 'gene_responsive', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know_safe', 'effective_child', 'month', 'age'], ['trikafta', 'prescription_medicine_use', 'treatment', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'trikafta', 'safe_effective_child', 'year', 'age'], ['orkambi', 'prescription_medicine_use', 'treatment', 'patient', 'age_year_old_copy', 'mutation', 'cftr', 'gene', 'orkambi', 'only', 'use', 'patient', 'know', 'orkambi', 'safe_effective', 'patient', 'year', 'age'], ['take_orkambi', 'patient', 'tell_doctor_medical', 'condition', 'include', 'have_liver', 'problem', 'kidney_problem', 'have', 'organ', 'transplant', 'pregnant_plan_become_pregnant', 'know', 'trikafta', 'orkambi', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'trikafta', 'orkambi', 'pass_breast_milk', 'take_orkambi', 'patient', 'tell_doctor', 'use', 'birth', 'control', 'hormonal_contraceptive', 'include', 'oral', 'injectable', 'transdermal', 'implantable', 'form', 'use', 'method', 'birth', 'control', 'when_take', 'orkambi'], ['orkambi', 'affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'kalydeco', 'trikafta', 'orkambi', 'work_therefore', 'dose', 'orkambi', 'need', 'adjust_when_take_certain', 'medication', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medication', 'such_voriconazole', 'fluconazole_antibiotic', 'such'], ['patient', 'avoid_food_drink_contain', 'grapefruit_seville', 'orange', 'take', 'patient', 'avoid_food_drink_contain', 'grapefruit', 'take', 'trikafta'], ['cause', 'serious_side_effect', 'such'], ['high_liver', 'enzyme_blood', 'report', 'patient', 'receive', 'kalydeco', 'orkambi', 'patient', 'doctor_blood_test_check', 'liver_start', 'treatment', 'orkambi', 'month', 'first', 'year', 'treatment', 'year', 'treatment', 'patient', 'have', 'high_liver', 'enzyme', 'past', 'doctor_blood_test_check', 'liver', 'more', 'often', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['abnormality_eye_lens_cataract', 'child_adolescent', 'treat', 'orkambi', 'patient', 'child_adolescent', 'doctor_perform_eye_examination', 'treatment', 'orkambi', 'look_cataract'], ['most_common_side_effect', 'orkambi', 'include', 'breathing', 'problem', 'such', 'shortness', 'breath', 'chest', 'tightness', 'nausea', 'diarrhea', 'fatigue', 'increase', 'certain', 'blood', 'enzyme', 'call', 'phosphokinase', 'rash', 'gas', 'common_cold', 'include', 'sore_throat', 'stuffy_runny', 'nose', 'flu', 'flu', 'like', 'symptom', 'irregular', 'missed', 'abnormal', 'period', 'mense', 'increase_amount', 'menstrual', 'bleed', 'additional', 'side_effect', 'see', 'child', 'include', 'cough', 'sputum', 'stomach', 'pain', 'increase', 'sputum'], ['possible_side_effect', 'trikafta', 'orkambi', 'click', 'product', 'link', 'see_full', 'prescribing_information', 'orkambi'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'potential', 'benefit', 'safety_efficacy', 'plan', 'present', 'datum', 'nacfc', 'include', 'datum', 'open_label_extension', 'study', 'scientific', 'abstract', 'orkambi', 'trikafta', 'scientific', 'presentation', 'regard', 'orkambi', 'trikafta', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support', 'registration', 'approval', 'further_development', 'compound_safety_efficacy', 'other_reason', 'risk', 'relate', 'approval', 'medicine', 'other_risk_list', 'risk_factor_most_recent', 'annual_report_subsequent_quarterly', 'report_file', 'available', 'company_website_wwwvrtxcom', 'place_undue_reliance', 'statement', 'scientific', 'datum', 'present_vertex_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news_home'], ['pharmaceutical_incorporate', 'today_announce', 'grant', 'priority', 'medicine', 'designation', 'investigational_autologous_gene_edit', 'therapy', 'treatment', 'severe_sickle', 'cell', 'disease', 'scd'], ['regulatory', 'mechanism', 'provide', 'early', 'proactive', 'support', 'developer', 'promise', 'medicine', 'optimize', 'development', 'plan', 'speed', 'evaluation', 'medicine', 'reach', 'patient', 'fast', 'goal', 'help', 'patient', 'benefit', 'as_early_possible', 'innovative', 'new', 'therapy', 'demonstrate', 'potential', 'significantly', 'address_unmet', 'medical', 'need', 'prime_designation', 'grant', 'base', 'clinical', 'datum', 'ongoing', 'phase', 'trial', 'patient', 'severe_scd'], ['investigational_autologous_gene_edit', 'therapy', 'evaluate', 'patient', 'suffer', 'transfusion_dependent_beta_thalassemia', 'severe_scd', 'patient', 'hematopoietic_stem', 'cell', 'engineer_produce_high_level', 'fetal_hemoglobin_red_blood', 'cell', 'form_oxygen_carry_hemoglobin', 'naturally_present_birth_then', 'switch_adult', 'form_hemoglobin', 'elevation_hbf_potential_alleviate', 'transfusion_requirement', 'patient', 'reduce_painful', 'debilitate_sickle_crisis', 'scd', 'patient'], ['base', 'progress', 'program', 'date_grant_regenerative', 'medicine', 'advanced', 'therapy', 'rmat', 'fast_track', 'orphan_drug', 'designation', 'drug', 'designation_tdt_scd'], ['develop', 'co', 'development', 'co', 'agreement', 'most', 'advanced', 'gene_edit', 'approach', 'development', 'tdt_scd'], ['crispr', 'vertex', 'collaboration', 'vertex', 'enter_strategic', 'research', 'collaboration', 'focus', 'use', 'cas', 'discover_develop', 'potential', 'new', 'treatment', 'aim', 'underlying_genetic', 'cause', 'human', 'disease', 'represent', 'first', 'treatment', 'emerge_joint', 'research', 'program', 'vertex', 'jointly', 'develop_commercialize', 'equally', 'share', 'research', 'development', 'cost', 'profit_worldwide'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security', 'as', 'amend', 'as_well', 'statement', 'regard', 'expectation', 'follow', 'status_clinical_trial', 'include_limitation', 'expect', 'timing', 'datum', 'release', 'discussion', 'regulatory_authority', 'relate', 'product_candidate', 'development', 'collaborator', 'include', 'expectation_regard', 'benefit', 'prime_designation', 'expect', 'benefit', 'collaboration', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'forward_look_statement', 'promise_guarantee_necessarily_subject', 'high_degree', 'uncertainty', 'risk', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'impact_due_coronavirus', 'pandemic', 'such', 'timing_progress', 'clinical_trial', 'potential', 'initial_preliminary', 'datum', 'clinical_trial', 'initial_datum_limited', 'number', 'patient', 'case_time_indicative', 'final', 'trial', 'result', 'potential', 'clinical_trial', 'result', 'favorable', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party_outcome_proceeding', 'such', 'interference_opposition_similar_proceeding', 'involve_portion', 'such', 'intellectual_property', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'quarterly_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available_website_existing', 'prospective_investor_caution_place', 'undue_reliance', 'forward_look_statement', 'speak_only_date', 'make_disclaim_obligation', 'undertaking_update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'regard', 'prime_designation', 'development', 'potential', 'benefit', 'plan', 'expectation', 'clinical_trial', 'clinical_trial', 'site', 'status_clinical_trial', 'product_candidate', 'development', 'collaborator', 'include', 'activity', 'clinical_trial', 'site', 'potential', 'outcome', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program', 'include', 'program', 'collaborator_support_registration', 'further_development', 'compound_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['second', 'collaboration', 'vertex', 'base', 'proprietary', 'lnp', 'technology'], ['collaboration', 'leverage', 'investment', 'capability', 'genetic', 'technology'], ['receive_upfront', 'potential', 'additional', 'development', 'regulatory', 'commercial', 'milestone_royalty', 'payment'], ['pharmaceutical_incorporate', 'announce_today', 'new', 'strategic', 'research', 'collaboration', 'licensing_agreement', 'aim', 'discovery', 'development', 'lipid', 'nanoparticle', 'lnps', 'mrna', 'delivery', 'gene_edit', 'therapy', 'treatment_cystic_fibrosis', 'year', 'research', 'collaboration', 'initially', 'focus', 'discovery', 'optimization', 'novel', 'lnps', 'mrna', 'deliver', 'gene_edit', 'therapy', 'cell', 'lung', 'enable', 'functional', 'cystic_fibrosis', 'conductance_regulator', 'cftr_protein', 'produce'], ['press_release_feature_view', 'full', 'release', 'here'], ['pleased', 'enter', 'second', 'collaboration', 'vertex', 'aim', 'deliver', 'potentially', 'novel', 'treatment', 'patient', 'cystic_fibrosis', 'use', 'gene_editing', 'say_chief_executive_officer', 'first', 'collaboration', 'vertex', 'deliver', 'mrna', 'code', 'cystic_fibrosis', 'protein', 'lung', 'cell', 'advance', 'well', 'second', 'collaboration', 'aim', 'use', 'technology', 'explore', 'use', 'gene_editing', 'lung', 'cell'], ['cftr_modulator', 'therapy', 'potential', 'treat', 'vast_majority', 'patient', 'address_underlie', 'cause', 'disease', 'however', 'approximately', 'percent', 'patient', 'produce', 'cftr_protein', 'so', 'unlikely', 'benefit', 'exist', 'medicine', 'past', 'year', 'make', 'important', 'progress', 'research', 'effort', 'aim', 'creation', 'genetic', 'therapy', 'delivery', 'such', 'therapy', 'remain', 'most', 'significant', 'technological', 'scientific', 'challenge', 'say_executive_vice', 'global', 'research', 'chief_scientific', 'officer', 'combination', 'unique', 'expertise', 'discovery', 'manufacturing', 'novel', 'lnp', 'delivery', 'system', 'mrna', 'technology', 'combine', 'scientific', 'clinical', 'regulatory', 'capability', 'accelerate', 'development', 'groundbreake', 'genetic', 'therapy', 'people', 'support', 'commitment', 'develop', 'therapy', 'people', 'live'], ['term', 'agreement', 'conduct', 'research', 'activity', 'discover', 'optimize', 'novel', 'lnps', 'delivery', 'gene_edit', 'therapy', 'lung', 'cell', 'treatment', 'receive_upfront', 'eligible', 'receive', 'development', 'regulatory', 'commercial_milestone', 'tiere', 'royalty', 'product', 'result', 'collaboration', 'responsible', 'discovery', 'manufacturing', 'lnps', 'mrna', 'construct', 'encode', 'gene_edit', 'endonuclease', 'vertex', 'responsible', 'provide', 'other', 'component', 'gene_edit', 'therapy', 'formulate', 'lnps', 'as_well', 'subsequent', 'preclinical', 'clinical', 'development', 'potential', 'effort', 'new', 'collaboration', 'add', 'exist', 'relationship', 'vertex', 'recently', 'extend', 'collaboration', 'aim', 'discovery', 'development', 'therapeutic', 'treatment'], [], ['advance', 'science', 'create_new_class', 'transformative_medicine', 'patient', 'mrna', 'medicine', 'design', 'direct', 'body', 'cell', 'produce', 'intracellular', 'membrane', 'secrete', 'protein', 'therapeutic', 'preventive', 'benefit', 'potential', 'address', 'broad', 'spectrum', 'platform', 'build', 'continuous', 'advance', 'basic', 'apply', 'science', 'delivery', 'technology', 'manufacturing', 'provide', 'company', 'capability', 'pursue', 'parallel', 'robust_pipeline', 'new', 'development', 'candidate', 'develop', 'therapeutic', 'vaccine', 'infectious_disease', 'immuno', 'oncology', 'rare', 'disease', 'cardiovascular', 'disease', 'autoimmune', 'inflammatory', 'disease', 'independently', 'strategic', 'collaborator'], ['headquarter', 'currently', 'strategic', 'alliance', 'development', 'program', 'as_well', 'defense', 'advance', 'research', 'project', 'agency', 'biomedical', 'advanced', 'research', 'development', 'division', 'office', 'assistant', 'secretary', 'preparedness', 'response', 'human', 'service', 'coalition', 'epidemic', 'preparedness', 'innovation', 'name', 'top_employer', 'science', 'past', 'year'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'press_release_statement', 'third_paragraph_press_release', 'information', 'provide', 'regard', 'future', 'development', 'therapy', 'treat_underlying_cause', 'potential', 'opportunity', 'therapy', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'support', 'further_development', 'therapy', 'subject', 'collaboration', 'safety_efficacy_other_reason', 'other_risk_list', 'heading_risk', 'factor_annual_report_subsequent', 'quarterly_report_file_available', 'website_wwwvrtxcom', 'website', 'as_well', 'risk_list_heading_risk', 'factor_most', 'recent', 'quarterly_report_form', 'file', 'subsequent_filing_make', 'available', 'website', 'wwwmodernatxcom', 'website', 'require_law', 'vertex_disclaim', 'intention', 'responsibility', 'update_revise', 'forward_look_statement', 'contain_press_release', 'event', 'new', 'information', 'future', 'development', 'otherwise'], [], ['source_version'], ['contact'], ['investor'], ['head', 'investor_relation'], ['medium'], ['senior', 'manager', 'corporate_communication'], ['contact'], [], [], ['source'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'validate', 'type', 'variation', 'marketing_authorization_application', 'expand', 'indication', 'ivacaftor_elexacaftor', 'combination', 'ivacaftor', 'treat', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene'], ['approve', 'eligible', 'patient', 'copy_mutation', 'cftr', 'mutation', 'such', 'gating_residual', 'function_mutation', 'also', 'eligible', 'treatment', 'maa', 'support', 'positive', 'result', 'global', 'phase_study', 'announce', 'application', 'now', 'review', 'committee_medicinal_product', 'human_use_chmp', 'issue', 'opinion', 'regard', 'potential', 'approval', 'patient'], ['ivacaftor_elexacaftor', 'combination', 'ivacaftor', 'currently', 'approve', 'treat', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation', 'del_mutation', 'cftr', 'gene'], ['ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'approve', 'treatment_cystic_fibrosis', 'patient', 'age_year_old', 'mutation_minimal', 'function_mutation', 'del_mutation_cystic_fibrosis', 'regulator_cftr_gene', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'complete', 'product', 'information', 'see', 'summary_product_characteristic', 'find', 'en', 'medicine', 'human'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'regard', 'potential', 'benefit', 'expectation_regard', 'maa', 'include', 'approve', 'patient', 'become', 'eligible', 'treatment', 'expectation_regard', 'additional', 'regulatory', 'review', 'opinion', 'approval', 'label_expansion', 'medicine', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'datum', 'company', 'development', 'program_support', 'registration', 'approval', 'further_development', 'compound_safety_efficacy', 'other_reason', 'risk', 'relate', 'approval', 'medicine', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'company', 'complete', 'global', 'phase_study', 'trikafta', 'ivacaftor', 'ivacaftor', 'child', 'age_year_old', 'cystic_fibrosis', 'copy_mutation', 'copy_mutation', 'minimal_function_mutation', 'base', 'result', 'submit', 'supplemental', 'new', 'drug_application', 'food', 'fourth_quarter', 'additional', 'global', 'regulatory_submission', 'follow'], ['aim', 'extend', 'eligibility', 'patient', 'benefit', 'transformative_medicine', 'positive', 'result', 'study', 'child', 'age_year_old', 'allow', 'take', 'step', 'forward', 'goal', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'look_forward', 'file', 'snda', 'come', 'month', 'bring', 'trikafta', 'young', 'people'], ['bring', 'trikafta', 'child', 'less', 'year', 'age'], ['global', 'phase_open_label', 'study', 'evaluate', 'safety_efficacy', 'trikafta', 'child', 'age_year_old_copy', 'mutation', 'copy_mutation', 'minimal_function_mutation', 'primary_endpoint', 'study', 'safety_tolerability', 'result', 'show', 'trikafta', 'generally_well_tolerate', 'safety', 'datum', 'consistent_observe', 'previous_phase', 'study', 'addition', 'clinically_meaningful', 'improvement', 'see', 'multiple', 'secondary', 'efficacy_endpoint', 'include', 'improvement', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'sweat_chloride', 'cystic_revise', 'respiratory_domain_score', 'body', 'mass', 'index', 'other', 'measure', 'week', 'treatment', 'study', 'show', 'benefit', 'risk', 'profile', 'trikafta', 'child', 'age_year_old', 'similar', 'see', 'people', 'age_old', 'phase_study', 'support', 'approval', 'base', 'result', 'submit', 'snda', 'fourth_quarter', 'additional', 'global', 'regulatory_submission', 'follow'], ['ivacaftor', 'ivacaftor', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'trikafta', 'safe_effective_child', 'year', 'age', 'trikafta', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'approval', 'trikafta', 'support', 'positive', 'result', 'global', 'phase_study', 'people', 'age_year_old', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'phase_study_people_del', 'mutation'], ['indication_important_safety', 'information', 'trikafta', 'ivacaftor', 'ivacaftor', 'tablet'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'trikafta', 'safe_effective_child', 'year', 'age'], ['patient', 'take', 'trikafta', 'take_certain', 'medicine', 'such_antibiotic', 'such', 'rifampin_rifabutin', 'seizure', 'medicine_such_phenobarbital', 'carbamazepine_phenytoin'], ['trikafta', 'affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'trikafta', 'work_therefore', 'dose', 'trikafta', 'need', 'adjust_when_take_certain', 'medicine', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medicine', 'include', 'posaconazole', 'voriconazole_fluconazole', 'antibiotic', 'include', 'other', 'medicine', 'include', 'rifampin', 'phenobarbital'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'potential', 'benefit', 'trikafta', 'plan', 'make', 'additional', 'submission', 'other', 'global', 'regulatory_agency', 'include', 'timing', 'additional', 'regulatory_submission', 'expectation_regard', 'additional', 'regulatory', 'review', 'approval', 'medicine', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'datum', 'company', 'development', 'program_support', 'registration', 'approval', 'further_development', 'compound_safety_efficacy', 'other_reason', 'risk', 'relate', 'approval', 'medicine', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['vertex', 'foundation_nonprofit_charitable_foundation', 'today_announce', 'donation', 'charity', 'rmhc', 'support', 'construction', 'house', 'new', 'child'], ['donation', 'support', 'building', 'house', 'new', 'child', 'hospital', 'provide', 'home', 'family', 'seriously', 'ill', 'child'], ['delighted', 'support', 'charity', 'create', 'amazing', 'new', 'facility', 'provide', 'high_level', 'support', 'family', 'say', 'chairman', 'foundation', 'executive_vice_president_chief', 'administrative', 'legal', 'business', 'development', 'officer', 'so', 'important', 'child', 'family', 'close', 'when', 'hospital', 'house', 'provide', 'opportunity', 'parent', 'family', 'when', 'need', 'most'], ['extraordinary', 'gift', 'foundation', 'help', 'provide', 'family', 'center', 'care', 'space', 'family', 'together', 'critical', 'time', 'life', 'say', 'rmhc', 'grateful', 'recognition', 'support', 'mission'], ['rmhc'], ['charity', 'rmhc', 'non', 'profit', 'corporation', 'create', 'find', 'support', 'program', 'directly', 'improve', 'health', 'well', 'being', 'child', 'family', 'global', 'network', 'chapter', 'country', 'region', 'rmhc', 'enable', 'facilitate', 'support', 'family', 'center', 'care', 'core', 'program', 'family', 'room', 'care', 'mobile', 'rmhc', 'program', 'help', 'family', 'ill', 'injure', 'child', 'stay', 'together', 'lead', 'hospital', 'health_care', 'service', 'worldwide', 'ensure', 'access', 'medical', 'care', 'child', 'need', 'fully', 'support', 'actively', 'involve', 'child', 'care', 'more_information_visit', 'follow', 'rmhc', 'twitter', 'facebook'], [], ['first', 'open', 'ground', 'lady', 'family', 'care', 'night', 'island', 'opening', 'care', 'excess', 'family', 'continue', 'care', 'family', 'house', 'new', 'hospital', 'open', 'expect', 'opening', 'date', 'more_information_visit', 'wwwrmhcie'], ['source_version'], ['pharmaceutical_incorporate_investor_medium', 'charity', 'medium'], ['more', 'people', 'certain', 'rare', 'mutation', 'become', 'newly_eligible', 'trikafta', 'kalydeco'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'accept', 'supplemental', 'new', 'drug_application', 'trikafta', 'ivacaftor', 'ivacaftor', 'symdeko', 'ivacaftor', 'ivacaftor', 'ivacaftor', 'regulatory_submission', 'intend', 'expand', 'label', 'trikafta', 'include', 'additional', 'rare', 'cftr', 'mutation', 'allow', 'people_cystic_fibrosis', 'previously', 'eligible', 'medicine', 'opportunity', 'benefit', 'treatment', 'target', 'underlying_cause', 'disease', 'addition', 'regulatory_submission', 'also', 'allow', 'certain', 'people', 'currently', 'eligible', 'kalydeco', 'become', 'eligible', 'symdeko', 'trikafta', 'certain', 'people', 'currently', 'eligible', 'symdeko', 'become', 'eligible', 'trikafta', 'assign', 'prescription', 'drug', 'user', 'pdufa_target_action', 'date', 'regulatory_submission', 'base', 'datum', 'cell', 'show', 'rare', 'cftr', 'mutation', 'respond', 'more', 'cftr_modulator', 'regimen'], ['spend', 'last', 'year', 'discover_develop', 'bring', 'new', 'medicine', 'thousand', 'people', 'regulatory_submission', 'announce_today', 'important', 'next_step', 'commitment', 'bring', 'transformative_medicine', 'live', 'disease', 'say', 'executive', 'research', 'chief_scientific', 'officer', 'use', 'well', 'establish', 'approach', 'able', 'generate', 'datum', 'provide', 'evidence', 'people', 'certain', 'rare', 'mutation', 'benefit', 'treat_underlying_cause', 'disease', 'cftr_modulator'], ['snda', 'base', 'datum', 'validate', 'cell', 'model', 'show', 'many', 'rare', 'mutation', 'cftr', 'gene_responsive', 'more', 'medicine', 'mutation', 'currently', 'indicate', 'therapy', 'approximately', 'people', 'certain', 'rare', 'mutation', 'benefit', 'trikafta', 'first', 'time', 'addition', 'more', 'people', 'currently', 'eligible', 'option', 'additional', 'cftr_modulator', 'regulatory_submission', 'allow', 'certain', 'people', 'currently', 'eligible', 'kalydeco', 'become', 'eligible', 'symdeko', 'trikafta', 'certain', 'people', 'currently', 'eligible', 'symdeko', 'become', 'eligible', 'trikafta'], ['datum', 'generate', 'model', 'phase', 'clinical', 'datum', 'already', 'lead', 'inclusion', 'nearly', 'additional', 'ultra', 'rare', 'rare', 'mutation', 'symdeko', 'include', 'first', 'ever', 'approval', 'base', 'datum', 'label_expansion', 'patient', 'residual_function', 'cftr', 'mutation'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_month', 'old_at_least', 'mutation', 'gene_responsive', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know_safe', 'effective_child', 'month', 'age'], ['take', 'trikafta', 'patient', 'tell_doctor_medical', 'condition', 'include', 'kidney_problem', 'have_liver', 'problem_pregnant', 'plan', 'become_pregnant', 'know', 'trikafta', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'trikafta', 'pass_breast_milk', 'take', 'patient', 'tell_doctor', 'drink', 'grapefruit', 'juice', 'eat', 'grapefruit_seville', 'orange'], ['patient', 'avoid_food_drink_contain', 'grapefruit_seville', 'orange', 'take', 'patient', 'avoid_food_drink_contain', 'grapefruit', 'take', 'symdeko', 'trikafta'], ['high_liver', 'enzyme_blood', 'report', 'patient', 'receive', 'trikafta', 'patient', 'doctor_blood_test_check', 'liver_start', 'treatment', 'trikafta', 'month', 'first', 'year', 'treatment', 'year', 'treatment', 'patient', 'have', 'high_liver', 'enzyme', 'past', 'doctor_blood_test_check', 'liver', 'more', 'often', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['possible_side_effect', 'trikafta', 'click', 'product', 'link', 'see_full', 'prescribing_information', 'trikafta'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'expectation', 'relate', 'potential', 'approval', 'trikafta', 'kalydeco', 'additional', 'cftr', 'mutation', 'target', 'action', 'date', 'information', 'regard', 'review', 'process', 'datum', 'support', 'product', 'approval', 'number', 'additional', 'patient', 'benefit', 'medicine', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'snda', 'datum', 'company', 'submission', 'support_registration', 'further_development', 'compound_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['first', 'time', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation', 'eligible', 'medicine_treat_underlying', 'cause_cystic_fibrosis'], ['people', 'year', 'age_old', 'mutation', 'also', 'eligible', 'new', 'triple_combination_regiman'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant_marketing_authorization', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'treat', 'people_cystic_fibrosis', 'age_year_old', 'mutation_minimal', 'function_mutation', 'del_mutation_cystic_fibrosis', 'regulator_cftr_gene'], ['first', 'time', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation', 'eligible', 'cftr_modulator', 'treat', 'underlie', 'cause', 'disease', 'approval', 'triple_combination_regiman', 'also', 'expand', 'number', 'treatment_option', 'available', 'people', 'age_year_old_copy', 'mutation', 'most_common', 'cf', 'cause', 'mutation', 'worldwide'], ['today', 'significant', 'day', 'family', 'vertex', 'one', 'bring_step_close', 'ultimate_goal', 'discover_develop', 'treatment', 'patient', 'say_chief_executive_officer', 'like_thank', 'dedicated', 'scientist', 'as_well', 'study', 'investigator', 'people', 'participate', 'clinical_trial', 'enable', 'innovative', 'medicine', 'approve', 'today', 'commitment', 'milestone', 'possible'], ['result', 'long_term', 'reimbursement_agreement', 'provision', 'access', 'health_care', 'system', 'such', 'eligible', 'patient', 'country', 'access', 'triple_combination_regiman', 'upcoming', 'week', 'commit', 'work_closely', 'national', 'health_authority', 'government', 'other', 'country', 'secure_access_eligible', 'patient', 'as_quickly_possible'], ['marketing_authorization', 'base', 'result', 'global', 'phase_study', 'show_statistically', 'significant_clinically', 'meaningful_improvement', 'lung_function', 'primary_endpoint', 'key_secondary_endpoint', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation', 'del_mutation', 'cftr', 'gene', 'triple_combination_generally_well', 'tolerate', 'study'], ['triple_combination', 'show', 'major', 'impact', 'several', 'outcome', 'measure', 'people', 'say', 'head', 'clinical', 'datum', 'show', 'significant_improvement', 'lung_function', 'other', 'important', 'measure', 'such', 'sweat_chloride', 'level', 'quality_life', 'measure', 'respiratory_domain_score', 'patient', 'treat', 'triple_combination_therapy', 'now', 'look_forward', 'see', 'impact', 'medicine', 'clinical', 'practice'], ['ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'develop', 'treatment_cystic_fibrosis', 'patient', 'age_year_old', 'mutation_minimal', 'function_mutation', 'del_mutation_cystic_fibrosis', 'regulator_cftr_gene', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'submission', 'support', 'positive', 'result', 'global', 'phase_study', 'people', 'age_year_old', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'week', 'phase_study_people_del', 'mutation'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'eligible', 'patient', 'population', 'expectation_regard', 'timing', 'access', 'triple_combination_regiman', 'country', 'plan', 'secure_access', 'medicine', 'additional', 'patient', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'commercialize', 'medicine', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['revenue', 'increase_compare'], ['raise', 'revenue_guidance', 'now', 'expect', 'revenue', 'billion'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'second_quarter_end', 'revise', 'upward', 'full_year_financial_guidance', 'total', 'cystic_fibrosis', 'product_revenue'], ['exceptional', 'first_half', 'vertex', 'front', 'most', 'importantly', 'effort', 'bring', 'cf', 'medicine', 'more', 'people', 'world', 'see', 'remarkable', 'uptake', 'trikafta', 'majority', 'eligible', 'patient', 'now', 'take', 'medicine', 'secure', 'positive', 'chmp_opinion', 'early', 'expect', 'enter', 'landmark', 'expansion', 'reimbursement_agreement', 'give', 'patient', 'access', 'medicine', 'rapidly', 'follow', 'approval', 'say_chief_executive_officer', 'president', 'additionally', 'challenge', 'unprecedented', 'year', 'continue', 'make', 'steady', 'progress', 'research', 'program', 'clinical', 'development', 'pipeline', 'position', 'continued_growth', 'future'], ['total_product_revenue', 'increase_compare', 'second_quarter', 'primarily_drive', 'uptake', 'trikafta', 'uptake', 'medicine', 'follow', 'completion', 'key', 'reimbursement_agreement'], ['gaap_non_gaap', 'net_income', 'increase', 'respectively', 'compare', 'second_quarter', 'largely_drive', 'strong', 'growth', 'total_product_revenue'], ['cash_cash', 'equivalent_marketable_security', 'increase', 'approximately', 'compare'], ['combine_gaap_non_gaap', 'expense', 'increase_compare', 'second_quarter', 'primarily_incremental', 'investment', 'support', 'global', 'use', 'vertex', 'medicine', 'expansion_pipeline', 'other', 'new', 'disease', 'area'], ['gaap', 'income_taxis', 'decrease', 'compare', 'second_quarter', 'non_gaap_income_taxis', 'increase_compare', 'second_quarter', 'primarily_due', 'increase', 'operate', 'income', 'refer_supplemental', 'income_tax', 'information', 'section', 'discussion_cash', 'non_cash_component', 'provision_income_taxis'], ['today', 'revise', 'upward', 'guidance', 'full_year', 'product_revenue', 'reiterate', 'guidance', 'gaap_non_gaap', 'combine', 'expense', 'non_gaap', 'effective_tax_rate', 'summarize_below'], [], ['development', 'pipeline'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'revenue_expense', 'relate', 'collaboration', 'agreement', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'acquisition_relate_cost', 'other', 'adjustment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe_certain_discrete', 'item', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'provide', 'guidance_regard', 'product_revenue', 'accordance_gaap', 'provide', 'guidance_regard_combine', 'research', 'development', 'sale_general', 'administrative_expense', 'gaap_non_gaap', 'basis', 'company', 'also', 'provide', 'guidance_regard', 'anticipated', 'income_taxis', 'percentage', 'pre_tax_income', 'non_gaap_basis', 'guidance_regard', 'gaap', 'research', 'development', 'expense', 'sale_general', 'administrative_expense', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['other', 'income', 'net', 'include', 'gain_loss_relate', 'change_fair_value', 'company', 'strategic_investment'], ['month_end', 'increase', 'fair_value_contingent_consideration', 'relate', 'potential', 'payment_exonic', 'former_equity_holder'], ['collaborative_revenue_expense', 'month_end', 'primarily_relate_collaborative_upfront', 'milestone_payment'], ['acquisition_relate_cost', 'month_end', 'relate_cost', 'associate', 'company', 'acquisition_exonic', 'comparable_amount_month_end'], ['month_end_tax_adjustment', 'primarily_relate', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'include', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'increase_decrease_fair', 'value', 'company', 'strategic_investment', 'collaborative', 'payment', 'month_end_tax_adjustment', 'also', 'include', 'non_recur', 'discrete_benefit', 'company', 'provision_income_taxis', 'approximately', 'respectively', 'company', 'exclude', 'non_gaap_measure'], ['company', 'record_provision_income_taxis', 'pre_tax_income', 'use', 'effective_tax_rate', 'approximating', 'statutory_rate', 'provision', 'include', 'significant', 'non_cash_charge', 'company', 'ability_offset', 'pre_tax_income', 'previously', 'benefit', 'net_operating', 'loss_credit', 'company', 'expect', 'portion', 'tax_provision_represent', 'non_cash', 'expense', 'net_operating', 'loss_credit', 'fully_utilize', 'company', 'federal_net_operating_loss', 'credit', 'available', 'offset', 'future', 'pre_tax_income', 'approximately'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'regulatory_filing', 'datum', 'submission', 'anticipate', 'regulatory_approval', 'include', 'anticipate', 'approval', 'future', 'label_expansion', 'development', 'plan', 'timeline', 'company', 'medicine', 'drug_candidate', 'pipeline', 'program', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'net_product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'different', 'more', 'significant', 'impact', 'company', 'business_operation', 'company', 'currently', 'expect', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['study', 'meet_primary_endpoint', 'secondary', 'endpoints'], ['post', 'marketing', 'commitment', 'submit', 'fda'], ['also', 'submit', 'support', 'indication', 'expansion', 'follow', 'triple_combination', 'approval'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'result', 'global', 'phase_study', 'trikafta', 'ivacaftor', 'ivacaftor', 'people_cystic_fibrosis', 'age_year_old_copy', 'mutation', 'gating_mutation', 'copy_mutation', 'residual_function_mutation', 'study', 'meet_primary_endpoint', 'mean_absolute_group', 'change', 'percent_predict', 'force_expiratory_volume_second', 'ppfev_baseline', 'week', 'treatment', 'demonstrate', 'statistically_significant', 'percentage_point', 'improvement', 'patient', 'treat', 'trikafta', 'compare', 'baseline', 'run', 'in', 'treatment', 'ivacaftor', 'tezacaftor_ivacaftor', 'study', 'meet', 'secondary_endpoint', 'include', 'statistically_significant', 'mean', 'group', 'reduction', 'mmol', 'baseline', 'sweat_chloride', 'generally_well_tolerate', 'safety', 'datum', 'consistent_observe', 'previous_phase', 'study', 'trikafta'], ['study', 'post', 'marketing', 'commitment', 'result', 'submit', 'food', 'trikafta', 'already_approve', 'use', 'people', 'age_year_old_at', 'least_copy_mutation', 'include', 'population', 'evaluate', 'study', 'receive', 'positive_opinion', 'committee_medicinal_product', 'human_use_chmp', 'initial', 'triple_combination', 'application', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation', 'del_mutation', 'datum', 'announce_today', 'study', 'submit', 'agency', 'support', 'potential', 'indication', 'expansion', 'once', 'approval', 'grant', 'initial', 'triple_combination', 'application', 'full', 'study', 'result', 'submit', 'presentation', 'future', 'medical', 'meeting', 'publication'], ['result', 'study', 'demonstrate', 'triple_combination', 'provide', 'significant', 'additional', 'benefit', 'compare', 'exist', 'cftr_modulator', 'therapy', 'patient', 'add', 'robust', 'body', 'evidence', 'support', 'benefit', 'medicine', 'patient', 'at_least_mutation', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'look_forward', 'submit', 'datum', 'support', 'potential', 'indication', 'expansion', 'follow', 'initial', 'approval'], ['study'], ['datum', 'announce_today', 'global', 'phase_randomize_double', 'blind', 'parallel', 'group', 'study', 'evaluate', 'efficacy_safety', 'trikafta', 'people', 'age_year_old_copy', 'mutation', 'gating_mutation', 'copy_mutation', 'residual_function_mutation', 'participant', 'run', 'period', 'ivacaftor', 'tezacaftor_ivacaftor', 'follow', 'run', 'patient', 'randomize_receive', 'trikafta', 'remain', 'prior', 'regiman', 'ivacaftor', 'tezacaftor_ivacaftor', 'week', 'baseline', 'measure', 'end', 'run', 'period', 'prior', 'start', 'treatment', 'period', 'total', 'participant', 'receive', 'trikafta', 'patient', 'control', 'group', 'receive', 'ivacaftor', 'tezacaftor_ivacaftor'], ['primary_endpoint', 'study', 'mean_absolute_group', 'improvement', 'baseline_week', 'treatment', 'trikafta', 'demonstrate', 'statistically_significant', 'improvement', 'percentage_point'], ['study', 'meet', 'secondary_endpoint', 'include', 'order', 'statistical', 'testing', 'hierarchy', 'statistically_significant', 'mean_absolute_group', 'change', 'sweat_chloride', 'baseline_week', 'patient', 'treat', 'trikafta', 'group', 'mean', 'change', 'percentage_point', 'sweat_chloride', 'patient', 'treat', 'trikafta', 'compare', 'control', 'group', 'receive', 'ivacaftor', 'tezacaftor_ivacaftor'], ['overall', 'safety', 'datum', 'similar_observe', 'previous_phase', 'study', 'trikafta', 'generally_well_tolerate', 'majority_adverse_event_mild', 'moderate', 'most_common', 'adverse_event', 'occur', 'more', 'patient', 'regardless', 'treatment', 'arm', 'headache', 'serious_adverse_event', 'observe', 'patient', 'receive', 'trikafta', 'patient', 'receive', 'ivacaftor', 'tezacaftor_ivacaftor', 'study', 'patient', 'take', 'ivacaftor', 'tezacaftor_ivacaftor', 'patient', 'take', 'trikafta', 'discontinue', 'treatment', 'adverse_event'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'potential', 'benefit', 'trikafta', 'plan_submit', 'datum', 'full', 'study', 'result', 'expectation_regard', 'potential', 'approval', 'triple_combination_regiman', 'potential', 'expansion', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'approval', 'medicine', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['vertex_pharmaceutical_incorporate', 'report_second_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['source_version'], ['patient', 'first', 'benefit', 'access', 'medicine', 'approve', 'european'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'expand', 'reimbursement_agreement', 'cystic_fibrosis', 'medicine', 'include', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'ahead', 'medicine', 'anticipate', 'approval'], ['new', 'expand', 'agreement', 'include', 'reimburse', 'access', 'currently', 'license', 'medicine', 'ivacaftor', 'lumacaftor_ivacaftor', 'ivacaftor', 'as_well', 'triple_combination_therapy', 'approve', 'future', 'additional', 'license', 'indication', 'medicine'], ['chief_executive', 'officer_president', 'say', 'be', 'please', 'recognize', 'value', 'able', 'work', 'quickly', 'collaboratively', 'flexibly', 'expand', 'exist', 'reimbursement_agreement', 'include', 'triple_combination_therapy', 'advance', 'medicine', 'licence', 'ensure', 'eligible', 'patient', 'first', 'benefit', 'access', 'innovative', 'medicine', 'approval'], ['medicinal_product', 'human_use_chmp', 'recently', 'adopt_positive_opinion', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'treat', 'people_cystic_fibrosis', 'age_old', 'mutation_minimal', 'function_mutation', 'del_mutation_cystic_fibrosis', 'regulator_cftr_gene'], ['part', 'agreement', 'commit', 'submit', 'symkevi', 'care', 'excellence', 'nice', 'agree', 'timetable', 'allow', 'period', 'real_world', 'datum', 'collection', 'medicine'], ['work_closely', 'authority', 'aim', 'secure', 'equivalent', 'agreement', 'country', 'as_soon', 'possible'], ['medicine', 'reimburse', 'more', 'country_world', 'include', 'denmark'], ['cystic', 'cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people', 'worldwide_cf_progressive_multi', 'system', 'disease', 'affect_lung_liver_tract', 'sinus_sweat_gland_pancrea', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['ivacaftor_elexacaftor_combination_regimen', 'ivacaftor'], ['ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'investigational', 'medicine', 'develop', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'recently', 'receive', 'chmp', 'positive_opinion', 'expect', 'next_few', 'month'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes', 'company_update_learn', 'more_history', 'innovation_visit'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'press_release_statement', 'regard', 'expectation', 'patient', 'population', 'able', 'access', 'medicine', 'timing', 'such', 'access', 'commitment', 'submit', 'orkambi', 'period', 'real_world', 'datum', 'collection', 'plan', 'secure', 'additional', 'agreement', 'other', 'country', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'obtain_approval_commercialize', 'medicine', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], [], ['grant_marketing_authorization', 'people', 'age_old', 'mutation_minimal', 'function_mutation', 'first', 'time', 'able', 'benefit', 'medicine', 'treat', 'underlie', 'cause', 'disease'], ['people', 'year', 'age_old', 'mutation', 'also', 'eligible', 'new', 'triple_combination_regiman'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'committee_medicinal_product', 'human_use_chmp', 'adopt_positive_opinion', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'treat', 'people_cystic_fibrosis', 'age_old', 'mutation_minimal', 'function_mutation', 'del_mutation_cystic_fibrosis', 'regulator_cftr_gene', 'approve', 'up', 'people', 'age_old', 'mutation_minimal', 'function_mutation', 'newly_eligible', 'medicine', 'target', 'disease', 'cause', 'protein', 'defect', 'additionally', 'people', 'year', 'age_old', 'del_mutation', 'currently', 'eligible', 'vertex', 'other', 'approve', 'cystic_fibrosis', 'medicine', 'eligible', 'new', 'triple_combination_regiman'], ['positive_opinion', 'base', 'result', 'global', 'phase_study', 'people', 'placebo_control', 'study', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation', 'head', 'head', 'study', 'triple_combination_therapy', 'comparison', 'tezacaftor_ivacaftor', 'people', 'age_year_old', 'del_mutation', 'phase_study', 'show_statistically', 'significant_clinically', 'meaningful_improvement', 'lung_function', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'primary_endpoint', 'key_secondary_endpoint', 'study', 'ivacaftor', 'tezacaftor_elexacaftor', 'ivacaftor', 'combination', 'generally_well_tolerate'], ['clinical', 'datum', 'ivacaftor', 'tezacaftor_elexacaftor', 'ivacaftor', 'people', 'age_year_old', 'genotype', 'unprecedented', 'addition', 'improvement_lung_function', 'datum', 'show', 'improvement', 'multiple', 'important', 'outcome', 'measure', 'include', 'quality_life', 'measure', 'respiratory_domain_score', 'say', 'head', 'pulmonology', 'immunology', 'critical_care', 'medicine', 'clinical', 'patient', 'community', 'excited', 'more', 'people', 'able', 'benefit_cftr_modulator'], ['delighted', 'receive', 'positive_opinion', 'approve', 'first', 'cftr_modulator', 'people_mutation_minimal', 'function_mutation', 'bring', 'additional', 'benefit', 'people', 'mutation', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'milestone', 'bring_step_close', 'deliver', 'innovative', 'medicine', 'wait', 'ultimate_goal', 'provide', 'therapeutic', 'option', 'person', 'rare', 'devastating', 'disease'], ['ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'investigational', 'medicine', 'develop', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'submission', 'support', 'positive', 'result', 'global', 'phase_study', 'people', 'age_year_old', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'week', 'phase_study_people_del', 'mutation'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'bozic', 'press_release_statement', 'regard', 'expectation', 'approval', 'ivacaftor_elexacaftor_combination_regimen', 'ivacaftor', 'expectation_regard', 'eligible', 'patient', 'population', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'obtain_approval_commercialize', 'medicine', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['announce', 'gift', 'antiracist'], ['focus', 'curriculum', 'establish', 'partnership', 'year'], ['commitment', 'make', 'steam', 'education'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'vertex', 'foundation_nonprofit_charitable_foundation', 'commit', 'year', 'fight', 'racism', 'injustice', 'world'], ['donation', 'extension', 'long_stand', 'commitment', 'equity', 'diversity', 'inclusion', 'exist', 'work', 'foundation', 'promote', 'value', 'community', 'education_innovation', 'health', 'program'], ['antiracist', 'research'], ['part', 'commitment', 'foundation', 'donate', 'allocate', 'year', 'help', 'establish', 'antiracist', 'research', 'leadership', 'found', 'director', 'center', 'study', 'develop', 'new', 'way', 'understand', 'explain', 'solve', 'seemingly', 'intractable', 'problem', 'racial', 'inequity', 'injustice', 'first', 'corporate', 'foundation', 'partner', 'center', 'contribution', 'support', 'advance', 'critical', 'mission'], ['donation', 'support', 'research', 'datum', 'collection', 'identify', 'innovative', 'policy', 'reduce', 'eliminate', 'racial', 'disparity', 'include', 'health', 'disparity', 'order', 'extend', 'center', 'reach', 'university', 'spark', 'dialogue', 'action', 'broad', 'community', 'foundation', 'gift', 'also', 'support', 'establishment', 'annual', 'public', 'symposium', 'lead', 'center', 'wide_range', 'topic', 'relate', 'antiracism'], ['brown', 'say', 'creation', 'center', 'antiracist', 'research', 'leadership', 'milestone', 'commitment', 'lead', 'research', 'lead', 'policy', 'change', 'end', 'systemic', 'racism', 'very', 'grateful', 'vertex', 'vertex', 'foundation', 'financial', 'support', 'thought', 'partnership', 'take', 'great', 'societal', 'inequity', 'time'], ['strong', 'long_stand', 'commitment', 'create', 'diverse', 'inclusive', 'workplace', 'promote', 'social', 'justice', 'economic', 'educational', 'opportunity', 'community', 'today_announcement', 'reflect', 'ongoing', 'commitment', 'address', 'root', 'systemic', 'racism', 'injustice', 'community', 'broad', 'society', 'say_chief_executive_officer', 'president', 'proud', 'serve', 'ally', 'antiracist', 'today', 'gift', 'foundation', 'as_well', 'additional', 'donation', 'year', 'other', 'important', 'organization', 'vertex', 'extension', 'long_term', 'commitment', 'address', 'issue', 'head', 'community', 'employee', 'patient', 'serve'], ['know', 'launch', 'center', 'bright', 'spot', 'many', 'people', 'think', 'gift', 'brighten', 'much', 'more', 'say', 'found', 'nation', 'lead', 'scholar', 'racism', 'well', 'sell', 'author', 'vertex', 'foundation', 'realize', 'importance', 'seriousness', 'work', 'take', 'lead'], ['year'], ['corporate', 'office', 'make', 'new', 'multiyear', 'commitment', 'year', 'establish', 'first', 'ever', 'biotechnology', 'curriculum', 'prepare', 'young', 'adult', 'future', 'career', 'research', 'development', 'medicine', 'year', 'up', 'mission', 'close', 'opportunity', 'divide', 'ensure', 'young', 'adult', 'gain', 'skill', 'experience', 'support', 'empower', 'reach', 'potential', 'career', 'high', 'education'], ['year', 'look_forward', 'partner', 'vertex', 'create', 'career', 'pathway', 'biotech', 'student', 'majority', 'black', 'hispanic', 'latino', 'say', 'year', 'founder', 'enable', 'young', 'people', 'color', 'launch', 'career', 'more', 'high', 'growth', 'industry', 'drive', 'real', 'change', 'behalf', 'social', 'justice', 'racial', 'equity', 'corporate'], ['addition', 'commitment', 'vertex', 'also', 'enhance', 'support', 'long_stand', 'partner', 'include'], ['additional', 'foundation', 'commitment'], ['foundation', 'longstanding', 'commitment', 'organization', 'promote', 'education_innovation', 'health', 'especially', 'focus', 'minority', 'girl', 'woman', 'foundation', 'augment', 'commitment', 'additional', 'donation', 'follow', 'organization', 'work', 'support', 'racial', 'social', 'justice'], ['foundation', 'also', 'double', 'match', 'employee', 'charitable', 'donation', 'eligible', 'organization', 'support', 'social', 'racial', 'justice'], ['source_version'], ['medium', 'international'], ['pharmaceutical_incorporate', 'today_announce', 'foundation_nonprofit_charitable_foundation', 'donate', 'brl', 'arcah', 'institution', 'promote', 'reintegration', 'people', 'experience', 'homelessness', 'society', 'support', 'response', 'fund'], ['people', 'experience', 'homelessness', 'severely', 'impact', 'reception', 'center', 'where', 'social', 'isolation', 'possible', 'face', 'increase', 'demand', 'support', 'hygiene', 'care', 'protective', 'measure', 'half', 'population', 'people', 'experience', 'homelessness', 'live', 'reception', 'center', 'however', 'access', 'soap', 'alcohol', 'sanitize', 'gel', 'wipe', 'face', 'mask', 'limit'], ['funding', 'allow', 'arcah', 'purchase', 'critical', 'protective', 'resource', 'resident', 'reception', 'center', 'healthcare', 'worker', 'donation', 'part', 'global', 'commitment', 'support', 'pandemic', 'response', 'also', 'include', 'double', 'match', 'employee', 'charitable', 'donation', 'eligible', 'organization', 'provide', 'front_line', 'response', 'foundation', 'fund', 'help', 'organization', 'provide', 'emergency_relief_assistance', 'global', 'community', 'where', 'vertex', 'employee', 'live', 'work', 'focus', 'provide', 'health_care', 'supply', 'support', 'vulnerable_population'], ['donation', 'receive', 'use', 'hygiene', 'protection', 'item', 'distribute', 'more', 'reception', 'center', 'city', 'help', 'reduce', 'contagion', 'preserve', 'health', 'people', 'already', 'risk', 'behalf', 'reception', 'center', 'benefit', 'donation', 'thank', 'say', 'co_founder', 'organization', 'arcah'], ['commit', 'give', 'back', 'local', 'community', 'where', 'presence', 'therefore', 'responsibility', 'active', 'member', 'time', 'priority', 'address', 'unprecedented', 'need', 'result', 'particularly', 'hard', 'hit', 'country', 'our', 'say', 'work', 'support', 'people', 'live', 'pandemic', 'security', 'permanent', 'home', 'testimony', 'brazilian', 'spirit', 'courage', 'unity', 'deep', 'thank', 'prayer', 'go', 'work', 'ground', 'help', 'vulnerable_population'], [], ['civil', 'society', 'organization', 'promote', 'reintegration', 'people', 'experience', 'homelessness', 'society', 'promote', 'socio', 'professional', 'training', 'volunteer', 'activity'], ['foundation', 'carry', 'initiative', 'objective', 'understand', 'challenge', 'experience', 'homeless', 'population', 'find', 'effective', 'solution', 'contribute', 'resumption', 'autonomy', 'self', 'esteem', 'confidence', 'visit', 'learn_more'], ['nonprofit_charitable', 'foundation', 'seek', 'improve', 'life', 'people', 'serious_disease', 'community', 'education_innovation', 'health', 'program', 'establish', 'foundation', 'long_term', 'source', 'charitable', 'giving', 'part', 'vertex_pharmaceutical', 'corporate', 'give', 'commitment'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'medicine', 'people', 'serious_disease', 'company', 'multiple_approve', 'medicine', 'treat_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], [], ['international'], ['pharmaceutical_incorporate', 'today_announce', 'foundation_nonprofit_charitable_foundation', 'donate', 'tafel', 'food_bank', 'pantry', 'support', 'response'], ['front_line', 'organization', 'severely', 'impact', 'face', 'increase', 'demand', 'support', 'operational', 'capacity', 'strain', 'network', 'see', 'challenge', 'logistic', 'decrease', 'traditional', 'food', 'donation', 'as_well', 'many', 'volunteer', 'stay', 'home', 'risk', 'work', 'tirelessly', 'food', 'people', 'country', 'need', 'most'], ['funding', 'help', 'network', 'adapt', 'pandemic', 'client', 'example', 'develop', 'home', 'delivery', 'contactless', 'supply', 'donation', 'part', 'global', 'commitment', 'support', 'pandemic', 'response', 'also', 'include', 'double', 'match', 'employee', 'charitable', 'donation', 'eligible', 'organization', 'front_line', 'foundation', 'fund', 'support', 'organization', 'provide', 'emergency_relief_assistance', 'global', 'community', 'where', 'vertex', 'employee', 'live', 'work', 'focus', 'provide', 'health_care', 'supply', 'support', 'vulnerable_population'], ['behalf', 'network', 'like_thank', 'vertex_pharmaceutical', 'generous', 'donation', 'thank', 'support', 'continue', 'collect', 'food', 'same', 'time', 'help', 'people', 'face', 'financial', 'difficulty', 'poor', 'people', 'hit', 'hard', 'coronaviru', 'unfortunately', 'already', 'see', 'many', 'new', 'face', 'food', 'pantry', 'also', 'very', 'much', 'want', 'help', 'comment', 'chairman'], ['make', 'indispensable', 'contribution', 'people', 'need', 'time', 'particularly', 'important', 'support', 'people', 'need', 'maintain', 'same', 'time', 'want', 'see', 'user', 'tafel', 'as_well', 'volunteer', 'protect', 'therefore', 'very_pleased', 'able', 'support', 'alternative', 'contactless', 'supply_chain', 'tafel', 'say', 'general', 'manager'], [], ['german', 'food_bank', 'system', 'more', 'volunteer', 'foodbank', 'volunteer', 'commit', 'more', 'hour', 'annually', 'organization', 'seek', 'reduce', 'food', 'waste', 'reallocation', 'socially', 'economically', 'disadvantaged', 'population', 'population', 'include', 'people', 'include', 'child', 'youth', 'visit', 'learn_more'], ['foundation_nonprofit_charitable_foundation', 'seek', 'improve', 'life', 'people', 'serious_disease', 'community', 'education_innovation', 'health', 'program', 'establish', 'foundation', 'long_term', 'source', 'charitable', 'giving', 'part', 'vertex_pharmaceutical', 'corporate', 'give', 'commitment'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'medicine', 'people', 'serious_disease', 'company', 'multiple_approve', 'medicine', 'treat_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['patient', 'transfusion_independent', 'month', 'infusion', 'datum', 'demonstrate', 'clinical_proof_concept', 'transfusion_dependent_beta_thalassemia'], ['cell', 'disease', 'patient', 'free_vaso_occlusive_crisis', 'month', 'infusion'], ['patient', 'beta_thalassemia', 'patient', 'sickle', 'cell', 'disease', 'treat', 'date', 'successfully', 'engrafted'], ['pharmaceutical_incorporate', 'today_announce', 'new', 'clinical', 'datum', 'investigational', 'crispr_gene_edit', 'therapy', 'phase', 'trial', 'transfusion_dependent_beta_thalassemia', 'severe_sickle', 'cell', 'disease', 'highlight', 'recent', 'progress', 'development', 'program', 'datum', 'present', 'oral_presentation', 'virtual', 'pediatric', 'chair', 'pediatric_hematology_oncology', 'stem', 'cell'], ['climb', 'trial', 'transfusion_dependent_beta_thalassemia', 'update', 'result', 'datum', 'present', 'today', 'demonstrate', 'clinical_proof_concept', 'datum', 'include', 'long', 'duration', 'follow', 'datum', 'first', 'patient', 'treat', 'new', 'datum', 'second', 'patient', 'treat', 'vertex', 'announce', 'initial', 'datum', 'first', 'patient'], ['patient', 'ivs', 'genotype', 'associate', 'severe', 'phenotype', 'similar', 'transfusion_requirement', 'unit', 'packed', 'red_blood_cell', 'year', 'annualize_rate', 'year', 'prior', 'consent', 'trial', 'enrol', 'clinical_trial', 'previously', 'report', 'patient', 'achieve', 'day', 'infusion', 'platelet', 'engraftment', 'day', 'infusion', 'infusion', 'serious_adverse_event', 'sae_occur', 'principal', 'investigator', 'consider_related', 'presence', 'occlusive', 'liver', 'disease', 'attribute', 'busulfan_conditioning', 'subsequently', 'resolve', 'new', 'datum', 'present', 'today', 'show', 'month', 'infusion', 'patient', 'transfusion_independent', 'total_hemoglobin_level_fetal', 'cell', 'erythrocyte', 'express', 'fetal_hemoglobin', 'bone', 'marrow', 'editing', 'month', 'year'], ['patient', 'ivs', 'genotype', 'transfusion_requirement', 'unit', 'packed', 'red_blood_cell', 'year', 'annualize_rate', 'year', 'prior', 'consent', 'trial', 'enrol', 'clinical_trial', 'patient', 'achieve', 'day', 'infusion', 'platelet', 'engraftment', 'day', 'infusion', 'infusion', 'sae_occur', 'pi', 'consider_related', 'upper', 'respiratory_tract_infection', 'subsequently', 'resolve', 'month', 'infusion', 'patient', 'transfusion_independent', 'total_hemoglobin_level_fetal', 'hemoglobin', 'cell', 'erythrocyte', 'express', 'fetal_hemoglobin'], ['hemoglobin', 'datum', 'time', 'present', 'patient', 'patient', 'below'], ['figure', 'accompany', 'announcement', 'available'], ['trial', 'severe_sickle', 'cell', 'disease', 'update', 'result', 'datum', 'present', 'today', 'reflect', 'long', 'duration', 'follow', 'datum', 'first', 'patient', 'scd', 'treat', 'crispr', 'therapeutic', 'vertex', 'announce', 'initial', 'datum', 'first', 'scd', 'patient'], ['patient', 'experience', 'vaso_occlusive', 'crisis', 'packed', 'red_blood_cell', 'transfusion', 'year', 'annualize_rate', 'year', 'prior', 'consent', 'trial', 'enrol', 'clinical_trial', 'previously', 'report', 'patient', 'achieve', 'engraftment', 'day', 'infusion', 'infusion', 'sae_occur', 'none', 'pi', 'consider_related', 'sepsis', 'presence', 'cholelithiasis', 'abdominal_pain', 'subsequently', 'resolve', 'new', 'datum', 'present', 'today', 'show', 'month', 'infusion', 'patient', 'free', 'transfusion_independent', 'total_hemoglobin_level_fetal', 'hemoglobin', 'cell', 'erythrocyte', 'express', 'fetal_hemoglobin', 'bone', 'marrow', 'editing', 'month', 'figure', 'present', 'hemoglobin', 'datum', 'time', 'patient'], ['figure', 'accompany', 'announcement', 'available'], ['new', 'datum', 'begin', 'see', 'early', 'evidence', 'potential', 'durability', 'benefit', 'treatment', 'as_well', 'consistency', 'therapeutic', 'effect', 'patient', 'say_chief_executive_officer', 'highly', 'encouraging', 'early', 'datum', 'represent', 'more', 'step', 'deliver', 'promise', 'potential', 'therapy', 'new_class', 'potentially_transformative', 'medicine', 'treat', 'serious_disease'], ['datum', 'announce_today', 'remarkable', 'include', 'demonstration', 'clinical_proof_concept', 'say_chief_executive_officer', 'president', 'still', 'early', 'day', 'datum', 'mark_important', 'milestone', 'program', 'field', 'gene_edit', 'result', 'present', 'medical', 'conference', 'add', 'result', 'previously', 'share', 'demonstrate', 'gene_editing', 'potential', 'curative', 'therapy', 'severe', 'genetic', 'disease', 'sickle', 'cell', 'beta_thalassemia'], ['year', 'care', 'child', 'young', 'adult', 'face', 'sickle', 'cell', 'disease_beta_thalassemia', 'see', 'how', 'disease', 'adversely_affect', 'patient', 'life', 'very', 'significant', 'way', 'say', 'medical', 'director', 'pediatric_hematology_oncology', 'senior', 'author', 'abstract', 'present', 'virtual', 'encourage', 'preliminary', 'result', 'demonstrate', 'essence', 'functional_cure', 'patient', 'beta_thalassemia_sickle', 'cell', 'disease'], ['recent', 'progress', 'phase', 'clinical_trial', 'dose', 'total', 'patient', 'patient', 'successfully', 'engraft', 'trial', 'also', 'now', 'open', 'concurrent_dosing', 'successful', 'dosing', 'engraftment', 'first', 'patient', 'additionally', 'expand', 'allow', 'enrollment', 'patient', 'process', 'expand', 'allow', 'enrollment', 'pediatric', 'patient', 'age_year_old'], ['scd', 'dose', 'total', 'patient', 'patient', 'successfully', 'engraft', 'trial', 'also', 'now', 'open', 'concurrent_dosing', 'successful', 'dosing', 'engraftment', 'first', 'patient'], ['initial', 'safety_profile', 'trial', 'appear', 'consistent', 'myeloablative_busulfan', 'conditioning', 'autologous', 'hematopoietic_stem', 'cell', 'transplant'], ['clinical_trial', 'site', 'temporarily', 'pause', 'elective', 'hematopoietic_stem', 'cell', 'transplant', 'program', 'due', 'pandemic', 'result', 'crispr', 'temporarily', 'pause', 'conditioning', 'dosing', 'trial', 'enrollment', 'mobilization', 'drug', 'product', 'manufacturing', 'trial', 'remain', 'ongoing', 'company', 'now', 'process', 're', 'initiating', 'dosing', 'certain', 'clinical_trial', 'site', 'clinical_trial', 'ongoing', 'patient', 'follow', 'year', 'follow', 'infusion', 'company', 'expect', 'provide', 'additional', 'datum', 'second_half'], ['investigational', 'vivo_gene_edit', 'therapy', 'evaluate', 'patient', 'suffer_severe_scd', 'patient', 'hematopoietic_stem', 'cell', 'engineer_produce_high_level', 'fetal_hemoglobin_red_blood', 'cell', 'form_oxygen_carry_hemoglobin', 'naturally_present_birth_then', 'switch_adult', 'form_hemoglobin', 'elevation_hbf_potential_alleviate', 'transfusion_requirement', 'patient', 'reduce_painful', 'debilitate_sickle_crisis', 'scd', 'patient'], ['base', 'progress', 'program', 'date_grant_regenerative', 'medicine', 'advanced', 'therapy', 'rmat_designation', 'fast_track_designation', 'scd', 'tdt'], ['ongoing_phase_open', 'label_trial', 'climb_design_assess_safety', 'efficacy_single', 'dose', 'patient', 'age', 'trial', 'enroll', 'patient', 'follow', 'patient', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'follow', 'trial'], ['ongoing_phase_open', 'label_trial', 'climb_design_assess_safety', 'efficacy_single', 'dose', 'patient', 'age', 'severe_scd', 'trial', 'enroll', 'patient', 'follow', 'patient', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'follow', 'trial'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security_amend', 'include', 'statement', 'make', 'frangoul', 'press_release', 'as_well', 'statement', 'regard', 'expectation', 'follow', 'status_clinical_trial', 'include_limitation', 'expect', 'timing', 'datum', 'release', 'activity', 'clinical_trial', 'site', 'relate', 'product_candidate', 'development', 'collaborator', 'include', 'expectation_regard', 'datum', 'present', 'expect', 'benefit', 'collaboration', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'forward_look_statement', 'promise_guarantee_necessarily_subject', 'high_degree', 'uncertainty', 'risk', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'impact_due_coronavirus', 'pandemic', 'such', 'timing_progress', 'clinical_trial', 'potential', 'initial_preliminary', 'datum', 'clinical_trial', 'initial_datum_limited', 'number', 'patient', 'case_time_indicative', 'final', 'trial', 'result', 'potential', 'clinical_trial', 'result', 'favorable', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party_outcome_proceeding', 'such', 'interference_opposition_similar_proceeding', 'involve_portion', 'such', 'intellectual_property', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available_website_existing', 'prospective_investor_caution_place', 'undue_reliance', 'forward_look_statement', 'speak_only_date', 'make_disclaim_obligation', 'undertaking_update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'frangoul', 'press_release_statement', 'regard', 'plan', 'expectation', 'clinical_trial', 'clinical_trial', 'site', 'expectation_regard', 'future', 'datum', 'announcement', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['ivacaftor', 'first', 'only', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'patient', 'mutation', 'most_common', 'residual_function_mutation', 'child', 'as', 'young', 'month', 'age'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant', 'approval', 'label_extension', 'ivacaftor', 'include', 'treatment', 'child_adolescent', 'cystic_fibrosis_age', 'month_old_weigh', 'least_kg', 'mutation_cystic_fibrosis', 'regulator_cftr_gene', 'most_common', 'residual_function_mutation', 'underlie'], ['little', 'year', 'ago', 'approve', 'first', 'only', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'patient', 'specific', 'mutation', 'say_chief_executive_officer', 'president', 'then', 'goal', 'ensure', 'as', 'many', 'people', 'possible', 'able', 'benefit', 'treatment', 'today', 'mean', 'approximately', 'young', 'patient', 'long', 'await', 'treatment_option', 'now', 'eligible'], ['now', 'approve', 'ivacaftor', 'immediately', 'available', 'additional', 'eligible', 'patient', 'shortly', 'country', 'where', 'respective', 'long_term', 'reimbursement_agreement', 'previously', 'secure', 'vertex', 'work_closely', 'other', 'relevant', 'government', 'authority', 'secure_access_eligible', 'patient', 'as_quickly_possible'], ['ivacaftor', 'already_approve', 'treatment', 'people', 'age_old', 'mutation', 'infant', 'age_month', 'old_weigh_least_kg', 'follow', 'mutation', 'cftr', 'gene'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'make', 'press_release_statement', 'regard', 'expectation', 'availability', 'plan', 'secure_access_eligible', 'patient', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'commercialize', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news'], [], [], [], ['pharmaceutical_incorporate', 'today_announce', 'appoint', 'board_director', 'independent', 'director', 'senior', 'technology', 'leader', 'innovator', 'deep', 'experience', 'pharma', 'biotechnology', 'technology', 'most', 'recently', 'serve', 'chief', 'information', 'officer', 'cloud', 'base', 'financial', 'human', 'capital', 'software', 'company', 'prior', 'serve', 'svp', 'chief', 'information', 'officer', 'lead', 'biotechnology', 'company'], ['thrilled', 'join', 'board', 'corporate', 'leadership', 'experience', 'industry', 'knowledge', 'passion', 'leverage', 'technology', 'drive', 'innovation', 'give', 'unique', 'perspective', 'industry', 'broad', 'robust', 'skillset', 'make', 'valuable', 'contributor', 'board_director', 'say', 'executive_chairman'], ['honor', 'join', 'company', 'industry', 'lead', 'track_record', 'discover_develop', 'commercialize', 'innovative', 'medicine', 'treat', 'serious_disease', 'say', 'look_forward', 'work', 'fellow', 'director', 'support', 'mission', 'create', 'more', 'transformative_medicine_people', 'serious_disease'], ['prior', 'spend', 'year', 'company', 'various', 'leadership', 'role', 'focus', 'drug', 'development', 'reduce', 'time', 'market', 'improve', 'technology', 'security', 'standard', 'current', 'member', 'board_director', 'special', 'advisor', 'hold', 'bachelor', 'science', 'degree', 'computer', 'information', 'system', 'complete', 'information', 'technology', 'management', 'program'], ['addition', 'bring', 'director', 'member', 'independent', 'woman'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['pharmaceutical_incorporate', 'today_announce', 'new', 'datum', 'ongoing', 'phase', 'clinical_trial', 'crispr_gene_edit', 'therapy', 'severe', 'accept', 'oral_presentation', 'take_place', 'virtually'], ['abstract', 'post', 'online', 'today', 'include', 'month', 'follow', 'datum', 'first', 'patient', 'treat', 'ongoing', 'phase', 'trial', 'transfusion_dependent_beta_thalassemia', 'month', 'follow', 'datum', 'first', 'patient', 'treat', 'ongoing', 'phase', 'trial', 'severe_sickle', 'cell', 'disease', 'scd', 'update', 'datum', 'present', 'include', 'long', 'duration', 'follow', 'datum', 'first', 'patient', 'treat', 'trial', 'initial', 'datum', 'second', 'patient', 'treat', 'trial'], ['accept', 'abstract', 'now', 'available', 'conference', 'website', 'eha', 'key', 'information'], ['title', 'initial', 'safety_efficacy', 'result', 'single_dose', 'autologous', 'crispr_cas', 'modify', 'cd', 'hematopoietic_stem', 'progenitor', 'cell', 'transfusion_dependent', 'thalassemia_sickle', 'cell', 'disease', 'title', 'immunotherapy', 'clinical', 'abstract', 'code'], ['phase_study', 'transfusion_dependent_beta_thalassemia', 'ongoing_phase_open', 'label_trial', 'climb_design_assess_safety', 'efficacy_single', 'dose', 'patient', 'age', 'study', 'enroll', 'patient', 'follow', 'patient', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'follow', 'study'], ['phase_study', 'sickle', 'cell', 'disease', 'ongoing_phase_open', 'label_trial', 'climb_design_assess_safety', 'efficacy_single', 'dose', 'patient', 'age', 'severe_scd', 'study', 'enroll', 'patient', 'follow', 'patient', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'follow', 'study'], ['investigational', 'vivo_gene_edit', 'therapy', 'evaluate', 'patient', 'suffer_severe_scd', 'patient', 'hematopoietic_stem', 'cell', 'engineer_produce_high_level', 'fetal_hemoglobin_red_blood', 'cell', 'form_oxygen_carry_hemoglobin', 'naturally_present_birth_then', 'replace', 'adult_form', 'hemoglobin_elevation', 'hbf_potential', 'alleviate_transfusion', 'requirement', 'patient', 'painful_debilitate_sickle_crisis', 'scd', 'patient', 'most', 'advanced', 'gene_edit', 'approach', 'development', 'beta_thalassemia', 'scd'], ['develop', 'co', 'development', 'co', 'agreement', 'vertex'], ['lead', 'gene_edit', 'company', 'focus', 'develop', 'transformative', 'gene', 'base', 'medicine', 'serious_disease', 'use', 'proprietary', 'crispr', 'platform', 'cas', 'revolutionary', 'gene_edit', 'technology', 'allow', 'precise', 'direct', 'change', 'establish', 'portfolio', 'therapeutic', 'program', 'broad_range', 'disease', 'area', 'include', 'oncology', 'regenerative_medicine', 'rare', 'disease', 'accelerate', 'expand', 'effort', 'establish', 'strategic', 'partnership', 'lead', 'company', 'include', 'bayer', 'vertex_pharmaceutical', 'headquarter', 'wholly_own', 'subsidiary', 'operation', 'base', 'business', 'office', 'more_information_visit', 'wwwcrisprtxcom'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security_amend', 'include', 'statement', 'regard', 'expectation', 'follow', 'status_clinical_trial', 'include_limitation', 'expect', 'timing', 'datum', 'release', 'relate', 'product_candidate', 'development', 'collaborator', 'include', 'expectation_regard', 'datum', 'expect', 'present', 'expect', 'benefit', 'collaboration', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'forward_look_statement', 'promise_guarantee_necessarily_subject', 'high_degree', 'uncertainty', 'risk', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'impact_due_coronavirus', 'pandemic', 'such', 'timing_progress', 'clinical_trial', 'potential', 'initial_preliminary', 'datum', 'clinical_trial', 'initial_datum_limited', 'number', 'patient', 'case_time_indicative', 'final', 'trial', 'result', 'potential', 'clinical_trial', 'result', 'favorable', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party_outcome_proceeding', 'such', 'interference_opposition_similar_proceeding', 'involve_portion', 'such', 'intellectual_property', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available_website_existing', 'prospective_investor_caution_place', 'undue_reliance', 'forward_look_statement', 'speak_only_date', 'make_disclaim_obligation', 'undertaking_update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['found_global_headquarters_now', 'locate_district', 'international_headquarters', 'additionally', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes', 'company_update_learn', 'more_history', 'innovation_visit', 'follow'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'information', 'regard', 'datum', 'expect', 'present', 'upcoming', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'development', 'proceed', 'support_registration', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['pharmaceutical_incorporate_investor_medium'], ['pharmaceutical_incorporate', 'today_announce', 'food', 'grant_regenerative', 'medicine', 'advanced', 'therapy', 'rmat_designation', 'investigational_autologous_gene_edit', 'hematopoietic_stem', 'cell', 'therapy', 'treatment', 'severe_sickle', 'cell', 'disease', 'transfusion_dependent_beta_thalassemia', 'tdt'], ['designation', 'important', 'regulatory', 'milestone', 'underscore', 'transformative', 'potential', 'crispr', 'base', 'therapy', 'patient', 'severe', 'say_chief_executive_officer', 'expect', 'share', 'additional', 'clinical', 'datum', 'medical', 'scientific', 'forum', 'year', 'continue', 'work_closely', 'global', 'regulatory_agency', 'expedite', 'clinical', 'development'], ['first', 'clinical', 'datum', 'announce', 'late', 'last', 'year', 'represent', 'key', 'advancement', 'effort', 'bring', 'crispr', 'base', 'therapy', 'people', 'beta_thalassemia_sickle', 'cell', 'disease', 'demonstrate', 'curative', 'potential', 'therapy', 'say_executive_vice', 'president_chief', 'cell', 'genetic', 'therapy', 'vertex', 'encourage', 'recent', 'regulatory', 'designation', 'speak', 'potential', 'impact', 'therapy', 'patient'], ['establish', 'st', 'designation', 'dedicated', 'program', 'design', 'expedite', 'drug', 'development', 'review', 'process', 'promise', 'pipeline', 'product', 'include', 'genetic', 'therapy', 'regenerative_medicine', 'therapy', 'eligible', 'rmat_designation', 'intend', 'treat', 'modify', 'reverse', 'cure', 'serious_life_threaten', 'disease', 'condition', 'preliminary', 'clinical', 'evidence', 'indicate', 'drug', 'therapy', 'potential', 'address_unmet', 'medical', 'need', 'such', 'disease', 'condition', 'similar', 'breakthrough', 'therapy', 'designation', 'designation', 'provide', 'benefit', 'intensive', 'guidance', 'efficient', 'drug', 'development', 'include', 'ability', 'early', 'interaction', 'discuss', 'surrogate', 'intermediate', 'endpoint', 'potential', 'way', 'support', 'accelerated_approval', 'satisfy', 'post', 'approval', 'requirement', 'potential', 'priority_review', 'license', 'application', 'other', 'opportunity', 'expedite', 'development', 'review'], ['addition', 'rmat_designation', 'receive', 'drug', 'designation', 'scd', 'also', 'fast_track', 'designation_tdt_scd'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security_amend', 'include', 'statement', 'regard', 'expectation', 'follow', 'status_clinical_trial', 'include_limitation', 'expect', 'timing', 'datum', 'release', 'discussion', 'regulatory_authority', 'relate', 'product_candidate', 'development', 'collaborator', 'include', 'expectation_regard', 'benefit', 'rmat_designation', 'expect', 'benefit', 'collaboration', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'forward_look_statement', 'promise_guarantee_necessarily_subject', 'high_degree', 'uncertainty', 'risk', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'impact_due_coronavirus', 'pandemic', 'such', 'timing_progress', 'clinical_trial', 'potential', 'initial_preliminary', 'datum', 'clinical_trial', 'initial_datum_limited', 'number', 'patient', 'case_time_indicative', 'final', 'trial', 'result', 'potential', 'clinical_trial', 'result', 'favorable', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party_outcome_proceeding', 'such', 'interference_opposition_similar_proceeding', 'involve_portion', 'such', 'intellectual_property', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available_website_existing', 'prospective_investor_caution_place', 'undue_reliance', 'forward_look_statement', 'speak_only_date', 'make_disclaim_obligation', 'undertaking_update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['found_global_headquarters_now', 'locate_district', 'international_headquarters', 'additionally', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'information', 'provide', 'regard', 'status', 'expectation', 'respect', 'clinical', 'development', 'program', 'relate', 'global', 'regulatory_approval', 'expectation_regard', 'rmat_designation', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'development', 'proceed', 'support_registration', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['pharmaceutical_incorporate_investor_medium'], ['donation', 'frontline_food', 'supply', 'meal', 'worker', 'woman'], ['purchase', 'meal', 'local', 'restaurant', 'also', 'support', 'restaurant', 'employee', 'impact', 'economically'], ['pharmaceutical_incorporate', 'today_announce', 'foundation_nonprofit_charitable_foundation', 'cover', 'cost', 'meal', 'local', 'restaurant', 'front_line', 'health_care', 'worker', 'hospital', 'week', 'deal', 'impact', 'city'], ['donation', 'part', 'recent', 'commitment', 'foundation', 'support', 'organization', 'provide', 'ground', 'emergency_relief_assistance', 'focus', 'essential', 'health_care', 'health', 'supply', 'provide', 'support', 'vulnerable_population', 'global', 'community', 'where', 'vertex', 'operate'], ['partner', 'organization', 'frontline_food', 'foundation', 'make', 'donation', 'ensure', 'front_line', 'health_care', 'worker', 'woman', 'receive', 'total', 'nutritious', 'meal', 'start', 'meal', 'feed', 'physician', 'nurse', 'janitorial', 'staff', 'security', 'other', 'work', 'front_line', 'pandemic', 'purchase', 'meal', 'local', 'restaurant', 'also', 'help', 'support', 'employee', 'affect', 'economic', 'impact', 'several', 'restaurant', 'partner', 'effort', 'include', 'flour', 'eastern', 'branch', 'line', 'orinoco'], ['front_line', 'health_care', 'worker', 'true', 'hero', 'pandemic', 'put', 'life', 'risk', 'day', 'help', 'patient', 'survive', 'say', 'chairman', 'pandemic', 'continue', 'fund', 'provide', 'thousand', 'nourish', 'meal', 'incredibly', 'grueling', 'shift', 'also', 'provide', 'economic', 'sustenance', 'local', 'restaurant', 'worker', 'together', 'humble', 'part', 'very', 'special', 'community', 'come', 'together', 'time', 'crisis', 'support', 'most', 'vulnerable'], ['want', 'thank', 'foundation', 'frontline_food', 'support', 'health_care', 'worker', 'unprecedented', 'public', 'health', 'economic', 'crisis', 'say', 'team', 'rise', 'daily', 'challenge', 'combat', 'comfort', 'community', 'support', 'thoughtful', 'effort', 'such'], ['so', 'appreciative', 'foundation', 'step', 'provide', 'full', 'week', 'meal', 'front_line', 'health_care', 'worker', 'hospital', 'say', 'true', 'gift', 'worker', 'hospital', 'restaurant', 'alike'], ['frontline_food', 'grassroots', 'organization', 'raise', 'money', 'community', 'pay', 'local', 'restaurant', 'prepare', 'meal', 'hero', 'respond', 'crisis', 'fuel', 'grow', 'army', 'volunteer', 'frontline_food', 'raise', 'deliver', 'more', 'meal', 'frontline', 'worker', 'more', 'hospital', 'nationwide', 'so', 'far', 'frontline_food', 'partner', 'world', 'central', 'kitchen', 'tax', 'exempt', 'register', 'charitable', 'organization'], ['approve', 'ivacaftor', 'first', 'only', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'patient', 'mutation', 'most_common', 'residual_function_mutation', 'young', 'month', 'age'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'committee_medicinal_product', 'human_use_chmp', 'adopt_positive_opinion', 'label_extension', 'ivacaftor', 'include', 'treatment', 'child_adolescent', 'cystic_fibrosis_age', 'month_old_weigh', 'least_kg', 'mutation_cystic_fibrosis', 'regulator_cftr_gene'], ['today_announcement', 'important', 'young', 'people', 'as_early', 'intervention', 'treatment', 'devastating', 'progressive', 'disease', 'key', 'keep', 'patient', 'healthy', 'long', 'say_vice_president_chief', 'medical_officer', 'milestone', 'also', 'bring_step_close', 'achieve', 'ultimate_goal', 'bring', 'medicine', 'forward', 'people'], ['now', 'review', 'positive_opinion', 'issue', 'favorable', 'adoption', 'ivacaftor', 'first', 'only', 'approve', 'medicine_treat_underlying', 'cause', 'patient', 'age_month', 'old', 'mutation', 'country', 'where', 'long_term', 'reimbursement_agreement', 'secure', 'ivacaftor', 'approve', 'available', 'eligible', 'patient', 'shortly', 'marketing_authorization', 'medicine', 'available', 'marketing_authorization', 'other', 'country', 'work_closely', 'relevant', 'authority', 'secure_access_eligible', 'patient', 'quickly'], ['ivacaftor', 'already_approve', 'treatment', 'people', 'age_old', 'mutation', 'child', 'age_month', 'old_weigh_least_kg', 'follow', 'mutation', 'cftr', 'gene'], ['found_global_headquarters_now', 'locate_district', 'international_headquarters', 'additionally', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_second_paragraph', 'press_release_statement', 'regard', 'expectation', 'approval', 'availability', 'plan', 'secure_access_eligible', 'patient', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'risk', 'relate', 'obtain', 'commercialize', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['revenue', 'increase_compare'], ['raise', 'revenue_guidance', 'now', 'expect', 'revenue', 'billion'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'first_quarter', 'end', 'revise', 'upward', 'full_year_financial_guidance', 'total', 'cystic_fibrosis', 'product_revenue'], ['pandemic', 'present', 'unprecedented', 'challenge', 'society', 'community', 'business', 'world', 'global', 'challenge', 'continue', 'time', 'come', 'very', 'proud', 'how', 'respond', 'ensure', 'continue', 'deliver', 'mission', 'patient', 'keep', 'employee', 'safe', 'achieve', 'business', 'goal', 'say_chief_executive_officer', 'president', 'importantly', 'business', 'continue', 'grow', 'first_quarter', 'thousand', 'patient', 'initiate', 'treatment', 'medicine', 'worldwide', 'launch', 'trikafta', 'remarkable', 'majority', 'eligible', 'patient', 'have', 'now', 'initiate', 'treatment', 'medicine', 'strong', 'interest', 'reflect', 'substantial', 'benefit', 'patient', 'result', 'significant', 'increase', 'revenue', 'support', 'continue', 'investment', 'internal', 'pipeline', 'business', 'development', 'effort', 'support', 'future', 'growth', 'look', 'ahead', 'continue', 'differentiate', 'focus', 'serial_innovation', 'investment', 'transformative_medicine', 'aim', 'underlying_cause', 'disease', 'breadth', 'pipeline', 'capability', 'financial', 'strength'], ['total_product_revenue', 'increase_compare', 'first_quarter', 'primarily_drive', 'uptake', 'trikafta', 'uptake', 'medicine', 'follow', 'completion', 'key', 'reimbursement_agreement'], ['gaap_non_gaap', 'net_income', 'increase', 'more', 'compare', 'first_quarter', 'largely_drive', 'strong', 'growth', 'total_product_revenue'], ['cash_cash', 'equivalent_marketable_security', 'increase', 'approximately', 'compare'], ['combine_gaap_non_gaap', 'expense', 'increase_compare', 'first_quarter', 'primarily_incremental', 'investment', 'support', 'global', 'use', 'vertex', 'medicine', 'expansion_pipeline', 'other', 'new', 'disease', 'area'], ['gaap_non_gaap', 'income_taxis', 'increase_compare', 'first_quarter', 'primarily_due', 'increase', 'operate', 'income', 'refer_supplemental', 'income_tax', 'information', 'discussion_cash', 'non_cash_component', 'provision_income_taxis'], ['supply_chain', 'approve', 'medicine'], ['ivacaftor'], ['continue', 'progress', 'expand', 'pipeline', 'program', 'clinic', 'span', 'various', 'disease', 'modality', 'stage', 'development', 'ensure', 'patient', 'safety', 'reduce', 'burden', 'healthcare', 'system', 'time', 'critical', 'need', 'vertex', 'temporarily', 'pause', 'delay', 'enrollment', 'certain', 'study'], ['focal', 'segmental', 'fsgs'], ['gaap', 'provision_income_taxis'], ['month_end', 'increase', 'fair_value_contingent_consideration', 'relate', 'potential', 'payment_exonic', 'former_equity_holder'], ['collaborative_revenue_expense', 'month_end', 'primarily_relate', 'collaborative', 'milestone_payment'], ['acquisition_relate_cost', 'month_end', 'relate_cost', 'associate', 'company', 'acquisition_exonic', 'comparable_amount_month_end'], ['month_end_tax_adjustment', 'primarily_relate', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'include', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'increase_decrease_fair', 'value', 'company', 'strategic_investment', 'collaborative', 'payment', 'month_end_tax_adjustment', 'also', 'include', 'non_recur', 'discrete_benefit', 'company', 'provision_income_taxis', 'approximately', 'company', 'exclude', 'non_gaap_measure'], ['company', 'record_provision_income_taxis', 'pre_tax_income', 'use', 'effective_tax_rate', 'approximating', 'statutory_rate', 'provision', 'include', 'significant', 'non_cash_charge', 'company', 'ability_offset', 'pre_tax_income', 'previously', 'benefit', 'net_operating_loss', 'company', 'expect', 'portion', 'tax_provision_represent', 'non_cash', 'expense', 'net_operating_loss', 'fully_utilize', 'company', 'federal_net_operating_loss', 'credit', 'available', 'offset', 'future', 'pre_tax_income', 'approximately'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'regulatory_filing', 'development', 'plan', 'timeline', 'company', 'drug_candidate', 'company', 'expectation_regard', 'effect', 'business_operation', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'net_product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'different', 'more', 'significant', 'impact', 'company', 'business_operation', 'company', 'currently', 'expect', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['company', 'host_conference_call_webcast', 'today', 'pm_access_call_dial', 'international', 'conference_call_webcast', 'live_link', 'webcast', 'access', 'website_wwwvrtxcom_investor_section', 'event', 'presentation_ensure_timely', 'connection_recommend_user_register', 'least_minute_prior_schedule', 'webcast_archive_webcast', 'available', 'company', 'website'], ['source_version_home'], ['investor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'public', 'health', 'travel', 'safety', 'concern', 'relate', 'ongoing', 'pandemic', 'annual_meeting', 'shareholder', 'hold', 'virtual', 'meeting', 'meeting', 'hold', 'exclusively', 'am_eastern', 'time', 'shareholder', 'record', 'date', 'meeting', 'attend', 'meeting', 'visit', 'follow', 'instruction', 'proxy_material'], ['further', 'announce', 'use', 'notice', 'access', 'method', 'provide', 'proxy_material', 'advance', 'annual_meeting', 'today', 'vertex', 'begin', 'mail', 'shareholder', 'record', 'date', 'notice', 'internet', 'availability', 'proxy_material', 'post', 'proxy_material', 'internet', 'notice', 'internet', 'availability', 'proxy_material', 'contain', 'instruction', 'how', 'access', 'company', 'proxy_material', 'online', 'include', 'proxy', 'statement', 'annual_report_form', 'year', 'end', 'as_well', 'instruction', 'how', 'shareholder', 'vote', 'share', 'annual_meeting', 'shareholder', 'request', 'paper', 'copy', 'proxy_material', 'annual_report'], ['more', 'information', 'shareholder', 'encourage', 'review', 'company', 'definitive', 'proxy', 'statement', 'file', 'today', 'shareholder', 'able', 'obtain', 'proxy', 'statement', 'amendment', 'supplement', 'proxy', 'statement', 'other', 'document_file', 'vertex', 'charge', 'visit', 'wwwsecgov', 'copy', 'also', 'available', 'company_website_wwwvrtxcom'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['proprietary', 'vector', 'technology', 'use', 'genetic', 'therapy', 'effort', 'focus', 'muscular_dystrophy', 'dystrophy_type', 'cystic_fibrosis'], ['vertex_pharmaceutical_incorporate', 'announce_today', 'company', 'enter_strategic', 'research', 'collaboration', 'engineer', 'novel', 'associate', 'virus', 'capsid', 'deliver', 'transformative', 'genetic', 'therapy', 'people', 'serious_disease', 'proprietary', 'aavsmartlibrary', 'associated', 'technology', 'provide', 'capsid', 'improved', 'tissue', 'tropism', 'pre', 'exist', 'immunity', 'collaboration', 'leverage', 'capsid', 'engineering', 'expertise', 'scientific', 'clinical', 'regulatory', 'capability', 'accelerate', 'development', 'genetic', 'therapy', 'people', 'affect', 'muscular_dystrophy', 'type', 'dm', 'cystic_fibrosis'], ['collaboration', 'enhance', 'exist', 'capability', 'discover_develop', 'transformative', 'therapy', 'people', 'serious_disease', 'say_vice_president_chief', 'cell', 'genetic', 'therapy', 'innovative', 'approach', 'discovery', 'design', 'capsid', 'bring', 'yet', 'tool', 'vertex', 'cell', 'genetic', 'therapy', 'toolkit', 'be', 'excited', 'partner', 'bring', 'together', 'technology_platform', 'research', 'development', 'expertise'], ['be', 'set', 'new', 'standard', 'genetic', 'therapy', 'leverage', 'platform', 'methodically', 'engineer', 'novel', 'aav', 'vector', 'unique', 'therapeutic', 'property', 'say_chief_executive_officer', 'establish', 'leader', 'develop', 'transformative_medicine', 'genetic', 'disease', 'renowned', 'scientific', 'rigor', 'thankful', 'scientific', 'validation', 'partnership', 'bring', 'look_forward', 'work_closely', 'advance', 'life', 'change', 'differentiated', 'genetic', 'therapy', 'make', 'meaningful', 'difference', 'affect', 'disease'], ['term', 'agreement', 'apply', 'vector', 'design', 'engineering', 'technology', 'develop', 'novel', 'capsid', 'improved', 'property', 'agreement', 'provide', 'vertex', 'exclusive', 'license', 'proprietary', 'technology', 'intellectual_property', 'dm', 'exclusive', 'option', 'license', 'right', 'additional', 'undisclosed', 'disease', 'scope', 'agreement', 'cover', 'genetic', 'therapy', 'modality', 'disease', 'therapeutic', 'eligible', 'receive_upfront', 'development', 'regulatory', 'commercial_milestone', 'include', 'upfront_payment', 'research', 'milestone', 'pay', 'research', 'term', 'tiere', 'royalty_future_net', 'global', 'sale', 'product', 'result', 'collaboration', 'responsible', 'discovery', 'capsid', 'meet', 'certain', 'pre', 'determined', 'criterion', 'vertex', 'responsible', 'fund', 'design', 'manufacturing', 'genetic', 'therapy', 'incorporate', 'select', 'capsid', 'preclinical', 'clinical', 'development', 'effort', 'approve', 'product', 'licensed', 'disease'], [], ['therapeutic', 'purpose', 'develop', 'gene', 'therapy', 'transformative', 'impact', 'people', 'affect', 'devastate', 'genetic', 'disease', 'proprietary', 'platform', 'enable', 'methodically', 'engineer', 'novel', 'aav', 'vector', 'gene', 'therapy', 'remarkable', 'tissue', 'targeting', 'other', 'property', 'build', 'world', 'class', 'capability', 'discover_develop', 'manufacture', 'commercialize', 'gene', 'therapy', 'product', 'initial', 'focus', 'muscle', 'central_nervous_system', 'disease', 'significant', 'unmet_need'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_second_paragraph', 'press_release_statement', 'third_paragraph_press_release', 'statement', 'regard', 'future', 'activity_party', 'pursuant_collaboration', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'belief_only_date_press', 'release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'vertex', 'realize_anticipate_benefit', 'collaboration', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['contact', 'investor'], ['medium'], ['contact', 'investor_medium'], ['source', 'pharmaceutical_incorporate', 'therapeutic'], ['vertex_pharmaceutical_incorporate', 'announce', 'foundation_nonprofit_charitable_foundation', 'donate', 'cad', 'food_bank', 'support', 'response', 'fund'], ['food_bank', 'severely', 'impact', 'face', 'increase', 'demand', 'support', 'operational', 'capacity', 'strain', 'many', 'see', 'drastic', 'reduction', 'food', 'recovery', 'effort', 'as_well', 'significant', 'drop', 'volunteer', 'yet', 'work', 'tirelessly', 'serve', 'rely', 'service', 'feel', 'safe', 'healthy'], ['funding', 'allow', 'food_bank', 'continue', 'purchase', 'food', 'other', 'necessity', 'donation', 'part', 'vertex', 'global', 'commitment', 'support', 'pandemic', 'response', 'include', 'double', 'match', 'employee', 'charitable', 'donation', 'eligible', 'organization', 'respond', 'pandemic', 'foundation', 'fund', 'help', 'organization', 'provide', 'emergency_relief_assistance', 'global', 'community', 'where', 'vertex', 'employee', 'live', 'work', 'focus', 'provide', 'health_care', 'supply', 'support', 'vulnerable_population'], ['thank', 'foundation', 'employee', 'support', 'neighbour', 'need', 'say', 'bank', 'money', 'use', 'purchase', 'food', 'keep', 'live', 'food', 'insecurity', 'afloat'], ['like', 'take', 'time', 'recognize', 'thank', 'employee', 'volunteer', 'currently', 'front_line', 'work', 'meet', 'basic', 'need', 'most', 'vulnerable', 'community', 'member', 'say', 'employee', 'volunteer', 'local', 'food_bank', 'past', 'hold', 'deep', 'appreciation', 'respect', 'impact', 'community'], ['food_bank'], ['food_bank', 'provide', 'national', 'leadership', 'relieve', 'hunger', 'today', 'prevent', 'hunger', 'tomorrow', 'collaboration', 'food_bank', 'network', 'coast', 'coast', 'coast', 'year', 'food_bank', 'dedicate', 'help', 'canadian', 'live', 'food', 'insecurity', 'food_bank', 'community', 'agency', 'come', 'together', 'serve', 'most', 'vulnerable', 'neighbour', 'last', 'year', 'make', 'visit', 'organization', 'month', 'alone', 'accord', 'hungercount', 'report', 'visit', 'learn_more'], ['nonprofit_charitable', 'foundation', 'seek', 'improve', 'life', 'people', 'serious_disease', 'community', 'education_innovation', 'health', 'program', 'establish', 'foundation', 'long_term', 'source', 'charitable', 'giving', 'part', 'vertex_pharmaceutical', 'corporate', 'giving', 'commitment'], ['source', 'pharmaceutical'], ['agreement', 'also', 'enable', 'possibility', 'rapid', 'patient', 'access', 'future', 'triple_combination', 'ivacaftor', 'ivacaftor', 'once', 'approve'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'reach', 'agreement', 'federal', 'swiss', 'federal', 'fsio', 'reimbursement', 'lumacaftor_ivacaftor', 'symdeko', 'ivacaftor', 'ivacaftor', 'eligible', 'patient', 'live_cystic_fibrosis'], ['term', 'agreement', 'announce_today', 'eligible', 'patient', 'age_year_old_copy', 'mutation_cystic_fibrosis', 'regulator_cftr_gene', 'treat', 'orkambi', 'eligible', 'patient', 'age_year_old_copy', 'mutation', 'copy_mutation_responsive', 'residual_function_mutation', 'cftr', 'gene', 'treat', 'symdeko', 'agreement', 'also', 'include', 'future', 'indication', 'extension', 'patient', 'different', 'age', 'symdeko'], ['agreement', 'also', 'enable', 'possibility', 'rapid', 'patient', 'access', 'potential', 'future', 'triple_combination', 'ivacaftor', 'ivacaftor', 'pende', 'marketing_authorization', 'swissmedic', 'swiss', 'agency', 'therapeutic', 'product', 'vertex', 'submit', 'application', 'swissmedic'], ['comment', 'today', 'news', 'fenaux_senior_vice', 'say', 'agreement', 'important_milestone', 'cystic_fibrosis', 'community', 'access', 'orkambi', 'symdeko', 'especially', 'important', 'time', 'give', 'outbreak', 'people', 'vulnerable', 'infection', 'pleased', 'vertex', 'swiss', 'authority', 'able', 'work_closely', 'flexibly', 'enable', 'agreement', 'almost', 'eligible', 'swiss', 'patient', 'now', 'access_cftr_modulator', 'treat_underlying_cause', 'disease'], ['medicine', 'reimburse', 'more', 'country_world', 'include', 'sweden'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'press_release_statement', 'regard', 'expectation', 'patient', 'population', 'able', 'access', 'vertex', 'medicine', 'timing', 'such', 'access', 'statement', 'plan_submit', 'marketing_authorization_application', 'triple_combination_regiman', 'swissmedic', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'obtain_approval_commercialize', 'elexacaftor_ivacaftor', 'develop', 'additional', 'medicine', 'treat_cystic_fibrosis', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news_home'], ['vertex_pharmaceutical_incorporate', 'report', 'first_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['source_version'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'foundation_nonprofit_charitable_foundation', 'commit', 'make', 'donation', 'total', 'support', 'global', 'relief', 'effort', 'include', 'double', 'match', 'employee', 'charitable', 'donation', 'eligible', 'organization', 'respond', 'pandemic', 'fund', 'help', 'organization', 'provide', 'emergency_relief_assistance', 'global', 'community', 'where', 'vertex', 'employee', 'live', 'work', 'focus', 'provide', 'health_care', 'supply', 'support', 'vulnerable_population'], ['immediate', 'priority', 'address', 'unprecedented', 'need', 'local', 'community', 'result', 'focused', 'provide', 'funding', 'organization', 'provide', 'immediate', 'access', 'health_care', 'health', 'supply', 'include', 'testing', 'personal', 'protective', 'equipment', 'hard', 'hit', 'country', 'work', 'ground', 'provide', 'vulnerable_population', 'food', 'care', 'education', 'say', 'chairman', 'foundation', 'executive_vice_president_chief', 'legal', 'administrative', 'business', 'development', 'officer'], ['essential', 'health_care', 'health', 'supply'], ['today_announce', 'commit', 'direct', 'relief', 'organization', 'dedicate', 'provide', 'essential', 'supply', 'health', 'worker', 'such', 'critical', 'personal', 'protective', 'equipment', 'mask', 'battery', 'power', 'oxygen', 'concentrator', 'ventilator', 'foundation', 'donation', 'help', 'establish', 'direct', 'relief', 'european', 'relief', 'effort', 'include', 'help', 'organization', 'expand', 'response'], ['direct', 'relief', 'deeply', 'grateful', 'foundation', 'generosity', 'support', 'relief', 'effort', 'allow', 'ramp', 'effort', 'say', 'direct', 'relief', 'president', 'significant', 'commitment', 'challenging', 'time', 'greatly', 'appreciate'], ['addition', 'foundation', 'also', 'support', 'follow', 'organization', 'help', 'provide', 'essential', 'health_care', 'health', 'supply'], ['support', 'vulnerable_population'], ['last', 'month', 'donate', 'help', 'establish', 'resiliency', 'fund', 'coordinate', 'fundraising', 'philanthropic', 'effort', 'assist', 'resident', 'health', 'well', 'most', 'immediately', 'impact', 'pandemic'], ['outpouring', 'support', 'generosity', 'see', 'private', 'philanthropic', 'partner', 'navigate', 'difficult', 'time', 'together', 'tremendous', 'say', 'foundation', 'instrumental', 'get', 'resiliency', 'fund', 'ground', 'support', 'frontline', 'worker', 'resident', 'most', 'need', 'thank', 'continue', 'effort', 'go', 'above', 'support', 'relief', 'effort', 'resident'], ['addition', 'foundation', 'announce_today', 'make', 'additional', 'donation', 'follow', 'organization', 'world', 'provide', 'essential', 'community', 'support', 'vulnerable_population', 'specifically', 'food', 'care', 'education'], ['source_version'], ['today', 'donation', 'part', 'recent', 'commitment', 'support', 'global', 'relief'], ['pharmaceutical_incorporate', 'today_announce', 'foundation_nonprofit_charitable_foundation', 'donate', 'additional', 'support', 'relief', 'effort', 'most', 'vulnerable', 'community', 'fund', 'help', 'organization', 'provide', 'emergency_relief_assistance', 'western', 'southern', 'region', 'state', 'include', 'provide', 'more', 'meal', 'need'], ['virus', 'continue', 'spread', 'become', 'clear', 'certain', 'community', 'resident', 'more', 'vulnerable', 'impact', 'pandemic', 'lack', 'access', 'basic', 'food', 'care', 'education', 'say', 'chairman', 'today', 'donation', 'focus', 'provide', 'essential', 'community', 'support', 'particularly', 'risk', 'fall'], ['today_announcement', 'include', 'donation', 'follow', 'charity'], ['extremely', 'grateful', 'very', 'generous', 'donation', 'critical', 'time', 'nation', 'history', 'say', 'director', 'food', 'support', 'enable', 'provide', 'emergency', 'food', 'assistance', 'ever', 'great', 'number', 'people', 'western', 'mass', 'lose', 'job', 'impact', 'local', 'economy'], ['only', 'defeat', 'pandemic', 'rally', 'together', 'support', 'other', 'time', 'need', 'say', 'generous', 'contribution', 'foundation', 'support', 'organization', 'way', 'great', 'fall', 'river', 'effort', 'lift', 'community', 'lead', 'safe', 'healthy', 'future'], ['grateful', 'foundation', 'generous', 'donation', 'support', 'community', 'organization', 'here', 'western', 'say', 'just', 'countless', 'business', 'step', 'aid', 'community', 'wake', 'pandemic', 'kindness', 'ensure', 'most', 'vulnerable', 'continue', 'care'], ['donation', 'announce_today', 'addition', 'donation', 'foundation', 'make', 'last', 'month', 'help', 'establish', 'resiliency', 'fund', 'coordinate', 'fundraising', 'philanthropic', 'effort', 'assist', 'resident', 'health', 'well', 'most', 'immediately', 'impact', 'donation', 'partner', 'support', 'expand', 'testing', 'capacity', 'donation', 'company', 'personal', 'protective', 'equipment', 'together', 'donation', 'part', 'recent', 'commitment', 'foundation', 'support', 'organization', 'provide', 'emergency_relief_assistance', 'global', 'community', 'where', 'vertex', 'operate'], ['vertex_pharmaceutical_incorporate_today', 'confirm', 'business', 'outlook', 'continuity', 'company', 'supply_chain', 'approve', 'cystic_fibrosis', 'medicine', 'provide', 'update', 'development', 'program', 'give', 'ongoing', 'pandemic'], ['widespread', 'impact', 'pandemic', 'outlook', 'business', 'remain', 'unchanged', 'continue', 'highly', 'confident', 'supply_chain', 'ability', 'supply', 'approve', 'medicine', 'patient', 'need', 'say_chief_executive_officer', 'vertex', 'pandemic', 'rapidly', 'evolve', 'global', 'health', 'crisis', 'require', 'unprecedented', 'utilization', 'health_care', 'resource', 'expect', 'impact', 'clinical_trial', 'order', 'ensure', 'patient', 'safety', 'appropriate', 'use', 'healthcare', 'resource', 'maintain', 'study', 'integrity', 'make', 'proactive', 'change', 'ongoing', 'plan', 'clinical_trial', 'give', 'rapidly', 'evolve', 'pandemic', 'too', 'early', 'precisely', 'determine', 'long_term', 'effect', 'outbreak', 'trial', 'timeline'], ['business', 'outlook', 'supply_chain'], ['global', 'outbreak', 'have', 'impact', 'continuity', 'supply_chain', 'approve', 'medicine', 'business', 'outlook', 'company', 'ample', 'supply', 'meet', 'commercial', 'need', 'well', 'future', 'remain', 'highly', 'confident', 'ability', 'continue', 'supply', 'medicine', 'patient', 'world', 'additionally', 'company', 'manufacturing', 'facility', 'remain', 'operational', 'continue', 'produce', 'new', 'supply', 'company', 'medicine'], ['development', 'program'], ['currently', 'conduct', 'multiple', 'clinical_trial', 'globally', 'span', 'various', 'disease', 'modality', 'stage', 'development', 'trial', 'include', 'late_stage', 'post', 'marketing', 'confirmatory', 'study', 'medicine', 'well', 'establish', 'benefit', 'risk', 'profile', 'as_well', 'early_stage', 'proof_concept_study', 'investigational', 'medicine', 'ongoing', 'study', 'work', 'clinical_trial', 'site', 'enable', 'virtual', 'clinic', 'visit', 'home', 'delivery', 'study', 'drug', 'ensure', 'study', 'continuity', 'medical', 'monitoring', 'facilitate', 'study', 'procedure', 'depend', 'disease', 'stage', 'development', 'type', 'study', 'reduce', 'burden', 'healthcare', 'system', 'time', 'critical', 'need', 'vertex', 'temporarily', 'pause', 'enrollment', 'certain', 'study', 'delay', 'new', 'study', 'start'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'company', 'supply_chain', 'business', 'outlook', 'development', 'activity', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'effect', 'incorrect', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['pharmaceutical_incorporate', 'today_announce', 'foundation_nonprofit_charitable_foundation', 'make', 'gift', 'partner', 'base', 'nonprofit', 'hospital', 'physician', 'network', 'support', 'need', 'patient', 'health_care', 'provider', 'bolster', 'preparedness', 'response', 'ongoing', 'novel', 'coronavirus', 'outbreak', 'enhance', 'testing', 'capacity'], ['health_care', 'company', 'member', 'community', 'commit', 'do', 'part', 'respond', 'outbreak', 'expand', 'testing', 'capacity', 'vital', 'limit', 'spread', 'virus', 'help', 'protect', 'health', 'community', 'why', 'foundation', 'make', 'gift', 'partner', 'large', 'provider', 'health_care', 'service', 'area', 'facilitate', 'testing', 'say_chief_executive_officer'], ['add', 'grateful', 'foundation', 'support', 'work', 'clinician', 'staff', 'member', 'resource', 'target', 'directly', 'patient', 'care', 'effort', 'respond', 'outbreak'], ['continue', 'monitor', 'evolve', 'outbreak', 'world', 'evaluate', 'additional', 'way', 'support', 'community', 'operate'], [], ['integrated', 'health_care', 'system', 'found', 'woman', 'offer', 'patient', 'continuum', 'coordinated', 'high_quality', 'care', 'addition', 'academic', 'medical', 'center', 'system', 'include', 'community', 'specialty', 'hospital', 'health', 'insurance', 'plan', 'physician', 'network', 'community', 'long_term', 'care', 'service', 'other', 'health_care', 'entity', 'partner', 'nonprofit', 'organization', 'commit', 'patient', 'care', 'research', 'teaching', 'service', 'community', 'addition', 'partner', 'nation', 'lead', 'biomedical', 'research', 'organization', 'principal', 'teaching', 'affiliate', 'more_information_visit'], ['source_version'], ['pharmaceutical_incorporate', 'today', 'confirm', 'global', 'coronavirus', 'outbreak', 'have', 'impact', 'company', 'supply_chain', 'business', 'outlook'], ['challenge', 'face', 'world', 'spread', 'significant', 'important', 'medical', 'patient', 'community', 'know', 'remain', 'highly', 'confident', 'ability', 'continue', 'supply', 'medicine', 'uninterrupted', 'patient', 'world', 'rely', 'say_chief_executive_officer', 'see', 'impact', 'trikafta', 'launch', 'other', 'element', 'business', 'well', 'prepare', 'business', 'continuity', 'perspective', 'ample', 'supply', 'meet', 'commercial', 'need', 'well', 'future'], ['construct', 'supply_chain', 'market', 'medicine', 'ensure', 'readiness', 'wide', 'variety', 'contingency', 'vertex', 'build', 'significant', 'safety', 'stock', 'supply_chain', 'manage', 'potential', 'disruption', 'also', 'secure', 'second', 'source', 'supplier', 'geographically', 'diverse'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'company', 'supply_chain', 'business', 'outlook', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'effect', 'incorrect', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news'], ['pharmaceutical_incorporate', 'today_announce', 'cancellation', 'plan', 'presentation', 'webcast', 'care', 'conference', 'follow', 'implementation', 'companywide', 'travel', 'meeting', 'policy', 'design', 'reduce', 'potential', 'disruption', 'senior', 'management', 'team', 'precautionary', 'measure', 'no', 'long', 'attend', 'conference'], ['source_version_news_home'], ['investor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'ivacaftor', 'available', 'eligible', 'patient', 'cystic_fibrosis', 'clinician', 'able', 'apply', 'patient', 'access', 'use', 'exceptional', 'circumstance', 'framework', 'set', 'pharmaceutical', 'management'], ['today', 'important', 'day', 'community', 'first', 'time', 'patient', 'access', 'medicine', 'treat', 'underlie', 'cause', 'disease', 'appreciate', 'engagement', 'collaboration', 'other', 'involve', 'party', 'bring', 'important', 'medicine', 'patient', 'say_fenaux_senior_vice'], ['medicine', 'reimburse', 'more', 'country_world', 'include', 'sweden'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people', 'worldwide_cf_progressive_multi', 'system', 'disease', 'affect_lung_liver_tract', 'sinus_sweat_gland_pancrea', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['people', 'specific', 'mutation', 'cftr', 'gene', 'currently', 'benefit', 'ivacaftor', 'country'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'statement', 'regard', 'availability', 'access', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['medium'], ['investor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'care', 'conference', 'am'], ['source_version_news_home'], ['full_year', 'total', 'gaap', 'product_revenue'], ['full_year', 'total', 'non_gaap', 'product_revenue', 'increase_compare', 'full_year'], ['company', 'provide', 'full_year', 'total_product_revenue', 'guidance'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'full_year_fourth_quarter', 'end', 'provide', 'full_year_financial_guidance'], ['differentiate', 'strategy', 'invest', 'serial', 'scientific_innovation', 'create_transformative', 'medicine', 'deliver', 'remarkable', 'performance', 'mark', 'early', 'approval', 'trikafta', 'rapid', 'progression', 'pipeline', 'additional', 'disease', 'continue', 'financial', 'growth', 'continue', 'treat', 'more', 'patient', 'medicine', 'worldwide', 'say_chief_executive_officer', 'vertex', 'success', 'culmination', 'many', 'year', 'hard', 'work', 'build', 'team', 'pipeline', 'company', 'believe', 'discover_develop', 'commercialize', 'transformative_medicine', 'year', 'come'], ['enter', 'vertex', 'never', 'strong', 'say_vice_president_chief', 'medical_officer', 'well', 'position', 'near', 'long_term', 'growth', 'base', 'treat', 'more', 'people', 'medicine', 'other', 'future', 'medicine', 'disease', 'align', 'strategy', 'include', 'deficiency_kidney', 'disease', 'pain', 'severe', 'go', 'forward', 'financial', 'strength', 'enable', 'continue', 'significantly', 'invest', 'internal_external', 'innovation', 'provide', 'access', 'new', 'technology', 'program', 'expertise', 'lead', 'further', 'growth', 'year', 'ahead'], ['clinical', 'development'], ['cystic'], ['aat', 'program'], ['sickle', 'cell', 'disease_beta_thalassemia'], ['pain'], ['company', 'record', 'gain_loss_relate', 'change_fair_value', 'strategic_investment', 'other', 'income', 'net'], ['fourth_quarter', 'company', 'record', 'non_cash', 'benefit_income_taxis', 'approximately', 'relate', 'release', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'result', 'company', 'record', 'defer_tax_asset', 'consolidated_balance', 'sheet', 'previously', 'subject', 'valuation_allowance', 'start', 'first_quarter', 'company', 'begin', 'record_provision_income_taxis', 'pre_tax_income', 'use', 'estimate', 'effective_tax_rate_approximate', 'statutory_rate', 'provision', 'include', 'significant', 'non_cash_charge', 'company', 'ability_offset', 'pre_tax_income', 'previously', 'benefit', 'net_operating_loss', 'company', 'expect', 'majority', 'tax_provision_represent', 'non_cash', 'expense', 'net_operating_loss', 'fully_utilize', 'company', 'federal_net_operating_loss', 'credit', 'available', 'offset', 'future', 'pre_tax_income', 'approximately'], ['month_end', 'increase', 'fair_value_contingent_consideration', 'relate', 'payment', 'potentially', 'payable', 'exonic', 'former_equity_holder', 'month_end', 'company', 'consolidate', 'financial', 'statement', 'variable_interest_entity_vie', 'result', 'change_fair_value_contingent', 'consideration'], ['orkambi', 'adjustment', 'month_end', 'include', 'adjustment', 'net_product_revenue', 'cost_sale', 'relate', 'conclusion', 'early', 'access', 'program', 'orkambi', 'fourth_quarter', 'company', 'previously', 'recognize', 'portion', 'net_product_revenue', 'relate', 'orkambi', 'distribute', 'early', 'access', 'program', 'result', 'company', 'recognize', 'adjustment', 'increase', 'net_product_revenue', 'cost_sale', 'relate', 'prior_period', 'shipment', 'orkambi', 'distribute', 'early', 'access', 'program', 'company', 'exclude', 'adjustment', 'net_product_revenue', 'cost_sale', 'non_gaap_measure', 'month_end', 'begin', 'company', 'expect', 'adjust', 'revenue', 'gaap', 'net_product_revenue'], ['collaborative_revenue_expense', 'month_end', 'primarily_relate_collaborative_upfront', 'milestone_payment', 'collaborative_revenue_expense', 'month_end', 'also', 'include', 'revenue_expense', 'attributable', 'vie', 'operation'], ['acquisition_relate_cost', 'month_end', 'primarily_relate', 'cost_associate', 'company', 'acquisition_exonic', 'comparable_amount_month_end'], ['month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'primarily_relate', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'increase_decrease_fair', 'value', 'company', 'strategic_investment', 'collaborative_upfront', 'payment', 'month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'relate', 'provision_income_taxis', 'attributable', 'company', 'vie', 'excess_tax_benefit', 'relate_stock_base_compensation'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'regulatory_filing', 'development', 'plan', 'timeline', 'drug_candidate', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'net_product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'datum', 'company', 'development', 'program_support_registration_further', 'development', 'potential', 'medicine', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['conference_call', 'company', 'host_conference_call_webcast', 'today', 'pm_access_call_dial', 'international', 'conference_call_webcast', 'live_link', 'webcast', 'access', 'website_wwwvrtxcom_investor_section', 'event', 'presentation_ensure_timely', 'connection_recommend_user_register', 'least_minute_prior_schedule', 'webcast_archive_webcast', 'available', 'company', 'website'], ['source_version'], ['investor'], ['vertex_pharmaceutical_incorporate', 'report', 'full_year_fourth_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'multiple_approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['source_version_home'], ['pharmaceutical_incorporate_investor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'conference', 'pm', 'am'], ['source_version'], ['vertex_pharmaceutical_incorporate_today', 'confirm', 'follow', 'recent', 'collaborative', 'discussion', 'negotiate', 'agreement', 'health', 'service', 'executive', 'expand', 'exist', 'long_term', 'cystic_fibrosis', 'reimbursement_agreement', 'include', 'triple_combination', 'review', 'pende', 'approval', 'eligible', 'patient', 'age_old', 'line', 'potential', 'future', 'license', 'indication'], ['expand', 'exist', 'agreement', 'already', 'include', 'access', 'current', 'future', 'vertex', 'medicine', 'people', 'age'], ['innovative', 'long_term', 'agreement', 'also', 'enable', 'rapid', 'access', 'people', 'mutation', 'label', 'exist', 'medicine', 'expand', 'cover', 'additional', 'age', 'group', 'new', 'vertex', 'medicine', 'approve', 'population'], ['fenaux_senior_vice', 'say', 'expand', 'agreement', 'even', 'more', 'patient', 'first', 'benefit', 'triple_combination_treatment', 'medicine', 'license'], ['triple_combination_treatment', 'ivacaftor', 'currently', 'license', 'use', 'submit', 'marketing_authorization_application'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'press_release_statement', 'regard', 'expansion', 'exist', 'long_term', 'cystic_fibrosis', 'reimbursement_agreement', 'marketing_authorization_application', 'submission', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'obtain_approval_commercialize', 'elexacaftor_tezacaftor', 'ivacaftor', 'develop', 'additional', 'medicine', 'treat_cystic_fibrosis', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate', 'irish', 'medium'], ['investor'], ['ivacaftor', 'first', 'only', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'child', 'young'], ['vertex_pharmaceutical', 'today_announce', 'grant', 'approval', 'label_extension', 'ivacaftor', 'include', 'treatment', 'infant', 'cystic_fibrosis_age', 'month', 'less_month', 'weigh', 'kg', 'more', 'at_least', 'follow', 'mutation_cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr_gene'], ['today', 'approval', 'milestone', 'commitment', 'treat', 'people', 'as_early', 'life', 'possible', 'give', 'manifestation', 'cf', 'often', 'present_birth', 'say_vice_president_chief', 'medical_officer', 'first', 'time', 'child', 'young', 'month', 'certain', 'mutation', 'now', 'access', 'medicine', 'treat', 'underlie', 'cause', 'disease'], ['label', 'update', 'base', 'datum', 'ongoing_phase_open', 'label_safety', 'study', 'arrival', 'child', 'cf', 'less_month', 'age', 'cftr', 'gating_mutation', 'study', 'show', 'safety_profile', 'similar_observe', 'previous_phase', 'study', 'old_child_adult', 'improvement_sweat_chloride', 'secondary_endpoint'], ['ivacaftor', 'already_approve', 'treatment', 'patient', 'age_month', 'old', 'follow', 'mutation', 'cftr', 'gene', 'also', 'approve', 'treatment', 'patient', 'year_old', 'mutation', 'cftr', 'gene'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate_forward_look', 'statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium', 'dessert'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'french', 'authority', 'sante', 'approve', 'national_reimbursement', 'lumacaftor_ivacaftor', 'people', 'age_old', 'cystic_fibrosis', 'copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene'], ['available', 'eligible', 'patient', 'agreement', 'publish', 'french', 'official', 'journal'], ['available', 'eligible', 'patient', 'age_old', 'temporary', 'use', 'authorization', 'autorisation', 'temporaire', 'post', 'atu', 'interim', 'access', 'program', 'addition', 'provide', 'reimbursement', 'patient', 'age_old', 'today', 'agreement', 'also', 'enable', 'people', 'age_year', 'access', 'orkambi', 'first', 'time', 'currently', 'prescribe', 'orkambi', 'atu', 'now', 'receive', 'new', 'agreement'], ['today_announcement', 'eligible', 'patient', 'receive', 'orkambi', 'national_reimbursement', 'agreement', 'importantly', 'child_cystic_fibrosis', 'as', 'young', 'year', 'age', 'copy_mutation', 'now', 'benefit', 'precision_medicine', 'say_fenaux_senior_vice', 'thank', 'french', 'authority', 'engagement', 'commitment', 'result', 'agreement', 'provide', 'sustainable', 'access', 'orkambi', 'eligible', 'patient'], ['medicine', 'reimburse', 'country_world', 'include', 'recent', 'agreement'], ['lumacaftor_ivacaftor', 'mutation', 'people', 'copy_mutation', 'cftr_protein', 'process', 'traffic', 'normally', 'cell', 'result', 'little', 'cftr_protein', 'cell', 'surface', 'patient', 'copy_mutation', 'easily', 'identify', 'simple', 'genetic_test'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_fourth_paragraph', 'press_release_statement', 'regard', 'expectation', 'availability', 'orkambi', 'patient', 'eligibility', 'access', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news'], ['medium'], ['patient', 'treat', 'successfully', 'engraft', 'demonstrate', 'initial', 'safety_profile', 'consistent', 'myeloablative_busulfan', 'conditioning', 'autologous', 'hematopoietic_stem', 'cell', 'transplant'], ['thalassemia', 'patient', 'transfusion_independent', 'total_hemoglobin_level_fetal', 'hemoglobin', 'month', 'infusion'], ['cell', 'disease', 'patient', 'free_vaso_occlusive_crisis', 'total_hemoglobin_level_fetal', 'hemoglobin', 'month', 'infusion'], ['therapeutic', 'host_conference_call', 'today', 'am', 'review', 'data'], ['pharmaceutical_incorporate', 'today_announce', 'positive', 'interim', 'datum', 'first', 'patient', 'severe', 'treat', 'investigational', 'crispr_gene_edit', 'therapy', 'ongoing', 'phase', 'clinical_trial', 'patient', 'transfusion_dependent_beta_thalassemia', 'tdt', 'receive', 'first_quarter', 'datum', 'patient', 'reflect', 'month', 'safety_efficacy', 'follow', 'patient', 'severe_sickle', 'cell', 'disease', 'scd', 'receive', 'mid', 'datum', 'patient', 'reflect', 'month', 'safety_efficacy', 'follow', 'study', 'ongoing', 'patient', 'follow', 'approximately', 'year', 'follow', 'infusion', 'several', 'additional', 'patient', 'enrol', 'have', 'drug', 'product', 'manufacture', 'study'], ['transfusion_dependent_beta_thalassemia', 'patient', 'ivs', 'genotype', 'require', 'transfusion', 'year', 'annualize_rate', 'year', 'prior', 'consent', 'study', 'enrol', 'clinical', 'study', 'patient', 'achieve', 'day', 'infusion', 'platelet', 'engraftment', 'day', 'infusion', 'serious_adverse_event', 'sae_occur', 'principal', 'investigator', 'consider_related', 'presence', 'occlusive', 'liver', 'disease', 'attribute', 'busulfan_conditioning', 'subsequently', 'resolve', 'month', 'infusion', 'patient', 'transfusion_independent', 'total_hemoglobin_level_fetal', 'hemoglobin', 'cell', 'erythrocyte', 'express', 'fetal_hemoglobin'], ['sickle', 'cell', 'patient', 'experience', 'vaso_occlusive', 'crisis', 'year', 'annualize_rate', 'year', 'prior', 'consent', 'study', 'enrol', 'clinical', 'study', 'patient', 'achieve', 'engraftment', 'day', 'infusion', 'sae_occur', 'none', 'pi', 'consider_related', 'sepsis', 'presence', 'cholelithiasis', 'abdominal_pain', 'resolve', 'month', 'infusion', 'patient', 'free', 'total_hemoglobin_level_fetal', 'hemoglobin', 'cell', 'erythrocyte', 'express', 'fetal_hemoglobin'], ['very', 'encouraged', 'preliminary_datum', 'first', 'such', 'datum', 'report', 'patient', 'beta_thalassemia_sickle', 'cell', 'disease', 'treat', 'crispr_cas', 'edit', 'autologous', 'hematopoietic_stem', 'cell', 'candidate', 'say_chief_executive_officer', 'datum', 'support', 'belief', 'potential', 'therapy', 'meaningful', 'benefit', 'patient', 'follow', 'time', 'intervention', 'continue', 'enroll', 'study', 'drive', 'forward', 'develop', 'therapy', 'new_class', 'transformative_medicine', 'treat', 'serious_disease'], ['datum', 'announce_today', 'remarkable', 'demonstrate', 'potential', 'curative', 'crispr_cas', 'base', 'gene_edit', 'therapy', 'people', 'sickle', 'cell', 'disease_beta_thalassemia', 'say_chief_executive_officer', 'datum', 'exciting', 'still', 'early', 'phase', 'clinical', 'program', 'look_forward', 'continue', 'work', 'physician', 'patient', 'caregiver', 'family', 'coming', 'month', 'year', 'bring', 'forward', 'good', 'possible', 'therapy', 'serious_disease', 'continue', 'accelerate', 'gene_edit', 'program', 'other', 'serious_disease', 'such', 'muscular_dystrophy', 'myotonic', 'dystrophy_type'], ['phase_study', 'transfusion_dependent_beta_thalassemia', 'ongoing_phase_open', 'label_trial', 'climb_design_assess_safety', 'efficacy_single', 'dose', 'patient', 'age', 'study', 'enroll', 'patient', 'follow', 'patient', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'follow', 'study', 'enrollment', 'ongoing', 'clinical_trial', 'site'], ['phase_study', 'sickle', 'cell', 'disease', 'ongoing_phase_open', 'label_trial', 'climb_design_assess_safety', 'efficacy_single', 'dose', 'patient', 'age', 'severe_scd', 'study', 'enroll', 'patient', 'follow', 'patient', 'approximately', 'year', 'infusion', 'patient', 'ask_participate_long_term', 'follow', 'study', 'enrollment', 'ongoing', 'clinical_trial', 'site'], ['gene_edit', 'process', 'trial', 'patient', 'enroll', 'study', 'hematopoietic_stem', 'progenitor', 'cell', 'collect', 'peripheral', 'blood', 'patient', 'cell', 'edit', 'use', 'crispr', 'technology', 'edit', 'cell', 'then', 'infuse', 'back', 'patient', 'part', 'stem', 'cell', 'transplant', 'process', 'involve', 'other_thing', 'patient', 'treat', 'myeloablative_busulfan', 'conditioning', 'patient', 'undergo', 'stem', 'cell', 'transplant', 'also', 'encounter', 'side_effect', 'range', 'mild', 'severe', 'unrelated', 'administration', 'patient', 'initially', 'monitor', 'determine', 'when', 'edit', 'cell', 'begin', 'produce', 'mature', 'blood', 'cell', 'process', 'know', 'engraftment', 'engraftment', 'patient', 'continue', 'monitor', 'track', 'impact', 'multiple', 'measure', 'disease'], ['conference_call', 'host_conference_call_webcast', 'today', 'am', 'presentation', 'make', 'available', 'therapeutic', 'website', 'webcom', 'event', 'investor_section', 'event', 'presentation', 'follow', 'live_audio', 'webcast', 'replay', 'available', 'company', 'website', 'approximately', 'day'], ['dial', 'information', 'live', 'live', 'international', 'would'], ['investigational', 'vivo_gene_edit', 'therapy', 'evaluate', 'patient', 'suffer_severe_scd', 'patient', 'hematopoietic_stem', 'cell', 'engineer_produce_high_level', 'fetal_hemoglobin_red_blood', 'cell', 'form_oxygen_carry_hemoglobin', 'naturally_present_birth_then', 'replace', 'adult_form', 'hemoglobin_elevation', 'hbf_potential', 'alleviate_transfusion', 'requirement', 'patient', 'painful_debilitate_sickle_crisis', 'scd', 'patient'], ['lead', 'gene_edit', 'company', 'focus', 'develop', 'transformative', 'gene', 'base', 'medicine', 'serious_disease', 'use', 'proprietary', 'crispr', 'platform', 'cas', 'revolutionary', 'gene_edit', 'technology', 'allow', 'precise', 'direct', 'change', 'establish', 'portfolio', 'therapeutic', 'program', 'broad_range', 'disease', 'area', 'include', 'oncology', 'regenerative_medicine', 'rare', 'disease', 'accelerate', 'expand', 'effort', 'establish', 'strategic', 'collaboration', 'lead', 'company', 'include', 'pharmaceutical', 'headquarter', 'wholly_own', 'subsidiary', 'operation', 'base', 'business', 'office', 'more_information_visit', 'wwwcrisprtxcom'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security_amend', 'include', 'statement', 'regard', 'expectation', 'follow', 'safety_efficacy', 'clinical', 'progress', 'crispr', 'clinical', 'program', 'status', 'scope', 'ongoing', 'potential', 'future', 'clinical_trial', 'include_limitation', 'timing', 'filing', 'clinical_trial', 'application', 'ind', 'approval', 'thereof', 'timing', 'commencement', 'clinical_trial', 'development', 'timeline', 'discussion', 'regulatory_authority', 'relate', 'product_candidate', 'development', 'collaborator', 'number', 'patient', 'evaluate', 'anticipate', 'date', 'enrollment', 'complete', 'datum', 'generate', 'ongoing', 'plan', 'clinical_trial', 'ability', 'use', 'datum', 'design', 'initiation', 'further', 'clinical_trial', 'intellectual_property', 'coverage', 'position', 'therapeutic', 'licensor', 'third_party', 'sufficiency_cash', 'resource', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'forward_look_statement', 'promise_guarantee_necessarily_subject', 'high_degree', 'uncertainty', 'risk', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'potential', 'initial_preliminary', 'datum', 'clinical_trial', 'include', 'indicative_final', 'trial', 'result', 'risk', 'initial_datum_limited', 'number', 'patient', 'case_time_indicative', 'result', 'full', 'plan', 'study', 'population', 'outcome', 'plan', 'clinical_trial', 'study', 'favorable', 'more', 'internal_external', 'product_candidate', 'program', 'proceed', 'plan', 'technical', 'scientific', 'commercial', 'reason', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'product_candidate', 'uncertainty', 'inherent', 'initiation_completion', 'preclinical', 'study', 'product_candidate', 'availability_timing', 'result', 'preclinical', 'study', 'result', 'preclinical', 'trial', 'predictive_future', 'result', 'future', 'trial', 'uncertainty', 'regulatory_approval', 'conduct', 'trial', 'market', 'product', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party_outcome_proceeding', 'such', 'interference_opposition_similar_proceeding', 'involve_portion', 'such', 'intellectual_property', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available_website_existing', 'prospective_investor_caution_place', 'undue_reliance', 'forward_look_statement', 'speak_only_date', 'make_disclaim_obligation', 'undertaking_update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational_small_molecule', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'include', 'pain_deficiency', 'kidney_disease_addition', 'vertex', 'rapidly_expand_pipeline', 'genetic', 'cell', 'therapy', 'disease', 'such_sickle', 'cell', 'disease_muscular_dystrophy', 'type_diabetes_mellitus'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'information', 'provide', 'regard', 'status', 'expectation', 'respect', 'clinical', 'development', 'program', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include', 'development', 'proceed', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['contact', 'wcg', 'behalf'], ['pharmaceutical_incorporate_investor'], ['medium'], ['template', 'receive_upfront', 'payment', 'include', 'equity_investment', 'potential', 'additional', 'milestone_royalty', 'payment', 'future', 'sales'], ['vertex_pharmaceutical_incorporate', 'molecular_template', 'today_announce', 'company', 'enter_strategic', 'research', 'collaboration', 'discover_develop', 'novel', 'target', 'conditioning', 'regimen', 'enhance', 'hematopoietic_stem', 'cell', 'transplant', 'process', 'include', 'transplant', 'conduct', 'part', 'treatment', 'gene_editing', 'therapy', 'such', 'currently', 'evaluate', 'ongoing', 'phase_study', 'patient', 'transfusion_dependent_beta_thalassemia', 'severe_sickle', 'cell', 'disease', 'where', 'hematopoietic_stem', 'cell', 'transplant', 'require', 'part', 'treatment', 'collaboration', 'seek', 'discover', 'new', 'conditioning', 'regiman', 'utilize', 'engineer', 'toxin', 'body', 'platform', 'design', 'specifically', 'target', 'remove', 'specific', 'cell', 'enable', 'successful', 'engraftment', 'new', 'cell'], ['believe', 'gene_editing', 'hold', 'significant', 'promise', 'treatment', 'severe', 'such_sickle', 'cell', 'disease_beta_thalassemia', 'molecular_template', 'unique', 'technology_platform', 'play', 'important', 'role', 'create', 'targeted', 'conditioning', 'regiman', 'replace', 'chemotherapy', 'currently', 'require', 'conditioning', 'regimen', 'thus', 'enhance', 'overall', 'future', 'treatment', 'experience', 'patient', 'say_executive_vice', 'president_chief', 'scientific', 'officer'], ['prove', 'history', 'employ', 'novel', 'technology', 'develop', 'innovative', 'medicine', 'disease', 'high_unmet', 'medical', 'need', 'make', 'ideal', 'partner', 'expand', 'use', 'platform', 'therapeutic', 'oncology', 'say_chief', 'executive', 'scientific', 'officer', 'excite', 'work', 'vertex', 'focus', 'discover_develop', 'next_generation', 'target', 'conditioning', 'agent', 'collaboration', 'further', 'validate', 'potential', 'platform', 'provide', 'meaningful', 'capital', 'support', 'continued', 'advancement', 'own', 'product', 'pipeline'], ['collaboration', 'mtem', 'conduct', 'research', 'activity', 'use', 'target', 'select', 'vertex', 'initial', 'research', 'focus', 'discover', 'novel', 'conditioning', 'regiman', 'use', 'technology_platform', 'addition', 'vertex', 'option', 'select', 'second', 'target', 'part', 'collaboration', 'designation', 'clinical', 'development', 'candidate', 'emerge', 'research', 'effort', 'vertex', 'option', 'exclusively_license', 'molecule', 'designate', 'target', 'vertex', 'exclusive', 'right', 'develop', 'molecule', 'emerge', 'research', 'program', 'indication'], ['make', 'front', 'payment', 'mtem', 'include', 'equity_investment', 'mtem', 'also', 'eligible', 'receive', 'future', 'development', 'regulatory', 'sale', 'milestone', 'option', 'payment', 'target', 'tiere', 'royalty_payment', 'future', 'sale'], ['molecular_template', 'molecular_template', 'clinical_stage', 'oncology', 'company', 'focus', 'discovery', 'development', 'differentiated', 'target', 'biologic', 'therapeutic', 'cancer', 'believe', 'proprietary', 'biologic', 'drug', 'platform', 'technology', 'refer', 'engineer', 'toxin', 'body', 'provide', 'differentiated', 'mechanism_action', 'address', 'limitation', 'associate', 'currently', 'available', 'cancer', 'therapeutic', 'utilize', 'genetically', 'engineer', 'form', 'shiga', 'like', 'toxin', 'subunit', 'slta', 'ribosome', 'inactivate', 'bacterial', 'protein', 'target', 'specifically', 'destroy', 'cancer', 'cell', 'additional', 'information', 'molecular_template', 'obtain'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'poma', 'third_paragraph', 'statement', 'regard', 'expectation', 'ability', 'conditioning', 'regimen', 'enhance', 'hematopoietic_stem', 'cell', 'transplant', 'process', 'discovery', 'new', 'conditioning', 'regimen', 'future', 'research', 'development', 'activity', 'right', 'agreement', 'future', 'payment', 'mtem', 'agreement', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'vertex', 'realize_anticipate_benefit', 'collaboration', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['forward_look_statement', 'press_release_contain', 'forward_look_statement_meaning', 'private_security_amend', 'word', 'expect', 'plan', 'anticipate', 'intend', 'believe', 'predict', 'project', 'potential', 'continue', 'target', 'similar_expression_intend_identify', 'forward_look_statement', 'forward_look_statement', 'contain', 'identify_word', 'example', 'such', 'statement', 'include', 'limit', 'statement', 'relate', 'outcome', 'collaboration', 'molecular_template', 'vertex', 'relate', 'molecular_template', 'platform', 'role', 'molecular_template', 'platform', 'respect', 'treatment', 'severe', 'vertex', 'exercise', 'option', 'molecular_template', 'receipt', 'future', 'development', 'regulatory', 'sale', 'milestone_royalty', 'payment'], ['forward_look_statement', 'guarantee', 'future', 'performance', 'involve', 'risk_uncertainty', 'actual_event', 'result_differ', 'materially', 'discuss', 'forward_look_statement', 'result', 'various', 'factor', 'include', 'limit', 'uncertainty', 'inherent', 'preclinical', 'clinical', 'development', 'process', 'molecular_template', 'cash', 'resource', 'sufficient_fund', 'continue', 'operation', 'period', 'trial', 'anticipate', 'future', 'operating', 'plan', 'respect', 'collaboration', 'decision', 'exercise', 'option', 'ability', 'molecular_template', 'protect', 'intellectual_property', 'right', 'legislative', 'regulatory', 'political_economic', 'development', 'forward_look_statement', 'make', 'date_press_release', 'molecular_template', 'assume', 'obligation_update_forward_look', 'statement', 'update', 'reason', 'why', 'actual_result_differ', 'project', 'forward_look_statement', 'require_law', 'investor', 'consult', 'information', 'set', 'also', 'refer', 'risk_factor', 'disclosure', 'set_forth', 'report', 'other', 'document', 'molecular_template', 'file_available', 'include_limitation', 'molecular_template', 'annual_report_form', 'fiscal_year', 'end', 'molecular_template', 'quarterly_report_form'], [], ['investor'], ['molecular_template'], ['investor', 'chief', 'financial', 'officer'], ['patient', 'soon', 'access_orkambi_lumacaftor', 'ivacaftor', 'ivacaftor', 'expand', 'access', 'ivacaftor', 'same', 'term'], ['vertex_pharmaceutical_incorporate_today', 'confirm', 'accept', 'offer', 'currently', 'license', 'vertex', 'cystic_fibrosis', 'medicine', 'future', 'indication', 'medicine', 'same', 'term', 'recently', 'announce', 'agreement'], ['mean', 'contract', 'finalize', 'patient', 'age_year_old_copy', 'mutation_cystic_fibrosis', 'regulator_cftr_gene', 'access_orkambi_lumacaftor', 'ivacaftor', 'patient', 'age_year_old_copy', 'mutation', 'copy_mutation_copy', 'other', 'license', 'mutation', 'access', 'ivacaftor', 'combination', 'ivacaftor', 'come', 'week'], ['agreement', 'also', 'offer', 'expand', 'access', 'ivacaftor', 'include', 'patient', 'age_month', 'old', 'license', 'gating_mutation'], ['today_announcement', 'good', 'news', 'approximately', 'eligible_cystic_fibrosis', 'patient', 'soon', 'access_cftr_modulator', 'treat_underlying_cause', 'disease', 'say_fenaux_senior_vice', 'thank', 'authority', 'wale', 'collaboration', 'accept', 'offer', 'same', 'term', 'recently', 'announce'], ['people', 'second', 'high', 'number', 'world', 'people', 'wale', 'debilitate', 'life', 'shortening', 'inherited', 'condition', 'cause', 'progressive', 'damage', 'organ', 'body', 'birth', 'currently', 'cure', 'cf', 'half', 'people', 'die', 'daily', 'impact', 'treatment', 'significant', 'take', 'more', 'hour', 'involve', 'nebulizer', 'physiotherapy', 'tablet', 'day', 'account', 'hospital', 'admission', 'hospital', 'bed', 'day', 'year', 'third', 'use', 'child'], ['ivacaftor', 'combination', 'ivacaftor', 'mutation', 'result', 'cftr_protein_process_fold', 'normally', 'cell', 'generally_reach', 'cell', 'surface', 'tezacaftor', 'design', 'address_trafficking_processing_defect', 'cftr_protein', 'enable', 'reach', 'cell', 'surface', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface'], ['indicate', 'people', 'age', 'old_copy', 'mutation', 'copy_mutation', 'following', 'mutation', 'cftr_protein', 'show', 'residual_function'], ['ivacaftor', 'ivacaftor', 'first', 'medicine_treat_underlying', 'cause', 'people', 'specific', 'mutation', 'cftr', 'gene', 'know_cftr_potentiator', 'ivacaftor', 'oral', 'medicine', 'design_keep', 'cftr_protein', 'cell', 'surface_open', 'long_improve_transport', 'salt_water_cell', 'membrane_help_hydrate_clear', 'mucus_airway'], ['indicate', 'people', 'age_month', 'old', 'follow', 'mutation', 'cftr', 'gene', 'also', 'indicate', 'treatment', 'patient', 'age_year_old', 'mutation', 'cftr', 'gene'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_fourth_paragraph', 'press_release_statement', 'regard', 'expectation', 'patient', 'population', 'able', 'access', 'vertex', 'medicine', 'timing', 'such', 'access', 'statement', 'expectation_regard', 'formal', 'agreement', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['pharmaceutical_incorporate', 'medium'], ['medium'], ['patient', 'soon', 'access_orkambi_lumacaftor', 'ivacaftor', 'ivacaftor', 'expand', 'access', 'ivacaftor', 'same', 'term'], ['vertex_pharmaceutical_incorporate_today', 'confirm', 'regional', 'accept', 'offer', 'access', 'currently', 'license', 'vertex', 'cystic_fibrosis', 'medicine', 'future', 'indication', 'medicine', 'same', 'term', 'recently', 'announce', 'agreement'], ['mean', 'contract', 'finalize', 'patient', 'age_year_old_copy', 'mutation_cystic_fibrosis', 'regulator_cftr_gene', 'access_orkambi_lumacaftor', 'ivacaftor', 'patient', 'age_year_old_copy', 'mutation', 'copy_mutation_copy', 'other', 'licensed', 'mutation', 'access', 'ivacaftor', 'combination', 'ivacaftor', 'support', 'arrangement', 'put', 'place', 'ensure', 'clinician', 'able', 'prescribe', 'eligible', 'patient', 'next_few', 'week'], ['agreement', 'also', 'offer', 'expand', 'access', 'ivacaftor', 'include', 'people', 'age_year_old', 'mutation', 'patient', 'age_month', 'old', 'license', 'gating_mutation'], ['pleased', 'nearly', 'eligible_cystic_fibrosis', 'patient', 'soon', 'access_cftr_modulator', 'treat_underlying_cause', 'disease', 'thank', 'authority', 'collaboration', 'commitment', 'agreement', 'say_fenaux_senior_vice'], ['people', 'second', 'high', 'number', 'world', 'nearly', 'people', 'debilitate', 'life', 'shortening', 'inherited', 'condition', 'cause', 'progressive', 'damage', 'organ', 'body', 'birth', 'currently', 'cure', 'cf', 'half', 'people', 'die', 'daily', 'impact', 'treatment', 'significant', 'take', 'more', 'hour', 'involve', 'nebulizer', 'physiotherapy', 'tablet', 'day', 'account', 'hospital', 'admission', 'hospital', 'bed', 'day', 'year', 'third', 'use', 'child'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_fourth_paragraph', 'press_release_statement', 'regard', 'expectation', 'patient', 'population', 'able', 'access', 'vertex', 'medicine', 'timing', 'such', 'access', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news_home'], ['pharmaceutical_incorporate', 'medium', 'medium', 'investor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'conference', 'pm'], ['remark', 'available', 'live', 'website_wwwvrtxcom_investor_section', 'news', 'event_page', 'replay', 'conference', 'webcast_archive', 'company', 'website'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['source_version'], ['investor_contact'], ['study', 'meet_primary', 'key_secondary_endpoint', 'demonstrate', 'significant_improvement', 'lung_function', 'other', 'measure', 'disease'], ['result', 'study', 'present', 'today', 'rd', 'annual', 'north', 'american', 'part', 'presentation', 'vertex', 'meeting'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'concurrent', 'publication', 'result', 'phase_study', 'elexacaftor_ivacaftor', 'ivacaftor', 'treatment_cystic_fibrosis', 'people', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'most_common', 'cf', 'cause', 'mutation', 'datum', 'highlight', 'primary', 'secondary_endpoint', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'cftr', 'gene', 'publish', 'addition', 'publish', 'datum', 'highlighting', 'primary', 'secondary_endpoint', 'phase_study_people_del', 'mutation', 'study', 'meet_primary', 'key_secondary_endpoint', 'demonstrate', 'statistically_significant', 'clinically_meaningful', 'improvement_lung_function', 'other', 'measure', 'disease', 'study', 'generally_well_tolerate'], ['result', 'trikafta', 'study', 'publish', 'impressive', 'represent', 'historic', 'moment', 'care', 'medicine', 'demonstrate', 'improvement', 'multiple', 'outcome', 'measure', 'clinical_trial', 'generally_well_tolerate', 'say', 'internal', 'medicine', 'pulmonary', 'critical_care', 'lead', 'author', 'publication'], ['detailed', 'outcome', 'study', 'previously', 'communicate', 'datum', 'publish', 'contain', 'additional', 'analysis', 'study', 'include', 'subgroup', 'analysis', 'distribution', 'response', 'safety'], ['follow', 'recent', 'approval', 'trikafta', 'people', 'age', 'old_at_least', 'mutation', 'simultaneous', 'publication', 'concurrent', 'presentation', 'further', 'testament', 'unprecedented', 'result', 'show', 'study', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'make', 'significant', 'progress', 'bring', 'medicine', 'target', 'underlying_cause', 'disease', 'people', 'grateful', 'individual', 'family', 'put', 'trust', 'participate', 'study'], ['result', 'publish', 'online', 'conjunction', 'presentation', 'study', 'rd', 'annual', 'north', 'american', 'oral_presentation', 'highlight', 'key', 'outcome', 'study', 'schedule', 'pm', 'ct'], ['study', 'form', 'basis', 'recent', 'approval', 'trikafta', 'support', 'marketing_authorization_application', 'currently', 'review', 'agency', 'other', 'global', 'submission', 'also', 'prepare', 'submit'], ['additional', 'presentation', 'highlight', 'datum', 'portfolio', 'include', 'long_term', 'safety_efficacy', 'datum', 'symdeko', 'ivacaftor', 'ivacaftor', 'patient', 'age_year', 'homozygous', 'heterozygous', 'del', 'cftr', 'residual_function_mutation', 'as_well', 'datum', 'demonstrate', 'burden', 'illness', 'patient', 'year', 'age'], ['presentation', 'type'], ['present', 'author'], ['date', 'time'], ['phase', 'efficacy_safety', 'tez', 'iva', 'triple_combination', 'people', 'homozygous', 'mutation'], ['poster'], [], ['pm'], ['phase', 'efficacy_safety', 'tez', 'iva', 'triple_combination', 'people', 'minimal_function', 'genotype'], ['poster'], [], ['phase', 'efficacy_safety', 'tez', 'iva', 'combination', 'therapy', 'people', 'homozygous', 'heterozygous', 'minimal_function_mutation'], ['oral_presentation', 'workshop'], ['pm', 'pm'], ['iva'], ['open_label_extension', 'study', 'ivacaftor', 'iva', 'therapy', 'patient', 'age_year', 'cystic_fibrosis', 'heterozygous', 'del', 'cftr', 'residual_function_mutation', 'rf'], ['late', 'break', 'poster'], [], [], ['development', 'cystic_revise', 'preference', 'base', 'scoring'], ['poster'], [], ['illness', 'patient', 'year', 'cystic_fibrosis', 'heterozygous', 'mutation_minimal', 'function_mutation'], ['poster'], [], ['indication_important_safety', 'information', 'ivacaftor', 'ivacaftor', 'tablet'], ['possible_side_effect', 'trikafta', 'click_here_see_full', 'prescribe_information', 'trikafta', 'ivacaftor', 'ivacaftor', 'tablet'], ['symdeko', 'ivacaftor', 'ivacaftor'], ['mutation', 'result', 'cftr_protein_process_fold', 'normally', 'cell', 'generally_reach', 'cell', 'surface', 'symdeko', 'combination_tezacaftor', 'design', 'address_trafficking_processing_defect', 'cftr_protein', 'enable', 'reach', 'cell', 'surface', 'where', 'ivacaftor', 'increase_amount', 'time', 'protein', 'stay', 'open'], ['indication_important_safety', 'information', 'symdeko', 'ivacaftor', 'ivacaftor', 'tablet'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_copy', 'mutation', 'at_least_mutation', 'gene_responsive', 'treatment', 'symdeko', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'symdeko', 'safe_effective_child', 'year', 'age'], ['patient', 'take', 'symdeko', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medicine_such_phenobarbital', 'carbamazepine_phenytoin'], ['take', 'symdeko', 'patient', 'tell_doctor', 'have_liver', 'problem', 'kidney_problem', 'pregnant_plan_become_pregnant', 'know', 'symdeko', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'symdeko', 'pass_breast_milk'], ['affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'symdeko', 'work_therefore', 'dose', 'need', 'adjust_when_take_certain', 'medicine', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medicine', 'such_voriconazole', 'fluconazole_antibiotic', 'such'], ['cause_dizziness', 'people', 'take', 'patient', 'drive_car', 'use', 'machinery', 'require', 'alertness', 'know', 'how', 'symdeko', 'affect'], ['patient', 'avoid_food_drink_contain', 'grapefruit_seville', 'orange', 'take', 'symdeko'], ['cause', 'serious_side_effect', 'include'], ['high_liver', 'enzyme_blood', 'report', 'people', 'treat', 'symdeko', 'treat', 'ivacaftor', 'alone', 'patient', 'doctor_blood_test_check', 'liver_start', 'symdeko', 'month', 'first', 'year', 'take', 'symdeko', 'year', 'take', 'symdeko', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['abnormality_eye_lens_cataract', 'child_adolescent', 'treat', 'symdeko', 'ivacaftor', 'alone', 'patient', 'child_adolescent', 'doctor_perform_eye_examination', 'treatment', 'symdeko', 'look_cataract'], ['possible_side_effect', 'symdeko', 'click_here_see_full', 'prescribe_information', 'ivacaftor', 'ivacaftor', 'tablet'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'fourth_paragraph', 'statement', 'regard', 'expectation', 'preparation', 'timing', 'global', 'regulatory_submission', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'obtain_approval_commercialize', 'elexacaftor_ivacaftor', 'develop', 'additional', 'medicine', 'treat_cystic_fibrosis', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['application', 'support', 'positive', 'result', 'global', 'phase_study', 'people_cystic_fibrosis', 'age_old', 'mutation_minimal', 'function_mutation', 'people', 'mutation'], ['vertex_pharmaceutical', 'today_announce', 'validate', 'marketing_authorization_application', 'elexacaftor_tezacaftor', 'ivacaftor', 'triple_combination_regiman', 'submission', 'support', 'previously', 'disclose', 'positive', 'result', 'global', 'phase_study', 'people_cystic_fibrosis', 'study', 'people_mutation_minimal', 'function_mutation', 'study', 'people_del', 'mutation', 'phase_study', 'show_statistically', 'significant_improvement', 'lung_function', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'primary_endpoint', 'key_secondary_endpoint', 'study', 'triple_combination_generally_well', 'tolerate'], ['today', 'mark', 'significant', 'milestone', 'effort', 'bring', 'new', 'medicine', 'more', 'people', 'world', 'live_cystic_fibrosis', 'say_vice_president_chief', 'medical_officer', 'look_forward', 'work', 'ema', 'important', 'application'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_second_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['source'], ['pharmaceutical_incorporate_investor_medium', 'dessert'], ['product_revenue', 'increase_compare'], ['continue', 'progression', 'pipeline_investigational', 'medicine', 'multiple', 'disease'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'third_quarter', 'end', 'reiterate_full_year', 'total_product_revenue', 'guidance'], ['year', 'significant', 'progress', 'vertex', 'part', 'business', 'historic', 'approval', 'trikafta', 'now', 'step_close', 'provide', 'treatment', 'people', 'also', 'have', 'tremendous', 'success', 'bring', 'medicine', 'more', 'patient', 'globally', 'reimbursement_agreement', 'recently', 'reach', 'label_expansion', 'young', 'patient', 'say_chief_executive_officer', 'vertex', 'company', 'also', 'continue', 'successfully', 'execute', 'strategy', 'create_transformative', 'medicine', 'serious_disease', 'serial_innovation', 'rapid', 'progress', 'pipeline', 'expect', 'yield', 'proof_concept', 'datum', 'multiple', 'disease', 'position', 'vertex', 'continued_growth', 'year', 'ahead'], ['third_quarter', 'financial', 'highlight'], ['total_product_revenue', 'net'], ['total_product_revenue', 'increase_compare', 'third_quarter', 'primarily_drive', 'global', 'uptake', 'symkevi', 'patient', 'age_old'], ['gaap', 'net_income', 'decrease', 'compare_third', 'quarter_primarily', 'drive', 'upfront_payment', 'part', 'recently', 'expand', 'collaboration', 'partially_offset', 'strong', 'growth', 'total_product_revenue'], ['non_gaap_net_income', 'increase_compare', 'third_quarter', 'drive_strong', 'growth', 'total_product_revenue', 'partially_offset', 'increase', 'operating', 'expense', 'income_taxis'], ['cash_cash', 'equivalent_marketable_security', 'increase', 'approximately', 'compare'], ['combine_gaap_expense', 'increase_compare', 'third_quarter', 'primarily', 'upfront_payment'], ['combined_non_gaap', 'expense', 'increase_compare', 'third_quarter', 'primarily_incremental', 'investment', 'support', 'global', 'use', 'vertex', 'medicine', 'expansion_pipeline', 'other', 'new', 'disease', 'area'], ['gaap_non_gaap', 'income_taxis', 'increase', 'significantly', 'compare_third', 'quarter', 'release', 'valuation_allowance_majority', 'defer_tax_asset', 'fourth_quarter', 'gaap_non_gaap', 'income_taxis', 'third_quarter', 'include', 'provision_income_taxis', 'pre_tax_income', 'use', 'estimate', 'effective_tax_rate_approximate', 'statutory_rate', 'provision_income_taxis', 'include', 'significant', 'non_cash_charge', 'ability_offset', 'pre_tax_income', 'previously', 'benefit', 'net_operating_loss', 'refer_supplemental', 'income_tax', 'information', 'discussion_cash', 'non_cash_component', 'provision_income_taxis'], ['full_year_financial_guidance'], ['today', 'reiterate', 'revenue_guidance', 'update', 'summary', 'company', 'current', 'financial', 'expectation', 'below'], ['current'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'revenue_expense', 'relate', 'business', 'development', 'transaction', 'include', 'collaboration', 'agreement', 'asset_acquisition', 'consolidated', 'variable_interest_entity', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'acquisition_relate_cost', 'other', 'adjustment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'benefit_income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'provide', 'guidance_regard', 'product_revenue', 'accordance_gaap', 'provide', 'guidance_regard_combine', 'research', 'development', 'sale_general', 'administrative_expense', 'gaap_non_gaap', 'basis', 'company', 'also', 'provide', 'guidance_regard', 'anticipated', 'income_taxis', 'percentage', 'pre_tax_income', 'non_gaap_basis', 'guidance_regard', 'gaap', 'research', 'development', 'expense', 'sale_general', 'administrative_expense', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['non_gaap', 'effective_tax_rate'], ['fourth_quarter', 'company', 'record', 'non_cash', 'benefit_income_taxis', 'approximately', 'relate', 'release', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'result', 'company', 'record', 'defer_tax_asset', 'consolidated_balance', 'sheet', 'previously', 'subject', 'valuation_allowance', 'start', 'first_quarter', 'company', 'begin', 'record_provision_income_taxis', 'pre_tax_income', 'use', 'estimate', 'effective_tax_rate_approximate', 'statutory_rate', 'provision', 'include', 'significant', 'non_cash_charge', 'company', 'ability_offset', 'pre_tax_income', 'previously', 'benefit', 'net_operating_loss', 'company', 'expect', 'majority', 'tax_provision_represent', 'non_cash', 'expense', 'net_operating_loss', 'fully_utilize', 'company', 'federal_net_operating_loss', 'credit', 'available', 'offset', 'future', 'pre_tax_income', 'approximately'], ['month_end', 'company', 'consolidate', 'financial', 'statement', 'variable_interest_entity_vie', 'vertex', 'license', 'right', 'develop', 'vie', 'most', 'significant', 'intellectual_property', 'asset', 'month_end', 'fair_value_contingent_payment', 'payable_vertex', 'vie', 'increase', 'increase', 'attributable_noncontrolle', 'interest', 'result', 'decrease', 'net_income_attributable', 'vertex', 'dollar', 'dollar', 'basis', 'company', 'deconsolidate', 'vie', 'therefore', 'comparable_amount_month_end'], ['collaborative_revenue_expense', 'month_end', 'primarily_relate_collaborative_upfront', 'milestone_payment', 'collaborative_revenue_expense', 'month_end', 'also', 'include', 'revenue_expense', 'attributable', 'vie', 'operation'], ['acquisition_relate_cost', 'month_end', 'primarily_relate', 'cost_associate', 'company', 'acquisition_exonic', 'comparable_amount_month_end'], ['month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'primarily_relate', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'increase_decrease_fair', 'value', 'company', 'strategic_investment', 'collaborative_upfront', 'payment', 'month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'relate', 'provision_income_taxis', 'attributable', 'company', 'vie', 'excess_tax_benefit', 'relate_stock_base_compensation'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'include', 'section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'timing', 'expect', 'outcome', 'regulatory', 'application', 'reimbursement', 'medicine', 'globally', 'development', 'plan', 'timeline', 'product', 'development', 'candidate', 'include', 'next_generation', 'triple_combination_regimen', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'net_product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['conference_call', 'company', 'host_conference_call_webcast', 'today', 'pm_access_call_dial', 'international', 'conference_call_webcast', 'live_link', 'webcast', 'access', 'website_wwwvrtxcom_investor_section', 'event', 'presentation_ensure_timely', 'connection_recommend_user_register', 'least_minute_prior_schedule', 'webcast_archive_webcast', 'available', 'company', 'website'], ['source_version_news'], ['patient', 'access_orkambi_lumacaftor', 'ivacaftor', 'ivacaftor', 'expand', 'access'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'access', 'agreement', 'currently', 'license', 'vertex', 'cystic_fibrosis', 'medicine', 'future', 'indication', 'medicine'], ['mean', 'day', 'patient', 'age_year_old_copy', 'mutation_cystic_fibrosis', 'regulator_cftr_gene', 'prescribe', 'orkambi_lumacaftor', 'ivacaftor', 'doctor', 'patient', 'age_year_old_copy', 'mutation', 'copy_mutation_copy', 'other', 'licensed', 'mutation', 'prescribe', 'ivacaftor', 'combination', 'ivacaftor'], ['today', 'significant', 'day', 'cystic', 'community', 'important', 'agreement', 'reach', 'collaboration', 'partnership', 'allow', 'more', 'eligible_cystic_fibrosis', 'patient', 'access_cftr_modulator', 'treat_underlying_cause', 'disease', 'say_fenaux_senior_vice'], ['addition', 'reimbursement_agreement', 'also', 'recently', 'announce'], ['people', 'second', 'high', 'number', 'world', 'people', 'debilitate', 'life', 'shortening', 'inherited', 'condition', 'cause', 'progressive', 'damage', 'organ', 'body', 'birth', 'currently', 'cure', 'cf', 'half', 'people', 'die', 'daily', 'impact', 'treatment', 'significant', 'take', 'more', 'hour', 'involve', 'nebulizer', 'physiotherapy', 'tablet', 'day', 'account', 'hospital', 'admission', 'hospital', 'bed', 'day', 'year', 'third', 'use', 'child'], ['found_global_headquarters_now', 'locate_district', 'international_headquarters', 'additionally', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'regard', 'expectation', 'patient', 'population', 'able', 'access', 'vertex', 'medicine', 'timing', 'such', 'access', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['vertex_pharmaceutical_incorporate', 'report', 'third_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['found_global_headquarters_now', 'locate_district', 'international_headquarters', 'additionally', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow'], ['source_version_home'], ['first', 'time', 'approximately', 'patient', 'minimal_function_mutation', 'mutation', 'medicine_treat_underlying', 'cause', 'disease'], ['people_del', 'mutation', 'currently', 'eligible', 'vertex', 'other', 'approve', 'cystic_fibrosis', 'medicine', 'now', 'also', 'eligible', 'trikafta'], ['base', 'positive', 'global', 'phase_study', 'people_cystic_fibrosis', 'age_old', 'mutation_minimal', 'function_mutation_people_del', 'mutations'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'approve', 'elexacaftor_ivacaftor', 'ivacaftor', 'treatment_cystic_fibrosis', 'people', 'age_year_old_at', 'least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'most_common', 'cf', 'cause', 'mutation', 'approval', 'first', 'time', 'approximately', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation', 'medicine', 'target', 'underlying_cause', 'cf', 'additionally', 'approximately', 'people_del', 'mutation', 'currently', 'eligible', 'vertex', 'other', 'approve', 'medicine', 'now', 'also', 'eligible', 'trikafta'], ['press_release_feature_view', 'full', 'release', 'here'], ['product', 'shot', 'photo', 'business', 'wire'], ['today', 'mark', 'milestone', 'patient', 'family', 'vertex', 'journey', 'together', 'receive', 'approval', 'trikafta', 'single', 'breakthrough', 'medicine', 'potential', 'treat', 'people', 'future', 'approximately', 'people', 'trikafta', 'first', 'medicine_treat_underlying', 'cause', 'disease', 'say', 'chairman', 'president_chief_executive_officer', 'want', 'personally', 'thank', 'hundred', 'vertex', 'scientist', 'work', 'program', 'nearly', 'year', 'dedicate', 'entire', 'career', 'change', 'course', 'disease', 'provide', 'support', 'encouragement', 'help', 'journey', 'most', 'importantly', 'thousand', 'patient', 'caregiver', 'doctor', 'advocate', 'courageously', 'persistently', 'work', 'side', 'side', 'where', 'today'], ['today', 'approval', 'historic', 'moment', 'cystic_fibrosis', 'care', 'potential', 'more', 'people', 'benefit_cftr_modulator', 'therapy', 'treat', 'basic', 'defect', 'disease', 'say', 'clinical_trial', 'trikafta', 'generally_well_tolerate', 'demonstrate', 'improvement', 'multiple', 'outcome', 'measure', 'include', 'improvement', 'improvement', 'respiratory', 'symptom', 'study', 'reduce', 'rate', 'pulmonary_exacerbation', 'improvement', 'bmi'], ['incredible', 'speed', 'approval', 'underscore', 'share', 'sense', 'urgency', 'community', 'bring', 'medicine', 'eligible', 'people', 'particularly', 'medicine', 'target', 'underlying_cause', 'disease', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'remain', 'committed', 'relentlessly', 'pursue', 'development', 'transformative', 'therapy', 'people', 'live', 'disease'], ['submit', 'marketing_authorization_application', 'elexacaftor_ivacaftor', 'combination', 'currently', 'evaluate', 'elexacaftor_ivacaftor', 'people', 'age', 'mutation', 'ongoing', 'phase_study', 'commit', 'evaluate', 'elexacaftor_ivacaftor', 'child', 'year', 'age', 'part', 'planned', 'future', 'study'], ['more', 'information', 'patient', 'assistance', 'program', 'visit'], ['trikafta', 'elexacaftor_ivacaftor', 'ivacaftor', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'trikafta', 'safe_effective_child', 'year', 'age', 'trikafta', 'design_increase_quantity', 'function_cftr_protein', 'cell', 'surface', 'approval', 'trikafta', 'support', 'positive', 'result', 'global', 'phase_study', 'people', 'age_year_old', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'phase_study_people_del', 'mutation'], ['help', 'patient', 'access', 'trikafta', 'people', 'work', 'vertex', 'understand', 'medicine', 'only', 'help', 'people', 'guidance', 'patient', 'support', 'program', 'provide', 'team', 'vertex', 'employee', 'dedicate', 'help', 'eligible', 'people', 'prescribe', 'medicine', 'understand', 'insurance', 'benefit', 'resource', 'available', 'help'], ['also', 'offer', 'co', 'pay', 'assistance', 'program', 'eligible', 'people', 'commercial', 'insurance', 'coverage', 'free', 'medicine', 'program', 'qualify', 'people', 'meet', 'certain', 'income', 'other', 'eligibility', 'criterion', 'more', 'information', 'available', 'visit', 'wwwvertexgpscom', 'call'], ['indication_important_safety', 'information', 'elexacaftor_ivacaftor', 'ivacaftor', 'tablet', 'trikafta', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_at', 'least_copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'trikafta', 'safe_effective_child', 'year', 'age'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'third_paragraph', 'fourth_paragraph', 'statement', 'regard', 'current', 'future', 'plan', 'study', 'elexacaftor_ivacaftor', 'fifth', 'paragraph_press_release', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'obtain_approval_commercialize', 'elexacaftor_ivacaftor', 'develop', 'additional', 'medicine', 'treat_cystic_fibrosis', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'spanish', 'government', 'approve', 'term', 'national_reimbursement', 'lumacaftor_ivacaftor', 'ivacaftor', 'combination', 'ivacaftor', 'eligible', 'patient', 'live_cystic_fibrosis'], ['term', 'announce_today', 'child', 'age_year', 'cf', 'copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'treat', 'orkambi', 'patient', 'age_year_old_copy', 'mutation', 'copy_mutation_copy', 'other', 'mutation', 'approve', 'license', 'cftr_protein', 'show', 'residual', 'activity', 'treat', 'combination'], ['fenaux_senior_vice', 'comment', 'today_announcement', 'mean', 'orkambi', 'prescribe', 'first', 'approximately', 'eligible_cystic_fibrosis', 'patient', 'live', 'treat_underlying_cause', 'disease', 'thank', 'spanish', 'authority', 'collaboration', 'commitment', 'work', 'innovative', 'way', 'come', 'solution', 'patient', 'also', 'like', 'acknowledge', 'medical', 'community', 'important', 'input', 'process'], ['medicine', 'reimburse', 'country_world', 'include'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people', 'worldwide_cf_progressive_multi', 'system', 'disease', 'affect_lung_liver_tract', 'sinus_sweat_gland_pancrea', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['ivacaftor', 'combination', 'ivacaftor', 'mutation', 'result', 'cftr_protein_process_fold', 'normally', 'cell', 'generally_reach', 'cell', 'surface', 'tezacaftor', 'design', 'address_trafficking_processing_defect', 'cftr_protein', 'enable', 'reach', 'cell', 'surface', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'second', 'third', 'fifth', 'paragraph_press_release', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['international', 'medium'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'symdeko', 'ivacaftor', 'ivacaftor', 'reimburse', 'people_cystic_fibrosis', 'age_year_old', 'homozygous', 'mutation', 'copy_mutation_responsive', 'residual_function_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'people', 'copy_mutation_responsive', 'rf', 'mutation', 'cftr', 'gene', 'access', 'medicine', 'cause', 'cf', 'first', 'time', 'addition', 'orkambi_lumacaftor', 'ivacaftor', 'now', 'also', 'reimburse', 'treatment', 'child', 'age', 'copy_mutation', 'cftr', 'gene', 'patient', 'age', 'already', 'able', 'access', 'orkambi'], ['follow', 'previously', 'receive', 'positive', 'recommendation', 'pharmaceutical', 'eligible', 'patient', 'able', 'access', 'medicine', 'immediately', 'medicine', 'list', 'pharmaceutical', 'benefit', 'scheme', 'st'], ['pleased', 'symdeko', 'orkambi', 'make', 'available', 'immediately', 'eligible_cystic_fibrosis', 'patient', 'appreciate', 'pbac', 'recognize', 'value', 'medicine', 'patient', 'thank', 'strong', 'engagement', 'collaboration', 'finalize', 'agreement', 'say_fenaux_senior_vice'], ['medicine', 'reimburse', 'country_world', 'include'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people', 'worldwide_cf_progressive_multi', 'system', 'disease', 'affect_lung_liver_tract', 'sinus_sweat_gland_pancrea', 'reproductive_tract_cause_defective', 'miss_cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['symdeko', 'ivacaftor', 'combination', 'ivacaftor', 'mutation', 'result', 'cftr_protein_process_fold', 'normally', 'cell', 'generally_reach', 'cell', 'surface', 'tezacaftor', 'design', 'address_trafficking_processing_defect', 'cftr_protein', 'enable', 'reach', 'cell', 'surface', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface'], ['mutation', 'cftr', 'gene_responsive', 'symdeko', 'currently', 'register', 'include'], ['lumacaftor_ivacaftor', 'mutation', 'people', 'copy_mutation', 'cftr_protein', 'process', 'traffic', 'normally', 'cell', 'result', 'little', 'cftr_protein', 'cell', 'surface', 'patient', 'copy_mutation', 'easily', 'identify', 'simple', 'genetic_test', 'lumacaftor_ivacaftor', 'combination_lumacaftor', 'design_increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'cftr_protein', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'second', 'third_paragraph_press_release', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_risk_uncertainty', 'cause_actual_event', 'result_differ_materially_express', 'imply_such_forward_look', 'statement_risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'subsequent_quarterly_report_file', 'available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['international', 'medium', 'medium', 'investor'], ['approve', 'ivacaftor', 'first', 'only', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'child', 'young'], ['vertex_pharmaceutical', 'today_announce', 'committee_medicinal_product', 'human_use_chmp', 'adopt_positive_opinion', 'ivacaftor', 'include', 'use', 'infant', 'cystic_fibrosis_age', 'month', 'less_month', 'follow', 'mutation_cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr_gene'], ['issue', 'favorable', 'adoption', 'chmp_opinion', 'extension', 'indication', 'ivacaftor', 'first', 'only', 'medicine', 'approve', 'treat_underlying_cause', 'patient', 'age_month', 'less_month', 'specific', 'mutation', 'cftr', 'gene'], ['cystic', 'present_birth', 'symptom', 'frequently', 'manifest', 'infancy', 'why', 'so', 'important', 'treat', 'condition', 'as_early_possible', 'say_vice_president_chief', 'medical_officer', 'commit', 'treat', 'person', 'life', 'limit', 'disease', 'today', 'bring_step_close', 'provide', 'medicine', 'very', 'young', 'child_cystic_fibrosis'], ['submission', 'support', 'datum', 'ongoing_phase_open', 'label_safety', 'study', 'arrival', 'child', 'age_month', 'less_month', 'certain', 'mutation', 'cftr', 'gene', 'study', 'show', 'safety_profile', 'similar_observe', 'previous_phase', 'study', 'old_child_adult', 'improvement_sweat_chloride', 'key_secondary', 'efficacy_endpoint'], ['ivacaftor', 'already_approve', 'treatment', 'patient', 'age_month', 'old', 'follow', 'mutation', 'cftr', 'gene', 'also', 'approve', 'treatment', 'patient', 'year_old', 'mutation', 'cftr', 'gene'], ['cystic', 'cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people', 'worldwide_cf_progressive_multi', 'system', 'disease', 'affect_lung', 'sinus_sweat', 'pancrea_reproductive', 'tract_cause', 'defective_miss', 'cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_del_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'pain', 'alpha', 'deficiency_muscular', 'dystrophy_apol', 'mediated_kidney', 'disease'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'second', 'third_paragraph_press_release', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['medium', 'dessert'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'appoint', 'company', 'executive_vice', 'global', 'medicine', 'development', 'medical', 'bozic', 'assume', 'additional', 'role', 'chief_medical_officer', 'when', 'reshma', 'company', 'current', 'chief_medical_officer', 'become', 'president_chief_executive_officer', 'bozic', 'serve', 'senior_vice_president', 'head', 'global', 'clinical', 'development', 'year'], ['also', 'announce', 'appointment', 'currently', 'vertex', 'senior_vice_president', 'global', 'regulatory', 'affair', 'senior_vice', 'president_chief', 'regulatory', 'officer', 'effective', 'immediately'], ['addition', 'carman', 'executive', 'team', 'further', 'strengthen', 'leadership', 'rank', 'work', 'complete', 'journey', 'bring', 'new', 'therapy', 'clinic', 'variety', 'new', 'disease', 'area', 'say_chief_executive_officer'], ['receive', 'md', 'complete', 'residency', 'internal', 'medicine', 'then', 'complete', 'fellowship', 'pulmonary', 'critical_care', 'medicine', 'woman', 'join', 'vertex', 'lead', 'clinical', 'development', 'company', 'cystic_fibrosis', 'deficiency', 'program', 'as_well', 'lead', 'clinical', 'operation', 'pipeline', 'other', 'area', 'prior', 'join', 'bozic', 'spend', 'more', 'year', 'biogen', 'include', 'senior_vice_president', 'global', 'development', 'tenure', 'biogen', 'lead', 'multiple', 'function', 'include', 'global', 'clinical', 'development', 'safety', 'preclinical', 'safety', 'regulatory', 'clinical', 'operation', 'biometric'], ['thrilled', 'take', 'leadership', 'talente', 'global', 'medicine', 'development_medical_affair', 'team', 'exciting', 'time', 'company', 'say', 'advance', 'cystic_fibrosis', 'portfolio', 'clinic', 'unprecedented', 'speed', 'purpose', 'now', 'potential', 'therapy', 'clinic', 'opportunity', 'transform', 'treatment', 'patient', 'other', 'serious_disease'], ['receive', 'phd', 'cell', 'molecular', 'biology', 'hold', 'bs', 'biology', 'post', 'doctoral', 'fellow', 'hold', 'position', 'increase', 'responsibility', 'pharmaceutical', 'company', 'include', 'prior', 'join', 'vertex', 'most', 'recently', 'vice_president', 'head', 'global', 'regulatory', 'affair', 'unit', 'focus', 'immunology', 'rare', 'disease', 'multiple', 'sclerosis', 'oncology'], ['company', 'relentlessly', 'focused', 'scientific_innovation', 'bring', 'transformative', 'advance', 'medicine', 'patient', 'serious_disease', 'say', 'outstanding', 'regulatory', 'team', 'honor', 'lead', 'role', 'work', 'deliver', 'mission', 'strategy'], ['found_global_headquarters_now', 'locate_innovation_district_international', 'headquarters_additionally_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'first', 'third', 'fifth', 'seventh', 'paragraph_press_release', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk_list_risk_factor', 'annual_report_quarterly_report', 'file_disclaim_obligation', 'update_information_contain_press', 'release', 'new_information_become', 'available'], ['source_version_home'], ['investor_contact'], ['medium_contact'], ['leverage', 'ribometrix', 'discovery', 'platform', 'therapeutic', 'programs'], ['ribometrix', 'receive_upfront', 'payment', 'vertex', 'equity_investment', 'potential', 'additional', 'milestone_royalty', 'payments'], ['vertex_pharmaceutical_incorporate', 'announce_today', 'company', 'enter_strategic', 'collaboration', 'discover_develop', 'novel', 'rna', 'target', 'small_molecule', 'therapeutic', 'candidate', 'serious_disease', 'collaboration', 'combine', 'proprietary', 'discovery', 'platform', 'identify', 'optimize', 'small_molecule', 'therapeutic', 'modulate', 'rna', 'function', 'target', 'dimensional', 'structure', 'scientific', 'clinical', 'regulatory', 'capability', 'therapeutic', 'program', 'include', 'ongoing', 'discovery', 'program', 'ribometrix'], ['press_release_feature_view', 'full', 'release', 'here'], ['target', 'potentially', 'powerful', 'new', 'approach', 'develop', 'small_molecule', 'therapeutic', 'develop', 'innovative', 'technology', 'accelerated', 'discovery', 'selective', 'candidate', 'new', 'space', 'say', 'senior_vice_president', 'site', 'research', 'partnership', 'add', 'novel', 'mechanism', 'internal', 'toolkit', 'potential', 'enhance', 'ongoing', 'research', 'capability', 'support', 'expansion_pipeline', 'transformative_medicine', 'serious_disease'], ['company', 'found', 'groundbreake', 'research', 'expertise', 'structural', 'biology', 'see', 'firsthand', 'how', 'new', 'technology', 'dramatically', 'expand', 'druggability', 'potential', 'transform', 'treatment', 'previously', 'intractable', 'disease', 'say_chief_executive_officer', 'leader', 'create_transformative', 'medicine', 'serial_innovation', 'proud', 'partner', 'rapidly', 'effectively', 'develop', 'core', 'discovery', 'platform', 'small_molecule', 'therapeutic', 'target', 'rna'], ['collaboration', 'term', 'agreement', 'vertex', 'pay', 'ribometrix', 'approximately', 'upfront', 'include', 'equity_investment', 'company', 'initially', 'ribometrix', 'undertake', 'discovery', 'program', 'vertex', 'vertex', 'option', 'add', 'third', 'program', 'follow', 'discovery', 'optimization', 'novel', 'therapeutic', 'molecule', 'vertex', 'option', 'take', 'exclusive', 'global', 'license', 'development', 'molecule', 'program', 'ribometrix', 'eligible', 'receive', 'more', 'total', 'potential', 'payment', 'base', 'successful_achievement_specify', 'research', 'development', 'regulatory', 'commercial_milestone', 'part', 'collaboration', 'addition', 'vertex', 'pay_tiered', 'royalty_future_net', 'global', 'sale', 'product', 'result', 'collaboration'], ['ribometrix', 'rna', 'target', 'therapeutic', 'platform', 'use', 'multiple', 'specialized', 'technology', 'first', 'identify', 'rna', 'motif', 'therapeutically', 'compelling', 'then', 'discover', 'small_molecule', 'bind', 'motif', 'therapeutic', 'way', 'show', 'many', 'implicate', 'contain', 'structural', 'pocket', 'target', 'small_molecule', 'ligand', 'ribometrix', 'scientist', 'use', 'state_art', 'proprietary', 'assay', 'identify', 'ligand', 'bind', 'specifically', 'pocket', 'therapeutically', 'modulate', 'potential', 'benefit', 'current', 'protein', 'rna', 'base', 'approach', 'include', 'potency', 'selectivity', 'oral', 'bioavailability', 'tissue', 'distribution', 'central_nervous_system', 'penetration'], ['biotechnology', 'company', 'pioneer', 'small_molecule', 'therapeutic', 'directly', 'target', 'modulate', 'function', 'rna', 'create', 'completely', 'new_class', 'medicine', 'treat', 'human', 'disease', 'ribometrix', 'leverage', 'world', 'lead', 'expertise', 'dimensional', 'structural', 'analysis', 'drive', 'discovery', 'platform', 'identification', 'novel_small_molecule', 'modulate', 'function', 'rna', 'protein', 'associate', 'human', 'complete', 'series', 'financing', 'late', 'headquarter', 'more_information_visit'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'bunnage', 'statement_second_paragraph', 'press_release_statement', 'third_paragraph_press_release', 'statement', 'regard', 'future', 'activity_party', 'pursuant_collaboration', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'belief_only_date_press', 'release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'vertex', 'realize_anticipate_benefit', 'collaboration', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['source'], ['contact', 'communication'], ['eligible', 'patient', 'immediately', 'access_orkambi_lumacaftor', 'ivacaftor', 'ivacaftor', 'combination', 'ivacaftor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'eligible_cystic_fibrosis', 'patient', 'live', 'now', 'access_orkambi_lumacaftor', 'ivacaftor', 'ivacaftor', 'combination', 'ivacaftor', 'follow', 'signing', 'access', 'agreement'], ['like_thank', 'scottish', 'authority', 'partnership', 'collaborative', 'flexible', 'way', 'work_together', 'find', 'access', 'solution', 'say_fenaux_senior_vice', 'mean', 'approximately', 'eligible_cystic_fibrosis', 'patient', 'now', 'access', 'orkambi', 'symkevi'], ['part', 'agreement', 'vertex', 'also', 'commit', 'collect', 'real_world', 'datum', 'medicine', 'support', 'future', 'submission', 'scottish', 'smc'], ['cystic_fibrosis', 'medicine', 'reimburse', 'country_world', 'include'], ['approximately', 'people', 'live', 'median_age', 'death', 'year', 'estimate', 'scot', 'cftr', 'mutation', 'carry', 'parent', 'lead', 'child', 'bear'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_third_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate_forward_look', 'statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], [], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'conference', 'pm'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['unique', 'investigational', 'approach', 'combine', 'robust', 'production', 'process', 'pancreatic_islet', 'cell', 'proprietary', 'delivery', 'system', 'restore', 'insulin', 'secretion', 'type_diabetes', 'patients'], ['acquire', 'cash'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'company', 'enter', 'definitive', 'agreement', 'acquire', 'therapeutic', 'privately', 'hold', 'biotechnology', 'company', 'pioneer', 'use', 'stem', 'cell', 'derive', 'human', 'islet', 'potentially', 'curative', 'treatment', 'type_diabetes', 'cash', 'semma', 'demonstrate', 'differentiated', 'approach', 'treat', 'type_diabete', 'serious_disease', 'affect', 'people', 'alone', 'make', 'major', 'scientific', 'advance', 'ability', 'produce', 'large', 'quantity', 'functional', 'human', 'pancreatic', 'beta', 'cell', 'restore', 'insulin', 'secretion', 'ameliorate', 'hypoglycemia', 'animal_model', 'novel', 'device', 'encapsulate', 'protect', 'cell', 'immune_system', 'enable', 'durable', 'implantation', 'need', 'ongoe', 'therapy'], ['press_release_feature_view', 'full', 'release', 'here', 'news'], ['acquisition', 'align', 'perfectly', 'strategy', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'specialty', 'market', 'say_chief_executive_officer', 'excited', 'work', 'talented', 'scientist', 'build', 'significant', 'progress', 'provide', 'effective', 'potentially', 'curative', 'cell', 'therapy', 'option', 'people', 'live', 'type_diabetes', 'see', 'substantial', 'opportunity', 'transform', 'treatment', 'paradigm', 'type_diabete', 'specialty', 'disease', 'care', 'endocrinologist', 'advance', 'development', 'manufacturing', 'cell', 'as_well', 'highly', 'innovative', 'cell', 'device', 'combination'], ['therapeutic', 'approach', 'pioneer', 'potential', 'address', 'causal_human', 'biology', 'type_diabete', 'serious_disease', 'inadequately', 'control', 'exist', 'therapy', 'insulin', 'injection', 'insulin', 'pump', 'islet', 'cell', 'transplantation', 'provide', 'physiologic', 'regulation', 'blood_glucose', 'thereby', 'potentially', 'ameliorate', 'prevent', 'hyperglycemic', 'hypoglycemic', 'episode', 'associate', 'current', 'standard_care', 'say', 'executive', 'research', 'chief_scientific', 'officer', 'vertex', 'compelling', 'proof_concept', 'datum', 'animal', 'demonstrate', 'opportunity', 'develop', 'transformative', 'potentially', 'curative', 'therapy', 'treat', 'people', 'type_diabetes', 'addition', 'acquisition', 'continue', 'expand', 'vertex', 'toolbox', 'cut_edge', 'technology', 'capability', 'bolster', 'team', 'lead', 'scientist'], ['type_diabetes', 'disease', 'afflict', 'million', 'people', 'worldwide', 'curative', 'therapy', 'available', 'say', 'president_chief_executive_officer', 'prove', 'track_record', 'serial_innovation', 'deep', 'commitment', 'develop', 'transformative', 'therapy', 'patient', 'need', 'part', 'vertex', 'allow', 'team', 'rapidly', 'effectively', 'advance', 'cell', 'therapy', 'delivery', 'approach', 'patient', 'need'], ['found', 'dramatically', 'improve', 'life', 'patient', 'type_diabetes', 'say', 'scientific', 'founder', 'ideally', 'suit', 'accelerate', 'achievement', 'goal'], [], ['found', 'other', 'develop', 'transformative', 'therapy', 'patient', 'currently', 'depend', 'insulin', 'injection', 'company', 'focus', 'advance', 'method', 'generate', 'billion', 'functional', 'insulin_produce', 'beta', 'cell', 'grow', 'stem', 'cell', 'laboratory', 'develop', 'islet', 'like', 'cluster', 'initial', 'preclinical', 'work', 'animal_model', 'diabetes', 'show', 'transplantation', 'cell', 'infusion', 'liver', 'sufficient', 'control', 'blood_glucose', 'level', 'breakthrough', 'technology', 'exclusively_license', 'development', 'cell', 'base', 'therapy', 'diabetes'], ['addition', 'purse', 'direct', 'intra', 'hepatic', 'transplantation', 'islet', 'cell', 'ongoing', 'research', 'focus', 'combine', 'proprietary', 'cell', 'state_art', 'cell', 'device', 'immune', 'protection', 'strategy', 'protect', 'cell', 'patient', 'immune_system', 'allow', 'beta', 'cell', 'function', 'non', 'diabetic', 'individual', 'implantation', 'islet', 'cell', 'fill', 'device', 'potential', 'replace', 'miss', 'beta', 'cell', 'diabetic', 'patient', 'require', 'patient', 'work', 'bring', 'new', 'therapeutic', 'option', 'clinic', 'improve', 'life', 'patient', 'diabetes'], ['recently', 'announce', 'achievement', 'preclinical', 'proof_concept', 'lead', 'program', 'base', 'datum', 'test', 'human', 'stem', 'cell', 'derive_islet', 'sc', 'islet', 'non', 'human', 'primate', 'pig', 'datum', 'present', 'plenary', 'session', 'international', 'society', 'stem', 'cell', 'research', 'isscr', 'date', 'cell', 'therapy', 'approach', 'only', 'islet', 'cell', 'transplantation', 'program', 'demonstrate', 'positive', 'peptide', 'release', 'marker', 'insulin', 'secretion', 'as_well', 'positive', 'glycemic_control', 'experimentally', 'induce', 'diabetes'], ['transaction', 'term'], ['term', 'acquisition', 'vertex', 'acquire', 'outstanding', 'share', 'cash', 'become', 'separate', 'operating', 'subsidiary', 'join', 'president', 'also', 'continue', 'role', 'chair', 'scientific', 'board', 'provide', 'oversight', 'guidance', 'research', 'development', 'program'], ['company', 'anticipate', 'acquisition', 'close', 'fourth_quarter', 'subject', 'certain', 'condition', 'include', 'expiration_waiting_period_antitrust', 'improvement', 'other', 'customary', 'condition', 'vertex', 'provide', 'appropriate', 'update', 'current', 'financial_guidance', 'conjunction', 'third_quarter', 'earning', 'release', 'close', 'transaction', 'occur', 'later'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_second_paragraph', 'press_release_statement', 'third_paragraph_press_release', 'statement_fourth_paragraph', 'press_release_statement', 'fifth', 'paragraph_press_release', 'statement', 'regard', 'timing', 'potential', 'closing_transaction', 'potential', 'benefit', 'acquisition', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'belief_only_date_press', 'release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'transaction', 'subject', 'certain', 'condition', 'include', 'expiration_waiting_period_antitrust', 'improvement', 'realize', 'potential', 'benefit', 'acquisition', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news'], ['investor_contact'], ['medium_contact', 'group'], ['grant', 'priority_review', 'application', 'set', 'pdufa_target_action', 'date'], ['support', 'positive', 'result', 'global', 'phase_study', 'people_cystic_fibrosis', 'age_old', 'mutation_minimal', 'function_mutation_people_del', 'mutations'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'accept', 'new', 'drug_application', 'elexacaftor_tezacaftor', 'ivacaftor', 'triple_combination', 'grant', 'priority_review', 'assign', 'prescription', 'drug', 'user', 'pdufa_target_action', 'date', 'submission', 'support', 'previously', 'disclose', 'positive', 'result', 'global', 'phase_study', 'people_cystic_fibrosis', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'phase_study_people_del', 'mutation', 'phase_study', 'show_statistically', 'significant_improvement', 'lung_function', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'primary_endpoint', 'key_secondary_endpoint', 'study', 'triple_combination_generally_well', 'tolerate'], ['approve', 'elexacaftor_tezacaftor', 'ivacaftor', 'triple_combination_regiman', 'significant', 'advance', 'treatment', 'first', 'cftr_modulator', 'mutation_minimal', 'function_mutation', 'bring', 'additional', 'benefit', 'patient', 'mutation', 'say_vice_president_chief', 'medical_officer', 'goal', 'provide', 'medicine_treat_underlying', 'cause', 'vast_majority', 'people', 'cf', 'share', 'sense', 'urgency', 'people', 'caregiver', 'clinician', 'rapidly', 'deliver', 'innovative', 'medicine', 'wait', 'look_forward', 'work', 'agency', 'review', 'application', 'course', 'coming', 'month'], ['cystic', 'cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people', 'worldwide_cf_progressive_multi', 'system', 'disease', 'affect_lung', 'sinus_sweat', 'pancrea_reproductive', 'tract_cause', 'defective_miss', 'cftr_protein', 'result', 'certain', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'many_different_type', 'cftr', 'mutation', 'cause_disease_vast', 'majority', 'people', 'at_least_mutation', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_second_paragraph', 'press_release', 'target', 'action', 'date', 'information', 'regard', 'review', 'process', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'nda', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['product_revenue', 'increase_compare'], ['company', 'increase', 'full_year', 'total_product_revenue', 'guidance'], ['company', 'advance', 'program', 'additional', 'disease', 'cystic_fibrosis'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'second_quarter_end', 'increase', 'full_year', 'total_product_revenue', 'guidance'], ['make', 'tremendous', 'progress', 'business', 'thus', 'far', 'submit', 'new', 'drug_application', 'triple_combination_regiman', 'believe', 'potential', 'treat', 'patient', 'future', 'continue', 'focus', 'ensure', 'eligible', 'patient', 'access', 'medicine', 'as_early_possible', 'say_chief_executive_officer', 'vertex', 'additionally', 'rapidly', 'grow', 'pipeline', 'advance', 'new', 'potential', 'medicine', 'disease', 'area', 'include', 'beta_thalassemia_sickle', 'cell', 'disease', 'deficiency_kidney', 'disease', 'pain', 'expand', 'collaboration', 'therapeutic', 'acquisition_exonic', 'therapeutic', 'now', 'establish', 'lead', 'gene_edit', 'platform', 'treatment', 'muscular_dystrophy', 'myotonic', 'dystrophy_type'], ['second_quarter_financial', 'highlight'], ['combine_gaap_expense', 'increase_compare', 'second_quarter', 'primarily', 'upfront_payment', 'therapeutic'], ['combined_non_gaap', 'expense', 'similar', 'second_quarter'], ['gaap_non_gaap', 'income_taxis', 'increase', 'significantly', 'compare', 'second_quarter', 'release', 'valuation_allowance_majority', 'defer_tax_asset', 'fourth_quarter', 'gaap_non_gaap', 'income_taxis', 'second_quarter', 'include', 'provision_income_taxis', 'pre_tax_income', 'use', 'estimate', 'effective_tax_rate_approximate', 'statutory_rate', 'provision_income_taxis', 'include', 'significant', 'non_cash_charge', 'ability_offset', 'pre_tax_income', 'previously', 'benefit', 'net_operating_loss', 'refer_supplemental', 'income_tax', 'information', 'discussion_cash', 'non_cash_component', 'provision_income_taxis'], ['program'], ['order', 'reduce', 'impact', 'dilution', 'employee', 'equity', 'program', 'board_director', 'authorize', 'share', 'repurchase', 'program', 'common_stock'], ['repurchase', 'expect', 'execute', 'time', 'time', 'subject', 'general', 'business', 'market', 'condition', 'other', 'investment', 'opportunity', 'open', 'market', 'purchase', 'privately', 'negotiate', 'transaction', 'include', 'rule', 'plan'], ['today_announce', 'update', 'financial_guidance', 'summarize_below'], [], [], [], [], ['increase', 'total_product_revenue', 'guidance', 'base', 'strong', 'product', 'performance', 'first_half'], ['company', 'revise', 'combine_gaap_expense', 'guidance', 'reflect', 'upfront_payment', 'make', 'therapeutic', 'transaction', 'announce', 'second_quarter'], ['business', 'highlight'], ['clinical', 'development'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'revenue_expense', 'relate', 'business', 'development', 'transaction', 'include', 'collaboration', 'agreement', 'asset_acquisition', 'consolidated', 'variable_interest_entity', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'other', 'adjustment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'benefit_income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'provide', 'guidance_regard', 'product_revenue', 'accordance_gaap', 'provide', 'guidance_regard_combine', 'research', 'development', 'sale_general', 'administrative_expense', 'gaap_non_gaap', 'basis', 'company', 'also', 'provide', 'guidance_regard', 'anticipated', 'income_taxis', 'percentage', 'pre_tax_income', 'non_gaap_basis', 'guidance_regard', 'gaap', 'research', 'development', 'expense', 'sale_general', 'administrative_expense', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], [], ['month_end', 'company', 'consolidate', 'financial', 'statement', 'variable_interest_entity_vie', 'vertex', 'license', 'right', 'develop', 'vie', 'most', 'significant', 'intellectual_property', 'asset', 'month_end', 'fair_value_contingent_payment', 'payable_vertex', 'vie', 'increase', 'increase', 'attributable_noncontrolle', 'interest', 'result', 'decrease', 'net_income_attributable', 'vertex', 'dollar', 'dollar', 'basis', 'change_fair_value_contingent', 'payment_payable', 'vertex', 'vie', 'decrease', 'month_end', 'company', 'deconsolidate', 'vie', 'therefore', 'comparable_amount_month_end'], ['collaborative_transaction', 'revenue_expense', 'month_end', 'primarily_relate_collaborative_upfront', 'milestone_payment', 'collaborative_transaction', 'revenue_expense', 'month_end', 'also', 'include', 'revenue_expense', 'attributable', 'vie', 'operation'], ['month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'primarily_relate', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'increase', 'fair_value_company', 'strategic_investment', 'collaborative_upfront', 'payment', 'month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'relate', 'provision_income_taxis', 'attributable', 'company', 'vie', 'excess_tax_benefit', 'relate_stock_base_compensation'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'include', 'section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'timing', 'expect', 'outcome', 'regulatory', 'application', 'include', 'development', 'plan', 'timeline', 'product', 'development', 'candidate', 'include', 'next_generation', 'triple_combination_regimen', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'net_product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['investor_medium'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'board_director', 'approve', 'plan', 'transition', 'chairman', 'president_chief_executive_officer', 'role', 'executive_chairman', 'board', 'effective', 'chief_medical_officer', 'reshma', 'become', 'president_chief_executive_officer', 'appoint', 'serve', 'company', 'board_director'], ['leadership', 'transform', 'vertex', 'deliver', 'extraordinary', 'value', 'patient', 'shareholder', 'development', 'multiple', 'transformative_medicine', 'vertex', 'never', 'strong', 'well', 'position', 'future', 'clear', 'differentiated', 'research', 'business', 'strategy', 'exceptionally', 'strong', 'financial', 'position', 'deep', 'leadership_team', 'inclusive', 'culture', 'innovation', 'say', 'sach', 'lead', 'independent', 'director', 'director', 'immensely', 'grateful', 'strategic', 'vision', 'relentless', 'dedication', 'science', 'serial_innovation', 'transform', 'treatment_cystic_fibrosis', 'produce', 'pipeline', 'breakthrough', 'medicine', 'other', 'serious_disease', 'board', 'look_forward', 'ongoing', 'leadership', 'strategic', 'guidance', 'role', 'executive_chairman'], ['continue', 'board', 'work', 'several', 'year', 'plan', 'smooth', 'effective', 'leadership', 'transition', 'ensure', 'strategic', 'operational', 'continuity', 'vertex', 'entire', 'board', 'excite', 'reshma', 'become', 'next', 'ceo', 'accomplished', 'scientist', 'physician', 'more', 'year', 'experience', 'medicine', 'biotechnology', 'deep_understanding', 'appreciation', 'strategy', 'business', 'culture'], ['tremendous', 'privilege', 'lead', 'vertex', 'outstanding', 'senior', 'leadership_team', 'look_forward', 'play', 'continue', 'active', 'role', 'company', 'next', 'several', 'year', 'support', 'reshma', 'team', 'transition', 'say', 'have', 'work_closely', 'reshma', 'last', 'several', 'year', 'know', 'tremendously', 'talente', 'extremely', 'passionate', 'patient', 'centric', 'mission', 'fully', 'prepared', 'lead', 'vertex', 'enter', 'next', 'phase', 'company', 'background', 'physician', 'scientist', 'give', 'deep_understanding', 'core', 'vertex', 'outstanding', 'science', 'commitment', 'serial_innovation', 'also', 'strong', 'collaborative', 'leader', 'prove', 'ability', 'execute', 'strategy', 'deliver', 'result', 'importantly', 'track_record', 'put', 'patient', 'first', 'drive', 'innovation', 'transformative', 'impact', 'patient', 'life'], ['comment', 'honor', 'become', 'next', 'ceo', 'continue', 'work', 'board', 'leadership_team', 'time', 'such', 'opportunity', 'company', 'consistent', 'execution', 'strategy', 'produce', 'leading', 'portfolio', 'product', 'potentially', 'treat', 'percent', 'patient', 'disease', 'productive', 'research', 'engine', 'already', 'lead', 'enviable', 'clinical_stage', 'pipeline', 'potentially', 'breakthrough', 'medicine', 'additional', 'disease', 'include', 'deficiency', 'pain', 'sickle', 'cell', 'disease_beta_thalassemia', 'apol_mediated', 'kidney_disease', 'financial', 'strength', 'continue', 'invest', 'future', 'innovation', 'most', 'importantly', 'talented', 'dedicated', 'team', 'people', 'company', 'incredibly', 'proud', 'lead'], ['join', 'currently', 'serve', 'company', 'executive_vice', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'role', 'oversee', 'clinical', 'development', 'drug', 'safety', 'other', 'related', 'function', 'responsible', 'develop', 'advise', 'drive', 'execution', 'clinical', 'development', 'program', 'prior', 'spend', 'more', 'year', 'where', 'hold', 'variety', 'role', 'research', 'development', 'include', 'vice_president', 'global', 'clinical', 'development', 'therapeutic', 'area', 'vice_president', 'medical', 'organization', 'group', 'establish', 'grow', 'assume', 'responsibility', 'full', 'portfolio', 'molecule', 'therapeutic', 'area'], ['complete', 'internship', 'residency', 'internal', 'medicine', 'fellowship', 'nephrology', 'woman', 'hospital', 'combine', 'program', 'receive', 'medical', 'degree', 'honor', 'also', 'complete', 'general', 'management', 'program', 'alumnus', 'school', 'industry', 'representative'], ['agree', 'serve', 'executive_chairman', 'first_quarter'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'company', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'rare_life_threaten_genetic', 'disease', 'several_ongoing_clinical', 'research_program_robust', 'pipeline_investigational', 'medicine', 'other', 'serious_disease_where_deep', 'insight_causal_human_biology', 'such_sickle', 'cell', 'disease', 'thalassemia_pain_deficiency', 'muscular_dystrophy', 'apol_mediated', 'kidney_disease'], ['found_global_headquarters_now', 'locate_innovation', 'international_headquarters', 'additionally', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work_include_consecutive', 'year', 'science_magazine_top_employer', 'list_top_good', 'employer_diversity', 'list_forbes', 'company_update_learn', 'more_history', 'innovation_visit_wwwvrtxcom', 'follow'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'regard', 'plan', 'transition', 'leiden', 'role', 'executive_chairman', 'plan', 'appointment', 'president_chief_executive_officer', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk_list_risk_factor', 'annual_report_quarterly_report', 'file_available_company', 'website_disclaim_obligation_update', 'information_contain_press', 'release', 'new_information_become', 'available'], [], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['support', 'positive', 'result', 'global', 'phase_study', 'people', 'age_old', 'mutation_minimal', 'function_mutation_people_del', 'mutations'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'submission', 'new', 'drug_application', 'food', 'elexacaftor_tezacaftor', 'ivacaftor', 'triple_combination_regiman', 'include', 'request', 'priority_review', 'grant', 'shorten', 'review', 'month', 'time', 'submission', 'standard', 'review', 'timeline', 'month', 'submission'], ['submission', 'support', 'previously', 'disclose', 'positive', 'result', 'global', 'phase_study', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'phase_study_people_del', 'mutation', 'phase_study', 'show_statistically', 'significant_improvement', 'lung_function', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'primary_endpoint', 'key_secondary_endpoint', 'study', 'triple_combination_generally_well', 'tolerate'], ['relentlessly', 'focus', 'progression', 'elexacaftor_tezacaftor', 'ivacaftor', 'discovery', 'clinical', 'development', 'regulatory_submission', 'say_vice_president_chief', 'medical_officer', 'submission', 'major', 'step', 'goal_bring', 'medicine', 'large', 'remaining', 'group', 'people', 'still', 'approve', 'vertex', 'medicine', 'as_well', 'provide', 'significantly', 'enhance', 'benefit', 'patient', 'del_mutation', 'continue', 'work', 'review', 'look_forward', 'potential', 'triple_combination_regiman', 'become', 'new', 'treatment_option', 'people'], ['elexacaftor_tezacaftor', 'ivacaftor', 'treatment', 'grant', 'breakthrough', 'therapy', 'designation', 'breakthrough', 'therapy', 'designation', 'process', 'design', 'expedite', 'development', 'review', 'drug', 'intend', 'treat', 'serious', 'condition', 'preliminary', 'clinical', 'evidence', 'indicate', 'drug', 'demonstrate', 'substantial_improvement', 'available', 'therapy', 'clinically', 'significant'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people'], ['cause_defective_missing', 'cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr', 'protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'early'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_life_threaten', 'disease', 'addition', 'clinical', 'development', 'program', 'more', 'dozen', 'ongoing', 'research', 'program', 'focus', 'underlie', 'mechanism', 'other', 'serious_disease'], ['found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row', 'additional', 'information', 'late', 'update', 'company', 'visit_wwwvrtxcom'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_third_paragraph', 'press_release_information', 'regard', 'review', 'process', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'nda', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['vertex_pharmaceutical_incorporate', 'report_second_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_life_threaten', 'disease', 'addition', 'clinical', 'development', 'program', 'more', 'dozen', 'ongoing', 'research', 'program', 'focus', 'underlie', 'mechanism', 'other', 'serious_disease'], ['found_headquarters_now_locate', 'innovation', 'today', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row'], ['additional', 'information', 'late', 'update', 'company', 'visit_wwwvrtxcom'], ['source_version'], [], ['now', 'approve', 'patient', 'year', 'age', 'old_copy', 'mutation', 'copy', 'responsive', 'mutation'], ['third', 'medicine', 'approve', 'treat_underlying_cause', 'eligible', 'patient', 'age'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'approve', 'symdeko', 'ivacaftor', 'ivacaftor', 'use', 'child_cystic_fibrosis', 'age_year', 'copy', 'cftr', 'mutation', 'at_least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene_responsive', 'symdeko', 'previously', 'approve', 'use', 'patient', 'cystic_fibrosis', 'year_old', 'copy_mutation_copy', 'responsive', 'mutation', 'additional', 'dosage_strength', 'symdeko', 'tablet', 'now', 'available', 'mg', 'connection', 'approval'], ['today', 'expand', 'approval', 'symdeko', 'child', 'age', 'important', 'step', 'effort', 'continue', 'bring', 'treatment_option', 'young', 'patient', 'possible', 'importantly', 'bring', 'close', 'goal', 'develop', 'medicine', 'people', 'live', 'say_vice_president_chief', 'medical_officer'], ['complete', 'phase_open_label', 'multicenter', 'study', 'evaluate', 'pharmacokinetic', 'safety_tolerability', 'tezacaftor_ivacaftor', 'ivacaftor', 'child', 'age_year', 'generally_well_tolerate', 'safety', 'datum', 'similar_observe', 'previous', 'study', 'patient', 'age_year_old', 'full', 'datum', 'study', 'publish', 'later', 'year'], ['have', 'see', 'clinical', 'impact', 'symdeko', 'people', 'aged', 'year', 'above', 'approval', 'mark', 'crucial', 'milestone', 'patient', 'age_year', 'benefit', 'cftr', 'modulation', 'enable', 'treat', 'basic', 'defect', 'early_stage', 'disease', 'say', 'hospital', 'baby', 'child', 'hospital', 'important', 'treatment_option', 'eligible', 'people', 'never', 'start', 'discontinue', 'cftr_modulator'], ['ivacaftor', 'ivacaftor', 'already_approve', 'treatment', 'patient', 'age_year_old', 'certain', 'mutation', 'vertex', 'plan_submit', 'application', 'use', 'patient', 'age_year', 'second_half', 'more', 'information', 'symdeko', 'patient', 'assistance', 'program', 'visit', 'symdekocom', 'vertexgpscom'], ['cause_defective_missing', 'cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr', 'protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'mid_late'], ['symdeko', 'ivacaftor', 'ivacaftor', 'mutation', 'result', 'cftr_protein_process_fold', 'normally', 'cell', 'generally_reach', 'cell', 'surface', 'symdeko', 'combination_tezacaftor', 'design', 'address_trafficking_processing_defect', 'cftr_protein', 'enable', 'reach', 'cell', 'surface', 'where', 'ivacaftor', 'increase_amount', 'time', 'protein', 'stay', 'open'], ['indication_important_safety', 'information', 'symdeko', 'ivacaftor', 'ivacaftor', 'tablet', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_copy', 'mutation', 'at_least_mutation', 'gene_responsive', 'treatment', 'symdeko', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'symdeko', 'safe_effective_child', 'year', 'age'], ['patient', 'take', 'symdeko', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medicine_such_phenobarbital', 'carbamazepine_phenytoin'], ['possible_side_effect', 'symdeko', 'click_here', 'see', 'fullusprescribe', 'information', 'ivacaftor', 'ivacaftor', 'tablet'], ['collaborative', 'history', 'cystic', 'initiate', 'research', 'program', 'part', 'collaboration', 'nonprofit_drug_discovery', 'development', 'affiliate', 'ivacaftor', 'lumacaftor_ivacaftor', 'ivacaftor', 'ivacaftor_elexacaftor', 'discover', 'vertex', 'part', 'collaboration'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'quote', 'second_paragraph', 'fourth_paragraph', 'statement', 'regard', 'plan_submit', 'application', 'second_half', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['vertex', 'lead', 'gene_edit', 'capability', 'develop', 'novel', 'therapy', 'muscular_dystrophy', 'myotonic', 'dystrophy_type'], ['receive_upfront', 'payment', 'potential', 'additional', 'milestone_royalty', 'payments'], ['acquire', 'upfront_payment', 'potential', 'additional', 'milestone', 'payments'], ['gray', 'appoint', 'senior_vice'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'company', 'enhance', 'gene_edit', 'capability', 'develop', 'novel', 'therapy', 'muscular_dystrophy', 'dystrophy_type', 'dm', 'expand', 'collaboration', 'therapeutic', 'acquire', 'exonic', 'therapeutic'], ['expand', 'collaboration', 'enter', 'exclusive', 'licensing_agreement', 'discover_develop', 'gene_editing', 'therapy', 'treatment', 'dm'], ['vertex', 'exonic', 'therapeutic', 'enter', 'definitive', 'agreement', 'acquire', 'privately', 'hold', 'exonic', 'company', 'focus', 'create_transformative', 'gene_edit', 'therapy', 'repair', 'mutation', 'cause', 'other', 'severe', 'neuromuscular', 'disease'], ['expand', 'collaboration', 'acquisition_exonic', 'bring', 'together', 'intellectual_property', 'technology', 'scientific', 'expertise', 'need', 'establish', 'lead', 'gene_edit', 'platform', 'dmd', 'dm', 'transaction', 'highly', 'align', 'strategy', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_disease', 'say_chief_executive_officer', 'continue', 'build', 'toolbox', 'small_molecule', 'nucleic', 'acid', 'technology', 'capability', 'allow', 'drive', 'scientific_innovation', 'produce', 'transformative_medicine', 'broad', 'portfolio', 'disease'], ['agreement', 'reflect', 'strong', 'collaboration', 'build', 'together', 'other', 'program', 'underscore', 'commitment', 'gene_editing', 'say_chief_executive_officer', 'continue', 'make', 'significant', 'advancement', 'enable', 'approach', 'gene_editing', 'excited', 'possibility', 'develop', 'potentially', 'curative', 'therapy', 'dmd', 'dm', 'together', 'vertex'], ['dm', 'devastate', 'muscle', 'disease', 'curative', 'therapy', 'available', 'say_chief', 'science', 'advisor', 'exonic', 'professor', 'chair', 'molecular', 'biology', 'southwestern', 'center', 'prove', 'track_record', 'develop', 'important', 'therapy', 'serious_disease', 'excited', 'combine', 'effort', 'potentially', 'develop', 'safe', 'efficacious', 'time', 'treatment', 'severe', 'neuromuscular', 'disease'], ['need', 'novel', 'approach', 'treat', 'cure', 'devastating', 'disease', 'exonic', 'technology', 'potential', 'dramatically', 'improve', 'life', 'patient', 'say', 'founder', 'provide', 'initial', 'seed', 'funding', 'exonic', 'delighted', 'talented', 'scientist', 'vertex', 'exonic', 'work_together', 'advance', 'promising', 'gene_edit', 'treatment', 'other', 'neuromuscular', 'disease'], ['collaboration', 'term', 'strategic', 'collaboration', 'license_agreement', 'vertex', 'pay', 'upfront', 'exclusive', 'worldwide', 'right', 'exist', 'future', 'intellectual_property', 'include', 'foundational', 'technology', 'novel', 'endonuclease', 'single', 'double', 'cut', 'aav', 'vector', 'dmd', 'dm', 'gene_editing', 'product'], ['program', 'responsible', 'research', 'development', 'manufacturing', 'activity', 'related', 'cost', 'dm', 'program', 'vertex', 'crispr', 'share', 'research', 'cost', 'specify', 'research', 'conduct', 'crispr', 'responsible', 'other', 'research', 'development', 'manufacturing', 'cost'], ['eligible', 'receive', 'payment', 'inclusive', 'upfront', 'potential', 'future', 'payment', 'base', 'successful_achievement_specify', 'research', 'development', 'regulatory', 'commercial_milestone', 'dm', 'program', 'addition', 'vertex', 'pay_tiered', 'royalty_future_net', 'sale', 'product', 'result', 'collaboration', 'file', 'option', 'forego', 'dm', 'milestone_royalty', 'co', 'develop', 'co', 'commercialize', 'dm', 'product', 'globally'], ['closing_transaction', 'subject', 'certain', 'condition', 'include', 'expiration_waiting_period_antitrust', 'improvement', 'act', 'company', 'anticipate', 'transaction', 'close', 'third_quarter'], ['acquisition_exonic', 'therapeutic', 'therapeutic', 'develop', 'gene_edit', 'therapy', 'treat', 'patient', 'other', 'severe', 'genetic', 'neuromuscular', 'disease', 'bring', 'vertex', 'intellectual_property', 'technology', 'scientific', 'expertise', 'gene_editing', 'therapy', 'serious_disease', 'multiple', 'small', 'large', 'animal', 'preclinical_model', 'use', 'singlecut', 'crispr', 'genetically', 'repair', 'restore', 'key', 'protein', 'miss', 'child'], ['exonic', 'technology', 'license', 'southwestern', 'medical', 'center', 'base', 'research', 'continue', 'role', 'exonic', 'chief', 'science', 'advisor', 'provide', 'oversight', 'guidance', 'research', 'development', 'transformative', 'gene_editing', 'therapy'], ['term', 'acquisition', 'vertex', 'acquire', 'outstanding', 'share', 'exonic', 'become', 'separate', 'wholly_own', 'subsidiary', 'equity_holder', 'eligible', 'receive', 'payment', 'approximately', 'include', 'upfront', 'potential', 'future', 'payment', 'base', 'primarily', 'successful_achievement_specify', 'development', 'regulatory', 'milestone', 'dmd', 'dm', 'program'], ['closing_transaction', 'subject', 'certain', 'condition', 'include', 'expiration_waiting_period_antitrust', 'improvement', 'other', 'customary', 'condition', 'company', 'anticipate', 'acquisition', 'close', 'third_quarter'], ['scientific', 'leadership', 'expansion', 'today_announce', 'appointment', 'senior_vice_president', 'genetic', 'therapy', 'effective'], ['more', 'year', 'academic', 'industry', 'setting', 'prove', 'leader', 'genetic', 'therapy', 'space', 'experience', 'scientific', 'manufacture', 'side', 'product', 'development', 'capability', 'expertise', 'ideal', 'fit', 'strategy', 'bring', 'multi', 'faceted', 'component', 'genetic', 'therapy', 'together', 'advance', 'science', 'genetic', 'therapy', 'such', 'vertex', 'genetic', 'therapy', 'platform', 'offer', 'good', 'emerge', 'approach', 'offer'], ['previously', 'serve', 'chief_scientific', 'officer', 'senior_vice_president', 'therapeutic', 'where', 'team', 'focus', 'gene', 'therapy', 'neuromuscular', 'liver', 'disorder', 'biochemistry', 'phd', 'biochemistry', 'postdoctoral', 'scientist'], ['new', 'genetic', 'therapy', 'research', 'site', 'establish', 'new', 'genetic', 'therapy', 'research', 'site', 'area', 'where', 'research', 'program', 'as_well', 'vector', 'development', 'clinical', 'manufacturing', 'genetic', 'therapy', 'include', 'dmd', 'dm', 'program', 'conduct'], ['found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_fourth_paragraph', 'press_release_statement', 'fifth', 'paragraph_press_release', 'statement', 'sixth', 'paragraph_press_release', 'statement', 'seventh', 'paragraph_press_release', 'statement', 'regard', 'timing', 'potential', 'closing_transaction', 'future', 'activity_party', 'pursuant_collaboration', 'potential', 'benefit', 'acquisition', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'belief_only_date_press', 'release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'transaction', 'subject', 'certain', 'condition', 'include', 'expiration_waiting_period_antitrust', 'improvement', 'realize', 'potential', 'benefit', 'collaboration', 'acquisition', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security_amend', 'include', 'statement', 'regard', 'expectation', 'follow', 'clinical_trial', 'include_limitation', 'timing', 'filing', 'clinical_trial', 'application', 'ind', 'approval', 'thereof', 'timing', 'commencement', 'clinical_trial', 'development', 'timeline', 'discussion', 'regulatory_authority', 'relate', 'product_candidate', 'development', 'collaborator', 'number', 'patient', 'evaluate', 'anticipate', 'date', 'enrollment', 'complete', 'datum', 'generate', 'ongoing', 'plan', 'clinical_trial', 'ability', 'use', 'datum', 'design', 'initiation', 'further', 'clinical_trial', 'scope', 'timing', 'ongoing', 'potential', 'future', 'clinical_trial', 'intellectual_property', 'coverage', 'position', 'therapeutic', 'licensor', 'third_party', 'sufficiency_cash', 'resource', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'forward_look_statement', 'promise_guarantee_necessarily_subject', 'high_degree', 'uncertainty', 'risk', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'outcome', 'plan', 'clinical_trial', 'study', 'favorable', 'more', 'internal_external', 'product_candidate', 'program', 'proceed', 'plan', 'technical', 'scientific', 'commercial', 'reason', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'product_candidate', 'uncertainty', 'inherent', 'initiation_completion', 'preclinical', 'study', 'product_candidate', 'availability_timing', 'result', 'preclinical', 'study', 'result', 'preclinical', 'trial', 'predictive_future', 'result', 'future', 'trial', 'uncertainty', 'regulatory_approval', 'conduct', 'trial', 'market', 'product', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available_website_existing', 'prospective_investor_caution_place', 'undue_reliance', 'forward_look_statement', 'speak_only_date', 'make_disclaim_obligation', 'undertaking_update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['therapeutic', 'therapeutic', 'develop', 'gene_edit', 'therapy', 'treat', 'patient', 'muscular_dystrophy', 'other', 'severe', 'genetic', 'neuromuscular', 'disease', 'preclinical_model', 'use', 'singlecut', 'crispr', 'genetically', 'repair', 'restore', 'key', 'protein', 'miss', 'child', 'initially', 'focused', 'repair', 'mutation', 'cause', 'order', 'develop', 'therapy', 'treat', 'many', 'child', 'devastating', 'disease', 'cure', 'exonic', 'technology', 'license', 'southwestern', 'medical', 'center', 'base', 'research', 'founder', 'chief', 'science', 'advisor', 'exonic', 'locate', 'watertown', 'mass', 'more_information_visit', 'wwwexonicstxcom'], ['source_version'], ['investor_contact'], ['contact', 'wcg', 'behalf'], ['medium_contact', 'degree'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'datum', 'scientific', 'abstract', 'company', 'portfolio', 'cystic_fibrosis', 'medicine', 'present', 'cystic_fibrosis', 'conference', 'take_place'], ['abstract', 'include', 'datum', 'present', 'ongoing', 'phase', 'arrival', 'study', 'pharmacokinetic', 'safety', 'ivacaftor', 'cohort', 'patient', 'month_old_at', 'least', 'cftr', 'gating_mutation', 'study', 'show', 'safety_profile', 'consistent_observe', 'child', 'age_month', 'demonstrate', 'substantial_improvement', 'sweat_chloride', 'improvement', 'exploratory', 'biomarker', 'pancreatic', 'disease', 'include', 'increase', 'fecal', 'fe', 'reduction', 'immunoreactive', 'irt', 'suggest', 'improvement', 'exocrine', 'pancreatic', 'function', 'inflammation', 'ivacaftor'], ['additionally', 'open_label_extension', 'study', 'lumacaftor_ivacaftor', 'patient', 'age_year', 'del_mutation', 'confirm', 'lumacaftor_ivacaftor', 'generally_well_tolerate', 'week', 'show', 'safety_profile', 'consistent', 'previous', 'study'], ['continue', 'evolve', 'rapidly', 'vital', 'help', 'deepen', 'understanding', 'potential', 'long_term', 'impact', 'medicine', 'particularly', 'young', 'patient', 'population', 'say_vice_president_chief', 'medical_officer', 'present', 'datum', 'excited', 'build', 'available', 'datum', 'cftr_modulator', 'identify', 'new', 'area', 'scientific', 'exploration'], [], [], [], [], ['cystic', 'cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people'], ['cause_defective_missing', 'cftr_protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'mid_late'], ['ivacaftor', 'ivacaftor', 'first', 'medicine_treat_underlying', 'cause', 'people', 'specific', 'mutation', 'cftr', 'gene', 'know_cftr_potentiator', 'oral', 'medicine', 'design_keep', 'cftr_protein', 'cell', 'surface_open', 'long_improve_transport', 'salt_water_cell', 'membrane_help_hydrate_clear', 'mucus', 'available', 'mg', 'tablet', 'adult_pediatric', 'patient', 'age_year_old', 'also', 'available', 'granule', 'pediatric', 'patient', 'age_month', 'less', 'year'], ['people', 'specific', 'mutation', 'cftr', 'gene', 'currently', 'indicate', 'kalydeco', 'different', 'country', 'other', 'international', 'market'], ['indication_important_safety', 'information', 'ivacaftor', 'ivacaftor', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_month', 'old_at_least', 'mutation', 'cftr', 'gene_responsive', 'patient', 'talk_doctor_learn_indicate', 'cftr', 'gene', 'mutation', 'know_safe', 'effective_child', 'month', 'age'], ['take', 'patient', 'tell_doctor', 'liver', 'kidney_problem', 'drink', 'grapefruit', 'juice', 'eat', 'grapefruit_seville', 'orange', 'pregnant_plan_become_pregnant', 'know', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'know', 'pass_breast_milk'], ['patient', 'avoid_food', 'contain_grapefruit', 'seville_orange', 'take'], ['possible_side_effect', 'kalydeco', 'click_here_see_full', 'prescribe_information', 'ivacaftor'], ['lumacaftor_ivacaftor', 'combination_lumacaftor', 'design_increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'protein', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface'], ['indication_important_safety', 'information', 'lumacaftor_ivacaftor', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_copy', 'mutation', 'cftr', 'gene', 'orkambi', 'only', 'use', 'patient', 'know', 'orkambi', 'safe_effective_child', 'year', 'age'], ['patient', 'take_orkambi', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medicine', 'phenobarbital_carbamazepine', 'phenytoin', 'sedative', 'anti', 'anxiety', 'medicine', 'medicine', 'cyclosporine', 'sirolimus', 'tacrolimus'], ['take_orkambi', 'patient', 'tell_doctor_medical', 'condition', 'include', 'have_liver', 'problem', 'kidney_problem', 'have', 'organ', 'transplant', 'use', 'birth', 'control', 'hormonal_contraceptive', 'include', 'oral', 'injectable', 'transdermal', 'implantable', 'form', 'use', 'method', 'birth', 'control', 'when_take', 'orkambi', 'patient', 'tell_doctor', 'pregnant_plan_become_pregnant', 'unknown', 'orkambi', 'harm_unborn_baby_breastfeed', 'plan_breastfeed', 'unknown', 'orkambi', 'pass_breast_milk'], ['orkambi', 'affect_way', 'other', 'medicine', 'work', 'other', 'medicine', 'affect_how', 'orkambi', 'work_therefore', 'dose', 'orkambi', 'other', 'medicine', 'need', 'adjust_when', 'take', 'together', 'patient', 'especially_tell_doctor', 'take_antifungal', 'medicine', 'such_voriconazole', 'antibiotic', 'such'], ['when_take', 'orkambi', 'patient', 'tell_doctor', 'stop', 'orkambi', 'more', 'week', 'doctor', 'need', 'change', 'dose', 'orkambi', 'other', 'medicine', 'patient', 'take'], ['orkambi', 'cause', 'serious_side_effect', 'include'], ['worsen', 'liver', 'function', 'people', 'severe', 'liver', 'disease', 'worsening', 'liver', 'function', 'serious', 'cause', 'death', 'patient', 'talk_doctor', 'tell', 'liver', 'disease', 'doctor', 'need', 'adjust', 'dose', 'orkambi'], ['high_liver', 'enzyme_blood', 'sign', 'liver', 'injury', 'patient', 'doctor_blood_test_check', 'liver_start', 'orkambi', 'month', 'first', 'year', 'take_orkambi', 'annually', 'thereafter', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine', 'confusion'], ['abnormality_eye_lens_cataract', 'child_adolescent', 'receive', 'orkambi', 'child_adolescent', 'patient', 'doctor_perform_eye_examination', 'treatment', 'orkambi', 'look_cataract'], ['most_common_side_effect', 'orkambi', 'include', 'breathe', 'problem', 'such', 'shortness', 'breath', 'chest', 'tightness', 'nausea', 'diarrhea', 'fatigue', 'increase', 'certain', 'blood', 'enzyme', 'call', 'phosphokinase', 'rash', 'gas', 'common_cold', 'include', 'sore_throat', 'stuffy_runny', 'nose', 'flu', 'flu', 'like', 'symptom', 'irregular', 'missed', 'abnormal', 'period', 'mense', 'increase_amount', 'menstrual', 'bleeding'], ['side_effect', 'see', 'child', 'similar', 'see', 'adult', 'adolescent', 'additional', 'common_side', 'effect', 'see', 'child', 'include', 'cough', 'sputum', 'stomach', 'pain', 'increase', 'sputum'], ['click_here_see_full', 'prescribe_information', 'lumacaftor_ivacaftor'], ['indication_important_safety', 'information', 'symdeko', 'ivacaftor', 'ivacaftor', 'tablet'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_copy', 'mutation', 'at_least_mutation', 'gene_responsive', 'treatment', 'symdeko', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know', 'symdeko', 'safe_effective_child', 'year', 'age'], ['patient', 'take', 'symdeko', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medicine_such_phenobarbital', 'carbamazepine_phenytoin', 'wort'], ['high_liver', 'enzyme_blood', 'report', 'people', 'treat', 'symdeko', 'treat', 'ivacaftor', 'alone', 'patient', 'doctor_blood_test_check', 'liver_start', 'symdeko', 'month', 'first', 'year', 'take', 'symdeko', 'year', 'take', 'symdeko', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['possible_side_effect', 'symdeko', 'click_here_see_full', 'prescribe_information', 'ivacaftor', 'ivacaftor'], ['found_headquarters_now_locate', 'innovation_district', 'today', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row', 'additional', 'information', 'late', 'update', 'company', 'visit_wwwvrtxcom'], ['collaborative', 'history', 'cystic', 'initiate', 'research', 'program', 'part', 'collaboration', 'nonprofit_drug_discovery', 'development', 'affiliate', 'ivacaftor', 'lumacaftor_ivacaftor', 'symdeko', 'ivacaftor', 'ivacaftor_elexacaftor', 'discover', 'vertex', 'part', 'collaboration'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_fourth_paragraph', 'information', 'provide', 'regard', 'ongoing', 'clinical_trial', 'include', 'phase', 'arrival', 'trial', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['absolute_improvement', 'ppfev_percentage_point_baseline', 'week', 'treatment', 'compare', 'patient', 'mutation_minimal', 'function_mutation'], ['statistically_significant', 'improvement', 'observe', 'key_secondary_endpoint', 'patient', 'mutation_minimal', 'function_mutation', 'include', 'reduction', 'annualize_rate', 'pulmonary_exacerbation', 'compare_placebo'], ['new', 'drug_application', 'plan', 'third_quarter', 'follow', 'marketing_authorization_application', 'fourth_quarter'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'select', 'triple_combination', 'next_generation_corrector', 'elexacaftor_tezacaftor', 'ivacaftor', 'submit', 'potential', 'global', 'regulatory_approval', 'people', 'age_old', 'cystic_fibrosis', 'final', 'datum', 'announce_today', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'phase_study_people_del', 'mutation', 'form', 'basis', 'submission', 'vertex', 'previously', 'announce', 'phase_study', 'meet_primary_endpoint', 'company', 'today_announce', 'final', 'result', 'study', 'include', 'result', 'key_secondary_endpoint', 'safety', 'datum'], ['study', 'treatment', 'triple_combination_regiman', 'result', 'statistically_significant', 'improvement', 'key_secondary_endpoint', 'datum', 'study', 'people_mutation_minimal', 'function_mutation', 'show', 'mean_absolute', 'improvement', 'percent_predict', 'force_expiratory_volume_second', 'ppfev_percentage', 'point', 'reduction', 'annualize_rate', 'pulmonary_exacerbation', 'week', 'patient_receive_triple', 'combination_regiman', 'compare', 'receive_triple', 'placebo', 'triple_combination_generally_well', 'tolerate', 'phase_study', 'study', 'people_mutation_minimal', 'function_mutation', 'patient', 'respectively', 'receive_triple', 'combination', 'triple_placebo', 'discontinue', 'treatment', 'adverse_event', 'discontinuation', 'adverse_event', 'arm', 'study', 'people_del', 'mutation'], ['plan_submit', 'new', 'drug_application', 'food', 'third_quarter', 'marketing_authorization_application', 'fourth_quarter', 'base', 'datum', 'people', 'age_year_old', 'mutation_minimal', 'function_mutation_people_del', 'mutation'], ['substantial_improvement', 'lung_function', 'other', 'measure', 'see', 'phase_study', 'unprecedented', 'represent', 'defining', 'moment', 'journey', 'provide', 'medicine_treat_underlying', 'cause', 'vast_majority', 'people', 'say', 'director', 'co', 'chair', 'triple_combination', 'steering', 'committee'], ['people_mutation_minimal', 'function_mutation', 'large', 'remaining', 'group', 'patient', 'treatment_option', 'underlying_cause', 'disease', 'final', 'phase', 'datum', 'announce_today', 'represent', 'significant', 'step', 'bring', 'disease', 'modify', 'medicine', 'patient', 'as_well', 'provide', 'significantly', 'enhance', 'benefit', 'patient', 'mutation', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'achieve', 'important_milestone', 'support', 'entire', 'community', 'particularly', 'grateful', 'participate', 'triple_combination', 'clinical_trial', 'now', 'look_forward', 'complete', 'regulatory_submission', 'aim', 'bring', 'triple_combination_regiman', 'as', 'many', 'patient', 'possible'], ['conduct', 'phase', 'program', 'parallel', 'evaluate', 'different', 'triple_combination_regimen', 'goal', 'select', 'good_regiman', 'submit', 'global', 'regulatory_approval', 'program', 'evaluate', 'combination_tezacaftor', 'ivacaftor', 'other', 'program', 'evaluate', 'combination_tezacaftor', 'ivacaftor', 'program', 'consist', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'phase_study_people_del', 'mutation', 'phase_study', 'program', 'meet_primary_endpoint', 'show_statistically', 'significant_improvement', 'key_secondary_endpoint', 'additionally', 'triple_combination_regimen', 'generally_well_tolerate', 'more', 'patient', 'program', 'complete', 'phase_study', 'treatment', 'period', 'elect', 'enroll', 'open_label_extension', 'study', 'regiman'], ['regimen', 'show', 'highly', 'similar', 'positive', 'benefit', 'risk', 'profile', 'vertex', 'ultimately', 'determine', 'triple_combination_regiman', 'benefit', 'great', 'number', 'patient', 'decision', 'base', 'detailed', 'assessment', 'multiple', 'factor', 'include', 'favorable', 'profile', 'safety_tolerability', 'drug', 'drug', 'interaction', 'ability', 'co', 'administration', 'hormonal_contraceptive', 'lack'], ['phase_study', 'tezacaftor_ivacaftor', 'people_mutation_minimal', 'function_mutation', 'final', 'efficacy_safety', 'datum', 'announce_today', 'randomized_double', 'blind_placebo_control', 'phase_study', 'enrol', 'people', 'age_old', 'mutation_minimal', 'function_mutation', 'patient', 'randomize', 'triple_combination', 'arm', 'receive', 'fix', 'dose', 'combination', 'ivacaftor', 'morning', 'follow', 'ivacaftor', 'evening', 'patient', 'randomize', 'control', 'arm', 'receive_triple', 'placebo', 'morning', 'ivacaftor', 'placebo', 'evening'], ['study', 'randomize', 'dose', 'patient', 'include', 'triple_combination_regiman', 'arm_placebo', 'arm', 'patient', 'complete', 'treatment', 'period', 'include', 'triple_combination_regiman', 'arm_placebo', 'arm', 'patient', 'elect', 'enroll', 'open_label_extension', 'study', 'where', 'patient_receive_triple', 'combination_regiman'], ['efficacy', 'result', 'previously', 'announce', 'treatment', 'triple_combination_regiman', 'result', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'compare', 'triple_placebo', 'primary_endpoint', 'study', 'improvement', 'maintain', 'week', 'treatment', 'study', 'announce_today', 'addition', 'statistically_significant', 'improvement', 'key_secondary_endpoint', 'observe', 'treatment', 'triple_combination', 'summary', 'phase', 'efficacy', 'datum', 'include', 'result', 'announce_today', 'key_secondary_endpoint', 'provide', 'below'], ['triple'], ['iva'], ['treatment', 'difference'], [], [], [], [], [], [], ['treatment', 'difference', 'provide', 'outcome', 'measure', 'change_ppfev', 'sweat_chloride', 'bmi', 'rate', 'ratio', 'provide', 'outcome', 'measure', 'number', 'pulmonary_exacerbation', 'primary_endpoint', 'evaluate', 'part', 'previously', 'announce', 'interim_analysis', 'secondary_endpoint', 'evaluate', 'part', 'final', 'analysis', 'absolute_change', 'ppfev_baseline', 'week', 'primary_endpoint', 'study'], ['safety', 'result', 'triple_combination_generally_well', 'tolerate', 'study', 'majority_adverse_event_mild', 'moderate', 'serious_adverse_event', 'observe', 'patient_receive_triple', 'combination_regiman', 'patient_receive_triple', 'placebo', 'most_common', 'adverse_event', 'occur', 'more', 'patient', 'regardless', 'treatment', 'arm', 'infective', 'pulmonary_exacerbation', 'sputum', 'increase', 'headache', 'cough', 'patient_receive_triple', 'combination', 'discontinue', 'treatment', 'adverse_event', 'patient_receive_triple', 'placebo', 'discontinue', 'treatment', 'adverse_event'], ['phase_study', 'tezacaftor_ivacaftor', 'people', 'mutation', 'final', 'datum', 'announce_today', 'randomized_double', 'blind', 'control', 'phase_study', 'enrol', 'people', 'age_old', 'del_mutation', 'patient', 'receive_tezacaftor', 'combination', 'ivacaftor', 'run', 'in', 'prior', 'randomization', 'patient', 'randomize', 'active', 'treatment', 'arm', 'receive', 'fix', 'dose', 'combination', 'ivacaftor', 'morning', 'follow', 'ivacaftor', 'evening', 'patient', 'randomize', 'control', 'arm', 'receive', 'placebo', 'tezacaftor_ivacaftor', 'morning', 'follow', 'ivacaftor', 'evening'], ['study', 'randomize', 'dose', 'patient', 'include', 'triple_combination_regiman', 'arm', 'control', 'arm', 'patient', 'complete', 'treatment', 'period', 'elect', 'enter', 'open_label_extension', 'study', 'where', 'patient_receive_triple', 'combination_regiman'], ['efficacy', 'result', 'previously', 'announce', 'datum', 'study', 'show', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'when_add', 'patient', 'already_receive', 'tezacaftor', 'combination', 'ivacaftor', 'compare_placebo', 'add', 'tezacaftor', 'primary_endpoint', 'study', 'addition', 'statistically_significant', 'improvement', 'key_secondary_endpoint', 'observe', 'week', 'study', 'summary', 'phase', 'efficacy', 'datum', 'include', 'result', 'announce_today', 'key_secondary_endpoint', 'provide', 'below'], ['iva'], ['iva'], ['treatment', 'difference'], [], [], [], ['primary', 'secondary_endpoint', 'evaluate', 'part', 'final', 'analysis'], ['safety', 'result', 'triple_combination_generally_well', 'tolerate', 'study', 'majority_adverse_event_mild', 'moderate', 'serious_adverse_event', 'observe', 'patient', 'receive_tezacaftor', 'ivacaftor', 'patient', 'receive', 'placebo', 'tezacaftor_ivacaftor', 'adverse_event', 'occur', 'more', 'patient', 'arm', 'study', 'discontinuation', 'due', 'adverse_event', 'arm', 'study'], ['rare_life_shorten_genetic', 'disease', 'affect_approximately', 'people', 'cause_defective_missing', 'cftr_protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'mid_late'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'fourth', 'statement', 'fifth', 'paragraph', 'information', 'provide', 'regard', 'plan', 'seek', 'global', 'regulatory_approval', 'triple_combination_regiman', 'population', 'expect', 'timing', 'maa', 'submission', 'triple_combination_regiman', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'company', 'experience', 'unforeseen', 'delay', 'submit', 'regulatory_filing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'triple_combination_regiman', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['investor'], ['year', 'collaboration', 'leverage', 'target_protein_degradation', 'platform', 'develop', 'novel', 'medicines'], ['receive_upfront', 'include', 'equity_investment', 'potential', 'additional', 'milestone_royalty', 'payment', 'program', 'collaboration'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'company', 'enter', 'year', 'strategic', 'research', 'development', 'collaboration', 'advance', 'small_molecule', 'protein', 'degrader', 'multiple', 'target', 'collaboration', 'leverage', 'expertise', 'target_protein_degradation', 'proprietary', 'pegasus', 'drug_discovery', 'platform', 'scientific', 'clinical', 'regulatory', 'capability', 'accelerate', 'development', 'first_class', 'medicine', 'people', 'serious_disease'], ['press_release_feature_view', 'full', 'release', 'here'], ['collaboration', 'enhance', 'drug_discovery', 'capability', 'support', 'strategy', 'invest_scientific', 'innovation', 'develop', 'transformative_medicine', 'serious_disease', 'say', 'senior_vice_president', 'site', 'research', 'have', 'impress', 'team', 'depth', 'knowledge', 'field', 'compelling', 'technology_platform', 'excited', 'bring', 'research', 'development', 'expertise', 'promising', 'new', 'therapeutic', 'modality'], ['thrilled', 'partner', 'vertex', 'combine', 'deep_understanding', 'human_biology', 'state_art', 'protein', 'degrader', 'platform', 'say', 'strategic', 'partnership', 'broaden', 'application', 'target_protein_degradation', 'address', 'serious_disease', 'cancer', 'limited', 'treatment_option', 'fit', 'perfectly', 'vision', 'build', 'platform', 'deliver', 'broad', 'possible', 'impact'], ['collaboration', 'term', 'year', 'agreement', 'vertex', 'pay', 'upfront', 'include', 'equity_investment', 'company', 'conduct', 'research', 'activity', 'multiple', 'target', 'collaboration', 'designation', 'clinical', 'development', 'candidate', 'vertex', 'option', 'exclusively_license', 'molecule', 'designate', 'target', 'also', 'eligible', 'receive', 'more', 'potential', 'payment', 'base', 'successful_achievement_specify', 'research', 'development', 'regulatory', 'commercial_milestone', 'program', 'optione', 'part', 'collaboration', 'addition', 'vertex', 'pay_tiered', 'royalty_future_net', 'sale', 'product', 'result', 'collaboration'], ['biotechnology', 'company', 'pioneer', 'transformative', 'new', 'approach', 'treat', 'previously', 'untreatable', 'disease', 'company', 'advance', 'field', 'target_protein_degradation', 'access', 'body', 'innate', 'protein', 'recycling', 'machinery', 'degrade', 'dysregulate', 'disease', 'cause', 'protein', 'power', 'game', 'change', 'integrate', 'degradation', 'platform', 'accelerate', 'drug_discovery', 'unmatched', 'ability', 'target', 'degrade', 'most', 'intractable', 'protein', 'advance', 'new', 'treatment_option', 'patient', 'more_information_visit', 'wwwkymeratxcom'], ['proprietary', 'protein_degradation', 'platform', 'create', 'team', 'experience', 'drug', 'hunter', 'improve', 'effectiveness', 'target_protein_degradation', 'generate', 'pipeline', 'novel', 'therapeutic', 'previously', 'undruggable', 'disease', 'platform', 'consist', 'informatic', 'drive', 'target', 'identification', 'novel', 'ligase', 'proprietary', 'ternary', 'complex', 'predictive', 'modeling', 'capability', 'degradation', 'tool'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'bunnage', 'statement_second_paragraph', 'press_release_statement', 'third_paragraph_press_release', 'statement', 'regard', 'future', 'activity_party', 'pursuant_collaboration', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'belief_only_date_press', 'release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'vertex', 'realize_anticipate_benefit', 'collaboration', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['contact', 'investor'], [], ['first_quarter', 'product_revenue', 'increase_compare'], ['first_quarter', 'gaap', 'operate', 'income', 'increase', 'non_gaap', 'operating_income', 'increase'], ['track', 'choose_good', 'triple_combination_regiman', 'plan'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'first_quarter', 'end', 'reiterate_full_year', 'financial_guidance'], ['goal', 'develop', 'transformative_medicine_people', 'other', 'serious_disease', 'ensure', 'eligible', 'patient', 'access', 'medicine', 'as_quickly_possible', 'say_chief_executive_officer', 'vertex', 'make', 'significant', 'progress', 'achieve', 'goal', 'rapidly', 'advance', 'triple_combination_regimen', 'late_stage', 'development', 'remain', 'track', 'submit', 'new', 'drug_application', 'medicine', 'third_quarter', 'also', 'continue', 'advance', 'early_stage', 'program', 'target', 'aat', 'pain', 'fsgs', 'sickle', 'cell', 'disease', 'first_quarter', 'again', 'deliver', 'strong', 'revenue', 'earning', 'growth', 'further', 'enhance', 'ability', 'make', 'significant', 'investment', 'internal_external', 'innovation'], ['first_quarter', 'financial', 'highlight'], ['total_product_revenue', 'increase_compare', 'first_quarter', 'primarily_drive', 'uptake', 'symdeko', 'launch'], ['gaap_non_gaap', 'net_income', 'increase_compare', 'first_quarter', 'largely_drive', 'strong', 'growth', 'total_product_revenue', 'partially_offset', 'increase', 'operating', 'expense', 'income_taxis'], ['cash_cash', 'equivalent_marketable_security', 'increase', 'approximately', 'compare'], ['first_quarter', 'expense'], ['combine_gaap_non_gaap', 'expense', 'increase_compare', 'first_quarter', 'primarily_incremental', 'investment', 'support', 'global', 'use', 'vertex', 'medicine', 'expansion_pipeline', 'other', 'new', 'disease', 'area'], ['gaap_non_gaap', 'income_taxis', 'increase', 'significantly', 'compare', 'first_quarter', 'release', 'valuation_allowance_majority', 'defer_tax_asset', 'fourth_quarter', 'gaap_non_gaap', 'income_taxis', 'first_quarter', 'include', 'provision_income_taxis', 'pre_tax_income', 'use', 'estimate', 'effective_tax_rate_approximate', 'statutory_rate', 'provision_income_taxis', 'include', 'significant', 'non_cash_charge', 'ability_offset', 'pre_tax_income', 'previously', 'benefit', 'net_operating_loss', 'vertex', 'expect', 'cash', 'pay', 'income_taxis', 'increase', 'significantly', 'once', 'net_operating_loss', 'utilize', 'offset_pre', 'tax_income', 'refer_supplemental', 'income_tax', 'information', 'discussion_cash', 'non_cash_component', 'provision_income_taxis'], ['today', 'reiterate_full_year', 'guidance', 'follow'], ['company', 'total_product', 'revenue_growth', 'expect', 'drive', 'primarily', 'full_year', 'impact', 'symdeko', 'launch', 'reimbursement_agreement', 'reach', 'label_expansion', 'company', 'medicine', 'company', 'full_year', 'revenue_guidance', 'reflect', 'only', 'market', 'where', 'medicine', 'currently', 'reimburse'], ['company', 'combine_gaap_non_gaap', 'expense', 'guidance', 'reflect', 'development', 'effort', 'incremental_investment_support', 'potential', 'launch', 'triple_combination_regiman', 'investment', 'support', 'expansion_pipeline', 'new', 'disease', 'area'], ['addition', 'base', 'release', 'company', 'valuation_allowance', 'fourth_quarter', 'vertex', 'also', 'begin', 'record', 'tax_provision', 'expect', 'full_year', 'non_gaap', 'tax_rate', 'vast_majority', 'tax_provision', 'non_cash', 'expense', 'company', 'fully_utilize', 'net_operating_loss'], ['investigational', 'medicine'], ['bring', 'medicine', 'more', 'people', 'as_quickly_possible'], ['approve', 'medicine'], ['secure_access', 'vertex', 'medicine'], ['positive', 'recommendation', 'age', 'pharmaceutical'], ['reimbursement', 'orkambi', 'age'], ['expand', 'pricing', 'agreement', 'orkambi', 'include', 'child', 'age'], ['treat', 'patient', 'young', 'age', 'cftr_modulator'], ['approval', 'infant', 'age_month'], ['approval', 'child', 'age_month'], ['approval', 'orkambi', 'child', 'age_year_old'], ['supplemental', 'new', 'drug_application', 'submit', 'tezacaftor_ivacaftor', 'child', 'age_year_old'], ['late_stage', 'research', 'development'], ['cell', 'beta_thalassemia'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'income', 'stock_base_compensation_expense', 'revenue_expense', 'relate', 'business', 'development', 'transaction', 'include', 'collaboration', 'agreement', 'asset_acquisition', 'consolidated', 'variable_interest_entity', 'other', 'adjustment', 'include', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'benefit_income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre_tax_income', 'describe', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'provide', 'guidance_regard', 'product_revenue', 'accordance_gaap', 'provide', 'guidance_regard_combine', 'research', 'development', 'sale_general', 'administrative_expense', 'gaap_non_gaap', 'basis', 'company', 'also', 'provide', 'guidance_regard', 'anticipated', 'income_taxis', 'percentage', 'pre_tax_income', 'non_gaap_basis', 'guidance_regard', 'gaap', 'research', 'development', 'expense', 'sale_general', 'administrative_expense', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activity', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['pharmaceutical_incorporate', 'first_quarter', 'result', 'consolidated', 'statement', 'operation', 'thousand_share_amount_unaudited'], ['reconciliation_gaap_non_gaap', 'net_income', 'first_quarter', 'result', 'thousand_share_amount_unaudited'], ['reconciliation_gaap_non_gaap', 'revenue_expense', 'first_quarter', 'result', 'thousand_unaudited'], ['company', 'record', 'gain', 'month_end', 'respectively', 'other', 'income', 'net', 'relate_change_fair', 'value', 'strategic_investment'], ['month_end', 'company', 'consolidate', 'financial', 'statement', 'variable_interest_entity_vie', 'vertex', 'license', 'right', 'develop', 'vie', 'most', 'significant', 'intellectual_property', 'asset', 'month_end', 'fair_value_contingent_payment', 'payable_vertex', 'vie', 'increase', 'increase', 'attributable_noncontrolle', 'interest', 'result', 'decrease', 'net_income_attributable', 'vertex', 'dollar', 'dollar', 'basis', 'company', 'deconsolidate', 'vie', 'therefore', 'comparable_amount_month_end'], ['other', 'adjustment', 'month_end', 'primarily_relate', 'collaborative', 'milestone_payment', 'other', 'adjustment', 'month_end', 'primarily_relate', 'revenue_expense', 'attributable', 'vie', 'operation', 'collaboration', 'revenue', 'payment', 'include', 'relate', 'company', 'oncology', 'collaboration'], ['month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'primarily_relate', 'stock_base_compensation', 'include_adjustment_excess', 'tax', 'benefit_relate_stock', 'base_compensation', 'increase', 'fair_value_company', 'strategic_investment', 'month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'relate', 'provision_income_taxis', 'attributable', 'company', 'vie', 'excess_tax_benefit', 'relate_stock_base_compensation'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'include', 'section_caption', 'full_year_financial_guidance', 'statement', 'regard', 'timing', 'expect', 'outcome', 'regulatory', 'application', 'include', 'timing', 'receipt', 'final', 'phase', 'week', 'datum', 'triple_combination', 'program', 'development', 'plan', 'timeline', 'product', 'development', 'candidate', 'include', 'next_generation', 'triple_combination_regimen', 'company', 'aat', 'corrector', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'net_product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news'], ['opportunity', 'treat_underlying_cause', 'early', 'ever', 'before'], ['datum', 'phase', 'arrival', 'study', 'support', 'treatment', 'kalydeco', 'child', 'age_month', 'eligible', 'mutations'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'approve', 'ivacaftor', 'use', 'child_cystic_fibrosis', 'age_month', 'less_month', 'at_least_mutation', 'cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr_gene', 'responsive', 'base', 'clinical', 'already_approve', 'treatment', 'patient', 'age_month', 'old'], ['today', 'approval', 'allow', 'physician', 'begin', 'treat_underlying_cause', 'eligible', 'infant', 'as', 'young', 'month', 'age', 'first', 'time', 'potential', 'modify', 'course', 'disease', 'say'], ['approval', 'base', 'datum', 'phase_open_label', 'safety', 'cohort', 'arrival', 'child_aged', 'month', 'less_month', 'mutation', 'cftr', 'gene', 'study', 'demonstrate', 'safety_profile', 'similar_observe', 'previous_phase', 'study', 'old_child_adult', 'most', 'adverse_event_mild_moderate', 'severity', 'patient', 'discontinue', 'therapy', 'adverse_event', 'most_common', 'adverse_event', 'cough', 'nasal', 'congestion', 'rhinorrhea', 'serious_adverse_event', 'consider', 'unrelated', 'study', 'treatment', 'investigator', 'observe', 'patient'], ['mean_sweat_chloride', 'child', 'cohort', 'mmol', 'follow', 'week', 'treatment', 'mean_sweat_chloride', 'level', 'mmol', 'subject', 'pair', 'sweat_chloride', 'sample', 'baseline_week', 'mean_absolute', 'change', 'mmol'], ['result', 'study', 'present', 'nd', 'annual', 'north', 'american'], ['manifestation', 'cf', 'often', 'present_birth', 'underscore', 'relentless', 'commitment', 'reach', 'young', 'patient', 'possible', 'clinical_trial', 'say_vice_president_chief', 'medical_officer', 'important', 'outcome', 'effort', 'now', 'able', 'treat', 'infant', 'cystic_fibrosis', 'as_early', 'month', 'age'], ['first', 'approve', 'now', 'available', 'more', 'country', 'more', 'patient', 'therapy', 'more', 'information', 'kalydeco', 'prescribe_information', 'patient', 'assistance', 'program', 'visit'], ['cystic', 'cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people'], ['indication_important_safety', 'information', 'ivacaftor', 'ivacaftor', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_month', 'old_at_least', 'mutation', 'gene_responsive', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know_safe', 'effective_child', 'month', 'age'], ['collaborative', 'history', 'cystic', 'initiate', 'research', 'program', 'part', 'collaboration', 'nonprofit_drug_discovery', 'development', 'affiliate', 'ivacaftor', 'lumacaftor_ivacaftor', 'symdeko', 'ivacaftor', 'ivacaftor', 'discover', 'vertex', 'part', 'collaboration'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'second', 'sixth', 'paragraph_press_release', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['pharmaceutical_incorporate', 'today_announce', 'food', 'grant_fast', 'track_designation', 'treatment', 'transfusion_dependent_beta_thalassemia', 'investigational_autologous_gene_edit', 'hematopoietic_stem', 'cell', 'therapy', 'patient', 'suffer_severe'], ['fast_track', 'program', 'design_facilitate', 'development', 'expedite', 'review', 'drug', 'treat', 'serious', 'condition', 'fill', 'unmet_medical_need', 'drug', 'grant_fast', 'track_designation', 'eligible', 'several', 'benefit', 'include', 'more', 'frequent', 'meeting', 'communication', 'relevant', 'criterion', 'meet', 'potential', 'accelerated_approval', 'priority_review', 'roll', 'review', 'biologics', 'license', 'application'], ['vertex', 'announce', 'first', 'patient', 'treat', 'phase', 'clinical', 'study', 'patient', 'mark', 'first', 'company', 'sponsor', 'use', 'crispr_cas', 'therapy', 'clinical_trial', 'phase_open_label', 'trial', 'design_assess', 'safety_efficacy', 'single_dose', 'patient', 'age', 'non', 'beta', 'beta', 'subtype', 'company', 'also', 'evaluate', 'treatment', 'sickle', 'cell', 'disease', 'receive', 'fast_track_designation', 'scd', 'company', 'announce', 'first', 'patient', 'enrol', 'phase', 'clinical', 'study', 'severe_scd', 'expect', 'infuse', 'mid', 'enrollment', 'study', 'ongoing'], ['investigational', 'vivo_gene_edit', 'therapy', 'evaluate', 'patient', 'suffer_severe_scd', 'patient', 'hematopoietic_stem', 'cell', 'engineer_produce_high_level', 'fetal_hemoglobin_red_blood', 'cell', 'form_oxygen', 'carrying', 'hemoglobin_naturally', 'present_birth', 'then', 'replace', 'adult_form', 'hemoglobin_elevation', 'hbf_potential', 'alleviate_transfusion', 'requirement', 'patient', 'painful_debilitate_sickle_crisis', 'scd', 'patient'], ['lead', 'gene_edit', 'company', 'focus', 'develop', 'transformative', 'gene', 'base', 'medicine', 'serious_disease', 'use', 'proprietary', 'crispr', 'platform', 'cas', 'revolutionary', 'gene_edit', 'technology', 'allow', 'precise', 'direct', 'change', 'establish', 'portfolio', 'therapeutic', 'program', 'broad_range', 'disease', 'area', 'include', 'oncology', 'regenerative_medicine', 'rare', 'disease', 'accelerate', 'expand', 'effort', 'establish', 'strategic', 'collaboration', 'lead', 'company', 'include', 'headquarter', 'wholly_own', 'subsidiary', 'operation', 'base', 'business', 'office', 'more_information_visit', 'wwwcrisprtxcom'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_life_threaten', 'disease', 'addition', 'clinical', 'development', 'program', 'cystic_fibrosis', 'vertex', 'more', 'dozen', 'ongoing', 'research', 'program', 'focus', 'underlie', 'mechanism', 'other', 'serious_disease'], ['found_headquarters_now_locate', 'innovation_district', 'today', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'regard', 'potential', 'benefit', 'fast_track_designation', 'ongoing', 'clinical_trial', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'develop', 'drug_candidate', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['pharmaceutical_incorporate_investor'], ['vertex_pharmaceutical_incorporate', 'report', 'first_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['source_version'], ['investor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'appointment', 'executive_vice_president_chief', 'financial', 'officer', 'effective', 'report', 'directly', 'chairman', 'president_chief_executive_officer', 'oversee', 'finance', 'internal', 'audit', 'investor_relation', 'global', 'security', 'facility', 'function', 'join', 'deep', 'corporate', 'finance', 'health_care', 'experience', 'include', 'more', 'decade', 'public', 'private', 'company', 'cfo', 'role'], ['prove', 'finance', 'leader', 'extensive', 'experience', 'work', 'public', 'company', 'set', 'tremendous', 'asset', 'vertex', 'strong', 'team', 'say', 'continue', 'build', 'vertex', 'future', 'strategic', 'mindset', 'operational', 'expertise', 'broad', 'leadership', 'experience', 'prove', 'invaluable', 'would', 'like_thank', 'interim', 'cfo', 'contribution', 'leadership', 'continue', 'role', 'corporate', 'controller', 'arrival'], ['join', 'group', 'portfolio', 'company', 'where', 'serve', 'cfo', 'evp', 'finance', 'role', 'leadership', 'responsibility', 'aspect', 'finance', 'accounting', 'global', 'information', 'system', 'lender', 'relation', 'acquisition', 'divestiture', 'as_well', 'share', 'responsibility', 'several', 'enterprise', 'wide', 'project', 'prior', 'serve', 'cfo', 'publicly', 'trade', 'corporation', 'addition', 'corporate', 'finance', 'role', 'serve', 'advisor', 'receive', 'bs', 'account', 'mba'], ['excited', 'join', 'vertex', 'dynamic', 'time', 'company', 'continue', 'deliver', 'more', 'medicine', 'cystic_fibrosis', 'patient', 'accelerate', 'pipeline', 'innovative', 'novel', 'life', 'change', 'treatment', 'patient', 'other', 'serious_disease', 'say', 'look_forward', 'work', 'senior', 'leadership_team', 'employee', 'help', 'company', 'continue', 'drive', 'value', 'remarkable', 'innovation'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'second', 'fourth_paragraph_press_release', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk_list_risk_factor', 'annual_report_quarterly_report', 'file_disclaim_obligation', 'update_information_contain_press', 'release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], ['new', 'treatment_option', 'patient', 'copy_mutation', 'most_common', 'mutation_cystic_fibrosis'], ['medicine_treat_underlying', 'cause_cystic_fibrosis', 'patient', 'certain', 'mutation', 'result', 'residual', 'cftr', 'function'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'therapeutic', 'good', 'grant', 'registration', 'symdeko', 'ivacaftor', 'ivacaftor', 'treatment', 'people_cystic_fibrosis', 'age_year_old', 'homozygous', 'mutation', 'at_least_mutation', 'cystic_fibrosis_regulator_cftr', 'gene_responsive', 'tezacaftor_ivacaftor', 'base', 'datum', 'clinical', 'evidence', 'mutation', 'cftr', 'gene', 'produce', 'cftr_protein', 'responsive', 'symdeko', 'include', 'mutation', 'cftr_protein', 'show', 'residual_function', 'symdeko', 'consider', 'australian', 'reimbursement', 'eligible', 'patient', 'age_year_old', 'meeting', 'pharmaceutical'], ['delighted', 'therapeutic', 'good', 'administration', 'recognize', 'safety_profile', 'efficacy', 'symdeko', 'approval', 'bring_step_close', 'future', 'goal_bring', 'treatment', 'people', 'live', 'say_vice_president_chief', 'medical_officer', 'new', 'medicine', 'especially', 'important', 'treatment_option', 'patient', 'residual_function_mutation', 'copy_mutation', 'never', 'start', 'discontinue', 'orkambi_lumacaftor', 'ivacaftor'], ['decision', 'base', 'result', 'pivotal', 'phase_study', 'evolve', 'expand', 'publish', 'result', 'show', 'treatment', 'tezacaftor_ivacaftor', 'combination', 'ivacaftor', 'provide', 'benefit', 'different', 'population', 'include', 'statistically_significant', 'improvement_lung_function', 'determine', 'absolute_change', 'baseline', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'generally_well_tolerate', 'safety_profile', 'lack', 'increase', 'respiratory', 'adverse_event', 'compare_placebo', 'improvement_lung_function', 'show', 'mean_absolute', 'change', 'compare_placebo', 'percentage_point', 'percentage_point', 'expand', 'respectively', 'most_common', 'adverse_reaction', 'incidence', 'experience', 'patient', 'receive_tezacaftor', 'ivacaftor', 'combination', 'ivacaftor', 'pooled', 'placebo_control', 'phase_study', 'headache', 'nasopharyngitis'], ['ivacaftor', 'combination', 'ivacaftor', 'approve'], ['indication_important_safety', 'information', 'symdeko', 'ivacaftor', 'ivacaftor', 'tablet'], ['expand'], ['datum', 'phase_study', 'evolve', 'expand', 'publish', 'study', 'enrol', 'approximately', 'people', 'age', 'old_copy', 'mutation', 'mutation', 'second', 'mutation', 'associate', 'residual', 'cftr', 'activity', 'study', 'patient', 'treat', 'tezacaftor_ivacaftor', 'combination', 'ivacaftor', 'experience', 'statistically_significant', 'improvement_lung_function', 'determine', 'absolute_change', 'baseline', 'treatment', 'generally_well_tolerate', 'most_common', 'adverse_reaction', 'experience', 'patient', 'receive_tezacaftor', 'ivacaftor', 'ivacaftor', 'pooled', 'placebo_control', 'phase_study', 'headache', 'placebo', 'nasopharyngitis', 'placebo'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'expect', 'meeting', 'pharmaceutical', 'quote', 'second_paragraph', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['absolute_improvement', 'ppfev_percentage_point_baseline', 'week', 'people_mutation_minimal', 'function_mutation', 'compare_placebo'], ['absolute_improvement', 'ppfev_percentage_point_baseline', 'week', 'when_add', 'people_del', 'mutation', 'already_receive', 'tezacaftor_ivacaftor', 'compare', 'group', 'add', 'tezacaftor_ivacaftor'], ['efficacy', 'profile', 'report', 'today', 'support', 'potential', 'submission', 'new', 'drug_application', 'triple_combination'], ['plan', 'seek', 'global', 'regulatory_approval', 'triple_combination_regiman', 'population', 'concurrently', 'base', 'final', 'datum', 'regimen', 'expect', 'second_quarter'], ['plan', 'third', 'fourth_quarter', 'respectively'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'treatment', 'triple_combination', 'next_generation_corrector', 'tezacaftor_ivacaftor', 'result', 'statistically_significant', 'improvement_lung_function', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'phase_study', 'people_cystic_fibrosis', 'datum', 'pre_specified_interim_analysis', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'show', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'treatment', 'compare', 'phase_study_people_del', 'mutation', 'addition', 'patient', 'already_receive', 'tezacaftor_ivacaftor', 'result', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'treatment', 'compare', 'control', 'group', 'placebo', 'add', 'tezacaftor', 'triple_combination_generally_well', 'tolerate', 'safety_efficacy', 'profile', 'result', 'release', 'today', 'support', 'potential', 'submission', 'new', 'drug_application', 'triple_combination_regiman'], ['phase', 'datum', 'announce_today', 'triple_combination_regiman', 'follow', 'phase', 'datum', 'announce', 'late', 'triple_combination_tezacaftor_ivacaftor', 'also', 'show', 'safety_efficacy', 'profile', 'supportive', 'potential', 'submission', 'give', 'similarity', 'datum', 'primary_efficacy', 'endpoint', 'regimen', 'near_term', 'availability', 'final', 'datum', 'regimen', 'second_quarter', 'vertex', 'plan', 'utilize', 'final', 'datum', 'choose_good_regiman_submit', 'regulatory_approval', 'globally', 'submission', 'include', 'final', 'datum', 'vertex', 'seek', 'approval', 'patient', 'age_old', 'mutation_minimal', 'function_mutation', 'patient', 'del_mutation', 'concurrently', 'vertex', 'plan_submit', 'nda', 'third_quarter', 'marketing_authorization_application', 'fourth_quarter', 'triple_combination_regimen', 'company', 'also', 'plan', 'disclose', 'more', 'detailed', 'datum', 'phase_study', 'select', 'triple_combination_regiman', 'include', 'datum', 'study', 'patient', 'mutation_minimal', 'function_mutation', 'second_quarter'], ['triple_combination_regimen', 'show', 'highly', 'consistent', 'significant_improvement', 'lung_function', 'phase', 'program', 'underscore', 'important', 'clinical', 'benefit', 'triple_combination_regiman', 'provide', 'patient', 'del_mutation', 'del', 'minimal_function_mutation', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'look_forward', 'submit', 'global', 'regulatory', 'application', 'triple_combination_regimen', 'patient', 'population', 'later', 'year'], ['phase_study', 'people_mutation_minimal', 'function_mutation'], ['datum', 'announce_today', 'people', 'age_old', 'mutation_minimal', 'function_mutation', 'ongoing', 'randomize_double_blind_placebo', 'control', 'phase_study', 'evaluate', 'triple_combination_tezacaftor_ivacaftor', 'compare', 'triple_placebo', 'week', 'study', 'randomize', 'patient', 'patient', 'receive', 'at_least', 'dose', 'triple_combination_regiman', 'triple_placebo', 'primary_endpoint', 'study', 'mean_absolute_change_ppfev', 'baseline_week', 'triple_combination_treatment', 'compare', 'triple_placebo', 'datum', 'announce_today', 'pre_specified_interim_analysis', 'evaluate', 'primary_endpoint', 'week', 'patient', 'complete', 'week', 'visit', 'study', 'time', 'interim_analysis', 'safety_efficacy', 'profile', 'interim_analysis', 'support', 'potential', 'submission', 'nda', 'triple_combination_regiman', 'patient', 'mutation_minimal', 'function_mutation'], ['datum'], ['treatment', 'triple_combination_tezacaftor_ivacaftor', 'result', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'compare', 'triple_placebo', 'primary_endpoint', 'study', 'mean_absolute_group', 'improvement', 'receive_triple', 'combination', 'percentage_point_baseline_week', 'mean_absolute_group', 'change', 'receive_triple', 'placebo', 'percentage_point_baseline_week'], ['triple_combination_generally_well', 'tolerate', 'study', 'safety_profile', 'reflect', 'available', 'safety', 'datum', 'patient', 'time', 'interim_analysis', 'include', 'patient', 'reach', 'week', 'visit', 'patient', 'randomize', 'triple_combination_regiman', 'patient', 'randomize', 'triple_placebo', 'patient', 'complete', 'treatment', 'period', 'patient', 'randomize_receive', 'triple_combination_regiman', 'patient', 'randomize_receive', 'triple_placebo'], ['study', 'ongoing', 'evaluate', 'triple_combination_regiman', 'total', 'week', 'generate', 'additional', 'safety_efficacy', 'datum', 'datum', 'key_secondary_endpoint', 'include', 'number', 'pulmonary_exacerbation', 'change', 'sweat_chloride', 'change', 'patient', 'report', 'outcome', 'measure', 'respiratory_domain_score', 'cystic_revise', 'change', 'body', 'mass', 'index', 'other'], ['open_label_extension', 'study'], ['patient', 'complete', 'treatment', 'study', 'regardless', 'treatment', 'assignment', 'give', 'opportunity', 'enroll', 'rollover', 'study', 'where', 'patient_receive_triple', 'combination_regimen', 'patient', 'complete', 'study', 'time', 'interim_analysis', 'elect', 'enter', 'open_label_extension', 'study'], ['phase_study_people_del', 'mutation'], ['datum', 'announce_today', 'people_del', 'mutation', 'randomized_double', 'blind', 'control', 'phase_study', 'evaluate', 'week', 'treatment', 'triple_combination_tezacaftor_ivacaftor', 'compare_placebo', 'tezacaftor_ivacaftor', 'study', 'randomize', 'patient', 'age_year_old', 'del_mutation', 'patient', 'receive_tezacaftor', 'combination', 'ivacaftor', 'run', 'in', 'prior', 'randomization', 'patient', 'randomize_receive', 'least', 'dose', 'triple_combination_tezacaftor_ivacaftor', 'placebo', 'tezacaftor_ivacaftor', 'primary_endpoint', 'study', 'mean_absolute_change_ppfev', 'baseline', 'end', 'tezacaftor_ivacaftor', 'run', 'week', 'triple_combination_tezacaftor_ivacaftor', 'compare_placebo', 'combination_tezacaftor', 'ivacaftor', 'datum', 'announce_today', 'reflect', 'topline', 'datum', 'primary_efficacy', 'safety', 'analysis', 'conduct', 'once', 'patient', 'complete', 'study', 'safety_efficacy', 'profile', 'study', 'support', 'potential', 'submission', 'nda', 'triple_combination_regiman', 'patient', 'del_mutation'], ['datum', 'study', 'show', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'when_add', 'patient', 'already_receive', 'tezacaftor', 'combination', 'ivacaftor', 'compare_placebo', 'add', 'tezacaftor', 'primary_endpoint', 'study', 'mean_absolute_group', 'improvement', 'baseline', 'receive_triple', 'combination_tezacaftor', 'ivacaftor', 'percentage_point', 'week_mean', 'absolute_group', 'change_ppfev', 'baseline', 'receive', 'placebo', 'tezacaftor_ivacaftor', 'percentage_point', 'week'], ['triple_combination_generally_well', 'tolerate', 'study', 'patient_receive_triple', 'combination_tezacaftor', 'ivacaftor', 'placebo', 'tezacaftor_ivacaftor', 'complete', 'triple_combination_treatment', 'period'], ['similar', 'study', 'people_mutation_minimal', 'function_mutation', 'patient', 'complete', 'treatment', 'regardless', 'treatment', 'assignment', 'give', 'opportunity', 'enroll', 'rollover', 'study', 'where', 'patient_receive_triple', 'combination_regimen', 'patient', 'complete', 'study', 'elect', 'enter', 'open_label_extension', 'study'], [], ['rare_life_shorten_genetic', 'disease', 'affect_approximately', 'people', 'cause_defective_missing', 'cftr_protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'mid_late'], ['collaborative', 'history', 'cystic'], ['initiate', 'research', 'program', 'part', 'collaboration', 'nonprofit_drug_discovery', 'development', 'affiliate', 'ivacaftor', 'lumacaftor_ivacaftor', 'symdeko', 'ivacaftor', 'ivacaftor', 'discover', 'vertex', 'part', 'collaboration'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_third_paragraph', 'information', 'provide', 'regard', 'plan', 'seek', 'global', 'regulatory_approval', 'triple_combination_regiman', 'expect', 'timing', 'maa', 'submission', 'triple_combination_therapy', 'plan', 'provide', 'additional', 'datum', 'regard', 'select', 'regimen', 'second_quarter', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'triple_combination', 'study', 'ongoing', 'company', 'experience', 'unforeseen', 'delay', 'submit', 'regulatory_filing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'triple_combination_regiman', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['investor'], ['patient', 'infuse', 'phase', 'clinical_trial', 'patient', 'beta_thalassemia'], ['patient', 'enrol', 'phase', 'clinical_trial', 'patient', 'sickle', 'cell', 'disease'], ['pharmaceutical_incorporate', 'today', 'review', 'recent', 'progress', 'clinical', 'development', 'program', 'investigational_autologous', 'crispr_gene_edit', 'hematopoietic_stem', 'cell', 'therapy', 'evaluate', 'patient', 'suffer_severe', 'company', 'announce', 'first', 'patient', 'treat', 'phase', 'clinical', 'study', 'patient', 'transfusion_dependent_beta_thalassemia', 'mark', 'first', 'company', 'sponsor', 'use', 'crispr_cas', 'therapy', 'clinical_trial', 'parallel', 'company', 'investigate', 'treatment', 'severe_sickle', 'cell', 'disease', 'also', 'announce', 'first', 'patient', 'enrol', 'phase', 'clinical', 'study', 'severe_scd', 'expect', 'infuse', 'mid'], ['make', 'tremendous', 'progress', 'pleased', 'announce', 'have', 'treat', 'first', 'patient', 'beta_thalassemia', 'clinical', 'study', 'say_chief_executive_officer', 'treat', 'first', 'patient', 'study', 'mark_important', 'scientific', 'medical', 'milestone', 'beginning', 'effort', 'fully', 'realize', 'promise', 'therapy', 'new_class', 'potentially_transformative', 'medicine', 'treat', 'serious_disease'], ['beta_thalassemia_sickle', 'cell', 'disease', 'serious_life_threaten', 'disease', 'evaluate', 'vivo', 'treatment', 'goal', 'create', 'time', 'potential', 'curative', 'therapy', 'say_executive_vice', 'president_chief', 'scientific', 'officer', 'collaboration', 'offer', 'exciting', 'new', 'potential', 'therapeutic', 'approach', 'complement', 'strategy', 'use', 'scientific_innovation', 'create_transformative', 'medicine', 'serious_disease'], ['phase_study', 'beta', 'phase_open_label', 'trial', 'design_assess', 'safety_efficacy', 'single_dose', 'patient', 'age', 'non', 'beta', 'beta', 'subtype', 'first', 'patient', 'trial', 'treat', 'sequentially', 'pende', 'datum', 'initial', 'patient', 'trial', 'open', 'broad', 'concurrent', 'enrollment', 'company', 'plan', 'target', 'presentation', 'datum', 'scientific', 'conference', 'sufficient', 'datum', 'multiple', 'patient'], ['study', 'currently', 'conduct', 'multiple', 'clinical_trial', 'site', 'addition', 'therapeutic', 'vertex', 'expand', 'investigational', 'new', 'drug_application', 'include', 'beta_thalassemia', 'plan', 'begin', 'enrollment', 'phase_study', 'clinical_trial', 'site', 'year'], ['phase_study', 'sickle', 'cell', 'disease', 'phase_open_label', 'trial', 'design_assess', 'safety_efficacy', 'single_dose', 'patient', 'age', 'severe_scd', 'similar', 'trial', 'beta_thalassemia', 'first', 'patient', 'trial', 'treat', 'sequentially', 'prior', 'broad', 'concurrent', 'enrollment', 'company', 'plan', 'target', 'presentation', 'datum', 'scientific', 'conference', 'sufficient', 'datum', 'multiple', 'patient'], ['study', 'currently', 'conduct', 'clinical_trial', 'site', 'grant_fast', 'track_designation', 'administration', 'treatment', 'scd', 'year', 'addition', 'therapeutic', 'vertex', 'obtain_approval', 'clinical_trial', 'application', 'cta', 'additional', 'country', 'plan', 'initiate', 'phase_study', 'clinical_trial', 'site', 'year'], ['gene_edit', 'process', 'trial', 'patient', 'enroll', 'study', 'hematopoietic_stem', 'cell', 'collect', 'peripheral', 'blood', 'patient', 'cell', 'edit', 'use', 'crispr', 'technology', 'edit', 'cell', 'then', 'infuse', 'back', 'patient', 'part', 'stem', 'cell', 'transplant', 'patient', 'initially', 'monitor', 'determine', 'when', 'edit', 'cell', 'begin', 'produce', 'mature', 'blood', 'cell', 'process', 'know', 'engraftment', 'engraftment', 'patient', 'continue', 'monitor', 'track', 'impact', 'multiple', 'measure', 'disease'], ['beta_thalassemia_sickle', 'cell', 'disease', 'inherited', 'blood', 'disorder', 'cause', 'mutation', 'beta', 'globin', 'gene', 'result', 'low', 'beta', 'globin', 'production', 'important', 'building', 'block', 'hemoglobin', 'patient', 'severe', 'form', 'beta_thalassemia', 'suffer', 'anemia', 'dependent', 'blood', 'transfusion', 'lead', 'iron', 'accumulation', 'complication', 'damage', 'organ', 'shorten', 'life', 'span'], ['inherited', 'blood', 'disorder', 'cause', 'mutation', 'beta', 'globin', 'gene', 'lead', 'abnormal', 'hemoglobin', 'call', 'abnormal', 'hemoglobin_red', 'blood', 'cell', 'become', 'rigid', 'block', 'small', 'blood', 'vessel', 'patient', 'severe_scd', 'suffer', 'acute_pain', 'acute', 'chest', 'syndrome', 'organ', 'damage', 'as_well', 'other', 'potential', 'complication', 'include', 'shorten', 'life', 'span'], ['forward_look_statement', 'press_release_contain', 'number', 'forward_look_statement_meaning', 'private_security_amend', 'include', 'statement', 'regard', 'expectation', 'follow', 'clinical_trial', 'include_limitation', 'timing', 'filing', 'clinical_trial', 'application', 'ind', 'approval', 'thereof', 'timing', 'commencement', 'clinical_trial', 'development', 'timeline', 'discussion', 'regulatory_authority', 'relate', 'product_candidate', 'development', 'collaborator', 'number', 'patient', 'evaluate', 'anticipate', 'date', 'enrollment', 'complete', 'datum', 'generate', 'ongoing', 'plan', 'clinical_trial', 'ability', 'use', 'datum', 'design', 'initiation', 'further', 'clinical_trial', 'scope', 'timing', 'ongoing', 'potential', 'future', 'clinical_trial', 'intellectual_property', 'coverage', 'position', 'therapeutic', 'licensor', 'third_party', 'sufficiency_cash', 'resource', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy_limit_forego', 'word_believe_anticipate', 'plan', 'expect_similar_expression', 'intend_identify_forward_look', 'statement', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'forward_look_statement', 'promise_guarantee_necessarily_subject', 'high_degree', 'uncertainty', 'risk', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'outcome', 'plan', 'clinical_trial', 'study', 'favorable', 'more', 'internal_external', 'product_candidate', 'program', 'proceed', 'plan', 'technical', 'scientific', 'commercial', 'reason', 'future_competitive', 'other', 'market_factor_adversely', 'affect_commercial', 'potential', 'product_candidate', 'uncertainty', 'inherent', 'initiation_completion', 'preclinical', 'study', 'product_candidate', 'availability_timing', 'result', 'preclinical', 'study', 'result', 'preclinical', 'trial', 'predictive_future', 'result', 'future', 'trial', 'uncertainty', 'regulatory_approval', 'conduct', 'trial', 'market', 'product', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available_website_existing', 'prospective_investor_caution_place', 'undue_reliance', 'forward_look_statement', 'speak_only_date', 'make_disclaim_obligation', 'undertaking_update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'information', 'provide', 'regard', 'status', 'expectation', 'respect', 'clinical', 'development', 'program', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include', 'development', 'proceed', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available', 'investor_contact'], ['pharmaceutical_incorporate_investor'], ['medium'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'appoint', 'board_director', 'independent', 'director', 'prominent', 'technology', 'executive', 'experience', 'lead', 'innovative', 'high', 'growth', 'organization', 'currently', 'serve', 'chairman', 'chief_executive_officer', 'technology', 'acquisition', 'company', 'addition', 'bring', 'director', 'member'], ['thrilled', 'join', 'board', 'wealth', 'leadership', 'management', 'experience', 'pair', 'passion', 'technology', 'innovation', 'bring', 'invaluable', 'perspective', 'leadership_team', 'say_chief_executive_officer'], ['honor', 'join', 'organization', 'strong', 'track_record', 'discover', 'new', 'medicine', 'treat', 'life_threaten', 'disease', 'cystic_fibrosis', 'say', 'look_forward', 'work', 'fellow', 'board', 'member', 'support', 'vertex', 'continue', 'effort', 'serially', 'innovate', 'benefit', 'people', 'serious_disease'], ['prior', 'role', 'serve', 'chief_executive_officer', 'communication', 'system', 'global', 'supplier', 'network', 'hardware', 'software', 'acquisition', 'broadcom', 'previously', 'serve', 'chief_executive_officer', 'system', 'cloud', 'base', 'infrastructure', 'solution', 'provider', 'acquisition', 'also', 'serve', 'chief_executive_officer', 'chairman', 'software', 'solution', 'provider', 'business', 'service', 'assurance', 'early', 'career', 'hold', 'senior', 'leadership', 'role', 'currently', 'serve', 'independent', 'director', 'chairman'], ['hold', 'bachelor', 'science', 'degree', 'electrical', 'engineering', 'technology', 'master', 'science', 'degree', 'apply', 'business', 'management', 'honorary', 'doctorate', 'degree', 'engineering'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['meet_primary_endpoint', 'statistically_significant', 'improvement', 'absolute_change', 'lung', 'clearance', 'week'], ['tezacaftor', 'combination', 'ivacaftor', 'generally_well_tolerate', 'safety', 'datum', 'consistent', 'previous', 'studies'], ['data', 'support', 'submission', 'second_half'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'result', 'phase_study', 'conduct', 'combination', 'ivacaftor', 'child', 'age_year', 'cystic_fibrosis', 'copy_mutation', 'copy_mutation', 'residual_function_mutation', 'study', 'meet_primary_endpoint', 'absolute_change', 'lung', 'clearance', 'week', 'treatment', 'demonstrate', 'statistically_significant', 'improvement', 'patient', 'treat', 'tezacaftor_ivacaftor', 'regimen', 'generally_well_tolerate', 'safety', 'datum', 'consistent_observe', 'previous', 'study', 'tezacaftor_ivacaftor', 'efficacy', 'study', 'design', 'support', 'submission', 'extend', 'indication', 'tezacaftor_ivacaftor', 'patient', 'population', 'vertex', 'plan_submit', 'application', 'second_half', 'late', 'vertex', 'submit', 'snda', 'food', 'ivacaftor', 'base', 'previously', 'complete', 'phase', 'safety', 'study', 'child', 'age_year', 'age', 'conduct'], ['datum', 'mark_important', 'milestone', 'effort', 'expand', 'treatment_option', 'patient', 'live', 'say_vice_president_chief', 'medical_officer', 'plan_submit', 'indication', 'extension', 'second_half', 'bring_step_close', 'potentially', 'provide', 'more', 'child', 'treatment_option', 'address_underlie', 'cause', 'disease'], ['summary', 'key', 'datum'], ['datum', 'announce_today', 'phase_randomize_double', 'blind', 'parallel', 'group', 'study', 'evaluate', 'efficacy_safety', 'tezacaftor', 'combination', 'ivacaftor', 'child', 'age', 'copy_mutation', 'copy_mutation', 'residual_function_mutation', 'subject', 'randomize', 'base', 'genotype', 'tezacaftor_ivacaftor', 'blinding', 'arm_placebo', 'copy', 'ivacaftor', 'copy_mutation', 'residual_function_mutation', 'study', 'randomize', 'treat', 'subject', 'tez', 'iva', 'placebo', 'ivacaftor'], ['primary_endpoint', 'study', 'within', 'group', 'absolute_change', 'lung', 'clearance', 'baseline_week', 'patient', 'treat', 'tezacaftor_ivacaftor', 'measure', 'efficiency', 'ventilation', 'lung', 'quantify', 'how', 'many', 'standard', 'lung', 'volume', 'take', 'reduce', 'exhale', 'nitrogen', 'percent', 'start', 'value', 'when', 'breathe', 'pure', 'oxygen', 'lci', 'consider', 'more', 'sensitive', 'measure', 'detect', 'early', 'lung', 'disease', 'force_expiratory_volume_second', 'high', 'score', 'indicate', 'poor', 'lung_function', 'participate', 'study', 'child', 'initial', 'screening', 'visit', 'consider', 'cutoff', 'abnormal', 'gas', 'exchange', 'study', 'child', 'treat', 'tezacaftor_ivacaftor', 'experience', 'mean', 'group', 'absolute_improvement', 'week'], ['overall', 'safety', 'datum', 'similar_observe', 'previous', 'study', 'tezacaftor_ivacaftor', 'most_common', 'adverse_event', 'patient', 'receive_tezacaftor', 'ivacaftor', 'cough', 'headache', 'productive', 'cough', 'serious_adverse_event', 'adverse_event', 'lead', 'treatment', 'discontinuation', 'interruption', 'observe'], ['initiate', 'research', 'program', 'part', 'collaboration', 'nonprofit_drug_discovery', 'development', 'affiliate', 'ivacaftor', 'ivacaftor', 'symdeko', 'ivacaftor', 'ivacaftor', 'discover', 'vertex', 'part', 'collaboration'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'first', 'paragraph_press_release', 'second_paragraph', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['full_year', 'product_revenue', 'increase_compare', 'fourth_quarter', 'product_revenue'], ['full_year', 'gaap', 'operate', 'income', 'increase', 'non_gaap', 'operating_income', 'increase'], ['company', 'provide', 'full_year_financial_guidance', 'total_product_revenue'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'full_year_fourth_quarter', 'end', 'provide', 'full_year_financial_guidance'], ['fourth_quarter_full_year', 'financial', 'highlight'], ['gaap', 'net_income', 'include', 'benefit_income_taxis', 'approximately', 'fourth_quarter_full_year', 'end', 'release', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset'], ['achievement', 'mark', 'significant', 'increase', 'number', 'patient', 'treat', 'approve', 'medicine', 'remarkable', 'progress', 'advance', 'triple_combination_regimen', 'late_stage', 'development', 'remain', 'track', 'submit', 'new', 'drug_application', 'triple_combination_regiman', 'no', 'later', 'mid', 'say_chief_executive_officer', 'vertex', 'make', 'tremendous', 'advance', 'research', 'development', 'pipeline', 'initiate', 'clinical', 'development', 'potential', 'medicine', 'treat', 'deficiency', 'sickle', 'cell', 'disease_beta_thalassemia', 'provide', 'multiple', 'positive', 'datum', 'readout', 'pain', 'progress', 'several', 'other', 'drug_candidate', 'late', 'preclinical', 'development', 'continue', 'progress', 'treat', 'cf', 'other', 'serious_disease', 'believe', 'vertex', 'continue', 'create', 'revenue', 'earning', 'growth'], ['full_year', 'net_product_revenue'], ['total', 'net_product_revenue', 'increase_compare', 'full_year', 'primarily_drive', 'rapid', 'uptake', 'symdeko', 'full_year', 'impact', 'expansion'], ['full_year', 'expense'], ['combine_gaap_non_gaap', 'expense', 'increase_compare', 'full_year', 'primarily', 'advancement', 'company', 'portfolio', 'triple_combination_regimen', 'investment', 'support', 'treatment', 'globally'], ['full_year', 'income_taxis'], ['release', 'valuation_allowance_majority', 'defer_tax_asset', 'fourth_quarter', 'base', 'other_thing', 'achievement', 'cumulative', 'profitability', 'last', 'several', 'year', 'expectation_regard', 'future', 'profitability', 'time', 'release', 'valuation_allowance', 'result', 'vertex', 'record', 'gaap', 'income_tax', 'benefit', 'compare', 'benefit'], ['report', 'non_gaap', 'income', 'taxexpenseof', 'exclude', 'release', 'valuation_allowance', 'compare', 'income_tax', 'expense'], ['full_year', 'net_income', 'cash', 'position'], ['gaap', 'net_income', 'increase_compare', 'full_year', 'largely_drive', 'release', 'tax', 'valuation_allowance', 'strong', 'growth', 'total_product_revenue'], ['non_gaap_net_income', 'increase_compare', 'full_year', 'largely_drive', 'strong', 'growth', 'total_product_revenue'], ['cash_cash', 'equivalent_marketable_security', 'approximately', 'increase', 'approximately', 'compare'], ['fourth_quarter', 'net_product_revenue'], ['total', 'net_product_revenue', 'increase_compare', 'fourth_quarter', 'primarily_drive', 'rapid', 'uptake', 'symdeko'], ['fourth_quarter', 'expense'], ['combine_gaap_expense', 'increase_compare', 'fourth_quarter_primarily', 'expense', 'relate', 'strategic', 'licensing_agreement', 'enter', 'fourth_quarter', 'advancement', 'company', 'portfolio', 'triple_combination_regimen', 'investment', 'support', 'treatment', 'globally'], ['combined_non_gaap', 'expense', 'increase_compare', 'fourth_quarter_primarily', 'advancement', 'company', 'portfolio', 'triple_combination_regimen', 'investment', 'support', 'treatment', 'globally'], ['fourth_quarter', 'income_taxis'], ['release', 'valuation_allowance_majority', 'defer_tax_asset', 'fourth_quarter', 'time', 'release', 'valuation_allowance', 'result', 'vertex', 'record', 'non_cash', 'gaap', 'income_tax', 'benefit', 'fourth_quarter', 'compare', 'income_tax', 'expense', 'fourth_quarter'], ['report', 'non_gaap', 'income_tax', 'expense', 'fourth_quarter', 'exclude', 'release', 'valuation_allowance', 'compare', 'income_tax', 'expense', 'fourth_quarter'], ['fourth_quarter', 'net_income'], ['gaap', 'net_income', 'increase_compare', 'fourth_quarter', 'largely_drive', 'release', 'tax', 'valuation_allowance', 'strong', 'growth', 'total_product_revenue', 'partially_offset', 'upfront_payment', 'strategic', 'licensing_agreement'], ['non_gaap_net_income', 'increase_compare', 'fourth_quarter', 'largely_drive', 'strong', 'growth', 'total_product_revenue'], ['today', 'provide', 'full_year', 'guidance', 'follow'], ['company', 'total_product', 'revenue_growth', 'expect', 'drive', 'primarily', 'full_year', 'impact', 'symdeko', 'launch', 'recently', 'complete', 'reimbursement_agreement', 'label_expansion', 'company', 'medicine', 'company', 'full_year', 'revenue_guidance', 'reflect', 'only', 'market', 'where', 'medicine', 'currently', 'reimburse'], ['base', 'release', 'company', 'valuation_allowance', 'fourth_quarter', 'vertex', 'also', 'begin', 'record', 'tax_provision', 'expect', 'full_year', 'gaap_non_gaap', 'tax_rate', 'vast_majority', 'tax_provision', 'non_cash', 'expense', 'company', 'fully_utilize', 'net_operating_loss'], ['triple_combination_regimen'], ['bring', 'triple_combination_regimen', 'people', 'as_quickly_possible', 'vertex', 'announce', 'positive', 'datum', 'phase_study', 'evaluate', 'triple_combination_tezacaftor_ivacaftor', 'people_mutation_minimal', 'function_mutation', 'people', 'mutation', 'datum', 'expect', 'first_quarter', 'phase_study', 'evaluate', 'triple_combination_tezacaftor_ivacaftor', 'people_mutation_minimal', 'function_mutation_people_del', 'mutation'], ['evaluate', 'datum', 'triple_combination', 'program', 'choose_good_regiman_submit', 'potential', 'regulatory_approval', 'together', 'datum', 'expect', 'provide', 'basis', 'submission', 'new', 'drug_application', 'food', 'no', 'later', 'mid'], ['vertex', 'announce', 'grant_marketing_authorization', 'ivacaftor', 'combination_regimen', 'ivacaftor', 'treatment', 'people', 'age', 'old_copy', 'mutation', 'copy_mutation_copy', 'following', 'mutation', 'cftr_protein', 'show', 'residual', 'activity'], ['now', 'reimburse', 'available', 'eligible', 'patient'], ['establish', 'long_term', 'reimbursement', 'vertex', 'establish', 'important', 'reimbursement_agreement', 'several', 'country', 'include', 'denmark', 'reimbursement_agreement', 'allow', 'patient', 'access', 'medicine_treat_underlying', 'cause', 'disease', 'first', 'time', 'provide', 'pathway', 'access', 'rapid', 'reimbursement', 'future', 'medicine', 'company', 'continue', 'work', 'establish', 'pricing', 'reimbursement_agreement', 'other', 'country', 'ensure', 'eligible', 'patient', 'access', 'current', 'future', 'medicine', 'vertex', 'as_quickly_possible'], ['symdeko', 'receive', 'rare_pediatric', 'disease', 'priority_review', 'grant', 'rare_pediatric', 'disease', 'priority_review', 'voucher', 'base', 'approval', 'treatment', 'people', 'age', 'old_copy', 'mutation', 'at_least_mutation', 'responsive', 'tezacaftor_ivacaftor', 'rare_pediatric', 'disease', 'priority_review', 'voucher', 'entitle', 'voucher', 'holder', 'priority_review', 'other', 'human', 'drug_application', 'limit', 'application', 'drug', 'treat', 'rare_pediatric', 'disease', 'rare_pediatric', 'disease', 'priority_review', 'voucher', 'transfer', 'include', 'sale', 'sponsor'], ['treat', 'patient', 'young', 'age', 'cftr_modulator', 'company', 'continue', 'make', 'significant', 'progress', 'gain', 'approval', 'medicine', 'use', 'early', 'course', 'disease', 'progression', 'recent', 'highlight', 'include'], ['continue', 'invest', 'discover_develop', 'transformative_medicine', 'other', 'serious_disease', 'company', 'portfolio', 'potential', 'medicine', 'range', 'disease', 'include'], ['cell', 'beta_thalassemia', 'vertex', 'partner', 'develop', 'autologous', 'gene_edit', 'hematopoietic_stem', 'cell', 'therapy', 'treatment', 'sickle', 'cell', 'disease_beta_thalassemia', 'vertex', 'announce', 'grant_fast', 'track_designation', 'treatment', 'sickle', 'cell', 'disease', 'phase', 'trial', 'sickle', 'cell', 'disease_beta_thalassemia', 'currently', 'underway'], ['selective_inhibitor', 'treatment', 'pain', 'datum', 'expect', 'first_half', 'phase', 'dose_range', 'study', 'evaluate', 'inhibitor', 'use', 'oral', 'formulation', 'patient', 'acute_pain_follow_bunionectomy', 'surgery', 'study', 'design', 'evaluate', 'multiple', 'oral', 'dose', 'potentially', 'support', 'pivotal', 'development', 'acute_pain'], ['company', 'announce', 'positive', 'result', 'phase_study', 'evaluate', 'treatment', 'pain', 'people', 'small_fiber', 'study', 'third', 'positive', 'proof_concept_study', 'far', 'validate', 'potential', 'role', 'inhibition', 'treatment', 'pain'], ['advance', 'multiple', 'pain', 'molecule', 'late_stage', 'preclinical', 'development', 'plan', 'initiate', 'clinical', 'development', 'first', 'molecule'], ['aat', 'program', 'vertex', 'initiate', 'clinical', 'development', 'first', 'potential', 'medicine', 'deficiency', 'genetic', 'disorder', 'cause', 'mutation', 'single', 'gene', 'result', 'life_shorten', 'systemic', 'complication', 'primarily', 'lung', 'liver'], ['company', 'advance', 'multiple', 'other', 'small_molecule_corrector', 'deficiency', 'preclinical', 'development'], ['focal', 'segmental', 'fsgs', 'multiple', 'candidate', 'preclinical', 'development', 'treatment', 'fsgs', 'company', 'goal', 'advance', 'first', 'potential', 'medicine', 'disease', 'clinical', 'development', 'fsgs', 'rare', 'disease', 'attack', 'kidney', 'filtering', 'unit', 'cause', 'serious', 'scarring', 'lead', 'permanent', 'kidney', 'damage', 'fsgs', 'leading', 'cause', 'nephrotic', 'syndrome', 'child', 'kidney', 'failure', 'adult'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'net_income', 'stock_base_compensation_expense', 'revenue_expense', 'relate', 'business', 'development', 'transaction', 'include', 'collaboration', 'agreement', 'asset_acquisition', 'revenue_expense', 'relate', 'consolidated', 'variable_interest_entity', 'include', 'asset', 'impairment_charge', 'effect', 'deconsolidation', 'variable_interest_entity', 'other', 'adjustment', 'include', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'benefit_income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre', 'tax', 'net_income', 'describe', 'above', 'as_well', 'non', 'operate', 'tax_adjustment', 'associate', 'normal', 'recurring', 'operation', 'include', 'release', 'company', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'fourth_quarter', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'provide', 'guidance_regard', 'product_revenue', 'accordance_gaap', 'provide', 'guidance_regard_combine', 'research', 'development', 'sale_general', 'administrative_expense', 'anticipated', 'income_taxis', 'percentage', 'pre_tax', 'net_income', 'gaap_non_gaap', 'basis', 'guidance_regard', 'gaap', 'research', 'development', 'expense', 'sale_general', 'administrative_expense', 'include', 'estimate_associate', 'potential', 'future', 'business', 'development', 'activitie', 'guidance_regard', 'gaap', 'effective_tax_rate', 'base', 'currently', 'available', 'information', 'low', 'current', 'guidance', 'due', 'actual', 'value', 'equity', 'exercise', 'employee', 'geographic', 'mix', 'business', 'business', 'development', 'activity', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['pharmaceutical_incorporate', 'full_year_fourth_quarter', 'result', 'consolidated', 'statement', 'operation', 'thousand_share_amount_unaudited'], ['reconciliation_gaap_non_gaap', 'net_income', 'full_year_fourth_quarter', 'result', 'thousand_share_amount_unaudited'], ['reconciliation_gaap_non_gaap', 'revenue_expense', 'full_year_fourth_quarter', 'result', 'thousand_unaudited'], ['condense_consolidated_balance_sheet', 'thousand_unaudited'], ['note', 'collaborative', 'royalty', 'revenue', 'primarily', 'attributable', 'milestone', 'earn', 'company', 'collaboration', 'fourth_quarter', 'upfront_payment', 'earn', 'company', 'collaboration', 'record', 'first_quarter', 'total', 'parion', 'company', 'vertex', 'consolidate', 'variable_interest_entity_vie', 'earn', 'collaboration', 'agreement', 'third_party', 'second', 'third_quarter'], ['note_month_end', 'company', 'research', 'development', 'expense', 'include', 'expense', 'relate', 'strategic', 'licensing_agreement', 'enter', 'fourth_quarter', 'include', 'license_agreement', 'company', 'research', 'development', 'expense', 'include', 'pay', 'acquire', 'third_quarter'], ['note_month_end', 'company', 'record', 'intangible_asset', 'impairment_charge', 'relate', 'license', 'month_end', 'company', 'record', 'intangible_asset', 'impairment_charge', 'relate', 'parion', 'pulmonary', 'enac', 'platform'], ['note', 'accordance', 'recognition', 'measurement', 'financial', 'asset', 'financial', 'liability', 'become', 'effective', 'company', 'record', 'loss', 'month_end', 'net', 'gain', 'month_end', 'other', 'expense', 'net', 'relate_change_fair', 'value', 'company', 'strategic_investment', 'prior', 'adoption', 'change_fair_value', 'company', 'strategic_investment', 'record', 'equity', 'company', 'condense_consolidated_balance_sheet', 'related', 'gain_loss', 'realize', 'therefore', 'comparable_amount_month_end'], ['note', 'company', 'consolidate', 'financial', 'statement', 'bioaxone', 'parion', 'vie', 'portion', 'month_end', 'vertex', 'license', 'right', 'develop', 'collaborator', 'most', 'significant', 'intellectual_property', 'asset', 'report', 'period', 'vertex', 'estimate', 'fair_value_contingent_payment', 'payable_vertex', 'bioaxone', 'parion', 'increase', 'fair_value_contingent_payment', 'result', 'decrease', 'net_income_attributable', 'vertex', 'dollar', 'dollar', 'basis', 'fair_value_contingent_payment', 'evaluate', 'quarter', 'change_fair_value', 'reflect', 'company', 'statement', 'operation'], ['company', 'deconsolidate', 'parion', 'bioaxone', 'company', 'impairment', 'parion', 'enac', 'platform', 'subsequent', 'deconsolidation', 'parion', 'third_quarter', 'result', 'impairment_charge', 'total', 'benefit_income_taxis', 'attributable_noncontrolle', 'interest', 'total', 'impact', 'parion', 'transaction', 'gaap', 'basis', 'loss_attributable', 'noncontrolle_interest', 'loss_attributable', 'vertex', 'impact', 'non_gaap_net_income', 'third_quarter', 'net', 'impact', 'attributable', 'vertex', 'result', 'deconsolidation', 'bioaxone', 'month_end', 'material'], ['note_month_end', 'company', 'record', 'non_cash', 'benefit_income_taxis', 'approximately', 'relate', 'release', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'base', 'other_thing', 'achievement', 'cumulative', 'profitability', 'last', 'several', 'year', 'expectation_regard', 'future', 'profitability', 'result', 'company', 'record', 'defer_tax_asset', 'consolidated_balance', 'sheet', 'previously', 'subject', 'valuation_allowance', 'start', 'first_quarter', 'company', 'record_provision_income_taxis', 'pre_tax', 'net_income', 'use', 'estimate', 'effective_tax_rate', 'expect', 'approximate_statutory', 'rate', 'provision', 'include', 'significant', 'non_cash_charge', 'company', 'ability_offset', 'pre_tax', 'net_income', 'previously', 'accumulate', 'net_operating_loss', 'company', 'expect', 'cash', 'pay', 'income_taxis', 'increase', 'significantly', 'once', 'net_operating_loss', 'utilize', 'offset_pre', 'tax', 'net_income', 'company', 'federal_net_operating_loss', 'credit', 'approximately'], ['note', 'collaborative_transaction', 'revenue_expense', 'month_end', 'primarily_relate', 'upfront_payment', 'describe_note', 'as_well', 'increase', 'decrease', 'respectively', 'fair_value_contingent_payment', 'payable_vertex', 'bioaxone', 'collaborative_transaction', 'revenue_expense', 'month_end', 'primarily_relate', 'collaborative_revenue', 'describe_note', 'concert', 'transaction', 'describe_note', 'decrease_fair_value_contingent', 'payment_payable', 'vertex', 'vie', 'full_year', 'charge', 'attributable', 'parion', 'record', 'other', 'expense', 'net', 'deconsolidation', 'third_quarter'], ['note_month_end', 'other', 'adjustment', 'primarily', 'consist', 'change_fair_value', 'company', 'strategic_investment', 'describe_note', 'month_end', 'other', 'adjustment', 'primarily', 'consist', 'restructuring', 'charge', 'relate', 'company', 'decision', 'consolidate', 'research', 'activity', 'location', 'close', 'research', 'site'], ['note', 'non', 'operate', 'tax_adjustment', 'include', 'portion', 'company', 'provision_income_taxis', 'associate', 'company', 'normal', 'recurring', 'operation', 'month_end', 'non', 'operate', 'tax_adjustment', 'include', 'non_cash', 'benefit_income_taxis', 'relate', 'release', 'company', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'describe_note', 'additionally', 'month_end', 'company', 'record_provision_income_taxis', 'relate_stock_base_compensation', 'gaap', 'basis', 'represent', 'reversal', 'net', 'benefit_income_taxis', 'record', 'month_end', 'relate_stock_base_compensation', 'accordingly', 'discrete_item', 'relate_stock_base_compensation', 'effect', 'company', 'gaap', 'annual', 'provision_income_taxis', 'company', 'exclude', 'amount', 'non_gaap_measure', 'month_end'], ['note_month_end', 'cost_sale', 'include', 'respectively', 'stock_base_compensation_expense', 'month_end', 'cost_sale', 'include', 'respectively', 'stock_base_compensation_expense', 'beginning', 'first_quarter', 'company', 'begin', 'adjust', 'stock_base_compensation_expense', 'record', 'cost_sale', 'reconciliation_non_gaap', 'net_income_attributable', 'vertex', 'non_gaap', 'cost_sale', 'non_gaap', 'reconciliation', 'company', 'adjust', 'stock_base_compensation_expense', 'record', 'cost_sale', 'month_end'], ['note_month_end', 'estimated', 'income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'relate', 'company', 'vie', 'income_taxis', 'month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'primarily_relate', 'benefit_income_taxis', 'record', 'result', 'impairment', 'subsequent', 'deconsolidation', 'parion', 'describe_note'], ['ivacaftor', 'indication_important_safety', 'information'], ['ivacaftor', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_month', 'old_at_least', 'mutation', 'gene_responsive', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know_safe', 'effective_child', 'month', 'age'], ['patient', 'take', 'kalydeco', 'take_certain_medicine_herbal', 'supplement_such_antibiotic_rifampin', 'rifabutin_seizure', 'medication', 'such_phenobarbital_carbamazepine_phenytoin', 'wort'], ['cause_dizziness', 'people', 'take', 'patient', 'drive_car', 'use', 'machinery', 'need', 'alert', 'know', 'how', 'affect', 'patient', 'avoid_food', 'contain_grapefruit', 'seville_orange', 'take'], ['cause', 'serious_side_effect', 'include'], ['high_liver', 'enzyme_blood', 'report', 'patient', 'receive', 'patient', 'doctor_blood_test_check', 'liver_start', 'month', 'first', 'year', 'take', 'kalydeco', 'year', 'take', 'patient', 'have', 'high_liver', 'enzyme', 'past', 'doctor_blood_test_check', 'liver', 'more', 'often', 'patient', 'call_doctor_right', 'away_follow_symptom_liver', 'problem_pain_discomfort_upper', 'right_stomach_abdominal_area', 'yellow_skin', 'white_part_eye_loss', 'appetite_nausea', 'vomiting_dark_amber_color', 'urine'], ['abnormality_eye_lens_cataract', 'note', 'child_adolescent', 'receive', 'patient', 'doctor_perform_eye_examination', 'prior', 'treatment', 'kalydeco', 'look_cataract', 'most_common_side_effect', 'include', 'respiratory_tract_infection', 'common_cold', 'include', 'sore_throat', 'nasal', 'sinus', 'congestion', 'runny_nose', 'stomach_abdominal', 'pain', 'diarrhea', 'rash', 'nausea', 'dizziness'], ['possible_side_effect', 'kalydeco'], ['click_here_see_full', 'prescribe_information'], ['indication_important_safety', 'information', 'lumacaftor_ivacaftor'], ['prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_year_old_copy', 'mutation', 'cftr', 'gene', 'orkambi', 'only', 'use', 'patient', 'know', 'orkambi', 'safe_effective_child', 'year', 'age'], ['click_here_see_full', 'prescribing_information'], ['possible_side_effect', 'symdeko'], ['click_here_see_full', 'prescribe_information'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'regard', 'future', 'financial_performance', 'include', 'section_caption', 'financial_guidance', 'statement', 'regard', 'timing', 'expect', 'outcome', 'regulatory', 'application', 'include', 'development', 'plan', 'timeline', 'product', 'development', 'candidate', 'include', 'next_generation', 'triple_combination_regimen', 'company', 'aat', 'corrector', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'net_product_revenue', 'expense_effective_tax', 'rate_incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['first', 'only', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'young', 'patients'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant', 'market', 'authorization', 'ivacaftor', 'include', 'use', 'child_cystic_fibrosis', 'age_month', 'follow', 'mutation_cystic_fibrosis', 'regulator_cftr_gene'], ['believe', 'important', 'treat_underlying_cause', 'cystic_fibrosis', 'as_early_possible', 'pleased', 'parent', 'physician', 'now', 'medicine_treat_underlying', 'cause', 'indicate', 'patient', 'as', 'young', 'year', 'age', 'say_vice_president_chief', 'medical_officer', 'look_forward', 'work', 'canadian', 'health', 'official', 'province', 'achieve', 'rapid', 'access', 'small', 'important', 'group', 'young', 'child'], ['label', 'update', 'base', 'datum', 'ongoing_phase_open', 'label_safety', 'study', 'arrival', 'child_aged', 'month', 'gating_mutation', 'cftr', 'gene', 'study', 'demonstrate', 'safety_profile', 'consistent_observe', 'previous_phase', 'study', 'old_child_adult', 'improvement_sweat_chloride', 'key_secondary', 'efficacy_endpoint'], ['previously', 'approve', 'expand', 'use', 'patient', 'age_month', 'same', 'year'], ['cystic_rare_life', 'threaten_genetic_disease', 'affect_approximately', 'people', 'include', 'people'], ['arrival', 'study'], ['arrival', 'study', 'ongoing_phase_open', 'label_safety', 'study', 'child_aged', 'month', 'mutation', 'cftr', 'gene', 'study', 'demonstrate', 'safety_profile', 'consistent_observe', 'previous_phase', 'study', 'old_child_adult', 'most', 'adverse_event_mild_moderate', 'severity', 'patient', 'discontinue', 'adverse_event', 'patient', 'elevate', 'liver_enzyme', 'great', 'time', 'upper', 'limit', 'normal', 'continue', 'receive', 'dose', 'interruption', 'most_common', 'adverse_event', 'cough', 'elevate', 'aspartate', 'elevate', 'alanine', 'runny_nose', 'serious_adverse_event', 'observe', 'patient'], ['mean_sweat_chloride', 'child', 'study', 'mmol', 'follow', 'week', 'treatment', 'mean_sweat_chloride', 'level', 'mmol', 'subject', 'pair', 'sweat_chloride', 'sample', 'baseline_week', 'mean_absolute', 'change', 'mmol', 'datum', 'present', 'st', 'european', 'conference', 'publish', 'medicine', 'volume'], ['ivacaftor', 'first', 'medicine_treat_underlying', 'cause', 'people', 'specific', 'mutation', 'cftr', 'gene', 'know_cftr_potentiator', 'oral', 'medicine', 'design_keep', 'cftr_protein', 'cell', 'surface_open', 'long_improve_transport', 'salt_water_cell', 'membrane_help_hydrate_clear', 'mucus', 'available', 'mg', 'tablet', 'adult_pediatric', 'patient', 'age_year_old', 'take', 'fat', 'contain', 'food', 'also', 'available', 'mg', 'granule', 'pediatric', 'age_month', 'less', 'year', 'administer', 'soft', 'food', 'liquid', 'fat', 'contain', 'food'], ['people', 'specific', 'mutation', 'cftr', 'gene', 'currently', 'benefit', 'different', 'country'], ['indication_important_safety', 'information', 'ivacaftor', 'ivacaftor', 'prescription_medicine_use', 'treatment_cystic_fibrosis', 'patient', 'age_month', 'old_at_least', 'mutation', 'gene_responsive', 'patient', 'talk_doctor_learn_indicate', 'gene', 'mutation', 'know_safe', 'effective_child', 'month', 'age'], ['abnormality_eye_lens_cataract', 'note', 'child_adolescent', 'receive', 'patient', 'doctor_perform_eye_examination', 'prior', 'treatment', 'kalydeco', 'look_cataract', 'most_common_side_effect', 'include', 'respiratory_tract_infection', 'common_cold', 'include', 'sore_throat', 'nasal', 'sinus', 'congestion', 'runny_nose', 'stomach_abdominal', 'pain', 'diarrhea', 'rash', 'nausea', 'dizziness'], ['possible_side_effect', 'kalydeco', 'click_here_see_full', 'prescribe_information'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include', 'statement_second_paragraph', 'company', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'company', 'drug_candidate', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'website_disclaim_obligation_update', 'information_contain_press', 'release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'terminate', 'chief', 'operating', 'officer', 'interim', 'chief', 'financial', 'officer', 'effective', 'immediately', 'termination', 'result', 'personal', 'behavior', 'violate', 'code', 'conduct', 'value', 'unrelated', 'company', 'financial', 'business', 'performance', 'company', 'board', 'make', 'determination', 'follow', 'prompt', 'comprehensive', 'investigation', 'conduct', 'assistance', 'independent', 'external', 'counsel'], ['senior_vice_president', 'company', 'corporate', 'controller', 'chief', 'accounting', 'officer', 'appoint', 'interim', 'cfo', 'effective', 'immediately', 'company', 'conduct', 'formal', 'search', 'identify', 'permanent', 'cfo', 'last', 'decade', 'hold', 'responsibility', 'global', 'accounting', 'tax', 'other', 'key', 'area'], ['deeply', 'committed', 'culture', 'diversity', 'inclusion', 'respect', 'insist', 'employee', 'regardless', 'seniority', 'live', 'value', 'adhere', 'code', 'conduct', 'say_chief_executive_officer', 'vertex', 'decision', 'relate', 'conduct', 'concern', 'company', 'operation', 'finance'], ['strong', 'management', 'team', 'place', 'as_well', 'deep', 'bench', 'confident', 'continue', 'successfully', 'execute', 'company', 'long_stand', 'strategy', 'bring', 'transformative', 'treatment', 'people', 'live_cystic_fibrosis', 'advance', 'diverse', 'pipeline', 'medicine', 'other', 'serious_disease', 'continue', 'make', 'difference', 'life', 'patient', 'family', 'caregiver', 'true', 'north', 'commitment', 'ideal', 'unwavere'], ['previously', 'announce', 'vertex', 'report', 'fourth_quarter_full_year', 'financial', 'result', 'financial', 'market', 'close'], ['found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row', 'vertex', 'recently', 'name', 'number', 'list', 'good_employer', 'diversity', 'additional', 'information', 'late', 'update', 'company', 'visit_wwwvrtxcom'], ['source_version'], ['contact', 'investor'], ['vertex_pharmaceutical_incorporate', 'report', 'full_year_fourth_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['source_version'], ['lumacaftor_ivacaftor', 'first', 'only', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'approximately', 'child', 'age', 'copy_mutation'], ['vertex_pharmaceutical', 'today_announce', 'grant', 'approval', 'label_extension', 'lumacaftor_ivacaftor', 'treatment', 'child_cystic_fibrosis', 'aged', 'year_old', 'copy_mutation', 'most_common', 'form', 'disease'], ['today', 'approval', 'bring_step_close', 'goal_bring', 'treatment', 'people', 'live', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'vertex', 'treat_underlying_cause', 'disease', 'early', 'potentially', 'modify', 'course', 'offer', 'patient', 'chance', 'improved', 'outcome'], ['label', 'update', 'base', 'datum', 'phase_open_label', 'safety', 'study', 'patient', 'show', 'treatment', 'lumacaftor_ivacaftor', 'generally_well_tolerate', 'week', 'safety_profile', 'pediatric', 'patient', 'generally_consistent', 'patient', 'age_year_old'], ['lumacaftor_ivacaftor', 'already_approve', 'treatment', 'patient', 'aged', 'old_copy', 'mutation'], ['cystic_fibrosis_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people'], ['cause_defective_missing', 'cftr_protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead', 'build', 'up', 'abnormally_thick', 'sticky_mucus', 'cause', 'chronic_lung_infection_progressive', 'lung_damage_many', 'patient', 'eventually_lead_death_median', 'age_death', 'mid_late'], ['phase_open_label', 'safety', 'study', 'approval', 'base', 'phase_open_label', 'safety', 'study', 'patient', 'show', 'treatment', 'lumacaftor_ivacaftor', 'generally_well_tolerate', 'week', 'safety_profile', 'similar', 'patient', 'age_year_old', 'improvement_sweat_chloride', 'secondary_endpoint', 'observe', 'week_mean', 'decrease', 'sweat_chloride', 'baseline', 'mmol', 'researcher', 'also', 'see', 'change', 'key', 'growth', 'parameter', 'also', 'secondary_endpoint', 'study', 'most_common', 'adverse_event', 'overall', 'cough', 'most', 'adverse_event_mild_moderate', 'severity', 'patient', 'experience', 'serious_adverse_event', 'infective', 'pulmonary_exacerbation', 'cystic_fibrosis', 'viral', 'constipation', 'patient', 'discontinue', 'treatment', 'elevated', 'transaminase', 'concurrent', 'elevation', 'total', 'bilirubin', 'finding', 'present', 'st', 'european', 'conference'], ['lumacaftor_ivacaftor', 'ivacaftor', 'combination_lumacaftor', 'design_increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'cftr_protein', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_second_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'commercialize', 'orkambi', 'people_cystic_fibrosis', 'age_year_old', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['pharmaceutical_incorporate_investor'], ['pharmaceutical_incorporate', 'today_announce', 'food', 'grant_fast', 'track_designation', 'treatment', 'sickle', 'cell', 'disease', 'investigational_autologous_gene_edit', 'hematopoietic_stem', 'cell', 'therapy', 'patient', 'suffer_severe'], ['fast_track', 'program', 'design_facilitate', 'development', 'expedite', 'review', 'drug', 'treat', 'serious', 'condition', 'fill', 'unmet_medical_need', 'drug', 'grant_fast', 'track_designation', 'eligible', 'several', 'benefit', 'include', 'more', 'frequent', 'meeting', 'communication', 'relevant', 'criterion', 'meet', 'potential', 'accelerated_approval', 'priority_review', 'roll', 'review', 'biologics', 'license', 'application'], ['crispr', 'announce', 'acceptance', 'investigational', 'new', 'drug_application', 'treatment', 'scd', 'enrollment', 'phase', 'trial', 'scd', 'currently', 'underway', 'company', 'also', 'evaluate', 'treatment', 'thalassemia', 'enrollment', 'phase', 'trial', 'thalassemia', 'currently', 'open', 'multiple', 'clinical_trial', 'site'], ['investigational', 'vivo_gene_edit', 'therapy', 'patient', 'suffer', 'thalassemia_sickle', 'cell', 'disease', 'patient', 'hematopoietic_stem', 'cell', 'engineer_produce_high_level', 'fetal_hemoglobin_red_blood', 'cell', 'form_oxygen', 'carrying', 'hemoglobin_naturally', 'present_birth', 'then', 'replace', 'adult_form', 'hemoglobin_elevation', 'hbf_potential', 'alleviate_transfusion', 'requirement', 'thalassemia', 'patient', 'painful_debilitate_sickle_crisis', 'sickle', 'cell', 'patient'], ['crispr', 'vertex', 'collaboration', 'vertex', 'enter_strategic', 'research', 'collaboration', 'aim', 'discovery', 'development', 'gene_editing', 'treatment', 'use', 'crispr', 'technology', 'correct', 'defect', 'specific', 'gene', 'target', 'know', 'cause', 'contribute', 'particular', 'disease', 'vertex', 'exclusive', 'right', 'license', 'new', 'cas', 'base', 'treatment', 'emerge', 'collaboration', 'represent', 'first', 'treatment', 'emerge_joint', 'research', 'program', 'crispr', 'vertex', 'equally', 'share', 'research', 'development', 'cost', 'profit_worldwide'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'regard', 'potential', 'benefit', 'fast_track_designation', 'ongoing', 'clinical_trial', 'vertex', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'develop', 'drug_candidate', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available', 'investor_contact'], ['contact', 'wcg', 'behalf'], ['medium'], ['year', 'research', 'collaboration', 'fund', 'vertex', 'use', 'proprietary', 'research', 'platform', 'enhance', 'effort', 'develop', 'gene_edit', 'therapy', 'diseases'], ['arbor', 'receive', 'front', 'cash', 'payment', 'convertible', 'note', 'investment', 'research', 'funding', 'potential', 'additional', 'milestone_royalty', 'payments'], ['vertex_pharmaceutical_incorporate', 'arbor', 'biotechnology', 'today_announce', 'company', 'enter_strategic', 'research', 'collaboration', 'focus', 'discovery', 'novel', 'protein', 'include', 'dna', 'endonuclease', 'advance', 'development', 'new', 'gene_edit', 'therapy', 'cystic_fibrosis', 'other', 'disease', 'select', 'later', 'arbor', 'develop', 'protein', 'biodiscovery', 'platform', 'include', 'comprehensive', 'set', 'technology', 'technique', 'integrate', 'machine_learn', 'sequencing', 'gene', 'synthesis', 'high', 'throughput', 'screening', 'augment', 'effort', 'develop', 'gene_edit', 'approach', 'treatment', 'serious_disease'], ['strategy', 'develop', 'transformative_medicine', 'serious_disease', 'base', 'address', 'causal_human', 'biology', 'innovative', 'therapeutic', 'say', 'executive', 'research', 'chief_scientific', 'officer', 'proprietary', 'high', 'throughput', 'screening', 'platform', 'enhance', 'ongoing', 'effort', 'develop', 'innovative', 'gene_edit', 'therapy'], ['prove', 'track_record', 'discover_develop', 'innovative', 'medicine', 'ideal', 'partner', 'say', 'founder', 'believe', 'use', 'powerful', 'biodiscovery', 'platform', 'able', 'identify', 'complementary', 'next_generation', 'tool', 'enhance', 'pipeline', 'transformative_medicine', 'new', 'gene_edit', 'therapy'], ['collaboration', 'term', 'collaboration', 'scientist', 'vertex', 'arbor', 'work_closely', 'together', 'discover', 'novel', 'protein', 'tool', 'vertex', 'use', 'development', 'new', 'medicine', 'focus', 'collaboration', 'discover', 'novel', 'programmable', 'dna', 'endonuclease', 'nickase', 'high', 'fidelity', 'catalytic', 'activity', 'as_well', 'novel', 'transduction', 'approach', 'discovery', 'activity', 'conduct', 'primarily', 'arbor', 'fund', 'vertex'], ['provide', 'arbor', 'front', 'cash', 'commitment', 'fund', 'research', 'activity', 'pay', 'research', 'development', 'regulatory', 'commercial_milestone', 'as_well', 'royalty_future_net', 'sale'], ['also', 'make', 'investment', 'arbor', 'form', 'convertible', 'note', 'obtain', 'observer', 'seat', 'director'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'press_release_statement', 'third_paragraph_press_release', 'statement', 'regard', 'future', 'activity_party', 'pursuant_collaboration', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'belief_only_date_press', 'release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'vertex', 'realize_anticipate_benefit', 'collaboration', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['biotechnology', 'biotechnology', 'early_stage', 'company', 'push', 'boundary', 'biodiscovery', 'base', 'unlock', 'genetic', 'diversity', 'create_transformative', 'product', 'human', 'health', 'sustainability', 'proprietary', 'platform', 'integrate', 'computational', 'search', 'engine', 'high', 'throughput', 'experimental', 'capability', 'enable', 'rapid', 'protein', 'product', 'generation'], ['more_information_visit', 'wwwarborbio'], ['source_version'], ['contact', 'investor_medium', 'arbor', 'contact', 'friendly'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'pm', 'am'], ['source_version'], ['accept', 'scottish', 'smc', 'use', 'nhs', 'eligible', 'patient', 'access', 'precision', 'cystic_fibrosis', 'medicine'], ['smc', 'review', 'submission', 'clinician', 'apply', 'access', 'medicine', 'pacs', 'tier', 'process', 'individual', 'patient', 'base', 'clinical', 'need'], ['vertex', 'scottish', 'government', 'agree', 'confidential', 'discount', 'apply', 'approve', 'pacs', 'tier', 'application'], ['vertex_pharmaceutical', 'today_announce', 'follow', 'constructive', 'discussion', 'scottish', 'government', 'submit', 'lumacaftor_ivacaftor', 'as_well', 'ivacaftor', 'use', 'combination', 'ivacaftor', 'scottish', 'smc', 'appraisal', 'accept', 'smc', 'use', 'nhs', 'eligible', 'patient', 'cystic_fibrosis', 'access', 'precision_medicine'], ['recent', 'conversation', 'scottish', 'government', 'smc', 'orphan', 'medicine', 'process', 'provide', 'important', 'flexibility', 'evaluate', 'precision_medicine', 'such', 'cystic_fibrosis', 'conductance_regulator', 'cftr_modulator', 'method', 'reflect', 'innovative', 'nature', 'medicine', 'potential', 'extend', 'life', 'patient', 'rare', 'disease', 'say_fenaux_senior_vice', 'hopeful', 'process', 'eligible', 'patient', 'access', 'medicine', 'soon'], ['smc', 'review', 'submission', 'clinician', 'apply', 'access', 'lumacaftor_ivacaftor', 'as_well', 'tezacaftor_ivacaftor', 'combination', 'ivacaftor', 'individual', 'patient', 'base', 'clinical', 'need', 'peer', 'approve', 'clinical', 'system', 'tier', 'process', 'individual', 'access', 'medicine', 'yet', 'generally', 'available', 'nhs', 'vertex', 'scottish', 'government', 'also', 'agree', 'confidential', 'discount', 'apply', 'application', 'pacs', 'tier', 'process'], ['approximately', 'people', 'live', 'median_age', 'death', 'estimate', 'scot', 'cftr', 'mutation', 'carry', 'parent', 'lead', 'child', 'bear', 'cf'], ['appraisal', 'positive', 'patient', 'join', 'other', 'country_world', 'where', 'eligible', 'access', 'lumacaftor_ivacaftor', 'include'], ['cystic', 'cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people'], ['cause_defective_missing', 'cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr', 'protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead', 'build', 'up', 'abnormally_thick', 'sticky_mucus', 'cause', 'chronic_lung_infection_progressive', 'lung_damage_many', 'patient', 'eventually_lead', 'death'], ['lumacaftor_ivacaftor', 'combination_lumacaftor', 'design_increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'cftr_protein', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface', 'lumacaftor_ivacaftor', 'typically', 'take', 'twice', 'day'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'first', 'third_paragraph_press_release', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'commercialize', 'product', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['available', 'https', 'work', 'registry', 'reporting', 'resource', 'access', 'datum', 'report', 'available', 'https', 'media', 'document', 'work', 'registry', 'annual', 'data', 'access', 'cystic_fibrosis', 'available', 'service', 'access', 'basharut', 'market', 'review', 'drug', 'cf', 'trust', 'cause', 'cf', 'available', 'cystic_fibrosis', 'cause_cystic_fibrosis', 'access', 'real_world', 'outcome', 'patient', 'cystic_fibrosis', 'treat', 'ivacaftor', 'analysis', 'poster', 'session', 'learn', 'cftr_modulator', 'use', 'real', 'life', 'poster', 'session', 'poster', 'present', 'st', 'european'], ['source_version'], ['pharmaceutical_incorporate_investor_medium', 'seyfrie'], ['inhibitor', 'show', 'significant', 'relief', 'pain', 'patient', 'small_fiber', 'neuropathy', 'generally_well', 'tolerated'], ['positive', 'phase_proof_concept', 'study', 'further', 'validate', 'potential', 'role', 'inhibition', 'treatment', 'multiple', 'pain', 'conditions'], ['initiate', 'phase', 'dose_range', 'study', 'evaluate', 'acute_pain_follow_bunionectomy', 'surgery', 'expect', 'advance', 'additional', 'inhibitor', 'clinical', 'development', 'begin'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'positive', 'result', 'phase_study', 'investigational', 'inhibitor', 'patient', 'pain', 'cause', 'small_fiber', 'study', 'meet_primary_endpoint', 'show', 'treatment', 'demonstrate', 'statistically_significant', 'clinically_meaningful', 'pain', 'reduction', 'measure', 'group', 'change_baseline', 'weekly', 'average_daily', 'pain_intensity', 'numeric', 'rating_scale', 'week', 'generally_well_tolerate', 'study'], ['phase_study', 'patient', 'small_fiber', 'neuropathy', 'third', 'positive', 'proof_concept_study', 'provide', 'further', 'validation', 'potential', 'role', 'inhibition', 'treatment', 'multiple', 'pain', 'condition', 'phase', 'dose_range', 'study', 'follow_bunionectomy', 'surgery', 'currently', 'ongoing', 'support', 'potential', 'pivotal', 'development', 'additionally', 'company', 'advance', 'multiple', 'pain', 'molecule', 'late_stage', 'preclinical', 'development', 'anticipate', 'initiate', 'clinical', 'development', 'first', 'molecule'], ['excited', 'now', 'positive', 'proof_concept_study', 'validate', 'potential', 'role', 'inhibitor', 'treat', 'variety', 'pain', 'condition', 'say_chief_executive_officer', 'vertex', 'result', 'show', 'potential', 'path', 'treatment', 'pain', 'time', 'when', 'great', 'clinical', 'societal', 'need', 'new', 'medicine', 'continue', 'progress', 'pivotal', 'development', 'also', 'plan', 'advance', 'additional', 'pain', 'medicine', 'clinical', 'development', 'beginning'], ['phase_study', 'patient', 'small_fiber', 'neuropathy'], ['datum', 'announce_today', 'phase_randomize_double', 'blind_placebo_control', 'study', 'evaluate', 'treatment', 'placebo', 'patient', 'chronic', 'pain', 'cause', 'small_fiber', 'neuropathy', 'study', 'mg', 'dose', 'orally', 'hour'], ['study', 'meet_primary_endpoint', 'show_statistically', 'significant', 'mean', 'group', 'change_baseline', 'point', 'treat', 'weekly', 'average_daily', 'pain_intensity', 'nrs', 'report', 'daily', 'diary', 'week_mean', 'within', 'group', 'change_baseline', 'treat', 'placebo'], ['second', 'pre_specified', 'analysis', 'compare', 'patient', 'randomize', 'placebo', 'analysis', 'demonstrate', 'treatment', 'difference', 'mean', 'change_baseline', 'weekly', 'average_daily', 'pain_intensity', 'nrs', 'report', 'daily', 'diary', 'week', 'treatment', 'difference', 'observe', 'as_early', 'week', 'sustain', 'week', 'treatment', 'period'], ['datum', 'efficacy', 'analysis', 'provide', 'below'], [], [], [], ['group', 'treatment', 'difference'], [], [], ['confidence', 'interval'], [], ['study', 'generally_well_tolerate', 'percent', 'patient', 'group', 'percent', 'patient', 'placebo', 'group', 'complete', 'treatment', 'patient', 'discontinue', 'treatment', 'adverse_event', 'placebo', 'patient', 'experience', 'serious_adverse_event', 'placebo', 'majority_adverse_event_mild', 'moderate', 'adverse_event', 'occur', 'percent', 'patient', 'receive', 'percent', 'patient', 'receive', 'placebo', 'most_common', 'adverse_event', 'treatment', 'group', 'occur', 'percent', 'patient', 'group', 'percent', 'patient', 'placebo', 'group'], ['also', 'announce_today', 'grant', 'breakthrough', 'therapy', 'designation', 'treatment', 'moderate_severe', 'acute_pain', 'breakthrough', 'therapy', 'designation', 'design', 'expedite', 'development', 'review', 'drug', 'intend', 'treat', 'serious', 'condition', 'preliminary', 'clinical', 'evidence', 'indicate', 'drug', 'demonstrate', 'substantial_improvement', 'available', 'therapy', 'clinically', 'significant', 'endpoint', 'endpoint'], ['recently', 'initiate', 'phase', 'dose_range', 'study', 'evaluate', 'patient', 'acute_pain_follow_bunionectomy', 'surgery', 'study', 'design', 'evaluate', 'multiple', 'oral', 'dose', 'potentially', 'support', 'pivotal', 'development'], ['now', 'positive', 'phase', 'datum', 'multiple', 'pain', 'condition', 'include', 'chronic', 'pain', 'cause', 'osteoarthritis', 'small_fiber', 'neuropathy', 'as_well', 'acute_pain_follow_bunionectomy', 'surgery', 'company', 'continue', 'invest', 'discovery', 'development', 'other', 'potential', 'pain', 'molecule', 'target', 'other', 'new', 'pain', 'mechanism', 'anticipate', 'initiate', 'clinical', 'development', 'first', 'molecule'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_third_paragraph', 'press_release_statement', 'caption', 'next_step', 'statement', 'regard', 'recently', 'initiate', 'phase_study', 'advancement', 'multiple', 'pain', 'molecule', 'late_stage', 'preclinical', 'development', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['orkambi', 'first', 'medicine_treat_underlying', 'cause', 'young', 'child', 'copy_mutation'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'grant', 'market', 'authorization', 'lumacaftor_ivacaftor', 'include', 'use', 'child', 'age_year', 'cystic_fibrosis', 'copy_mutation'], ['believe', 'important', 'treat_underlying_cause', 'cystic_fibrosis', 'as_early_possible', 'commit', 'expand', 'treatment_option', 'young', 'child', 'say_vice_president_chief', 'medical_officer', 'approval', 'progress', 'have', 'make', 'research', 'development', 'multiple', 'potential', 'new', 'medicine', 'last', 'year', 'testament', 'how', 'far', 'have', 'come', 'goal_bring', 'effective', 'medicine', 'people', 'live'], ['approval', 'base', 'phase_open_label', 'safety', 'study', 'patient', 'show', 'treatment', 'generally_well_tolerate', 'week', 'safety_profile', 'similar', 'patient', 'age_year', 'improvement_sweat_chloride', 'secondary_endpoint', 'observe', 'week_mean', 'decrease', 'sweat_chloride', 'baseline', 'mmol'], ['phase_study', 'researcher', 'also', 'see', 'change', 'key', 'growth', 'parameter', 'also', 'secondary_endpoint', 'study', 'most_common', 'adverse_event', 'cough', 'most', 'adverse_event_mild_moderate', 'severity', 'patient', 'experience', 'serious_adverse_event', 'pulmonary_exacerbation', 'gastroenteritis', 'constipation', 'patient', 'discontinue', 'treatment', 'treatment', 'emergent', 'adverse_event', 'elevated', 'liver', 'function', 'test', 'finding', 'present', 'conference'], ['approve', 'year', 'use', 'patient', 'age_year', 'copy_mutation', 'marketing_authorization_application', 'line', 'extension', 'orkambi', 'child', 'age_year', 'submit', 'committee_medicinal_product', 'human_use_chmp', 'adopt_positive_opinion', 'orkambi', 'use', 'patient', 'population', 'company', 'expect', 'decision', 'come', 'month'], ['cystic_rare_life', 'threaten_genetic_disease', 'affect_approximately', 'people'], ['lumacaftor_ivacaftor'], ['combination_lumacaftor', 'design_increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'protein', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface'], ['indication_important_safety', 'information', 'lumacaftor_ivacaftor'], ['found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row'], ['press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include', 'statement_second_paragraph', 'statement', 'regard', 'anticipate', 'timing', 'decision', 'line', 'extension', 'company', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'company', 'drug_candidate', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'website_disclaim_obligation_update', 'information_contain_press', 'release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor'], [], [], ['medium'], [], [], ['ivacaftor', 'first', 'only', 'approve', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'young', 'patient'], ['vertex_pharmaceutical', 'today_announce', 'grant', 'approval', 'label_extension', 'ivacaftor', 'include', 'treatment', 'people_cystic_fibrosis', 'age_month', 'at_least', 'follow', 'mutation_cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr_gene'], ['first', 'time', 'now', 'treat_underlying_cause', 'early', 'ever', 'help', 'improve', 'clinical', 'outcome', 'child', 'as', 'young', 'month', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'look_forward', 'support', 'additional', 'research', 'potential', 'benefit', 'early', 'intervention', 'medicine', 'goal_bring', 'treatment', 'people', 'live'], ['label', 'update', 'base', 'datum', 'ongoing_phase_open', 'label_safety', 'study', 'arrival', 'child_aged', 'month', 'mutation', 'cftr', 'gene', 'demonstrate', 'safety_profile', 'consistent_observe', 'previous_phase', 'study', 'old_child_adult', 'improvement_sweat_chloride', 'key_secondary', 'efficacy_endpoint'], ['ivacaftor', 'already_approve', 'treatment', 'patient', 'age_year_old', 'follow', 'mutation', 'cftr', 'gene', 'also', 'approve', 'treatment', 'patient', 'age_year_old', 'mutation', 'cftr', 'gene'], ['arrival', 'study', 'arrival', 'study', 'ongoing_phase_open', 'label_safety', 'study', 'child_aged', 'month', 'mutation', 'cftr', 'gene', 'patient', 'mutation', 'eligible', 'enroll', 'region', 'where', 'ivacaftor', 'approve', 'use', 'patient', 'year', 'age', 'mutation', 'study', 'demonstrate', 'safety_profile', 'consistent_observe', 'previous_phase', 'study', 'old_child_adult', 'most', 'adverse_event_mild_moderate', 'severity', 'patient', 'discontinue', 'adverse_event', 'treatment', 'interrupt', 'patient', 'elevate', 'liver_enzyme', 'great', 'time', 'upper', 'limit', 'normal', 'continue', 'receive', 'ivacaftor', 'dose', 'interruption', 'most_common', 'adverse_event', 'cough', 'elevate', 'aspartate', 'elevate', 'alanine', 'runny_nose', 'serious_adverse_event', 'observe', 'patient'], ['mean_sweat_chloride', 'child', 'study', 'mmol', 'follow', 'week', 'treatment', 'ivacaftor', 'mean_sweat_chloride', 'level', 'mmol', 'subject', 'pair', 'sweat_chloride', 'sample', 'baseline_week', 'mean_absolute', 'change', 'sweat_chloride', 'use', 'tool', 'diagnose', 'infant', 'where', 'level', 'great', 'equal', 'mmol', 'indicate', 'likely', 'level', 'mmol', 'indicate', 'possible', 'level', 'less', 'indicate', 'unlikely', 'datum', 'present', 'st', 'european', 'conference', 'publish', 'medicine', 'volume'], ['ivacaftor', 'ivacaftor', 'first', 'medicine_treat_underlying', 'cause', 'people', 'specific', 'mutation', 'cftr', 'gene', 'know_cftr_potentiator', 'ivacaftor', 'oral', 'medicine', 'design_keep', 'cftr_protein', 'cell', 'surface_open', 'long_improve_transport', 'salt_water_cell', 'membrane_help_hydrate_clear', 'mucus_airway'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_second_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'commercialize', 'people_cystic_fibrosis', 'age_month', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_home'], ['pharmaceutical_incorporate_investor_medium', 'seyfrie'], ['absolute_improvement', 'ppfev_percentage_point_baseline', 'week', 'people_mutation_minimal', 'function_mutation', 'compare_placebo'], ['absolute_improvement', 'ppfev_percentage_point_baseline', 'week', 'when_add', 'people_del', 'mutation', 'already_receive', 'tezacaftor_ivacaftor', 'compare', 'group', 'add', 'tezacaftor_ivacaftor'], ['efficacy', 'profile', 'support', 'potential', 'submission', 'new', 'drug_application', 'triple_combination'], ['phase_study', 'triple_combination_tezacaftor_ivacaftor', 'now', 'fully', 'enrol', 'datum', 'expect', 'first_quarter'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'treatment', 'triple_combination', 'next_generation_corrector', 'tezacaftor_ivacaftor', 'result', 'statistically_significant', 'improvement_lung_function', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'phase_study', 'people_cystic_fibrosis', 'datum', 'pre_specified_interim_analysis', 'phase_study', 'people_mutation_minimal', 'function_mutation', 'show', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'treatment', 'compare', 'phase_study_people_del', 'mutation', 'addition', 'patient', 'already_receive', 'tezacaftor_ivacaftor', 'result', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'treatment', 'compare', 'control', 'group', 'placebo', 'add', 'tezacaftor', 'triple_combination_generally_well', 'tolerate', 'safety_efficacy', 'profile', 'result', 'release', 'today', 'support', 'potential', 'submission', 'new', 'drug_application', 'triple_combination_regiman'], ['also', 'today_announce', 'enrollment', 'complete', 'phase_study', 'triple_combination', 'next_generation_corrector', 'tezacaftor_ivacaftor', 'people_mutation_minimal', 'function_mutation', 'people', 'mutation', 'remain', 'track', 'report', 'topline', 'datum', 'phase_study', 'triple_combination_regiman', 'first_quarter'], ['datum', 'expect', 'first_quarter', 'datum', 'report', 'today', 'enable', 'vertex', 'choose_good_regiman_submit', 'potential', 'regulatory_approval', 'globally', 'provide', 'basis', 'potential', 'submission', 'nda', 'triple_combination_regiman', 'no', 'later', 'mid'], ['datum', 'mark', 'major', 'milestone', 'effort', 'develop', 'new', 'medicine', 'underscore', 'important', 'clinical', 'benefit', 'triple_combination_regiman', 'provide', 'vast_majority', 'patient', 'at_least_mutation', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'plan', 'evaluate', 'datum', 'triple_combination_regimen', 'first_quarter', 'next', 'year', 'choose_good_regiman_submit', 'potential', 'approval', 'goal_bring', 'new', 'treatment_option', 'mutation_minimal', 'function_mutation', 'del_mutation', 'as', 'rapidly', 'possible'], ['phase_study', 'people_mutation_minimal', 'function_mutation'], ['datum', 'announce_today', 'people', 'age_old', 'mutation_minimal', 'function_mutation', 'ongoing', 'randomize_double_blind_placebo', 'control', 'phase_study', 'evaluate', 'triple_combination_tezacaftor_ivacaftor', 'compare', 'triple_placebo', 'week', 'study', 'randomize', 'patient', 'patient', 'receive', 'at_least', 'dose', 'triple_combination_regiman', 'triple_placebo', 'primary_endpoint', 'study', 'mean_absolute_change_ppfev', 'baseline_week', 'triple_combination_treatment', 'compare', 'triple_placebo', 'datum', 'announce_today', 'pre_specified_interim_analysis', 'evaluate', 'primary_endpoint', 'week', 'patient', 'complete', 'week', 'visit', 'study', 'time', 'interim_analysis', 'safety_efficacy', 'profile', 'interim_analysis', 'support', 'potential', 'submission', 'nda', 'triple_combination_regiman', 'patient', 'mutation_minimal', 'function_mutation'], ['treatment', 'triple_combination_tezacaftor_ivacaftor', 'result', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'compare', 'triple_placebo', 'primary_endpoint', 'study', 'mean_absolute_group', 'improvement', 'receive_triple', 'combination', 'percentage_point_baseline_week', 'mean_absolute_group', 'change', 'receive_triple', 'placebo', 'percentage_point_baseline_week'], ['triple_combination_generally_well', 'tolerate', 'study', 'safety_profile', 'reflect', 'available', 'safety', 'datum', 'patient', 'time', 'interim_analysis', 'include', 'patient', 'reach', 'week', 'visit', 'patient', 'randomize_receive', 'triple_combination_regiman', 'patient', 'randomize_receive', 'triple_placebo', 'patient', 'complete', 'treatment', 'period', 'patient', 'randomize_receive', 'triple_combination_regiman', 'patient', 'randomize_receive', 'triple_placebo'], ['study', 'ongoing', 'evaluate', 'triple_combination_regiman', 'total', 'week', 'generate', 'additional', 'safety_efficacy', 'datum', 'datum', 'key_secondary_endpoint', 'include', 'number', 'pulmonary_exacerbation', 'change', 'sweat_chloride', 'change', 'patient', 'report', 'outcome', 'measure', 'respiratory_domain_score', 'cystic_revise', 'change', 'body', 'mass', 'index', 'other', 'preserve', 'integrity', 'ongoing', 'study', 'ongoing', 'phase_study', 'intend', 'wait', 'disclose', 'additional', 'safety_efficacy', 'datum', 'study', 'include', 'key_secondary_endpoint', 'second_half', 'follow', 'completion', 'phase_study'], ['patient', 'complete', 'treatment', 'study', 'regardless', 'treatment', 'assignment', 'give', 'opportunity', 'enroll', 'rollover', 'study', 'where', 'patient_receive_triple', 'combination_regiman', 'patient', 'complete', 'study', 'time', 'interim_analysis', 'elect', 'enter', 'open_label_extension', 'study'], ['phase_study_people_del', 'mutation'], ['datum', 'announce_today', 'people_del', 'mutation', 'randomized_double', 'blind', 'control', 'phase_study', 'evaluate', 'week', 'treatment', 'triple_combination_tezacaftor_ivacaftor', 'compare_placebo', 'tezacaftor_ivacaftor', 'study', 'randomize', 'patient', 'age_year_old', 'del_mutation', 'patient', 'receive_tezacaftor', 'combination', 'ivacaftor', 'run', 'in', 'prior', 'randomization', 'patient', 'randomize_receive', 'least', 'dose', 'triple_combination_tezacaftor_ivacaftor', 'placebo', 'tezacaftor_ivacaftor', 'primary_endpoint', 'study', 'mean_absolute_change_ppfev', 'baseline', 'end', 'tezacaftor_ivacaftor', 'run', 'week', 'triple_combination_tezacaftor_ivacaftor', 'compare_placebo', 'combination_tezacaftor', 'ivacaftor', 'datum', 'announce_today', 'reflect', 'topline', 'datum', 'primary_efficacy', 'safety', 'analysis', 'conduct', 'once', 'patient', 'complete', 'study', 'safety_efficacy', 'profile', 'study', 'support', 'potential', 'submission', 'nda', 'triple_combination_regiman', 'patient', 'del_mutation'], ['datum', 'study', 'show', 'mean_absolute_improvement_ppfev', 'percentage_point_baseline_week', 'when_add', 'patient', 'already_receive', 'tezacaftor', 'combination', 'ivacaftor', 'compare_placebo', 'add', 'tezacaftor', 'primary_endpoint', 'study', 'mean_absolute_group', 'improvement', 'baseline', 'receive_triple', 'combination_tezacaftor', 'ivacaftor', 'percentage_point', 'week_mean', 'absolute_group', 'change_ppfev', 'baseline', 'receive', 'placebo', 'tezacaftor_ivacaftor', 'percentage_point', 'week'], ['triple_combination_generally_well', 'tolerate', 'study', 'patient', 'randomize', 'study', 'complete', 'triple_combination_treatment', 'period'], ['preserve', 'integrity', 'ongoing', 'phase_study', 'vertex', 'intend', 'wait', 'disclose', 'additional', 'safety_efficacy', 'datum', 'study', 'include', 'key_secondary_endpoint', 'second_half', 'follow', 'completion', 'phase_study'], ['open_label_extension', 'study', 'similar', 'study', 'people_mutation_minimal', 'function_mutation', 'patient', 'complete', 'treatment', 'regardless', 'treatment', 'assignment', 'give', 'opportunity', 'enroll', 'rollover', 'study', 'where', 'patient_receive_triple', 'combination', 'patient', 'complete', 'study', 'elect', 'enter', 'open_label_extension', 'study'], ['enrollment', 'complete', 'phase_study'], ['today_announce', 'complete_enrollment', 'phase_study', 'evaluate', 'triple_combination_tezacaftor_ivacaftor', 'people_mutation_minimal', 'function_mutation_people_del', 'mutation', 'study', 'design', 'same', 'use', 'phase', 'program', 'note', 'above'], ['similar', 'program', 'phase_study', 'triple_combination_regiman', 'patient', 'mutation_minimal', 'function_mutation', 'design', 'pre_specified_interim_analysis', 'evaluate', 'primary_endpoint', 'ppfev', 'week', 'datum', 'interim_analysis', 'expect', 'first_quarter', 'similar', 'vertex', 'expect', 'disclose', 'first_quarter', 'only', 'topline', 'result', 'primary_efficacy', 'endpoint', 'phase_study', 'safety_efficacy', 'profile', 'observe', 'support', 'potential', 'submission', 'intend', 'disclose', 'additional', 'safety_efficacy', 'datum', 'include', 'key_secondary_endpoint', 'study', 'second_half', 'follow', 'completion', 'phase_study'], ['submission', 'approval'], ['datum', 'study', 'also', 'use', 'regulatory_submission', 'plan', 'late'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_fourth_paragraph', 'information', 'provide', 'regard', 'company', 'plan', 'regard', 'announcement', 'additional', 'datum', 'ongoing', 'study', 'include', 'topline', 'datum', 'ongoing', 'triple_combination', 'study', 'company', 'plan', 'regard', 'potential', 'submission', 'regulatory_filing', 'triple_combination_regimen', 'outside', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'report', 'press_release_base', 'pre_specified_interim_analysis', 'ongoing', 'triple_combination', 'study', 'final', 'datum', 'differ', 'triple_combination', 'study', 'ongoing', 'company', 'experience', 'unforeseen', 'delay', 'submit', 'regulatory_filing', 'regulatory_authority', 'approve_approve_timely', 'basis', 'triple_combination_regiman', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['approve', 'lumacaftor_ivacaftor', 'first', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'approximately', 'young', 'child', 'copy_mutation'], ['vertex_pharmaceutical', 'today_announce', 'committee_medicinal_product', 'human_use_chmp', 'adopt_positive_opinion', 'lumacaftor_ivacaftor', 'treatment', 'people_cystic_fibrosis', 'aged', 'year_old', 'copy_mutation', 'most_common', 'form', 'disease'], ['issue', 'favorable', 'adoption', 'chmp_opinion', 'extension', 'indication', 'lumacaftor_ivacaftor', 'first', 'only', 'medicine', 'approve', 'treat_underlying_cause', 'patient', 'age_year_old_copy', 'mutation'], ['cystic', 'chronic', 'progressive', 'disease', 'important', 'treat', 'early', 'ensure', 'good', 'possible', 'outcome', 'patient', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'today_announcement', 'bring_step_close', 'provide', 'more', 'young', 'child', 'treatment', 'address_underlie', 'cause', 'disease', 'also', 'mark_important', 'milestone', 'path', 'goal', 'treat', 'person', 'rare_life', 'limit', 'disease'], ['submission', 'support', 'datum', 'phase_open_label', 'safety', 'study', 'patient', 'show', 'treatment', 'lumacaftor_ivacaftor', 'generally_well_tolerate', 'week', 'safety_profile', 'pediatric', 'patient', 'generally_consistent', 'patient', 'age_year_old'], ['lumacaftor_ivacaftor', 'already_approve', 'treatment', 'patient', 'aged', 'old_copy', 'mutation'], ['phase_open_label', 'safety', 'study', 'chmp', 'positive_opinion', 'base', 'phase_open_label', 'safety', 'study', 'patient', 'show', 'treatment', 'lumacaftor_ivacaftor', 'generally_well_tolerate', 'week', 'safety_profile', 'similar', 'patient', 'age_year_old', 'improvement_sweat_chloride', 'secondary_endpoint', 'observe', 'week_mean', 'decrease', 'sweat_chloride', 'baseline', 'mmol', 'researcher', 'also', 'see', 'change', 'key', 'growth', 'parameter', 'also', 'secondary_endpoint', 'study', 'most_common', 'adverse_event', 'overall', 'cough', 'most', 'adverse_event_mild_moderate', 'severity', 'patient', 'experience', 'serious_adverse_event', 'infective', 'pulmonary_exacerbation', 'cystic_fibrosis', 'viral', 'constipation', 'patient', 'discontinue', 'treatment', 'elevated', 'transaminase', 'concurrent', 'elevation', 'total', 'bilirubin', 'finding', 'present', 'conference'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_third_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'vertex', 'experience', 'unforeseen', 'delay', 'obtain', 'favorable', 'adoption', 'chmp_opinion', 'extension', 'indication', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium', 'seyfrie'], ['new', 'treatment_option', 'patient', 'copy_mutation', 'most_common', 'mutation_cystic_fibrosis'], ['first', 'medicine', 'treat', 'cftr_protein', 'defect', 'patient', 'copy_mutation', 'copy_mutation', 'result', 'residual', 'cftr', 'activity'], ['vertex_pharmaceutical', 'today_announce', 'grant_marketing_authorization', 'ivacaftor', 'combination_regimen', 'ivacaftor', 'treatment', 'people_cystic_fibrosis', 'aged', 'old_copy', 'mutation_cystic_fibrosis', 'regulator_cftr_gene', 'copy_mutation_copy', 'following', 'mutation', 'cftr_protein', 'show', 'residual', 'activity', 'addition', 'medicinal_product', 'recently', 'recommend', 'maintenance', 'orphan', 'designation', 'tezacaftor_ivacaftor', 'combination', 'ivacaftor'], ['authorization', 'ivacaftor', 'combination', 'ivacaftor', 'welcome', 'news', 'patient', 'family', 'involve', 'treatment', 'care', 'new', 'medicine', 'especially', 'important', 'patient', 'residual_function_mutation', 'tolerate', 'orkambi_lumacaftor', 'ivacaftor', 'say', 'head'], ['marketing_authorization', 'base', 'result', 'pivotal', 'phase_study', 'evolve', 'expand', 'publish', 'result', 'show', 'treatment', 'tezacaftor_ivacaftor', 'combination', 'ivacaftor', 'provide', 'benefit', 'different', 'population', 'include', 'statistically_significant', 'improvement_lung_function', 'determine', 'absolute_change', 'baseline', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'generally_well_tolerate', 'safety_profile', 'lack', 'increase', 'respiratory', 'adverse_event', 'compare_placebo', 'improvement_lung_function', 'show', 'mean_absolute', 'change', 'compare_placebo', 'percentage_point', 'percentage_point', 'expand', 'respectively', 'most_common', 'adverse_reaction', 'experience', 'patient', 'receive_tezacaftor', 'ivacaftor', 'combination', 'ivacaftor', 'pooled', 'placebo_control', 'phase_study', 'headache', 'nasopharyngitis'], ['today', 'mark_important', 'milestone', 'many', 'patient', 'include', 'so', 'far', 'have', 'available', 'option', 'treat', 'cftr_protein', 'defect', 'responsible', 'disease', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'today', 'marketing_authorization', 'rapidly', 'move', 'treat', 'percent', 'patient'], ['ivacaftor', 'combination', 'ivacaftor', 'approve', 'market', 'symdeko'], ['ivacaftor', 'ivacaftor', 'mutation', 'result', 'cftr_protein_process_fold', 'normally', 'cell', 'generally_reach', 'cell', 'surface', 'tezacaftor', 'design', 'address_trafficking_processing_defect', 'cftr_protein', 'enable', 'reach', 'cell', 'surface', 'where', 'ivacaftor', 'increase_amount', 'time', 'protein', 'stay', 'open'], ['complete', 'product', 'information', 'see', 'summary_product_characteristic', 'find', 'wwwemaeuropaeu', 'once', 'post'], ['expand', 'datum', 'phase_study', 'evolve', 'expand', 'publish', 'study', 'enrol', 'approximately', 'people', 'age', 'old_copy', 'mutation', 'mutation', 'second', 'mutation', 'associate', 'residual', 'cftr', 'activity', 'study', 'patient', 'treat', 'tezacaftor_ivacaftor', 'combination', 'ivacaftor', 'experience', 'statistically_significant', 'improvement_lung_function', 'determine', 'absolute_change', 'baseline', 'treatment', 'generally_well_tolerate', 'most_common', 'adverse_reaction', 'experience', 'patient', 'receive_tezacaftor', 'ivacaftor', 'ivacaftor', 'pooled', 'placebo_control', 'phase_study', 'headache', 'placebo', 'nasopharyngitis', 'placebo'], ['orphan', 'designation', 'medicine', 'orphan', 'designation', 'grant', 'medicinal_product', 'treatment', 'address', 'exist', 'unmet_need', 'provide', 'significant', 'benefit', 'people', 'life_threaten', 'chronically', 'debilitate', 'disease', 'affect', 'small', 'number', 'patient'], ['found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row'], ['special_note_regard', 'forward_look_statement', 'press_release_contain', 'forward_look_statement_define', 'private_security_amend', 'include', 'quote', 'second', 'fourth_paragraph_press_release', 'company', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'commercialize', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium', 'seyfrie'], ['third_quarter', 'total_product_revenue', 'increase_compare', 'third_quarter'], ['reiterate_full_year', 'total_product_revenue', 'guidance', 'reiterate_full_year', 'combined_non_gaap', 'expense', 'guidance', 'billion'], ['vertex_pharmaceutical_incorporate_today', 'report', 'consolidated_financial', 'result', 'third_quarter', 'end', 'review', 'recent', 'progress', 'approved', 'investigational', 'medicine', 'vertex', 'also', 'reiterate', 'guidance', 'full_year', 'total_product_revenue', 'guidance', 'combine_gaap_non_gaap', 'expense'], ['third_quarter', 'financial', 'highlight'], [], ['continue', 'make', 'significant', 'progress', 'goal', 'develop', 'medicine', 'people', 'mark', 'recent', 'approval', 'orkambi', 'young', 'child', 'launch', 'symdeko', 'rapid', 'progress', 'make', 'triple_combination', 'pivotal', 'study', 'say_chief_executive_officer', 'development', 'pipeline', 'advance', 'potential', 'medicine', 'pain', 'sickle', 'cell', 'disease_beta_thalassemia', 'also', 'begin', 'advance', 'additional', 'compound', 'research', 'early', 'clinical', 'development', 'fundamentally', 'change', 'treatment', 'other', 'serious_disease', 'future'], ['continue', 'ability', 'treat', 'more', 'more', 'people', 'drive', 'revenue', 'earning', 'growth', 'significant', 'cash_flow', 'generation', 'enable', 'company', 'invest', 'discover_develop', 'transformative', 'future', 'medicine', 'treatment', 'other', 'life_threaten', 'disease'], ['third_quarter', 'net_product_revenue'], ['total', 'net_product_revenue', 'increase_compare', 'third_quarter', 'primarily_drive', 'rapid', 'uptake', 'symdeko', 'eligible', 'patient'], ['third_quarter', 'expense'], ['third_quarter', 'include', 'upfront_payment', 'concert', 'pharmaceutical'], ['combined_non_gaap', 'expense', 'increase_compare', 'third_quarter', 'advancement', 'company', 'portfolio', 'triple_combination_regimen', 'investment', 'support', 'treatment', 'globally'], ['combine_gaap_expense', 'decrease', 'compare_third', 'quarter', 'upfront_payment', 'relate', 'acquisition', 'investigational', 'once_daily', 'cftr_potentiator', 'concert', 'pharmaceutical', 'third_quarter', 'partially_offset', 'expense', 'relate', 'advancement', 'company', 'portfolio', 'triple_combination_regimen', 'investment', 'support', 'treatment', 'globally'], ['third_quarter', 'net_income', 'cash', 'position'], ['non_gaap_net_income', 'increase_compare', 'third_quarter', 'largely_drive', 'strong', 'growth', 'total_product_revenue'], ['gaap', 'net_income', 'increase_compare', 'third_quarter', 'largely_drive', 'strong', 'growth', 'total_product_revenue', 'reduction', 'research', 'development', 'expense', 'payment', 'concert', 'third_quarter'], ['cash_cash', 'equivalent_marketable_security', 'approximately', 'increase', 'approximately', 'compare'], ['financial_guidance'], ['today', 'reiterate_full_year', 'total_product_revenue', 'guidance', 'guidance', 'combine_gaap_non_gaap', 'expense', 'summarize_below'], ['create', 'strong', 'financial', 'profile', 'business', 'poise', 'continued_growth', 'make', 'progress', 'develop', 'medicine', 'many', 'more', 'people', 'say_executive_vice', 'president_chief', 'operating', 'officer', 'nearer', 'term', 'anticipate', 'revenue_growth', 'drive', 'impact', 'launch', 'recently', 'complete', 'reimbursement_agreement', 'label_expansion', 'medicine', 'potential', 'additional', 'revenue_growth', 'dependent', 'gain', 'new', 'reimbursement_agreement', 'key', 'country', 'include', 'continue', 'growth', 'drive', 'potential', 'approval', 'reimbursement', 'uptake', 'triple_combination', 'medicine', 'large', 'number', 'patient', 'minimal_function_mutation', 'currently', 'treatment', 'cause', 'cf'], ['bring', 'triple_combination_regimen', 'people', 'as_quickly_possible'], ['evaluate', 'child'], ['potential', 'once_daily', 'regimen'], [], ['establish', 'long_term', 'reimbursement'], ['cell', 'thalassemia', 'vertex', 'partner', 'develop', 'autologous', 'gene_edit', 'hematopoietic_stem', 'cell', 'therapy', 'treatment', 'thalassemia_sickle', 'cell', 'disease'], ['pain', 'potential', 'role', 'inhibition'], ['deficiency', 'aat'], ['acute', 'cord', 'injury'], ['press_release_vertex', 'financial', 'result', 'financial_guidance_provide_accordance', 'accounting_principle_generally_accept', 'use', 'certain', 'non_gaap_financial_measure', 'particular_non_gaap_financial', 'result', 'guidance_exclude_pre_tax', 'net_income', 'loss', 'stock_base_compensation_expense', 'revenue_expense', 'relate', 'business', 'development', 'transaction', 'include', 'collaboration', 'agreement', 'asset_acquisition', 'consolidated', 'variable_interest_entity', 'include', 'asset', 'impairment_charge', 'effect', 'deconsolidation', 'variable_interest_entity', 'other', 'adjustment', 'include', 'gain_loss_relate', 'fair_value_company', 'strategic_investment', 'company', 'non_gaap', 'financial', 'result', 'also_exclude_provision', 'benefit_income_taxis', 'estimate_tax', 'impact', 'relate_non_gaap', 'adjustment_pre', 'tax', 'net_income', 'loss', 'describe', 'above', 'as_well', 'non', 'operate', 'tax_adjustment', 'associate', 'normal', 'recurring', 'operation', 'result_provide_complement', 'result', 'provide_accordance', 'gaap', 'management_believe', 'non_gaap_financial_measure', 'help_indicate_underlie', 'trend', 'company', 'business', 'important', 'compare', 'current', 'result', 'prior_period', 'result', 'provide', 'additional', 'information', 'regard', 'company', 'financial', 'position', 'management', 'also', 'use', 'non_gaap_financial_measure', 'establish_budget_operational_goal', 'communicate_internally_externally_manage', 'company', 'business', 'evaluate', 'performance', 'company', 'adjust_where_appropriate', 'revenue_expense', 'order_reflect', 'company', 'operation', 'company', 'provide', 'guidance_regard', 'product_revenue', 'accordance_gaap', 'provide', 'guidance_regard_combine', 'research', 'development', 'sale_general', 'administrative_expense', 'gaap_non_gaap', 'basis', 'guidance_regard', 'gaap', 'research', 'development', 'expense', 'sale_general', 'administrative_expense', 'include', 'estimate', 'regard', 'expense', 'associate', 'potential', 'future', 'business', 'development', 'activity', 'reconciliation_gaap_financial', 'result', 'non_gaap', 'financial', 'result', 'include', 'attach_financial_information'], ['pharmaceutical_incorporate', 'third_quarter', 'result', 'consolidated', 'statement', 'operation', 'thousand_share_amount_unaudited'], ['note_month_end', 'collaborative_revenue', 'primarily', 'attributable', 'upfront_payment', 'earn', 'company', 'collaboration', 'month_end', 'collaborative_revenue', 'also', 'include', 'respectively', 'parion', 'science', 'company', 'vertex', 'consolidate', 'variable_interest_entity_vie', 'first_quarter', 'earn', 'collaboration', 'agreement', 'third_party'], ['note', 'company', 'complete', 'acquisition', 'formerly', 'company', 'pay', 'concert', 'cash', 'acquire', 'record', 'research', 'development', 'expense', 'month_end'], ['note', 'company', 'consolidate', 'financial', 'statement', 'collaborator', 'month_end', 'bioaxone', 'consolidated', 'license', 'right', 'develop', 'most', 'significant', 'intellectual_property', 'asset', 'report', 'period', 'vertex', 'estimate', 'fair_value_contingent_payment', 'payable_vertex', 'bioaxone', 'increase', 'fair_value_contingent_payment', 'result', 'decrease', 'net_income_attributable', 'vertex', 'dollar', 'dollar', 'basis', 'fair_value_contingent_payment', 'evaluate', 'quarter', 'change_fair_value', 'reflect', 'company', 'statement', 'operation'], ['also', 'consolidate', 'parion', 'first_quarter', 'third_quarter', 'company', 'determine', 'value', 'parion', 'platform', 'become', 'impaired', 'fair_value', 'intangible_asset', 'accordingly', 'impairment_charge', 'benefit_income_taxis', 'result', 'charge', 'subsequent', 'deconsolidation', 'parion', 'attributable_noncontrolle', 'interest', 'record', 'third_quarter', 'total', 'impact', 'transaction', 'gaap', 'basis', 'loss_attributable', 'noncontrolle_interest', 'loss_attributable', 'vertex', 'impact', 'non_gaap_net_income', 'third_quarter'], ['note', 'accordance', 'recognition', 'measurement', 'financial', 'asset', 'financial', 'liability', 'become', 'effective', 'company', 'record', 'loss', 'month_end', 'net', 'gain', 'month_end', 'other', 'income', 'expense', 'net', 'relate_change_fair', 'value', 'company', 'investment', 'prior', 'adoption', 'change_fair_value', 'company', 'investment', 'record', 'equity', 'company', 'condense_consolidated_balance_sheet', 'related', 'gain_loss', 'realize', 'therefore', 'comparable', 'income', 'month_end'], ['note', 'company', 'continue', 'maintain', 'valuation_allowance_majority', 'net_operating_loss', 'other', 'defer_tax_asset', 'valuation_allowance', 'company', 'record', 'significant', 'provision_income_taxis', 'month_end', 'company', 'profitable', 'federal', 'income_tax', 'perspective', 'use', 'portion', 'net_operating_loss', 'offset', 'income', 'become', 'profitable', 'company', 'release', 'portion', 'valuation_allowance', 'near_term', 'however', 'release', 'valuation_allowance', 'as_well', 'exact', 'timing', 'amount', 'such', 'release', 'continue', 'subject', 'other_thing', 'company', 'level', 'profitability', 'revenue_growth', 'clinical', 'program', 'progression', 'expectation_regard', 'future', 'profitability', 'period', 'release', 'valuation_allowance', 'company', 'recognize', 'significant', 'non_cash', 'credit', 'net_income', 'reflect', 'defer_tax_asset', 'currently', 'subject', 'valuation_allowance', 'condense_consolidated_balance_sheet', 'follow', 'release', 'company', 'expect', 'continue', 'utilize', 'net_operating_loss', 'offset', 'income', 'begin', 'record_provision_income_taxis', 'reflect', 'utilization', 'defer_tax_asset', 'company', 'federal_net_operating_loss', 'carry', 'forward', 'total', 'approximately', 'total', 'defer_tax_asset', 'balance', 'subject', 'valuation_allowance', 'approximately'], ['note_month_end', 'collaborative_transaction', 'revenue_expense', 'primarily', 'consist', 'revenue', 'operating', 'cost', 'expense', 'attributable', 'bioaxone', 'parion', 'change_fair_value_contingent', 'milestone_payment', 'royalty', 'payable_vertex', 'bioaxone', 'parion', 'collaboration', 'revenue', 'payment', 'collaborative_transaction', 'revenue_expense', 'month_end', 'primarily', 'include', 'increase', 'fair_value_contingent_payment', 'payable_vertex', 'bioaxone', 'collaborative_transaction', 'revenue_expense', 'month_end', 'primarily_relate', 'concert', 'payment', 'describe_note', 'net', 'credit', 'respectively', 'associate', 'company', 'oncology', 'program', 'include', 'upfront_payment', 'describe_note', 'month_end', 'loss', 'relate', 'deconsolidation', 'parion', 'note', 'note'], ['note_month_end', 'other', 'adjustment', 'primarily', 'consist', 'change_fair_value', 'company', 'investment', 'describe_note', 'month_end', 'other', 'adjustment', 'primarily', 'consist', 'restructuring', 'charge', 'relate', 'company', 'decision', 'consolidate', 'research', 'activity', 'location', 'close', 'research', 'site'], ['note_month_end', 'non', 'operate', 'tax_adjustment', 'include', 'discrete_item', 'relate_stock_base_compensation', 'gaap', 'basis', 'company', 'record_provision_income_taxis', 'relate_stock_base_compensation', 'month_end', 'net', 'benefit_income_taxis', 'relate_stock_base_compensation', 'month_end', 'company', 'expect', 'net', 'benefit_income_taxis', 'month_end', 'reverse', 'fourth_quarter', 'result', 'effect', 'gaap', 'annual', 'provision_income_taxis', 'accordingly', 'company', 'exclude', 'adjustment', 'non_gaap_measure'], ['note_month_end', 'cost_sale', 'include', 'respectively', 'stock_base_compensation_expense', 'month_end', 'cost_sale', 'include', 'respectively', 'stock_base_compensation_expense', 'beginning', 'first_quarter', 'company', 'adjust', 'stock_base_compensation_expense', 'record', 'cost_sale', 'reconciliation_non_gaap', 'net_income_attributable', 'vertex', 'non_gaap', 'cost_sale', 'non_gaap', 'reconciliation', 'company', 'adjust', 'stock_base_compensation_expense', 'record', 'cost_sale', 'month_end'], ['note_month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'loss', 'relate', 'bioaxone', 'income_taxis', 'month_end', 'estimate_income_taxis', 'relate_non_gaap', 'adjustment_pre_tax_income', 'loss', 'primarily_relate', 'benefit_income_taxis', 'record', 'result', 'impairment', 'subsequent', 'deconsolidation', 'parion', 'describe_note'], ['found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement', 'press_release_information', 'provide', 'section_caption', 'financial_guidance', 'statement', 'regard', 'timing', 'expect', 'outcome', 'regulatory', 'application', 'include', 'development', 'plan', 'timeline', 'product', 'development', 'candidate', 'include', 'tezacaftor', 'combination', 'ivacaftor', 'next_generation', 'triple_combination_regimen', 'company', 'aat', 'corrector', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'company', 'expectation_regard', 'net_product_revenue', 'expense', 'incorrect', 'include', 'more', 'company', 'assumption_underlie_expectation_realize', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['contact', 'investor_medium'], ['approve', 'ivacaftor', 'first', 'only', 'medicine_treat_underlying', 'cause_cystic_fibrosis', 'young', 'child'], ['vertex_pharmaceutical', 'today_announce', 'committee_medicinal_product', 'human_use_chmp', 'adopt_positive_opinion', 'ivacaftor', 'include', 'treatment', 'people_cystic_fibrosis', 'age_month', 'at_least', 'follow', 'mutation_cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr_gene'], ['issue', 'favorable', 'adoption', 'chmp_opinion', 'extension', 'indication', 'ivacaftor', 'first', 'only', 'medicine', 'approve', 'treat_underlying_cause', 'patient', 'age_month', 'specific', 'mutation', 'cftr', 'gene'], ['cystic', 'chronic', 'progressive', 'disease', 'present_birth', 'symptom', 'often', 'occur', 'infancy', 'so', 'early', 'treatment', 'crucial', 'deliver', 'good', 'possible', 'outcome', 'patient', 'say', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'today_announcement', 'mark_important', 'step', 'allow', 'young', 'patient', 'benefit', 'treatment', 'early_stage', 'disease', 'bring_step_close', 'goal', 'treat', 'people', 'live'], ['submission', 'support', 'datum', 'ongoing_phase_open', 'label_safety', 'study', 'arrival', 'child_aged', 'month', 'mutation', 'cftr', 'gene', 'demonstrate', 'safety_profile', 'consistent_observe', 'previous_phase', 'study', 'old_child_adult', 'improvement_sweat_chloride', 'key_secondary', 'efficacy_endpoint'], ['cystic_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people'], ['arrival', 'study', 'ongoing_phase_open', 'label_safety', 'study', 'child_aged', 'month', 'mutation', 'cftr', 'gene', 'patient', 'mutation', 'eligible', 'enroll', 'region', 'where', 'ivacaftor', 'approve', 'use', 'patient', 'year', 'age', 'mutation', 'study', 'demonstrate', 'safety_profile', 'consistent_observe', 'previous_phase', 'study', 'old_child_adult', 'most', 'adverse_event_mild_moderate', 'severity', 'patient', 'discontinue', 'adverse_event', 'treatment', 'interrupt', 'patient', 'elevate', 'liver_enzyme', 'great', 'time', 'upper', 'limit', 'normal', 'continue', 'receive', 'ivacaftor', 'dose', 'interruption', 'most_common', 'adverse_event', 'cough', 'elevate', 'aspartate', 'elevate', 'alanine', 'runny_nose', 'serious_adverse_event', 'observe', 'patient'], ['ivacaftor', 'first', 'medicine_treat_underlying', 'cause', 'people', 'specific', 'mutation', 'cftr', 'gene', 'know_cftr_potentiator', 'ivacaftor', 'oral', 'medicine', 'design_keep', 'cftr_protein', 'cell', 'surface_open', 'long_improve_transport', 'salt_water_cell', 'membrane_help_hydrate_clear', 'mucus_airway'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_third_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'vertex', 'experience', 'unforeseen', 'delay', 'obtain', 'marketing', 'approval', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium', 'seyfrie'], ['phase', 'result', 'triple_combination_regimen', 'concurrently', 'publish'], ['phase', 'arrival', 'datum', 'support', 'treat_underlying_cause', 'cystic_fibrosis', 'ivacaftor', 'as_early', 'month', 'age'], ['patient', 'report', 'outcome', 'datum', 'phase', 'evolve', 'expand', 'study', 'continue', 'support', 'clinical', 'benefit', 'symdeko', 'ivacaftor', 'ivacaftor'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'scientific', 'abstract', 'company', 'portfolio', 'cystic_fibrosis', 'medicine', 'present', 'american', 'cystic', 'take_place'], ['key', 'highlight', 'include', 'presentation', 'phase', 'datum', 'evaluate', 'clinical', 'safety_efficacy', 'as_well', 'datum', 'triple_combination_regimen', 'tezacaftor_ivacaftor', 'tezacaftor_ivacaftor', 'patient', 'mutation_minimal', 'function_mutation', 'patient', 'mutation', 'as_well', 'once_daily', 'triple_combination_regimen', 'tezacaftor', 'tezacaftor', 'patient', 'datum', 'study', 'also', 'publish', 'online', 'today'], ['phase', 'ivacaftor', 'datum', 'arrival', 'first', 'study', 'infant', 'month', 'old', 'cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr', 'gating_mutation', 'also', 'present'], ['datum', 'present', 'year', 'conference', 'reinforce', 'belief', 'treat_underlying_cause', 'early', 'life', 'modify', 'course', 'disease', 'demonstrate', 'rapid', 'progress', 'make', 'goal', 'develop', 'single', 'medicine_treat_underlying', 'cause', 'percent', 'people', 'devastating', 'disease', 'say_vice_president_chief', 'medical_officer'], ['presentation', 'highlight', 'include'], ['tezacaftor_ivacaftor', 'phase', 'triple_combination', 'result'], ['preliminary', 'safety_efficacy', 'triple_combination', 'cftr_modulator', 'iva', 'poster', 'thematic', 'poster', 'session', 'clinical', 'care', 'era', 'cftr_modulator', 'am', 'am', 'mt'], ['phase_randomize_double', 'blind', 'study', 'assess', 'combination_tezacaftor', 'ivacaftor', 'week', 'people', 'age_old', 'mutation', 'combination_tezacaftor', 'patient', 'age_old', 'mutation', 'primary_endpoint', 'include', 'safety_tolerability', 'as_well', 'efficacy', 'measure', 'mean_absolute', 'change', 'percent_predict', 'force_expiratory_volume_second', 'ppfev', 'from', 'baseline', 'secondary_endpoint', 'include', 'change', 'sweat_chloride', 'swcl', 'cystic_revise', 'respiratory_domain_score', 'rd'], ['study', 'meet_primary_endpoint', 'show', 'treatment', 'triple_combination_regiman', 'result', 'statistically_significant', 'clinically_meaningful', 'increase', 'lung_function', 'as_well', 'improvement_sweat_chloride', 'rd', 'improvement', 'patient', 'observe', 'when_add', 'people', 'already_receive', 'tezacaftor_ivacaftor', 'most', 'adverse_event_mild_moderate', 'severity', 'most_common_ae', 'group', 'cough', 'infective', 'pulmonary_exacerbation', 'cystic', 'oropharyngeal', 'pain', 'sputum', 'increase'], ['phase', 'eclipse', 'clinical_trial', 'program', 'assess', 'tezacaftor_ivacaftor', 'people', 'today', 'medicine_treat_underlying', 'cause', 'disease', 'mutation', 'currently', 'ongoing'], ['discovery', 'cftr_modulator', 'envision', 'highly', 'effective', 'cftr', 'modulation', 'therapy', 'modify', 'progression', 'disease', 'patient', 'say', 'chair', 'triple_combination', 'steer', 'committee', 'director', 'impressive', 'result', 'show', 'marked', 'improvement_lung_function', 'substantial', 'reduction', 'sweat_chloride', 'patient', 'del_mutation', 'demonstrate', 'important', 'step_close', 'achieve', 'goal'], ['tezacaftor_ivacaftor', 'phase', 'triple_combination', 'result'], ['preliminary', 'safety_efficacy', 'triple_combination', 'cftr_modulator', 'iva', 'poster', 'thematic', 'poster', 'session', 'clinical', 'care', 'era', 'cftr_modulator', 'am', 'am', 'mt'], ['phase_randomize_double', 'blind', 'study', 'assess', 'combination_tezacaftor', 'ivacaftor', 'week', 'people', 'age_old', 'mutation', 'combination_tezacaftor', 'patient', 'age_old', 'mutation', 'primary_endpoint', 'include', 'safety_tolerability', 'as_well', 'efficacy', 'measure', 'mean_absolute_change_ppfev', 'baseline', 'secondary_endpoint', 'include', 'change', 'rd'], ['study', 'meet_primary_endpoint', 'show', 'treatment', 'triple_combination_regiman', 'result', 'statistically_significant', 'clinically_meaningful', 'increase', 'lung_function', 'as_well', 'improvement_sweat_chloride', 'rd', 'improvement', 'patient', 'observe', 'when_add', 'people', 'already_receive', 'tezacaftor_ivacaftor', 'most', 'adverse_event_mild_moderate', 'severity', 'most_common_ae', 'include', 'cough', 'sputum', 'increase', 'infective', 'pulmonary_exacerbation', 'cystic_fibrosis'], ['phase', 'clinical_trial', 'program', 'assess', 'ivacaftor', 'people', 'today', 'medicine_treat_underlying', 'cause', 'disease', 'mutation', 'ongoing'], ['result', 'study', 'truly', 'exciting', 'represent', 'potential', 'regimen', 'provide', 'significant', 'clinical', 'benefit', 'even', 'more', 'people', 'say', 'co', 'chair', 'triple_combination', 'steer', 'committee', 'associate', 'professor', 'department', 'medicine', 'division', 'medical', 'director', 'clinical', 'research', 'service', 'co', 'director', 'director', 'jewish', 'health'], ['result', 'phase', 'arrival', 'study', 'infant', 'age_month'], ['ivacaftor', 'treatment', 'patient', 'month', 'old', 'cftr', 'gating_mutation', 'result', 'phase', 'part', 'single_arm', 'study', 'poster', 'duringposter', 'session', 'am', 'pm'], ['result', 'ongoing', 'open_label', 'phase', 'arrival', 'study', 'infant', 'aged_month', 'cftr', 'gating_mutation', 'show', 'treatment', 'week', 'generally', 'safe', 'well_tolerate', 'result', 'substantial_improvement', 'sweat_chloride', 'secondary_endpoint', 'indicate', 'improved', 'cftr', 'function', 'additionally', 'patient', 'treat', 'increase', 'fecal', 'elastase', 'reduction', 'immunoreactive', 'trypsin', 'trypsinogen', 'lipase', 'amylase', 'level', 'exploratory', 'endpoint', 'suggest', 'pancreatic', 'benefit', 'early', 'life'], ['total', 'patient', 'enrol', 'safety', 'portion', 'study', 'mean_sweat_chloride', 'mmol', 'baseline', 'follow', 'week', 'treatment', 'safety_profile', 'consistent_observe', 'previous_phase', 'study', 'old_child_adult', 'most', 'ae', 'mild_moderate_severity', 'patient', 'discontinue', 'treatment', 'most_common_ae', 'patient', 'cough', 'sae', 'tract_infection', 'viral', 'rash', 'cough', 'occur', 'patient', 'assess', 'related', 'unlikely', 'related', 'treatment', 'mean_sweat_chloride', 'level', 'reduce', 'mmol', 'mmol', 'patient', 'baseline_week', 'sweat_chloride', 'measurement', 'sweat_chloride', 'use', 'tool', 'diagnose', 'where', 'level', 'great', 'equal', 'mmol', 'indicate', 'likely', 'level', 'mmol', 'indicate', 'possible', 'level', 'less', 'indicate', 'unlikely'], ['study', 'ongoing', 'infant', 'young', 'month', 'old', 'datum', 'support', 'plan', 'submission', 'food', 'child', 'age_month', 'later', 'year'], ['cause_defective_missing', 'cftr_protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'mid_late'], ['ivacaftor', 'first', 'medicine_treat_underlying', 'cause', 'people', 'specific', 'mutation', 'cftr', 'gene', 'know_cftr_potentiator', 'oral', 'medicine', 'design_keep', 'cftr_protein', 'cell', 'surface_open', 'long_improve_transport', 'salt_water_cell', 'membrane_help_hydrate_clear', 'mucus', 'available', 'mg', 'tablet', 'adult_pediatric', 'patient', 'age_year_old', 'take', 'fat', 'contain', 'food', 'also', 'available', 'mg', 'oral', 'granule', 'weight', 'base', 'dosing', 'pediatric', 'patient', 'age', 'less', 'year', 'administer', 'soft', 'food', 'liquid', 'fat', 'contain', 'food'], ['found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row', 'additional', 'information', 'late', 'update', 'company', 'visit_wwwvrtxcom'], ['initiate', 'research', 'program', 'part', 'collaboration', 'nonprofit_drug_discovery', 'development', 'affiliate', 'ivacaftor', 'lumacaftor_ivacaftor', 'ivacaftor', 'ivacaftor', 'discover', 'vertex', 'part', 'collaboration'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'fourth', 'eighth', 'twelfth', 'paragraph_press_release', 'statement', 'regard', 'ongoing', 'clinical_trial', 'include', 'phase', 'eclipse', 'trial', 'phase', 'trial', 'phase', 'arrival', 'trial', 'patient', 'less_month', 'age', 'plan', 'regulatory_submission', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'datum', 'company', 'development', 'program_support_registration_further', 'development_compound', 'safety_efficacy_other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version_news'], ['pharmaceutical_incorporate_investor_medium'], ['vertex_pharmaceutical_incorporate', 'report', 'third_quarter', 'financial', 'result', 'financial', 'market', 'close', 'company', 'host_conference_call_webcast', 'pm_access_call_dial', 'international'], ['source_version'], ['company', 'focus', 'create_transformative', 'gene', 'base', 'medicine', 'serious_disease', 'vertex_pharmaceutical_incorporate_today', 'announce', 'food', 'lift', 'clinical', 'hold', 'accept', 'investigational', 'new', 'drug_application', 'treatment', 'sickle', 'cell', 'disease', 'investigational_autologous_gene_edit', 'hematopoietic_stem', 'cell', 'therapy', 'patient', 'suffer_severe'], ['addition', 'acceptance', 'announce_today', 'crispr', 'previously', 'announce', 'obtain_approval', 'clinical_trial', 'application', 'multiple', 'country', 'thalassemia', 'scd', 'company', 'remain', 'track', 'initiate', 'phase', 'clinical', 'study', 'scd', 'end', 'currently', 'enrol', 'patient', 'transfusion_dependent', 'thalassemia', 'phase', 'trial', 'thalassemia'], ['investigational', 'vivo_gene_edit', 'therapy', 'patient', 'suffer', 'thalassemia_sickle', 'cell', 'disease', 'patient', 'hematopoietic_stem', 'cell', 'engineer_produce_high_level', 'fetal_hemoglobin_red_blood', 'cell', 'form_oxygen', 'carrying', 'hemoglobin_naturally', 'present_birth', 'then', 'replace', 'adult_form', 'hemoglobin_elevation', 'hbf_potential', 'alleviate_transfusion', 'requirement', 'thalassemia', 'patient', 'painful_debilitate_sickle_crisis', 'sickle', 'cell', 'patient'], ['develop', 'co', 'development', 'co', 'agreement', 'vertex', 'company', 'obtain_approval', 'clinical_trial', 'application', 'multiple', 'country', 'thalassemia_sickle', 'cell', 'disease', 'scd'], ['forward_look_statement', 'certain', 'statement', 'set', 'press_release', 'constitute_forward_look', 'statement_meaning', 'private_security_amend', 'include', 'limit', 'statement', 'concern', 'timing', 'filing', 'clinical_trial', 'application', 'ind', 'approval', 'thereof', 'timing', 'commencement', 'clinical_trial', 'intellectual_property', 'coverage', 'position', 'therapeutic', 'licensor', 'third_party', 'sufficiency_cash', 'resource', 'therapeutic', 'value', 'development', 'commercial', 'potential', 'gene_edit', 'technology', 'therapy', 'caution_forward_look', 'statement_inherently_uncertain', 'believe', 'such', 'statement_base_reasonable', 'assumption_bound_knowledge_business', 'operation', 'forward_look_statement', 'promise_guarantee_necessarily_subject', 'high_degree', 'uncertainty', 'risk', 'actual_performance', 'result_differ', 'materially_project_suggest', 'forward_look_statement', 'due_various_risk_uncertainty', 'risk_uncertainty', 'include', 'other', 'uncertainty', 'regard_intellectual_property', 'protection_technology_intellectual_property', 'belong_third', 'party', 'uncertainty', 'inherent', 'initiation_completion', 'preclinical', 'study', 'product_candidate', 'availability_timing', 'result', 'preclinical', 'study', 'result', 'preclinical', 'trial', 'predictive_future', 'result', 'future', 'trial', 'expectation', 'regulatory_approval', 'conduct', 'trial', 'market', 'product', 'risk_uncertainty', 'describe_heading_risk_factor', 'most_recent', 'annual_report_form', 'other', 'subsequent_filing_make', 'therapeutic', 'available_website_existing', 'prospective_investor_caution_place', 'undue_reliance', 'forward_look_statement', 'speak_only_date', 'make_disclaim_obligation', 'undertaking_update_revise', 'forward_look_statement', 'contain_press_release', 'other_extent', 'require_law'], ['found_headquarters_now_locate', 'innovation_district', 'today', 'company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row'], ['investor_contact'], ['source', 'pharmaceutical_incorporate'], ['news', 'provide', 'acquire', 'medium'], ['first', 'kind', 'contract', 'danish', 'pharmaceutical', 'procurement', 'organization', 'effective', 'today'], ['also', 'announce', 'reimbursement', 'lumacaftor_ivacaftor', 'treat', 'patient', 'age', 'copy_mutation'], ['vertex_pharmaceutical', 'today_announce', 'enter', 'innovative', 'access', 'contract', 'danish', 'pharmaceutical', 'procurement', 'organization', 'amgro', 'effective', 'today', 'first', 'kind', 'contract', 'include', 'current', 'future', 'cftr_modulator', 'medicine', 'mean', 'eligible', 'danish', 'cystic_fibrosis', 'patient', 'access', 'current', 'medicine', 'as_well', 'future', 'medicine', 'regulatory_approval'], ['be', 'delighted', 'collaborate', 'amgro', 'finalize', 'pioneering', 'contract', 'say_fenaux', 'senior', 'international', 'commercial', 'operation', 'vertex', 'medicine', 'fundamentally', 'change', 'way', 'treat', 'share', 'community', 'sense', 'urgency', 'rapid', 'access', 'contract', 'also', 'allow', 'dane', 'first', 'world', 'access', 'future', 'cftr_modulator', 'medicine'], ['like_thank', 'vertex', 'will', 'engagement', 'make', 'deal', 'most', 'be', 'happy', 'make', 'possible', 'offer', 'group', 'patient', 'new', 'treatment', 'naturally', 'be', 'also', 'enthusiastic', 'new', 'kind', 'contract', 'give', 'danish', 'hospital', 'owner', 'region', 'much', 'more', 'predictable', 'budget', 'time', 'rise', 'cost', 'hospital', 'medicine', 'say', 'amgro'], ['early', 'month', 'agreement', 'also', 'secure', 'provide', 'access_orkambi_lumacaftor', 'ivacaftor', 'child', 'age', 'copy_mutation', 'agreement', 'also', 'effective', 'today'], ['dane', 'patient', 'other', 'country_world', 'access_cftr_modulator', 'treatment', 'include'], ['cause_defective_missing', 'cystic_fibrosis', 'transmembrane_conductance', 'regulator_cftr', 'protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead', 'build', 'up', 'abnormally_thick', 'sticky_mucus', 'cause', 'chronic_lung_infection_progressive', 'lung_damage_many', 'patient', 'eventually_lead_death_median', 'age_death', 'mid_late'], ['combination_lumacaftor', 'design_increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'cftr_protein', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface', 'lumacaftor_ivacaftor', 'available', 'tablet', 'typically', 'take', 'twice', 'day'], ['found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement', 'second', 'third_paragraph_press_release', 'believe_forward_look_statement', 'contain_press_release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'commercialize', 'product', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['source', 'limit'], ['pharmaceutical_incorporate_investor'], ['medium'], [], ['vertex_pharmaceutical_incorporate_today', 'announce', 'management', 'present', 'pm'], ['audio', 'portion', 'remark', 'available', 'live', 'website_wwwvrtxcom_investor_section', 'news', 'event_page', 'replay', 'conference', 'webcast_archive', 'company', 'website'], ['found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row', 'additional', 'information', 'late', 'update', 'company', 'visit_wwwvrtxcom'], ['source_version'], ['oversee', 'global', 'effort', 'lead', 'vertex', 'foundation'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'appoint', 'head', 'corporate', 'social', 'responsibility', 'role', 'oversee', 'aspect', 'global', 'effort', 'lead', 'corporate', 'give', 'commitment', 'focus', 'provide', 'patient', 'caregiver', 'support', 'include', 'access', 'medicine', 'expand', 'commitment', 'science', 'technology', 'engineering', 'art', 'math', 'steam', 'education', 'develop', 'young', 'physician', 'scientist', 'invest', 'community', 'also', 'serve', 'executive', 'director', 'foundation', 'organization', 'long_term', 'source', 'charitable', 'giving'], ['delighted', 'welcome', 'vertex', 'family', 'begin', 'next', 'chapter', 'effort', 'give', 'back', 'patient', 'community', 'say_chief_executive_officer', 'vertex', 'depth', 'experience', 'create', 'launching', 'manage', 'successful', 'program', 'combine', 'strong', 'business', 'acuman', 'passion', 'change', 'life', 'make', 'tremendous', 'addition', 'team', 'look', 'expand', 'corporate', 'giving', 'initiative'], ['deeply', 'commit', 'patient', 'community', 'stakeholder', 'evidence', 'corporate', 'give', 'commitment', 'creation', 'say', 'together', 'partner', 'colleague', 'look_forward', 'advance', 'program', 'achieve', 'even', 'great', 'impact'], ['accomplished', 'executive', 'year', 'international', 'experience', 'prior', 'join', 'spend', 'year', 'lead', 'global', 'effort', 'laboratory', 'responsible', 'reporting', 'stakeholder', 'engagement', 'create', 'award', 'win', 'volunteer', 'philanthropy', 'sustainability', 'initiative', 'leadership', 'industry', 'leader', 'previously', 'work', 'worldwide', 'where', 'advise', 'fortune', 'client', 'program', 'receive', 'mba'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_life_threaten', 'disease', 'addition', 'clinical', 'development', 'program', 'more', 'dozen', 'ongoing', 'research', 'program', 'focus', 'underlie', 'mechanism', 'other', 'serious_disease', 'found_headquarters_now_locate', 'district_today_company', 'research', 'development', 'site_commercial_office_consistently', 'recognize_industry_top_place', 'work', 'include', 'name_science_magazine_top', 'employer_life_science_rank', 'year_row'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['expect', 'late', 'phase_study', 'tezacaftor_ivacaftor', 'people_mutation_minimal', 'function_mutation_people_del', 'mutations'], ['enrollment', 'phase_study', 'triple_combination_tezacaftor_ivacaftor', 'expect', 'complete', 'fourth_quarter', 'datum', 'study', 'tezacaftor_ivacaftor', 'expect', 'first_quarter'], ['plan', 'evaluate', 'triple_combination', 'datum', 'choose_good_regiman_submit', 'potential', 'regulatory_approval', 'submission', 'new', 'drug_application', 'plan', 'later'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'enrollment', 'complete', 'phase_study', 'next_generation_corrector', 'triple_combination_tezacaftor_ivacaftor', 'people_cystic_fibrosis', 'mutation_minimal', 'function_mutation', 'people', 'mutation', 'base', 'completion_enrollment', 'vertex', 'expect', 'report', 'datum', 'phase_study', 'triple_combination_regiman', 'late', 'vertex', 'expect', 'complete_enrollment', 'phase_study', 'next_generation_corrector', 'triple_combination_tezacaftor_ivacaftor', 'fourth_quarter', 'report', 'datum', 'study', 'first_quarter', 'vertex', 'plan', 'evaluate', 'datum', 'phase', 'triple_combination', 'program', 'choose_good_regiman_submit', 'potential', 'regulatory_approval', 'datum', 'expect', 'late', 'first_quarter', 'expect', 'provide', 'basis', 'submission', 'new', 'drug_application', 'people_mutation_minimal', 'function_mutation', 'no', 'later', 'mid'], ['phase_study', 'tezacaftor_ivacaftor', 'enrol', 'nearly', 'people', 'less_month', 'underscore', 'significant', 'interest', 'community', 'advance', 'triple_combination_regimen', 'potential', 'treat', 'percent', 'people', 'disease', 'global', 'medicine', 'development_medical_affair', 'chief_medical_officer', 'goal_bring', 'good', 'triple_combination_regiman', 'people', 'as_quickly_possible', 'look_forward', 'obtain', 'datum', 'later', 'year', 'first_quarter', 'support', 'submission', 'potential', 'approval', 'triple_combination_regiman'], ['phase_study', 'triple_combination_regiman', 'patient', 'mutation_minimal', 'function_mutation', 'design', 'pre_specified_interim_analysis', 'evaluate', 'primary_endpoint', 'ppfev', 'week', 'safety', 'week', 'interim_analysis', 'conduct', 'once', 'patient', 'primary_efficacy', 'endpoint', 'week', 'efficacy_safety', 'datum', 'interim_analysis', 'expect', 'late', 'intend', 'support', 'potential', 'submission', 'tezacaftor_ivacaftor', 'triple_combination_regiman', 'people_mutation_minimal', 'function_mutation'], ['similar', 'interim_analysis', 'triple_combination_regimen', 'phase_study', 'triple_combination_regiman', 'patient', 'mutation_minimal', 'function_mutation', 'design', 'pre_specified_interim_analysis', 'evaluate', 'primary_endpoint', 'ppfev', 'week', 'safety', 'week', 'interim_analysis', 'also', 'conduct', 'once', 'patient', 'primary_efficacy', 'endpoint', 'week', 'datum', 'interim_analysis', 'expect', 'first_quarter', 'interim_analysis', 'triple_combination_regimen', 'enable', 'vertex', 'evaluate', 'comparable', 'datum', 'phase', 'triple_combination', 'program', 'determine', 'good_regiman', 'submit', 'potential', 'regulatory_approval'], ['preserve', 'integrity', 'phase_study', 'tezacaftor_ivacaftor', 'phase_study', 'tezacaftor_ivacaftor', 'ongoing', 'mid', 'vertex', 'expect', 'disclose', 'late', 'first_quarter', 'only', 'topline', 'result', 'primary_efficacy', 'endpoint', 'phase_study', 'respectively', 'safety_efficacy', 'profile', 'observe', 'support', 'potential', 'submission', 'second_half', 'vertex', 'intend', 'disclose', 'additional', 'safety_efficacy', 'datum', 'include', 'secondary_endpoint', 'study', 'follow', 'completion', 'phase', 'triple_combination', 'program'], ['phase_study', 'people_mutation_minimal', 'function_mutation', 'ongoing', 'randomize_double_blind_placebo', 'control', 'phase_study', 'evaluate', 'triple_combination_tezacaftor_ivacaftor', 'triple_placebo', 'patient', 'age_old', 'mutation_minimal', 'function_mutation', 'primary_endpoint', 'study', 'mean_absolute', 'change', 'percent_predict', 'force_expiratory_volume_second', 'ppfev_baseline', 'week', 'triple_combination_treatment', 'compare', 'triple_placebo', 'study', 'design', 'include', 'pre_specified_interim_analysis', 'evaluate', 'primary_endpoint', 'week', 'safety', 'week', 'interim_analysis', 'conduct', 'once', 'patient', 'primary_efficacy', 'endpoint', 'week', 'datum', 'expect', 'form', 'basis', 'potential', 'submission', 'people_mutation_minimal', 'function_mutation', 'study', 'evaluate', 'combination_tezacaftor', 'ivacaftor', 'total', 'week', 'treatment', 'generate', 'additional', 'safety', 'datum', 'datum', 'key_secondary_endpoint', 'include', 'number', 'pulmonary_exacerbation', 'change', 'body', 'mass', 'index', 'change', 'sweat_chloride', 'change', 'patient', 'report', 'outcome', 'measure', 'respiratory_domain_score', 'cystic_revise', 'other'], ['phase_study', 'people', 'mutation', 'randomized_double', 'blind', 'control', 'phase_study', 'evaluate', 'week', 'treatment', 'placebo', 'combination_tezacaftor', 'ivacaftor', 'patient', 'age_year_old', 'del_mutation', 'patient', 'receive_tezacaftor', 'combination', 'ivacaftor', 'run', 'in', 'prior', 'start', 'triple_combination_treatment', 'period', 'primary_endpoint', 'study', 'mean_absolute_change_ppfev', 'baseline', 'end', 'tezacaftor_ivacaftor', 'run', 'week', 'treatment', 'triple_combination_tezacaftor_ivacaftor', 'compare', 'receive', 'placebo', 'tezacaftor_ivacaftor'], ['phase_study', 'expect', 'complete_enrollment', 'fourth_quarter', 'phase_study', 'evaluate', 'triple_combination_tezacaftor_ivacaftor', 'people_mutation_minimal', 'function_mutation_people_del', 'mutation', 'study', 'design', 'include', 'pre_specified_interim_analysis', 'study', 'people_mutation_minimal', 'function_mutation', 'same', 'use', 'phase', 'program', 'note', 'above'], ['rare_life_shorten_genetic', 'disease', 'affect_approximately', 'people'], ['cause_defective_missing', 'cftr_protein', 'result', 'mutation', 'cftr', 'gene_child_inherit', 'defective_cftr', 'gene_parent', 'cf_approximately_know', 'mutation', 'cftr', 'gene', 'mutation_determine', 'genetic_test_genotype_test', 'lead', 'create_non_working', 'too_few_cftr_protein', 'cell', 'surface_defective_function_absence', 'cftr_protein_result_poor', 'flow_salt_water', 'cell', 'number_organ', 'lung_lead_buildup_abnormally', 'thick_sticky', 'mucus_cause_chronic_lung', 'infection_progressive_lung_damage', 'many', 'patient', 'eventually_lead_death_median', 'age_death', 'mid_late'], ['collaborative', 'history', 'cystic', 'initiate', 'research', 'program', 'part', 'collaboration', 'nonprofit_drug_discovery', 'development', 'affiliate', 'ivacaftor', 'lumacaftor_ivacaftor', 'tezacaftor_ivacaftor', 'ivacaftor', 'discover', 'vertex', 'part', 'collaboration'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include', 'statement_second_paragraph', 'information', 'provide', 'regard', 'timing', 'expect', 'datum', 'phase_study', 'timing', 'expect', 'completion_enrollment', 'phase_study', 'company', 'expectation', 'evaluate', 'datum', 'choose_good_regiman_submit', 'potential', 'regulatory_approval', 'no', 'later', 'mid', 'information', 'regard', 'plan', 'interim_analysis', 'information', 'regard', 'timing', 'type', 'datum', 'company', 'intend', 'disclose', 'phase_study', 'believe_forward_look_statement', 'contain_press_release_accurate', 'forward_look_statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include', 'datum', 'phase', 'development', 'program_support', 'continue', 'development', 'approval', 'company', 'triple_combination_regimen', 'due_safety_efficacy', 'other_reason', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file_available', 'company_website_disclaim', 'obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['pharmaceutical_incorporate_investor_medium'], ['approximately', 'patient', 'join', 'thousand', 'patient', 'worldwide', 'already', 'access', 'lumacaftor_ivacaftor'], ['pathway', 'access', 'future', 'vertex', 'ivacaftor', 'also', 'establish'], ['vertex_pharmaceutical', 'limited', 'announce', 'finalization', 'agreement', 'australian', 'government', 'allow', 'reimbursement', 'lumacaftor_ivacaftor', 'people', 'age', 'over', 'cystic_fibrosis', 'copy_mutation', 'cystic_fibrosis_regulator_cftr', 'gene', 'agreement', 'mean', 'lumacaftor_ivacaftor', 'list', 'pharmaceutical', 'benefit', 'scheme', 'follow', 'positive', 'recommendation', 'pharmaceutical', 'pathway', 'access', 'future', 'vertex', 'ivacaftor', 'establish', 'part', 'process'], ['delighted', 'lumacaftor_ivacaftor', 'make', 'available', 'eligible', 'patient', 'say_executive_vice', 'president_chief', 'commercial', 'officer', 'like', 'recognize', 'pbac', 'see', 'value', 'medicine', 'acknowledge', 'active', 'engagement', 'willingness', 'finalize', 'agreement', 'rapidly'], ['australian', 'join', 'thousand', 'patient', 'worldwide', 'already_receive', 'lumacaftor_ivacaftor', 'country', 'where', 'lumacaftor_ivacaftor', 'reimburse', 'include'], ['cystic_fibrosis_rare_life', 'shorten_genetic_disease', 'affect_approximately', 'people', 'include', 'country', 'as_well'], ['combination_lumacaftor', 'design_increase_amount', 'mature_protein', 'cell', 'surface_target_processing', 'trafficking_defect', 'cftr_protein', 'ivacaftor', 'design_enhance', 'function_cftr_protein', 'reach', 'cell', 'surface', 'lumacaftor_ivacaftor', 'available', 'tablet', 'typically', 'take', 'twice', 'day'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk', 'relate', 'commercialize', 'orkambi', 'other_risk_list', 'risk_factor_annual_report', 'quarterly_report_file', 'disclaim_obligation_update_information', 'contain_press_release', 'new_information_become', 'available'], ['source_version'], ['multi', 'year', 'collaboration', 'combine', 'expertise', 'genomic', 'machine', 'learning', 'drug_discovery', 'identify', 'novel', 'target', 'innovative', 'medicine'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'year', 'collaboration', 'extendable', 'year', 'use', 'human', 'genetic', 'machine_learn', 'improve', 'discovery', 'target', 'precision_medicine', 'advance', 'understanding', 'clinical', 'impact', 'human', 'genetic', 'variation', 'patient', 'stratification', 'disease', 'significant', 'unmet_need', 'goal', 'collaboration', 'further', 'advance', 'vertex', 'effort', 'develop', 'transformative', 'precision_medicine', 'people', 'serious_disease'], ['press_release_feature_view', 'full', 'release', 'here'], ['develop', 'unique', 'analysis', 'engine', 'use', 'genetic', 'understand', 'human_biology', 'likely', 'efficacy_safety', 'potential', 'novel', 'medicine', 'genomic', 'engine', 'large', 'kind', 'world', 'datum', 'point', 'link', 'human', 'genetic', 'variation', 'position', 'human', 'genome', 'change', 'molecular', 'cellular', 'physiological', 'measurement', 'disease', 'outcome', 'company', 'use', 'proprietary', 'machine', 'learning', 'statistical', 'algorithm', 'predict', 'impact', 'therapeutic', 'intervention'], ['human_biology', 'genetic', 'foundation', 'drug_discovery', 'vertex', 'team', 'genomic', 'bring', 'together', 'unique', 'combination', 'sophisticated', 'datum', 'science', 'human', 'genetic', 'say', 'executive', 'research', 'chief_scientific', 'officer', 'vertex', 'partnership', 'pioneer', 'new', 'use', 'genomic', 'tool', 'technology', 'advance', 'ongoing', 'work', 'investment', 'research', 'site', 'globally', 'bring', 'new', 'medicine', 'patient', 'need'], ['human', 'already', 'show', 'substantial', 'impact', 'success', 'novel', 'drug', 'target', 'next_generation', 'datum', 'algorithm', 'promise', 'transformative', 'just', 'target', 'discovery', 'biomarker', 'selection', 'patient', 'stratification', 'say', 'donnelly', 'founder', 'chief_executive', 'delighted', 'partner', 'most', 'innovative', 'successful', 'company', 'global', 'biotech', 'sector', 'help', 'realise', 'promise', 'benefit', 'patient', 'family'], ['scientist', 'vertex', 'genomic', 'work_closely', 'together', 'incorporate', 'deep_understanding', 'human', 'genetic', 'research', 'development', 'relate', 'target', 'discovery', 'target', 'validation', 'certain', 'disease', 'company', 'also', 'opportunity', 'suggest', 'additional', 'disease', 'collaboration', 'where', 'human', 'genetic', 'evidence', 'particularly', 'powerful'], ['addition', 'fund', 'resource', 'commit', 'genomic', 'collaboration', 'vertex', 'make', 'milestone_royalty', 'payment', 'company', 'novel', 'target', 'result', 'collaboration', 'take', 'clinical', 'development', 'also', 'join', 'director'], ['additionally', 'make', 'equity_investment', 'part', 'series', 'funding', 'round', 'also', 'announce_today'], ['global_biotechnology', 'company', 'invest_scientific_innovation_create', 'transformative_medicine_people', 'serious_life_threaten', 'disease', 'addition', 'clinical', 'development', 'program', 'cystic_fibrosis', 'vertex', 'more', 'dozen', 'ongoing', 'research', 'program', 'focus', 'underlie', 'mechanism', 'other', 'serious_disease'], [], ['lead', 'genome', 'analysis', 'company', 'form', 'lead', 'scientist', 'include', 'professor', 'donnelly', 'then', 'director', 'centre', 'human', 'genetic', 'director', 'vision', 'use', 'genomic', 'insight', 'transform', 'drug_discovery', 'industry', 'get', 'well', 'drug', 'develop', 'more', 'quickly', 'target', 'right', 'group', 'patient'], ['individual', 'carry', 'unique', 'set', 'genetic_variant', 'many', 'variant', 'change', 'aspect', 'biology', 'powerful', 'idea', 'underpin', 'company', 'work', 'understand', 'consequence', 'propose', 'drug', 'one', 'look', 'individual', 'happen', 'carry', 'genetic_variant', 'affect', 'same', 'part', 'biology', 'drug', 'human', 'genetic', 'approach', 'allow', 'genomic', 'learn', 'human_biology', 'directly', 'human', 'rather', 'have', 'rely', 'model', 'system', 'lead', 'drug', 'target', 'fail', 'when', 'test', 'human'], ['develop', 'large', 'platform', 'kind', 'world', 'link', 'genetic_variant', 'change', 'thousand', 'measurement', 'disease', 'outcome', 'together', 'breakthrough', 'machine_learn', 'algorithm', 'use', 'datum', 'scale', 'learn', 'directly', 'human_biology'], ['back', 'lead', 'investor', 'life_science', 'genomic', 'expert', 'cross', 'disciplinary', 'team', 'people', 'primarily', 'scientist', 'software', 'engineer', 'office'], ['additional', 'information_visit'], ['press_release_contain', 'forward_look_statement_define', 'private_security_include_limitation', 'statement_second_paragraph', 'press_release', 'donnelly', 'statement_third_paragraph', 'press_release_believe_forward', 'look_statement_contain_press', 'release_accurate_forward_look', 'statement_represent', 'company_belief_only', 'date_press_release', 'number_factor_cause_actual', 'event_result_differ', 'materially_indicate_such', 'forward_look_statement', 'risk_uncertainty', 'include_other_thing', 'risk_list_risk_factor', 'annual_report_quarterly_report', 'file_available_company', 'website_disclaim_obligation_update', 'information_contain_press', 'release', 'new_information_become', 'available'], ['source_version'], ['investor_medium'], ['lead', 'expand', 'international', 'organization'], ['announce', 'retirement'], ['vertex_pharmaceutical_incorporate_today', 'announce', 'ludovic', 'fenaux', 'appoint', 'senior_vice', 'international', 'commercial', 'operation', 'responsibility', 'commercial', 'activity', 'include', 'oversee', 'office', 'operation', 'start', 'role', 'vertex', 'report', 'stuart', 'arbuckle', 'executive_vice_president_chief', 'commercial', 'officer', 'base', 'international_headquarters', 'succeed', 'retire', 'year', 'senior_vice_president', 'general', 'manager', 'commercial', 'operation', 'nearly', 'year', 'pharmaceutical', 'industry'], ['join', 'successfully', 'lead', 'global', 'expansion', 'include', 'establishment', 'company', 'international_headquarters', 'commercial_office', 'operation'], ['like_thank', 'leadership', 'dedication', 'enormous', 'contribution', 'play', 'pivotal', 'role', 'growth', 'company', 'internationally', 'wish', 'good', 'retirement', 'say_executive_vice', 'president_chief', 'commercial', 'officer', 'also', 'thrill', 'welcome', 'ludovic', 'vertex', 'global', 'commercial', 'leadership_team', 'ludovic', 'bring', 'leadership', 'skill', 'functional', 'geographic', 'experience', 'grow', 'international', 'organization', 'need', 'become', 'lead', 'global_biotechnology', 'company'], ['join', 'more', 'decade', 'pharmaceutical', 'industry', 'experience', 'most', 'recently', 'where', 'hold', 'position', 'senior_vice_president', 'head'], ['excited', 'join', 'vertex', 'time', 'when', 'company', 'only', 'pursue', 'medicine', 'treat_cystic_fibrosis', 'also', 'invest', 'other', 'serious_disease', 'tackle', 'big', 'challenge', 'medicine', 'say', 'look_forward', 'part', 'industry', 'leader', 'drive', 'understanding', 'human_biology', 'progress', 'scientific_innovation', 'address_underlie', 'cause', 'disease'], ['ludovic', 'addition', 'leadership', 'position', 'senior_vice_president', 'head', 'region', 'head', 'specialty', 'care', 'head', 'commercial', 'virology', 'transplant', 'vice_president', 'general', 'manager', 'benelux', 'global', 'oncology'], ['prior', 'join', 'hold', 'position', 'hold', 'master', 'science', 'degree', 'biochemistry', 'advanced', 'master', 'marketing', 'management', 'school', 'addition', 'have', 'complete', 'general', 'management', 'program', 'executive', 'development', 'cedep', 'graduate', 'advance', 'management', 'program'], ['source_version_home'], ['pharmaceutical_incorporate_investor_medium', 'seyfrie'], ['drive', 'innovate'], [], ['aspire', 'write', 'future', 'cell', 'therapy', 'focus', 'position', 'pioneer', 'treatment', 'uniquely', 'qualified', 'change', 'life', 'people', 'live_serious_chronic', 'disease', 'work', 'develop', 'treatment', 'disease', 'advance', 'dry_age', 'relate_macular_degeneration', 'chronic', 'heart_failure', 'type_diabetes', 'potential', 'halt', 'disease', 'progression', 'even', 'reverse', 'collaborate', 'good', 'world', 'aim', 'accelerate', 'research', 'need', 'develop', 'transformative', 'cell', 'therapy', 'fast', 'live_serious_chronic', 'disease', 'drive', 'change', 'shape', 'future', 'where', 'people', 'propel', 'aspiration', 'rather', 'limit', 'day', 'breakthrough', 'come', 'close', 'achieve', 'together'], ['aspire', 'write', 'future', 'cell', 'therapy'], ['focus', 'position', 'pioneer', 'treatment', 'uniquely', 'qualified', 'change', 'life', 'people', 'live_serious_chronic', 'disease', 'work', 'develop', 'treatment', 'disease', 'advance', 'dry_age', 'relate_macular_degeneration', 'chronic', 'heart_failure', 'type_diabetes', 'potential', 'halt', 'disease', 'progression', 'even', 'reverse'], ['collaborate', 'good', 'world', 'aim', 'accelerate', 'research', 'need', 'develop', 'transformative', 'cell', 'therapy', 'fast', 'live_serious_chronic', 'disease', 'drive', 'change', 'shape', 'future', 'where', 'people', 'propel', 'aspiration', 'rather', 'limit'], ['day', 'breakthrough', 'come', 'close', 'achieve', 'together'], ['relentlessly', 'pursue', 'innovative', 'solution', 'most', 'prevalent', 'unmet', 'cell', 'therapy', 'offer', 'potential', 'therapeutic', 'option', 'halt', 'disease', 'progression', 'improve_motor', 'function', 'ability', 'participate', 'activity', 'daily', 'live', 'long', 'advance', 'dry_age', 'relate_macular_degeneration', 'damd', 'cell', 'therapy', 'solution', 'potentially', 'prevent', 'advanced_damd', 'progression', 'preserve', 'vision', 'otherwise', 'lose', 'disease', 'heart_failure', 'chf', 'cell', 'therapy', 'offer', 'people', 'chf', 'possibility', 'restore', 'heart', 'function', 'greatly', 'reduce', 'cardiovascular', 'event', 'such', 'heart_attack', 'type_diabetes', 'cell', 'therapy', 'offer', 'option', 'replace', 'insulin_produce_islet', 'cell', 'lose'], ['relentlessly', 'pursue', 'innovative', 'solution', 'most', 'prevalent', 'unmet', 'cell', 'therapy', 'offer', 'potential', 'therapeutic', 'option', 'halt', 'disease', 'progression', 'improve_motor', 'function', 'ability', 'participate', 'activity', 'daily', 'live', 'long', 'advance', 'dry_age', 'relate_macular_degeneration', 'damd', 'cell', 'therapy', 'solution', 'potentially', 'prevent', 'advanced_damd', 'progression', 'preserve', 'vision', 'otherwise', 'lose', 'disease'], ['relentlessly', 'pursue', 'innovative', 'solution', 'most', 'prevalent', 'unmet', 'health', 'need'], ['cell', 'therapy', 'offer', 'potential', 'therapeutic', 'option', 'halt', 'disease', 'progression', 'improve_motor', 'function', 'ability', 'participate', 'activity', 'daily', 'live', 'long'], [], ['cell', 'therapy', 'offer', 'potential', 'therapeutic', 'option', 'halt', 'disease', 'progression', 'improve_motor', 'function', 'ability', 'participate', 'activity', 'daily', 'live', 'long'], ['advanced', 'dry_age', 'relate_macular_degeneration', 'damd', 'cell', 'therapy', 'solution', 'potentially', 'prevent', 'advanced_damd', 'progression', 'preserve', 'vision', 'otherwise', 'lose', 'disease'], ['advanced', 'dry_age', 'relate_macular_degeneration', 'damd'], ['cell', 'therapy', 'solution', 'potentially', 'prevent', 'advanced_damd', 'progression', 'preserve', 'vision', 'otherwise', 'lose', 'disease'], ['chronic', 'heart_failure', 'chf', 'cell', 'therapy', 'offer', 'people', 'chf', 'possibility', 'restore', 'heart', 'function', 'greatly', 'reduce', 'cardiovascular', 'event', 'such', 'heart_attack', 'type_diabetes', 'cell', 'therapy', 'offer', 'option', 'replace', 'insulin_produce_islet', 'cell', 'lose'], ['chronic', 'heart_failure', 'chf', 'cell', 'therapy', 'offer', 'people', 'chf', 'possibility', 'restore', 'heart', 'function', 'greatly', 'reduce', 'cardiovascular', 'event', 'such', 'heart_attack'], ['chronic', 'heart_failure', 'chf'], ['cell', 'therapy', 'offer', 'people', 'chf', 'possibility', 'restore', 'heart', 'function', 'greatly', 'reduce', 'cardiovascular', 'event', 'such', 'heart_attack'], ['type_diabetes', 'cell', 'therapy', 'offer', 'option', 'replace', 'insulin_produce_islet', 'cell', 'lose'], ['type_diabetes'], ['cell', 'therapy', 'offer', 'option', 'replace', 'insulin_produce_islet', 'cell', 'lose'], ['see', 'how', 'front_line', 'tap', 'therapeutic', 'potential', 'cell'], ['aspire', 'write', 'future', 'cell', 'therapy', 'commitment', 'cell', 'therapy', 'research', 'development', 'support', 'long_stand', 'heritage', 'deliver', 'innovative', 'treatment', 'patient', 'serious_chronic', 'disease'], ['aspire', 'write', 'future', 'cell', 'therapy'], ['aspire'], ['write'], ['future'], ['cell'], ['therapy'], ['commitment', 'cell', 'therapy', 'research', 'development', 'support', 'long_stand', 'heritage', 'deliver', 'innovative', 'treatment', 'patient', 'serious_chronic', 'disease'], ['focus', 'develop', 'deliver', 'transformative', 'cell', 'therapy', 'goal', 'reduce', 'global', 'burden', 'disease', 'empower', 'individual', 'community', 'aspire', 'more'], ['live', 'disease'], ['debilitate', 'progressive', 'disease', 'movement', 'quality_life', 'affect', 'such', 'thing', 'mood', 'sleep', 'progressive', 'aged', 'population', 'half', 'unable', 'live', 'independently', 'rely', 'heavily', 'supportive', 'care', 'currently', 'treatment_option', 'delay', 'halt', 'progression', 'work', 'expert', 'partner', 'accelerate', 'development', 'cell', 'therapy', 'aim', 'replace', 'neuron', 'lose', 'progression', 'innovative', 'investigational', 'cell', 'therapy', 'potential', 'restore', 'dopamine', 'goal', 'improve_motor', 'function', 'quality_life', 'people', 'live', 'engage', 'activity', 'daily', 'live', 'long', 'click_here', 'learn_more', 'story'], ['debilitate', 'progressive', 'disease', 'movement', 'quality_life', 'affect', 'such', 'thing', 'mood', 'sleep', 'progressive', 'aged', 'population', 'half', 'unable', 'live', 'independently', 'rely', 'heavily', 'supportive', 'care', 'currently', 'treatment_option', 'delay', 'halt', 'progression', 'work', 'expert', 'partner', 'accelerate', 'development', 'cell', 'therapy', 'aim', 'replace', 'neuron', 'lose', 'progression', 'innovative', 'investigational', 'cell', 'therapy', 'potential', 'restore', 'dopamine', 'goal', 'improve_motor', 'function', 'quality_life', 'people', 'live', 'engage', 'activity', 'daily', 'live', 'long'], ['live', 'chronic', 'heart_failure', 'denmark'], ['chronic', 'heart_failure', 'chf', 'progressive', 'disease', 'heart', 'unable', 'pump', 'sufficiently', 'meet', 'body', 'need', 'blood', 'oxygen', 'lead', 'symptom', 'such', 'severe', 'breathlessness', 'exhaustion', 'chest', 'pain', 'leave', 'many', 'patient', 'unable', 'perform', 'simple', 'daily', 'activity', 'chf', 'continue', 'impose', 'large', 'medical', 'economic', 'burden', 'option', 'available', 'treat', 'associated', 'cellular', 'damage', 'lead', 'reduced', 'heart', 'function', 'global', 'collaborator', 'work_together', 'unlock', 'potential', 'transformative', 'cell', 'therapy', 'change', 'treatment', 'paradigm', 'chf', 'goal', 'simple', 'ensure', 'people', 'chronic', 'disease', 'live', 'long', 'strengthen', 'heart', 'less', 'fatigue', 'high_quality', 'life'], ['dry_age', 'relate_macular_degeneration', 'damd', 'lead', 'cause', 'blindness', 'old', 'adult', 'worldwide', 'treatment_option', 'available', 'slow', 'progression', 'more', 'advanced', 'stage', 'advanced_damd', 'pose', 'significant', 'threat', 'increasingly', 'age', 'population', 'harness', 'potential', 'cell', 'replace', 'retinal', 'pigment', 'epithelial', 'cell', 'lose', 'advanced_damd', 'network', 'cell', 'therapy', 'expert', 'work', 'future', 'where', 'halt', 'loss', 'vision', 'cause', 'disease'], ['type_diabetes', 'lifelong', 'disease', 'affect', 'body', 'ability', 'convert', 'glucose', 'food', 'energy', 'most', 'case', 'develop', 'early', 'life', 'often', 'diagnose', 'childhood', 'disease', 'start', 'when', 'immune_system', 'attack', 'cell', 'pancrea', 'produce_insulin', 'hormone', 'help', 'convert', 'glucose', 'energy', 'body', 'cell', 'goal', 'cure', 'building', 'commitment', 'research', 'development', 'treatment', 'diabetes', 'progress', 'research', 'cell', 'therapy', 'aim', 'help', 'patient', 'regain', 'insulin_produce_islet', 'cell', 'reduce', 'even', 'eliminate', 'need', 'daily', 'insulin', 'see', 'how', 'be', 'strive', 'improve', 'diabetes', 'treatment'], ['type_diabetes', 'lifelong', 'disease', 'affect', 'body', 'ability', 'convert', 'glucose', 'food', 'energy', 'most', 'case', 'develop', 'early', 'life', 'often', 'diagnose', 'childhood', 'disease', 'start', 'when', 'immune_system', 'attack', 'cell', 'pancrea', 'produce_insulin', 'hormone', 'help', 'convert', 'glucose', 'energy', 'body', 'cell', 'goal', 'cure', 'building', 'commitment', 'research', 'development', 'treatment', 'diabetes', 'progress', 'research', 'cell', 'therapy', 'aim', 'help', 'patient', 'regain', 'insulin_produce_islet', 'cell', 'reduce', 'even', 'eliminate', 'need', 'daily', 'insulin'], ['see', 'how', 'be', 'strive', 'improve', 'diabetes', 'treatment'], ['former', 'nurse'], ['live', 'live', 'disease', 'year', 'as', 'long', 'kid', 'remember', 'begin', 'experience', 'symptom', 'relatively', 'young', 'age', 'now', 'focus', 'raise', 'awareness', 'serious', 'progressive', 'neurological', 'disease', 'watch', 'story'], ['live'], [], [], ['live', 'disease', 'year', 'as', 'long', 'kid', 'remember', 'begin', 'experience', 'symptom', 'relatively', 'young', 'age', 'now', 'focus', 'raise', 'awareness', 'serious', 'progressive', 'neurological', 'disease', 'watch', 'story'], ['partnership', 'aspire', 'more', 'partner', 'global', 'innovator', 'accelerate', 'development', 'therapeutic', 'breakthrough', 'scale', 'strategic', 'collaboration', 'lead', 'expert', 'large_scale', 'manufacturing_capability', 'aim', 'develop', 'deliver', 'transformative', 'cell', 'therapy', 'treatment', 'need', 'sustainability_guide_force', 'ability', 'innovate', 'cell', 'therapy', 'potential', 'significantly', 'impact', 'disease', 'depend', 'partnership', 'ground', 'long_term', 'commitment', 'mutual', 'interest', 'partner', 'academia', 'biotech', 'device', 'expert', 'share', 'knowledge', 'datum', 'capability', 'way', 'bring', 'close', 'develop', 'potential', 'cell', 'therapy', 'people', 'live_serious_chronic', 'disease', 'research', 'technology', 'therapeutic', 'breakthrough', 'almost_century_successfully_leverage', 'core', 'capability', 'develop', 'lead', 'biologic', 'provide', 'treatment', 'live_serious_chronic', 'disease', 'continuously', 'evolve', 'strengthen_capability', 'investment', 'advanced', 'technology_platform', 'such', 'cell', 'therapy', 'accelerate', 'future', 'success', 'research', 'process', 'innovate', 'global', 'scale', 'global', 'center', 'locate', 'continent', 'allow', 'diversify_pipeline', 'innovative', 'medicine', 'sustainability_guide_force', 'include', 'fremont', 'facility', 'dedicated', 'gmp', 'manufacturing', 'cell', 'therapy', 'use', 'clinical_trial', 'global', 'approach', 'enable', 'work', 'sustainable', 'way', 'see', 'more', 'sustainability'], ['partnership', 'aspire', 'more', 'partner', 'global', 'innovator', 'accelerate', 'development', 'therapeutic', 'breakthrough', 'scale', 'strategic', 'collaboration', 'lead', 'expert', 'large_scale', 'manufacturing_capability', 'aim', 'develop', 'deliver', 'transformative', 'cell', 'therapy', 'treatment', 'need', 'sustainability_guide_force', 'ability', 'innovate', 'cell', 'therapy', 'potential', 'significantly', 'impact', 'disease', 'depend', 'partnership', 'ground', 'long_term', 'commitment', 'mutual', 'interest', 'partner', 'academia', 'biotech', 'device', 'expert', 'share', 'knowledge', 'datum', 'capability', 'way', 'bring', 'close', 'develop', 'potential', 'cell', 'therapy', 'people', 'live_serious_chronic', 'disease'], ['partnership', 'aspire', 'more'], ['partnership'], [], ['partner', 'global', 'innovator', 'accelerate', 'development', 'therapeutic', 'breakthrough', 'scale', 'strategic', 'collaboration', 'lead', 'expert', 'large_scale', 'manufacturing_capability', 'aim', 'develop', 'deliver', 'transformative', 'cell', 'therapy', 'treatment', 'need', 'sustainability_guide_force', 'ability', 'innovate', 'cell', 'therapy', 'potential', 'significantly', 'impact', 'disease', 'depend', 'partnership', 'ground', 'long_term', 'commitment', 'mutual', 'interest', 'partner', 'academia', 'biotech', 'device', 'expert', 'share', 'knowledge', 'datum', 'capability', 'way', 'bring', 'close', 'develop', 'potential', 'cell', 'therapy', 'people', 'live_serious_chronic', 'disease'], ['partner', 'global', 'innovator', 'accelerate', 'development', 'therapeutic', 'breakthrough', 'scale'], ['strategic', 'collaboration', 'lead', 'expert', 'large_scale', 'manufacturing_capability', 'aim', 'develop', 'deliver', 'transformative', 'cell', 'therapy', 'treatment', 'need', 'sustainability_guide_force'], ['ability', 'innovate', 'cell', 'therapy', 'potential', 'significantly', 'impact', 'disease', 'depend', 'partnership', 'ground', 'long_term', 'commitment', 'mutual', 'interest', 'partner', 'academia', 'biotech', 'device', 'expert', 'share', 'knowledge', 'datum', 'capability', 'way', 'bring', 'close', 'develop', 'potential', 'cell', 'therapy', 'people', 'live_serious_chronic', 'disease'], ['research', 'technology', 'therapeutic', 'breakthrough', 'almost_century_successfully_leverage', 'core', 'capability', 'develop', 'lead', 'biologic', 'provide', 'treatment', 'live_serious_chronic', 'disease', 'continuously', 'evolve', 'strengthen_capability', 'investment', 'advanced', 'technology_platform', 'such', 'cell', 'therapy', 'accelerate', 'future', 'success', 'research', 'process'], ['research', 'technology', 'therapeutic', 'breakthrough'], ['technology'], ['therapeutic'], [], ['almost_century_successfully_leverage', 'core', 'capability', 'develop', 'lead', 'biologic', 'provide', 'treatment', 'live_serious_chronic', 'disease', 'continuously', 'evolve', 'strengthen_capability', 'investment', 'advanced', 'technology_platform', 'such', 'cell', 'therapy', 'accelerate', 'future', 'success', 'research', 'process'], ['almost_century_successfully_leverage', 'core', 'capability', 'develop', 'lead', 'biologic', 'provide', 'treatment', 'live_serious_chronic', 'disease'], ['continuously', 'evolve', 'strengthen_capability', 'investment', 'advanced', 'technology_platform', 'such', 'cell', 'therapy', 'accelerate', 'future', 'success', 'research', 'process'], ['innovate', 'global', 'scale', 'global', 'center', 'locate', 'continent', 'allow', 'diversify_pipeline', 'innovative', 'medicine', 'sustainability_guide_force', 'include', 'fremont', 'facility', 'dedicated', 'gmp', 'manufacturing', 'cell', 'therapy', 'use', 'clinical_trial', 'global', 'approach', 'enable', 'work', 'sustainable', 'way', 'see', 'more', 'sustainability'], ['innovate', 'global', 'scale'], ['innovate'], ['global'], ['global', 'center', 'locate', 'continent', 'allow', 'diversify_pipeline', 'innovative', 'medicine', 'sustainability_guide_force', 'include', 'fremont', 'facility', 'dedicated', 'gmp', 'manufacturing', 'cell', 'therapy', 'use', 'clinical_trial', 'global', 'approach', 'enable', 'work', 'sustainable', 'way', 'see', 'more', 'sustainability'], ['global', 'center', 'locate', 'continent', 'allow', 'diversify_pipeline', 'innovative', 'medicine', 'sustainability_guide_force', 'include', 'fremont', 'facility', 'dedicated', 'gmp', 'manufacturing', 'cell', 'therapy', 'use', 'clinical_trial', 'global', 'approach', 'enable', 'work', 'sustainable', 'way'], ['see', 'more', 'sustainability'], ['research', 'discovery', 'unit', 'design', 'provide', 'good', 'scientific', 'environment', 'discovery', 'development', 'breakthrough', 'medicine', 'global', 'unit', 'design', 'work', 'core', 'organisation', 'drive', 'concept', 'project', 'expand', 'diversify_pipeline', 'disruptive', 'medicine', 'global', 'research', 'development', 'network', 'work', 'well', 'establish', 'cut_edge', 'research', 'technology_platform', 'provide', 'technique', 'method', 'process', 'enhance', 'treatment', 'accuracy', 'search', 'know', 'global', 'centre', 'even', 'well'], ['research', 'discovery', 'unit', 'design', 'provide', 'good', 'scientific', 'environment', 'discovery', 'development', 'breakthrough', 'medicine', 'global', 'unit', 'design', 'work', 'core', 'organisation', 'drive', 'concept', 'project', 'expand', 'diversify_pipeline', 'disruptive', 'medicine', 'global', 'research', 'development', 'network', 'work', 'well', 'establish', 'cut_edge', 'research', 'technology_platform', 'provide', 'technique', 'method', 'process', 'enhance', 'treatment', 'accuracy', 'search', 'know', 'global', 'centre', 'even', 'well'], ['first', 'global', 'pharmaceutical', 'company', 'establish', 'research', 'facility', 'locate', 'park', 'research', 'centre', 'technology', 'centre', 'excellence', 'play', 'key', 'role', 'discovery', 'novel', 'drug_candidate', 'launch', 'open', 'innovation', 'platform', 'increase', 'partnership', 'local', 'academic', 'institution', 'small', 'biotech', 'company'], ['centre', 'bangalore', 'operate', 'integrate', 'part', 'project', 'centric', 'development', 'organisation', 'team', 'deliver', 'data', 'management', 'biostatistic', 'programming', 'medical', 'writing', 'publishing', 'safety', 'surveillance', 'medical', 'communication', 'clinical_trial', 'market', 'product'], ['malÃ¸v', 'large', 'research', 'centre', 'site', 'innovation', 'idea', 'generation', 'protein_peptide', 'engineering', 'formulation', 'preclinical_testing', 'medicine', 'candidate', 'therapy', 'area', 'site', 'house', 'early', 'drug_discovery', 'laboratory', 'as_well', 'facility', 'production', 'upscaling', 'formulation', 'lead', 'medicine', 'candidate', 'clinical', 'testing'], ['team', 'research', 'centre', 'responsible', 'develop', 'formulating', 'manufacture', 'drug_candidate', 'pre', 'clinical', 'clinical', 'testing', 'team', 'involve', 'collection', 'adverse_event', 'safety', 'surveillance', 'event', 'adjudication', 'relate', 'clinical_trial', 'as_well', 'handling', 'complaint', 'product', 'recall', 'when', 'need'], ['centre', 'project', 'centric', 'workplace', 'focus', 'late_stage', 'development', 'therapy', 'area', 'include', 'conduct', 'report', 'clinical_trial', 'register', 'product', 'share', 'science', 'engage', 'health_authority', 'professional', 'association', 'medical', 'community'], ['research', 'centre', 'device', 'innovation', 'hub', 'key', 'location', 'long_stand', 'industry', 'leadership', 'pioneer', 'new', 'medical', 'device', 'delivery', 'technology'], ['location', 'heart', 'research', 'centre', 'research', 'unit', 'bring', 'industry', 'academia', 'closely', 'together', 'research', 'focus', 'discover', 'novel', 'disruptive', 'therapy', 'cardiometabolic', 'disease', 'combine', 'deep', 'disease', 'understanding', 'human_biology', 'big', 'datum', 'learn_more'], ['stem', 'cell', 'research', 'clinical', 'manufacturing', 'facility', 'locate', 'other', 'team', 'leverage', 'stem', 'cell', 'technology', 'find', 'new', 'treatment', 'patient', 'diabetes', 'heart_failure', 'explore', 'other', 'high', 'need', 'area', 'such', 'neurology'], ['establish', 'late', 'when', 'acquire', 'calibrium', 'private', 'company', 'co', 'found', 'focus', 'develop', 'peptide', 'base', 'drug_candidate', 'treatment', 'diabetes_obesity', 'today', 'home', 'elite', 'research', 'team', 'work', 'global', 'research', 'mission', 'transform', 'management', 'cardio', 'metabolic', 'disease', 'scientist', 'focus', 'innovative', 'discovery', 'project', 'pertain', 'diabetes_obesity', 'related', 'disease', 'develop', 'employ', 'cutting', 'edge', 'biotechnology', 'identify', 'refine', 'select', 'suitable', 'drug_candidate', 'possess', 'novel', 'mechanism', 'biological', 'action', 'collaboration', 'internationally', 'acclaim', 'academic', 'centre', 'excellence'], ['innovation', 'hub', 'headquarters', 'global', 'business', 'development', 'therapeutic', 'technology', 'area', 'contain', 'function', 'business', 'development', 'search', 'alliance', 'management', 'innovation', 'hub', 'house', 'full', 'complement', 'business', 'function', 'need', 'external', 'partnering', 'activity', 'have', 'physical', 'presence', 'world', 'large', 'life_science', 'ecosystem', 'part', 'strategy', 'access', 'high_level', 'innovation', 'offer', 'work', 'local', 'company', 'venture', 'capitalist', 'university', 'teaching', 'hospital', 'access', 'technology', 'therapeutic', 'molecule', 'allow', 'help', 'patient', 'current', 'therapeutic', 'area', 'variety', 'partnership', 'model', 'use', 'innovation', 'help', 'advance', 'expand', 'product', 'portfolio'], ['research', 'centre', 'focus', 'early', 'discovery', 'project', 'diabetes_obesity', 'chronic', 'kidney_disease', 'unit', 'scientist', 'apply', 'advanced', 'technology', 'identify', 'protein', 'base', 'therapy', 'obesity', 'prevention', 'treatment', 'type_diabetes', 'furthermore', 'dedicated', 'team', 'device', 'engineer', 'work', 'digitalisation', 'connectivity', 'medical', 'device', 'improved', 'treatment', 'outcome'], ['how', 'research', 'new', 'medicine'], ['almost_century_successfully_leverage', 'core', 'capability', 'engineering', 'formulate', 'develop', 'deliver', 'protein', 'base', 'treatment', 'live_serious_chronic', 'disease', 'primarily', 'base', 'core', 'technology_platform', 'peptide', 'protein', 'ensure', 'future', 'success', 'discovery', 'process', 'continuously', 'strengthen_capability', 'invest', 'emerge', 'cut_edge', 'technology', 'today', 'technology_platform', 'cover', 'number', 'core', 'area', 'essential', 'drive', 'innovation', 'disease', 'target'], ['almost_century_successfully_leverage', 'core', 'capability', 'engineering', 'formulate', 'develop', 'deliver', 'protein', 'base', 'treatment', 'live_serious_chronic', 'disease', 'primarily', 'base', 'core', 'technology_platform', 'peptide', 'protein'], ['ensure', 'future', 'success', 'discovery', 'process', 'continuously', 'strengthen_capability', 'invest', 'emerge', 'cut_edge', 'technology', 'today', 'technology_platform', 'cover', 'number', 'core', 'area', 'essential', 'drive', 'innovation', 'disease', 'target'], ['protein_peptide', 'core_expertise', 'discover', 'address', 'target', 'use', 'protein_peptide', 'technology', 'include', 'expression', 'engineering', 'formulation', 'biological_process', 'use', 'complex_multicellular_organism_control', 'gene', 'express_silence', 'gene_edit', 'gene_editing', 'type_genetic_engineering', 'insert_delete_modify_replace', 'genome_live_organism', 'stem', 'cell', 'stem', 'cell', 'precursor', 'cell', 'fully_specialised', 'cell', 'body', 'development', 'stem', 'cell', 'become', 'more', 'more', 'specialised', 'number', 'different', 'cell', 'type', 'develop', 'reduce_way'], ['protein_peptide', 'core_expertise', 'discover', 'address', 'target', 'use', 'protein_peptide', 'technology', 'include', 'expression', 'engineering', 'formulation', 'biological_process', 'use', 'complex_multicellular_organism_control', 'gene', 'express_silence'], ['protein_peptide', 'core_expertise', 'discover', 'address', 'target', 'use', 'protein_peptide', 'technology', 'include', 'expression', 'engineering', 'formulation'], ['protein_peptide'], ['core_expertise', 'discover', 'address', 'target', 'use', 'protein_peptide', 'technology', 'include', 'expression', 'engineering', 'formulation'], ['biological_process', 'use', 'complex_multicellular_organism_control', 'gene', 'express_silence'], [], ['biological_process', 'use', 'complex_multicellular_organism_control', 'gene', 'express_silence'], ['gene_edit', 'gene_editing', 'type_genetic_engineering', 'insert_delete_modify_replace', 'genome_live_organism', 'stem', 'cell', 'stem', 'cell', 'precursor', 'cell', 'fully_specialised', 'cell', 'body', 'development', 'stem', 'cell', 'become', 'more', 'more', 'specialised', 'number', 'different', 'cell', 'type', 'develop', 'reduce_way'], ['gene_edit', 'gene_editing', 'type_genetic_engineering', 'insert_delete_modify_replace', 'genome_live_organism'], ['gene_editing'], ['gene_editing', 'type_genetic_engineering', 'insert_delete_modify_replace', 'genome_live_organism'], ['stem', 'cell', 'stem', 'cell', 'precursor', 'cell', 'fully_specialised', 'cell', 'body', 'development', 'stem', 'cell', 'become', 'more', 'more', 'specialised', 'number', 'different', 'cell', 'type', 'develop', 'reduce_way'], ['stem', 'cell'], ['stem', 'cell', 'precursor', 'cell', 'fully_specialised', 'cell', 'body', 'development', 'stem', 'cell', 'become', 'more', 'more', 'specialised', 'number', 'different', 'cell', 'type', 'develop', 'reduce_way'], ['protein_peptide', 'core_expertise', 'lie', 'discover_develop', 'new', 'protein_peptide', 'base', 'drug', 'therapy', 'apply', 'comprehensive', 'spectrum', 'state_art', 'protein_peptide', 'technology', 'generate', 'optimal', 'cell', 'base', 'expression', 'system', 'engineer', 'modify', 'protein_peptide', 'create', 'new', 'improved', 'formulation', 'use', 'hone', 'technology', 'design', 'engineer', 'protein', 'mimic', 'action', 'naturally_occur', 'protein', 'when', 'introduce', 'life', 'save', 'treatment', 'various', 'disease', 'protein', 'therapeutic', 'strategy', 'protein', 'key', 'element', 'orchestrate', 'almost', 'physiological', 'function', 'require', 'survive', 'grow', 'thrive', 'specific', 'protein', 'absent', 'reduce', 'quantity_function', 'state', 'serious_disease', 'follow', 'case', 'diabetes', 'protein', 'hormone', 'insulin', 'lack', 'ineffective', 'cell', 'produce_insulin', 'destroy', 'immune_system', 'body', 'develop', 'resistance', 'effect', 'insulin', 'founder', 'successful', 'purify', 'mass', 'produce_insulin', 'order', 'provide', 'well_tolerate', 'effective', 'treatment', 'diabetes', 'otherwise', 'deadly', 'disease', 'then', 'further', 'refining', 'improve', 'ability', 'engineer', 'manufacture', 'purify', 'administer', 'protein', 'treatment', 'diabetes_obesity', 'rare', 'blood', 'disorder', 'rare', 'endocrine', 'disorder', 'chronic', 'kidney', 'cardiovascular', 'disease', 'as_well', 'other', 'disease', 'condition'], ['protein_peptide', 'core_expertise', 'lie', 'discover_develop', 'new', 'protein_peptide', 'base', 'drug', 'therapy', 'apply', 'comprehensive', 'spectrum', 'state_art', 'protein_peptide', 'technology', 'generate', 'optimal', 'cell', 'base', 'expression', 'system', 'engineer', 'modify', 'protein_peptide', 'create', 'new', 'improved', 'formulation', 'use', 'hone', 'technology', 'design', 'engineer', 'protein', 'mimic', 'action', 'naturally_occur', 'protein', 'when', 'introduce', 'life', 'save', 'treatment', 'various', 'disease'], ['core_expertise', 'lie', 'discover_develop', 'new', 'protein_peptide', 'base', 'drug', 'therapy', 'apply', 'comprehensive', 'spectrum', 'state_art', 'protein_peptide', 'technology', 'generate', 'optimal', 'cell', 'base', 'expression', 'system', 'engineer', 'modify', 'protein_peptide', 'create', 'new', 'improved', 'formulation', 'use', 'hone', 'technology', 'design', 'engineer', 'protein', 'mimic', 'action', 'naturally_occur', 'protein', 'when', 'introduce', 'life', 'save', 'treatment', 'various', 'disease'], ['protein', 'therapeutic', 'strategy', 'protein', 'key', 'element', 'orchestrate', 'almost', 'physiological', 'function', 'require', 'survive', 'grow', 'thrive', 'specific', 'protein', 'absent', 'reduce', 'quantity_function', 'state', 'serious_disease', 'follow', 'case', 'diabetes', 'protein', 'hormone', 'insulin', 'lack', 'ineffective', 'cell', 'produce_insulin', 'destroy', 'immune_system', 'body', 'develop', 'resistance', 'effect', 'insulin', 'founder', 'successful', 'purify', 'mass', 'produce_insulin', 'order', 'provide', 'well_tolerate', 'effective', 'treatment', 'diabetes', 'otherwise', 'deadly', 'disease', 'then', 'further', 'refining', 'improve', 'ability', 'engineer', 'manufacture', 'purify', 'administer', 'protein', 'treatment', 'diabetes_obesity', 'rare', 'blood', 'disorder', 'rare', 'endocrine', 'disorder', 'chronic', 'kidney', 'cardiovascular', 'disease', 'as_well', 'other', 'disease', 'condition'], ['protein', 'therapeutic', 'strategy'], ['protein', 'key', 'element', 'orchestrate', 'almost', 'physiological', 'function', 'require', 'survive', 'grow', 'thrive', 'specific', 'protein', 'absent', 'reduce', 'quantity_function', 'state', 'serious_disease', 'follow', 'case', 'diabetes', 'protein', 'hormone', 'insulin', 'lack', 'ineffective', 'cell', 'produce_insulin', 'destroy', 'immune_system', 'body', 'develop', 'resistance', 'effect', 'insulin', 'founder', 'successful', 'purify', 'mass', 'produce_insulin', 'order', 'provide', 'well_tolerate', 'effective', 'treatment', 'diabetes', 'otherwise', 'deadly', 'disease', 'then', 'further', 'refining', 'improve', 'ability', 'engineer', 'manufacture', 'purify', 'administer', 'protein', 'treatment', 'diabetes_obesity', 'rare', 'blood', 'disorder', 'rare', 'endocrine', 'disorder', 'chronic', 'kidney', 'cardiovascular', 'disease', 'as_well', 'other', 'disease', 'condition'], ['protein', 'key', 'element', 'orchestrate', 'almost', 'physiological', 'function', 'require', 'survive', 'grow', 'thrive', 'specific', 'protein', 'absent', 'reduce', 'quantity_function', 'state', 'serious_disease', 'follow'], ['case', 'diabetes', 'protein', 'hormone', 'insulin', 'lack', 'ineffective', 'cell', 'produce_insulin', 'destroy', 'immune_system', 'body', 'develop', 'resistance', 'effect', 'insulin'], ['founder', 'successful', 'purify', 'mass', 'produce_insulin', 'order', 'provide', 'well_tolerate', 'effective', 'treatment', 'diabetes', 'otherwise', 'deadly', 'disease'], ['then', 'further', 'refining', 'improve', 'ability', 'engineer', 'manufacture', 'purify', 'administer', 'protein', 'treatment', 'diabetes_obesity', 'rare', 'blood', 'disorder', 'rare', 'endocrine', 'disorder', 'chronic', 'kidney', 'cardiovascular', 'disease', 'as_well', 'other', 'disease', 'condition'], ['stem', 'cell', 'stem', 'cell', 'precursor', 'cell', 'proliferate', 'over', 'over', 'again', 'when', 'expose', 'right', 'trigger', 'unique', 'ability', 'develop', 'different', 'fully_specialised', 'cell', 'make', 'organ', 'system', 'naturally', 'stem', 'cell', 'find', 'stage', 'human', 'development', 'play', 'crucial', 'role', 'maintain', 'right', 'cell', 'composition', 'body', 'grow', 'replace', 'specialised', 'cell', 'damage', 'lose', 'differentiation_process', 'individual', 'stem', 'cell', 'case', 'pluripotent_stem', 'cell', 'become', 'more', 'more', 'specialised', 'number', 'different', 'cell', 'type', 'potential', 'develop', 'reduce_way', 'research', 'production', 'development', 'process', 'use', 'knowledge', 'experience', 'drive', 'pluripotent_stem', 'cell', 'require', 'cell', 'type', 'different_regenerative', 'cell', 'therapy', 'clinical_trial', 'stem', 'cell', 'therapeutic', 'strategy', 'serious_chronic', 'disease', 'cause', 'loss', 'malfunction', 'specific', 'cell', 'type', 'pluripotent_stem', 'cell', 'potentially', 'use', 'curative', 'process', 'replace', 'absent', 'dysfunctional', 'cell', 'almost', 'decade', 'intensely', 'focus', 'understand', 'biology', 'underpin', 'development', 'pancrea', 'translate', 'knowledge', 'direct', 'differentiation_process', 'drive', 'transformation', 'pluripotent_stem', 'cell', 'insulin_produce', 'pancreatic', 'beta', 'cell', 'aim', 'replace', 'cell', 'lose', 'type_diabetes', 'now', 'expand', 'commitment', 'stem', 'cell', 'base', 'research', 'other', 'serious_chronic', 'disease', 'hope', 'continue', 'offer', 'life', 'change', 'treatment', 'even', 'more', 'people', 'future', 'aim', 'grow', 'high_quality', 'stem', 'cell', 'differentiate', 'specialised', 'cell', 'choice', 'process', 'require', 'cut_edge', 'skill', 'expertise', 'build', 'stem', 'cell', 'technology_platform', 'exclusive', 'collaboration', 'develop', 'good_manufacturing_practice', 'compliant', 'human', 'embryonic', 'stem', 'cell', 'hesc', 'line', 'important', 'foundation', 'different_regenerative', 'medicine', 'therapy', 'programme', 'employee', 'work_together', 'new', 'gmp', 'laboratory', 'derive', 'cell', 'line', 'expect', 'define', 'new', 'quality', 'standard', 'production', 'stem', 'cell', 'base', 'therapy', 'stem', 'cell', 'site', 'dedicate', 'manufacturing', 'stem', 'cell', 'stem', 'cell', 'base', 'therapy', 'inaugurate'], ['stem', 'cell', 'stem', 'cell', 'precursor', 'cell', 'proliferate', 'over', 'over', 'again', 'when', 'expose', 'right', 'trigger', 'unique', 'ability', 'develop', 'different', 'fully_specialised', 'cell', 'make', 'organ', 'system', 'naturally', 'stem', 'cell', 'find', 'stage', 'human', 'development', 'play', 'crucial', 'role', 'maintain', 'right', 'cell', 'composition', 'body', 'grow', 'replace', 'specialised', 'cell', 'damage', 'lose', 'differentiation_process', 'individual', 'stem', 'cell', 'case', 'pluripotent_stem', 'cell', 'become', 'more', 'more', 'specialised', 'number', 'different', 'cell', 'type', 'potential', 'develop', 'reduce_way', 'research', 'production', 'development', 'process', 'use', 'knowledge', 'experience', 'drive', 'pluripotent_stem', 'cell', 'require', 'cell', 'type', 'different_regenerative', 'cell', 'therapy', 'clinical_trial'], ['stem', 'cell', 'precursor', 'cell', 'proliferate', 'over', 'over', 'again', 'when', 'expose', 'right', 'trigger', 'unique', 'ability', 'develop', 'different', 'fully_specialised', 'cell', 'make', 'organ', 'system', 'naturally', 'stem', 'cell', 'find', 'stage', 'human', 'development', 'play', 'crucial', 'role', 'maintain', 'right', 'cell', 'composition', 'body', 'grow', 'replace', 'specialised', 'cell', 'damage', 'lose', 'differentiation_process', 'individual', 'stem', 'cell', 'case', 'pluripotent_stem', 'cell', 'become', 'more', 'more', 'specialised', 'number', 'different', 'cell', 'type', 'potential', 'develop', 'reduce_way', 'research', 'production', 'development', 'process', 'use', 'knowledge', 'experience', 'drive', 'pluripotent_stem', 'cell', 'require', 'cell', 'type', 'different_regenerative', 'cell', 'therapy', 'clinical_trial'], ['stem', 'cell', 'precursor', 'cell', 'proliferate', 'over', 'over', 'again', 'when', 'expose', 'right', 'trigger', 'unique', 'ability', 'develop', 'different', 'fully_specialised', 'cell', 'make', 'organ', 'system'], ['naturally', 'stem', 'cell', 'find', 'stage', 'human', 'development', 'play', 'crucial', 'role', 'maintain', 'right', 'cell', 'composition', 'body', 'grow', 'replace', 'specialised', 'cell', 'damage', 'lose'], ['differentiation_process', 'individual', 'stem', 'cell', 'case', 'pluripotent_stem', 'cell', 'become', 'more', 'more', 'specialised', 'number', 'different', 'cell', 'type', 'potential', 'develop', 'reduce_way'], ['research', 'production', 'development', 'process', 'use', 'knowledge', 'experience', 'drive', 'pluripotent_stem', 'cell', 'require', 'cell', 'type', 'different_regenerative', 'cell', 'therapy', 'clinical_trial'], ['stem', 'cell', 'therapeutic', 'strategy', 'serious_chronic', 'disease', 'cause', 'loss', 'malfunction', 'specific', 'cell', 'type', 'pluripotent_stem', 'cell', 'potentially', 'use', 'curative', 'process', 'replace', 'absent', 'dysfunctional', 'cell', 'almost', 'decade', 'intensely', 'focus', 'understand', 'biology', 'underpin', 'development', 'pancrea', 'translate', 'knowledge', 'direct', 'differentiation_process', 'drive', 'transformation', 'pluripotent_stem', 'cell', 'insulin_produce', 'pancreatic', 'beta', 'cell', 'aim', 'replace', 'cell', 'lose', 'type_diabetes', 'now', 'expand', 'commitment', 'stem', 'cell', 'base', 'research', 'other', 'serious_chronic', 'disease', 'hope', 'continue', 'offer', 'life', 'change', 'treatment', 'even', 'more', 'people', 'future', 'aim', 'grow', 'high_quality', 'stem', 'cell', 'differentiate', 'specialised', 'cell', 'choice', 'process', 'require', 'cut_edge', 'skill', 'expertise'], ['stem', 'cell', 'therapeutic', 'strategy'], ['serious_chronic', 'disease', 'cause', 'loss', 'malfunction', 'specific', 'cell', 'type', 'pluripotent_stem', 'cell', 'potentially', 'use', 'curative', 'process', 'replace', 'absent', 'dysfunctional', 'cell', 'almost', 'decade', 'intensely', 'focus', 'understand', 'biology', 'underpin', 'development', 'pancrea', 'translate', 'knowledge', 'direct', 'differentiation_process', 'drive', 'transformation', 'pluripotent_stem', 'cell', 'insulin_produce', 'pancreatic', 'beta', 'cell', 'aim', 'replace', 'cell', 'lose', 'type_diabetes', 'now', 'expand', 'commitment', 'stem', 'cell', 'base', 'research', 'other', 'serious_chronic', 'disease', 'hope', 'continue', 'offer', 'life', 'change', 'treatment', 'even', 'more', 'people', 'future', 'aim', 'grow', 'high_quality', 'stem', 'cell', 'differentiate', 'specialised', 'cell', 'choice', 'process', 'require', 'cut_edge', 'skill', 'expertise'], ['serious_chronic', 'disease', 'cause', 'loss', 'malfunction', 'specific', 'cell', 'type', 'pluripotent_stem', 'cell', 'potentially', 'use', 'curative', 'process', 'replace', 'absent', 'dysfunctional', 'cell'], ['almost', 'decade', 'intensely', 'focus', 'understand', 'biology', 'underpin', 'development', 'pancrea', 'translate', 'knowledge', 'direct', 'differentiation_process', 'drive', 'transformation', 'pluripotent_stem', 'cell', 'insulin_produce', 'pancreatic', 'beta', 'cell', 'aim', 'replace', 'cell', 'lose', 'type_diabetes'], ['now', 'expand', 'commitment', 'stem', 'cell', 'base', 'research', 'other', 'serious_chronic', 'disease', 'hope', 'continue', 'offer', 'life', 'change', 'treatment', 'even', 'more', 'people', 'future'], ['aim', 'grow', 'high_quality', 'stem', 'cell', 'differentiate', 'specialised', 'cell', 'choice', 'process', 'require', 'cut_edge', 'skill', 'expertise'], ['build', 'stem', 'cell', 'technology_platform', 'exclusive', 'collaboration', 'develop', 'good_manufacturing_practice', 'compliant', 'human', 'embryonic', 'stem', 'cell', 'hesc', 'line', 'important', 'foundation', 'different_regenerative', 'medicine', 'therapy', 'programme', 'employee', 'work_together', 'new', 'gmp', 'laboratory', 'derive', 'cell', 'line', 'expect', 'define', 'new', 'quality', 'standard', 'production', 'stem', 'cell', 'base', 'therapy', 'stem', 'cell', 'site', 'dedicate', 'manufacturing', 'stem', 'cell', 'stem', 'cell', 'base', 'therapy', 'inaugurate'], ['build', 'stem', 'cell', 'technology_platform'], ['exclusive', 'collaboration', 'develop', 'good_manufacturing_practice', 'compliant', 'human', 'embryonic', 'stem', 'cell', 'hesc', 'line', 'important', 'foundation', 'different_regenerative', 'medicine', 'therapy', 'programme', 'employee', 'work_together', 'new', 'gmp', 'laboratory', 'derive', 'cell', 'line', 'expect', 'define', 'new', 'quality', 'standard', 'production', 'stem', 'cell', 'base', 'therapy', 'stem', 'cell', 'site', 'dedicate', 'manufacturing', 'stem', 'cell', 'stem', 'cell', 'base', 'therapy', 'inaugurate'], ['exclusive', 'collaboration', 'develop', 'good_manufacturing_practice', 'compliant', 'human', 'embryonic', 'stem', 'cell', 'hesc', 'line', 'important', 'foundation', 'different_regenerative', 'medicine', 'therapy', 'programme', 'employee', 'work_together', 'new', 'gmp', 'laboratory', 'derive', 'cell', 'line', 'expect', 'define', 'new', 'quality', 'standard', 'production', 'stem', 'cell', 'base', 'therapy'], ['stem', 'cell', 'site', 'dedicate', 'manufacturing', 'stem', 'cell', 'stem', 'cell', 'base', 'therapy', 'inaugurate'], [], ['biological_process', 'use', 'complex_multicellular_organism_control', 'gene', 'express_silence', 'defence', 'mechanism', 'protect', 'cell', 'viral', 'invasion', 'parasitic', 'nucleotide', 'sequence', 'become', 'clear', 'precise', 'efficient', 'stable', 'valuable', 'technique', 'artificial', 'suppression', 'undesired', 'target', 'gene', 'therapeutic', 'strategy', 'many', 'disease', 'symptom', 'relieve', 'silence_gene', 'silence_gene', 'direct', 'benefit', 'give', 'disease', 'target', 'cell', 'systemically', 'addition', 'rnai', 'silence_gene', 'otherwise', 'prevent', 'beneficial', 'gene', 'express', 'such', 'case', 'therapeutic', 'approach', 'target', 'molecule', 'carry', 'code', 'gene', 'interest', 'degradation', 'transcribe', 'way', 'protein', 'produce', 'therefore', 'gene', 'become', 'silence', 'build', 'platform', 'multi', 'target', 'co', 'creation', 'collaboration', 'explore', 'novel', 'target', 'treat', 'liver', 'relate', 'cardiometabolic', 'disease', 'include', 'diabetes_obesity', 'cardiovascular', 'disease', 'nash', 'as_well', 'other', 'rare', 'disease', 'collaboration', 'combine', 'world', 'lead', 'expertise', 'technology', 'interference', 'extensive', 'disease', 'understanding', 'development', 'experience', 'accumulate', 'past', 'century'], ['biological_process', 'use', 'complex_multicellular_organism_control', 'gene', 'express_silence', 'defence', 'mechanism', 'protect', 'cell', 'viral', 'invasion', 'parasitic', 'nucleotide', 'sequence', 'become', 'clear', 'precise', 'efficient', 'stable', 'valuable', 'technique', 'artificial', 'suppression', 'undesired', 'target', 'gene'], [], ['biological_process', 'use', 'complex_multicellular_organism_control', 'gene', 'express_silence', 'defence', 'mechanism', 'protect', 'cell', 'viral', 'invasion', 'parasitic', 'nucleotide', 'sequence', 'become', 'clear', 'precise', 'efficient', 'stable', 'valuable', 'technique', 'artificial', 'suppression', 'undesired', 'target', 'gene'], ['biological_process', 'use', 'complex_multicellular_organism_control', 'gene', 'express_silence', 'defence', 'mechanism', 'protect', 'cell', 'viral', 'invasion', 'parasitic', 'nucleotide', 'sequence'], ['discovery', 'become', 'clear', 'precise', 'efficient', 'stable', 'valuable', 'technique', 'artificial', 'suppression', 'undesired', 'target', 'gene'], ['therapeutic', 'strategy', 'many', 'disease', 'symptom', 'relieve', 'silence_gene', 'silence_gene', 'direct', 'benefit', 'give', 'disease', 'target', 'cell', 'systemically', 'addition', 'rnai', 'silence_gene', 'otherwise', 'prevent', 'beneficial', 'gene', 'express', 'such', 'case', 'therapeutic', 'approach', 'target', 'molecule', 'carry', 'code', 'gene', 'interest', 'degradation', 'transcribe', 'way', 'protein', 'produce', 'therefore', 'gene', 'become', 'silence'], ['therapeutic', 'strategy'], ['many', 'disease', 'symptom', 'relieve', 'silence_gene', 'silence_gene', 'direct', 'benefit', 'give', 'disease', 'target', 'cell', 'systemically', 'addition', 'rnai', 'silence_gene', 'otherwise', 'prevent', 'beneficial', 'gene', 'express', 'such', 'case', 'therapeutic', 'approach', 'target', 'molecule', 'carry', 'code', 'gene', 'interest', 'degradation', 'transcribe', 'way', 'protein', 'produce', 'therefore', 'gene', 'become', 'silence'], ['many', 'disease', 'symptom', 'relieve', 'silence_gene', 'silence_gene', 'direct', 'benefit', 'give', 'disease', 'target', 'cell', 'systemically', 'addition', 'rnai', 'silence_gene', 'otherwise', 'prevent', 'beneficial', 'gene', 'express'], ['such', 'case', 'therapeutic', 'approach', 'target', 'molecule', 'carry', 'code', 'gene', 'interest', 'degradation', 'transcribe', 'way', 'protein', 'produce', 'therefore', 'gene', 'become', 'silence'], ['build', 'platform', 'multi', 'target', 'co', 'creation', 'collaboration', 'explore', 'novel', 'target', 'treat', 'liver', 'relate', 'cardiometabolic', 'disease', 'include', 'diabetes_obesity', 'cardiovascular', 'disease', 'nash', 'as_well', 'other', 'rare', 'disease', 'collaboration', 'combine', 'world', 'lead', 'expertise', 'technology', 'interference', 'extensive', 'disease', 'understanding', 'development', 'experience', 'accumulate', 'past', 'century'], ['build', 'platform'], ['multi', 'target', 'co', 'creation', 'collaboration', 'explore', 'novel', 'target', 'treat', 'liver', 'relate', 'cardiometabolic', 'disease', 'include', 'diabetes_obesity', 'cardiovascular', 'disease', 'nash', 'as_well', 'other', 'rare', 'disease', 'collaboration', 'combine', 'world', 'lead', 'expertise', 'technology', 'interference', 'extensive', 'disease', 'understanding', 'development', 'experience', 'accumulate', 'past', 'century'], [], ['editing', 'type_genetic_engineering', 'insert_delete_modify_replace', 'genome_live_organism', 'early', 'genetic_engineering', 'technique', 'randomly', 'insert', 'genetic', 'material', 'host', 'genome', 'undefined', 'site', 'genome_editing', 'target', 'intend', 'modification', 'specific', 'genetic', 'location', 'interest', 'gene', 'therapy', 'therapeutic', 'strategy', 'genome', 'large', 'complex', 'set', 'instruction', 'include', 'code', 'individual', 'gene', 'section', 'regulatory', 'code', 'use', 'help', 'control', 'when', 'where', 'give', 'gene', 'express', 'disease', 'gene', 'therapy', 'replace', 'defective', 'gene', 'normal', 'allele', 'natural', 'location', 'do', 'take', 'advantage', 'associate', 'regulatory', 'process', 'code', 'nearby', 'allow', 'small', 'possible', 'modification', 'many', 'chronic', 'disease', 'cause', 'genetic', 'mutation', 'exist', 'curative', 'treatment', 'available', 'protein', 'replacement', 'alter', 'level', 'protein', 'body', 'effect', 'treatment', 'temporary', 'limitation', 'effectiveness', 'alter', 'incorrect', 'code', 'right', 'source', 'affect', 'other', 'part', 'genome', 'hold', 'promise', 'deliver', 'true', 'cure', 'genetic', 'disease', 'correct', 'cell', 'continue', 'grow', 'divide', 'body', 'maintain', 'treatment', 'life', 'no', 'matter', 'age', 'patient', 'when', 'treatment', 'administer', 'build', 'genome_editing', 'technology_platform', 'value', 'genome_editing', 'technology', 'potential', 'cure', 'chronic', 'disease', 'pass', 'year', 'explore', 'number', 'way', 'apply', 'approach', 'order', 'transform_life', 'affect', 'serious_chronic', 'disease', 'enter', 'partnership', 'jointly', 'develop', 'genome_editing', 'treatment', 'genetic', 'disease', 'initial', 'focus', 'correct', 'fviii', 'clot', 'factor', 'deficiency', 'ambition', 'offer', 'lifetime', 'free', 'factor', 'replacement', 'therapy', 'people', 'live'], ['editing', 'type_genetic_engineering', 'insert_delete_modify_replace', 'genome_live_organism', 'early', 'genetic_engineering', 'technique', 'randomly', 'insert', 'genetic', 'material', 'host', 'genome', 'undefined', 'site', 'genome_editing', 'target', 'intend', 'modification', 'specific', 'genetic', 'location', 'interest'], [], ['editing', 'type_genetic_engineering', 'insert_delete_modify_replace', 'genome_live_organism', 'early', 'genetic_engineering', 'technique', 'randomly', 'insert', 'genetic', 'material', 'host', 'genome', 'undefined', 'site', 'genome_editing', 'target', 'intend', 'modification', 'specific', 'genetic', 'location', 'interest'], ['gene', 'therapy', 'therapeutic', 'strategy', 'genome', 'large', 'complex', 'set', 'instruction', 'include', 'code', 'individual', 'gene', 'section', 'regulatory', 'code', 'use', 'help', 'control', 'when', 'where', 'give', 'gene', 'express', 'disease', 'gene', 'therapy', 'replace', 'defective', 'gene', 'normal', 'allele', 'natural', 'location', 'do', 'take', 'advantage', 'associate', 'regulatory', 'process', 'code', 'nearby', 'allow', 'small', 'possible', 'modification', 'many', 'chronic', 'disease', 'cause', 'genetic', 'mutation', 'exist', 'curative', 'treatment', 'available', 'protein', 'replacement', 'alter', 'level', 'protein', 'body', 'effect', 'treatment', 'temporary', 'limitation', 'effectiveness', 'alter', 'incorrect', 'code', 'right', 'source', 'affect', 'other', 'part', 'genome', 'hold', 'promise', 'deliver', 'true', 'cure', 'genetic', 'disease', 'correct', 'cell', 'continue', 'grow', 'divide', 'body', 'maintain', 'treatment', 'life', 'no', 'matter', 'age', 'patient', 'when', 'treatment', 'administer'], ['gene', 'therapy', 'therapeutic', 'strategy'], ['genome', 'large', 'complex', 'set', 'instruction', 'include', 'code', 'individual', 'gene', 'section', 'regulatory', 'code', 'use', 'help', 'control', 'when', 'where', 'give', 'gene', 'express', 'disease', 'gene', 'therapy', 'replace', 'defective', 'gene', 'normal', 'allele', 'natural', 'location', 'do', 'take', 'advantage', 'associate', 'regulatory', 'process', 'code', 'nearby', 'allow', 'small', 'possible', 'modification', 'many', 'chronic', 'disease', 'cause', 'genetic', 'mutation', 'exist', 'curative', 'treatment', 'available', 'protein', 'replacement', 'alter', 'level', 'protein', 'body', 'effect', 'treatment', 'temporary', 'limitation', 'effectiveness', 'alter', 'incorrect', 'code', 'right', 'source', 'affect', 'other', 'part', 'genome', 'hold', 'promise', 'deliver', 'true', 'cure', 'genetic', 'disease', 'correct', 'cell', 'continue', 'grow', 'divide', 'body', 'maintain', 'treatment', 'life', 'no', 'matter', 'age', 'patient', 'when', 'treatment', 'administer'], ['genome', 'large', 'complex', 'set', 'instruction', 'include', 'code', 'individual', 'gene', 'section', 'regulatory', 'code', 'use', 'help', 'control', 'when', 'where', 'give', 'gene', 'express', 'disease', 'gene', 'therapy', 'replace', 'defective', 'gene', 'normal', 'allele', 'natural', 'location', 'do', 'take', 'advantage', 'associate', 'regulatory', 'process', 'code', 'nearby', 'allow', 'small', 'possible', 'modification'], ['many', 'chronic', 'disease', 'cause', 'genetic', 'mutation', 'exist', 'curative', 'treatment', 'available', 'protein', 'replacement', 'alter', 'level', 'protein', 'body', 'effect', 'treatment', 'temporary', 'limitation', 'effectiveness'], ['alter', 'incorrect', 'code', 'right', 'source', 'affect', 'other', 'part', 'genome', 'hold', 'promise', 'deliver', 'true', 'cure', 'genetic', 'disease', 'correct', 'cell', 'continue', 'grow', 'divide', 'body', 'maintain', 'treatment', 'life', 'no', 'matter', 'age', 'patient', 'when', 'treatment', 'administer'], ['build', 'genome_editing', 'technology_platform', 'value', 'genome_editing', 'technology', 'potential', 'cure', 'chronic', 'disease', 'pass', 'year', 'explore', 'number', 'way', 'apply', 'approach', 'order', 'transform_life', 'affect', 'serious_chronic', 'disease', 'enter', 'partnership', 'jointly', 'develop', 'genome_editing', 'treatment', 'genetic', 'disease', 'initial', 'focus', 'correct', 'fviii', 'clot', 'factor', 'deficiency', 'ambition', 'offer', 'lifetime', 'free', 'factor', 'replacement', 'therapy', 'people', 'live'], ['build', 'genome_editing', 'technology_platform'], ['value', 'genome_editing', 'technology', 'potential', 'cure', 'chronic', 'disease', 'pass', 'year', 'explore', 'number', 'way', 'apply', 'approach', 'order', 'transform_life', 'affect', 'serious_chronic', 'disease', 'enter', 'partnership', 'jointly', 'develop', 'genome_editing', 'treatment', 'genetic', 'disease', 'initial', 'focus', 'correct', 'fviii', 'clot', 'factor', 'deficiency', 'ambition', 'offer', 'lifetime', 'free', 'factor', 'replacement', 'therapy', 'people', 'live'], [], ['deep_understanding', 'chronic', 'disease', 'biology', 'allow', 'identify', 'target', 'target', 'molecule', 'pathway', 'body', 'often', 'protein', 'contribute', 'development', 'disease', 'symptom', 'address', 'drug', 'produce', 'desire', 'therapeutic', 'effect'], ['hit', 'right', 'target'], ['once', 'target', 'identify', 'validate', 'next_step', 'find', 'molecule', 'inhibit', 'enhance', 'target', 'activity', 'current', 'technique', 'allow', 'many', 'thousand', 'compound', 'screen', 'quickly', 'compound', 'initially', 'show', 'effect', 'want', 'call', 'hit', 'refine', 'hit', 'test', 'efficacy_safety', 'many_different', 'way', 'only', 'very', 'good', 'molecule', 'make', 'way', 'research', 'development', 'pipeline', 'become', 'medicine', 'molecule', 'efficacious', 'effect', 'disease', 'show', 'significant', 'negative', 'side_effect', 'safe', 'take', 'extensive', 'rigorous', 'process', 'take', 'year', 'more', 'initial', 'idea', 'advancement', 'clinical', 'development', 'finally', 'receive', 'approval', 'regulator', 'stake', 'high', 'correct', 'target', 'very', 'beginning', 'develop', 'treatment', 'rely', 'research', 'technology_platform', 'drive', 'innovation', 'provide', 'technique', 'method', 'process', 'enhance', 'accuracy', 'search'], ['once', 'target', 'identify', 'validate', 'next_step', 'find', 'molecule', 'inhibit', 'enhance', 'target', 'activity', 'current', 'technique', 'allow', 'many', 'thousand', 'compound', 'screen', 'quickly', 'compound', 'initially', 'show', 'effect', 'want', 'call', 'hit'], ['refine', 'hit', 'test', 'efficacy_safety', 'many_different', 'way', 'only', 'very', 'good', 'molecule', 'make', 'way', 'research', 'development', 'pipeline', 'become', 'medicine', 'molecule', 'efficacious', 'effect', 'disease', 'show', 'significant', 'negative', 'side_effect', 'safe', 'take'], ['extensive', 'rigorous', 'process', 'take', 'year', 'more', 'initial', 'idea', 'advancement', 'clinical', 'development', 'finally', 'receive', 'approval', 'regulator'], ['stake', 'high', 'correct', 'target', 'very', 'beginning', 'develop', 'treatment', 'rely', 'research', 'technology_platform', 'drive', 'innovation', 'provide', 'technique', 'method', 'process', 'enhance', 'accuracy', 'search'], ['meet', 'global', 'team', 'network', 'talented', 'scientist', 'researcher', 'spread', 'world', 'together', 'search', 'next', 'breakthrough', 'visit', 'global', 'research', 'centre', 'career', 'always', 'lookout', 'scientific', 'research', 'talent', 'learn_more', 'career', 'join'], ['meet', 'global', 'team', 'network', 'talented', 'scientist', 'researcher', 'spread', 'world', 'together', 'search', 'next', 'breakthrough', 'visit', 'global', 'research', 'centre'], ['meet', 'global', 'team'], ['network', 'talented', 'scientist', 'researcher', 'spread', 'world', 'together', 'search', 'next', 'breakthrough'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], ['life_science'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['diagnostic'], ['lab_solution'], ['lab_solution'], ['lab_solution'], ['lab_solution'], ['lab_solution'], ['lab_solution'], ['lab_solution'], ['lab_solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['brand'], ['brand'], ['brand'], ['brand'], ['brand'], ['brand'], ['brand'], ['antibody'], ['cell', 'analysis'], ['cell', 'transfection'], ['cloning'], [], [], [], ['gene', 'expression', 'analysis', 'genotype'], [], ['analysis'], [], [], [], ['real', 'time', 'pcr'], [], ['sequencing'], ['cell', 'research'], ['synthetic', 'biology'], ['agrigenomic'], ['animal'], ['bioprocesse'], ['company', 'solution'], [], [], [], [], ['environmental'], ['food'], ['forensic'], ['geoscience'], ['manufacturing', 'processing'], [], ['material'], [], [], ['measurement'], ['threat', 'detection'], ['semiconductor', 'analysis'], ['isotope', 'analysis'], ['allergy', 'diagnostic'], ['autoimmune', 'diagnostic'], ['biobanke'], ['cancer', 'research'], ['gene', 'therapy'], ['clinical', 'genomic'], ['clinical', 'mass', 'spectrometry'], ['clinical', 'microbiology'], ['clinical', 'translational', 'research'], ['diagnostic', 'development'], ['diagnostic', 'testing'], ['precision'], ['preclinical', 'companion_diagnostic', 'development'], ['public'], ['chemical'], ['lab', 'equipment'], ['supply'], ['management'], ['chemical'], ['lab', 'equipment'], ['supply'], ['management'], [], ['connect', 'platform'], ['instrument', 'connectivity'], ['software'], ['lab', 'automation'], ['service'], [], [], ['applied', 'biosystem'], [], ['fisher', 'scientific'], ['unity', 'lab', 'service'], [], [], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['solution'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], ['gene_sequencing'], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], [], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['cftr'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['therapeutic'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['cell', 'therapy'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing'], ['gene_editing']]\n"
     ]
    }
   ],
   "source": [
    "bigram_phrases = gensim.models.Phrases(data_words, min_count=5, threshold=25)\n",
    "trigram_phrases = gensim.models.Phrases(bigram_phrases[data_words], threshold=50)\n",
    "\n",
    "bigram = gensim.models.phrases.Phraser(bigram_phrases)\n",
    "trigram = gensim.models.phrases.Phraser(trigram_phrases)\n",
    "\n",
    "def make_bigrams(texts):\n",
    "    return([bigram[doc] for doc in texts])\n",
    "\n",
    "def make_trigrams(texts):\n",
    "    return ([trigram[bigram[doc]] for doc in texts])\n",
    "\n",
    "data_bigrams = make_bigrams(data_words)\n",
    "data_bigrams_trigrams = make_trigrams(data_bigrams)\n",
    "\n",
    "print (data_bigrams_trigrams)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "385bce90",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: gensim in c:\\python\\lib\\site-packages (4.2.0)Note: you may need to restart the kernel to use updated packages.\n",
      "\n",
      "Requirement already satisfied: Cython==0.29.28 in c:\\python\\lib\\site-packages (from gensim) (0.29.28)\n",
      "Requirement already satisfied: numpy>=1.17.0 in c:\\python\\lib\\site-packages (from gensim) (1.21.5)\n",
      "Requirement already satisfied: scipy>=0.18.1 in c:\\python\\lib\\site-packages (from gensim) (1.7.3)\n",
      "Requirement already satisfied: smart-open>=1.8.1 in c:\\python\\lib\\site-packages (from gensim) (5.2.1)\n"
     ]
    }
   ],
   "source": [
    "pip install --upgrade gensim"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "2952725d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[(0, 1), (1, 1), (2, 1), (3, 1), (4, 1), (5, 1), (6, 1)]\n"
     ]
    }
   ],
   "source": [
    "#TF-IDF REMOVAL\n",
    "from gensim.models import TfidfModel\n",
    "from gensim import corpora\n",
    "\n",
    "id2word = corpora.Dictionary(data_bigrams_trigrams)\n",
    "\n",
    "texts = data_bigrams_trigrams\n",
    "\n",
    "corpus = [id2word.doc2bow(text) for text in texts]\n",
    "print (corpus[0][0:20])\n",
    "\n",
    "tfidf = TfidfModel(corpus, id2word=id2word)\n",
    "low_value = 0.03\n",
    "words  = []\n",
    "words_missing_in_tfidf = []\n",
    "for i in range(0, len(corpus)):\n",
    "    bow = corpus[i]\n",
    "    low_value_words = [] #reinitialize to be safe. You can skip this.\n",
    "    tfidf_ids = [id for id, value in tfidf[bow]]\n",
    "    bow_ids = [id for id, value in bow]\n",
    "    low_value_words = [id for id, value in tfidf[bow] if value < low_value]\n",
    "    drops = low_value_words+words_missing_in_tfidf\n",
    "    for item in drops:\n",
    "        words.append(id2word[item])\n",
    "    words_missing_in_tfidf = [id for id in bow_ids if id not in tfidf_ids] # The words with tf-idf socre 0 will be missing\n",
    "\n",
    "    new_bow = [b for b in bow if b[0] not in low_value_words and b[0] not in words_missing_in_tfidf]\n",
    "    corpus[i] = new_bow"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "730f9ae8",
   "metadata": {},
   "outputs": [],
   "source": [
    "lda_model = gensim.models.ldamodel.LdaModel(corpus=corpus[:-1],\n",
    "                                           id2word=id2word,\n",
    "                                           num_topics=10,\n",
    "                                           random_state=100,\n",
    "                                           update_every=1,\n",
    "                                           chunksize=100,\n",
    "                                           passes=10,\n",
    "                                           alpha=\"auto\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "83e0901f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[(0, 0.16641265), (1, 0.067168586), (2, 0.04866797), (3, 0.2048982), (4, 0.046087854), (5, 0.029047718), (6, 0.09645673), (7, 0.09652922), (8, 0.033004243), (9, 0.2117268)]\n",
      "[(9, 0.2117268), (3, 0.2048982), (0, 0.16641265), (7, 0.09652922), (6, 0.09645673), (1, 0.067168586), (2, 0.04866797), (4, 0.046087854), (8, 0.033004243), (5, 0.029047718)]\n"
     ]
    }
   ],
   "source": [
    "test_doc = corpus[-1]\n",
    "\n",
    "vector = lda_model[test_doc]\n",
    "print (vector)\n",
    "\n",
    "def Sort(sub_li):\n",
    "    sub_li.sort(key = lambda x: x[1])\n",
    "    sub_li.reverse()\n",
    "    return (sub_li)\n",
    "new_vector = Sort(vector)\n",
    "print (new_vector)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "bd820cf7",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pyLDAvis.gensim_models\n",
    "import pickle \n",
    "import pyLDAvis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "ba3f328b",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Python\\lib\\site-packages\\pyLDAvis\\_prepare.py:246: FutureWarning: In a future version of pandas all arguments of DataFrame.drop except for the argument 'labels' will be keyword-only.\n",
      "  default_term_info = default_term_info.sort_values(\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<link rel=\"stylesheet\" type=\"text/css\" href=\"https://cdn.jsdelivr.net/gh/bmabey/pyLDAvis@3.3.1/pyLDAvis/js/ldavis.v1.0.0.css\">\n",
       "\n",
       "\n",
       "<div id=\"ldavis_el101624397227855841257897949\"></div>\n",
       "<script type=\"text/javascript\">\n",
       "\n",
       "var ldavis_el101624397227855841257897949_data = {\"mdsDat\": {\"x\": [0.093070230769986, 0.09631267694334678, -0.0636857113062043, -0.3390143101932313, 0.13962811178210868, 0.1486528560595616, 0.08399927329617668, -0.2953538729444358, 0.05295630104496479, 0.08343444454772705], \"y\": [0.22552220143291973, -0.15346850654029887, -0.051849078375178964, 0.3475313797091497, -0.06444409683066464, -0.0022755792954369234, 0.014904818670802612, -0.2530697931994004, -0.030833914672427687, -0.032017430899464704], \"topics\": [1, 2, 3, 4, 5, 6, 7, 8, 9, 10], \"cluster\": [1, 1, 1, 1, 1, 1, 1, 1, 1, 1], \"Freq\": [16.439280478442626, 15.93176518637465, 13.577744394114555, 11.733711132801242, 9.88724945456784, 8.081218017391667, 7.7679616551039015, 7.496050241289462, 6.243855205653265, 2.8411642342607926]}, \"tinfo\": {\"Term\": [\"gene_editing\", \"cell\", \"therapy\", \"therapeutic\", \"cftr\", \"gene_sequencing\", \"patient\", \"include\", \"study\", \"company\", \"datum\", \"development\", \"disease\", \"research\", \"treatment\", \"result\", \"people\", \"mutation\", \"solution\", \"gene\", \"collaboration\", \"vertex\", \"global\", \"potential\", \"provide\", \"phase_study\", \"other\", \"forward_look_statement\", \"future\", \"use\", \"therapeutic\", \"gene_sequencing\", \"vertex\", \"potential\", \"use\", \"available\", \"more\", \"stem\", \"statement\", \"lead\", \"follow\", \"benefit\", \"plan\", \"approve\", \"child\", \"live\", \"focus\", \"expand\", \"time\", \"today\", \"significant\", \"report\", \"offer\", \"life\", \"month\", \"addition\", \"ability\", \"where\", \"now\", \"bring\", \"company\", \"patient\", \"study\", \"datum\", \"global\", \"phase_study\", \"clinical_trial\", \"support\", \"first\", \"evaluate\", \"announce\", \"phase\", \"week\", \"access\", \"additional\", \"trikafta\", \"tezacaftor_ivacaftor\", \"eligible\", \"vertex_pharmaceutical_incorporate_today\", \"function_mutation\", \"triple_combination_regiman\", \"trial\", \"receive\", \"become\", \"submission\", \"early\", \"orkambi\", \"pain\", \"dose\", \"code\", \"triple_combination\", \"treatment\", \"treat\", \"new\", \"year\", \"cftr\", \"people\", \"mutation\", \"target\", \"protein\", \"disease\", \"cause\", \"such\", \"make\", \"symdeko\", \"body\", \"number\", \"take\", \"advance\", \"replace\", \"many\", \"function\", \"when\", \"human\", \"most\", \"design\", \"multiple\", \"approach\", \"molecule\", \"progress\", \"lose\", \"partner\", \"demonstrate\", \"level\", \"progression\", \"also\", \"other\", \"medicine\", \"treatment\", \"cell\", \"therapy\", \"ivacaftor\", \"develop\", \"base\", \"genetic\", \"source_version\", \"serious_disease\", \"show\", \"lumacaftor_ivacaftor\", \"medicine_treat_underlying\", \"drug\", \"cftr_protein\", \"fourth_quarter\", \"specific\", \"technology_platform\", \"copy_mutation\", \"transformative\", \"announce_today\", \"today_announce\", \"surface\", \"technique\", \"preclinical\", \"initiate\", \"cause_cystic_fibrosis\", \"sickle\", \"genome\", \"enhance\", \"discover\", \"gene_edit\", \"disease\", \"research\", \"solution\", \"collaboration\", \"future\", \"technology\", \"expect\", \"age\", \"increase\", \"as_well\", \"experience\", \"market\", \"agreement\", \"drive\", \"activity\", \"chronic\", \"discovery\", \"effect\", \"team\", \"outcome\", \"partnership\", \"application\", \"conduct\", \"together\", \"accelerate\", \"commercial\", \"development\", \"strong\", \"centre\", \"director\", \"observe\", \"clinical\", \"product\", \"year\", \"regulatory\", \"new\", \"gene\", \"forward_look_statement\", \"press_release_contain\", \"contain_press_release\", \"forward_look_statement_define\", \"new_information_become\", \"include_other_thing\", \"other_risk_list\", \"risk_uncertainty\", \"believe_forward_look_statement\", \"contain_press_release_accurate\", \"risk_factor_annual_report\", \"obligation_update_information\", \"number_factor_cause_actual\", \"materially_indicate_such\", \"event_result_differ\", \"forward_look_statement_represent\", \"date_press_release\", \"company_belief_only\", \"regard\", \"private_security_include_limitation\", \"company_website_disclaim\", \"diagnostic\", \"life_science\", \"quarterly_report_file_available\", \"expectation\", \"timing\", \"program_support_registration_further\", \"triple_combination_regimen\", \"safety_efficacy_other_reason\", \"development\", \"month_end\", \"expense\", \"release\", \"compare\", \"increase_compare\", \"gaap\", \"record\", \"adverse_event\", \"analysis\", \"full_year\", \"interest\", \"close\", \"non_gaap\", \"hold\", \"revenue_expense\", \"prior\", \"manufacturing\", \"net_income\", \"total_product_revenue\", \"income_taxis\", \"period\", \"conference\", \"net_operating_loss\", \"non_gaap_financial_measure\", \"reflect\", \"employee\", \"investor\", \"provision_income_taxis\", \"crispr\", \"defer_tax_asset\", \"company\", \"other\", \"also\", \"impact\", \"gene_editing\", \"program\", \"continue\", \"process\", \"say\", \"ongoing\", \"cystic_fibrosis\", \"part\", \"need\", \"combination\", \"first_quarter\", \"complete\", \"third_quarter\", \"commitment\", \"innovative\", \"allow\", \"strategy\", \"deliver\", \"see\", \"community\", \"give\", \"foundation\", \"build\", \"pipeline\", \"total\", \"note\", \"important\", \"knowledge\", \"curative\", \"enrollment\", \"medicine\", \"work\", \"include\", \"provide\", \"relate\", \"financial\", \"change\", \"business\", \"information\", \"safety\", \"management\", \"result\", \"control\", \"investment\", \"key\", \"position\", \"guidance\", \"anticipate\", \"leadership\", \"operation\", \"update\", \"biology\", \"relate_non_gaap\", \"product_revenue\", \"reimbursement_agreement\", \"end\", \"discover_develop\", \"guidance_regard\", \"pre_tax_income\", \"therefore\", \"corporate\", \"efficacy\", \"approval\", \"approximately\", \"role\", \"young\", \"certain\", \"previously\", \"type_diabetes\", \"establish\", \"primarily\", \"payment\", \"good\", \"recognize_industry_top_place\", \"site_commercial_office_consistently\", \"possible\", \"daily\", \"production\", \"affect_approximately\", \"tablet\", \"oral\", \"cut_edge\", \"facility\", \"once\", \"replacement\", \"employer_life_science_rank\", \"found_headquarters_now_locate\", \"name_science_magazine_top\", \"year_row\", \"globally\", \"invest\", \"as\"], \"Freq\": [6542.0, 6070.0, 6035.0, 6638.0, 2830.0, 1442.0, 727.0, 204.0, 322.0, 324.0, 294.0, 267.0, 251.0, 187.0, 328.0, 162.0, 186.0, 174.0, 143.0, 122.0, 116.0, 158.0, 151.0, 153.0, 86.0, 133.0, 143.0, 87.0, 93.0, 123.0, 6631.11032969779, 1435.3994120349298, 152.04745226623308, 146.54660316634659, 116.15543030732397, 106.7874919501122, 95.33879535831046, 87.61682915343766, 70.93051836277833, 64.9708067381282, 55.56450362300809, 55.39193837614872, 54.311109790901384, 46.04312799522817, 44.00019484413014, 42.066802542923746, 42.004269946029034, 41.79119865244784, 41.33064311681339, 39.538541059592944, 39.16544759712082, 38.76956594719458, 38.522442938823275, 36.80671351595058, 36.36519673624013, 34.30306162122927, 33.48804227102135, 32.95318357833755, 32.886303120620326, 30.538658478264658, 168.73004191474703, 720.6538614853056, 315.6928550425558, 287.9765123442548, 144.90175834853324, 127.4778241730408, 109.57378888603498, 104.13305630495094, 98.53266962662195, 89.86799730249213, 89.85913137962388, 88.18030013354938, 86.28603792818915, 84.85669257062885, 80.80856786462061, 78.36829640752852, 72.50144277243244, 72.17119347236677, 66.70277491711187, 62.276013724004386, 61.087908356191676, 58.58162331260531, 54.450246662937, 54.28429953195302, 52.22062733991193, 49.77710391967452, 49.29535362840781, 48.30137485432064, 45.24786581790533, 44.591218115765756, 44.18594168155146, 224.2805843775966, 76.90111692621551, 75.52142411099823, 49.51170829706945, 2823.8285738547834, 180.18918760751234, 167.48394521994578, 95.78553589519147, 86.26951963313404, 231.99592148948804, 63.27161103025702, 54.984015030697776, 53.64316532523569, 48.167498819061834, 48.00088742150526, 47.18056982515584, 46.67495186250406, 44.731123467252765, 40.181978090131864, 38.87870311905292, 38.3536309841557, 38.04164170631044, 36.71531792657707, 35.070850851466254, 35.057112151111106, 33.558375230657056, 32.87349634492547, 31.32936995053514, 30.696681590825644, 28.731404000121916, 27.89665214127221, 27.788685439410063, 27.101367592874983, 26.684436499705743, 70.09880331202766, 99.0186381527087, 65.15634360294456, 98.78052943697736, 6062.882058045685, 6027.475619816399, 25.45749176727966, 14.363965686880253, 10.852100684997668, 7.534126359608497, 6.529091832821997, 6.248978854798102, 5.463627761732555, 5.2945982992806515, 4.022347173084026, 3.9136699822822836, 3.861362609226608, 3.67725604847242, 3.4699117759946847, 3.3653634300020543, 3.3082702004362408, 2.98835753487781, 2.770468845886257, 2.750546868746083, 2.6452024979383792, 2.5470295341049134, 2.4264096412483385, 2.416103838026649, 2.392038260495425, 2.379326714960668, 2.3545247173993036, 2.3204964039264477, 2.268972435780241, 3.4624007964834798, 12.430186098364766, 180.44258210548517, 137.0585561008127, 110.07098149815043, 86.4920316107456, 78.2216282821802, 72.0195037434532, 62.61636136540485, 57.9689325586414, 49.78646479329718, 47.30101428881675, 42.16353462377835, 41.229680616075015, 40.16587599111517, 39.97795606436601, 37.7052769552667, 33.39887134050234, 31.240358737025797, 29.144746996328465, 28.687743303787492, 26.05445875739356, 25.44506116846712, 25.11662600181572, 24.758551781096532, 24.466893856311465, 22.673274314483773, 205.58979734918347, 21.860493342841956, 21.72441493033925, 20.32187227581087, 20.174229318499233, 69.87837722114934, 30.177093337106843, 67.02996544181703, 25.154858627772988, 42.212787334309084, 115.31458136999134, 80.70760981873387, 52.57116107363138, 48.798659879333236, 48.406792113654625, 48.17391189672034, 46.162438707957456, 45.494965709890465, 44.01656464434099, 41.51462453806087, 41.51462453806087, 38.77803702091733, 35.57058217897438, 33.89399865816485, 33.89233843723383, 33.86174202030799, 32.45126452965268, 32.07526085959711, 31.52777091569541, 51.074784265475735, 28.72178145682351, 28.59092352766808, 26.925317575926904, 25.956749819476553, 25.086306254753108, 23.821196510719904, 23.752288784242925, 23.49096444710523, 22.62305400297756, 21.951821973756203, 56.068561948092345, 49.854882516798014, 39.28049220364322, 34.74393762396564, 29.76892943381909, 25.6485665599603, 24.830196323222175, 23.70606782341916, 21.84638337217676, 20.166747858774983, 19.900694962276503, 19.872353963848386, 19.111757739797373, 19.01260229104825, 18.979387323657456, 18.389805714386714, 18.16862623677667, 17.86617281258226, 17.647734685447848, 16.568644126692348, 15.850330097524298, 15.625268925223516, 15.159604377906582, 15.06830074919944, 14.976434660360951, 14.539807245857734, 14.02902763773122, 13.771795185486294, 13.520325121863063, 13.50166213944269, 13.326685625419127, 149.75631175266557, 38.28728015539927, 18.279588206966608, 14.922839510514411, 6534.912364511225, 18.743014603962674, 13.029539196736954, 11.09806592098632, 9.51384445521548, 9.3940209145584, 8.458297465436155, 8.400972046695703, 7.918097774138429, 7.749902562508058, 7.498231650244867, 7.208720523973729, 7.166931075620648, 7.109908299210665, 6.261641041569356, 6.135599441358564, 5.98279433643498, 5.929605194922589, 5.301407036623923, 5.267978950886234, 4.990667287342792, 4.689650791164163, 4.525419697927964, 4.234711397979086, 4.0272210565471624, 3.7895237856571695, 5.756608389072094, 3.640963859587118, 3.6294334348637447, 3.603728930240108, 29.329562396150276, 8.420992084923691, 197.8589139928997, 79.62402937445337, 41.953148565576434, 41.92750018587747, 38.12174084149702, 35.80091953275047, 35.52573007291773, 27.24275809463631, 21.71241300600781, 119.78992756404624, 18.542113923333687, 18.280806591157038, 16.68973425113079, 15.934341861794993, 15.569473989546132, 13.081534047453633, 12.45208667445284, 19.93487912756682, 12.174094505946497, 11.923697157400499, 11.85863067623843, 11.30129664200841, 10.878528164209433, 10.559402051359895, 10.233543156187988, 9.889213328123827, 9.659999531127339, 9.518447452603123, 9.223339007505333, 9.141355439604466, 18.57274874078895, 13.286944671505793, 10.740481560381292, 10.712919308217405, 10.346169029246795, 9.448681984302391, 8.896480163884343, 8.48344879948427, 7.592738925950412, 7.3986350201594115, 7.046503423360161, 6.993363930725221, 6.993363930725221, 6.917653674215004, 6.283092297034884, 5.6782974451394725, 5.463605154524526, 5.14965099651861, 4.764997627056534, 4.621809384014205, 4.578806689438557, 4.539648403639745, 4.485561912247216, 4.417865792562044, 4.417865792562044, 4.417865792562044, 4.417865792562044, 4.020258698633076, 3.816263958717439, 3.5975888576009574], \"Total\": [6542.0, 6070.0, 6035.0, 6638.0, 2830.0, 1442.0, 727.0, 204.0, 322.0, 324.0, 294.0, 267.0, 251.0, 187.0, 328.0, 162.0, 186.0, 174.0, 143.0, 122.0, 116.0, 158.0, 151.0, 153.0, 86.0, 133.0, 143.0, 87.0, 93.0, 123.0, 6638.035422810828, 1442.3320339926277, 158.97219234104526, 153.47131784302027, 123.08015630019248, 113.71220811647173, 102.26350274371723, 94.54157017148124, 77.85522549721729, 71.89553672201805, 62.48921311987976, 62.3166444317549, 61.23581652341633, 52.96782920289756, 50.9249066005845, 48.991513417924075, 48.92898475129725, 48.71590923884133, 48.2553468440566, 46.46325155405498, 46.09016240067379, 45.69427817667711, 45.44716217027391, 43.73143231339457, 43.28991113339952, 41.227783539644754, 40.412764851125395, 39.87790556616229, 39.811002261882265, 37.46336347915864, 324.4976031939242, 727.0916725957634, 322.13065956554084, 294.41433556262325, 151.33959797174663, 133.91562958388667, 116.0116169697597, 110.57087378447987, 104.9704843544079, 96.30583649718847, 96.2969447729476, 94.61810592158125, 92.7238438258711, 91.29451500904392, 87.24641084560848, 84.80628369131404, 78.93971059592289, 78.60900894950979, 73.14060172277952, 68.71383390686401, 67.52644625707363, 65.0194354270906, 60.88806415046866, 60.72229354055989, 58.65845670698466, 56.214947110458226, 55.733996162911126, 54.739195693733905, 51.685663289632544, 51.029638009546794, 50.629128721461086, 328.40551603822274, 104.86214171107305, 123.06453698360983, 121.87195800319068, 2830.5944060826414, 186.95479236468555, 174.24954603918806, 102.55114694508896, 93.03512659912182, 251.06483547310623, 70.03721178785844, 61.74963424983438, 60.40878540831959, 54.939203028123885, 54.766510845568135, 53.94619617048947, 53.44055517360276, 51.49673051863141, 46.94761737773629, 45.644302690563144, 45.11924619993914, 44.80726742691182, 43.48094255997641, 41.83648546134745, 41.822732318038554, 40.323984092345384, 39.63911262251384, 38.095001521547815, 37.46229027697825, 35.497295989047274, 34.66228401940272, 34.554289840086724, 33.86697778058811, 33.450077569545236, 94.23044393917405, 143.1579716134364, 101.05134287209816, 328.40551603822274, 6070.6154161655195, 6035.2091550472705, 33.189666022517244, 22.096135064796403, 18.584262579710455, 15.266280747909018, 14.261216160795016, 13.981120720707153, 13.195795484673688, 13.026758704583461, 11.754485502957223, 11.645818183025652, 11.593693662768356, 11.40948119916377, 11.20207503236263, 11.097640834819984, 11.040430416331795, 10.720516095176848, 10.502644193416534, 10.482685088545445, 10.377334060050496, 10.27931901358756, 10.158641498869223, 10.148264637619306, 10.12418226361383, 10.111482052382586, 10.08753935064958, 10.052653688010327, 10.001126699035801, 15.522041741360715, 251.06483547310623, 187.19407738456266, 143.81011129950917, 116.8224787891237, 93.24353491843648, 84.97312872474367, 78.7710154740484, 69.3678710040962, 64.72043257516718, 56.53797354229912, 54.052537140708125, 48.91501769775212, 47.98117305793843, 46.91737781760563, 46.72947237950476, 44.45684442567262, 40.15036342843595, 37.991910199799236, 35.89624346494998, 35.439257527083484, 32.80596111840955, 32.19656261778183, 31.86815841903471, 31.510049562525435, 31.218399636390668, 29.424777667159, 267.506236942163, 28.61198270380772, 28.478482608511534, 27.073363424110713, 26.925794317690205, 106.82522079704536, 42.836520655114285, 121.87195800319068, 37.758386115732506, 123.06453698360983, 122.27007846801379, 87.66299040004881, 59.52654096843408, 55.754039978871205, 55.36217284130854, 55.12929584903902, 53.117819188354765, 52.45035011928369, 50.971945047407885, 48.47000938263802, 48.47000938263802, 45.73342157238185, 42.5259687961916, 40.84938072988391, 40.847721885594716, 40.817208951436264, 39.406646548247224, 39.0306401855854, 38.48315939939993, 62.4104495576119, 35.67716209537647, 35.547187729676956, 33.88096308496754, 32.91257737958692, 32.041732578284815, 30.776579532538545, 30.707677239911394, 30.44636070201363, 29.583886902106467, 28.90722122210589, 267.506236942163, 56.80032306056654, 46.22593526682591, 41.689418920564684, 36.71439843848125, 32.59401039896849, 31.775635452885137, 30.65152522874878, 28.791946819902854, 27.112224304818213, 26.846140383773474, 26.817912862151132, 26.057244335535035, 25.958042140037083, 25.92488142081638, 25.335274598657506, 25.114111097539173, 24.81174337872218, 24.59317892504303, 23.514732616663505, 22.79577160580882, 22.570740808139604, 22.10507311853326, 22.013749312289892, 21.92187284510078, 21.485275060393374, 20.97455485742386, 20.71723996852733, 20.46634322013616, 20.44716503430479, 20.272588206159273, 324.4976031939242, 143.1579716134364, 94.23044393917405, 46.9205123617716, 6542.586114522248, 26.401868424658783, 20.688398555442316, 18.756947768662684, 17.172686360541874, 17.052902472471136, 16.11719347629992, 16.059824684689048, 15.576954896387477, 15.408776045166949, 15.15711269453575, 14.867606220551513, 14.825831470160585, 14.768765846699653, 13.9204982493858, 13.794469658270842, 13.641653836882124, 13.588460987784865, 12.960265164355217, 12.926819026669255, 12.649540399158614, 12.348493083793455, 12.184287575216286, 11.893551184793951, 11.686097355766762, 11.448501116995198, 17.829875916480017, 11.299900151178454, 11.288379748008136, 11.262597389653678, 101.05134287209816, 35.39684315207024, 204.93909090091603, 86.70420989797282, 49.03333287043623, 49.00765941611704, 45.201942394622904, 42.88108123143206, 42.60590022017544, 34.32295213478823, 28.792581480764234, 162.84411212892155, 25.622313506535843, 25.361003787266213, 23.769930086377162, 23.014521510149653, 22.649635656820656, 20.16170015184768, 19.53227671330237, 31.369678289706286, 19.254258883024466, 19.00404209051039, 18.93907807809358, 18.38455078680278, 17.959243650358992, 17.6395763585492, 17.313764015771948, 16.969379322761984, 16.74038503320653, 16.59866264544416, 16.303519395549674, 16.2215277733914, 26.052320863294383, 20.76648843890006, 18.220062779955263, 18.192469001313526, 17.825743565002263, 16.92824440387346, 16.37606844585509, 15.963006604103331, 15.072301109503005, 14.878183169753797, 14.526067354687518, 14.472918844517636, 14.472918844517636, 14.39722903696983, 13.762725163543088, 13.157971547022882, 12.943178498928127, 12.629198872442782, 12.244546049049102, 12.101525306950652, 12.058486709396336, 12.019347871944744, 11.965549581025414, 11.915999739002428, 11.915999739002428, 11.915999739002428, 11.915999739002428, 11.499831008989347, 11.295886782285404, 11.077171674215563], \"Category\": [\"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Default\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic1\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic2\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic3\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic4\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic5\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic6\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic7\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic8\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic9\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\", \"Topic10\"], \"logprob\": [30.0, 29.0, 28.0, 27.0, 26.0, 25.0, 24.0, 23.0, 22.0, 21.0, 20.0, 19.0, 18.0, 17.0, 16.0, 15.0, 14.0, 13.0, 12.0, 11.0, 10.0, 9.0, 8.0, 7.0, 6.0, 5.0, 4.0, 3.0, 2.0, 1.0, -1.0364, -2.5667, -4.8117, -4.8485, -5.081, -5.165, -5.2784, -5.3629, -5.5742, -5.6619, -5.8183, -5.8214, -5.8412, -6.0063, -6.0517, -6.0966, -6.0981, -6.1032, -6.1143, -6.1586, -6.1681, -6.1782, -6.1846, -6.2302, -6.2423, -6.3006, -6.3247, -6.3408, -6.3428, -6.4169, -4.7076, -3.2244, -4.0498, -4.1416, -4.8285, -4.9566, -5.1079, -5.1589, -5.2141, -5.3062, -5.3063, -5.3251, -5.3469, -5.3636, -5.4124, -5.4431, -5.5209, -5.5255, -5.6043, -5.6729, -5.6922, -5.7341, -5.8072, -5.8103, -5.849, -5.897, -5.9067, -5.9271, -5.9924, -6.007, -6.0161, -4.3916, -5.462, -5.4801, -5.9023, -1.6988, -4.4506, -4.5238, -5.0825, -5.1872, -4.1979, -5.4972, -5.6376, -5.6623, -5.77, -5.7734, -5.7907, -5.8014, -5.844, -5.9512, -5.9842, -5.9978, -6.006, -6.0414, -6.0873, -6.0877, -6.1314, -6.152, -6.2001, -6.2205, -6.2867, -6.3161, -6.32, -6.3451, -6.3606, -5.3947, -5.0493, -5.4679, -5.0517, -0.7887, -0.7946, -6.2617, -6.834, -7.1143, -7.4792, -7.6224, -7.6663, -7.8006, -7.832, -8.1068, -8.1342, -8.1477, -8.1965, -8.2545, -8.2851, -8.3023, -8.404, -8.4797, -8.4869, -8.5259, -8.5637, -8.6123, -8.6165, -8.6265, -8.6319, -8.6423, -8.6569, -8.6793, -8.2567, -6.9785, -4.132, -4.407, -4.6263, -4.8674, -4.9679, -5.0505, -5.1904, -5.2675, -5.4197, -5.4709, -5.5859, -5.6083, -5.6344, -5.6391, -5.6977, -5.8189, -5.8857, -5.9552, -5.971, -6.0673, -6.0909, -6.1039, -6.1183, -6.1301, -6.2063, -4.0016, -6.2428, -6.249, -6.3158, -6.3231, -5.0807, -5.9204, -5.1223, -6.1024, -5.5847, -4.3781, -4.7349, -5.1636, -5.238, -5.2461, -5.2509, -5.2936, -5.3082, -5.3412, -5.3997, -5.3997, -5.4679, -5.5542, -5.6025, -5.6026, -5.6035, -5.646, -5.6577, -5.6749, -5.1925, -5.7681, -5.7727, -5.8327, -5.8693, -5.9034, -5.9552, -5.9581, -5.9691, -6.0068, -6.0369, -5.0992, -5.1771, -5.4155, -5.5382, -5.6928, -5.8417, -5.8742, -5.9205, -6.0022, -6.0822, -6.0955, -6.0969, -6.1359, -6.1411, -6.1429, -6.1744, -6.1865, -6.2033, -6.2156, -6.2787, -6.323, -6.3373, -6.3676, -6.3736, -6.3797, -6.4093, -6.4451, -6.4636, -6.482, -6.4834, -6.4964, -4.0772, -5.4411, -6.1804, -6.3833, -0.2657, -6.1198, -6.4834, -6.6438, -6.7978, -6.8105, -6.9154, -6.9222, -6.9814, -7.0029, -7.0359, -7.0753, -7.0811, -7.0891, -7.2161, -7.2365, -7.2617, -7.2706, -7.3826, -7.3889, -7.443, -7.5052, -7.5409, -7.6073, -7.6575, -7.7183, -7.3002, -7.7583, -7.7615, -7.7686, -5.672, -6.9199, -3.5803, -4.4905, -5.1313, -5.1319, -5.227, -5.2898, -5.2976, -5.563, -5.7899, -4.0821, -5.9478, -5.962, -6.053, -6.0993, -6.1225, -6.2966, -6.3459, -5.8753, -6.3685, -6.3893, -6.3948, -6.4429, -6.481, -6.5108, -6.5421, -6.5764, -6.5998, -6.6146, -6.6461, -6.655, -5.1587, -5.4936, -5.7064, -5.709, -5.7438, -5.8345, -5.8948, -5.9423, -6.0532, -6.0791, -6.1279, -6.1355, -6.1355, -6.1463, -6.2426, -6.3438, -6.3823, -6.4415, -6.5191, -6.5496, -6.559, -6.5676, -6.5796, -6.5948, -6.5948, -6.5948, -6.5948, -6.6891, -6.7412, -6.8002], \"loglift\": [30.0, 29.0, 28.0, 27.0, 26.0, 25.0, 24.0, 23.0, 22.0, 21.0, 20.0, 19.0, 18.0, 17.0, 16.0, 15.0, 14.0, 13.0, 12.0, 11.0, 10.0, 9.0, 8.0, 7.0, 6.0, 5.0, 4.0, 3.0, 2.0, 1.0, 1.8045, 1.8007, 1.761, 1.7593, 1.7476, 1.7427, 1.7354, 1.7294, 1.7123, 1.7042, 1.688, 1.6877, 1.6855, 1.6654, 1.6593, 1.6531, 1.6529, 1.6522, 1.6506, 1.6441, 1.6427, 1.6412, 1.6402, 1.6331, 1.6312, 1.6216, 1.6175, 1.6148, 1.6144, 1.6011, 1.1515, 1.828, 1.8167, 1.8147, 1.7934, 1.7876, 1.7798, 1.7769, 1.7736, 1.7677, 1.7677, 1.7664, 1.7649, 1.7637, 1.7602, 1.7579, 1.7518, 1.7514, 1.7447, 1.7385, 1.7366, 1.7326, 1.7251, 1.7248, 1.7206, 1.7152, 1.7141, 1.7117, 1.7038, 1.702, 1.7007, 1.4555, 1.5267, 1.3486, 0.9361, 1.9943, 1.9599, 1.9571, 1.9285, 1.9212, 1.9177, 1.8951, 1.8807, 1.878, 1.8652, 1.8649, 1.8627, 1.8614, 1.8559, 1.8411, 1.8363, 1.8343, 1.833, 1.8276, 1.8203, 1.8203, 1.8131, 1.8096, 1.8012, 1.7976, 1.7853, 1.7796, 1.7788, 1.7739, 1.7708, 1.7009, 1.6281, 1.5579, 0.7954, 2.1414, 2.1414, 1.8775, 1.712, 1.6047, 1.4365, 1.3614, 1.3374, 1.2609, 1.2424, 1.0703, 1.0522, 1.0433, 1.0104, 0.9707, 0.9495, 0.9376, 0.8653, 0.8101, 0.8048, 0.7758, 0.7475, 0.7108, 0.7076, 0.6999, 0.6959, 0.6877, 0.6766, 0.6593, 0.6424, -0.8629, 2.2772, 2.2658, 2.2544, 2.2388, 2.2311, 2.2243, 2.2115, 2.2038, 2.1868, 2.1805, 2.1654, 2.1623, 2.1586, 2.1579, 2.1492, 2.1298, 2.1183, 2.1056, 2.1026, 2.0835, 2.0786, 2.0758, 2.0728, 2.0702, 2.0533, 2.0507, 2.0448, 2.0432, 2.0271, 2.0252, 1.8895, 1.9636, 1.7161, 1.9078, 1.2439, 2.4571, 2.433, 2.3914, 2.3824, 2.3814, 2.3808, 2.3753, 2.3734, 2.3689, 2.3607, 2.3607, 2.3507, 2.337, 2.329, 2.329, 2.3288, 2.3214, 2.3194, 2.3163, 2.3152, 2.2988, 2.2979, 2.2858, 2.2782, 2.2709, 2.2594, 2.2588, 2.2563, 2.2474, 2.2404, 0.9531, 2.4247, 2.3923, 2.3729, 2.3455, 2.3155, 2.3085, 2.2982, 2.2791, 2.2592, 2.2558, 2.2554, 2.2452, 2.2438, 2.2433, 2.2348, 2.2314, 2.2268, 2.2233, 2.205, 2.1918, 2.1874, 2.178, 2.1761, 2.1742, 2.1647, 2.153, 2.1468, 2.1406, 2.1401, 2.1357, 1.7819, 1.2363, 0.9152, 1.4096, 2.5896, 2.2482, 2.1284, 2.066, 2.0002, 1.9945, 1.9461, 1.9428, 1.9142, 1.9035, 1.887, 1.8669, 1.8639, 1.8598, 1.7919, 1.7806, 1.7666, 1.7615, 1.6969, 1.6931, 1.6607, 1.6226, 1.6004, 1.5581, 1.5255, 1.4852, 1.4603, 1.4582, 1.4561, 1.4513, 1.3538, 1.1549, 2.7384, 2.6884, 2.6176, 2.6175, 2.6032, 2.5931, 2.5918, 2.5425, 2.4913, 2.4665, 2.4502, 2.4462, 2.4199, 2.4059, 2.3987, 2.341, 2.3234, 2.3202, 2.3152, 2.3074, 2.3054, 2.287, 2.2723, 2.2604, 2.2477, 2.2336, 2.2237, 2.2175, 2.2039, 2.2, 3.2225, 3.1144, 3.0325, 3.0314, 3.0169, 2.9778, 2.9508, 2.9288, 2.8753, 2.8624, 2.8375, 2.8336, 2.8336, 2.828, 2.7769, 2.7206, 2.6985, 2.6639, 2.6172, 2.5984, 2.5926, 2.5873, 2.5798, 2.5687, 2.5687, 2.5687, 2.5687, 2.51, 2.4758, 2.4363]}, \"token.table\": {\"Topic\": [1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 4, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 8, 9, 1, 2, 3, 5, 6, 7, 9, 1, 2, 3, 5, 6, 7, 9, 10, 1, 2, 3, 5, 6, 7, 9, 10], \"Freq\": [0.8165736771925178, 0.024744656884621755, 0.024744656884621755, 0.024744656884621755, 0.024744656884621755, 0.024744656884621755, 0.024744656884621755, 0.03203239152702497, 0.03203239152702497, 0.03203239152702497, 0.7687773966485995, 0.03203239152702497, 0.03203239152702497, 0.03203239152702497, 0.01095356057152981, 0.9310526485800339, 0.01095356057152981, 0.01095356057152981, 0.01095356057152981, 0.01095356057152981, 0.01095356057152981, 0.021399770831536147, 0.021399770831536147, 0.021399770831536147, 0.8559908332614459, 0.021399770831536147, 0.021399770831536147, 0.021399770831536147, 0.8246865846500213, 0.024255487783824158, 0.024255487783824158, 0.024255487783824158, 0.024255487783824158, 0.024255487783824158, 0.024255487783824158, 0.011461789548794198, 0.92840495345233, 0.011461789548794198, 0.011461789548794198, 0.011461789548794198, 0.011461789548794198, 0.011461789548794198, 0.019418708526324834, 0.019418708526324834, 0.8738418836846175, 0.019418708526324834, 0.019418708526324834, 0.019418708526324834, 0.019418708526324834, 0.034731934115296965, 0.034731934115296965, 0.034731934115296965, 0.034731934115296965, 0.034731934115296965, 0.7641025505365333, 0.034731934115296965, 0.07726077486166275, 0.07726077486166275, 0.07726077486166275, 0.07726077486166275, 0.07726077486166275, 0.07726077486166275, 0.07726077486166275, 0.38630387430831375, 0.014415895796210174, 0.014415895796210174, 0.014415895796210174, 0.908201435161241, 0.014415895796210174, 0.014415895796210174, 0.014415895796210174, 0.020841507955474032, 0.020841507955474032, 0.020841507955474032, 0.8545018261744353, 0.020841507955474032, 0.020841507955474032, 0.020841507955474032, 0.0724928195699371, 0.0724928195699371, 0.0724928195699371, 0.0724928195699371, 0.0724928195699371, 0.0724928195699371, 0.4349569174196226, 0.0724928195699371, 0.0106122815323411, 0.0106122815323411, 0.742859707263877, 0.0106122815323411, 0.0106122815323411, 0.19102106758213977, 0.0106122815323411, 0.036883731440001635, 0.036883731440001635, 0.036883731440001635, 0.036883731440001635, 0.036883731440001635, 0.7376746288000328, 0.036883731440001635, 0.010384545453210754, 0.9346090907889678, 0.010384545453210754, 0.010384545453210754, 0.010384545453210754, 0.010384545453210754, 0.010384545453210754, 0.09521411766256338, 0.09521411766256338, 0.09521411766256338, 0.28564235298769014, 0.09521411766256338, 0.09521411766256338, 0.09521411766256338, 0.09521411766256338, 0.04959899177492514, 0.04959899177492514, 0.04959899177492514, 0.04959899177492514, 0.04959899177492514, 0.04959899177492514, 0.6447868930740268, 0.031059216223526618, 0.031059216223526618, 0.031059216223526618, 0.7764804055881654, 0.031059216223526618, 0.031059216223526618, 0.031059216223526618, 0.02522760813348858, 0.02522760813348858, 0.8325110684051231, 0.02522760813348858, 0.02522760813348858, 0.02522760813348858, 0.02522760813348858, 0.038384296172588574, 0.038384296172588574, 0.038384296172588574, 0.038384296172588574, 0.038384296172588574, 0.038384296172588574, 0.038384296172588574, 0.7293016272791829, 0.868451675144044, 0.018879384242261824, 0.018879384242261824, 0.018879384242261824, 0.018879384242261824, 0.018879384242261824, 0.018879384242261824, 0.04815450637897869, 0.04815450637897869, 0.04815450637897869, 0.04815450637897869, 0.04815450637897869, 0.04815450637897869, 0.04815450637897869, 0.6260085829267229, 0.0902757517361322, 0.0902757517361322, 0.0902757517361322, 0.0902757517361322, 0.0902757517361322, 0.0902757517361322, 0.0902757517361322, 0.3611030069445288, 0.017687227492365742, 0.017687227492365742, 0.017687227492365742, 0.8843613746182871, 0.017687227492365742, 0.017687227492365742, 0.017687227492365742, 0.9409719657400669, 0.008794130520935205, 0.008794130520935205, 0.008794130520935205, 0.008794130520935205, 0.008794130520935205, 0.008794130520935205, 0.05380896851359383, 0.05380896851359383, 0.05380896851359383, 0.5918986536495322, 0.05380896851359383, 0.05380896851359383, 0.05380896851359383, 0.05380896851359383, 0.01646841615644908, 0.8892944724482502, 0.01646841615644908, 0.01646841615644908, 0.01646841615644908, 0.01646841615644908, 0.01646841615644908, 0.02063131434751074, 0.02063131434751074, 0.02063131434751074, 0.02063131434751074, 0.8665152025954511, 0.02063131434751074, 0.02063131434751074, 0.8825892424331735, 0.01604707713514861, 0.01604707713514861, 0.01604707713514861, 0.01604707713514861, 0.01604707713514861, 0.01604707713514861, 0.052620384402292344, 0.052620384402292344, 0.052620384402292344, 0.052620384402292344, 0.052620384402292344, 0.052620384402292344, 0.6314446128275081, 0.018259333752698306, 0.018259333752698306, 0.8764480201295186, 0.018259333752698306, 0.018259333752698306, 0.018259333752698306, 0.018259333752698306, 0.8274750882217425, 0.026692744781346534, 0.026692744781346534, 0.026692744781346534, 0.026692744781346534, 0.026692744781346534, 0.026692744781346534, 0.08207291512341448, 0.08207291512341448, 0.08207291512341448, 0.08207291512341448, 0.08207291512341448, 0.08207291512341448, 0.41036457561707246, 0.08207291512341448, 0.02332030749418218, 0.02332030749418218, 0.02332030749418218, 0.02332030749418218, 0.02332030749418218, 0.02332030749418218, 0.8395310697905585, 0.014278124078225493, 0.014278124078225493, 0.8995218169282061, 0.014278124078225493, 0.014278124078225493, 0.014278124078225493, 0.014278124078225493, 0.09877340944305063, 0.09877340944305063, 0.09877340944305063, 0.19754681888610126, 0.09877340944305063, 0.09877340944305063, 0.09877340944305063, 0.09877340944305063, 0.00016472794460625642, 0.00016472794460625642, 0.00016472794460625642, 0.9987455281477328, 0.00016472794460625642, 0.00016472794460625642, 0.00016472794460625642, 0.00016472794460625642, 0.035114230408509334, 0.035114230408509334, 0.035114230408509334, 0.7725130689872054, 0.035114230408509334, 0.035114230408509334, 0.035114230408509334, 0.05609864162768085, 0.05609864162768085, 0.05609864162768085, 0.05609864162768085, 0.05609864162768085, 0.05609864162768085, 0.05609864162768085, 0.5609864162768086, 0.00035328268785210206, 0.00035328268785210206, 0.9976703104943362, 0.00035328268785210206, 0.00035328268785210206, 0.00035328268785210206, 0.00035328268785210206, 0.08625378840320495, 0.08625378840320495, 0.08625378840320495, 0.3450151536128198, 0.08625378840320495, 0.08625378840320495, 0.08625378840320495, 0.08625378840320495, 0.022122943108722627, 0.022122943108722627, 0.022122943108722627, 0.022122943108722627, 0.022122943108722627, 0.022122943108722627, 0.8406718381314598, 0.8640172940345654, 0.01963675668260376, 0.01963675668260376, 0.01963675668260376, 0.01963675668260376, 0.01963675668260376, 0.01963675668260376, 0.022493724260431926, 0.022493724260431926, 0.022493724260431926, 0.8547615218964131, 0.022493724260431926, 0.022493724260431926, 0.022493724260431926, 0.009361085261877209, 0.2995547283800707, 0.009361085261877209, 0.6552759683314046, 0.009361085261877209, 0.009361085261877209, 0.009361085261877209, 0.00861982641152796, 0.9481809052680756, 0.00861982641152796, 0.00861982641152796, 0.00861982641152796, 0.00861982641152796, 0.00861982641152796, 0.03837704352475486, 0.03837704352475486, 0.03837704352475486, 0.03837704352475486, 0.03837704352475486, 0.7291638269703423, 0.03837704352475486, 0.019596454903578125, 0.8818404706610157, 0.019596454903578125, 0.019596454903578125, 0.019596454903578125, 0.019596454903578125, 0.019596454903578125, 0.008559996418198764, 0.008559996418198764, 0.008559996418198764, 0.941599606001864, 0.008559996418198764, 0.008559996418198764, 0.008559996418198764, 0.06489808126672435, 0.06489808126672435, 0.06489808126672435, 0.06489808126672435, 0.06489808126672435, 0.06489808126672435, 0.5191846501337948, 0.06489808126672435, 0.03398496366944856, 0.03398496366944856, 0.03398496366944856, 0.7816541643973169, 0.03398496366944856, 0.03398496366944856, 0.03398496366944856, 0.06771046479983756, 0.06771046479983756, 0.06771046479983756, 0.06771046479983756, 0.06771046479983756, 0.06771046479983756, 0.47397325359886294, 0.06771046479983756, 0.07735855185540272, 0.07735855185540272, 0.07735855185540272, 0.07735855185540272, 0.07735855185540272, 0.07735855185540272, 0.38679275927701356, 0.07735855185540272, 0.52080507941072, 0.0030816868604184615, 0.0030816868604184615, 0.0030816868604184615, 0.0030816868604184615, 0.4622530290627692, 0.0030816868604184615, 0.025985392457553602, 0.025985392457553602, 0.025985392457553602, 0.025985392457553602, 0.8315325586417153, 0.025985392457553602, 0.025985392457553602, 0.028131620639152255, 0.028131620639152255, 0.028131620639152255, 0.028131620639152255, 0.8158169985354153, 0.028131620639152255, 0.028131620639152255, 0.027237270458771178, 0.027237270458771178, 0.027237270458771178, 0.027237270458771178, 0.027237270458771178, 0.8171181137631354, 0.027237270458771178, 0.06726032322659303, 0.06726032322659303, 0.06726032322659303, 0.06726032322659303, 0.06726032322659303, 0.06726032322659303, 0.47082226258615123, 0.06726032322659303, 0.0313792842012077, 0.0313792842012077, 0.0313792842012077, 0.7844821050301924, 0.0313792842012077, 0.0313792842012077, 0.0313792842012077, 0.04523848415419099, 0.04523848415419099, 0.04523848415419099, 0.04523848415419099, 0.04523848415419099, 0.6785772623128649, 0.04523848415419099, 0.01793591998676624, 0.01793591998676624, 0.01793591998676624, 0.01793591998676624, 0.8788600793515458, 0.01793591998676624, 0.01793591998676624, 0.02063131434751074, 0.02063131434751074, 0.02063131434751074, 0.02063131434751074, 0.8665152025954511, 0.02063131434751074, 0.02063131434751074, 0.048336269108511486, 0.048336269108511486, 0.048336269108511486, 0.048336269108511486, 0.048336269108511486, 0.048336269108511486, 0.6283714984106493, 0.048336269108511486, 0.039028481941918165, 0.039028481941918165, 0.039028481941918165, 0.039028481941918165, 0.039028481941918165, 0.039028481941918165, 0.7415411568964451, 0.09057617885265853, 0.09057617885265853, 0.09057617885265853, 0.27172853655797563, 0.09057617885265853, 0.09057617885265853, 0.09057617885265853, 0.09057617885265853, 0.06133644986327107, 0.06133644986327107, 0.06133644986327107, 0.06133644986327107, 0.06133644986327107, 0.06133644986327107, 0.5520280487694396, 0.0489065353716406, 0.0489065353716406, 0.0489065353716406, 0.0489065353716406, 0.0489065353716406, 0.6846914952029683, 0.0489065353716406, 0.088586672518388, 0.088586672518388, 0.088586672518388, 0.088586672518388, 0.088586672518388, 0.088586672518388, 0.354346690073552, 0.088586672518388, 0.08263421136058265, 0.08263421136058265, 0.08263421136058265, 0.08263421136058265, 0.08263421136058265, 0.08263421136058265, 0.08263421136058265, 0.4131710568029132, 0.06204554170491806, 0.06204554170491806, 0.06204554170491806, 0.06204554170491806, 0.06204554170491806, 0.06204554170491806, 0.49636433363934446, 0.06204554170491806, 0.07266002830957928, 0.07266002830957928, 0.07266002830957928, 0.07266002830957928, 0.07266002830957928, 0.07266002830957928, 0.07266002830957928, 0.4359601698574757, 0.02562089669155145, 0.02562089669155145, 0.02562089669155145, 0.02562089669155145, 0.8198686941296464, 0.02562089669155145, 0.02562089669155145, 0.003396573737107633, 0.9782132362869983, 0.003396573737107633, 0.003396573737107633, 0.003396573737107633, 0.003396573737107633, 0.003396573737107633, 0.049327692637498415, 0.049327692637498415, 0.049327692637498415, 0.049327692637498415, 0.049327692637498415, 0.6412600042874794, 0.049327692637498415, 0.0735918512699072, 0.0735918512699072, 0.0735918512699072, 0.0735918512699072, 0.0735918512699072, 0.0735918512699072, 0.44155110761944316, 0.0735918512699072, 0.02893996677772528, 0.02893996677772528, 0.8103190697763079, 0.02893996677772528, 0.02893996677772528, 0.02893996677772528, 0.02893996677772528, 0.023910441632449018, 0.023910441632449018, 0.8368654571357156, 0.023910441632449018, 0.023910441632449018, 0.023910441632449018, 0.023910441632449018, 0.045256783463149694, 0.045256783463149694, 0.045256783463149694, 0.6335949684840958, 0.045256783463149694, 0.045256783463149694, 0.045256783463149694, 0.045256783463149694, 0.003738230597652226, 0.003738230597652226, 0.003738230597652226, 0.7700755031163585, 0.20934091346852465, 0.003738230597652226, 0.003738230597652226, 0.029515099600096212, 0.029515099600096212, 0.029515099600096212, 0.029515099600096212, 0.7969076892025978, 0.029515099600096212, 0.029515099600096212, 0.03693667404137273, 0.03693667404137273, 0.03693667404137273, 0.7387334808274545, 0.03693667404137273, 0.03693667404137273, 0.03693667404137273, 0.09998873427894969, 0.09998873427894969, 0.09998873427894969, 0.19997746855789938, 0.09998873427894969, 0.09998873427894969, 0.09998873427894969, 0.09998873427894969, 0.057757515875176045, 0.057757515875176045, 0.057757515875176045, 0.057757515875176045, 0.057757515875176045, 0.057757515875176045, 0.5775751587517605, 0.02490637480237012, 0.02490637480237012, 0.02490637480237012, 0.821910368478214, 0.02490637480237012, 0.02490637480237012, 0.02490637480237012, 0.003983034892622861, 0.003983034892622861, 0.9240640950885038, 0.04779641871147434, 0.003983034892622861, 0.003983034892622861, 0.003983034892622861, 0.003983034892622861, 0.019347725004442127, 0.8706476251998957, 0.019347725004442127, 0.019347725004442127, 0.019347725004442127, 0.019347725004442127, 0.019347725004442127, 0.021314064138187032, 0.021314064138187032, 0.021314064138187032, 0.8525625655274813, 0.021314064138187032, 0.021314064138187032, 0.021314064138187032, 0.08586773245846727, 0.08586773245846727, 0.08586773245846727, 0.34347092983386907, 0.08586773245846727, 0.08586773245846727, 0.08586773245846727, 0.08586773245846727, 0.01778886312985537, 0.8894431564927685, 0.01778886312985537, 0.01778886312985537, 0.01778886312985537, 0.01778886312985537, 0.01778886312985537, 0.02632139302133022, 0.02632139302133022, 0.02632139302133022, 0.8159631836612368, 0.02632139302133022, 0.02632139302133022, 0.02632139302133022, 0.061646474608903754, 0.061646474608903754, 0.061646474608903754, 0.061646474608903754, 0.061646474608903754, 0.061646474608903754, 0.5548182714801337, 0.012721188237372328, 0.9159255530908077, 0.012721188237372328, 0.012721188237372328, 0.012721188237372328, 0.012721188237372328, 0.012721188237372328, 0.047676816351888106, 0.047676816351888106, 0.047676816351888106, 0.047676816351888106, 0.047676816351888106, 0.6674754289264334, 0.047676816351888106, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.33568312249181603, 0.056690703885036324, 0.056690703885036324, 0.056690703885036324, 0.056690703885036324, 0.056690703885036324, 0.056690703885036324, 0.6235977427353996, 0.09947622100945219, 0.09947622100945219, 0.09947622100945219, 0.19895244201890439, 0.09947622100945219, 0.09947622100945219, 0.09947622100945219, 0.09947622100945219, 0.08878946528965374, 0.08878946528965374, 0.08878946528965374, 0.08878946528965374, 0.08878946528965374, 0.08878946528965374, 0.355157861158615, 0.08878946528965374, 0.06264484033621508, 0.06264484033621508, 0.06264484033621508, 0.06264484033621508, 0.06264484033621508, 0.06264484033621508, 0.06264484033621508, 0.5011587226897206, 0.010383586669009346, 0.9345228002108412, 0.010383586669009346, 0.010383586669009346, 0.010383586669009346, 0.010383586669009346, 0.010383586669009346, 0.0244994703383513, 0.0244994703383513, 0.0244994703383513, 0.0244994703383513, 0.8329819915039443, 0.0244994703383513, 0.0244994703383513, 0.8621413549747171, 0.020527175118445644, 0.020527175118445644, 0.020527175118445644, 0.020527175118445644, 0.020527175118445644, 0.020527175118445644, 0.012695024863929249, 0.012695024863929249, 0.012695024863929249, 0.9140417902029059, 0.012695024863929249, 0.012695024863929249, 0.012695024863929249, 0.03249223972218062, 0.03249223972218062, 0.03249223972218062, 0.03249223972218062, 0.7798137533323349, 0.03249223972218062, 0.03249223972218062, 0.021632877609242252, 0.021632877609242252, 0.021632877609242252, 0.021632877609242252, 0.021632877609242252, 0.8436822267604479, 0.021632877609242252, 0.018500519178162287, 0.018500519178162287, 0.018500519178162287, 0.8695244013736275, 0.018500519178162287, 0.018500519178162287, 0.018500519178162287, 0.0829291455967497, 0.0829291455967497, 0.0829291455967497, 0.0829291455967497, 0.0829291455967497, 0.0829291455967497, 0.0829291455967497, 0.41464572798374855, 0.020404973669710336, 0.020404973669710336, 0.020404973669710336, 0.020404973669710336, 0.020404973669710336, 0.020404973669710336, 0.857008894127834, 0.009526487432636184, 0.9431222558309822, 0.009526487432636184, 0.009526487432636184, 0.009526487432636184, 0.009526487432636184, 0.009526487432636184, 0.06597562610724056, 0.06597562610724056, 0.06597562610724056, 0.06597562610724056, 0.06597562610724056, 0.06597562610724056, 0.46182938275068386, 0.06597562610724056, 0.858386909384758, 0.020437783556779953, 0.020437783556779953, 0.020437783556779953, 0.020437783556779953, 0.020437783556779953, 0.020437783556779953, 0.8961546674074643, 0.016002761917990434, 0.016002761917990434, 0.016002761917990434, 0.016002761917990434, 0.016002761917990434, 0.016002761917990434, 0.011407322467970967, 0.011407322467970967, 0.011407322467970967, 0.011407322467970967, 0.9239931199056484, 0.011407322467970967, 0.011407322467970967, 0.018062874859814913, 0.018062874859814913, 0.018062874859814913, 0.018062874859814913, 0.8670179932711158, 0.018062874859814913, 0.018062874859814913, 0.02537642980545573, 0.02537642980545573, 0.02537642980545573, 0.02537642980545573, 0.8120457537745833, 0.02537642980545573, 0.02537642980545573, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.33568312249181603, 0.08098154108475235, 0.08098154108475235, 0.08098154108475235, 0.08098154108475235, 0.08098154108475235, 0.08098154108475235, 0.40490770542376175, 0.08098154108475235, 0.08764640412162585, 0.08764640412162585, 0.08764640412162585, 0.3505856164865034, 0.08764640412162585, 0.08764640412162585, 0.08764640412162585, 0.08764640412162585, 0.03724930234680687, 0.03724930234680687, 0.03724930234680687, 0.03724930234680687, 0.03724930234680687, 0.7449860469361375, 0.03724930234680687, 0.02216349084310165, 0.02216349084310165, 0.8422126520378627, 0.02216349084310165, 0.02216349084310165, 0.02216349084310165, 0.02216349084310165, 0.014553110242042647, 0.9022928350066441, 0.014553110242042647, 0.014553110242042647, 0.014553110242042647, 0.014553110242042647, 0.014553110242042647, 0.010724604133409747, 0.010724604133409747, 0.010724604133409747, 0.9223159554732383, 0.010724604133409747, 0.010724604133409747, 0.010724604133409747, 0.031470653088361854, 0.031470653088361854, 0.031470653088361854, 0.031470653088361854, 0.031470653088361854, 0.7867663272090463, 0.031470653088361854, 0.008178615835775413, 0.008178615835775413, 0.008178615835775413, 0.008178615835775413, 0.9405408211141726, 0.008178615835775413, 0.008178615835775413, 0.0644245142915288, 0.3865470857491728, 0.0644245142915288, 0.1932735428745864, 0.0644245142915288, 0.0644245142915288, 0.0644245142915288, 0.0644245142915288, 0.00015284475931930808, 0.00015284475931930808, 0.00015284475931930808, 0.00015284475931930808, 0.00015284475931930808, 0.00015284475931930808, 0.9988405021516783, 0.00015284475931930808, 0.9949165422247946, 0.0006933216322124004, 0.0006933216322124004, 0.0006933216322124004, 0.0006933216322124004, 0.0006933216322124004, 0.0006933216322124004, 0.06550383924630544, 0.06550383924630544, 0.06550383924630544, 0.5240307139704435, 0.06550383924630544, 0.06550383924630544, 0.06550383924630544, 0.06550383924630544, 0.09913220313094548, 0.09913220313094548, 0.09913220313094548, 0.19826440626189096, 0.09913220313094548, 0.09913220313094548, 0.09913220313094548, 0.09913220313094548, 0.07905425560493211, 0.07905425560493211, 0.07905425560493211, 0.07905425560493211, 0.07905425560493211, 0.07905425560493211, 0.39527127802466056, 0.07905425560493211, 0.006607655982981325, 0.9581101175322921, 0.006607655982981325, 0.006607655982981325, 0.006607655982981325, 0.006607655982981325, 0.006607655982981325, 0.08695779957273339, 0.08695779957273339, 0.08695779957273339, 0.08695779957273339, 0.08695779957273339, 0.08695779957273339, 0.08695779957273339, 0.34783119829093356, 0.06884175706904615, 0.06884175706904615, 0.06884175706904615, 0.06884175706904615, 0.06884175706904615, 0.06884175706904615, 0.06884175706904615, 0.48189229948332307, 0.04415082057617392, 0.04415082057617392, 0.04415082057617392, 0.04415082057617392, 0.04415082057617392, 0.04415082057617392, 0.7064131292187827, 0.05892967450251075, 0.05892967450251075, 0.05892967450251075, 0.05892967450251075, 0.05892967450251075, 0.05892967450251075, 0.5892967450251074, 0.03857298260184327, 0.03857298260184327, 0.03857298260184327, 0.03857298260184327, 0.03857298260184327, 0.7328866694350221, 0.03857298260184327, 0.022998581473265618, 0.022998581473265618, 0.8509475145108278, 0.022998581473265618, 0.022998581473265618, 0.022998581473265618, 0.022998581473265618, 0.5541286463270476, 0.021312640243347985, 0.021312640243347985, 0.021312640243347985, 0.021312640243347985, 0.31968960365021976, 0.021312640243347985, 0.05608563989364097, 0.05608563989364097, 0.05608563989364097, 0.05608563989364097, 0.05608563989364097, 0.28042819946820485, 0.3365138393618458, 0.05608563989364097, 0.004879498565178471, 0.004879498565178471, 0.004879498565178471, 0.004879498565178471, 0.004879498565178471, 0.004879498565178471, 0.9661407159053372, 0.018826074098675233, 0.018826074098675233, 0.018826074098675233, 0.018826074098675233, 0.8659994085390608, 0.018826074098675233, 0.018826074098675233, 0.043867784661659796, 0.043867784661659796, 0.043867784661659796, 0.043867784661659796, 0.043867784661659796, 0.7018845545865567, 0.043867784661659796, 0.015451071017465567, 0.015451071017465567, 0.015451071017465567, 0.8961621190130029, 0.015451071017465567, 0.015451071017465567, 0.015451071017465567, 0.03068048355386323, 0.03068048355386323, 0.03068048355386323, 0.03068048355386323, 0.03068048355386323, 0.797692572400444, 0.03068048355386323, 0.023470927614069367, 0.023470927614069367, 0.023470927614069367, 0.023470927614069367, 0.023470927614069367, 0.023470927614069367, 0.8449533941064973, 0.09853901486693899, 0.09853901486693899, 0.09853901486693899, 0.19707802973387797, 0.09853901486693899, 0.09853901486693899, 0.09853901486693899, 0.09853901486693899, 0.07183650915972939, 0.07183650915972939, 0.07183650915972939, 0.07183650915972939, 0.07183650915972939, 0.07183650915972939, 0.4310190549583764, 0.07183650915972939, 0.037288509554795665, 0.037288509554795665, 0.037288509554795665, 0.037288509554795665, 0.037288509554795665, 0.7457701910959132, 0.037288509554795665, 0.0885277994790311, 0.0885277994790311, 0.0885277994790311, 0.0885277994790311, 0.0885277994790311, 0.0885277994790311, 0.0885277994790311, 0.3541111979161244, 0.039430615932564195, 0.039430615932564195, 0.039430615932564195, 0.039430615932564195, 0.039430615932564195, 0.039430615932564195, 0.7097510867861555, 0.04826897798737446, 0.04826897798737446, 0.04826897798737446, 0.04826897798737446, 0.04826897798737446, 0.6757656918232424, 0.04826897798737446, 0.030129860280050984, 0.030129860280050984, 0.030129860280050984, 0.7532465070012746, 0.030129860280050984, 0.030129860280050984, 0.030129860280050984, 0.030129860280050984, 0.04206995966610404, 0.04206995966610404, 0.04206995966610404, 0.04206995966610404, 0.04206995966610404, 0.04206995966610404, 0.7151893143237686, 0.08849635719088289, 0.08849635719088289, 0.08849635719088289, 0.08849635719088289, 0.08849635719088289, 0.08849635719088289, 0.35398542876353156, 0.08849635719088289, 0.9040895021247364, 0.013909069263457483, 0.013909069263457483, 0.013909069263457483, 0.013909069263457483, 0.013909069263457483, 0.013909069263457483, 0.051197308674157505, 0.051197308674157505, 0.051197308674157505, 0.051197308674157505, 0.051197308674157505, 0.051197308674157505, 0.61436770408989, 0.02952728780461717, 0.02952728780461717, 0.7972367707246637, 0.02952728780461717, 0.02952728780461717, 0.02952728780461717, 0.02952728780461717, 0.8460733628582116, 0.022866847644816526, 0.022866847644816526, 0.022866847644816526, 0.022866847644816526, 0.022866847644816526, 0.022866847644816526, 0.030383521426074072, 0.030383521426074072, 0.030383521426074072, 0.030383521426074072, 0.7899715570779259, 0.030383521426074072, 0.030383521426074072, 0.8572913361895419, 0.02041169848070338, 0.02041169848070338, 0.02041169848070338, 0.02041169848070338, 0.02041169848070338, 0.02041169848070338, 0.028171159862670977, 0.028171159862670977, 0.8169636360174584, 0.028171159862670977, 0.028171159862670977, 0.028171159862670977, 0.028171159862670977, 0.07676506663535192, 0.07676506663535192, 0.07676506663535192, 0.3838253331767596, 0.07676506663535192, 0.07676506663535192, 0.07676506663535192, 0.07676506663535192, 0.016553883565788075, 0.016553883565788075, 0.8939097125525559, 0.016553883565788075, 0.016553883565788075, 0.016553883565788075, 0.016553883565788075, 0.03473116853617591, 0.03473116853617591, 0.03473116853617591, 0.03473116853617591, 0.03473116853617591, 0.03473116853617591, 0.76408570779587, 0.0403034959993005, 0.0403034959993005, 0.0403034959993005, 0.0403034959993005, 0.0403034959993005, 0.725462927987409, 0.0403034959993005, 0.021908539314956996, 0.021908539314956996, 0.8544330332833228, 0.021908539314956996, 0.021908539314956996, 0.021908539314956996, 0.021908539314956996, 0.020443619302747483, 0.020443619302747483, 0.020443619302747483, 0.8586320107153943, 0.020443619302747483, 0.020443619302747483, 0.020443619302747483, 0.02448116942239215, 0.02448116942239215, 0.02448116942239215, 0.02448116942239215, 0.8323597603613331, 0.02448116942239215, 0.02448116942239215, 0.009895959534805107, 0.009895959534805107, 0.643237369762332, 0.009895959534805107, 0.009895959534805107, 0.009895959534805107, 0.28698282650934814, 0.009895959534805107, 0.08507390644604712, 0.08507390644604712, 0.08507390644604712, 0.3402956257841885, 0.08507390644604712, 0.08507390644604712, 0.08507390644604712, 0.08507390644604712, 0.026250163015070792, 0.026250163015070792, 0.8137550534671946, 0.026250163015070792, 0.026250163015070792, 0.026250163015070792, 0.026250163015070792, 0.8316025387315908, 0.023100070520321966, 0.023100070520321966, 0.023100070520321966, 0.023100070520321966, 0.023100070520321966, 0.023100070520321966, 0.017605533668068996, 0.017605533668068996, 0.017605533668068996, 0.017605533668068996, 0.017605533668068996, 0.8802766834034498, 0.017605533668068996, 0.9289726779463021, 0.00977865976785581, 0.00977865976785581, 0.00977865976785581, 0.00977865976785581, 0.00977865976785581, 0.00977865976785581, 0.02390258141841039, 0.02390258141841039, 0.8365903496443636, 0.02390258141841039, 0.02390258141841039, 0.02390258141841039, 0.02390258141841039, 0.024799136853886117, 0.024799136853886117, 0.843170653032128, 0.024799136853886117, 0.024799136853886117, 0.024799136853886117, 0.024799136853886117, 0.005738895869347653, 0.005738895869347653, 0.958395610181058, 0.005738895869347653, 0.005738895869347653, 0.005738895869347653, 0.005738895869347653, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.33568312249181603, 0.06419739972617591, 0.06419739972617591, 0.06419739972617591, 0.06419739972617591, 0.06419739972617591, 0.06419739972617591, 0.5135791978094073, 0.06419739972617591, 0.04066168115345627, 0.04066168115345627, 0.04066168115345627, 0.04066168115345627, 0.04066168115345627, 0.7319102607622128, 0.04066168115345627, 0.04542615552734206, 0.04542615552734206, 0.04542615552734206, 0.04542615552734206, 0.04542615552734206, 0.6813923329101309, 0.04542615552734206, 0.0081258177579881, 0.6175621496070955, 0.0081258177579881, 0.3412843458355002, 0.0081258177579881, 0.0081258177579881, 0.0081258177579881, 0.018139175997065295, 0.018139175997065295, 0.018139175997065295, 0.018139175997065295, 0.8706804478591342, 0.018139175997065295, 0.018139175997065295, 0.03852370662645713, 0.03852370662645713, 0.03852370662645713, 0.03852370662645713, 0.03852370662645713, 0.7319504259026854, 0.03852370662645713, 0.045616540478359974, 0.045616540478359974, 0.045616540478359974, 0.045616540478359974, 0.045616540478359974, 0.6842481071753996, 0.045616540478359974, 0.08734767894772782, 0.08734767894772782, 0.08734767894772782, 0.08734767894772782, 0.08734767894772782, 0.08734767894772782, 0.3493907157909113, 0.08734767894772782, 0.8289165839865434, 0.02511868436322859, 0.02511868436322859, 0.02511868436322859, 0.02511868436322859, 0.02511868436322859, 0.02511868436322859, 0.018536988165757575, 0.018536988165757575, 0.8712384437906061, 0.018536988165757575, 0.018536988165757575, 0.018536988165757575, 0.018536988165757575, 0.024480175271505072, 0.024480175271505072, 0.024480175271505072, 0.024480175271505072, 0.8323259592311725, 0.024480175271505072, 0.024480175271505072, 0.023515043356038833, 0.023515043356038833, 0.023515043356038833, 0.023515043356038833, 0.846541560817398, 0.023515043356038833, 0.023515043356038833, 0.037139108625776046, 0.037139108625776046, 0.037139108625776046, 0.742782172515521, 0.037139108625776046, 0.037139108625776046, 0.037139108625776046, 0.8581393895152628, 0.022003574090134943, 0.022003574090134943, 0.022003574090134943, 0.022003574090134943, 0.022003574090134943, 0.022003574090134943, 0.0831991893948069, 0.0831991893948069, 0.0831991893948069, 0.0831991893948069, 0.0831991893948069, 0.0831991893948069, 0.0831991893948069, 0.4159959469740345, 0.05864104375277589, 0.05864104375277589, 0.05864104375277589, 0.05864104375277589, 0.05864104375277589, 0.05864104375277589, 0.527769393774983, 0.05864104375277589, 0.03187791697335137, 0.03187791697335137, 0.03187791697335137, 0.03187791697335137, 0.15938958486675686, 0.03187791697335137, 0.6375583394670274, 0.08166901377921307, 0.08166901377921307, 0.08166901377921307, 0.08166901377921307, 0.08166901377921307, 0.08166901377921307, 0.08166901377921307, 0.4083450688960653, 0.01794237034568611, 0.8791761469386193, 0.01794237034568611, 0.01794237034568611, 0.01794237034568611, 0.01794237034568611, 0.01794237034568611, 0.006985290366506862, 0.006985290366506862, 0.6915437462841794, 0.006985290366506862, 0.006985290366506862, 0.26544103392726076, 0.006985290366506862, 0.019065649661551904, 0.019065649661551904, 0.019065649661551904, 0.019065649661551904, 0.8579542347698357, 0.019065649661551904, 0.019065649661551904, 0.028217295445193153, 0.028217295445193153, 0.028217295445193153, 0.8183015679106015, 0.028217295445193153, 0.028217295445193153, 0.028217295445193153, 0.018268445258037867, 0.8768853723858177, 0.018268445258037867, 0.018268445258037867, 0.018268445258037867, 0.018268445258037867, 0.018268445258037867, 0.062267180348075025, 0.062267180348075025, 0.062267180348075025, 0.062267180348075025, 0.062267180348075025, 0.062267180348075025, 0.4981374427846002, 0.062267180348075025, 0.028849801110631814, 0.028849801110631814, 0.8077944310976909, 0.028849801110631814, 0.028849801110631814, 0.028849801110631814, 0.028849801110631814, 0.03048226498807972, 0.03048226498807972, 0.03048226498807972, 0.7925388896900727, 0.03048226498807972, 0.03048226498807972, 0.03048226498807972, 0.0013753423917371196, 0.9916218644424634, 0.0013753423917371196, 0.0013753423917371196, 0.0013753423917371196, 0.0013753423917371196, 0.0013753423917371196, 0.06721250764225857, 0.06721250764225857, 0.06721250764225857, 0.06721250764225857, 0.06721250764225857, 0.06721250764225857, 0.06721250764225857, 0.47048755349581006, 0.005348886687265755, 0.005348886687265755, 0.962799603707836, 0.005348886687265755, 0.005348886687265755, 0.005348886687265755, 0.005348886687265755, 0.04430514746947843, 0.04430514746947843, 0.04430514746947843, 0.04430514746947843, 0.04430514746947843, 0.7088823595116549, 0.04430514746947843, 0.010568801713583152, 0.9300545507953173, 0.010568801713583152, 0.010568801713583152, 0.010568801713583152, 0.010568801713583152, 0.010568801713583152, 0.007467388258616861, 0.9483583088443412, 0.007467388258616861, 0.007467388258616861, 0.007467388258616861, 0.007467388258616861, 0.007467388258616861, 0.08407917740149065, 0.08407917740149065, 0.08407917740149065, 0.08407917740149065, 0.08407917740149065, 0.08407917740149065, 0.3363167096059626, 0.08407917740149065, 0.88183685734558, 0.016330312173066297, 0.016330312173066297, 0.016330312173066297, 0.016330312173066297, 0.016330312173066297, 0.016330312173066297, 0.043450827320437195, 0.043450827320437195, 0.043450827320437195, 0.043450827320437195, 0.043450827320437195, 0.043450827320437195, 0.6952132371269951, 0.06945781007110165, 0.06945781007110165, 0.06945781007110165, 0.06945781007110165, 0.06945781007110165, 0.06945781007110165, 0.06945781007110165, 0.4862046704977115, 0.9578336986091465, 0.006515875500742493, 0.006515875500742493, 0.006515875500742493, 0.006515875500742493, 0.006515875500742493, 0.006515875500742493, 0.05973578254122483, 0.05973578254122483, 0.05973578254122483, 0.05973578254122483, 0.05973578254122483, 0.05973578254122483, 0.5973578254122482, 0.09843835911635546, 0.09843835911635546, 0.09843835911635546, 0.1968767182327109, 0.09843835911635546, 0.09843835911635546, 0.09843835911635546, 0.09843835911635546, 0.016799229112443862, 0.016799229112443862, 0.016799229112443862, 0.016799229112443862, 0.8903591429595247, 0.016799229112443862, 0.016799229112443862, 0.05907287112248826, 0.05907287112248826, 0.05907287112248826, 0.05907287112248826, 0.05907287112248826, 0.05907287112248826, 0.05907287112248826, 0.5316558401023943, 0.06634686984653626, 0.06634686984653626, 0.06634686984653626, 0.06634686984653626, 0.06634686984653626, 0.06634686984653626, 0.06634686984653626, 0.5307749587722901, 0.03981825182329411, 0.03981825182329411, 0.03981825182329411, 0.03981825182329411, 0.03981825182329411, 0.7167285328192939, 0.03981825182329411, 0.0280291352021408, 0.0280291352021408, 0.0280291352021408, 0.0280291352021408, 0.8128449208620833, 0.0280291352021408, 0.0280291352021408, 0.0533135781116107, 0.0533135781116107, 0.0533135781116107, 0.0533135781116107, 0.0533135781116107, 0.0533135781116107, 0.5864493592277177, 0.0533135781116107, 0.02334456638183123, 0.02334456638183123, 0.02334456638183123, 0.7003369914549369, 0.1634119646728186, 0.02334456638183123, 0.02334456638183123, 0.0543934965611367, 0.0543934965611367, 0.0543934965611367, 0.0543934965611367, 0.0543934965611367, 0.0543934965611367, 0.5983284621725037, 0.07599955634698569, 0.07599955634698569, 0.07599955634698569, 0.07599955634698569, 0.07599955634698569, 0.07599955634698569, 0.07599955634698569, 0.45599733808191417, 0.03787610724800148, 0.03787610724800148, 0.03787610724800148, 0.03787610724800148, 0.03787610724800148, 0.03787610724800148, 0.7196460377120282, 0.03787610724800148, 0.03284464799544541, 0.03284464799544541, 0.03284464799544541, 0.03284464799544541, 0.7554269038952445, 0.03284464799544541, 0.03284464799544541, 0.026693509462621706, 0.026693509462621706, 0.8274987933412729, 0.026693509462621706, 0.026693509462621706, 0.026693509462621706, 0.026693509462621706, 0.02989529689194067, 0.02989529689194067, 0.8071730160823981, 0.02989529689194067, 0.02989529689194067, 0.02989529689194067, 0.02989529689194067, 0.010748628357425584, 0.010748628357425584, 0.9243820387386001, 0.010748628357425584, 0.010748628357425584, 0.010748628357425584, 0.010748628357425584, 0.011533465343571287, 0.011533465343571287, 0.011533465343571287, 0.011533465343571287, 0.011533465343571287, 0.011533465343571287, 0.9226772274857029, 0.04886070702733711, 0.04886070702733711, 0.04886070702733711, 0.04886070702733711, 0.04886070702733711, 0.6840498983827195, 0.04886070702733711, 0.031209298609455212, 0.031209298609455212, 0.031209298609455212, 0.031209298609455212, 0.7802324652363802, 0.031209298609455212, 0.031209298609455212, 0.016423580121200206, 0.8868733265448112, 0.016423580121200206, 0.016423580121200206, 0.016423580121200206, 0.016423580121200206, 0.016423580121200206, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.48366193959911624, 0.03262480390574746, 0.03262480390574746, 0.03262480390574746, 0.03262480390574746, 0.03262480390574746, 0.782995293737939, 0.03262480390574746, 0.04654350466489634, 0.04654350466489634, 0.04654350466489634, 0.04654350466489634, 0.04654350466489634, 0.6981525699734451, 0.04654350466489634, 0.01602295780736024, 0.01602295780736024, 0.01602295780736024, 0.01602295780736024, 0.8171708481753722, 0.0801147890368012, 0.01602295780736024, 0.026484182796767827, 0.026484182796767827, 0.026484182796767827, 0.6621045699191956, 0.18538927957737478, 0.026484182796767827, 0.026484182796767827, 0.05568163222619961, 0.05568163222619961, 0.05568163222619961, 0.05568163222619961, 0.05568163222619961, 0.05568163222619961, 0.6124979544881958, 0.02039428979144373, 0.02039428979144373, 0.02039428979144373, 0.02039428979144373, 0.02039428979144373, 0.02039428979144373, 0.8565601712406367, 0.052800880585453534, 0.052800880585453534, 0.052800880585453534, 0.052800880585453534, 0.052800880585453534, 0.052800880585453534, 0.6336105670254425, 0.023986901854050956, 0.023986901854050956, 0.023986901854050956, 0.023986901854050956, 0.023986901854050956, 0.8395415648917834, 0.023986901854050956, 0.021300335477178536, 0.021300335477178536, 0.8520134190871416, 0.021300335477178536, 0.021300335477178536, 0.021300335477178536, 0.021300335477178536, 0.08357326115515563, 0.08357326115515563, 0.08357326115515563, 0.08357326115515563, 0.08357326115515563, 0.08357326115515563, 0.08357326115515563, 0.33429304462062254, 0.8534985463432937, 0.021884578111366505, 0.021884578111366505, 0.021884578111366505, 0.021884578111366505, 0.021884578111366505, 0.021884578111366505, 0.005342049353119475, 0.005342049353119475, 0.005342049353119475, 0.9615688835615056, 0.005342049353119475, 0.005342049353119475, 0.005342049353119475, 0.0061408422258970785, 0.20878863568050066, 0.03070421112948539, 0.0061408422258970785, 0.0061408422258970785, 0.0061408422258970785, 0.7369010671076494, 0.03947065961751956, 0.03947065961751956, 0.03947065961751956, 0.03947065961751956, 0.03947065961751956, 0.7104718731153522, 0.03947065961751956, 0.021865847024310426, 0.021865847024310426, 0.021865847024310426, 0.021865847024310426, 0.8527680339481066, 0.021865847024310426, 0.021865847024310426, 0.0196186352918242, 0.0196186352918242, 0.0196186352918242, 0.0196186352918242, 0.8632199528402648, 0.0196186352918242, 0.0196186352918242, 0.0548845529281132, 0.0548845529281132, 0.0548845529281132, 0.0548845529281132, 0.0548845529281132, 0.0548845529281132, 0.0548845529281132, 0.6037300822092452, 0.02913502300364321, 0.02913502300364321, 0.02913502300364321, 0.02913502300364321, 0.02913502300364321, 0.02913502300364321, 0.7866456210983667, 0.03459343228865185, 0.03459343228865185, 0.03459343228865185, 0.03459343228865185, 0.7610555103503408, 0.03459343228865185, 0.03459343228865185, 0.058232007445132516, 0.058232007445132516, 0.058232007445132516, 0.058232007445132516, 0.058232007445132516, 0.058232007445132516, 0.5823200744513252, 0.058232007445132516, 0.07715891513935323, 0.07715891513935323, 0.07715891513935323, 0.07715891513935323, 0.07715891513935323, 0.07715891513935323, 0.3857945756967661, 0.07715891513935323, 0.07152502435079616, 0.07152502435079616, 0.07152502435079616, 0.42915014610477703, 0.07152502435079616, 0.07152502435079616, 0.07152502435079616, 0.07152502435079616, 0.07578171404379934, 0.07578171404379934, 0.07578171404379934, 0.3789085702189967, 0.07578171404379934, 0.07578171404379934, 0.07578171404379934, 0.07578171404379934, 0.09889747069910175, 0.09889747069910175, 0.09889747069910175, 0.1977949413982035, 0.09889747069910175, 0.09889747069910175, 0.09889747069910175, 0.09889747069910175, 0.8461675543896513, 0.021696603958709006, 0.021696603958709006, 0.021696603958709006, 0.021696603958709006, 0.021696603958709006, 0.021696603958709006, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.06909456279987375, 0.48366193959911624, 0.006953613977235084, 0.006953613977235084, 0.006953613977235084, 0.9526451148812064, 0.006953613977235084, 0.006953613977235084, 0.006953613977235084, 0.07012024701996056, 0.07012024701996056, 0.07012024701996056, 0.4908417291397239, 0.07012024701996056, 0.07012024701996056, 0.07012024701996056, 0.07012024701996056, 0.08926917531894892, 0.08926917531894892, 0.08926917531894892, 0.26780752595684676, 0.08926917531894892, 0.08926917531894892, 0.08926917531894892, 0.08926917531894892, 0.9119490637470145, 0.012844353010521331, 0.012844353010521331, 0.012844353010521331, 0.012844353010521331, 0.012844353010521331, 0.012844353010521331, 0.9308074727380133, 0.010577357644750152, 0.010577357644750152, 0.010577357644750152, 0.010577357644750152, 0.010577357644750152, 0.010577357644750152, 0.07330489484320148, 0.07330489484320148, 0.07330489484320148, 0.07330489484320148, 0.07330489484320148, 0.07330489484320148, 0.43982936905920883, 0.07330489484320148, 0.034950391601729816, 0.034950391601729816, 0.034950391601729816, 0.7689086152380559, 0.034950391601729816, 0.034950391601729816, 0.034950391601729816, 0.003104330402292985, 0.9809684071245832, 0.003104330402292985, 0.003104330402292985, 0.003104330402292985, 0.003104330402292985, 0.003104330402292985, 0.01704784026274811, 0.8864876936629017, 0.01704784026274811, 0.01704784026274811, 0.01704784026274811, 0.01704784026274811, 0.01704784026274811, 0.01619442790469131, 0.01619442790469131, 0.8906935347580219, 0.01619442790469131, 0.01619442790469131, 0.01619442790469131, 0.01619442790469131, 0.009043973026288624, 0.940573194734017, 0.009043973026288624, 0.009043973026288624, 0.009043973026288624, 0.009043973026288624, 0.009043973026288624, 0.09636386322472634, 0.09636386322472634, 0.09636386322472634, 0.28909158967417903, 0.09636386322472634, 0.09636386322472634, 0.09636386322472634, 0.09636386322472634, 0.018201938595434133, 0.018201938595434133, 0.8736930525808384, 0.018201938595434133, 0.018201938595434133, 0.018201938595434133, 0.018201938595434133, 0.07918158626688698, 0.07918158626688698, 0.07918158626688698, 0.07918158626688698, 0.07918158626688698, 0.07918158626688698, 0.07918158626688698, 0.3959079313344349, 0.018712380452476196, 0.018712380452476196, 0.8794818812663813, 0.018712380452476196, 0.018712380452476196, 0.018712380452476196, 0.018712380452476196, 0.009751231749123686, 0.009751231749123686, 0.936118247915874, 0.009751231749123686, 0.009751231749123686, 0.009751231749123686, 0.009751231749123686, 0.027858068239826426, 0.027858068239826426, 0.027858068239826426, 0.8078839789549663, 0.027858068239826426, 0.027858068239826426, 0.027858068239826426, 0.09728270896916083, 0.09728270896916083, 0.09728270896916083, 0.29184812690748246, 0.09728270896916083, 0.09728270896916083, 0.09728270896916083, 0.09728270896916083, 0.01176842626613566, 0.01176842626613566, 0.01176842626613566, 0.9179372487585815, 0.01176842626613566, 0.01176842626613566, 0.01176842626613566, 0.09010924167435638, 0.09010924167435638, 0.09010924167435638, 0.2703277250230691, 0.09010924167435638, 0.09010924167435638, 0.09010924167435638, 0.09010924167435638, 0.012667895441355322, 0.9247563672189385, 0.012667895441355322, 0.012667895441355322, 0.012667895441355322, 0.012667895441355322, 0.012667895441355322, 0.9989401347894813, 0.00015064698156982072, 0.00015064698156982072, 0.00015064698156982072, 0.00015064698156982072, 0.00015064698156982072, 0.00015064698156982072, 0.00016569434037985178, 0.00016569434037985178, 0.00016569434037985178, 0.9986397894693666, 0.00016569434037985178, 0.00016569434037985178, 0.00016569434037985178, 0.00016569434037985178, 0.06024581747099187, 0.06024581747099187, 0.06024581747099187, 0.06024581747099187, 0.06024581747099187, 0.06024581747099187, 0.6024581747099187, 0.06744984266229276, 0.06744984266229276, 0.06744984266229276, 0.06744984266229276, 0.06744984266229276, 0.06744984266229276, 0.4721488986360493, 0.06744984266229276, 0.8496467786771238, 0.020723092162856678, 0.020723092162856678, 0.020723092162856678, 0.020723092162856678, 0.020723092162856678, 0.020723092162856678, 0.03256514623972534, 0.03256514623972534, 0.03256514623972534, 0.03256514623972534, 0.7815635097534082, 0.03256514623972534, 0.03256514623972534, 0.860895410074009, 0.021522385251850226, 0.021522385251850226, 0.021522385251850226, 0.021522385251850226, 0.021522385251850226, 0.021522385251850226, 0.09539540600076901, 0.09539540600076901, 0.09539540600076901, 0.28618621800230704, 0.09539540600076901, 0.09539540600076901, 0.09539540600076901, 0.09539540600076901, 0.031735906921241064, 0.031735906921241064, 0.031735906921241064, 0.7933976730310267, 0.031735906921241064, 0.031735906921241064, 0.031735906921241064, 0.08557176699426759, 0.08557176699426759, 0.08557176699426759, 0.08557176699426759, 0.08557176699426759, 0.08557176699426759, 0.34228706797707037, 0.08557176699426759, 0.042526530762733786, 0.042526530762733786, 0.042526530762733786, 0.042526530762733786, 0.042526530762733786, 0.7229510229664743, 0.042526530762733786, 0.09327909133496841, 0.09327909133496841, 0.09327909133496841, 0.2798372740049052, 0.09327909133496841, 0.09327909133496841, 0.09327909133496841, 0.09327909133496841, 0.009536330115737124, 0.7342974189117586, 0.21933559266195385, 0.009536330115737124, 0.009536330115737124, 0.009536330115737124, 0.009536330115737124, 0.003045015845238151, 0.6820835493333458, 0.30145656867857695, 0.003045015845238151, 0.003045015845238151, 0.003045015845238151, 0.003045015845238151, 0.015380016658578154, 0.9074209828561111, 0.015380016658578154, 0.015380016658578154, 0.015380016658578154, 0.015380016658578154, 0.015380016658578154, 0.011791579072606164, 0.9197431676632808, 0.011791579072606164, 0.011791579072606164, 0.011791579072606164, 0.011791579072606164, 0.011791579072606164, 0.01975147558832297, 0.8690649258862106, 0.01975147558832297, 0.01975147558832297, 0.01975147558832297, 0.01975147558832297, 0.01975147558832297, 0.014809012696936448, 0.9033497745131233, 0.014809012696936448, 0.014809012696936448, 0.014809012696936448, 0.014809012696936448, 0.014809012696936448, 0.033802184388718605, 0.033802184388718605, 0.033802184388718605, 0.033802184388718605, 0.7774502409405278, 0.033802184388718605, 0.033802184388718605, 0.06106471790261159, 0.06106471790261159, 0.06106471790261159, 0.06106471790261159, 0.06106471790261159, 0.06106471790261159, 0.06106471790261159, 0.5495824611235043, 0.05193656146805271, 0.05193656146805271, 0.05193656146805271, 0.05193656146805271, 0.05193656146805271, 0.05193656146805271, 0.6232387376166325, 0.9424752412328435, 0.008124786562352099, 0.008124786562352099, 0.008124786562352099, 0.008124786562352099, 0.008124786562352099, 0.008124786562352099, 0.9561420633484898, 0.0062904083115032225, 0.0062904083115032225, 0.0062904083115032225, 0.0062904083115032225, 0.0062904083115032225, 0.0062904083115032225, 0.013672296596495619, 0.9160438719652064, 0.013672296596495619, 0.013672296596495619, 0.013672296596495619, 0.013672296596495619, 0.013672296596495619, 0.010784712526347917, 0.9274852772659209, 0.010784712526347917, 0.010784712526347917, 0.010784712526347917, 0.010784712526347917, 0.010784712526347917, 0.02231780819107454, 0.02231780819107454, 0.8480767112608325, 0.02231780819107454, 0.02231780819107454, 0.02231780819107454, 0.02231780819107454, 0.8275259076796044, 0.02507654265695771, 0.02507654265695771, 0.02507654265695771, 0.02507654265695771, 0.02507654265695771, 0.02507654265695771, 0.565022138106411, 0.02825110690532055, 0.02825110690532055, 0.02825110690532055, 0.02825110690532055, 0.02825110690532055, 0.2260088552425644, 0.02825110690532055, 0.00820533301002532, 0.410266650501266, 0.00820533301002532, 0.5497573116716964, 0.00820533301002532, 0.00820533301002532, 0.00820533301002532, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.08392078062295401, 0.33568312249181603, 0.054967800133549675, 0.054967800133549675, 0.054967800133549675, 0.054967800133549675, 0.054967800133549675, 0.054967800133549675, 0.054967800133549675, 0.6046458014690465], \"Term\": [\"ability\", \"ability\", \"ability\", \"ability\", \"ability\", \"ability\", \"ability\", \"accelerate\", \"accelerate\", \"accelerate\", \"accelerate\", \"accelerate\", \"accelerate\", \"accelerate\", \"access\", \"access\", \"access\", \"access\", \"access\", \"access\", \"access\", \"activity\", \"activity\", \"activity\", \"activity\", \"activity\", \"activity\", \"activity\", \"addition\", \"addition\", \"addition\", \"addition\", \"addition\", \"addition\", \"addition\", \"additional\", \"additional\", \"additional\", \"additional\", \"additional\", \"additional\", \"additional\", \"advance\", \"advance\", \"advance\", \"advance\", \"advance\", \"advance\", \"advance\", \"adverse_event\", \"adverse_event\", \"adverse_event\", \"adverse_event\", \"adverse_event\", \"adverse_event\", \"adverse_event\", \"affect_approximately\", \"affect_approximately\", \"affect_approximately\", \"affect_approximately\", \"affect_approximately\", \"affect_approximately\", \"affect_approximately\", \"affect_approximately\", \"age\", \"age\", \"age\", \"age\", \"age\", \"age\", \"age\", \"agreement\", \"agreement\", \"agreement\", \"agreement\", \"agreement\", \"agreement\", \"agreement\", \"allow\", \"allow\", \"allow\", \"allow\", \"allow\", \"allow\", \"allow\", \"allow\", \"also\", \"also\", \"also\", \"also\", \"also\", \"also\", \"also\", \"analysis\", \"analysis\", \"analysis\", \"analysis\", \"analysis\", \"analysis\", \"analysis\", \"announce\", \"announce\", \"announce\", \"announce\", \"announce\", \"announce\", \"announce\", \"announce_today\", \"announce_today\", \"announce_today\", \"announce_today\", \"announce_today\", \"announce_today\", \"announce_today\", \"announce_today\", \"anticipate\", \"anticipate\", \"anticipate\", \"anticipate\", \"anticipate\", \"anticipate\", \"anticipate\", \"application\", \"application\", \"application\", \"application\", \"application\", \"application\", \"application\", \"approach\", \"approach\", \"approach\", \"approach\", \"approach\", \"approach\", \"approach\", \"approval\", \"approval\", \"approval\", \"approval\", \"approval\", \"approval\", \"approval\", \"approval\", \"approve\", \"approve\", \"approve\", \"approve\", \"approve\", \"approve\", \"approve\", \"approximately\", \"approximately\", \"approximately\", \"approximately\", \"approximately\", \"approximately\", \"approximately\", \"approximately\", \"as\", \"as\", \"as\", \"as\", \"as\", \"as\", \"as\", \"as\", \"as_well\", \"as_well\", \"as_well\", \"as_well\", \"as_well\", \"as_well\", \"as_well\", \"available\", \"available\", \"available\", \"available\", \"available\", \"available\", \"available\", \"base\", \"base\", \"base\", \"base\", \"base\", \"base\", \"base\", \"base\", \"become\", \"become\", \"become\", \"become\", \"become\", \"become\", \"become\", \"believe_forward_look_statement\", \"believe_forward_look_statement\", \"believe_forward_look_statement\", \"believe_forward_look_statement\", \"believe_forward_look_statement\", \"believe_forward_look_statement\", \"believe_forward_look_statement\", \"benefit\", \"benefit\", \"benefit\", \"benefit\", \"benefit\", \"benefit\", \"benefit\", \"biology\", \"biology\", \"biology\", \"biology\", \"biology\", \"biology\", \"biology\", \"body\", \"body\", \"body\", \"body\", \"body\", \"body\", \"body\", \"bring\", \"bring\", \"bring\", \"bring\", \"bring\", \"bring\", \"bring\", \"build\", \"build\", \"build\", \"build\", \"build\", \"build\", \"build\", \"build\", \"business\", \"business\", \"business\", \"business\", \"business\", \"business\", \"business\", \"cause\", \"cause\", \"cause\", \"cause\", \"cause\", \"cause\", \"cause\", \"cause_cystic_fibrosis\", \"cause_cystic_fibrosis\", \"cause_cystic_fibrosis\", \"cause_cystic_fibrosis\", \"cause_cystic_fibrosis\", \"cause_cystic_fibrosis\", \"cause_cystic_fibrosis\", \"cause_cystic_fibrosis\", \"cell\", \"cell\", \"cell\", \"cell\", \"cell\", \"cell\", \"cell\", \"cell\", \"centre\", \"centre\", \"centre\", \"centre\", \"centre\", \"centre\", \"centre\", \"certain\", \"certain\", \"certain\", \"certain\", \"certain\", \"certain\", \"certain\", \"certain\", \"cftr\", \"cftr\", \"cftr\", \"cftr\", \"cftr\", \"cftr\", \"cftr\", \"cftr_protein\", \"cftr_protein\", \"cftr_protein\", \"cftr_protein\", \"cftr_protein\", \"cftr_protein\", \"cftr_protein\", \"cftr_protein\", \"change\", \"change\", \"change\", \"change\", \"change\", \"change\", \"change\", \"child\", \"child\", \"child\", \"child\", \"child\", \"child\", \"child\", \"chronic\", \"chronic\", \"chronic\", \"chronic\", \"chronic\", \"chronic\", \"chronic\", \"clinical\", \"clinical\", \"clinical\", \"clinical\", \"clinical\", \"clinical\", \"clinical\", \"clinical_trial\", \"clinical_trial\", \"clinical_trial\", \"clinical_trial\", \"clinical_trial\", \"clinical_trial\", \"clinical_trial\", \"close\", \"close\", \"close\", \"close\", \"close\", \"close\", \"close\", \"code\", \"code\", \"code\", \"code\", \"code\", \"code\", \"code\", \"collaboration\", \"collaboration\", \"collaboration\", \"collaboration\", \"collaboration\", \"collaboration\", \"collaboration\", \"combination\", \"combination\", \"combination\", \"combination\", \"combination\", \"combination\", \"combination\", \"combination\", \"commercial\", \"commercial\", \"commercial\", \"commercial\", \"commercial\", \"commercial\", \"commercial\", \"commitment\", \"commitment\", \"commitment\", \"commitment\", \"commitment\", \"commitment\", \"commitment\", \"commitment\", \"community\", \"community\", \"community\", \"community\", \"community\", \"community\", \"community\", \"community\", \"company\", \"company\", \"company\", \"company\", \"company\", \"company\", \"company\", \"company_belief_only\", \"company_belief_only\", \"company_belief_only\", \"company_belief_only\", \"company_belief_only\", \"company_belief_only\", \"company_belief_only\", \"company_website_disclaim\", \"company_website_disclaim\", \"company_website_disclaim\", \"company_website_disclaim\", \"company_website_disclaim\", \"company_website_disclaim\", \"company_website_disclaim\", \"compare\", \"compare\", \"compare\", \"compare\", \"compare\", \"compare\", \"compare\", \"complete\", \"complete\", \"complete\", \"complete\", \"complete\", \"complete\", \"complete\", \"complete\", \"conduct\", \"conduct\", \"conduct\", \"conduct\", \"conduct\", \"conduct\", \"conduct\", \"conference\", \"conference\", \"conference\", \"conference\", \"conference\", \"conference\", \"conference\", \"contain_press_release\", \"contain_press_release\", \"contain_press_release\", \"contain_press_release\", \"contain_press_release\", \"contain_press_release\", \"contain_press_release\", \"contain_press_release_accurate\", \"contain_press_release_accurate\", \"contain_press_release_accurate\", \"contain_press_release_accurate\", \"contain_press_release_accurate\", \"contain_press_release_accurate\", \"contain_press_release_accurate\", \"continue\", \"continue\", \"continue\", \"continue\", \"continue\", \"continue\", \"continue\", \"continue\", \"control\", \"control\", \"control\", \"control\", \"control\", \"control\", \"control\", \"copy_mutation\", \"copy_mutation\", \"copy_mutation\", \"copy_mutation\", \"copy_mutation\", \"copy_mutation\", \"copy_mutation\", \"copy_mutation\", \"corporate\", \"corporate\", \"corporate\", \"corporate\", \"corporate\", \"corporate\", \"corporate\", \"crispr\", \"crispr\", \"crispr\", \"crispr\", \"crispr\", \"crispr\", \"crispr\", \"curative\", \"curative\", \"curative\", \"curative\", \"curative\", \"curative\", \"curative\", \"curative\", \"cut_edge\", \"cut_edge\", \"cut_edge\", \"cut_edge\", \"cut_edge\", \"cut_edge\", \"cut_edge\", \"cut_edge\", \"cystic_fibrosis\", \"cystic_fibrosis\", \"cystic_fibrosis\", \"cystic_fibrosis\", \"cystic_fibrosis\", \"cystic_fibrosis\", \"cystic_fibrosis\", \"cystic_fibrosis\", \"daily\", \"daily\", \"daily\", \"daily\", \"daily\", \"daily\", \"daily\", \"daily\", \"date_press_release\", \"date_press_release\", \"date_press_release\", \"date_press_release\", \"date_press_release\", \"date_press_release\", \"date_press_release\", \"datum\", \"datum\", \"datum\", \"datum\", \"datum\", \"datum\", \"datum\", \"defer_tax_asset\", \"defer_tax_asset\", \"defer_tax_asset\", \"defer_tax_asset\", \"defer_tax_asset\", \"defer_tax_asset\", \"defer_tax_asset\", \"deliver\", \"deliver\", \"deliver\", \"deliver\", \"deliver\", \"deliver\", \"deliver\", \"deliver\", \"demonstrate\", \"demonstrate\", \"demonstrate\", \"demonstrate\", \"demonstrate\", \"demonstrate\", \"demonstrate\", \"design\", \"design\", \"design\", \"design\", \"design\", \"design\", \"design\", \"develop\", \"develop\", \"develop\", \"develop\", \"develop\", \"develop\", \"develop\", \"develop\", \"development\", \"development\", \"development\", \"development\", \"development\", \"development\", \"development\", \"diagnostic\", \"diagnostic\", \"diagnostic\", \"diagnostic\", \"diagnostic\", \"diagnostic\", \"diagnostic\", \"director\", \"director\", \"director\", \"director\", \"director\", \"director\", \"director\", \"discover\", \"discover\", \"discover\", \"discover\", \"discover\", \"discover\", \"discover\", \"discover\", \"discover_develop\", \"discover_develop\", \"discover_develop\", \"discover_develop\", \"discover_develop\", \"discover_develop\", \"discover_develop\", \"discovery\", \"discovery\", \"discovery\", \"discovery\", \"discovery\", \"discovery\", \"discovery\", \"disease\", \"disease\", \"disease\", \"disease\", \"disease\", \"disease\", \"disease\", \"disease\", \"dose\", \"dose\", \"dose\", \"dose\", \"dose\", \"dose\", \"dose\", \"drive\", \"drive\", \"drive\", \"drive\", \"drive\", \"drive\", \"drive\", \"drug\", \"drug\", \"drug\", \"drug\", \"drug\", \"drug\", \"drug\", \"drug\", \"early\", \"early\", \"early\", \"early\", \"early\", \"early\", \"early\", \"effect\", \"effect\", \"effect\", \"effect\", \"effect\", \"effect\", \"effect\", \"efficacy\", \"efficacy\", \"efficacy\", \"efficacy\", \"efficacy\", \"efficacy\", \"efficacy\", \"eligible\", \"eligible\", \"eligible\", \"eligible\", \"eligible\", \"eligible\", \"eligible\", \"employee\", \"employee\", \"employee\", \"employee\", \"employee\", \"employee\", \"employee\", \"employer_life_science_rank\", \"employer_life_science_rank\", \"employer_life_science_rank\", \"employer_life_science_rank\", \"employer_life_science_rank\", \"employer_life_science_rank\", \"employer_life_science_rank\", \"employer_life_science_rank\", \"end\", \"end\", \"end\", \"end\", \"end\", \"end\", \"end\", \"enhance\", \"enhance\", \"enhance\", \"enhance\", \"enhance\", \"enhance\", \"enhance\", \"enhance\", \"enrollment\", \"enrollment\", \"enrollment\", \"enrollment\", \"enrollment\", \"enrollment\", \"enrollment\", \"enrollment\", \"establish\", \"establish\", \"establish\", \"establish\", \"establish\", \"establish\", \"establish\", \"establish\", \"evaluate\", \"evaluate\", \"evaluate\", \"evaluate\", \"evaluate\", \"evaluate\", \"evaluate\", \"event_result_differ\", \"event_result_differ\", \"event_result_differ\", \"event_result_differ\", \"event_result_differ\", \"event_result_differ\", \"event_result_differ\", \"expand\", \"expand\", \"expand\", \"expand\", \"expand\", \"expand\", \"expand\", \"expect\", \"expect\", \"expect\", \"expect\", \"expect\", \"expect\", \"expect\", \"expectation\", \"expectation\", \"expectation\", \"expectation\", \"expectation\", \"expectation\", \"expectation\", \"expense\", \"expense\", \"expense\", \"expense\", \"expense\", \"expense\", \"expense\", \"experience\", \"experience\", \"experience\", \"experience\", \"experience\", \"experience\", \"experience\", \"facility\", \"facility\", \"facility\", \"facility\", \"facility\", \"facility\", \"facility\", \"facility\", \"financial\", \"financial\", \"financial\", \"financial\", \"financial\", \"financial\", \"financial\", \"first\", \"first\", \"first\", \"first\", \"first\", \"first\", \"first\", \"first_quarter\", \"first_quarter\", \"first_quarter\", \"first_quarter\", \"first_quarter\", \"first_quarter\", \"first_quarter\", \"first_quarter\", \"focus\", \"focus\", \"focus\", \"focus\", \"focus\", \"focus\", \"focus\", \"follow\", \"follow\", \"follow\", \"follow\", \"follow\", \"follow\", \"follow\", \"forward_look_statement\", \"forward_look_statement\", \"forward_look_statement\", \"forward_look_statement\", \"forward_look_statement\", \"forward_look_statement\", \"forward_look_statement\", \"forward_look_statement_define\", \"forward_look_statement_define\", \"forward_look_statement_define\", \"forward_look_statement_define\", \"forward_look_statement_define\", \"forward_look_statement_define\", \"forward_look_statement_define\", \"forward_look_statement_represent\", \"forward_look_statement_represent\", \"forward_look_statement_represent\", \"forward_look_statement_represent\", \"forward_look_statement_represent\", \"forward_look_statement_represent\", \"forward_look_statement_represent\", \"found_headquarters_now_locate\", \"found_headquarters_now_locate\", \"found_headquarters_now_locate\", \"found_headquarters_now_locate\", \"found_headquarters_now_locate\", \"found_headquarters_now_locate\", \"found_headquarters_now_locate\", \"found_headquarters_now_locate\", \"foundation\", \"foundation\", \"foundation\", \"foundation\", \"foundation\", \"foundation\", \"foundation\", \"foundation\", \"fourth_quarter\", \"fourth_quarter\", \"fourth_quarter\", \"fourth_quarter\", \"fourth_quarter\", \"fourth_quarter\", \"fourth_quarter\", \"fourth_quarter\", \"full_year\", \"full_year\", \"full_year\", \"full_year\", \"full_year\", \"full_year\", \"full_year\", \"function\", \"function\", \"function\", \"function\", \"function\", \"function\", \"function\", \"function_mutation\", \"function_mutation\", \"function_mutation\", \"function_mutation\", \"function_mutation\", \"function_mutation\", \"function_mutation\", \"future\", \"future\", \"future\", \"future\", \"future\", \"future\", \"future\", \"gaap\", \"gaap\", \"gaap\", \"gaap\", \"gaap\", \"gaap\", \"gaap\", \"gene\", \"gene\", \"gene\", \"gene\", \"gene\", \"gene\", \"gene\", \"gene_edit\", \"gene_edit\", \"gene_edit\", \"gene_edit\", \"gene_edit\", \"gene_edit\", \"gene_edit\", \"gene_edit\", \"gene_editing\", \"gene_editing\", \"gene_editing\", \"gene_editing\", \"gene_editing\", \"gene_editing\", \"gene_editing\", \"gene_editing\", \"gene_sequencing\", \"gene_sequencing\", \"gene_sequencing\", \"gene_sequencing\", \"gene_sequencing\", \"gene_sequencing\", \"gene_sequencing\", \"genetic\", \"genetic\", \"genetic\", \"genetic\", \"genetic\", \"genetic\", \"genetic\", \"genetic\", \"genome\", \"genome\", \"genome\", \"genome\", \"genome\", \"genome\", \"genome\", \"genome\", \"give\", \"give\", \"give\", \"give\", \"give\", \"give\", \"give\", \"give\", \"global\", \"global\", \"global\", \"global\", \"global\", \"global\", \"global\", \"globally\", \"globally\", \"globally\", \"globally\", \"globally\", \"globally\", \"globally\", \"globally\", \"good\", \"good\", \"good\", \"good\", \"good\", \"good\", \"good\", \"good\", \"guidance\", \"guidance\", \"guidance\", \"guidance\", \"guidance\", \"guidance\", \"guidance\", \"guidance_regard\", \"guidance_regard\", \"guidance_regard\", \"guidance_regard\", \"guidance_regard\", \"guidance_regard\", \"guidance_regard\", \"hold\", \"hold\", \"hold\", \"hold\", \"hold\", \"hold\", \"hold\", \"human\", \"human\", \"human\", \"human\", \"human\", \"human\", \"human\", \"impact\", \"impact\", \"impact\", \"impact\", \"impact\", \"impact\", \"impact\", \"important\", \"important\", \"important\", \"important\", \"important\", \"important\", \"important\", \"important\", \"include\", \"include\", \"include\", \"include\", \"include\", \"include\", \"include\", \"include_other_thing\", \"include_other_thing\", \"include_other_thing\", \"include_other_thing\", \"include_other_thing\", \"include_other_thing\", \"include_other_thing\", \"income_taxis\", \"income_taxis\", \"income_taxis\", \"income_taxis\", \"income_taxis\", \"income_taxis\", \"income_taxis\", \"increase\", \"increase\", \"increase\", \"increase\", \"increase\", \"increase\", \"increase\", \"increase_compare\", \"increase_compare\", \"increase_compare\", \"increase_compare\", \"increase_compare\", \"increase_compare\", \"increase_compare\", \"information\", \"information\", \"information\", \"information\", \"information\", \"information\", \"information\", \"initiate\", \"initiate\", \"initiate\", \"initiate\", \"initiate\", \"initiate\", \"initiate\", \"initiate\", \"innovative\", \"innovative\", \"innovative\", \"innovative\", \"innovative\", \"innovative\", \"innovative\", \"innovative\", \"interest\", \"interest\", \"interest\", \"interest\", \"interest\", \"interest\", \"interest\", \"invest\", \"invest\", \"invest\", \"invest\", \"invest\", \"invest\", \"invest\", \"invest\", \"investment\", \"investment\", \"investment\", \"investment\", \"investment\", \"investment\", \"investment\", \"investor\", \"investor\", \"investor\", \"investor\", \"investor\", \"investor\", \"investor\", \"ivacaftor\", \"ivacaftor\", \"ivacaftor\", \"ivacaftor\", \"ivacaftor\", \"ivacaftor\", \"ivacaftor\", \"ivacaftor\", \"key\", \"key\", \"key\", \"key\", \"key\", \"key\", \"key\", \"knowledge\", \"knowledge\", \"knowledge\", \"knowledge\", \"knowledge\", \"knowledge\", \"knowledge\", \"knowledge\", \"lead\", \"lead\", \"lead\", \"lead\", \"lead\", \"lead\", \"lead\", \"leadership\", \"leadership\", \"leadership\", \"leadership\", \"leadership\", \"leadership\", \"leadership\", \"level\", \"level\", \"level\", \"level\", \"level\", \"level\", \"level\", \"life\", \"life\", \"life\", \"life\", \"life\", \"life\", \"life\", \"life_science\", \"life_science\", \"life_science\", \"life_science\", \"life_science\", \"life_science\", \"life_science\", \"live\", \"live\", \"live\", \"live\", \"live\", \"live\", \"live\", \"lose\", \"lose\", \"lose\", \"lose\", \"lose\", \"lose\", \"lose\", \"lumacaftor_ivacaftor\", \"lumacaftor_ivacaftor\", \"lumacaftor_ivacaftor\", \"lumacaftor_ivacaftor\", \"lumacaftor_ivacaftor\", \"lumacaftor_ivacaftor\", \"lumacaftor_ivacaftor\", \"lumacaftor_ivacaftor\", \"make\", \"make\", \"make\", \"make\", \"make\", \"make\", \"make\", \"management\", \"management\", \"management\", \"management\", \"management\", \"management\", \"management\", \"manufacturing\", \"manufacturing\", \"manufacturing\", \"manufacturing\", \"manufacturing\", \"manufacturing\", \"manufacturing\", \"many\", \"many\", \"many\", \"many\", \"many\", \"many\", \"many\", \"market\", \"market\", \"market\", \"market\", \"market\", \"market\", \"market\", \"materially_indicate_such\", \"materially_indicate_such\", \"materially_indicate_such\", \"materially_indicate_such\", \"materially_indicate_such\", \"materially_indicate_such\", \"materially_indicate_such\", \"medicine\", \"medicine\", \"medicine\", \"medicine\", \"medicine\", \"medicine\", \"medicine\", \"medicine\", \"medicine_treat_underlying\", \"medicine_treat_underlying\", \"medicine_treat_underlying\", \"medicine_treat_underlying\", \"medicine_treat_underlying\", \"medicine_treat_underlying\", \"medicine_treat_underlying\", \"medicine_treat_underlying\", \"molecule\", \"molecule\", \"molecule\", \"molecule\", \"molecule\", \"molecule\", \"molecule\", \"month\", \"month\", \"month\", \"month\", \"month\", \"month\", \"month\", \"month_end\", \"month_end\", \"month_end\", \"month_end\", \"month_end\", \"month_end\", \"month_end\", \"more\", \"more\", \"more\", \"more\", \"more\", \"more\", \"more\", \"most\", \"most\", \"most\", \"most\", \"most\", \"most\", \"most\", \"multiple\", \"multiple\", \"multiple\", \"multiple\", \"multiple\", \"multiple\", \"multiple\", \"mutation\", \"mutation\", \"mutation\", \"mutation\", \"mutation\", \"mutation\", \"mutation\", \"name_science_magazine_top\", \"name_science_magazine_top\", \"name_science_magazine_top\", \"name_science_magazine_top\", \"name_science_magazine_top\", \"name_science_magazine_top\", \"name_science_magazine_top\", \"name_science_magazine_top\", \"need\", \"need\", \"need\", \"need\", \"need\", \"need\", \"need\", \"need\", \"net_income\", \"net_income\", \"net_income\", \"net_income\", \"net_income\", \"net_income\", \"net_income\", \"net_operating_loss\", \"net_operating_loss\", \"net_operating_loss\", \"net_operating_loss\", \"net_operating_loss\", \"net_operating_loss\", \"net_operating_loss\", \"new\", \"new\", \"new\", \"new\", \"new\", \"new\", \"new\", \"new_information_become\", \"new_information_become\", \"new_information_become\", \"new_information_become\", \"new_information_become\", \"new_information_become\", \"new_information_become\", \"non_gaap\", \"non_gaap\", \"non_gaap\", \"non_gaap\", \"non_gaap\", \"non_gaap\", \"non_gaap\", \"non_gaap_financial_measure\", \"non_gaap_financial_measure\", \"non_gaap_financial_measure\", \"non_gaap_financial_measure\", \"non_gaap_financial_measure\", \"non_gaap_financial_measure\", \"non_gaap_financial_measure\", \"note\", \"note\", \"note\", \"note\", \"note\", \"note\", \"note\", \"note\", \"now\", \"now\", \"now\", \"now\", \"now\", \"now\", \"now\", \"number\", \"number\", \"number\", \"number\", \"number\", \"number\", \"number\", \"number_factor_cause_actual\", \"number_factor_cause_actual\", \"number_factor_cause_actual\", \"number_factor_cause_actual\", \"number_factor_cause_actual\", \"number_factor_cause_actual\", \"number_factor_cause_actual\", \"obligation_update_information\", \"obligation_update_information\", \"obligation_update_information\", \"obligation_update_information\", \"obligation_update_information\", \"obligation_update_information\", \"obligation_update_information\", \"observe\", \"observe\", \"observe\", \"observe\", \"observe\", \"observe\", \"observe\", \"offer\", \"offer\", \"offer\", \"offer\", \"offer\", \"offer\", \"offer\", \"once\", \"once\", \"once\", \"once\", \"once\", \"once\", \"once\", \"once\", \"ongoing\", \"ongoing\", \"ongoing\", \"ongoing\", \"ongoing\", \"ongoing\", \"ongoing\", \"ongoing\", \"operation\", \"operation\", \"operation\", \"operation\", \"operation\", \"operation\", \"operation\", \"oral\", \"oral\", \"oral\", \"oral\", \"oral\", \"oral\", \"oral\", \"oral\", \"orkambi\", \"orkambi\", \"orkambi\", \"orkambi\", \"orkambi\", \"orkambi\", \"orkambi\", \"other\", \"other\", \"other\", \"other\", \"other\", \"other\", \"other\", \"other_risk_list\", \"other_risk_list\", \"other_risk_list\", \"other_risk_list\", \"other_risk_list\", \"other_risk_list\", \"other_risk_list\", \"outcome\", \"outcome\", \"outcome\", \"outcome\", \"outcome\", \"outcome\", \"outcome\", \"pain\", \"pain\", \"pain\", \"pain\", \"pain\", \"pain\", \"pain\", \"part\", \"part\", \"part\", \"part\", \"part\", \"part\", \"part\", \"part\", \"partner\", \"partner\", \"partner\", \"partner\", \"partner\", \"partner\", \"partner\", \"partnership\", \"partnership\", \"partnership\", \"partnership\", \"partnership\", \"partnership\", \"partnership\", \"patient\", \"patient\", \"patient\", \"patient\", \"patient\", \"patient\", \"patient\", \"payment\", \"payment\", \"payment\", \"payment\", \"payment\", \"payment\", \"payment\", \"payment\", \"people\", \"people\", \"people\", \"people\", \"people\", \"people\", \"people\", \"period\", \"period\", \"period\", \"period\", \"period\", \"period\", \"period\", \"phase\", \"phase\", \"phase\", \"phase\", \"phase\", \"phase\", \"phase\", \"phase_study\", \"phase_study\", \"phase_study\", \"phase_study\", \"phase_study\", \"phase_study\", \"phase_study\", \"pipeline\", \"pipeline\", \"pipeline\", \"pipeline\", \"pipeline\", \"pipeline\", \"pipeline\", \"pipeline\", \"plan\", \"plan\", \"plan\", \"plan\", \"plan\", \"plan\", \"plan\", \"position\", \"position\", \"position\", \"position\", \"position\", \"position\", \"position\", \"possible\", \"possible\", \"possible\", \"possible\", \"possible\", \"possible\", \"possible\", \"possible\", \"potential\", \"potential\", \"potential\", \"potential\", \"potential\", \"potential\", \"potential\", \"pre_tax_income\", \"pre_tax_income\", \"pre_tax_income\", \"pre_tax_income\", \"pre_tax_income\", \"pre_tax_income\", \"pre_tax_income\", \"preclinical\", \"preclinical\", \"preclinical\", \"preclinical\", \"preclinical\", \"preclinical\", \"preclinical\", \"preclinical\", \"press_release_contain\", \"press_release_contain\", \"press_release_contain\", \"press_release_contain\", \"press_release_contain\", \"press_release_contain\", \"press_release_contain\", \"previously\", \"previously\", \"previously\", \"previously\", \"previously\", \"previously\", \"previously\", \"previously\", \"primarily\", \"primarily\", \"primarily\", \"primarily\", \"primarily\", \"primarily\", \"primarily\", \"primarily\", \"prior\", \"prior\", \"prior\", \"prior\", \"prior\", \"prior\", \"prior\", \"private_security_include_limitation\", \"private_security_include_limitation\", \"private_security_include_limitation\", \"private_security_include_limitation\", \"private_security_include_limitation\", \"private_security_include_limitation\", \"private_security_include_limitation\", \"process\", \"process\", \"process\", \"process\", \"process\", \"process\", \"process\", \"process\", \"product\", \"product\", \"product\", \"product\", \"product\", \"product\", \"product\", \"product_revenue\", \"product_revenue\", \"product_revenue\", \"product_revenue\", \"product_revenue\", \"product_revenue\", \"product_revenue\", \"production\", \"production\", \"production\", \"production\", \"production\", \"production\", \"production\", \"production\", \"program\", \"program\", \"program\", \"program\", \"program\", \"program\", \"program\", \"program\", \"program_support_registration_further\", \"program_support_registration_further\", \"program_support_registration_further\", \"program_support_registration_further\", \"program_support_registration_further\", \"program_support_registration_further\", \"program_support_registration_further\", \"progress\", \"progress\", \"progress\", \"progress\", \"progress\", \"progress\", \"progress\", \"progression\", \"progression\", \"progression\", \"progression\", \"progression\", \"progression\", \"progression\", \"protein\", \"protein\", \"protein\", \"protein\", \"protein\", \"protein\", \"protein\", \"provide\", \"provide\", \"provide\", \"provide\", \"provide\", \"provide\", \"provide\", \"provision_income_taxis\", \"provision_income_taxis\", \"provision_income_taxis\", \"provision_income_taxis\", \"provision_income_taxis\", \"provision_income_taxis\", \"provision_income_taxis\", \"quarterly_report_file_available\", \"quarterly_report_file_available\", \"quarterly_report_file_available\", \"quarterly_report_file_available\", \"quarterly_report_file_available\", \"quarterly_report_file_available\", \"quarterly_report_file_available\", \"receive\", \"receive\", \"receive\", \"receive\", \"receive\", \"receive\", \"receive\", \"recognize_industry_top_place\", \"recognize_industry_top_place\", \"recognize_industry_top_place\", \"recognize_industry_top_place\", \"recognize_industry_top_place\", \"recognize_industry_top_place\", \"recognize_industry_top_place\", \"recognize_industry_top_place\", \"record\", \"record\", \"record\", \"record\", \"record\", \"record\", \"record\", \"reflect\", \"reflect\", \"reflect\", \"reflect\", \"reflect\", \"reflect\", \"reflect\", \"regard\", \"regard\", \"regard\", \"regard\", \"regard\", \"regard\", \"regard\", \"regulatory\", \"regulatory\", \"regulatory\", \"regulatory\", \"regulatory\", \"regulatory\", \"regulatory\", \"reimbursement_agreement\", \"reimbursement_agreement\", \"reimbursement_agreement\", \"reimbursement_agreement\", \"reimbursement_agreement\", \"reimbursement_agreement\", \"reimbursement_agreement\", \"relate\", \"relate\", \"relate\", \"relate\", \"relate\", \"relate\", \"relate\", \"relate_non_gaap\", \"relate_non_gaap\", \"relate_non_gaap\", \"relate_non_gaap\", \"relate_non_gaap\", \"relate_non_gaap\", \"relate_non_gaap\", \"release\", \"release\", \"release\", \"release\", \"release\", \"release\", \"release\", \"replace\", \"replace\", \"replace\", \"replace\", \"replace\", \"replace\", \"replace\", \"replacement\", \"replacement\", \"replacement\", \"replacement\", \"replacement\", \"replacement\", \"replacement\", \"replacement\", \"report\", \"report\", \"report\", \"report\", \"report\", \"report\", \"report\", \"research\", \"research\", \"research\", \"research\", \"research\", \"research\", \"research\", \"result\", \"result\", \"result\", \"result\", \"result\", \"result\", \"result\", \"revenue_expense\", \"revenue_expense\", \"revenue_expense\", \"revenue_expense\", \"revenue_expense\", \"revenue_expense\", \"revenue_expense\", \"risk_factor_annual_report\", \"risk_factor_annual_report\", \"risk_factor_annual_report\", \"risk_factor_annual_report\", \"risk_factor_annual_report\", \"risk_factor_annual_report\", \"risk_factor_annual_report\", \"risk_uncertainty\", \"risk_uncertainty\", \"risk_uncertainty\", \"risk_uncertainty\", \"risk_uncertainty\", \"risk_uncertainty\", \"risk_uncertainty\", \"role\", \"role\", \"role\", \"role\", \"role\", \"role\", \"role\", \"role\", \"safety\", \"safety\", \"safety\", \"safety\", \"safety\", \"safety\", \"safety\", \"safety_efficacy_other_reason\", \"safety_efficacy_other_reason\", \"safety_efficacy_other_reason\", \"safety_efficacy_other_reason\", \"safety_efficacy_other_reason\", \"safety_efficacy_other_reason\", \"safety_efficacy_other_reason\", \"say\", \"say\", \"say\", \"say\", \"say\", \"say\", \"say\", \"say\", \"see\", \"see\", \"see\", \"see\", \"see\", \"see\", \"see\", \"see\", \"serious_disease\", \"serious_disease\", \"serious_disease\", \"serious_disease\", \"serious_disease\", \"serious_disease\", \"serious_disease\", \"serious_disease\", \"show\", \"show\", \"show\", \"show\", \"show\", \"show\", \"show\", \"show\", \"sickle\", \"sickle\", \"sickle\", \"sickle\", \"sickle\", \"sickle\", \"sickle\", \"sickle\", \"significant\", \"significant\", \"significant\", \"significant\", \"significant\", \"significant\", \"significant\", \"site_commercial_office_consistently\", \"site_commercial_office_consistently\", \"site_commercial_office_consistently\", \"site_commercial_office_consistently\", \"site_commercial_office_consistently\", \"site_commercial_office_consistently\", \"site_commercial_office_consistently\", \"site_commercial_office_consistently\", \"solution\", \"solution\", \"solution\", \"solution\", \"solution\", \"solution\", \"solution\", \"source_version\", \"source_version\", \"source_version\", \"source_version\", \"source_version\", \"source_version\", \"source_version\", \"source_version\", \"specific\", \"specific\", \"specific\", \"specific\", \"specific\", \"specific\", \"specific\", \"specific\", \"statement\", \"statement\", \"statement\", \"statement\", \"statement\", \"statement\", \"statement\", \"stem\", \"stem\", \"stem\", \"stem\", \"stem\", \"stem\", \"stem\", \"strategy\", \"strategy\", \"strategy\", \"strategy\", \"strategy\", \"strategy\", \"strategy\", \"strategy\", \"strong\", \"strong\", \"strong\", \"strong\", \"strong\", \"strong\", \"strong\", \"study\", \"study\", \"study\", \"study\", \"study\", \"study\", \"study\", \"submission\", \"submission\", \"submission\", \"submission\", \"submission\", \"submission\", \"submission\", \"such\", \"such\", \"such\", \"such\", \"such\", \"such\", \"such\", \"support\", \"support\", \"support\", \"support\", \"support\", \"support\", \"support\", \"surface\", \"surface\", \"surface\", \"surface\", \"surface\", \"surface\", \"surface\", \"surface\", \"symdeko\", \"symdeko\", \"symdeko\", \"symdeko\", \"symdeko\", \"symdeko\", \"symdeko\", \"tablet\", \"tablet\", \"tablet\", \"tablet\", \"tablet\", \"tablet\", \"tablet\", \"tablet\", \"take\", \"take\", \"take\", \"take\", \"take\", \"take\", \"take\", \"target\", \"target\", \"target\", \"target\", \"target\", \"target\", \"target\", \"team\", \"team\", \"team\", \"team\", \"team\", \"team\", \"team\", \"technique\", \"technique\", \"technique\", \"technique\", \"technique\", \"technique\", \"technique\", \"technique\", \"technology\", \"technology\", \"technology\", \"technology\", \"technology\", \"technology\", \"technology\", \"technology_platform\", \"technology_platform\", \"technology_platform\", \"technology_platform\", \"technology_platform\", \"technology_platform\", \"technology_platform\", \"technology_platform\", \"tezacaftor_ivacaftor\", \"tezacaftor_ivacaftor\", \"tezacaftor_ivacaftor\", \"tezacaftor_ivacaftor\", \"tezacaftor_ivacaftor\", \"tezacaftor_ivacaftor\", \"tezacaftor_ivacaftor\", \"therapeutic\", \"therapeutic\", \"therapeutic\", \"therapeutic\", \"therapeutic\", \"therapeutic\", \"therapeutic\", \"therapy\", \"therapy\", \"therapy\", \"therapy\", \"therapy\", \"therapy\", \"therapy\", \"therapy\", \"therefore\", \"therefore\", \"therefore\", \"therefore\", \"therefore\", \"therefore\", \"therefore\", \"third_quarter\", \"third_quarter\", \"third_quarter\", \"third_quarter\", \"third_quarter\", \"third_quarter\", \"third_quarter\", \"third_quarter\", \"time\", \"time\", \"time\", \"time\", \"time\", \"time\", \"time\", \"timing\", \"timing\", \"timing\", \"timing\", \"timing\", \"timing\", \"timing\", \"today\", \"today\", \"today\", \"today\", \"today\", \"today\", \"today\", \"today_announce\", \"today_announce\", \"today_announce\", \"today_announce\", \"today_announce\", \"today_announce\", \"today_announce\", \"today_announce\", \"together\", \"together\", \"together\", \"together\", \"together\", \"together\", \"together\", \"total\", \"total\", \"total\", \"total\", \"total\", \"total\", \"total\", \"total\", \"total_product_revenue\", \"total_product_revenue\", \"total_product_revenue\", \"total_product_revenue\", \"total_product_revenue\", \"total_product_revenue\", \"total_product_revenue\", \"transformative\", \"transformative\", \"transformative\", \"transformative\", \"transformative\", \"transformative\", \"transformative\", \"transformative\", \"treat\", \"treat\", \"treat\", \"treat\", \"treat\", \"treat\", \"treat\", \"treatment\", \"treatment\", \"treatment\", \"treatment\", \"treatment\", \"treatment\", \"treatment\", \"trial\", \"trial\", \"trial\", \"trial\", \"trial\", \"trial\", \"trial\", \"trikafta\", \"trikafta\", \"trikafta\", \"trikafta\", \"trikafta\", \"trikafta\", \"trikafta\", \"triple_combination\", \"triple_combination\", \"triple_combination\", \"triple_combination\", \"triple_combination\", \"triple_combination\", \"triple_combination\", \"triple_combination_regiman\", \"triple_combination_regiman\", \"triple_combination_regiman\", \"triple_combination_regiman\", \"triple_combination_regiman\", \"triple_combination_regiman\", \"triple_combination_regiman\", \"triple_combination_regimen\", \"triple_combination_regimen\", \"triple_combination_regimen\", \"triple_combination_regimen\", \"triple_combination_regimen\", \"triple_combination_regimen\", \"triple_combination_regimen\", \"type_diabetes\", \"type_diabetes\", \"type_diabetes\", \"type_diabetes\", \"type_diabetes\", \"type_diabetes\", \"type_diabetes\", \"type_diabetes\", \"update\", \"update\", \"update\", \"update\", \"update\", \"update\", \"update\", \"use\", \"use\", \"use\", \"use\", \"use\", \"use\", \"use\", \"vertex\", \"vertex\", \"vertex\", \"vertex\", \"vertex\", \"vertex\", \"vertex\", \"vertex_pharmaceutical_incorporate_today\", \"vertex_pharmaceutical_incorporate_today\", \"vertex_pharmaceutical_incorporate_today\", \"vertex_pharmaceutical_incorporate_today\", \"vertex_pharmaceutical_incorporate_today\", \"vertex_pharmaceutical_incorporate_today\", \"vertex_pharmaceutical_incorporate_today\", \"week\", \"week\", \"week\", \"week\", \"week\", \"week\", \"week\", \"when\", \"when\", \"when\", \"when\", \"when\", \"when\", \"when\", \"where\", \"where\", \"where\", \"where\", \"where\", \"where\", \"where\", \"work\", \"work\", \"work\", \"work\", \"work\", \"work\", \"work\", \"work\", \"year\", \"year\", \"year\", \"year\", \"year\", \"year\", \"year\", \"year_row\", \"year_row\", \"year_row\", \"year_row\", \"year_row\", \"year_row\", \"year_row\", \"year_row\", \"young\", \"young\", \"young\", \"young\", \"young\", \"young\", \"young\", \"young\"]}, \"R\": 30, \"lambda.step\": 0.01, \"plot.opts\": {\"xlab\": \"PC1\", \"ylab\": \"PC2\"}, \"topic.order\": [1, 7, 8, 4, 2, 9, 5, 10, 3, 6]};\n",
       "\n",
       "function LDAvis_load_lib(url, callback){\n",
       "  var s = document.createElement('script');\n",
       "  s.src = url;\n",
       "  s.async = true;\n",
       "  s.onreadystatechange = s.onload = callback;\n",
       "  s.onerror = function(){console.warn(\"failed to load library \" + url);};\n",
       "  document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
       "}\n",
       "\n",
       "if(typeof(LDAvis) !== \"undefined\"){\n",
       "   // already loaded: just create the visualization\n",
       "   !function(LDAvis){\n",
       "       new LDAvis(\"#\" + \"ldavis_el101624397227855841257897949\", ldavis_el101624397227855841257897949_data);\n",
       "   }(LDAvis);\n",
       "}else if(typeof define === \"function\" && define.amd){\n",
       "   // require.js is available: use it to load d3/LDAvis\n",
       "   require.config({paths: {d3: \"https://d3js.org/d3.v5\"}});\n",
       "   require([\"d3\"], function(d3){\n",
       "      window.d3 = d3;\n",
       "      LDAvis_load_lib(\"https://cdn.jsdelivr.net/gh/bmabey/pyLDAvis@3.3.1/pyLDAvis/js/ldavis.v3.0.0.js\", function(){\n",
       "        new LDAvis(\"#\" + \"ldavis_el101624397227855841257897949\", ldavis_el101624397227855841257897949_data);\n",
       "      });\n",
       "    });\n",
       "}else{\n",
       "    // require.js not available: dynamically load d3 & LDAvis\n",
       "    LDAvis_load_lib(\"https://d3js.org/d3.v5.js\", function(){\n",
       "         LDAvis_load_lib(\"https://cdn.jsdelivr.net/gh/bmabey/pyLDAvis@3.3.1/pyLDAvis/js/ldavis.v3.0.0.js\", function(){\n",
       "                 new LDAvis(\"#\" + \"ldavis_el101624397227855841257897949\", ldavis_el101624397227855841257897949_data);\n",
       "            })\n",
       "         });\n",
       "}\n",
       "</script>"
      ],
      "text/plain": [
       "PreparedData(topic_coordinates=              x         y  topics  cluster       Freq\n",
       "topic                                                \n",
       "0      0.093070  0.225522       1        1  16.439280\n",
       "6      0.096313 -0.153469       2        1  15.931765\n",
       "7     -0.063686 -0.051849       3        1  13.577744\n",
       "3     -0.339014  0.347531       4        1  11.733711\n",
       "1      0.139628 -0.064444       5        1   9.887249\n",
       "8      0.148653 -0.002276       6        1   8.081218\n",
       "4      0.083999  0.014905       7        1   7.767962\n",
       "9     -0.295354 -0.253070       8        1   7.496050\n",
       "2      0.052956 -0.030834       9        1   6.243855\n",
       "5      0.083434 -0.032017      10        1   2.841164, topic_info=                           Term         Freq        Total Category  logprob  \\\n",
       "1520               gene_editing  6542.000000  6542.000000  Default  30.0000   \n",
       "239                        cell  6070.000000  6070.000000  Default  29.0000   \n",
       "35                      therapy  6035.000000  6035.000000  Default  28.0000   \n",
       "156                 therapeutic  6638.000000  6638.000000  Default  27.0000   \n",
       "6188                       cftr  2830.000000  2830.000000  Default  26.0000   \n",
       "...                         ...          ...          ...      ...      ...   \n",
       "7357  name_science_magazine_top     4.417866    11.916000  Topic10  -6.5948   \n",
       "7359                   year_row     4.417866    11.916000  Topic10  -6.5948   \n",
       "2454                   globally     4.020259    11.499831  Topic10  -6.6891   \n",
       "1632                     invest     3.816264    11.295887  Topic10  -6.7412   \n",
       "1624                         as     3.597589    11.077172  Topic10  -6.8002   \n",
       "\n",
       "      loglift  \n",
       "1520  30.0000  \n",
       "239   29.0000  \n",
       "35    28.0000  \n",
       "156   27.0000  \n",
       "6188  26.0000  \n",
       "...       ...  \n",
       "7357   2.5687  \n",
       "7359   2.5687  \n",
       "2454   2.5100  \n",
       "1632   2.4758  \n",
       "1624   2.4363  \n",
       "\n",
       "[352 rows x 6 columns], token_table=      Topic      Freq     Term\n",
       "term                          \n",
       "1127      1  0.816574  ability\n",
       "1127      2  0.024745  ability\n",
       "1127      3  0.024745  ability\n",
       "1127      5  0.024745  ability\n",
       "1127      6  0.024745  ability\n",
       "...     ...       ...      ...\n",
       "2162      5  0.054968    young\n",
       "2162      6  0.054968    young\n",
       "2162      7  0.054968    young\n",
       "2162      9  0.054968    young\n",
       "2162     10  0.604646    young\n",
       "\n",
       "[2284 rows x 3 columns], R=30, lambda_step=0.01, plot_opts={'xlab': 'PC1', 'ylab': 'PC2'}, topic_order=[1, 7, 8, 4, 2, 9, 5, 10, 3, 6])"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pyLDAvis.enable_notebook()\n",
    "vis = pyLDAvis.gensim_models.prepare(lda_model, corpus, id2word, mds=\"mmds\", R=30)\n",
    "vis"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
